Citrus Sinensis ID: 040656
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 332 | 2.2.26 [Sep-21-2011] | |||||||
| Q08466 | 403 | Casein kinase II subunit | yes | no | 0.828 | 0.682 | 0.824 | 1e-131 | |
| Q08467 | 409 | Casein kinase II subunit | no | no | 0.828 | 0.672 | 0.821 | 1e-131 | |
| P28523 | 332 | Casein kinase II subunit | N/A | no | 0.828 | 0.828 | 0.824 | 1e-129 | |
| O64816 | 432 | Casein kinase II subunit | no | no | 0.825 | 0.634 | 0.794 | 1e-126 | |
| O64817 | 333 | Probable casein kinase II | no | no | 0.813 | 0.810 | 0.797 | 1e-124 | |
| P40231 | 332 | Casein kinase II subunit | yes | no | 0.825 | 0.825 | 0.653 | 1e-110 | |
| P28020 | 392 | Casein kinase II subunit | N/A | no | 0.810 | 0.686 | 0.706 | 1e-110 | |
| O76484 | 353 | Casein kinase II subunit | N/A | no | 0.810 | 0.762 | 0.709 | 1e-109 | |
| Q60737 | 391 | Casein kinase II subunit | yes | no | 0.810 | 0.687 | 0.702 | 1e-109 | |
| P19139 | 391 | Casein kinase II subunit | yes | no | 0.810 | 0.687 | 0.702 | 1e-109 |
| >sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3 | Back alignment and function desciption |
|---|
Score = 468 bits (1203), Expect = e-131, Method: Compositional matrix adjust.
Identities = 249/302 (82%), Positives = 262/302 (86%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY DVNV RP+DYWDYESL VQWG+Q+DYEVVRKVGRGKYSEVFEGIN+ NNEKC
Sbjct: 71 MSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKC 130
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 131 IIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLY 190
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALD+CHSQGIMHRDVK
Sbjct: 191 PTLTDYDIRYYIYELLK---------------------------ALDFCHSQGIMHRDVK 223
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 224 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 283
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDNQDQLVKIA+VLGTDELNAYL+KY LELD QLEALVGR
Sbjct: 284 GCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDTQLEALVGRHSR 343
Query: 301 WP 302
P
Sbjct: 344 KP 345
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 466 bits (1200), Expect = e-131, Method: Compositional matrix adjust.
Identities = 248/302 (82%), Positives = 262/302 (86%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY +VNV RP+DYWDYESL VQWG+Q+DYEVVRKVGRGKYSEVFEGINV + EKC
Sbjct: 77 MSKARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRGKYSEVFEGINVNSKEKC 136
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 137 IIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLY 196
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALD+CHSQGIMHRDVK
Sbjct: 197 PTLTDYDIRYYIYELLK---------------------------ALDFCHSQGIMHRDVK 229
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 230 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 289
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDNQDQLVKIA+VLGTDELNAYL+KY LELDPQLEALVGR
Sbjct: 290 GCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDPQLEALVGRHSR 349
Query: 301 WP 302
P
Sbjct: 350 KP 351
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 249/302 (82%), Positives = 262/302 (86%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVYADVNV RP++YWDYE+LTVQWG+Q+DYEVVRKVGRGKYSEVFEGINV NNEKC
Sbjct: 1 MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE+VN+TDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTD LN YL+KY +ELDPQLEALVGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRHSR 273
Query: 301 WP 302
P
Sbjct: 274 KP 275
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 239/301 (79%), Positives = 258/301 (85%), Gaps = 27/301 (8%)
Query: 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI 61
S+ARVYADVNV RP+DYWDYESL VQWG Q+DYEVVRKVGRGKYSEVFEGI+ T+NEKC+
Sbjct: 100 SKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCV 159
Query: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP 121
IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ SKTPSLIFEHVN+ DFKVLYP
Sbjct: 160 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYP 219
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
TL+ ++RYYI+ELLK ALD+CHS+GIMHRDVKP
Sbjct: 220 TLSDYDVRYYIFELLK---------------------------ALDFCHSRGIMHRDVKP 252
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
HNVMIDHEQ+KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLG
Sbjct: 253 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 312
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVW 301
CMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KY +ELDP L +LVGR
Sbjct: 313 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRK 372
Query: 302 P 302
P
Sbjct: 373 P 373
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 237/297 (79%), Positives = 254/297 (85%), Gaps = 27/297 (9%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY DVNV RP++YWDYESL VQWG Q+DYEVVRKVGRGKYSEVFEG NV NE+C
Sbjct: 1 MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
+IKILKPVKKKKIKREIKILQNLCGGPNIVKL DIVRD+HSKTPSL+FE VNS DFKVLY
Sbjct: 61 VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALD+CHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDFCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDH+ +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHQLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGT+EL+ YL+KY L+LDPQLEALVGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTNELDHYLNKYQLDLDPQLEALVGR 270
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P40231|CSK2A_SCHPO Casein kinase II subunit alpha OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cka1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 398 bits (1023), Expect = e-110, Method: Compositional matrix adjust.
Identities = 198/303 (65%), Positives = 234/303 (77%), Gaps = 29/303 (9%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
+S +RVYA VN PR+YWDYE++ +G Q++YE++RKVGRGKYSEVFEG+NV NN KC
Sbjct: 10 VSVSRVYAHVNEEMPREYWDYENMQEVFGYQDNYEIIRKVGRGKYSEVFEGLNVLNNSKC 69
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIK+LKPVK KKIKREIKILQNL GGPNI+ LLDIVRD SKTPSLIFE V++ DF+ LY
Sbjct: 70 IIKVLKPVKYKKIKREIKILQNLAGGPNIISLLDIVRDPESKTPSLIFEFVDNIDFRTLY 129
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTL+ +IRYY YELLK ALD+CHS+GIMHRDVK
Sbjct: 130 PTLSDYDIRYYSYELLK---------------------------ALDFCHSRGIMHRDVK 162
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDH+++KLRLIDWGLAEFYH G EYNVRVASRYFKGPELLVD ++YDYSLD+WS
Sbjct: 163 PHNVMIDHKKRKLRLIDWGLAEFYHAGMEYNVRVASRYFKGPELLVDFREYDYSLDIWSF 222
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR--K 298
G MFA +IF+K+ FF G DN DQLVKIA+VLGTDEL AY+ KY + LD Q + ++G+ K
Sbjct: 223 GVMFAALIFKKDTFFRGRDNYDQLVKIAKVLGTDELFAYVQKYQIVLDRQYDNILGQYPK 282
Query: 299 RVW 301
R W
Sbjct: 283 RDW 285
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Plays a role in the translation of cell polarity into polarized growth. The alpha and alpha' chains contain the catalytic site. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28020|CSK21_XENLA Casein kinase II subunit alpha OS=Xenopus laevis GN=csnk2a1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 397 bits (1020), Expect = e-110, Method: Compositional matrix adjust.
Identities = 209/296 (70%), Positives = 242/296 (81%), Gaps = 27/296 (9%)
Query: 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI 61
SRARVY DVN HRPRDYWDYES V+WG+Q+DY++VRK+GRGKYSEVFE IN+TNNEK +
Sbjct: 7 SRARVYTDVNTHRPRDYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 66
Query: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP 121
+KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVN+TDFK LY
Sbjct: 67 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 126
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
TLT +IR+Y+YE+LK ALDYCHS GIMHRDVKP
Sbjct: 127 TLTDYDIRFYMYEILK---------------------------ALDYCHSMGIMHRDVKP 159
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
HNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLG
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 219
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
CM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DKY++ELDP+ ++GR
Sbjct: 220 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O76484|CSK2A_SPOFR Casein kinase II subunit alpha OS=Spodoptera frugiperda PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1016), Expect = e-109, Method: Compositional matrix adjust.
Identities = 210/296 (70%), Positives = 240/296 (81%), Gaps = 27/296 (9%)
Query: 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI 61
SRARVYADVN RPR+YWDYES V WG+QEDY++VRK+GRGKYSEVFE IN+TNNEKC+
Sbjct: 7 SRARVYADVNSQRPREYWDYESYVVDWGNQEDYQLVRKLGRGKYSEVFEAINITNNEKCV 66
Query: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP 121
+KILKPVKKKKIKREIKIL+NL GG NI+ L +V+D S+TP+LIFEHVN+TDFK LY
Sbjct: 67 VKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQLYQ 126
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
TL+ +IRYY+YELLK ALDYCHS GIMHRDVKP
Sbjct: 127 TLSDYDIRYYLYELLK---------------------------ALDYCHSMGIMHRDVKP 159
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
HNVMIDH+ +KLRLIDWGLAEFYHPG++YNVRVASRYFKGPELLVD Q YDYSLDMWSLG
Sbjct: 160 HNVMIDHDHRKLRLIDWGLAEFYHPGQDYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 219
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
CM A MIFRKEPFF+GHDN DQLV+IA+VLGT+EL YLDKYH+ELDP+ ++GR
Sbjct: 220 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFNDILGR 275
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May participate in Wnt signaling. Spodoptera frugiperda (taxid: 7108) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 208/296 (70%), Positives = 242/296 (81%), Gaps = 27/296 (9%)
Query: 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI 61
SRARVY DVN HRPR+YWDYES V+WG+Q+DY++VRK+GRGKYSEVFE IN+TNNEK +
Sbjct: 7 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 66
Query: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP 121
+KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVN+TDFK LY
Sbjct: 67 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 126
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
TLT +IR+Y+YE+LK ALDYCHS GIMHRDVKP
Sbjct: 127 TLTDYDIRFYMYEILK---------------------------ALDYCHSMGIMHRDVKP 159
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
HNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLG
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 219
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
CM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DKY++ELDP+ ++GR
Sbjct: 220 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 208/296 (70%), Positives = 242/296 (81%), Gaps = 27/296 (9%)
Query: 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI 61
SRARVY DVN HRPR+YWDYES V+WG+Q+DY++VRK+GRGKYSEVFE IN+TNNEK +
Sbjct: 7 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 66
Query: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP 121
+KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVN+TDFK LY
Sbjct: 67 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 126
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
TLT +IR+Y+YE+LK ALDYCHS GIMHRDVKP
Sbjct: 127 TLTDYDIRFYMYEILK---------------------------ALDYCHSMGIMHRDVKP 159
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
HNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLG
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 219
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
CM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DKY++ELDP+ ++GR
Sbjct: 220 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 332 | ||||||
| 391605 | 333 | casein kinase II catalytic subunit [Arab | 0.828 | 0.825 | 0.817 | 1e-139 | |
| 225458802 | 333 | PREDICTED: casein kinase II subunit alph | 0.849 | 0.846 | 0.818 | 1e-132 | |
| 388510076 | 333 | unknown [Medicago truncatula] | 0.828 | 0.825 | 0.821 | 1e-132 | |
| 357476359 | 388 | Casein kinase 2 alpha subunit [Medicago | 0.828 | 0.708 | 0.827 | 1e-131 | |
| 449448246 | 397 | PREDICTED: casein kinase II subunit alph | 0.828 | 0.692 | 0.837 | 1e-130 | |
| 21698930 | 333 | casein kinase 2 catalytic subunit [Nicot | 0.828 | 0.825 | 0.837 | 1e-130 | |
| 225438950 | 405 | PREDICTED: casein kinase II subunit alph | 0.828 | 0.679 | 0.834 | 1e-130 | |
| 224074233 | 333 | predicted protein [Populus trichocarpa] | 0.828 | 0.825 | 0.827 | 1e-130 | |
| 449450269 | 333 | PREDICTED: casein kinase II subunit alph | 0.828 | 0.825 | 0.837 | 1e-130 | |
| 44804336 | 333 | protein kinase CK2 alpha subunit [Nicoti | 0.828 | 0.825 | 0.837 | 1e-130 |
| >gi|391605|dbj|BAA01091.1| casein kinase II catalytic subunit [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1291), Expect = e-139, Method: Compositional matrix adjust.
Identities = 247/302 (81%), Positives = 261/302 (86%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY DVNV RP+DYWDYESL VQWG+Q+DYEVVRKVGRGKYSEVFEGIN+ NNEKC
Sbjct: 1 MSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKK+I+REIKILQNLCGGPNIVKLLD+VRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 61 IIKILKPVKKKEIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALD+CHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDFCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDH +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHGLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDNQDQLVKIA+VLGTDELNAYL+KY LELD QLEALVGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDTQLEALVGRHSR 273
Query: 301 WP 302
P
Sbjct: 274 KP 275
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458802|ref|XP_002285210.1| PREDICTED: casein kinase II subunit alpha-2 [Vitis vinifera] gi|302142218|emb|CBI19421.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1228), Expect = e-132, Method: Compositional matrix adjust.
Identities = 257/314 (81%), Positives = 270/314 (85%), Gaps = 32/314 (10%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS ARVYADVN+HRPRDYWDYESLTVQWGDQ+DYEVVRKVGRGKYSEVFEGINVTNNE+C
Sbjct: 1 MSSARVYADVNIHRPRDYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVTNNERC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
++KILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 61 VVKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KY LELDPQL+ALVGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYRLELDPQLDALVGRHSR 273
Query: 301 WPI-----PNNKKL 309
P P+N+ L
Sbjct: 274 KPWSRFINPDNQHL 287
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388510076|gb|AFK43104.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1224), Expect = e-132, Method: Compositional matrix adjust.
Identities = 248/302 (82%), Positives = 263/302 (87%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY DVNV RP++YWDYESLTVQWGDQ+DYEVVRKVGRGKYSEVFEGINV ++E+C
Sbjct: 1 MSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSSERC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
+IKILKPVKKKKIKRE+KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 61 VIKILKPVKKKKIKREMKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRY IYELLK ALDYCHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYCIYELLK---------------------------ALDYCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KYHLELDPQL+ALVGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 273
Query: 301 WP 302
P
Sbjct: 274 KP 275
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357476359|ref|XP_003608465.1| Casein kinase 2 alpha subunit [Medicago truncatula] gi|355509520|gb|AES90662.1| Casein kinase 2 alpha subunit [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1215), Expect = e-131, Method: Compositional matrix adjust.
Identities = 250/302 (82%), Positives = 264/302 (87%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY DVNV RP++YWDYESLTVQWGDQ+DYEVVRKVGRGKYSEVFEGINV ++E+C
Sbjct: 56 MSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSSERC 115
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
+IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 116 VIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 175
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 176 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 208
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 209 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 268
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KYHLELDPQL+ALVGR
Sbjct: 269 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 328
Query: 301 WP 302
P
Sbjct: 329 KP 330
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448246|ref|XP_004141877.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus] gi|449510998|ref|XP_004163833.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1214), Expect = e-130, Method: Compositional matrix adjust.
Identities = 253/302 (83%), Positives = 263/302 (87%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVYADVNV RP+DYWDYESL VQWGDQ+DYEVVRKVGRGKYSEVFEGINV NNE+C
Sbjct: 65 MSKARVYADVNVLRPKDYWDYESLAVQWGDQDDYEVVRKVGRGKYSEVFEGINVNNNERC 124
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKIKREIKILQNLCGGPNIVKL DIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 125 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLFDIVRDQHSKTPSLIFEYVNSTDFKVLY 184
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 185 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 217
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 218 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 277
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KYHLELDPQL+ALVGR
Sbjct: 278 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 337
Query: 301 WP 302
P
Sbjct: 338 KP 339
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|21698930|dbj|BAC02726.1| casein kinase 2 catalytic subunit [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1213), Expect = e-130, Method: Compositional matrix adjust.
Identities = 253/302 (83%), Positives = 263/302 (87%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY D+NV RPR+YWDYESLTVQWGDQ+DYEVVRKVGRGKYSEVFEGINV +NEKC
Sbjct: 1 MSKARVYTDINVLRPREYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNEKC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDNQDQLVKIA+VLGTDELNAYL KY LELDPQLEA+VGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLHKYRLELDPQLEAMVGRHSR 273
Query: 301 WP 302
P
Sbjct: 274 KP 275
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438950|ref|XP_002284196.1| PREDICTED: casein kinase II subunit alpha-2 isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 252/302 (83%), Positives = 264/302 (87%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVYADVNV RP+DYWDYESLTVQWGDQ+DYEVVRKVGRGKYSEVFEGINV +NE+C
Sbjct: 73 MSKARVYADVNVLRPKDYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 132
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 133 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 192
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 193 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 225
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 226 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 285
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KY LELDPQL+ALVGR
Sbjct: 286 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYRLELDPQLDALVGRHSR 345
Query: 301 WP 302
P
Sbjct: 346 KP 347
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074233|ref|XP_002304312.1| predicted protein [Populus trichocarpa] gi|222841744|gb|EEE79291.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 250/302 (82%), Positives = 264/302 (87%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY DVNV RP++YWDYESLTVQWGDQ+DYEVVRKVGRGKYSEVFEGINV +NE+C
Sbjct: 1 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 61 VIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KYHLELDPQL+ALVGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 273
Query: 301 WP 302
P
Sbjct: 274 KP 275
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450269|ref|XP_004142886.1| PREDICTED: casein kinase II subunit alpha-2-like [Cucumis sativus] gi|449523638|ref|XP_004168830.1| PREDICTED: casein kinase II subunit alpha-2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1212), Expect = e-130, Method: Compositional matrix adjust.
Identities = 253/302 (83%), Positives = 262/302 (86%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MSR+RVYADVNVHRPRDYWDYESL VQW Q+DYEVVRKVGRGKYSEVFEGIN+TNNEKC
Sbjct: 1 MSRSRVYADVNVHRPRDYWDYESLAVQWSGQDDYEVVRKVGRGKYSEVFEGINITNNEKC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE+VNSTDFK+LY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKILY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+KY L LDPQLEALVGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYQLVLDPQLEALVGRHSR 273
Query: 301 WP 302
P
Sbjct: 274 KP 275
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|44804336|emb|CAD26882.1| protein kinase CK2 alpha subunit [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 253/302 (83%), Positives = 263/302 (87%), Gaps = 27/302 (8%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
MS+ARVY D+NV RPR+YWDYESLTVQWGDQ+DYEVVRKVGRGKYSEVFEGINV +NEKC
Sbjct: 1 MSKARVYTDINVLRPREYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNEKC 60
Query: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY 120
IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE+VNSTDFKVLY
Sbjct: 61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
PTLT +IRYYIYELLK ALDYCHSQGIMHRDVK
Sbjct: 121 PTLTDYDIRYYIYELLK---------------------------ALDYCHSQGIMHRDVK 153
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
PHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL
Sbjct: 154 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 213
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV 300
GCMFAGMIFRKEPFFYGHDNQDQLVKIA+VLGTDELNAYL KY LELDPQLEA+VGR
Sbjct: 214 GCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLHKYQLELDPQLEAMVGRHSR 273
Query: 301 WP 302
P
Sbjct: 274 KP 275
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 332 | ||||||
| UNIPROTKB|Q9AR27 | 333 | OSCKA2 "Casein kinase II alpha | 0.418 | 0.417 | 0.900 | 6.5e-123 | |
| TAIR|locus:2045339 | 432 | AT2G23070 [Arabidopsis thalian | 0.418 | 0.321 | 0.872 | 1.6e-117 | |
| TAIR|locus:2045349 | 333 | CKA3 "casein kinase II, alpha | 0.406 | 0.405 | 0.903 | 1.4e-116 | |
| UNIPROTKB|P21868 | 391 | CSNK2A1 "Casein kinase II subu | 0.418 | 0.355 | 0.780 | 9.4e-105 | |
| UNIPROTKB|P68399 | 391 | CSNK2A1 "Casein kinase II subu | 0.418 | 0.355 | 0.780 | 9.4e-105 | |
| UNIPROTKB|E2RHZ1 | 391 | CSNK2A1 "Uncharacterized prote | 0.418 | 0.355 | 0.780 | 9.4e-105 | |
| UNIPROTKB|E7EU96 | 385 | CSNK2A1 "Casein kinase II subu | 0.418 | 0.361 | 0.780 | 9.4e-105 | |
| UNIPROTKB|P68400 | 391 | CSNK2A1 "Casein kinase II subu | 0.418 | 0.355 | 0.780 | 9.4e-105 | |
| UNIPROTKB|F2Z5I5 | 391 | CSNK2A1 "Uncharacterized prote | 0.418 | 0.355 | 0.780 | 9.4e-105 | |
| MGI|MGI:88543 | 391 | Csnk2a1 "casein kinase 2, alph | 0.418 | 0.355 | 0.780 | 9.4e-105 |
| UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)] | Back alignment and assigned GO terms |
|---|
Score = 696 (250.1 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 127/141 (90%), Positives = 135/141 (95%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHSQGIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGP
Sbjct: 136 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGT+ LNAYL+K
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTEALNAYLNK 255
Query: 283 YHLELDPQLEALVGR--KRVW 301
YH+ELDPQLEALVGR ++ W
Sbjct: 256 YHIELDPQLEALVGRHSRKPW 276
|
|
| TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 1.6e-117, Sum P(2) = 1.6e-117
Identities = 123/141 (87%), Positives = 134/141 (95%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALD+CHS+GIMHRDVKPHNVMIDHEQ+KLRLIDWGLAEFYHPGKEYNVRVASRYFKGP
Sbjct: 234 LKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 293
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGTDELNAYL+K
Sbjct: 294 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 353
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y +ELDP L +LVGR ++ W
Sbjct: 354 YRIELDPNLTSLVGRHSRKPW 374
|
|
| TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 1.4e-116, Sum P(2) = 1.4e-116
Identities = 122/135 (90%), Positives = 131/135 (97%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALD+CHSQGIMHRDVKPHNVMIDH+ +KLRLIDWGLAEFYHPGKEYNVRVASRYFKGP
Sbjct: 136 LKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIA+VLGT+EL+ YL+K
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTNELDHYLNK 255
Query: 283 YHLELDPQLEALVGR 297
Y L+LDPQLEALVGR
Sbjct: 256 YQLDLDPQLEALVGR 270
|
|
| UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 110/141 (78%), Positives = 126/141 (89%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHS GIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGP
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 200
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DK
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y++ELDP+ ++GR ++ W
Sbjct: 261 YNIELDPRFNDILGRHSRKRW 281
|
|
| UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 110/141 (78%), Positives = 126/141 (89%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHS GIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGP
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 200
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DK
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y++ELDP+ ++GR ++ W
Sbjct: 261 YNIELDPRFNDILGRHSRKRW 281
|
|
| UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 110/141 (78%), Positives = 126/141 (89%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHS GIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGP
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 200
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DK
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y++ELDP+ ++GR ++ W
Sbjct: 261 YNIELDPRFNDILGRHSRKRW 281
|
|
| UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 110/141 (78%), Positives = 126/141 (89%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHS GIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGP
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 200
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DK
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y++ELDP+ ++GR ++ W
Sbjct: 261 YNIELDPRFNDILGRHSRKRW 281
|
|
| UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 110/141 (78%), Positives = 126/141 (89%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHS GIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGP
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 200
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DK
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y++ELDP+ ++GR ++ W
Sbjct: 261 YNIELDPRFNDILGRHSRKRW 281
|
|
| UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 110/141 (78%), Positives = 126/141 (89%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHS GIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGP
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 200
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DK
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y++ELDP+ ++GR ++ W
Sbjct: 261 YNIELDPRFNDILGRHSRKRW 281
|
|
| MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 9.4e-105, Sum P(2) = 9.4e-105
Identities = 110/141 (78%), Positives = 126/141 (89%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 222
L+ALDYCHS GIMHRDVKPHNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGP
Sbjct: 141 LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 200
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDK 282
ELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DK
Sbjct: 201 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260
Query: 283 YHLELDPQLEALVGR--KRVW 301
Y++ELDP+ ++GR ++ W
Sbjct: 261 YNIELDPRFNDILGRHSRKRW 281
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P19454 | CSK22_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5762 | 0.8042 | 0.7876 | yes | no |
| O64817 | CSK23_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7979 | 0.8132 | 0.8108 | no | no |
| P21868 | CSK21_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7027 | 0.8102 | 0.6879 | yes | no |
| Q8TG13 | CSK2A_NEUCR | 2, ., 7, ., 1, 1, ., 1 | 0.7040 | 0.8042 | 0.7946 | N/A | no |
| P68399 | CSK21_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7027 | 0.8102 | 0.6879 | yes | no |
| P28523 | CSK2A_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.8245 | 0.8283 | 0.8283 | N/A | no |
| P18334 | CSK2A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6621 | 0.8102 | 0.7472 | yes | no |
| P08181 | CSK2A_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.6925 | 0.8102 | 0.8005 | yes | no |
| P19139 | CSK21_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7027 | 0.8102 | 0.6879 | yes | no |
| O76484 | CSK2A_SPOFR | 2, ., 7, ., 1, 1, ., 1 | 0.7094 | 0.8102 | 0.7620 | N/A | no |
| P28547 | CSK2A_THEPA | 2, ., 7, ., 1, 1, ., 1 | 0.6354 | 0.8132 | 0.7758 | yes | no |
| P68400 | CSK21_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7027 | 0.8102 | 0.6879 | yes | no |
| P40231 | CSK2A_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6534 | 0.8253 | 0.8253 | yes | no |
| Q02720 | CSK2A_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.6423 | 0.8222 | 0.8100 | yes | no |
| P33674 | CSK21_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.6993 | 0.8102 | 0.6879 | yes | no |
| P28020 | CSK21_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7060 | 0.8102 | 0.6862 | N/A | no |
| Q60737 | CSK21_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7027 | 0.8102 | 0.6879 | yes | no |
| Q08466 | CSK22_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8245 | 0.8283 | 0.6823 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 332 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-54 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-50 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-43 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-41 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-40 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-39 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-35 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-33 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-32 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-31 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-31 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-31 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-31 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-31 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-30 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-30 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-30 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-29 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-28 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-27 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-27 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-25 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-25 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-25 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-24 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-24 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-24 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-24 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-24 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 7e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 0.003 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.003 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.003 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-56
Identities = 70/250 (28%), Positives = 115/250 (46%), Gaps = 41/250 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-----REIKILQNLCGGPN 88
YE++RK+G G + V++ + + +KILK +K K REI+IL+ L PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFK---VLYPTLTANEIRYYIYELLKHAMPRKVI 145
IV+L+D D L+ E+ D L+ +E + ++L
Sbjct: 60 IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQIL--------- 108
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE-FY 204
+ L+Y HS GI+HRD+KP N+++D +++ D+GLA+
Sbjct: 109 ------------------RGLEYLHSNGIIHRDLKPENILLDENGV-VKIADFGLAKKLL 149
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
V + ++ PE+L+ Y +D+WSLG + ++ K P F G + DQL
Sbjct: 150 KSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP-FSGENILDQL 208
Query: 265 VKIARVLGTD 274
I R+LG
Sbjct: 209 QLIRRILGPP 218
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 5e-54
Identities = 77/271 (28%), Positives = 132/271 (48%), Gaps = 45/271 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNI 89
YE++ K+G G + +V+ + + IK++K K KK I REIKIL+ L PNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTD-FKVL--YPTLTANEIRYYIYELLKHAMPRKVII 146
V+L D+ D+ L+ E+ D F +L L+ +E R+Y+ ++L
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL---------- 107
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
AL+Y HS+GI+HRD+KP N+++D + ++L D+GLA P
Sbjct: 108 -----------------SALEYLHSKGIVHRDLKPENILLDEDGH-VKLADFGLARQLDP 149
Query: 207 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266
G++ V + + PE+L+ + Y ++D+WSLG + ++ K P F G D +L K
Sbjct: 150 GEKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGK-PPFPGDDQLLELFK 207
Query: 267 IARVLGTDELNAYLDKYHLELDPQLEALVGR 297
+ ++ P+ + L+ +
Sbjct: 208 KIG-----KPKPPFPPPEWDISPEAKDLIRK 233
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-50
Identities = 81/250 (32%), Positives = 129/250 (51%), Gaps = 43/250 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-IK----REIKILQNLCGGPN 88
YE + K+G G Y V++ + E +K ++ +++ I REI +L+ L PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKHAMPRKV 144
IVKLLD++ + L+FE+ + D K L+ N I+ +Y+LL
Sbjct: 60 IVKLLDVIH--TERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLL-------- 108
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EF 203
+ L YCHS I+HRD+KP N++I+ + L+L D+GLA F
Sbjct: 109 -------------------RGLAYCHSHRILHRDLKPQNILINRDGV-LKLADFGLARAF 148
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
P + Y V + +++ PE+L+ + Y ++D+WS+GC+FA MI +P F G DQ
Sbjct: 149 GIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQ 207
Query: 264 LVKIARVLGT 273
L KI ++LGT
Sbjct: 208 LFKIFQILGT 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-44
Identities = 86/250 (34%), Positives = 131/250 (52%), Gaps = 43/250 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 88
Y+ + K+G G Y V++ + E IK +K K REIK+L+ L PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKHAMPRKV 144
I+KLLD+ R + L+FE +++ +K++ L + I+ Y+Y+LL
Sbjct: 60 IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLL-------- 108
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EF 203
Q L +CHS GI+HRD+KP N++I+ E L+L D+GLA F
Sbjct: 109 -------------------QGLAFCHSHGILHRDLKPENLLINTEGV-LKLADFGLARSF 148
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
P + Y V +R+++ PELL+ + Y +D+WS+GC+FA ++ R+ P F G DQ
Sbjct: 149 GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQ 207
Query: 264 LVKIARVLGT 273
L KI R LGT
Sbjct: 208 LFKIFRTLGT 217
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 76/251 (30%), Positives = 125/251 (49%), Gaps = 42/251 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 88
YE + ++G G Y +V++ N E +K ++ +K+ REIK+LQ L PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKHAMPRKV 144
IV+L +IV + + ++FE++ D L T ++I+ Y+ +LL+
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLE------- 111
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
L Y HS GI+HRD+K N++I+++ L+L D+GLA Y
Sbjct: 112 --------------------GLQYLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPY 150
Query: 205 HP--GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+Y RV + +++ PELL+ Y +DMWS+GC+ A + F +P F G +
Sbjct: 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL-FLGKPIFQGSTELE 209
Query: 263 QLVKIARVLGT 273
QL KI + G+
Sbjct: 210 QLEKIFELCGS 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 44/252 (17%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKKKKIK----REIKILQNLCGGP 87
Y+++ ++G G + VF+ + E +K + + I REIK LQ C P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKHAMPRK 143
+VKLLD+ H L+ E++ S +VL P L +++ Y+ LLK
Sbjct: 60 YVVKLLDVFP--HGSGFVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLK------ 110
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
+ Y H+ GIMHRD+KP N++I + L++ D+GLA
Sbjct: 111 ---------------------GVAYMHANGIMHRDLKPANLLISADGV-LKIADFGLARL 148
Query: 204 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
+ + Y+ +VA+R+++ PELL + YD +D+W++GC+FA ++ P F G ++
Sbjct: 149 FSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL-NGSPLFPGENDI 207
Query: 262 DQLVKIARVLGT 273
+QL + R LGT
Sbjct: 208 EQLAIVFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 83/261 (31%), Positives = 127/261 (48%), Gaps = 58/261 (22%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 88
YE+++ +G G Y V ++ K IK I K+I REIK+L++L N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVN------STDF-KVLY--PTLTANEIRYYIYELLKHA 139
I+ LLDI+R + F V TD KV+ LT + I+Y++Y++L+
Sbjct: 61 IIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR-- 114
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
L Y HS ++HRD+KP N++++ L++ D+G
Sbjct: 115 -------------------------GLKYLHSANVIHRDLKPSNILVNSNCD-LKICDFG 148
Query: 200 LA-----EFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
LA + G EY V +R+++ PELL+ Y ++D+WS+GC+FA ++ RK
Sbjct: 149 LARGVDPDEDEKGFLTEY---VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK- 204
Query: 253 PFFYGHDNQDQLVKIARVLGT 273
P F G D DQL I VLGT
Sbjct: 205 PLFPGRDYIDQLNLIVEVLGT 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 82/252 (32%), Positives = 130/252 (51%), Gaps = 44/252 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK--------REIKILQNLCG 85
YE +K+G G Y+ V++ + IK +K ++K+ K REIK+LQ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
PNI+ LLD+ H +L+FE + TD + + I+ + ++
Sbjct: 61 HPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKV--------IK-----------DKSIV 98
Query: 146 IMPGEGLMENQDISVW---DLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+ P DI + L+ L+Y HS I+HRD+KP+N++I L+L D+GLA
Sbjct: 99 LTPA-------DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA-SDGVLKLADFGLAR 150
Query: 203 FY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
+ P ++ +V +R+++ PELL + Y +DMWS+GC+FA ++ R PF G +
Sbjct: 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDI 209
Query: 262 DQLVKIARVLGT 273
DQL KI LGT
Sbjct: 210 DQLGKIFEALGT 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-40
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 39/217 (17%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 95
+G G + V+ + +K IKI+K + REI+IL+ L PNIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 96 VRDQHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEG 151
D+ L+ E+ K L L+ +EI + ++L+
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILE-------------- 103
Query: 152 LMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY-HPGKEY 210
L+Y HS GI+HRD+KP N+++D + K++L D+GL++
Sbjct: 104 -------------GLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150
Query: 211 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247
V + + PE+L+ Y D+WSLG + +
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-39
Identities = 86/266 (32%), Positives = 122/266 (45%), Gaps = 48/266 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 86
YEV+ VG G Y V + N E IK K KK RE+K+L+ L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RH 59
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPT-LTANEIRYYIYELLKHAMPRK 143
NIV L + R L+FE+V T ++L P L + +R YI++LL
Sbjct: 60 ENIVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLL------- 110
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
QA+ YCHS I+HRD+KP N+++ E L+L D+G A
Sbjct: 111 --------------------QAIAYCHSHNIIHRDIKPENILVS-ESGVLKLCDFGFARA 149
Query: 204 YH--PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
P VA+R+++ PELLV +Y +D+W++GC+ A ++ EP F G +
Sbjct: 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL-DGEPLFPGDSDI 208
Query: 262 DQLVKIARVLGTDELNAYLDKYHLEL 287
DQL I + LG L H EL
Sbjct: 209 DQLYLIQKCLGP------LPPSHQEL 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-35
Identities = 83/259 (32%), Positives = 125/259 (48%), Gaps = 60/259 (23%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIKIL 80
Y+ V K+G G Y V++ + E V KKI+ REI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFK-----VLYPTLTANEIRYYIYEL 135
+ L PNIV+LLD+V ++ L+FE ++ D K L I+ Y+Y+L
Sbjct: 53 KEL-NHPNIVRLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L Q + YCHS ++HRD+KP N++ID + L+L
Sbjct: 109 L---------------------------QGIAYCHSHRVLHRDLKPQNLLID-REGALKL 140
Query: 196 IDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
D+GLA F P + Y V + +++ PE+L+ + Y +D+WS+GC+FA M+ R+ P
Sbjct: 141 ADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PL 199
Query: 255 FYGHDNQDQLVKIARVLGT 273
F G DQL +I R LGT
Sbjct: 200 FPGDSEIDQLFRIFRTLGT 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 58/265 (21%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-----------REIKIL 80
+ YE + K+G G Y +V++ + + L +KK +++ REI +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54
Query: 81 QNLCGGPNIVKLLDIVR-DQHSKTPSL--IFEHVNSTDFKVLYPT--------LTANEIR 129
Q L IV+LLD+ ++ + PSL +FE++ +D K + L A I+
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 130 YYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE 189
++Y+LLK + +CH G+MHRD+KP N+++D +
Sbjct: 114 SFMYQLLK---------------------------GVAHCHKHGVMHRDLKPQNLLVDKQ 146
Query: 190 QQKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248
+ L++ D GL F P K Y + + +++ PE+L+ Y +D+WS+GC+FA M
Sbjct: 147 KGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
Query: 249 FRKEPFFYGHDNQDQLVKIARVLGT 273
RK+P F G QL+ I ++LGT
Sbjct: 207 -RKQPLFPGDSELQQLLHIFKLLGT 230
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 70/252 (27%), Positives = 118/252 (46%), Gaps = 47/252 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK--------REIKILQNLCG 85
Y+V++++G G + V+ N E IK +K KK RE+K L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKHAMP 141
PNIVKL ++ R+ + +FE++ ++++ + + IR IY++L
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQIL----- 109
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
Q L + H G HRD+KP N+++ + +++ D+GLA
Sbjct: 110 ----------------------QGLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLA 146
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
Y V++R+++ PE+L+ Y +D+W+LGC+ A + + P F G
Sbjct: 147 REIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEI 205
Query: 262 DQLVKIARVLGT 273
DQL KI VLGT
Sbjct: 206 DQLYKICSVLGT 217
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 39/231 (16%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK---IKREIKILQNLCGGPNI 89
+E++ K+G+G + EV++ + ++ IK++K K+K I EI+IL+ C PNI
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59
Query: 90 VKLLDIVRDQHSKTPSLIFEHVN----STDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
VK ++ E + K TLT ++I Y ELL
Sbjct: 60 VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELL--------- 108
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
+ L+Y HS GI+HRD+K N+++ + + ++LID+GL+
Sbjct: 109 ------------------KGLEYLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLS 149
Query: 206 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
K N V + Y+ PE++ + YDY D+WSLG + K P+
Sbjct: 150 DTKARNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 82/263 (31%), Positives = 128/263 (48%), Gaps = 65/263 (24%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKI-------------KREIKIL 80
YE+++K+G+G Y V++ I+ E V KKI REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTAN-----EIRYYIYEL 135
Q L PNIVKLL++++ ++ K L+FE++ TD L+ + AN RY +Y+L
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TD---LHAVIRANILEDVHKRYIMYQL 116
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
LK AL Y HS ++HRD+KP N++++ + + ++L
Sbjct: 117 LK---------------------------ALKYIHSGNVIHRDLKPSNILLNSDCR-VKL 148
Query: 196 IDWGLAEFYHPGKEYNVR------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249
D+GLA +E VA+R+++ PE+L+ Y +DMWS+GC+ M+
Sbjct: 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 250 RKEPFFYGHDNQDQLVKIARVLG 272
K P F G +QL KI V+G
Sbjct: 209 GK-PLFPGTSTLNQLEKIIEVIG 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (310), Expect = 2e-32
Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 55/281 (19%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK------IKREIKILQNLCGG 86
Y ++RK+G G + EV+ + + +K+L + K REI+IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY------PTLTANEIRYYIYELLKHAM 140
PNIVKL D Q + L+ E+V+ + L L+ +E + + ++L
Sbjct: 58 PNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS--- 112
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
AL+Y HS+GI+HRD+KP N+++D + + ++LID+GL
Sbjct: 113 ------------------------ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL 148
Query: 201 AEFY-------HPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRK 251
A+ + V + + PE+L+ L S D+WSLG ++
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
Query: 252 EPF--FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQ 290
PF Q +KI L T L + L + EL +
Sbjct: 209 PPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISK 249
|
Length = 384 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 48/253 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--------KKKIKREIKILQNLCG 85
YE + K+G G Y VF+ N +E I LK V+ REI +L+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMP 141
NIV+L D++ T L+FE+ + D K + + ++ ++++L
Sbjct: 58 HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQL------ 108
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
L+ L +CHS ++HRD+KP N++I+ + L+L D+GLA
Sbjct: 109 ---------------------LKGLAFCHSHNVLHRDLKPQNLLINKNGE-LKLADFGLA 146
Query: 202 EFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
+ P + Y+ V + +++ P++L + Y S+DMWS GC+FA + P F G+D
Sbjct: 147 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
Query: 261 QDQLVKIARVLGT 273
DQL +I R+LGT
Sbjct: 207 DDQLKRIFRLLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 70/267 (26%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIKIL 80
YE + ++G G Y V++ ++ + V KK++ REI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52
Query: 81 QNL--CGGPNIVKLLDI---VRDQHSKTPSLIFEHVNS--TDF--KVLYPTLTANEIRYY 131
+ L PNIV+LLD+ R +L+FEHV+ + K P L I+
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 132 IYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191
+ +LL+ +D+ HS I+HRD+KP N+++ + Q
Sbjct: 113 MRQLLR---------------------------GVDFLHSHRIVHRDLKPQNILVTSDGQ 145
Query: 192 KLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAG 246
+++ D+GLA Y + + V + +++ PE+L LQ Y +DMWS+GC+FA
Sbjct: 146 -VKIADFGLARIY----SFEMALTSVVVTLWYRAPEVL--LQSSYATPVDMWSVGCIFAE 198
Query: 247 MIFRKEPFFYGHDNQDQLVKIARVLGT 273
+ FR+ P F G DQL KI V+G
Sbjct: 199 L-FRRRPLFRGTSEADQLDKIFDVIGL 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 78/252 (30%), Positives = 125/252 (49%), Gaps = 46/252 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 87
++ V K+G G Y V++ N E +K ++ V I REI +L+ L P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEI-----RYYIYELLKHAMPR 142
NIVKLLD++ + L+FE ++ D K + I + Y+++LL
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLL------ 110
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
Q L +CHS ++HRD+KP N++I+ + ++L D+GLA
Sbjct: 111 ---------------------QGLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLAR 148
Query: 203 -FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
F P + Y V + +++ PE+L+ + Y ++D+WSLGC+FA M+ R+ F G
Sbjct: 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEI 207
Query: 262 DQLVKIARVLGT 273
DQL +I R LGT
Sbjct: 208 DQLFRIFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 83/255 (32%), Positives = 130/255 (50%), Gaps = 47/255 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLCG 85
+ YE V K+G G Y V++ + NE +K ++ V I REI +L+ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
Query: 86 GPNIVKLLDIVRDQHS-KTPSLIFEHVNSTDFKVLY---PTLTANE--IRYYIYELLKHA 139
G NIV+L D+V HS K L+FE+++ D K P N I+ Y+Y++L+
Sbjct: 61 G-NIVRLQDVV---HSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILR-- 113
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+ YCHS ++HRD+KP N++ID L+L D+G
Sbjct: 114 -------------------------GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148
Query: 200 LAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
LA F P + + V + +++ PE+L+ + Y +D+WS+GC+FA M+ +K P F G
Sbjct: 149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGD 207
Query: 259 DNQDQLVKIARVLGT 273
D+L KI R+LGT
Sbjct: 208 SEIDELFKIFRILGT 222
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 69/248 (27%), Positives = 127/248 (51%), Gaps = 39/248 (15%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 89
Y+++ K+G G +SEV + + + KC+ K K +++ REI+ L+ L PNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKHAMPRKVI 145
++L++++ D+ + +L+FE ++ ++++ P L ++ Y+Y+LLK
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLK-------- 111
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
+LD+ H GI HRD+KP N++I L+L D+G +
Sbjct: 112 -------------------SLDHMHRNGIFHRDIKPENILIK--DDILKLADFGSCRGIY 150
Query: 206 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265
Y +++R+++ PE L+ Y +D+W++GC+F ++ P F G + DQ+
Sbjct: 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF-PLFPGTNELDQIA 209
Query: 266 KIARVLGT 273
KI VLGT
Sbjct: 210 KIHDVLGT 217
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 81/254 (31%), Positives = 130/254 (51%), Gaps = 41/254 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINV--TNNEKCIIKILKPVKKKKIK-----REIKILQNLCGG 86
YE+++++G+G Y V N + E IK + V KKI RE+K+L++ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
NI L D+ + V +F NE+ Y+YE L A + II
Sbjct: 62 KNITCLYDM-------------DIVFPGNF---------NEL--YLYEELMEADLHQ-II 96
Query: 147 MPGEGLMEN--QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
G+ L + Q L L Y HS ++HRD+KP N++++ + + L++ D+GLA +
Sbjct: 97 RSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGF 155
Query: 205 HPGKEYNVR-----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
N VA+R+++ PE+++ Q Y ++D+WS+GC+ A ++ RK P F G D
Sbjct: 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKD 214
Query: 260 NQDQLVKIARVLGT 273
DQL +I +VLGT
Sbjct: 215 YVDQLNQILQVLGT 228
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 87/248 (35%), Positives = 131/248 (52%), Gaps = 37/248 (14%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-----KPVKKKKIKREIKILQNLCGG 86
E YE + K+G G Y VF+ N + IK PV KK REI++L+ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KH 59
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PN+V L+++ R + L+FE+ + T VL EL K+ PR V
Sbjct: 60 PNLVNLIEVFR--RKRKLHLVFEYCDHT---VLN-------------ELEKN--PRGV-- 97
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH- 205
E L++ I LQA+++CH +HRDVKP N++I + Q ++L D+G A
Sbjct: 98 --PEHLIKK--IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTG 152
Query: 206 PGKEYNVRVASRYFKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
PG +Y VA+R+++ PELLV D Q Y +D+W++GC+FA ++ +P + G + DQL
Sbjct: 153 PGDDYTDYVATRWYRAPELLVGDTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQL 210
Query: 265 VKIARVLG 272
I + LG
Sbjct: 211 YLIRKTLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 75/254 (29%), Positives = 130/254 (51%), Gaps = 50/254 (19%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-------KKKIKREIKILQNLCGG 86
++ + K+G G Y+ V++G N T E I LK + REI +++ L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAM 140
NIV+L D++ ++ L+FE+++ D K T L N ++ + Y+LLK
Sbjct: 58 ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLK--- 111
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+ +CH ++HRD+KP N++I+ + L+L D+GL
Sbjct: 112 ------------------------GIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGL 146
Query: 201 AE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
A F P ++ V + +++ P++L+ + Y S+D+WS+GC+ A MI + P F G +
Sbjct: 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTN 205
Query: 260 NQDQLVKIARVLGT 273
N+DQL+KI R++GT
Sbjct: 206 NEDQLLKIFRIMGT 219
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 61/261 (23%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIKI 79
DY + K+G G Y V++G N + V KKI+ REI +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANE------IRYYIY 133
L+ L PNIV L D++ Q S+ LIFE + S D K +L + ++ Y+Y
Sbjct: 53 LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 134 ELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193
++L Q + +CHS+ ++HRD+KP N++ID + +
Sbjct: 109 QIL---------------------------QGILFCHSRRVLHRDLKPQNLLID-NKGVI 140
Query: 194 RLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
+L D+GLA F P + Y V + +++ PE+L+ Y +D+WS+G +FA M +K
Sbjct: 141 KLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK- 199
Query: 253 PFFYGHDNQDQLVKIARVLGT 273
P F+G DQL +I R+LGT
Sbjct: 200 PLFHGDSEIDQLFRIFRILGT 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 77/257 (29%), Positives = 128/257 (49%), Gaps = 50/257 (19%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 88
Y+ + +G G Y V I+ + +K IK + P K+ RE+KIL++ N
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDN 65
Query: 89 IVKLLDIVR--DQHSKTPSLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKV 144
I+ + DI+R K ++ + + S +++ LT IRY++Y+LL+
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR------- 118
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
L Y HS ++HRD+KP N++++ E +LR+ D+G+A
Sbjct: 119 --------------------GLKYIHSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGL 157
Query: 205 ------HPG--KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
H EY VA+R+++ PELL+ L +Y ++DMWS+GC+FA M+ R++ F
Sbjct: 158 SSSPTEHKYFMTEY---VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFP 213
Query: 257 GHDNQDQLVKIARVLGT 273
G + QL I VLG+
Sbjct: 214 GKNYVHQLKLILSVLGS 230
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 59/264 (22%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK------------R 75
+G E Y+ + K+G G Y+ V++G + + V K+I+ R
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTG--------QLVALKEIRLEHEEGAPFTAIR 52
Query: 76 EIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPT-LTANEIRYY 131
E +L++L NIV L DI+ + KT +L+FE+++ TD K L+ + +R +
Sbjct: 53 EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108
Query: 132 IYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191
+++LL+ L YCH + ++HRD+KP N++I E+
Sbjct: 109 LFQLLR---------------------------GLAYCHQRRVLHRDLKPQNLLIS-ERG 140
Query: 192 KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250
+L+L D+GLA P K Y+ V + +++ P++L+ +Y SLDMW +GC+F M
Sbjct: 141 ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-T 199
Query: 251 KEPFFYGH-DNQDQLVKIARVLGT 273
P F G D +DQL KI RVLGT
Sbjct: 200 GRPLFPGSTDVEDQLHKIFRVLGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 58/270 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKKKKIK----REIKILQNLCG 85
DYE++ K+G G + EV++ + +K IL +K REIKIL+ L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
PN+V L+D+ ++ K ++ P Y ++L
Sbjct: 66 HPNVVPLIDMAVERPDK------SKRKRGSVYMVTP--------YMDHDL---------- 101
Query: 146 IMPGEGLMENQDISV-------WDLQALD---YCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
GL+EN + + + LQ L+ Y H I+HRD+K N++ID++ L++
Sbjct: 102 ----SGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI-LKI 156
Query: 196 IDWGLAEFYH-----PGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
D+GLA Y P +Y V +R+++ PELL+ + Y ++D+W +GC+
Sbjct: 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCV 216
Query: 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
FA M R+ P G + DQL I ++ GT
Sbjct: 217 FAEMFTRR-PILQGKSDIDQLHLIFKLCGT 245
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 77/252 (30%), Positives = 124/252 (49%), Gaps = 43/252 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL------KPVKKKKIKREIKILQNLCG 85
E YE + VG G Y V + + + IK K VKK + REI++L+ L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-R 58
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPT-LTANEIRYYIYELLKHAMPR 142
N+V L+++ R + K L+FE V+ T L YP L + +R Y++++L+
Sbjct: 59 HENLVNLIEVFRRK--KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR----- 111
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+++CHS I+HRD+KP N+++ + ++L D+G A
Sbjct: 112 ----------------------GIEFCHSHNIIHRDIKPENILVS-QSGVVKLCDFGFAR 148
Query: 203 FYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
PG+ Y VA+R+++ PELLV Y ++D+W++GC+ M EP F G +
Sbjct: 149 TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM-LTGEPLFPGDSDI 207
Query: 262 DQLVKIARVLGT 273
DQL I + LG
Sbjct: 208 DQLYHIIKCLGN 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-29
Identities = 76/258 (29%), Positives = 125/258 (48%), Gaps = 53/258 (20%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK---IK--REIKILQNLCGG 86
++YE + ++ G Y V+ + E +K LK K+K+ I REI IL L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PNIV + ++V V S K+ Y + E ++H +
Sbjct: 64 PNIVTVKEVV--------------VGSNLDKI-----------YMVMEYVEHDL------ 92
Query: 147 MPGEGLMEN--QDISVWD--------LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLI 196
+ LME Q + L + + H I+HRD+K N+++++ L++
Sbjct: 93 ---KSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-LKIC 148
Query: 197 DWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
D+GLA E+ P K Y V + +++ PELL+ ++Y ++DMWS+GC+FA ++ K+P F
Sbjct: 149 DFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL-TKKPLF 207
Query: 256 YGHDNQDQLVKIARVLGT 273
G DQL KI ++LGT
Sbjct: 208 PGKSEIDQLNKIFKLLGT 225
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 74/257 (28%), Positives = 131/257 (50%), Gaps = 41/257 (15%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK--------REIKILQNL 83
+ YE V ++G G Y +VF+ ++ N + + LK V+ + + RE+ +L++L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 84 CG--GPNIVKLLDIV---RDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKH 138
PN+V+L D+ R +L+FEHV+ ++ Y+ ++ +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-------------QDLTTYLDKVPEP 105
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
+P + I +D+ L+ LD+ HS ++HRD+KP N+++ Q ++L D+
Sbjct: 106 GVPTETI----------KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADF 154
Query: 199 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
GLA Y V + +++ PE+L+ Y +D+WS+GC+FA M FR++P F G
Sbjct: 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGS 212
Query: 259 DNQDQLVKIARVLGTDE 275
+ DQL KI V+G
Sbjct: 213 SDVDQLGKILDVIGLPG 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 71/269 (26%), Positives = 129/269 (47%), Gaps = 60/269 (22%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-----KPVKKKKIKREIKILQN 82
W + Y+ + VG G Y +V + K IK L + K+ RE+++L++
Sbjct: 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP-------------TLTANEIR 129
+ N++ LLD+ TP+ E D ++ L+ + I+
Sbjct: 71 MDH-ENVIGLLDVF------TPASSLEDF--QDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121
Query: 130 YYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE 189
+ +Y++L+ L Y HS GI+HRD+KP N+ ++ E
Sbjct: 122 FLVYQILR---------------------------GLKYIHSAGIIHRDLKPSNIAVN-E 153
Query: 190 QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249
+L+++D+GLA H E VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++
Sbjct: 154 DCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 250 RKEPFFYGHDNQDQLVKIARVLGT--DEL 276
K F G D+ DQL +I ++GT +EL
Sbjct: 212 GK-TLFPGSDHIDQLKRIMNLVGTPDEEL 239
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 73/257 (28%), Positives = 129/257 (50%), Gaps = 48/257 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK----KIKREIKILQNLCGGP 87
Y+ + +G G Y V + K IK + P + + + REIKIL+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63
Query: 88 NIVKLLDIVRDQHSKTPSLIF--EHVNSTD-FKVLYP-TLTANEIRYYIYELLKHAMPRK 143
NI+ +LDI+R ++ + ++ + + TD +K++ L+ + I+Y++Y++L+
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR------ 117
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-- 201
L Y HS ++HRD+KP N++++ L++ D+GLA
Sbjct: 118 ---------------------GLKYIHSANVLHRDLKPSNLLLN-TNCDLKICDFGLARI 155
Query: 202 ---EFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
E H G EY VA+R+++ PE++++ + Y ++D+WS+GC+ A M+ + P F
Sbjct: 156 ADPEHDHTGFLTEY---VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211
Query: 257 GHDNQDQLVKIARVLGT 273
G D QL I VLGT
Sbjct: 212 GKDYLHQLNLILGVLGT 228
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 72/260 (27%), Positives = 135/260 (51%), Gaps = 38/260 (14%)
Query: 28 WGDQ--EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKIL 80
WG + + ++++ ++G G Y +V++ + E +K ++ +K+ REIKIL
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
+ L NIV L +IV D+ ++ DFK Y ++E + H +
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQ-----------DALDFK------KDKGAFYLVFEYMDHDL 102
Query: 141 PRKVIIMPGEGLM---ENQDISVWD--LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
+ + GL+ E+ S L+ L+YCH + +HRD+K N++++++ Q ++L
Sbjct: 103 ----MGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ-IKL 157
Query: 196 IDWGLAEFYHPG--KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
D+GLA Y+ + Y +V + +++ PELL+ + Y ++D+WS GC+ G +F K+P
Sbjct: 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKP 216
Query: 254 FFYGHDNQDQLVKIARVLGT 273
F + QL I+R+ G+
Sbjct: 217 IFQANQELAQLELISRLCGS 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 79/263 (30%), Positives = 139/263 (52%), Gaps = 36/263 (13%)
Query: 18 YWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-KPVKK----KK 72
Y+ E W + Y +++VG G Y V ++ K IK L +P + K+
Sbjct: 1 YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 73 IKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYI 132
RE+++L+++ N++ LLD+ TP L + + DF ++ P + + +
Sbjct: 61 AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTD-----L 106
Query: 133 YELLKHAMPRKVIIMPGEGLMEN--QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190
+L+KH E L E+ Q + L+ L Y H+ GI+HRD+KP N+ ++ E
Sbjct: 107 GKLMKH-----------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-ED 154
Query: 191 QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250
+L+++D+GLA E V +R+++ PE++++ Y ++D+WS+GC+ A M+
Sbjct: 155 CELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
Query: 251 KEPFFYGHDNQDQLVKIARVLGT 273
K P F GHD+ DQL++I +V GT
Sbjct: 213 K-PLFKGHDHLDQLMEIMKVTGT 234
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 60/249 (24%), Positives = 106/249 (42%), Gaps = 43/249 (17%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIK--ILKPVKKKK---IKREIKILQNLCGGP 87
++ +GRG + V+ ++ E +K L +++ ++REI+IL +L P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNS---TDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
NIV+ RD+ T ++ E+V+ + + L IR Y ++
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--------- 110
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA--- 201
L+ L Y HS GI+HRD+K N+++D + ++L D+G A
Sbjct: 111 ------------------LEGLAYLHSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRL 151
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
G+ + Y+ PE++ ++Y + D+WSLGC M K P + N
Sbjct: 152 GDIETGEGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPP-WSELGNP 209
Query: 262 DQLV-KIAR 269
+ KI
Sbjct: 210 MAALYKIGS 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 67/255 (26%), Positives = 109/255 (42%), Gaps = 65/255 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKK---IKREIKILQNLCG 85
+D++ + +G G +S V N++ IKIL +K+KK +K E ++L L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 86 GPNIVKLLDIVRDQHSKTPSLIF--EHVNSTDFKVL---YPTLTANEIRYYIYELLKHAM 140
P I+KL +D+ + L F E+ + + Y +L R+Y E+L
Sbjct: 61 HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL--- 113
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
AL+Y HS+GI+HRD+KP N+++D + +++ D+G
Sbjct: 114 ------------------------ALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGT 148
Query: 201 AEFYHPGK---------------EYNVRVASRYFKG------PELLVDLQDYDYSLDMWS 239
A+ P R F G PELL + + S D+W+
Sbjct: 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWA 207
Query: 240 LGCMFAGMIFRKEPF 254
LGC+ M+ K PF
Sbjct: 208 LGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 73/250 (29%), Positives = 129/250 (51%), Gaps = 38/250 (15%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-PVKKKKIK----REIKILQNL--CGG 86
YE V ++G G Y V++ + + +K ++ + + RE+ +L+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 87 PNIVKLLDIV----RDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
PNIV+L+D+ D+ +K +L+FEHV+ ++R Y+ ++ +P
Sbjct: 62 PNIVRLMDVCATSRTDRETKV-TLVFEHVD-------------QDLRTYLDKVPPPGLPA 107
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+ I +D+ L+ LD+ H+ I+HRD+KP N+++ Q ++L D+GLA
Sbjct: 108 ETI----------KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ-VKLADFGLAR 156
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
Y V + +++ PE+L+ Y +DMWS+GC+FA M FR++P F G+ D
Sbjct: 157 IYSCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEAD 214
Query: 263 QLVKIARVLG 272
QL KI ++G
Sbjct: 215 QLGKIFDLIG 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 61/261 (23%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 88
Y ++ +GRG Y V N NEK IK + + K+ REIK+L++L N
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVN------STDFKVLY---PTLTANEIRYYIYELLKHA 139
++ + DI+ H + F V TD + TL+ + +Y++Y+LL+
Sbjct: 66 VIAIKDIMPPPHREA----FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR-- 119
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
L Y HS ++HRD+KP N++++ L++ D+G
Sbjct: 120 -------------------------GLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFG 153
Query: 200 LA-------EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
LA +F EY V +R+++ PELL++ +Y ++D+WS+GC+FA ++ RK
Sbjct: 154 LARTTSEKGDFM---TEY---VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK- 206
Query: 253 PFFYGHDNQDQLVKIARVLGT 273
P F G D QL I +LG+
Sbjct: 207 PLFPGKDYVHQLKLITELLGS 227
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-25
Identities = 70/252 (27%), Positives = 124/252 (49%), Gaps = 37/252 (14%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK----REIKILQNL 83
+G Y + K+G G Y+ V++GI+ N + +K++ ++ + RE +L+ L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPT-LTANEIRYYIYELLKHAMPR 142
NIV L DI+ + + T + H + + + +P L +R ++++LL+
Sbjct: 61 -KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR----- 114
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
L Y H Q I+HRD+KP N++I + + L+L D+GLA
Sbjct: 115 ----------------------GLAYIHGQHILHRDLKPQNLLISYLGE-LKLADFGLAR 151
Query: 203 FYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
P + Y+ V + +++ P++L+ DY +LD+W GC+F M + +P F G +
Sbjct: 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDV 210
Query: 262 -DQLVKIARVLG 272
+QL KI VLG
Sbjct: 211 FEQLEKIWTVLG 222
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 78/242 (32%), Positives = 123/242 (50%), Gaps = 22/242 (9%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKL 92
Y++ +G G + V+E I + +EK IK +L+ + K RE+ I++NL NI+ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124
Query: 93 LDIVRDQH-SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEG 151
D + K IF +V P +++Y HA+P ++ +
Sbjct: 125 KDYYYTECFKKNEKNIFLNV----VMEFIPQTVHKYMKHYARN--NHALPLFLVKLYSYQ 178
Query: 152 LMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN 211
L +AL Y HS+ I HRD+KP N++ID L+L D+G A+ G+
Sbjct: 179 L----------CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 212 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVL 271
+ SR+++ PEL++ +Y +D+WSLGC+ A MI P F G + DQLV+I +VL
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVL 287
Query: 272 GT 273
GT
Sbjct: 288 GT 289
|
Length = 440 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 78/248 (31%), Positives = 122/248 (49%), Gaps = 43/248 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGIN-VTNNEKCIIKILKP----VKKKKIKREIKILQNLCGGPN 88
Y ++ VG G + V + +T I KI+KP V K+ RE+K+L++L N
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
I+ L DI ++ E Y++ ELL + R + P
Sbjct: 71 IISLSDIF--------------------------ISPLEDIYFVTELLGTDLHRLLTSRP 104
Query: 149 GEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
+E Q I + Q L Y HS G++HRD+KP N++I+ E L++ D+GLA
Sbjct: 105 ----LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQD 159
Query: 206 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265
P + V++RY++ PE+++ Q YD +D+WS GC+FA M +P F G D+ +Q
Sbjct: 160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFS 216
Query: 266 KIARVLGT 273
I +LGT
Sbjct: 217 IITDLLGT 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 71/255 (27%), Positives = 133/255 (52%), Gaps = 42/255 (16%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK----REIKILQNL 83
+G E Y + K+G G Y+ V++G + + +K ++ ++ RE+ +L++L
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHA 139
NIV L DI+ + K+ +L+FE+++ D K ++ + ++ ++++LL+
Sbjct: 62 -KHANIVTLHDIIHTE--KSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLR-- 115
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
L+YCH + ++HRD+KP N++I+ E+ +L+L D+G
Sbjct: 116 -------------------------GLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFG 149
Query: 200 LAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
LA P K Y+ V + +++ P++L+ DY +DMW +GC+F M + P F G
Sbjct: 150 LARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGS 208
Query: 259 DNQDQLVKIARVLGT 273
++QL I R+LGT
Sbjct: 209 TVEEQLHFIFRILGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 3e-24
Identities = 75/255 (29%), Positives = 131/255 (51%), Gaps = 41/255 (16%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK----REIKILQNL 83
+G + YE + K+G G Y+ V++G + N + +K+++ +++ RE +L+ L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 84 CGGPNIVKLLDIVRDQHSK-TPSLIFEHVNSTDFKVL--YPT-LTANEIRYYIYELLKHA 139
NIV L DI+ H+K T +L+FE+V++ + + +P L ++ ++++LL+
Sbjct: 61 -KHANIVLLHDII---HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-- 114
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
L Y H + I+HRD+KP N++I + +L+L D+G
Sbjct: 115 -------------------------GLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFG 148
Query: 200 LAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
LA P Y+ V + +++ P++L+ +Y LDMW +GC+F MI F
Sbjct: 149 LARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
Query: 259 DNQDQLVKIARVLGT 273
D QDQL +I VLGT
Sbjct: 209 DIQDQLERIFLVLGT 223
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 73/262 (27%), Positives = 128/262 (48%), Gaps = 54/262 (20%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-KP----VKKKKIKREIKILQN 82
W E Y+ + VG G Y V + +K +K L +P + ++ RE+++L++
Sbjct: 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS---------TDFK--VLYPTLTANEIRYY 131
+ N++ LLD+ TP+ E+ N D V L+ +++
Sbjct: 71 M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 132 IYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191
IY+LL+ L Y HS GI+HRD+KP NV ++ E
Sbjct: 124 IYQLLR---------------------------GLKYIHSAGIIHRDLKPSNVAVN-EDC 155
Query: 192 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251
+LR++D+GLA E VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ +
Sbjct: 156 ELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KG 212
Query: 252 EPFFYGHDNQDQLVKIARVLGT 273
+ F G+D DQL +I V+GT
Sbjct: 213 KALFPGNDYIDQLKRIMEVVGT 234
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 8e-24
Identities = 72/254 (28%), Positives = 129/254 (50%), Gaps = 41/254 (16%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-KPVKK----KKIKREIKILQN 82
W E Y +++VG G Y V I+ EK IK L +P + K+ RE+ +L++
Sbjct: 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70
Query: 83 LCGGPNIVKLLDIVRDQHS----KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKH 138
+ N++ LLD+ S + L+ ++ + K++ L+ ++++Y +Y++L
Sbjct: 71 M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC- 128
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
L Y HS GI+HRD+KP N+ ++ E +L+++D+
Sbjct: 129 --------------------------GLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDF 161
Query: 199 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
GLA H E V +R+++ PE++++ Y+ ++D+WS+GC+ A M+ K F G
Sbjct: 162 GLAR--HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGK 218
Query: 259 DNQDQLVKIARVLG 272
D DQL +I +V G
Sbjct: 219 DYLDQLTQILKVTG 232
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-24
Identities = 78/249 (31%), Positives = 119/249 (47%), Gaps = 43/249 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN 88
+EV+ VG G Y V + + E IK K + K+ RE+K+L+ L N
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQEN 61
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPT-LTANEIRYYIYELLKHAMPRKVI 145
IV+L + R + L+FE+V ++L P + ++R YIY+L+K
Sbjct: 62 IVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK-------- 111
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
A+ +CH I+HRD+KP N++I H L+L D+G A
Sbjct: 112 -------------------AIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLS 151
Query: 206 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
G Y VA+R+++ PELL+ Y ++DMWS+GC+ G + +P F G DQ
Sbjct: 152 EGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQ 209
Query: 264 LVKIARVLG 272
L I +VLG
Sbjct: 210 LFTIQKVLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 9e-24
Identities = 79/252 (31%), Positives = 127/252 (50%), Gaps = 36/252 (14%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK----REIKILQNL 83
+G E Y + K+G G Y+ VF+G + +K ++ ++ RE+ +L++L
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRK 143
NIV L DIV S T L+FE Y+ + LK M
Sbjct: 62 -KHANIVTLHDIVHTDKSLT--LVFE---------------------YLDKDLKQYMDDC 97
Query: 144 VIIMPGEGLMENQDISVWD-LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
IM M N I ++ L+ L YCH + ++HRD+KP N++I+ E+ +L+L D+GLA
Sbjct: 98 GNIMS----MHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLAR 152
Query: 203 FYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
P K Y+ V + +++ P++L+ +Y +DMW +GC+F M + P F G +
Sbjct: 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVE 211
Query: 262 DQLVKIARVLGT 273
D+L I R+LGT
Sbjct: 212 DELHLIFRLLGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 78/256 (30%), Positives = 131/256 (51%), Gaps = 44/256 (17%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGIN-VTNNEKCIIKILKPVKKKKIK-------REIKI 79
+G E Y + K+G G Y+ VF+G + +T N + LK ++ + + RE+ +
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 56
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA 139
L+NL NIV L DI+ + T L+FE+++S LK
Sbjct: 57 LKNL-KHANIVTLHDIIHTERCLT--LVFEYLDSD---------------------LKQY 92
Query: 140 MPRKVIIMPGEGLMENQDISVWDL-QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
+ +M M N I ++ L + L YCH + I+HRD+KP N++I+ E+ +L+L D+
Sbjct: 93 LDNCGNLMS----MHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADF 147
Query: 199 GLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
GLA P K Y+ V + +++ P++L+ +Y +DMW +GC+ M + P F G
Sbjct: 148 GLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR-PMFPG 206
Query: 258 HDNQDQLVKIARVLGT 273
+++L I R+LGT
Sbjct: 207 STVKEELHLIFRLLGT 222
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 71/264 (26%), Positives = 127/264 (48%), Gaps = 54/264 (20%)
Query: 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-KP----VKKKKIKREIKILQN 82
W E Y+ + VG G Y V + + +K L +P + K+ RE+++L++
Sbjct: 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFE---------HVNSTDFK--VLYPTLTANEIRYY 131
+ N++ LLD+ TP+ E H+ D V LT + +++
Sbjct: 73 M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 132 IYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191
IY++L+ L Y HS I+HRD+KP N+ ++ E
Sbjct: 126 IYQILR---------------------------GLKYIHSADIIHRDLKPSNLAVN-EDC 157
Query: 192 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251
+L+++D+GLA H E VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ +
Sbjct: 158 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
Query: 252 EPFFYGHDNQDQLVKIARVLGTDE 275
F G D+ DQL I R++GT
Sbjct: 216 T-LFPGTDHIDQLKLILRLVGTPG 238
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-22
Identities = 59/246 (23%), Positives = 112/246 (45%), Gaps = 42/246 (17%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 87
YE+++++G+G + +V+ ++ + ++K + +++ E+KIL+ L P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 88 NIVKLLD-IVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
NI+K + ++ E+ + D + + +K
Sbjct: 60 NIIKYYESFEEKGKL---CIVMEYADGGD----------------LSQKIKKQ------K 94
Query: 147 MPGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
G+ E Q I W +Q AL Y HS+ I+HRD+KP N+ + ++L D+G+++
Sbjct: 95 KEGKPFPEEQ-ILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKV 152
Query: 204 YHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ V + Y+ PEL + + Y+Y D+WSLGC+ + K PF +N
Sbjct: 153 LSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPF--EGENLL 209
Query: 263 QLV-KI 267
+L KI
Sbjct: 210 ELALKI 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 45/253 (17%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK--------REIKILQNLC 84
++E + ++G G Y V+ + T+ E I LK V+ + REI +L N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMP 141
PNIV+L ++V +H + L+ E+ +L + ++++ + +LL+
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLR---- 119
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
L Y H I+HRD+K N+++ + L++ D+GLA
Sbjct: 120 -----------------------GLQYLHENFIIHRDLKVSNLLLTDKGC-LKIADFGLA 155
Query: 202 EFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
Y P K +V + +++ PELL+ Y ++DMW++GC+ A + +P G
Sbjct: 156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSE 214
Query: 261 QDQLVKIARVLGT 273
+QL I ++LGT
Sbjct: 215 IEQLDLIIQLLGT 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 53/274 (19%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKKKKIK----REIKILQNLCGGPN 88
YE + K+G+G + EVF+ + + +K +L +K+ REIKILQ L N
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHEN 72
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
+V L++I R T + + + Y ++E +H +
Sbjct: 73 VVNLIEICR-----TKATPYNRYKGS--------------FYLVFEFCEHDLA------- 106
Query: 149 GEGLMENQDISVWD----------LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
GL+ N+++ L L Y H I+HRD+K N++I + L+L D+
Sbjct: 107 --GLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADF 163
Query: 199 GLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
GLA + K Y RV + +++ PELL+ +DY +DMW GC+ A M R P
Sbjct: 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SP 222
Query: 254 FFYGHDNQDQLVKIARVLG--TDELNAYLDKYHL 285
G+ Q QL I+++ G T E+ +DK L
Sbjct: 223 IMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 65/253 (25%), Positives = 114/253 (45%), Gaps = 49/253 (19%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIV 90
Y +R +G G VF ++ +++ +K + + +K REIKI++ L NIV
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65
Query: 91 KLLDIVRDQHSKTPSLIFE--HVNS---------TDFKVL--YPTLTANEIRYYIYELLK 137
K+ +++ S + +NS TD + L+ R ++Y+LL+
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
L Y HS ++HRD+KP NV I+ E L++ D
Sbjct: 126 ---------------------------GLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158
Query: 198 WGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
+GLA P + + + +++++ P LL+ +Y ++DMW+ GC+FA M+ K
Sbjct: 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
Query: 254 FFYGHD-NQDQLV 265
F H+ Q QL+
Sbjct: 219 FAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-20
Identities = 55/236 (23%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLCG 85
++++ +K+G+G++S V++ I + + +K ++ ++ +EI +L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
PN++K L + + ++ E ++ D ++KH +K +
Sbjct: 61 HPNVIKYLASFIENNELN--IVLELADAGDLS----------------RMIKHFKKQKRL 102
Query: 146 IMPGEGLMENQDISVWDL-----QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
I + ++W AL++ HS+ IMHRD+KP NV I ++L D GL
Sbjct: 103 I---------PERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGL 152
Query: 201 AEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
F+ + V + Y+ PE + + Y++ D+WSLGC+ M + PF+
Sbjct: 153 GRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-20
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKK--------KKIKREIKILQNLCGGPNIVK 91
+G G + V+EG+N+ + + +K + K++++EI +L L PNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQ 66
Query: 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPRKVIIMP 148
L R+ + E V L Y + IR Y ++L
Sbjct: 67 YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----------- 113
Query: 149 GEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK 208
L+Y H + +HRD+K N+++D ++L D+G+A+
Sbjct: 114 ----------------GLEYLHDRNTVHRDIKGANILVDTNGV-VKLADFGMAKQVVEFS 156
Query: 209 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
S Y+ PE++ Y + D+WSLGC M K P+
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 69/255 (27%), Positives = 125/255 (49%), Gaps = 36/255 (14%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGP 87
D E R +G G + V+ + + ++ +K + V K++ RE+K+L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59
Query: 88 NIVKLLDIVRDQHSKTPSL-IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
N++ LDI+ + P + FE + Y + EL++ + K+I+
Sbjct: 60 NVLSALDIL-----QPPHIDPFEEI------------------YVVTELMQSDL-HKIIV 95
Query: 147 MPGEGLMENQDISVWD-LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
P ++ + ++ L+ L Y HS GI+HRD+KP N++++ L++ D+GLA
Sbjct: 96 SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEE 154
Query: 206 P--GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
P K V ++Y++ PE+L+ + Y ++D+WS+GC+FA ++ R+ F Q
Sbjct: 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQ 213
Query: 264 LVKIARVLGTDELNA 278
L I +LGT L A
Sbjct: 214 LDLITDLLGTPSLEA 228
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 2e-19
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 59/240 (24%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 90
+G+G + +V + +K+LK KKKI + E IL + P IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56
Query: 91 KLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLY--PTLTANEIRYYIYELLKHAMPR 142
KL H +T L+ E+ + F L + R+Y E++
Sbjct: 57 KL-------HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIV------ 103
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA- 201
AL+Y HS GI++RD+KP N+++D + ++L D+GLA
Sbjct: 104 ---------------------LALEYLHSLGIIYRDLKPENILLDADGH-IKLTDFGLAK 141
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
E G N + + PE+L + Y ++D WSLG + M+ K P FY D +
Sbjct: 142 ELSSEGSRTNTFCGTPEYLAPEVL-LGKGYGKAVDWWSLGVLLYEMLTGKPP-FYAEDRK 199
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 69/274 (25%), Positives = 127/274 (46%), Gaps = 66/274 (24%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK--------------REIKI 79
YE+ +GRG Y V++ + K KK K REI +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDG------KEYAIKKFKGDKEQYTGISQSACREIAL 55
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLK-H 138
L+ L N+V L+++ + K+ L+F++ + +++++K H
Sbjct: 56 LREL-KHENVVSLVEVFLEHADKSVYLLFDYA-----------------EHDLWQIIKFH 97
Query: 139 AMPRKVIIMPG--EGLMENQDISVWD-LQALDYCHSQGIMHRDVKPHNVMI---DHEQQK 192
++V I P + L+ W L + Y HS ++HRD+KP N+++ E+
Sbjct: 98 RQAKRVSIPPSMVKSLL-------WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV 150
Query: 193 LRLIDWGLAEFYH----PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248
+++ D GLA ++ P + + V + +++ PELL+ + Y ++D+W++GC+FA ++
Sbjct: 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
Query: 249 FRKEPFFYGHDNQ---------DQLVKIARVLGT 273
EP F G + + DQL +I VLGT
Sbjct: 211 -TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 45/232 (19%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGG 86
D++++ +VG+G Y +VF E +K +K + + + E IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRK 143
+VKLL +D + L E+V DF+ L L+ + R+Y+ E+
Sbjct: 61 EWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMF------- 111
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
+A+D H G +HRD+KP N +ID ++L D+GL++
Sbjct: 112 --------------------EAVDALHELGYIHRDLKPENFLIDASGH-IKLTDFGLSK- 149
Query: 204 YHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
Y N V S + PE+L + YD+++D WSLGCM + PF
Sbjct: 150 --GIVTYANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 72/255 (28%), Positives = 121/255 (47%), Gaps = 45/255 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPN 88
Y++ +G+G Y V I+ EK IK + V +I REIK+L+ L P+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPD 60
Query: 89 IVKLLDIV---RDQHSKTPSLIFEHVNSTDFKVLYPT--LTANEIRYYIYELLKHAMPRK 143
IV++ I+ + K ++FE + S +V+ LT ++++Y+LL+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------ 114
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
AL Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 115 ---------------------ALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV 152
Query: 204 YHPGKEYNV----RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
+ VA+R+++ PEL Y ++D+WS+GC+FA ++ K P F G
Sbjct: 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGK 211
Query: 259 DNQDQLVKIARVLGT 273
+ QL I +LGT
Sbjct: 212 NVVHQLDLITDLLGT 226
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 26 VQWGDQED-YEVVRKVGRGKYSEVFEGINVTNNEKCIIK--ILKPVKKKKIKREIKILQN 82
V GD + Y+ + K+G G EV++ + ++ IK L+ K+ I EI I+++
Sbjct: 12 VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD 71
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS---TDFKVLYPT---LTANEIRYYIYELL 136
C PNIV D ++ E+++ TD ++ + +I Y E+L
Sbjct: 72 -CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVL 126
Query: 137 KHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLI 196
Q L+Y HSQ ++HRD+K N+++ + ++L
Sbjct: 127 ---------------------------QGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLA 158
Query: 197 DWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248
D+G A+ + N V + Y+ PE++ +DY +D+WSLG M M
Sbjct: 159 DFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 46/228 (20%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 89
+E+V +G G Y +V++ + + IKI+ ++ +++IK E IL+ PNI
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 90 VKL--LDIVRDQHSKTPSLIF-----EHVNSTD----FKVLYPTLTANEIRYYIYELLKH 138
I ++ L + TD + L I Y + E L+
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR- 124
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
L Y H ++HRD+K N+++ + ++L+D+
Sbjct: 125 --------------------------GLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDF 157
Query: 199 GL-AEFYHPGKEYNVRVASRYFKGPE-LLVDLQD---YDYSLDMWSLG 241
G+ A+ N + + Y+ PE + D Q YD D+WSLG
Sbjct: 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 50/223 (22%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLCGGPN 88
+E ++++ K+G G Y V++ I+ + IK++ PV++ ++I +EI IL+ C P
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59
Query: 89 IVKL---------LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA 139
IVK L IV + + S+ + + T+ TLT EI +Y+ LK
Sbjct: 60 IVKYYGSYFKNTDLWIVME-YCGAGSVS-DIMKITN-----KTLTEEEIAAILYQTLK-- 110
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
L+Y HS +HRD+K N++++ E Q +L D+G
Sbjct: 111 -------------------------GLEYLHSNKKIHRDIKAGNILLNEEGQ-AKLADFG 144
Query: 200 LA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
++ + + N + + ++ PE++ + Y+ D+WSLG
Sbjct: 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 56/233 (24%), Positives = 110/233 (47%), Gaps = 41/233 (17%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGP 87
+Y++ +GRG + V++G+N+ + IK + K K+ I +EI +L+NL P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHV-NSTDFKVL--YPTLTANEIRYYIYELLKHAMPRKV 144
NIVK + + S + +I E+ N + +++ + + + Y+Y++
Sbjct: 60 NIVKYIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV--------- 108
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EF 203
LQ L Y H QG++HRD+K N++ + ++L D+G+A +
Sbjct: 109 ------------------LQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKL 149
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
K+ V + Y+ PE ++++ + D+WSLGC ++ P++
Sbjct: 150 NDVSKDDASVVGTPYWMAPE-VIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 38/234 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVKKKKIK---REIKILQNLCGG 86
+E++R +G+G + +V + K + K K V+K ++ E +ILQ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL--- 57
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
H +L + + + ++ L ++RY++ + +K + +
Sbjct: 58 ------------NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW 105
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
+ L AL+Y HS+GI+HRD+KP N+++D EQ + + D+ +A P
Sbjct: 106 ICEIVL------------ALEYLHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTP 152
Query: 207 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
+ + PE+L Q Y ++D WSLG + K P + GH
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRP-YRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-17
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 87
+DYE++ +G G + V+ I + NNEK IK + ++++E++ + + C P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKV 144
N+VK + + L+ P L+ + +++K + PR
Sbjct: 60 NVVKY-----------------YTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRG- 97
Query: 145 IIMPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-A 201
GL E +V L+ L+Y HS G +HRD+K N+++ E +++ D+G+ A
Sbjct: 98 ------GLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSA 150
Query: 202 EFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
G K V + + PE++ + YD+ D+WS G
Sbjct: 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 37/227 (16%)
Query: 54 VTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109
VT I K+ +P + K+ RE+ +++ L NI+ LL++ TP E
Sbjct: 39 VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVF------TPQKSLE 91
Query: 110 HVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL--- 166
+F+ +Y + EL+ + +VI M ++++ +S Q L
Sbjct: 92 -----EFQDVY----------LVMELMDANL-CQVIQM----DLDHERMSYLLYQMLCGI 131
Query: 167 DYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 226
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 132 KHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 190
Query: 227 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
+ Y ++D+WS+GC+ MI R F G D+ DQ KI LGT
Sbjct: 191 GM-GYKENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGT 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 17/140 (12%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA---------------EFYHPG 207
L L+ H MHRD+ P N+ I+ + ++ D+GLA E
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 208 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267
+E +V + +++ PELL+ + Y +++DMWS+GC+FA ++ K P F G + DQL +I
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRI 246
Query: 268 ARVLGTDELNAYLDKYHLEL 287
+LGT + + L L
Sbjct: 247 FELLGTPNEDNWPQAKKLPL 266
|
Length = 335 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 72/278 (25%), Positives = 119/278 (42%), Gaps = 45/278 (16%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGP 87
DYEV+ +G+G + V + ++ + + K + +K+++ E+ IL+ L P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
NIV+ D + D+ ++T ++ E+ D A I+ E + + + I
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDL--------AQLIQKCKKE--RKYIEEEFIW- 108
Query: 148 PGEGLMENQDISVWDLQALDYCH-----SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
I L AL CH ++HRD+KP N+ +D ++L D+GLA+
Sbjct: 109 ---------RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAK 158
Query: 203 FYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
+ V + Y+ PE L YD D+WSLGC+ + P F NQ
Sbjct: 159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPP-FTAR-NQ 215
Query: 262 DQLV------KIARVLG--TDELNAYLDKYHLELDPQL 291
QL K R+ + ELN + K L +DP
Sbjct: 216 LQLASKIKEGKFRRIPYRYSSELNEVI-KSMLNVDPDK 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 54/235 (22%), Positives = 110/235 (46%), Gaps = 42/235 (17%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKC------IIKILKPVKKKKIKREIKILQNLCGG 86
++++ +K+GRG++SEV+ + + + I +++ ++ +EI +L+ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PN++K LD + + ++ A ++ +++K+ +K +I
Sbjct: 62 PNVIKYLD--------------SFIEDNELNIVLELADAGDLS----QMIKYFKKQKRLI 103
Query: 147 MPGEGLMENQDISVWDL-----QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+ +VW A+++ HS+ +MHRD+KP NV I ++L D GL
Sbjct: 104 ---------PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLG 153
Query: 202 EFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
F+ + V + Y+ PE + + Y++ D+WSLGC+ M + PF+
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 66/276 (23%), Positives = 126/276 (45%), Gaps = 55/276 (19%)
Query: 20 DYESLTVQWGDQ-----EDYEVVRKVGRGKYSEVFE------GINVTNNEKCIIKILKPV 68
D + +VQ D + Y+ ++ +G G V GINV + K+ +P
Sbjct: 4 DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVA-----VKKLSRPF 58
Query: 69 KK----KKIKREIKILQNLCGGPNIVKLLDIVRDQHS----KTPSLIFEHVNSTDFKVLY 120
+ K+ RE+ +L+ + NI+ LL++ Q S + L+ E +++ +V++
Sbjct: 59 QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH 117
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180
L + Y +Y++L + + HS GI+HRD+K
Sbjct: 118 MELDHERMSYLLYQML---------------------------CGIKHLHSAGIIHRDLK 150
Query: 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
P N+++ + L+++D+GLA V +RY++ PE+++ + Y ++D+WS+
Sbjct: 151 PSNIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSV 208
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDEL 276
GC+ ++ + F G D+ DQ K+ LGT
Sbjct: 209 GCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSA 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 54/236 (22%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR--------EIKILQNLCGGPNIVK 91
+ +G Y VF + + IK++K K I++ E IL P +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57
Query: 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPRKVIIMP 148
L Q K L+ E++ D L +L + R YI E++
Sbjct: 58 LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIV------------ 103
Query: 149 GEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK 208
AL+Y HS GI+HRD+KP N++ID L+L D+GL++ +
Sbjct: 104 ---------------LALEYLHSNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRR 147
Query: 209 EYNVRVASR---------YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+ N+ + + PE+++ Q + ++D WSLGC+ + PF
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 62/249 (24%), Positives = 115/249 (46%), Gaps = 40/249 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGIN-VTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPN 88
Y+ ++ +G G V + V + I K+ +P + K+ RE+ +L N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 77
Query: 89 IVKLLDIVRDQHS----KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
I+ LL++ Q S + L+ E +++ +V+ L + Y +Y++L
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML-------- 129
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+ + HS GI+HRD+KP N+++ + L+++D+GLA
Sbjct: 130 -------------------CGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTA 169
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
V +RY++ PE+++ + Y ++D+WS+GC+ M+ R + F G D DQ
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQW 227
Query: 265 VKIARVLGT 273
K+ LGT
Sbjct: 228 NKVIEQLGT 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-14
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 43/234 (18%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGG--PNIVKLL 93
+GRG Y V+ G +V +KI+ I+RE+ +L L PNI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 94 DIVRDQHSKTPSL--IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEG 151
+ K P L I E+ + L + A I E + R+V
Sbjct: 69 G----SYLKGPRLWIIMEYAEGGSVRTL---MKAGPIA----EKYISVIIREV------- 110
Query: 152 LMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AEFYHPGKEY 210
L AL Y H G++HRD+K N+++ + ++L D+G+ A +
Sbjct: 111 -----------LVALKYIHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKR 158
Query: 211 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+ V + Y+ PE++ + + YD D+WSLG M P + + D
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP----YSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99
+G+G + EV V K + K + KK++K+ + N K+L+ V +
Sbjct: 1 LGKGGFGEVC-ACQVKATGK--MYACKKLDKKRLKKR----KGEQMALNEKKILEKVSSR 53
Query: 100 HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDIS 159
+ + FE D ++ + +++Y+IY + + P Q I
Sbjct: 54 FIVSLAYAFE--TKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-----EARAIFYAAQIIC 106
Query: 160 VWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYF 219
L++ H + I++RD+KP NV++D + +R+ D GLA GK+ R + +
Sbjct: 107 -----GLEHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160
Query: 220 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
PE+L + YD+S+D ++LGC MI + PF
Sbjct: 161 MAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 59/254 (23%), Positives = 119/254 (46%), Gaps = 39/254 (15%)
Query: 39 KVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 94
KVGRG Y V++ + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYA-LKQIEGTGISMSACREIALLREL-KHPNVISLQK 65
Query: 95 IVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLME 154
+ + L+F++ A ++I + + + K + G+++
Sbjct: 66 VFLSHADRKVWLLFDY--------------AEHDLWHIIKFHRASKANKKPVQLPRGMVK 111
Query: 155 NQDISVWDLQALDYCHSQGIMHRDVKPHNVMI---DHEQQKLRLIDWGLAEFYH----PG 207
+ + D + Y H+ ++HRD+KP N+++ E+ ++++ D G A ++ P
Sbjct: 112 SLLYQILD--GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 208 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-------- 259
+ + V + +++ PELL+ + Y ++D+W++GC+FA ++ EP F+
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNP 228
Query: 260 -NQDQLVKIARVLG 272
+ DQL +I V+G
Sbjct: 229 YHHDQLDRIFNVMG 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 60/249 (24%), Positives = 113/249 (45%), Gaps = 40/249 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGIN-VTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPN 88
Y+ ++ +G G V + + I K+ +P + K+ RE+ +L N
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 84
Query: 89 IVKLLDIVRDQHS----KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
I+ LL++ Q S + ++ E +++ +V+ L + Y +Y++L
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML-------- 136
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+ + HS GI+HRD+KP N+++ + L+++D+GLA
Sbjct: 137 -------------------CGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTA 176
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
V +RY++ PE+++ + Y ++D+WS+GC+ MI F G D+ DQ
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQW 234
Query: 265 VKIARVLGT 273
K+ LGT
Sbjct: 235 NKVIEQLGT 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 36/226 (15%)
Query: 29 GDQED-YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLCG 85
GD D +E++ +G+G Y +V++ N + +KIL P+ ++I+ E ILQ+L
Sbjct: 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN 77
Query: 86 GPNIVKLLDIV--RDQHSKTPS-LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
PN+VK + D+ L+ E N + EL+K +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGS----------------VTELVKGLLIC 121
Query: 143 KVIIMPGEGLMEN--QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
G+ L E I L L + H+ I+HRDVK +N+++ E ++L+D+G+
Sbjct: 122 ------GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGV 174
Query: 201 -AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL----DMWSLG 241
A+ N V + ++ PE++ Q YDYS D+WSLG
Sbjct: 175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG 220
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 48/233 (20%)
Query: 38 RKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKL 92
K+G G + +V+ +N+ E +K ++ P K+I E+K+L+ L PN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKY 64
Query: 93 --LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA--MPRKVIIMP 148
+++ R++ IF S TL ELL+H + VI
Sbjct: 65 YGVEVHREK-----VYIFMEYCSGG------TLE---------ELLEHGRILDEHVI--- 101
Query: 149 GEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP-- 206
+ ++ L+ L Y HS GI+HRD+KP N+ +DH ++L D+G A
Sbjct: 102 -------RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNNT 153
Query: 207 ---GKEYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
G+E + + PE++ + + + D+WSLGC+ M K P+
Sbjct: 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 61/268 (22%), Positives = 100/268 (37%), Gaps = 81/268 (30%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKI-----------KREIKIL 80
+D+EV++ +GRG + EV+ V + + + +K ++K + +R+I
Sbjct: 1 DDFEVIKVIGRGAFGEVWL---VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLK 137
+ P IVKL +D+ L+ E++ D L R+YI EL+
Sbjct: 58 AD---SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV- 111
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
ALD H G +HRD+KP N++ID ++L D
Sbjct: 112 --------------------------LALDSVHKLGFIHRDIKPDNILID-ADGHIKLAD 144
Query: 198 WGLA--------------------------EFYHPGKEYNVR----VASRYFKGPELLVD 227
+GL K+ VR V + + PE+L
Sbjct: 145 FGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG 204
Query: 228 LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
Y D WSLG + M++ PF+
Sbjct: 205 -TPYGLECDWWSLGVILYEMLYGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 8e-13
Identities = 58/254 (22%), Positives = 119/254 (46%), Gaps = 39/254 (15%)
Query: 39 KVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 94
KVGRG Y V++ ++ LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYA-LKQIEGTGISMSACREIALLREL-KHPNVIALQK 65
Query: 95 IVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLME 154
+ + L+F++ A ++I + + + K + +++
Sbjct: 66 VFLSHSDRKVWLLFDY--------------AEHDLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 155 NQDISVWDLQALDYCHSQGIMHRDVKPHNVMI---DHEQQKLRLIDWGLAEFYH----PG 207
+ + D + Y H+ ++HRD+KP N+++ E+ ++++ D G A ++ P
Sbjct: 112 SLLYQILD--GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 208 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-------- 259
+ + V + +++ PELL+ + Y ++D+W++GC+FA ++ EP F+
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNP 228
Query: 260 -NQDQLVKIARVLG 272
+ DQL +I V+G
Sbjct: 229 FHHDQLDRIFSVMG 242
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 43/220 (19%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 87
E + ++ +G+G + EV++ I+ N+ IK++ + + I++EI+ L C P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59
Query: 88 NIVKLLDIVRDQHSKTPSL--IFEHV-NSTDFKVLYP-TLTANEIRYYIYELLKHAMPRK 143
I K K L I E+ + +L P L I + + E+L
Sbjct: 60 YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLL------ 109
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-E 202
L+Y H +G +HRD+K N+++ E+ ++L D+G++ +
Sbjct: 110 ---------------------GLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGVSGQ 147
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 242
+ N V + ++ PE++ YD D+WSLG
Sbjct: 148 LTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 57/235 (24%), Positives = 108/235 (45%), Gaps = 42/235 (17%)
Query: 33 DYEVVRKVGRGKYSEVF------EGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGG 86
++ + +K+GRG++SEV+ +G+ V + I ++ + +EI +L+ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PN++K + + +++ E ++ D ++KH +K +I
Sbjct: 62 PNVIKYYASFIEDNEL--NIVLELADAGDLS----------------RMIKHFKKQKRLI 103
Query: 147 MPGEGLMENQDISVWDL-----QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+ +VW AL++ HS+ +MHRD+KP NV I ++L D GL
Sbjct: 104 ---------PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLG 153
Query: 202 EFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
F+ + V + Y+ PE + + Y++ D+WSLGC+ M + PF+
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 57/244 (23%), Positives = 103/244 (42%), Gaps = 37/244 (15%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 89
YE+++K+G G + +++ +++E C+IK + PVK+K+ ++ IL PNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149
V + + N + + E K I
Sbjct: 62 V---------------------------TFFASFQENGRLFIVMEYCDGGDLMKRINRQR 94
Query: 150 EGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
L I W +Q L + H + I+HRD+K N+ + +L D+G+A +
Sbjct: 95 GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154
Query: 207 GKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265
E V + Y+ PE+ + + Y+ D+WSLGC+ + K P F G++ ++
Sbjct: 155 SMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVL 212
Query: 266 KIAR 269
KI +
Sbjct: 213 KICQ 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 89
+ +E++ +G+G Y +VF+ +N N K +KIL P+ ++I+ E IL+ L PN+
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 90 VKLLDIVRDQHSKTPS---LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
VK + + K L+ E N + +L+K + R
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGS----------------VTDLVKGFLKR---- 117
Query: 147 MPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AEF 203
GE + E + L L + H +HRDVK +N+++ E ++L+D+G+ A+
Sbjct: 118 --GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQL 174
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLG 241
N V + ++ PE++ Q YD D+WSLG
Sbjct: 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG 216
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKI---KREIKILQNLCGGPNIV 90
++ + +G + V+ + + IK+LK + K ++ K E I+ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPRKVIIM 147
KL Q L+ E++N D L T L + + YI E++
Sbjct: 61 KLYYSF--QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVV----------- 107
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG 207
++ H +GI+HRD+KP N++ID + L+L D+GL+
Sbjct: 108 ----------------LGVEDLHQRGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN 150
Query: 208 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
K++ V + + PE ++ + D D D WSLGC+ +F PF
Sbjct: 151 KKF---VGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 54/250 (21%), Positives = 97/250 (38%), Gaps = 48/250 (19%)
Query: 37 VRKVGRGKYSEV------FEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGG 86
++++G G + +V G N E+ +K L + +REI+IL+ L
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTG--EQVAVKSLNHSGEEQHRSDFEREIEILRTL-DH 65
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
NIVK + ++ LI E++ S + LL +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK---RLLLFS------- 115
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
I + +DY SQ +HRD+ N++++ E +++ D+GLA+
Sbjct: 116 ---------SQIC----KGMDYLGSQRYIHRDLAARNILVESEDL-VKISDFGLAKVLPE 161
Query: 207 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
K+Y + ++ PE L + S D+WS G + F YG +Q
Sbjct: 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSAS-DVWSFGVTLYEL------FTYGDPSQS 214
Query: 263 QLVKIARVLG 272
+ R++G
Sbjct: 215 PPAEFLRMIG 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 90
+R++G G + V+ +V N+E IK + K+ I +E++ LQ L PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGE 150
+ +H T L+ E Y +A+++ L H P +
Sbjct: 79 QYRGCYLREH--TAWLVME----------YCLGSASDL------LEVHKKPLQE------ 114
Query: 151 GLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY 210
+E ++ LQ L Y HS ++HRDVK N+++ E ++L D+G A P +
Sbjct: 115 --VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF 171
Query: 211 NVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 255
V + Y+ PE+++ + + YD +D+WSLG + RK P F
Sbjct: 172 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 42/222 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 87
+D E + ++G G V + ++ + K I + +K+I RE+ IL C P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
IV + S+ E+++ I + ++ +P +++
Sbjct: 60 YIVGFYGAFYNNG--DISICMEYMDGGSLDK-------------ILKEVQGRIPERIL-- 102
Query: 148 PGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
I+V L+ L Y H + I+HRDVKP N++++ Q ++L D+G++
Sbjct: 103 --------GKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ-IKLCDFGVS----- 148
Query: 207 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244
G+ N V + + PE + DY D+WSLG
Sbjct: 149 GQLVNSLAKTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSL 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 45/227 (19%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 90
+G+G + EV + V N K + K + KK++K+ E +IL+ + P IV
Sbjct: 1 LGKGGFGEVC-AVQVKNTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIV 56
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGE 150
+L + + T ++ + +++Y+IY + GE
Sbjct: 57 --------------NLAYAFESKTHLCLVMSLMNGGDLKYHIYNV-------------GE 89
Query: 151 GLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG 207
+E + + + Q + + HS I++RD+KP NV++D +Q RL D GLA G
Sbjct: 90 RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDG 148
Query: 208 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
K R + + PE+L + + Y Y +D +++GC M+ + PF
Sbjct: 149 KTITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 39/227 (17%)
Query: 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 90
+R++G G + V+ +V NE IK + K+ I +E+K LQ + PN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGE 150
+ +H T L+ E Y +A+++ L H P + +
Sbjct: 89 EYKGCYLREH--TAWLVME----------YCLGSASDL------LEVHKKPLQEV----- 125
Query: 151 GLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY 210
E I+ LQ L Y HS ++HRD+K N+++ E +++L D+G A P +
Sbjct: 126 ---EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF 181
Query: 211 NVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 255
V + Y+ PE+++ + + YD +D+WSLG + RK P F
Sbjct: 182 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 68/259 (26%), Positives = 116/259 (44%), Gaps = 43/259 (16%)
Query: 26 VQWGD-QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK---ILKPVKKKKIKREIKILQ 81
V GD ++ Y K+G+G VF I+V ++ IK + K KK+ I EI +++
Sbjct: 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
L PNIV LD L +E+ + + E L
Sbjct: 72 EL-KNPNIVNFLD--------------------------SFLVGDEL-FVVMEYLAGGSL 103
Query: 142 RKVIIMPGEGLMENQDISVWD---LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
V+ E M+ I+ LQAL++ H+ ++HRD+K NV++ + ++L D+
Sbjct: 104 TDVVT---ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS-VKLTDF 159
Query: 199 GLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
G P + + + V + Y+ PE +V + Y +D+WSLG M M+ + P+
Sbjct: 160 GFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL-- 216
Query: 258 HDNQDQLVKIARVLGTDEL 276
++N + + + GT EL
Sbjct: 217 NENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 29/225 (12%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 93
YE +R VGRG + V + + IIK + PV++ K E QN C ++KLL
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMT-KDERLAAQNEC---QVLKLL 56
Query: 94 DIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANE---IRYYIYELLKHAMPRKVIIMPGE 150
H P++I + N + K L + + YI + + I+
Sbjct: 57 -----SH---PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL---- 104
Query: 151 GLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKE 209
V L AL + H++ I+HRD+K N+++D + +++ D+G++ K
Sbjct: 105 ------HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158
Query: 210 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
Y V V + + PE L + + Y+ D+W+LGC+ + K F
Sbjct: 159 YTV-VGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK------KIKREIKILQNLCGGPNIV 90
+ ++G G + V+ N NE +K + K+ I +E+K LQ L PN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGE 150
+ +H T L+ E Y +A+++ L H P + +
Sbjct: 85 EYKGCYLKEH--TAWLVME----------YCLGSASDL------LEVHKKPLQEV----- 121
Query: 151 GLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY 210
E I+ LQ L Y HS ++HRD+K N+++ E +++L D+G A P +
Sbjct: 122 ---EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF 177
Query: 211 NVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 255
V + Y+ PE+++ + + YD +D+WSLG + RK P F
Sbjct: 178 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 105 SLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDI--SVWD 162
SL + TD ++ + ++RY+IY + + G E + +
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE----------NPGFPEPRACFYTAQI 106
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVA-SRYFKG 221
+ L++ H + I++RD+KP NV++D++ +R+ D GLA G+ A + F
Sbjct: 107 ISGLEHLHQRRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
Query: 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
PELL ++YD+S+D ++LG MI + PF
Sbjct: 166 PELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 41/125 (32%), Positives = 61/125 (48%), Gaps = 8/125 (6%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-----EFYHPGKEYNVRVASR 217
L+ L Y H I+HRDVK N++ID Q+LR+ D+G A + G+ + +
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 218 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNQDQLV-KIARVLGTDE 275
F PE+L + Y S D+WS+GC+ M K P+ H N L+ KIA
Sbjct: 173 AFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
Query: 276 LNAYL 280
+ +L
Sbjct: 232 IPEHL 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 65/264 (24%), Positives = 123/264 (46%), Gaps = 55/264 (20%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNE----KCI-IKILKPVKKKKIKREIKILQNLCGGP 87
+YEV++K+G G++ EVF + E K I + LK +K ++ E+ +++ L
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHK 72
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYY--IYELLKHAMPRKVI 145
NIV+ +D ++ ++ ++ E ++ D L+ N + Y ++ +HA+
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGD-------LSRNIQKCYKMFGKIEEHAI----- 120
Query: 146 IMPGEGLMENQDISVWDLQALDYCHS-------QGIMHRDVKPHNVMIDHEQQKL----- 193
DI+ L AL YCH+ + ++HRD+KP N+ + + +
Sbjct: 121 ----------VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 194 -----------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDMWSLG 241
++ D+GL++ + V + Y+ PELL+ + + YD DMW+LG
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLV 265
C+ + K P F+ +N QL+
Sbjct: 231 CIIYELCSGKTP-FHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 41/231 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK------IKREIKILQNLCGGP 87
+ +R++G G + V+ +V NE IK + K+ I +E++ LQ P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
N ++ +H T L+ E Y +A++I E+ K + I
Sbjct: 76 NTIEYKGCYLREH--TAWLVME----------YCLGSASDI----LEVHKKPLQEVEIAA 119
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI-DHEQQKLRLIDWGLAEFYHP 206
G LQ L Y HS +HRD+K N+++ + KL D+G A P
Sbjct: 120 ICHGA----------LQGLAYLHSHERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSP 167
Query: 207 GKEYNVRVASRYFKGPE--LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
N V + Y+ PE L +D YD +D+WSLG + RK P F
Sbjct: 168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 2e-10
Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 46/223 (20%)
Query: 38 RKVGRGKYSEVFEGI---NVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIV 90
+K+G G + EV++G + +K LK ++K +E ++++ L G PN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGE 150
+LL + ++ L+ E++ D Y L K R V P +
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLL-----------DY----LRKS---RPVFPSPEK 99
Query: 151 GLMENQDISVWDLQA---LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG 207
+ +D+ + +Q ++Y S+ +HRD+ N ++ + +++ D+GL+ +
Sbjct: 100 STLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDD 158
Query: 208 KEYNVRVASRYFKG--------PELLVDLQDYDYSLDMWSLGC 242
Y + G PE L D + D+WS G
Sbjct: 159 DYYRKKT-----GGKLPIRWMAPESLKD-GIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 36/102 (35%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG + + + PE
Sbjct: 108 ALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNQDQ 263
+L +DY +S+D W+LG + M+ + PF DN DQ
Sbjct: 167 ILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 61/250 (24%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKK---IKREIKILQNLCG 85
+D+E ++ +G G + V + + + +KIL K VK K+ + E +ILQ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
P +V L Q L+ E+V E+ ++ RK
Sbjct: 61 -PFLVNLYG--SFQDDSNLYLVMEYVP------------GGELFSHL---------RKS- 95
Query: 146 IMPGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
G + Q AL+Y HS I++RD+KP N+++D +++ D+G A
Sbjct: 96 -----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS-DGYIKITDFGFA- 148
Query: 203 FYHPGKEYNVRVASRYFK--------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
RV R + PE+++ + Y ++D W+LG + M+ PF
Sbjct: 149 ---------KRVKGRTYTLCGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPF 198
Query: 255 FYGHDNQDQL 264
F DN Q+
Sbjct: 199 F--DDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 2/89 (2%)
Query: 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 225
L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE+
Sbjct: 115 LEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV- 172
Query: 226 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
V + Y +S D W LGC+ MI K PF
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 31/91 (34%), Positives = 54/91 (59%), Gaps = 3/91 (3%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL++ H +GI++RD+K NV++D E ++L D+G+ E PG + + + PE
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+L +DY +S+D W+LG + M+ + PF
Sbjct: 167 ILRG-EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 49/225 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK---KKIKREIKILQNLCGGP 87
QEDYE+++++G G Y +V++ ++ E IK++K + I++EI +L+ C P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYY--------IYELLKHA 139
N IV S + V+ Y IY++ +
Sbjct: 61 N------IVAYFGS-------YLRRDKLWIVME----------YCGGGSLQDIYQVTRGP 97
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+ I + L+ L Y H G +HRD+K N+++ E ++L D+G
Sbjct: 98 LSELQIAY----------VCRETLKGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFG 146
Query: 200 L-AEFYHPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLG 241
+ A+ + + + Y+ PE+ + YD D+W+LG
Sbjct: 147 VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 59/245 (24%), Positives = 111/245 (45%), Gaps = 51/245 (20%)
Query: 40 VGRGKYSEVFEGINVTNNE----KCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVKLL 93
+G G + V + N KC+ K I++ +++ I E +IL+ C P IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59
Query: 94 DIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI--IMPGEG 151
+D+ YIY L++ + I+ G
Sbjct: 60 RTFKDK------------------------------KYIYMLME-YCLGGELWTILRDRG 88
Query: 152 LMENQDI-----SVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
L + V + A +Y H++GI++RD+KP N+++D ++L+D+G A+
Sbjct: 89 LFDEYTARFYIACV--VLAFEYLHNRGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKS 145
Query: 207 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266
G++ + + PE++++ + YD+S+D WSLG + ++ + PF G D++D +
Sbjct: 146 GQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPF--GEDDEDPMEI 202
Query: 267 IARVL 271
+L
Sbjct: 203 YNDIL 207
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 56/253 (22%), Positives = 104/253 (41%), Gaps = 58/253 (22%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 87
+G G + V+ G+N ++ E +K + +K+ + REI +L+ L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPRKV 144
NIV+ L D + E+V L Y +R ++ ++LK
Sbjct: 67 NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK------- 117
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
L+Y H++GI+HRD+K N+++D+ + +++ D+G+++
Sbjct: 118 --------------------GLNYLHNRGIIHRDIKGANILVDN-KGGIKISDFGISKKL 156
Query: 205 HPGKEYNVRVASR-------YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
+R ++ PE +V Y D+WSLGC+ M+ K PF
Sbjct: 157 EANSLSTKTNGARPSLQGSVFWMAPE-VVKQTSYTRKADIWSLGCLVVEMLTGKHPF--- 212
Query: 258 HDNQDQLVKIARV 270
+ QL I ++
Sbjct: 213 -PDCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 53/230 (23%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKK-------------KKIKREIKILQNLCGG 86
+G+G Y V+ +NVT E +K ++ K ++ EI+ L++L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
NIV+ L + + S+ E+V T E E L +V
Sbjct: 68 LNIVQYLGFETTE--EYLSIFLEYVPGGSIGSCLRTYGRFE------EQLVRFFTEQV-- 117
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL----AE 202
L+ L Y HS+GI+HRD+K N+++D ++ D+G+ +
Sbjct: 118 ----------------LEGLAYLHSKGILHRDLKADNLLVDA-DGICKISDFGISKKSDD 160
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYS--LDMWSLGC----MFAG 246
Y + +++ S ++ PE ++ YS +D+WSLGC MFAG
Sbjct: 161 IYDNDQNMSMQ-GSVFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 224
L+ H + ++RD+KP N+++D + +R+ D GLA G+ RV + + PE+
Sbjct: 114 GLEDLHRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV 172
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
L + Q Y S D W LGC+ MI + PF
Sbjct: 173 LNN-QRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 14/128 (10%)
Query: 149 GEGLMENQDISVWD-----LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
G L E+Q VW L L + HS+ I+HRD+K N+ +D +++ D G+A+
Sbjct: 95 GRPLPEDQ---VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKL 150
Query: 204 YHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ N V + Y+ PEL D + Y+ D+W+LG + K PF +NQ
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPF--DANNQG 207
Query: 263 QLV-KIAR 269
L+ KI R
Sbjct: 208 ALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 59/233 (25%), Positives = 107/233 (45%), Gaps = 37/233 (15%)
Query: 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 97
R +GRG Y++V + + N++ I +K VKK+ + + I D V
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDI--------------DWV- 42
Query: 98 DQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY-------ELLKHAMPRKVIIMPGE 150
+T +FE +S F V + R ++ +L+ H M R+ +
Sbjct: 43 ----QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEH 97
Query: 151 GLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKE 209
+I + AL++ H +GI++RD+K NV++D + ++L D+G+ E PG
Sbjct: 98 ARFYAAEICI----ALNFLHERGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDT 152
Query: 210 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ + + PE+L ++Y +S+D W+LG + M+ + PF DN D
Sbjct: 153 TSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 45/240 (18%)
Query: 26 VQWGD-QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK---ILKPVKKKKIKREIKILQ 81
V GD ++ Y K+G+G V+ I+V ++ IK + + KK+ I EI +++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
PNIV LD L +E+ + + E L
Sbjct: 72 EN-KHPNIVNYLD--------------------------SYLVGDEL-WVVMEYLAGGSL 103
Query: 142 RKVIIMPGEGLMENQDISVW---DLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
V+ E M+ I+ LQAL++ HS ++HRD+K N+++ + ++L D+
Sbjct: 104 TDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDF 159
Query: 199 GLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
G P E + R V + Y+ PE +V + Y +D+WSLG M M+ + P+
Sbjct: 160 GFCAQITP--EQSKRSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 2/90 (2%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 224
L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE+
Sbjct: 114 GLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 172
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
V + Y +S D W+LGC+ MI + PF
Sbjct: 173 -VKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 43/259 (16%)
Query: 26 VQWGD-QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK---ILKPVKKKKIKREIKILQ 81
V GD ++ Y K+G+G V+ I++ ++ IK + + KK+ I EI +++
Sbjct: 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
PNIV LD L +E+ + + E L
Sbjct: 72 E-NKNPNIVNYLD--------------------------SYLVGDEL-WVVMEYLAGGSL 103
Query: 142 RKVIIMPGEGLMENQDISVWD---LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
V+ E M+ I+ LQALD+ HS ++HRD+K N+++ + ++L D+
Sbjct: 104 TDVVT---ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS-VKLTDF 159
Query: 199 GLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
G P + + + V + Y+ PE +V + Y +D+WSLG M M+ + P+
Sbjct: 160 GFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL-- 216
Query: 258 HDNQDQLVKIARVLGTDEL 276
++N + + + GT EL
Sbjct: 217 NENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 56/231 (24%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 87
D E V+ +G+G V++ + + +K + +K++ RE+K L++ C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVN--STDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
+VK S++ E+++ S +LLK KV
Sbjct: 60 YVVKCYGAF--YKEGEISIVLEYMDGGSLA------------------DLLK-----KVG 94
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+P L I+ L+ LDY H++ I+HRD+KP N++I+ + + +++ D+G+++
Sbjct: 95 KIPEPVLAY---IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE-VKIADFGISKVL 150
Query: 205 HPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+ N V + + PE + + Y Y+ D+WSLG K PF
Sbjct: 151 ENTLDQCNTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 43/133 (32%), Positives = 70/133 (52%), Gaps = 7/133 (5%)
Query: 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 225
L++ H++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 110 LEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVL 167
Query: 226 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYL-DKYH 284
YD S D +SLGCM ++ P F H +D+ +I R T + L D +
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH-EIDR--MTLTMAVELPDSFS 223
Query: 285 LELDPQLEALVGR 297
EL LE L+ R
Sbjct: 224 PELRSLLEGLLQR 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 40/246 (16%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 92
D++V++K+G+G Y V++ +++N+ +K + + +RE + N +++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--------NEIRI 52
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
L V P++I D L + + K RK L
Sbjct: 53 LASV-----NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRK--------L 99
Query: 153 MENQDISVWD--------LQALDYCHSQGIMHRDVKPHNVMI-DHEQQKLRLIDWGLAEF 203
+ Q+I W LQAL H Q I+HRD+K N+++ ++ K+ D G+++
Sbjct: 100 IPEQEI--WRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIG--DLGISKV 152
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ + ++ PE+ + Y Y D+WSLGC+ M P F QD
Sbjct: 153 LKKNMAKTQ-IGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPP-FEARSMQDL 209
Query: 264 LVKIAR 269
K+ R
Sbjct: 210 RYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIV 96
++ +G+G Y +VF+ VT + I +K +KK I R K
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK------------------ 42
Query: 97 RDQHSKTPSLIFEHVNSTDFKV--LYPTLTANEIRYYIYELLKHA-----MPRKVIIMPG 149
H+K I E V F V +Y T ++ Y I E L + R+ I M
Sbjct: 43 DTAHTKAERNILEAVKHP-FIVDLIYAFQTGGKL-YLILEYLSGGELFMHLEREGIFMED 100
Query: 150 EGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGK 208
+IS+ AL++ H QGI++RD+KP N+++D Q ++L D+GL E H G
Sbjct: 101 TACFYLSEISL----ALEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGT 155
Query: 209 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+ + + PE+L+ + ++D WSLG + M+ PF
Sbjct: 156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 7/134 (5%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 224
L++ H++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEV 166
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYL-DKY 283
L YD S D +SLGCM ++ P F H +D+ +I R+ T +N L D +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH-EIDRM--TLTVNVELPDSF 222
Query: 284 HLELDPQLEALVGR 297
EL LE L+ R
Sbjct: 223 SPELKSLLEGLLQR 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR---VASRYF 219
L+AL H+QG++HRD+K ++++ H+ +++L D+G KE R V + Y+
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCA--QVSKEVPRRKSLVGTPYW 182
Query: 220 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
PEL+ L Y +D+WSLG M M+ + P+F
Sbjct: 183 MAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 31/96 (32%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR---VASRYF 219
L+AL + H+QG++HRD+K ++++ + + ++L D+G KE R V + Y+
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181
Query: 220 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
PE++ L Y +D+WSLG M M+ + P+F
Sbjct: 182 MAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYF 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGG 86
+E + + K+G+G + EVF+GI+ + IKI+ + + I++EI +L C
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 61
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
P + K Y + + + I E L ++
Sbjct: 62 PYVTKY---------------------------YGSYLKDTKLWIIMEYLGGGSALD-LL 93
Query: 147 MPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EF 203
PG L E Q ++ L+ LDY HS+ +HRD+K NV++ E +++L D+G+A +
Sbjct: 94 EPGP-LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQL 151
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
+ N V + ++ PE ++ YD D+WSLG + A + + EP
Sbjct: 152 TDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLG-ITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL Y HS I++RD+KP N+++D Q + L D+GL E K + + + PE
Sbjct: 108 ALGYLHSLNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+L Q YD ++D W LG + M++ PF+
Sbjct: 167 VLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 39/192 (20%), Positives = 78/192 (40%), Gaps = 50/192 (26%)
Query: 38 RKVGRGKYSEVFEGI----NVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 89
+K+G G + EV++G + +K LK ++ RE +I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149
VKLL + ++ ++ E++ D Y L K+
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLL-----------DY----LRKN----------- 95
Query: 150 EGLMENQDISVWDL--------QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+++S+ DL + ++Y S+ +HRD+ N ++ +++ D+GL+
Sbjct: 96 ----RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV-VKISDFGLS 150
Query: 202 EFYHPGKEYNVR 213
+ Y V+
Sbjct: 151 RDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 41/219 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGG 86
+E + + ++G+G + EV++GI+ E IKI+ + + I++EI +L C
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 61
Query: 87 PNIVKLLDIVRDQHSKTPSL--IFEHVNS-TDFKVLYPTLTANEIRYYIYELLKHAMPRK 143
P I + + K L I E++ + +L P YI +L+
Sbjct: 62 PYITRYYG----SYLKGTKLWIIMEYLGGGSALDLLKPGPLEET---YIATILREI---- 110
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-E 202
L+ LDY HS+ +HRD+K NV++ EQ ++L D+G+A +
Sbjct: 111 -------------------LKGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQ 150
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
+ N V + ++ PE ++ YD+ D+WSLG
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKADIWSLG 188
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGP 222
ALD+ HS GI++RD+KP N+++D E+ ++L D+GL++ H K Y+ Y P
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM-AP 167
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAR 269
E +V+ + + S D WS G + M+ P F G D ++ + I +
Sbjct: 168 E-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 4e-09
Identities = 35/184 (19%), Positives = 75/184 (40%), Gaps = 35/184 (19%)
Query: 38 RKVGRGKYSEVFEGI----NVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 89
+K+G G + EV++G + +K LK ++ RE +I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149
VKLL + ++ ++ E++ D + +R +L + +
Sbjct: 64 VKLLGVCTEEEP--LYIVMEYMEGGDLL--------SYLRKNRPKLS---LSDLLSFA-- 108
Query: 150 EGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE 209
I+ + ++Y S+ +HRD+ N ++ +++ D+GL+ +
Sbjct: 109 ------LQIA----RGMEYLESKNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDY 157
Query: 210 YNVR 213
Y R
Sbjct: 158 YRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 67 PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTAN 126
P +K+I RE++I ++ C P IVK D+ S + + E+ +Y +
Sbjct: 40 PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 127 EIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186
R L K A E + L+ L Y HS+ I+HRD+KP N+++
Sbjct: 99 GGRIGEKVLGKIA----------ESV----------LKGLSYLHSRKIIHRDIKPSNILL 138
Query: 187 DHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
+ Q ++L D+G++ E + + ++ PE + + Y + D+WSLG
Sbjct: 139 TRKGQ-VKLCDFGVSGELVNSLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLG 190
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 52/242 (21%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--------VKKKKIKREIKILQNL 83
+D++V VGRG + EV + +K++K V + +R+I + N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHA 139
P I +L +D+ + L+ E+ D L + ++Y+ EL+
Sbjct: 60 --SPWIPQLQYAFQDKDNLY--LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV--- 112
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
A+ H G +HRD+KP NV+ID ++L D+G
Sbjct: 113 ------------------------LAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFG 147
Query: 200 LAEFYHPGKEYNVR--VASRYFKGPELLVDLQD-----YDYSLDMWSLGCMFAGMIFRKE 252
A K N + V + + PE+L + Y D WSLG + MI+ +
Sbjct: 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
Query: 253 PF 254
PF
Sbjct: 208 PF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 93
Y+V +K + E INV N K + I E+ I++ PNIV+
Sbjct: 17 YKVRKKNNGQNLLALKE-INVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRY- 74
Query: 94 DIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLM 153
Y T N+ Y + +L++ A + E
Sbjct: 75 --------------------------YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ 108
Query: 154 ENQDISVWDL-----QALDYCHSQG-IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG 207
+ +W++ AL Y H + I+HRD+ P+N+M+ E K+ + D+GLA+ P
Sbjct: 109 RFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPE 167
Query: 208 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+ V + + PE++ + Y D+W+ GC+ M + PF+
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 48/178 (26%), Positives = 87/178 (48%), Gaps = 22/178 (12%)
Query: 90 VKLLDIVRDQHSKTPSLIF---------EHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
VK++D+ + Q + L+F +H N + +Y + E + + E L+
Sbjct: 51 VKMMDLRKQQRRE---LLFNEVVIMRDYQHQNVVE---MYKSYLVGEELWVLMEFLQGGA 104
Query: 141 PRKVIIMPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
I+ L E Q +V + LQAL Y HSQG++HRD+K ++++ + +++L D+
Sbjct: 105 LTD--IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDF 161
Query: 199 GL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
G A+ + V + Y+ PE ++ Y +D+WSLG M M+ + P+F
Sbjct: 162 GFCAQISKDVPKRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 31/94 (32%), Positives = 55/94 (58%), Gaps = 3/94 (3%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 221
L+AL Y H+QG++HRD+K ++++ + +++L D+G A+ + V + Y+
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186
Query: 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
PE++ L Y +D+WSLG M MI + P+F
Sbjct: 187 PEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
A+ Y HS I++RD+KP N+++D Q + L D+GL E P + + + + PE
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+L + YD ++D W LG + M++ PF+
Sbjct: 167 VLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-09
Identities = 64/259 (24%), Positives = 115/259 (44%), Gaps = 43/259 (16%)
Query: 26 VQWGD-QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK---ILKPVKKKKIKREIKILQ 81
V GD ++ Y K+G+G V+ ++V ++ I+ + + KK+ I EI +++
Sbjct: 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
PNIV LD L +E+ + + E L
Sbjct: 73 E-NKNPNIVNYLD--------------------------SYLVGDEL-WVVMEYLAGGSL 104
Query: 142 RKVIIMPGEGLMENQDISVWD---LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
V+ E M+ I+ LQAL++ HS ++HRD+K N+++ + ++L D+
Sbjct: 105 TDVVT---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDF 160
Query: 199 GLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
G P + + + V + Y+ PE +V + Y +D+WSLG M MI + P+
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 217
Query: 258 HDNQDQLVKIARVLGTDEL 276
++N + + + GT EL
Sbjct: 218 NENPLRALYLIATNGTPEL 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-09
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 42/238 (17%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 88
QED+E+++++G G Y +V++ NV E IK++K P + + ++ I+ C N
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 89 IVKLLD--IVRDQHSKTPSLIFEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPRK 143
IV + RD+ + E + +Y L+ ++I Y E
Sbjct: 68 IVAYFGSYLRRDKL----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE--------- 114
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AE 202
LQ L Y HS+G MHRD+K N+++ + ++L D+G+ A+
Sbjct: 115 ------------------TLQGLYYLHSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQ 155
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
+ + + Y+ PE+ + Y+ D+W++G + + P F H
Sbjct: 156 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 42/219 (19%)
Query: 37 VRKVGRGKYSEVF------EGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGG 86
+R +G G + +V EG N E+ +K LKP +K+EI+IL+NL
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH- 65
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
NIVK I + LI E + S K P N+ + + + LK+A
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYA------- 115
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
V + +DY S+ +HRD+ NV+++ E Q +++ D+GL +
Sbjct: 116 -------------VQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIET 161
Query: 207 GKEYNV----RVASRYFKGPELLVDLQDYDYSLDMWSLG 241
KEY + ++ PE L+ + Y S D+WS G
Sbjct: 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS-DVWSFG 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 29/89 (32%), Positives = 51/89 (57%), Gaps = 2/89 (2%)
Query: 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 225
L+ + I++RD+KP N+++D ++ +R+ D GLA G+ RV + + PE++
Sbjct: 115 LEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI 173
Query: 226 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+ + Y +S D W LGC+ MI + PF
Sbjct: 174 NN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 55/236 (23%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99
+G+G + +V++ V + I +K + KK+I + ++ + G NI +VR
Sbjct: 1 IGKGTFGQVYQ---VRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51
Query: 100 HSKTPSLI---FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQ 156
++P ++ F +D ++ ++ E+ ++ L+ EG
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWH----LQK-----------EGRFSED 96
Query: 157 DISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF-YHPGKEYNV 212
+ + AL++ H I++RD+KP N+++D + L D+GL++ K N
Sbjct: 97 RAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNT 155
Query: 213 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIA 268
+ + PE+L+D + Y +D WSLG + M P FY D Q IA
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP-FYAEDTQQMYRNIA 210
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 45/230 (19%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNIVK 91
+G+G + V+ + + +K ++ P K++ EI++L+NL IV+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQ 68
Query: 92 LLDIVRDQHSKTPSLIFEHVNSTDFK---VLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
+RD +T S+ EH+ K Y LT N R Y ++L
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL------------ 116
Query: 149 GEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG----LAEFY 204
EG+ Y HS I+HRD+K N++ D ++L D+G L
Sbjct: 117 -EGVS--------------YLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTIC 160
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
G + Y+ PE ++ + Y D+WS+GC M+ K P+
Sbjct: 161 LSGTGMKSVTGTPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL Y HS I++RD+KP N+++D Q + L D+GL E + + + PE
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+L Q YD ++D W LG + M++ PF+
Sbjct: 167 VL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVK 91
+E+V VG G Y +V++G +V + IK++ + +++IK EI +L+ NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 92 LLDIVRDQ----HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
+ H L+ E + L N ++ E + R++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK----EDWIAYICREI--- 130
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AEFYHP 206
L+ L + H+ ++HRD+K NV++ E +++L+D+G+ A+
Sbjct: 131 ---------------LRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT 174
Query: 207 GKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLG 241
N + + Y+ PE++ ++ YDY D+WSLG
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 40/259 (15%)
Query: 21 YESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR---EI 77
YE + E +E++ ++G G + +V++ N K+++ +++++ EI
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60
Query: 78 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLK 137
+IL C P IVKLL F + + E
Sbjct: 61 EILAT-CNHPYIVKLLGA------------FYWDGKL---------------WIMIEFCP 92
Query: 138 HAMPRKVIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
+++ GL E Q I L+AL Y HS I+HRD+K NV++ + ++L
Sbjct: 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD-IKL 151
Query: 196 IDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFR 250
D+G+ A+ + + + + Y+ PE+++ ++D YDY D+WSLG M +
Sbjct: 152 ADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-Q 210
Query: 251 KEPFFYGHDNQDQLVKIAR 269
EP + + L+KIA+
Sbjct: 211 IEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 29/98 (29%), Positives = 57/98 (58%), Gaps = 4/98 (4%)
Query: 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 224
L + HS+GI++RD+K N+++D + +++ D+G+ + G + + + PE+
Sbjct: 109 LQFLHSKGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
L+ Q Y+ S+D WS G + M+ + P F+GHD ++
Sbjct: 168 LLG-QKYNTSVDWWSFGVLLYEMLIGQSP-FHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 4e-08
Identities = 49/219 (22%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVK 91
+E+V VG G Y +V++G +V + IK++ ++++IK+EI +L+ NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 92 LLDIVRDQHSKTPS----LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
++ L+ E + L N ++ E + R++
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK----EEWIAYICREI--- 120
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AEFYHP 206
L+ L + H ++HRD+K NV++ E +++L+D+G+ A+
Sbjct: 121 ---------------LRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT 164
Query: 207 GKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLG 241
N + + Y+ PE++ ++ YD+ D+WSLG
Sbjct: 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGG 86
+E + + ++G+G + EVF+GI+ + IKI+ + + I++EI +L C
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 61
Query: 87 PNIVKLLDIVRDQHSKTPSL--IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
P + K + K L I E++ L +E + I +LK
Sbjct: 62 PYVTKYYG----SYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--FQIATMLKEI----- 110
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EF 203
L+ LDY HS+ +HRD+K NV++ EQ ++L D+G+A +
Sbjct: 111 ------------------LKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQL 151
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
+ N V + ++ PE ++ YD D+WSLG
Sbjct: 152 TDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADIWSLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 57/252 (22%), Positives = 114/252 (45%), Gaps = 48/252 (19%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI---IKILK----PVKKKKIKREIKILQN 82
+ED + R +G G++ +V++G+ ++ + I +K K P ++K +E I++
Sbjct: 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 83 LCGGPNIVKLLDIVRDQHSKTPS-LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
P+IVKL+ ++ + P ++ E L P E+R Y+ ++ K+++
Sbjct: 64 F-DHPHIVKLIGVITEN----PVWIVME---------LAPL---GELRSYL-QVNKYSLD 105
Query: 142 RKVIIMPGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
+I+ + Q AL Y S+ +HRD+ NV++ ++L D+
Sbjct: 106 LASLIL-------------YSYQLSTALAYLESKRFVHRDIAARNVLVS-SPDCVKLGDF 151
Query: 199 GLAEFYHPGKEYNVRVASRYFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFF 255
GL+ + Y K PE ++ + + + D+W G CM+ ++ +PF
Sbjct: 152 GLSRYLEDESYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
Query: 256 YGHDNQDQLVKI 267
G N D + +I
Sbjct: 211 -GVKNNDVIGRI 221
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 16/136 (11%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 221
A+ Y H GI+HRD+K N+ + + ++L D+G+++ G EY++ V + Y+
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMS 169
Query: 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV-KIARVLGTDELNAYL 280
PE L Y++ D+W+LGC+ ++ K F N LV KI + T ++ Y
Sbjct: 170 PE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPVVSVYS 226
Query: 281 DKYH------LELDPQ 290
+ L+ DP+
Sbjct: 227 SELISLVHSLLQQDPE 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 34/106 (32%), Positives = 61/106 (57%), Gaps = 5/106 (4%)
Query: 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 224
L + HS+GI++RD+K NVM+D + +++ D+G+ E + + + PE+
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARV 270
L L+ Y +S+D WS G + M+ + P F+G D++D+L + RV
Sbjct: 168 LQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 30/101 (29%), Positives = 55/101 (54%), Gaps = 5/101 (4%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
L + H +GI++RD+K NV++D E +++ D+G+ E G + + + PE
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+L Q Y ++D W+LG + M+ + PF D++D+L
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPF--EGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 221
+ AL+Y HS+ +++RD+K N+M+D + +++ D+GL E G + +
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLA 163
Query: 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
PE+L D DY ++D W LG + M+ + PF+ NQD
Sbjct: 164 PEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 57/247 (23%), Positives = 115/247 (46%), Gaps = 36/247 (14%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR---EIKILQNLCGGP 87
+E +E++ ++G G + +V++ N K++ +++++ EI IL + C P
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS-CDHP 62
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
NIVKLLD + +E+ + +L + + EL + ++ ++
Sbjct: 63 NIVKLLD----------AFYYEN----NLWILIEFCAGGAVDAVMLELERPLTEPQIRVV 108
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AEFYHP 206
+ L+AL+Y H I+HRD+K N++ + ++L D+G+ A+
Sbjct: 109 CKQ-----------TLEALNYLHENKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRT 156
Query: 207 GKEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ + + + Y+ PE+++ + YDY D+WSLG M + EP + +
Sbjct: 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMR 215
Query: 263 QLVKIAR 269
L+KIA+
Sbjct: 216 VLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKI----------KREIKILQN 82
++E++R +G G Y +VF V ++ + +K +KK I + E ++L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-FKVLYPT--LTANEIRYYIYELLKHA 139
+ P +V L Q LI ++VN + F LY T +E+R YI E++
Sbjct: 61 VRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV--- 115
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
ALD+ H GI++RD+K N+++D E + L D+G
Sbjct: 116 ------------------------LALDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFG 150
Query: 200 LAEFYHPGKEY--NVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPF 254
L++ + +E + + PE++ +D ++D WSLG + ++ PF
Sbjct: 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 53/237 (22%), Positives = 103/237 (43%), Gaps = 45/237 (18%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 92
++E+++ +G G Y +VF VT ++ + +K ++K + ++ K ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVE----------- 49
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY-------ELLKHAMPR--- 142
H++T + EHV + F V E + ++ E+ H R
Sbjct: 50 -------HTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF 102
Query: 143 ---KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+V GE ++ AL++ H GI++RD+K N+++D E + L D+G
Sbjct: 103 SEDEVRFYSGEIIL-----------ALEHLHKLGIVYRDIKLENILLDSEGH-VVLTDFG 150
Query: 200 LA-EFYHPGKEYNVR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
L+ EF KE + + PE++ + ++D WSLG + ++ PF
Sbjct: 151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 54/246 (21%), Positives = 112/246 (45%), Gaps = 42/246 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 88
Y V+K+G G + + + + ++ +IK + P ++++ ++E+ +L N+ PN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
IV+ + + + ++ ++ D L K ++ ++ P
Sbjct: 61 IVQYQESF--EENGNLYIVMDYCEGGD-------------------LYKKINAQRGVLFP 99
Query: 149 GEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
+ +++ W +Q AL + H + I+HRD+K N+ + + ++L D+G+A +
Sbjct: 100 EDQILD------WFVQICLALKHVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLN 152
Query: 206 PGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
E + + Y+ PE + + + Y+ D+W+LGC+ M K F G N L
Sbjct: 153 STVELARTCIGTPYYLSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNL 209
Query: 265 V-KIAR 269
V KI R
Sbjct: 210 VLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL + H G+++RD+K N+++D E +L D+G+ E G + + PE
Sbjct: 108 ALMFLHRHGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+L + +Y S+D W+LG + M+ + PF DN+D L
Sbjct: 167 ILQE-LEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 5/101 (4%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL + H +GI++RD+K NV++DHE +L D+G+ E GK + + + PE
Sbjct: 108 ALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+L ++ Y S+D W++G + M+ PF +N+D L
Sbjct: 167 ILQEML-YGPSVDWWAMGVLLYEMLCGHAPF--EAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 54/259 (20%), Positives = 111/259 (42%), Gaps = 48/259 (18%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 92
++E+++ +G G Y +VF V+ ++ + +K +KK I ++ K +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTE----------- 49
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY-------ELLKHAMPR--- 142
H++T + EH+ + F V + + ++ EL H R
Sbjct: 50 -------HTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF 102
Query: 143 ---KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+V I GE ++ AL++ H GI++RD+K N+++D + L D+G
Sbjct: 103 KEQEVQIYSGEIVL-----------ALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFG 150
Query: 200 LAEFYHPG---KEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFF 255
L++ +H + Y+ Y P+++ +D ++D WS+G + ++ PF
Sbjct: 151 LSKEFHEDEVERAYSFCGTIEYM-APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
Query: 256 YGHDNQDQLVKIARVLGTD 274
+ Q R+L ++
Sbjct: 210 VDGEKNSQAEISRRILKSE 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 54/234 (23%), Positives = 84/234 (35%), Gaps = 51/234 (21%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNE--KCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 91
Y ++ + G EVF + + K I+K + K REI IL+ + I+
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRAIIN 150
Query: 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELL-----KHAMPRKVII 146
L+ R + + + Y +L +P + I
Sbjct: 151 LIHAYR----------------------WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI 188
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA----- 201
L+E AL Y H +GI+HRDVK N+ +D + + L D+G A
Sbjct: 189 TIQRRLLE----------ALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLDA 237
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
P + Y + PELL L Y D+WS G + M + F
Sbjct: 238 HPDTP-QCYG-WSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 19/39 (48%), Positives = 24/39 (61%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
L ALD HS GI+HRDVKP N++ ++ID G A
Sbjct: 265 LFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 28/91 (30%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 224
AL+Y HS+ I++RD+KP N+++D E ++L D+G A+ + + + Y PE+
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLR-DRTWTLCGTPEYL-APEV 169
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+ + ++ ++D W+LG + M+ PFF
Sbjct: 170 IQS-KGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 38/230 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 88
Y VR VG+G Y EV + T+ ++ +IK L ++K ++E ++L L PN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
IV R+ L++ + + LY L +
Sbjct: 61 IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK--------------------- 95
Query: 149 GEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
G+ L ENQ + W +Q AL Y H + I+HRD+K NV + +++ D G+A
Sbjct: 96 GKLLPENQVVE-WFVQIAMALQYLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLE 153
Query: 206 PGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+ + + + Y+ PEL + + Y+Y D+W+LGC M K F
Sbjct: 154 NQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 48/221 (21%), Positives = 90/221 (40%), Gaps = 51/221 (23%)
Query: 38 RKVGRGKYSEVFEGI----NVTNNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNI 89
+K+G G + EV++G K +K LK ++++ E I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149
V+LL + + ++ E++ D L + + + +LL+ A
Sbjct: 64 VRLLGVCT--QGEPLYIVTEYMPGGDLLDF---LRKHGEKLTLKDLLQMA---------- 108
Query: 150 EGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE 209
I+ + ++Y S+ +HRD+ N ++ E +++ D+GL+ +
Sbjct: 109 ------LQIA----KGMEYLESKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDY 157
Query: 210 YNVR---------VASRYFKGPELLVDLQDYDYSLDMWSLG 241
Y R +A PE L D + S D+WS G
Sbjct: 158 YRKRGGGKLPIKWMA------PESLKDGKFTSKS-DVWSFG 191
|
Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 152 LMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY-HPG 207
L I W +Q + + H + ++HRD+K N+ + + K++L D+G A PG
Sbjct: 96 LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPG 154
Query: 208 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
V + Y+ PE+ ++ Y+ D+WSLGC+ + K PF
Sbjct: 155 AYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 44/239 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK---IKREIKILQNLCGGP 87
Q DYE++++VG G Y +V++ N+ E +KI+K I++EI +++ C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66
Query: 88 NIVKLLD--IVRDQHSKTPSLIFEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPR 142
NIV + R++ + E+ + +Y L+ +I Y E
Sbjct: 67 NIVAYFGSYLSREKLW----ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE-------- 114
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-A 201
LQ L Y HS+G MHRD+K N+++ + ++L D+G+ A
Sbjct: 115 -------------------TLQGLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAA 154
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
+ + + + Y+ PE+ ++ Y+ D+W++G + + P F H
Sbjct: 155 KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 221
+ ALDY HS I++RD+K N+M+D + +++ D+GL E + +
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLA 163
Query: 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL-------VKIARVLGTD 274
PE+L D DY ++D W LG + M+ + P FY D++ +K R L D
Sbjct: 164 PEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELILMEDIKFPRTLSAD 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL Y HS +++RD+K N+M+D + +++ D+GL E G + + PE
Sbjct: 107 ALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+L D DY ++D W LG + M+ + PF+ NQD
Sbjct: 166 VLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY----NQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 66/249 (26%), Positives = 100/249 (40%), Gaps = 68/249 (27%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR-------EIKILQNLC 84
EDYEVV+ +GRG + EV + + + +K+L K + IKR E + +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
P +V+L +D Y+Y ++++
Sbjct: 101 NSPWVVQLFYAFQDDR------------------------------YLYMVMEY------ 124
Query: 145 IIMPGE---GLMENQDI-SVWD-------LQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193
MPG LM N D+ W + ALD HS G +HRDVKP N+++D + L
Sbjct: 125 --MPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHL 181
Query: 194 RLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD---YDYSLDMWSLGCMFAG 246
+L D+G KE VR V + + PE+L Y D WS+G
Sbjct: 182 KLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 247 MIFRKEPFF 255
M+ PF+
Sbjct: 240 MLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 37/186 (19%)
Query: 76 EIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFK---VLYPTLTANEIRYYI 132
EI++L+NL IV+ +RD+ KT ++ E++ K Y LT + R Y
Sbjct: 54 EIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 133 YELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQK 192
++L + + Y HS I+HRD+K N++ D
Sbjct: 113 RQIL---------------------------EGMSYLHSNMIVHRDIKGANILRD-SAGN 144
Query: 193 LRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248
++L D+G L G + Y+ PE ++ + Y D+WSLGC M+
Sbjct: 145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEML 203
Query: 249 FRKEPF 254
K P+
Sbjct: 204 TEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGP 222
A+D H G +HRD+KP NV++D + +RL D+G L + NV V + + P
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 223 ELLVDLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF 255
E+L ++D Y D WSLG CM+ M++ + PF+
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 65/231 (28%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 87
+ E V ++G G V++ I+ +K++ + +++I REI+IL+++ P
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHP 132
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
N+VK D+ F+H EI+ LL+ M
Sbjct: 133 NVVKCHDM------------FDH--------------NGEIQV----LLEF--------M 154
Query: 148 PGEGLMENQ---------DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
G G +E D++ L + Y H + I+HRD+KP N++I+ + +++ D+
Sbjct: 155 DG-GSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN-VKIADF 212
Query: 199 G----LAEFYHPGKEYNVRVASRYFKGPELL-VDLQD--YD-YSLDMWSLG 241
G LA+ P N V + + PE + DL YD Y+ D+WSLG
Sbjct: 213 GVSRILAQTMDP---CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLG 260
|
Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 29/179 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 87
Y+++R +G+G EV+ + + + +K ++ P+ KK+ RE KI +L P
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
IV + I +D +Y T+ E Y + LLK ++ +
Sbjct: 63 GIVPVYSI-----------------CSDGDPVYYTMPYIE-GYTLKSLLKSVWQKESLSK 104
Query: 148 P-GEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
E +S++ ++Y HS+G++HRD+KP N+++ + + ++DWG A F
Sbjct: 105 ELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 45/238 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL--KPVKKKKIKR------EIKILQNL 83
++ + + +GRG + EV+ + + +K + P ++ K EI++L+NL
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFK---VLYPTLTANEIRYYIYELLKHAM 140
IV+ +RD K S+ E++ K Y LT N R Y ++L
Sbjct: 62 -RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL---- 116
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
Q + Y HS I+HRD+K N++ D ++L D+G
Sbjct: 117 -----------------------QGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGA 152
Query: 201 AE----FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
++ G + Y+ PE ++ + Y D+WS+ C M+ K P+
Sbjct: 153 SKRIQTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 49/220 (22%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR---EIKILQNLCGGPN 88
+ +E++ ++G G + +V++ + KI++ +++++ EI IL C PN
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKV--LYPTLTANEIRYYIYELLKHAMPRKVII 146
IV L + ++ + F + D + L LT +IRY ++L
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML---------- 113
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AEFYH 205
+AL++ HS ++HRD+K N+++ + ++L D+G+ A+
Sbjct: 114 -----------------EALNFLHSHKVIHRDLKAGNILLTLDGD-VKLADFGVSAKNKS 155
Query: 206 PGKEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLG 241
++ + + + Y+ PE++ YDY D+WSLG
Sbjct: 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG 195
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 8/103 (7%)
Query: 149 GEGLMENQDISVWDLQAL---DYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
G+ L ENQ W +Q L Y H + I+HRD+K N+ + + L++ D+G++
Sbjct: 100 GKTLSENQVCE-WFIQLLLGVHYMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLM 156
Query: 206 PGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247
+ + Y+ PE L Q YD D+WSLGC+ M
Sbjct: 157 GSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 8/103 (7%)
Query: 163 LQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 220
+ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G + +
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYL 163
Query: 221 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
PE+L D DY ++D W LG + M+ + PF+ NQD
Sbjct: 164 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY----NQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 224
L + HS+GI++RD+K NVM+D E +++ D+G+ E GK + + PE
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPE- 171
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
++ Q Y S+D W+ G + M+ + PF
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
AL Y HS I++RD+KP N+++D Q + L D+GL E + + PE
Sbjct: 108 ALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE 166
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
++ Q YD ++D W LG + M++ PF+
Sbjct: 167 VIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 60/257 (23%), Positives = 96/257 (37%), Gaps = 59/257 (22%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 93
Y V++ + G VF + ++KI +K E +LQN+ P+++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123
Query: 94 DIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLM 153
D + ++ H +S LY LT + + ++
Sbjct: 124 DTL--VSGAITCMVLPHYSSD----LYTYLTKRSRP---------------LPIDQALII 162
Query: 154 ENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR 213
E Q L+ L Y H+Q I+HRDVK N+ I+ Q + + D G A+F
Sbjct: 163 EKQI-----LEGLRYLHAQRIIHRDVKTENIFINDVDQ-VCIGDLGAAQF---------P 207
Query: 214 VASRYFKG---------PELLVDLQDYDYSLDMWSLGCMFAGM------IFRKEPFF--- 255
V + F G PE+L Y+ D+WS G + M IF P
Sbjct: 208 VVAPAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266
Query: 256 YGHDNQDQLVKIARVLG 272
Y L+KI L
Sbjct: 267 YVKSCHSHLLKIISTLK 283
|
Length = 357 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 26/127 (20%)
Query: 165 ALDYCHSQ-GIMHRDVKPHNVMIDHEQQ---------------KLRLIDWGLAEFYHPGK 208
ALDY H++ +MH D+KP N++++ ++R+ D G
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-----CD 297
Query: 209 EYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265
E + R V++R+++ PE+++ L + YS DMWS+GC+ + + + + HDN + L
Sbjct: 298 ERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLEHLH 355
Query: 266 KIARVLG 272
+ + LG
Sbjct: 356 LMEKTLG 362
|
Length = 467 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 18/98 (18%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFK---G 221
A +Y HS+ I++RD+KP N+++D + +++ D+G A+ +V R F
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAK----------KVPDRTFTLCGT 178
Query: 222 PELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
PE L + + + ++D W++G + I PFF
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 31/102 (30%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGP 222
L + H +GI++RD+K NV++D + +++ D+G+ GK + + + P
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKA-STFCGTPDYIAP 165
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
E+L Q Y+ S+D WS G + M+ + P F+G D +D+L
Sbjct: 166 EILKG-QKYNESVDWWSFGVLLYEMLIGQSP-FHGED-EDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 42/231 (18%)
Query: 37 VRKVGRGKYSEV----FEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGPN 88
+R +G G + +V ++ N E +K LK K+EI IL+ L N
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHEN 67
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
IVK +Q K LI E+V +R Y L KH + +++
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYV------------PLGSLRDY---LPKHKLNLAQLLLF 112
Query: 149 GEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK 208
+ + E + Y HSQ +HRD+ NV++D+++ +++ D+GLA+ G
Sbjct: 113 AQQICE----------GMAYLHSQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAVPEGH 161
Query: 209 EYNVRVASR-----YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
EY RV ++ E L + + Y+ D+WS G ++ +
Sbjct: 162 EY-YRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 29/88 (32%), Positives = 52/88 (59%), Gaps = 5/88 (5%)
Query: 158 ISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVAS 216
I+V ++AL+Y HS+ ++HRDVKP NV+I+ Q ++L D+G++ + +
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGYLVDSVAKTIDAGC 166
Query: 217 RYFKGPELL---VDLQDYDYSLDMWSLG 241
+ + PE + ++ + YD D+WSLG
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLG 194
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR-------EIKILQNLC 84
EDY+VV+ +GRG + EV + ++ + +K+L K + IKR E + +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANE--IRYYIYELLKHAMPR 142
P +V+L +D K ++ E++ D L E ++Y E++
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV------ 152
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA- 201
ALD HS G++HRDVKP N+++D + L+L D+G
Sbjct: 153 ---------------------LALDAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCM 190
Query: 202 EFYHPGKEY-NVRVASRYFKGPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 255
+ G + V + + PE+L Y D WS+G M+ PF+
Sbjct: 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGP 222
A+ H +HRD+KP NV++D +RL D+G L + +V V + + P
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 223 ELLVDLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF 255
E+L ++D Y D WSLG CM+ M++ + PF+
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 7/97 (7%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGP 222
A+D H +HRD+KP N+++D +RL D+G L + +V V + + P
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 223 ELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 255
E+L ++D Y D WSLG M++ + PF+
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 39 KVGRGKYSEVFEGINVTNNEKCIIK----ILKPVKKKKIKREIKILQNLCGGPNIVKLLD 94
++GRG + EVF G +N +K L P K K +E +IL+ PNIV+L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60
Query: 95 IVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLME 154
+ + ++ E V DF L R + EL++ ++E
Sbjct: 61 VCTQKQPIY--IVMELVQGGDFLTF---LRTEGPRLKVKELIQ--------------MVE 101
Query: 155 NQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG---KEYN 211
N ++Y S+ +HRD+ N ++ E+ L++ D+G++ G
Sbjct: 102 NA------AAGMEYLESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGG 154
Query: 212 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244
++ + PE L + Y D+WS G +
Sbjct: 155 MKQIPVKWTAPEAL-NYGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 90
+E ++V+K+G G++ EV+ G N+ K +K LKP +Q N++
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS--------VQAFLEEANLM 55
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYE---------LLKHAMP 141
K L QH K L Y +T E Y I E LK
Sbjct: 56 KTL-----QHDKLVRL-------------YAVVTKEEPIYIITEYMAKGSLLDFLKSDEG 97
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
KV+ L + D S + + Y + +HRD++ NV++ E ++ D+GLA
Sbjct: 98 GKVL------LPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLA 150
Query: 202 EFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYG 257
EY R +++ + PE ++ + D+WS G + ++ + K P + G
Sbjct: 151 RVIE-DNEYTAREGAKFPIKWTAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPG 207
Query: 258 HDNQDQLVKIAR 269
N D + + R
Sbjct: 208 MSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 32/175 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQN---LCGG 86
E++ +V+ + RG + +V+ G N++ +K++K K + +++ ++ L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
P IV L + Q + L+ E++ D K L +IY M K I
Sbjct: 64 PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLL----------HIYGYFDEEMAVKYI- 110
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
E + ALDY H GI+HRD+KP N++I +E ++L D+GL+
Sbjct: 111 --SEVAL-----------ALDYLHRHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 12/99 (12%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 221
L+ L Y H I+HRD+K NV+++ +++ D+G ++ + + + F G
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGT 172
Query: 222 -----PELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
PE++ + Y D+WSLGC M K PF
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 55/231 (23%), Positives = 100/231 (43%), Gaps = 43/231 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 87
+D+E + ++G G VF+ + + K I +KP + +I RE+++L C P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 63
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA--MPRKVI 145
IV S+ EH++ ++LK A +P +++
Sbjct: 64 YIVGFYGAFYSDGEI--SICMEHMDGGSLD----------------QVLKKAGRIPEQIL 105
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+S+ ++ L Y + IMHRDVKP N++++ + +++L D+G++
Sbjct: 106 ----------GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQL 154
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 253
N V +R + PE LQ YS+ D+WS+G M + P
Sbjct: 155 IDSMA-NSFVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKG 221
L AL+ H +++RD+KP N+++D+ Q + L D+GL + + N + +
Sbjct: 103 LCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161
Query: 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
PELL+ Y ++D W+LG + M+ PF+
Sbjct: 162 PELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 42/184 (22%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKRE----IKILQNLCG-- 85
+D+E ++ +GRG + EV +K L+ K + +++E ++ +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 86 -GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMP 141
P +VKL +D LI E++ D L T T E R+YI E +
Sbjct: 59 DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI----- 111
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
A+D H G +HRD+KP N+++D + ++L D+GL
Sbjct: 112 ----------------------LAIDSIHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLC 148
Query: 202 EFYH 205
Sbjct: 149 TGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 33/163 (20%)
Query: 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALD 167
F+ V+ F + Y + ++ Y+I ++ K P+ V +ISV L
Sbjct: 70 FQTVDRLYFVMEY--VNGGDLMYHIQQVGKFKEPQAVFYA--------AEISV----GLF 115
Query: 168 YCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR-VASRYFKG----- 221
+ H +GI++RD+K NVM+D E +++ D+G+ KE+ V V +R F G
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KEHMVDGVTTRTFCGTPDYI 168
Query: 222 -PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
PE++ Q Y S+D W+ G + M+ + PF D +D+
Sbjct: 169 APEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPF----DGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 158 ISVWDLQALDYC-HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVAS 216
++V ++AL Y G++HRDVKP N+++D ++L D+G++ K
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 217 RYFKGPELLVDLQD----YDYSLDMWSLG 241
+ PE + D D YD D+WSLG
Sbjct: 178 AAYMAPERI-DPPDPNPKYDIRADVWSLG 205
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 158 ISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE--FYHPGKEYNVRVA 215
I+V ++ L Y S I+HRDVKP N++++ Q ++L D+G++ K Y V
Sbjct: 100 IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNSIAKTY---VG 155
Query: 216 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267
+ + PE + Q Y D+WSLG F + + P+ NQ L+ +
Sbjct: 156 TNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL 206
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 21/127 (16%)
Query: 147 MPGE---GLMENQDIS-VWD-------LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
MPG LM N DI W + ALD HS G +HRDVKP N+++D + L+L
Sbjct: 125 MPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KSGHLKL 183
Query: 196 IDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMI 248
D+G VR V + + PE+L Y D WS+G M+
Sbjct: 184 ADFGTC--MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 249 FRKEPFF 255
PF+
Sbjct: 242 VGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 33/123 (26%), Positives = 49/123 (39%), Gaps = 40/123 (32%)
Query: 71 KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS----LIFEHVNSTDFKVLYPTLTAN 126
+ +RE + L PNIV LLD + P +FE+V P T
Sbjct: 23 ARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLFAVFEYV---------PGRTLR 67
Query: 127 EIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALD---YCHSQGIMHRDVKPHN 183
E+ + +G + + LQ LD H+QGI+HRD+KP N
Sbjct: 68 EV------------------LAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQN 109
Query: 184 VMI 186
+M+
Sbjct: 110 IMV 112
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
L Y H I++RD+K N+++D E +++ D+GL E G + + F PE
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+L + Y ++D W LG + M+ + PF
Sbjct: 172 VLTE-TSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 46/191 (24%), Positives = 78/191 (40%), Gaps = 39/191 (20%)
Query: 71 KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFK---VLYPTLTANE 127
++ EI++L+NL IV+ +RD +T S+ E++ K Y LT
Sbjct: 49 NALECEIQLLKNL-QHERIVQYYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETV 105
Query: 128 IRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187
R Y ++L + ++Y HS I+HRD+K N++ D
Sbjct: 106 TRKYTRQIL---------------------------EGVEYLHSNMIVHRDIKGANILRD 138
Query: 188 HEQQKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
++L D+G L G + Y+ PE ++ + Y D+WS+GC
Sbjct: 139 -SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCT 196
Query: 244 FAGMIFRKEPF 254
M+ K P+
Sbjct: 197 VVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVA---SRYFKG 221
ALD HS+ +MHRD+K N+ + ++L D+G ++ Y +V + + Y+
Sbjct: 181 ALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
PEL + + Y DMWSLG + ++ PF
Sbjct: 240 PELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 32/103 (31%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPE 223
L + HS+GI++RD+K NVM+D E +++ D+G+ E G + + PE
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171
Query: 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266
++ Q Y S+D W+ G + M+ + P F G D +D+L +
Sbjct: 172 IIA-YQPYGKSVDWWAFGVLLYEMLAGQAP-FEGED-EDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 50/225 (22%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
D+ +++RK+G G++ EV+EG+ N +K LKP + K E +I++ L
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL---- 58
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKH--------A 139
+H P LI LY T E Y + EL+K+
Sbjct: 59 -----------RH---PKLI----------QLYAVCTLEEPIYIVTELMKYGSLLEYLQG 94
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+ + +P + D++ + Y +Q +HRD+ NV++ E ++ D+G
Sbjct: 95 GAGRALKLP-----QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFG 148
Query: 200 LAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 241
LA Y R +++ + PE + D+WS G
Sbjct: 149 LARVIKE-DIYEAREGAKFPIKWTAPE-AALYNRFSIKSDVWSFG 191
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 26/111 (23%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE---------FYHPGKEYNVRVA 215
AL+Y H+ GI+HRD+KP N++I ++L D+GL++ Y E ++
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY----EGHIEKD 167
Query: 216 SRYFK-----------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+R F PE+++ Q Y +D W++G + + PFF
Sbjct: 168 TREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFF 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 30/133 (22%), Positives = 51/133 (38%), Gaps = 33/133 (24%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL---------AEFYHPGKEYNVRVA 215
AL+Y H GI++RD+KP N+++ HE + L D+ L K
Sbjct: 115 ALEYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 216 SRY---------------FKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+ F G PE++ + ++D W+LG + M++ PF
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPF 232
Query: 255 FYGHDNQDQLVKI 267
G + + I
Sbjct: 233 K-GSNRDETFSNI 244
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 15/87 (17%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF--------YHPGKEYNVRV 214
L A+DY H +GI+HRD+K NV+++ + + L D+G A F +H G V
Sbjct: 270 LSAIDYIHGEGIIHRDIKTENVLVNGPED-ICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 215 ASRYFKGPELLVDLQDYDYSLDMWSLG 241
PE+L Y S+D+WS G
Sbjct: 329 -----NAPEVLAG-DPYTPSVDIWSAG 349
|
Length = 461 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 48/231 (20%), Positives = 92/231 (39%), Gaps = 45/231 (19%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGI--NVTNNE---KCIIKILKPV----KKKKIKREIKIL 80
+E ++R++G+G + V+EG+ V E + IK + ++ + E ++
Sbjct: 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM 63
Query: 81 QNL-CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA 139
+ C ++V+LL +V + ++ E + D K L+
Sbjct: 64 KEFNC--HHVVRLLGVVSTG--QPTLVVMELMAKGDLK----------------SYLRSR 103
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALD---YCHSQGIMHRDVKPHNVMIDHEQQKLRLI 196
P PG G Q + D Y ++ +HRD+ N M+ E +++
Sbjct: 104 RPEAENN-PGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLTVKIG 161
Query: 197 DWGLA------EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
D+G+ ++Y G + + V R+ PE L D + D+WS G
Sbjct: 162 DFGMTRDIYETDYYRKGGKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 24/126 (19%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRV-ASRYF-- 219
L+A+ Y H I+HRD+K N+ I+H + L D+G A + V + A++Y+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGD-VCLGDFGAA-------CFPVDINANKYYGW 243
Query: 220 ------KGPELLVDLQDYDYSLDMWSLGCMFAGM------IFRKEPFFYGHDNQDQLVKI 267
PELL Y ++D+WS G + M +F K+ D+ Q+ I
Sbjct: 244 AGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302
Query: 268 ARVLGT 273
R GT
Sbjct: 303 IRRSGT 308
|
Length = 391 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 156 QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
++I L L+Y H GI H D+KP N+M+D + +ID+G+A +
Sbjct: 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 35/192 (18%)
Query: 65 LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLT 124
+KP + +I RE+++L C P IV S+ EH++
Sbjct: 42 IKPAIRNQIIRELQVLHE-CNSPYIVGFYGAFYSDGEI--SICMEHMDGGSLD------- 91
Query: 125 ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHN 183
++LK A +++ P E L + +S+ L+ L Y + IMHRDVKP N
Sbjct: 92 ---------QVLKEA--KRI---PEEILGK---VSIAVLRGLAYLREKHQIMHRDVKPSN 134
Query: 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL--DMWSLG 241
++++ + +++L D+G++ N V +R + PE LQ YS+ D+WS+G
Sbjct: 135 ILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE---RLQGTHYSVQSDIWSMG 189
Query: 242 CMFAGMIFRKEP 253
+ + P
Sbjct: 190 LSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 54/246 (21%), Positives = 94/246 (38%), Gaps = 46/246 (18%)
Query: 40 VGRGKYSEVFEGINV------TNNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 89
+G G + EV+EG + + +K L+ +KK+ +E ++ N PNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149
VKLL + + +I E + D LL + +V
Sbjct: 62 VKLLGVCLLNEPQ--YIIMELMEGGD-------------------LLSYLRDARVERFGP 100
Query: 150 EGL--MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLI----DWGLAEF 203
L E DI + + Y +HRD+ N ++ + + D+GLA
Sbjct: 101 PLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
Query: 204 YHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPFFYGH 258
+ Y + R+ PE L+D + S D+WS G M+ + ++P +
Sbjct: 161 IYKSDYYRKEGEGLLPVRWM-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPAL 217
Query: 259 DNQDQL 264
+NQ+ L
Sbjct: 218 NNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 105 SLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI---IMPGEGLMENQDISVW 161
S +F H N ++ + + NE+ + + + + + +I M G + I
Sbjct: 53 SKLFNHPNIVPYRATF--IADNEL-WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQG 109
Query: 162 DLQALDYCHSQGIMHRDVKPHNVMIDHEQQ--------KLRLIDWGL-AEFYHPGKEYNV 212
L+ALDY H G +HR VK +++I + + L +I+ G H +Y+V
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSV 169
Query: 213 RVASRYFKGPELL-VDLQDYDYSLDMWSLG 241
+V + PE+L +LQ YD D++S+G
Sbjct: 170 KVLP--WLSPEVLQQNLQGYDAKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG----LAEFYHPGKEYNVRVASR- 217
L + Y H+ ++HRD+K +NVM+ ++LID+G LA G N+ +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 218 --YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
Y+ PE++ + Y D+WS+GC M K P
Sbjct: 171 TPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 46/134 (34%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL---------AEFYHPG-------- 207
A++ H G +HRD+KP N++ID + ++L D+GL +++Y G
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 208 -----------------KEYNVR----------VASRYFKGPELLVDLQDYDYSLDMWSL 240
+ R V + + PE+L+ Y D WS+
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV 230
Query: 241 GCMFAGMIFRKEPF 254
G + M+ + PF
Sbjct: 231 GVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 43/219 (19%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 87
+D+E + ++G G V + ++ + K I +KP + +I RE+K+L C P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVN--STDFKVLYPTLTANEIRYYIYELLKHA--MPRK 143
IV S+ EH++ S D ++LK A +P
Sbjct: 60 YIVGFYGAF--YSDGEISICMEHMDGGSLD------------------QVLKKAGRIPEN 99
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
++ G+ IS+ L+ L Y + IMHRDVKP N++++ + +++L D+G++
Sbjct: 100 IL---GK-------ISIAVLRGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSG 148
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
N V +R + PE L Y D+WSLG
Sbjct: 149 QLIDSMA-NSFVGTRSYMSPERLQG-THYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 51/250 (20%), Positives = 101/250 (40%), Gaps = 46/250 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGP 87
+E++ + RK+G G + EV+EG+ N + IKILK +K++ ++E++ L+ L
Sbjct: 5 REEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL---- 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
+H S L+ + E Y I EL++ +
Sbjct: 60 -----------RHKHLIS-------------LFAVCSVGEPVYIITELMEKGSLLAFLRS 95
Query: 148 PGE---GLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA--- 201
P + D++ + + Y Q +HRD+ N+++ E ++ D+GLA
Sbjct: 96 PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLI 154
Query: 202 --EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
+ Y + ++ ++ PE + D+WS G + M + + G +
Sbjct: 155 KEDVYLS---SDKKIPYKW-TAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
Query: 260 NQDQLVKIAR 269
N + +I
Sbjct: 210 NHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 77/268 (28%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKK---IKREIKILQNLCG 85
+D+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPR 142
G +VK+ +D+ + LI E + D L TL+ ++YI E
Sbjct: 60 GAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE-------- 109
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-- 200
+ A+D H G +HRD+KP N+++D + ++L D+GL
Sbjct: 110 -------------------TVLAIDAIHQLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCT 149
Query: 201 -------AEFY-----HPGKEYNVR----------------------VASRYFKGPELLV 226
EFY +P +++ + V + + PE+ +
Sbjct: 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209
Query: 227 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
Y+ D WSLG + M+ PF
Sbjct: 210 Q-TGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 7e-04
Identities = 30/156 (19%), Positives = 55/156 (35%), Gaps = 37/156 (23%)
Query: 55 TNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113
T +E ++KI K +RE+ ILQ L V + + + L+ E +
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77
Query: 114 TDFKVL---YPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170
+ A ++ + +L H +P V+
Sbjct: 78 ETLDEVSEEEKEDIAEQLAELLAKL--HQLPLLVLC------------------------ 111
Query: 171 SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
H D+ P N+++D + + L +IDW A + P
Sbjct: 112 -----HGDLHPGNILVD-DGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 33/203 (16%), Positives = 74/203 (36%), Gaps = 38/203 (18%)
Query: 37 VRKVGRGKYSEVFEGINVTNNEKCIIKI-LKPVKKKKIKREIKILQNLCG-GPNIVKLLD 94
+R + G + + T + + ++K+ ++++RE+ +L++L G + ++L
Sbjct: 2 LRPLSGGASNRTYLV--GTGDGRYVLKLAPPAEAAEELRRELALLRHLAAAGIPVPRVLA 59
Query: 95 IVRDQH-SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLK-----HAMPRKVIIMP 148
D P L+ E + +VL L E + L + H++P + + +
Sbjct: 60 GGTDGGGLGLPFLLMEGL---PGEVLTRPLDPAERGALLEALARLLARLHSVPPEALPLA 116
Query: 149 GEG---------LMENQDISVW----------DLQALDYCHSQ------GIMHRDVKPHN 183
L V + L + ++H D+ P N
Sbjct: 117 RRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGN 176
Query: 184 VMIDHEQQKLRLIDWGLAEFYHP 206
+++D + +ID+ A P
Sbjct: 177 LLVDPGGRVTGVIDFEDAGLGDP 199
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 224
AL+ H I+H D+K NV+ D + ++ L D+GL + Y+ + YF PE
Sbjct: 121 ALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD--YFS-PEK 177
Query: 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
+ +YD S D W++G + ++ K PF D
Sbjct: 178 IKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 57/253 (22%), Positives = 100/253 (39%), Gaps = 47/253 (18%)
Query: 30 DQEDYEVVRKVGRGKYSEV----FEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCG 85
ED E + +G G V +K + K +K+I RE++I+ C
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CR 61
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
P IV ++++ + F S D + K P V
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLD------------------RIYKKGGPIPVE 103
Query: 146 IMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
I+ I+V ++ L Y ++ IMHRD+KP N++++ Q ++L D+G++
Sbjct: 104 IL--------GKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ-IKLCDFGVS--- 151
Query: 205 HPGKEYN----VRVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGH 258
G+ N V + + PE +Q Y++ D+WSLG + K PF + +
Sbjct: 152 --GELINSIADTFVGTSTYMSPE---RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206
Query: 259 DNQDQLVKIARVL 271
+ D +L
Sbjct: 207 IDDDGQDDPMGIL 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 26/85 (30%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 164 QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP----GKEYNVRVASRYF 219
+ ++Y SQ +HRD+ NV++ E +++ D+GLA H K N R+ ++
Sbjct: 145 RGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM 203
Query: 220 KGPELLVDLQDYDYSLDMWSLGCMF 244
PE L D + Y + D+WS G +
Sbjct: 204 -APEALFD-RVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 164 QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP----GKEYNVRVASRYF 219
+ ++Y S+ +HRD+ NV++ E +++ D+GLA H K N R+ ++
Sbjct: 151 RGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM 209
Query: 220 KGPELLVDLQDYDYSLDMWSLGCMF 244
PE L D + Y + D+WS G +
Sbjct: 210 -APEALFD-RIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 7/84 (8%)
Query: 164 QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP----GKEYNVRVASRYF 219
+ ++Y SQ +HRD+ NV++ E +++ D+GLA + K N R+ ++
Sbjct: 148 RGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWM 206
Query: 220 KGPELLVDLQDYDYSLDMWSLGCM 243
PE L D + Y + D+WS G +
Sbjct: 207 -APEALFD-RVYTHQSDVWSFGVL 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 16/41 (39%), Positives = 27/41 (65%), Gaps = 1/41 (2%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
A++ H G +HRD+KP N++ID ++L D+GL+ +H
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 38/212 (17%)
Query: 38 RKVGRGKYSEVFEGINVTNNE---KCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 94
K+G+G + +V++G+ N E K L P K+K +E +IL+ PNIVKL+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59
Query: 95 IVRDQHSKTPSLI-FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLM 153
+ K P I E V L + R + +LL+
Sbjct: 60 VCVQ---KQPIYIVMELVPGGSLLTF---LRKKKNRLTVKKLLQ---------------- 97
Query: 154 ENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR 213
+S+ ++Y S+ +HRD+ N ++ L++ D+G++ G Y V
Sbjct: 98 ----MSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSREEEGG-IYTVS 151
Query: 214 VASRY----FKGPELLVDLQDYDYSLDMWSLG 241
+ + PE L + Y D+WS G
Sbjct: 152 DGLKQIPIKWTAPEAL-NYGRYTSESDVWSYG 182
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.003
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 4/87 (4%)
Query: 158 ISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVAS 216
I+V ++AL+Y + I+HRDVKP N+++D ++L D+G++
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 217 RYFKGPELLV--DLQDYDYSLDMWSLG 241
R + PE + YD D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 332 | |||
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.01 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.53 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.27 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.14 | |
| PLN02236 | 344 | choline kinase | 96.79 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.68 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.66 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.3 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.29 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.15 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.08 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.8 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.61 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.21 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.17 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 94.62 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.17 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.07 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.53 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-59 Score=378.59 Aligned_cols=305 Identities=75% Similarity=1.219 Sum_probs=290.7
Q ss_pred CCccccccccccCCCCCccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHH
Q 040656 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKIL 80 (332)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l 80 (332)
.|.|+|||+++...|++||||+++.++|++.++|++.+++|+|.+++||.|....+++.++||++++..++++.+|+.||
T Consensus 7 ~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL 86 (338)
T KOG0668|consen 7 PSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKIL 86 (338)
T ss_pred chhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHH
Confidence 37899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHH
Q 040656 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISV 160 (332)
Q Consensus 81 ~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (332)
+.|+.||||++++++..++.+..+.+|+|+.+..++..+++.++..+.+.++.++++
T Consensus 87 ~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLk----------------------- 143 (338)
T KOG0668|consen 87 QNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLK----------------------- 143 (338)
T ss_pred HhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHH-----------------------
Confidence 999889999999999999999999999999999999999999999999999999998
Q ss_pred hHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHH
Q 040656 161 WDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240 (332)
Q Consensus 161 ~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSl 240 (332)
||.|+|+.||.|||+||.|+|++....+++|+|+|+|.+.+++...+..+.+..|..||.+..-+.|+..-|+|||
T Consensus 144 ----ALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~ 219 (338)
T KOG0668|consen 144 ----ALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL 219 (338)
T ss_pred ----HHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHH
Confidence 9999999999999999999999998888999999999999999999999999999999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccc--ccc
Q 040656 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCR--SSR 316 (332)
Q Consensus 241 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~--~~~ 316 (332)
||++..|+..+.||+.+.++.+++.+|.+.+|+..+..++.++..+++|+..+++.+- .+|..+....++.+. ..-
T Consensus 220 GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peai 299 (338)
T KOG0668|consen 220 GCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAI 299 (338)
T ss_pred HHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHH
Confidence 9999999999999999999999999999999999999999999999999999999877 899988887776554 445
Q ss_pred ccCceEEEeCCCCCCC
Q 040656 317 TSTNICITFSPSGFPF 332 (332)
Q Consensus 317 ~~~~~cl~~dP~~RP~ 332 (332)
+|+++.|.+|-++||+
T Consensus 300 DlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 300 DLLDKLLRYDHQERLT 315 (338)
T ss_pred HHHHHHHhhccccccc
Confidence 8899999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=336.22 Aligned_cols=231 Identities=29% Similarity=0.523 Sum_probs=200.9
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
....++|++++.||+|+||.||.++...+++.+|+|++++. +.+....|..+|.++ +||+|+.++..| ++.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysF--Qt~ 97 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSF--QTE 97 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEec--ccC
Confidence 45679999999999999999999999999999999999753 245688999999998 999999999999 666
Q ss_pred CCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+|+|+||+.||.|..+++ .+++..++.|+.+++. ||.|||++||||||
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~l---------------------------AL~~LH~~gIiyRD 150 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVL---------------------------ALGYLHSKGIIYRD 150 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHH---------------------------HHHHHHhCCeeecc
Confidence 78999999999999999885 7999999999999987 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|||+|||++.+| +++|+|||+++... .+....+++||+.|||||++.+ ..|+.++|.||||+++|||++|..|| .+
T Consensus 151 lKPENILLd~~G-Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF-~~ 227 (357)
T KOG0598|consen 151 LKPENILLDEQG-HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPF-YA 227 (357)
T ss_pred CCHHHeeecCCC-cEEEeccccchhcccCCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCC-cC
Confidence 999999999777 89999999998544 3455677899999999999988 78999999999999999999999999 46
Q ss_pred CCCHHHHHHHHHHh-------CCchHHHHHHhcCCCCChhHH
Q 040656 258 HDNQDQLVKIARVL-------GTDELNAYLDKYHLELDPQLE 292 (332)
Q Consensus 258 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 292 (332)
.+......+|.+.- .+...++++.++ +..+|..|
T Consensus 228 ~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L-L~rdp~~R 268 (357)
T KOG0598|consen 228 EDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL-LKRDPRQR 268 (357)
T ss_pred ccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH-hccCHHHh
Confidence 66677777777654 234566677666 56666655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=341.47 Aligned_cols=194 Identities=22% Similarity=0.410 Sum_probs=172.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEec----ccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++.+.+..||+|..|+||+|+++.+++.+|+|++. ...++++.+|+++++.. +||+||.+||.|+++.. ..+++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence 47899999999999999999999999999999993 34567889999999999 99999999999987654 69999
Q ss_pred EeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlkp~N 183 (332)
||||++|+|..++. ++++..+..++.+++. ||.|||. ++||||||||+|
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~---------------------------GL~YLh~~~~IIHRDIKPsN 209 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLR---------------------------GLSYLHEERKIIHRDIKPSN 209 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHhhccCeeeccCCHHH
Confidence 99999999999875 4777777666666665 9999995 999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
||++..+ .|||+|||.+..+... -..+++||..|||||.+.+ ..|+.++||||||++++|+++|+.||-+.
T Consensus 210 lLvNskG-eVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 210 LLVNSKG-EVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred eeeccCC-CEEeccccccHHhhhh-hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 9999777 7999999999877644 5678899999999999988 78999999999999999999999999543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=340.35 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=195.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----------hHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
..+.|.+.+.||+|+||.|-+|...++|+.||||+++++. ...+++|+++|++| +|||||+++++|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence 4577999999999999999999999999999999997432 23468999999999 999999999999654
Q ss_pred CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...|+||||+.||+|.... ..+.+...+.+++|++. |+.|||+.||+|
T Consensus 249 --ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~---------------------------avkYLH~~GI~H 299 (475)
T KOG0615|consen 249 --DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLT---------------------------AVKYLHSQGIIH 299 (475)
T ss_pred --CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHH---------------------------HHHHHHHcCccc
Confidence 4569999999999988864 56778888888888887 999999999999
Q ss_pred cCCCCCCeeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCC--CCCCcccHHHHHHHHHHHHhCCC
Q 040656 177 RDVKPHNVMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~sDiwSlG~il~elltg~~ 252 (332)
|||||+|||+..+ .-.+||+|||+|+..+......++|||+.|.|||++.+.. .+..+.|+||+||++|-+++|.+
T Consensus 300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 300 RDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred ccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 9999999999755 2368999999999998788888999999999999997632 24458899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhC----------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLG----------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIPN 305 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~ 305 (332)
||.....+....++|.++-- ++...+++.++ +.++|+.|..+... |||+...
T Consensus 380 PFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~m-L~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 380 PFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWM-LVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred CcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHh-hEeCcccCcCHHHHhcChhhhcc
Confidence 99544444334455544311 23344555554 55566555555444 6776533
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=351.08 Aligned_cols=264 Identities=27% Similarity=0.491 Sum_probs=216.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.-++|.++++||.|.||.||+|....+++.||||.+++.. .-.-.+|+..|+++..|||||++.+++.+.+. +++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 4588999999999999999999999999999999987432 12347899999999569999999999987654 899
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|||||+.+.+..+. ..+++..++.++.|++. ||+|+|.+|+.|||+||+
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~Qilq---------------------------GL~hiHk~GfFHRDlKPE 139 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQ---------------------------GLAHIHKHGFFHRDLKPE 139 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHH---------------------------HHHHHHhcCcccccCChh
Confidence 999999988776654 34788888888887776 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|||+.... .+||+|||+|+.+......+.++.|++|+|||+++....|+.+.||||+|||++|+.+-++. +++.++.+
T Consensus 140 NiLi~~~~-~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL-FPG~sE~D 217 (538)
T KOG0661|consen 140 NILISGND-VIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL-FPGASEID 217 (538)
T ss_pred heEecccc-eeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc-CCCCcHHH
Confidence 99998555 79999999999998888889999999999999999888999999999999999999998855 59999999
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC---CCCCCCCccc---ccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK---RVWPIPNNKK---LQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~---~~~~~~~~~~---~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
++.+|...+|++...+|... ..+...+ .|........ .......-.++..|+.|||.+||+
T Consensus 218 qi~KIc~VLGtP~~~~~~eg---------~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT 284 (538)
T KOG0661|consen 218 QIYKICEVLGTPDKDSWPEG---------YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT 284 (538)
T ss_pred HHHHHHHHhCCCccccchhH---------HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc
Confidence 99999999999877665553 1222222 2222111111 112222347788899999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=349.59 Aligned_cols=239 Identities=23% Similarity=0.452 Sum_probs=197.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc------cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
...+|+..+.||+|||+.||.+++..+|+.||+|++.+ ...+++.+|++|.+.| +|||||+++++|+ ++.+
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FE--Ds~n 92 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFE--DSNN 92 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEee--cCCc
Confidence 45789999999999999999999999999999999964 2457899999999999 9999999999995 4578
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.|++.|+|..+++..++ ..+++.++++++.|++. ||.|||+++|+|||||
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~---------------------------GlkYLH~~~IiHRDLK 145 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVE---------------------------GLKYLHSLGIIHRDLK 145 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHH---------------------------HHHHHHhcCceecccc
Confidence 99999999999998886 46999999999999988 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
..|++++.+. .|||+|||+|+.+... +...+.|||+.|.|||++.. ..+++.+||||+|||+|.|++|++||. ..+
T Consensus 146 LGNlfL~~~~-~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFe-tk~ 222 (592)
T KOG0575|consen 146 LGNLFLNENM-NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFE-TKT 222 (592)
T ss_pred hhheeecCcC-cEEecccceeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcc-cch
Confidence 9999999666 6999999999988755 56678899999999999986 789999999999999999999999993 333
Q ss_pred CHHHHHHHHHHhC------CchHHHHHHhcCCCCChhHHHHhccC--CCCC
Q 040656 260 NQDQLVKIARVLG------TDELNAYLDKYHLELDPQLEALVGRK--RVWP 302 (332)
Q Consensus 260 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 302 (332)
-.+.+.+|...-- +..+.+++.++ ++.+|..|..+..+ |+|+
T Consensus 223 vkety~~Ik~~~Y~~P~~ls~~A~dLI~~l-L~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 223 VKETYNKIKLNEYSMPSHLSAEAKDLIRKL-LRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHHHHHHHhcCcccccccCHHHHHHHHHH-hcCCcccCCCHHHHhcCHhh
Confidence 4455555544311 22334444444 44444444444443 4444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=336.29 Aligned_cols=206 Identities=31% Similarity=0.575 Sum_probs=179.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
...+|.+.++||+|+||+||+|+++.++..||||.+.+.. .+-+..|+.+|+.+ +|||||.+++++.+ ...+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~--~~~i 84 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIED--DDFI 84 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEec--CCeE
Confidence 3478999999999999999999999999999999997542 34567899999999 89999999999954 4589
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
|+|||||.||+|..++ +.+++..++.++.|+.. ||++||+++||||||||
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~---------------------------alq~L~~~~IiHRDLKP 137 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLAS---------------------------ALQFLHENNIIHRDLKP 137 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeeccCCc
Confidence 9999999999999986 46788888888888776 99999999999999999
Q ss_pred CCeeecCC-C----CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDHE-Q----QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~~-~----~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+|||++.. + -.+||+|||+|+.+..+.-..+.+|++.|||||++.. +.|+.|+|+||+|+++|++++|..|| .
T Consensus 138 QNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf-~ 215 (429)
T KOG0595|consen 138 QNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPF-D 215 (429)
T ss_pred ceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCc-c
Confidence 99999764 1 2589999999999987777788899999999999976 78999999999999999999999999 3
Q ss_pred CCCCHHHHHHH
Q 040656 257 GHDNQDQLVKI 267 (332)
Q Consensus 257 ~~~~~~~~~~~ 267 (332)
.....+.+..+
T Consensus 216 a~t~~eL~~~~ 226 (429)
T KOG0595|consen 216 AETPKELLLYI 226 (429)
T ss_pred ccCHHHHHHHH
Confidence 44444444433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=326.79 Aligned_cols=211 Identities=34% Similarity=0.649 Sum_probs=188.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|+.+.++|+|+||+||+|+++.||+.||||.+...+ ++...+|+++|+++ +|+|+|.++++|.. ...+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrr--krklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRR--KRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHh--cceeEE
Confidence 57999999999999999999999999999999986433 35578999999999 99999999999954 467999
Q ss_pred EEeeecCCCceee---ccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||++..-|..+ -..++.+.++.+++|++. |+.|+|+++++||||||+|
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~---------------------------ai~~cHk~n~IHRDIKPEN 131 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLK---------------------------AIHFCHKNNCIHRDIKPEN 131 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHH---------------------------HhhhhhhcCeecccCChhh
Confidence 9999998776665 356788888888888887 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.++ .+||+|||+|+.+. ++...+.++.|++|+|||.+.+...|+.+.||||+||++.||++|.+-| ++..+.+
T Consensus 132 ILit~~g-vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~-PG~SDiD 209 (396)
T KOG0593|consen 132 ILITQNG-VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW-PGRSDID 209 (396)
T ss_pred eEEecCC-cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC-CCcchHH
Confidence 9999777 79999999999887 6777888999999999999999889999999999999999999999665 8999999
Q ss_pred HHHHHHHHhCCc
Q 040656 263 QLVKIARVLGTD 274 (332)
Q Consensus 263 ~~~~~~~~~~~~ 274 (332)
++-.|...+|.-
T Consensus 210 QLy~I~ktLG~L 221 (396)
T KOG0593|consen 210 QLYLIRKTLGNL 221 (396)
T ss_pred HHHHHHHHHccc
Confidence 999999988753
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=328.05 Aligned_cols=264 Identities=29% Similarity=0.513 Sum_probs=214.3
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC---CceeEEe
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK---TPSLIFE 109 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~---~~~lv~e 109 (332)
.|+-.+.+|+|+||.||+|...++++.||||.... ..+.-.+|+++|+++ .||||+++..+|...++. .+.+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~-d~r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQ-DKRYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecC-CCCcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 48899999999999999999999999999998753 223346899999999 999999999888654433 6778999
Q ss_pred eecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 110 HVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 110 ~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|++......+. ..++..+++.|.+|++. ||+|||+.||+||||||+|
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfr---------------------------gl~yLh~~~IcHRDIKPqN 155 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFR---------------------------GLAYLHSHGICHRDIKPQN 155 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHH---------------------------HHHHHHhcCcccCCCChhe
Confidence 99977655554 56778888888888887 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
+|+|.+.+.+||+|||.|+.+..++...++..|+.|+|||.+.+...|+.+.||||.||++.||+-|+..| ++.+..++
T Consensus 156 lLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF-pG~s~~dQ 234 (364)
T KOG0658|consen 156 LLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF-PGDSSVDQ 234 (364)
T ss_pred EEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc-CCCCHHHH
Confidence 99999988999999999999998999899999999999999999889999999999999999999999555 89999999
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+..|.+.+|.+...+ +..+.+..... ...++ ++|.+.. .....++.-+|+.++|.++|.+|-+
T Consensus 235 L~eIik~lG~Pt~e~-I~~mn~~y~~~---~~p~ik~~~~~~~~--~~~~~~d~~dll~~~L~Y~P~~R~~ 299 (364)
T KOG0658|consen 235 LVEIIKVLGTPTRED-IKSMNPNYTEF---KFPQIKAHPWHKVF--FKRLPPDALDLLSKLLQYSPSKRLS 299 (364)
T ss_pred HHHHHHHhCCCCHHH-HhhcCcccccc---cCcccccccceeec--ccCCCHHHHHHHHHHhccChhhcCC
Confidence 999999999887544 33333332211 11112 5664411 1112222348889999999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=337.20 Aligned_cols=245 Identities=28% Similarity=0.454 Sum_probs=207.4
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.....+|.+++.||+|+|++|++|+...+++.+|||++.+. ..+.+..|-.+|.+|.+||.|++++..|.| .
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--E 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--c
Confidence 44568999999999999999999999999999999998753 235688999999999999999999999954 5
Q ss_pred CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+|+|+||+++|+|..++ +.+.+...++|+.+++. ||+|||++||||||
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIld---------------------------AleylH~~GIIHRD 199 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILD---------------------------ALEYLHSNGIIHRD 199 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHH---------------------------HHHHHHhcCceecc
Confidence 6799999999999988774 67999999999999988 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc--------------ccccccccceeccccccCCCCCCCcccHHHHHHHH
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il 244 (332)
|||+|||++.++ +++|+|||.|+.+..... ..+++||..|.+||++.. ...++.+|+|+||||+
T Consensus 200 lKPENILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCil 277 (604)
T KOG0592|consen 200 LKPENILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCIL 277 (604)
T ss_pred CChhheeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHH
Confidence 999999999777 899999999987653221 145899999999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHhC------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCCC
Q 040656 245 AGMIFRKEPFFYGHDNQDQLVKIARVLG------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIPN 305 (332)
Q Consensus 245 ~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~ 305 (332)
|+|+.|.+|| .+.++.-.+++|+...- .+...+++.++ +-.+|.-|..++++ |||+...
T Consensus 278 yQmlaG~PPF-ra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KL-Lv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 278 YQMLAGQPPF-RAANEYLIFQKIQALDYEFPEGFPEDARDLIKKL-LVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred HHHhcCCCCC-ccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHH-HccCccccccHHHHhhCcccccC
Confidence 9999999999 67788888888887633 34555666666 56666666666666 6666544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=337.00 Aligned_cols=268 Identities=28% Similarity=0.532 Sum_probs=213.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..+.|+.+++||+|.||.||+|++..+|+.||+|.++... .....+|+.||++| +||||+++.+...+..+..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceE
Confidence 4478999999999999999999999999999999987432 34578999999999 99999999999987767789
Q ss_pred eeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
|+|||||+......+.. .+++.+++.|++|++. ||+|+|++||+|||||.
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~---------------------------Gl~~cH~~gvlHRDIK~ 246 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLE---------------------------GLEYCHSRGVLHRDIKG 246 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHH---------------------------HHHHHhhcCeeeccccc
Confidence 99999999765544432 5889999999999887 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
.|||+++++ .+||+|||+|+++.... ..+..+.|.+|+|||.+++...|+.+.|+||.||||.||++|+++| ++.+
T Consensus 247 SNiLidn~G-~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~-~G~t 324 (560)
T KOG0600|consen 247 SNILIDNNG-VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL-QGRT 324 (560)
T ss_pred cceEEcCCC-CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc-CCcc
Confidence 999999777 79999999999876554 4677899999999999999889999999999999999999999666 8999
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCccc-ccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKK-LQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.+++.+|.+.+|++....|.....+.. ......+++.....+. ..+......|+...|..||.+|.+
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~-----~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHA-----TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcc-----cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc
Confidence 9999999999999887655441111100 0000012222111111 112222236677788899999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=308.09 Aligned_cols=264 Identities=33% Similarity=0.583 Sum_probs=207.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccch-----HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|...++||+|.||+||+|++.++|+.||||.++..+. ....+|+..|+.+ +|+||+.+.++| .+...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F--~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF--PHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc--cCCCceEE
Confidence 579999999999999999999999999999999975432 3578999999999 999999999999 66678999
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|+||++...-..+. -.++..+.+.|+.+++. |++|+|++.|+||||||.|
T Consensus 79 VfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~Lk---------------------------Gl~y~H~~~IlHRDlKPnN 131 (318)
T KOG0659|consen 79 VFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLK---------------------------GLAYCHSKWILHRDLKPNN 131 (318)
T ss_pred EEEeccccHHHHhcccccccCHHHHHHHHHHHHH---------------------------HHHHHHhhhhhcccCCccc
Confidence 99999865543332 24677777777777776 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
+|++.++ .+||+|||+|+.+..... .+..+.|++|+|||.+.+...|+...||||.|||+.||+.|. ||+++..+.+
T Consensus 132 LLis~~g-~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDid 209 (318)
T KOG0659|consen 132 LLISSDG-QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDID 209 (318)
T ss_pred eEEcCCC-cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHH
Confidence 9999777 799999999998864433 344588999999999999889999999999999999999876 8889999999
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
++..|.+.+|++...+|.+- ..-|...++- ..|...............-+++..+|.+||.+|.+
T Consensus 210 QL~~If~~LGTP~~~~WP~~---~~lpdY~~~~--~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit 274 (318)
T KOG0659|consen 210 QLSKIFRALGTPTPDQWPEM---TSLPDYVKIQ--QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT 274 (318)
T ss_pred HHHHHHHHcCCCCcccCccc---cccccHHHHh--cCCCCccccccccccHHHHHHHHhhhccCchhccc
Confidence 99999999998876655432 1112221111 11111111111111222236777789999998864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=306.57 Aligned_cols=241 Identities=21% Similarity=0.385 Sum_probs=204.9
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++++.||.|+||.|.+++++.++..+|+|++++.. .++..+|..+|+.+ .||+++++++.| .+..
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~--~d~~ 117 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTF--KDNS 117 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEee--ccCC
Confidence 35688999999999999999999999999999999998543 35678899999999 899999999999 5557
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++||||.+||.+..++ +++++..+++|+.+++. ||+|||+++|++|||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivl---------------------------AleylH~~~iiYRDL 170 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVL---------------------------ALEYLHSLDIIYRDL 170 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHH---------------------------HHHHHHhcCeeeccC
Confidence 899999999999988876 57999999999999987 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
||+|||+|.+| .+||+|||+|+.+... ..+.|||+.|+|||++.. .+|+.++|.|||||++|||+.|.+||+ +.+
T Consensus 171 KPENiLlD~~G-~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~-~~~ 245 (355)
T KOG0616|consen 171 KPENLLLDQNG-HIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFY-DDN 245 (355)
T ss_pred ChHHeeeccCC-cEEEEeccceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCc-CCC
Confidence 99999999777 7999999999987633 567899999999999988 889999999999999999999999995 555
Q ss_pred CHHHHHHHHHHhC------CchHHHHHHhcCCCCChhHH-HHhc----cC--CCCCCCC
Q 040656 260 NQDQLVKIARVLG------TDELNAYLDKYHLELDPQLE-ALVG----RK--RVWPIPN 305 (332)
Q Consensus 260 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~-~~i~----~~--~~~~~~~ 305 (332)
+.....+|..+-- +++.++++.++ ++.+-..| ..+. .+ |+|+...
T Consensus 246 ~~~iY~KI~~~~v~fP~~fs~~~kdLl~~L-L~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 246 PIQIYEKILEGKVKFPSYFSSDAKDLLKKL-LQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred hHHHHHHHHhCcccCCcccCHHHHHHHHHH-HhhhhHhhhcCcCCCccccccCcccccc
Confidence 6778888877532 56777777776 55555544 2222 12 8888644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=317.15 Aligned_cols=195 Identities=27% Similarity=0.567 Sum_probs=168.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..+|++.++||.|+||+||++....+|..+|.|.+.- ..+.....|+.+|++| +|||||++++.-..++..-+.
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence 5779999999999999999999999999999999862 3446788999999999 999999999943344444589
Q ss_pred eEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH--cC--C
Q 040656 106 LIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS--QG--I 174 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~--i 174 (332)
++||+|.+|++..+.+ .+++..+..++.|++. ||.++|+ .+ |
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~---------------------------AL~~cH~~~~r~~V 149 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCR---------------------------ALYHCHSKIPRGTV 149 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHH---------------------------HHHHHhccccccce
Confidence 9999999999998863 4667766666666655 9999998 45 8
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
+||||||.||+++.+| .+||.|||+++.+..... ..+.+||++||+||.+.+ .+|+++|||||+||++|||..-.+|
T Consensus 150 mHRDIKPaNIFl~~~g-vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~P 227 (375)
T KOG0591|consen 150 MHRDIKPANIFLTANG-VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSP 227 (375)
T ss_pred eeccCcchheEEcCCC-ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCC
Confidence 9999999999999777 799999999998875544 467799999999999988 8999999999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 228 F~ 229 (375)
T KOG0591|consen 228 FY 229 (375)
T ss_pred cc
Confidence 94
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=326.98 Aligned_cols=242 Identities=28% Similarity=0.434 Sum_probs=199.3
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++++.||+|+||.||+|+.+.||..+|+|++++.. -+.++.|-.+|... .++.||++|..| ++..
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsF--QD~~ 214 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSF--QDKE 214 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEe--cCCC
Confidence 35689999999999999999999999999999999998643 35688999999996 999999999999 6667
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
++||||||++||++..++ ..+++..+++|+.+.+- |++.+|+.|+|||||
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vl---------------------------AI~~iH~~gyIHRDI 267 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVL---------------------------AIESIHQLGYIHRDI 267 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHH---------------------------HHHHHHHcCcccccC
Confidence 899999999999998886 67999999999999987 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecC----------------------CCc--------------------------cc
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHP----------------------GKE--------------------------YN 211 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~----------------------~~~--------------------------~~ 211 (332)
||+|+|+|..| ++||+|||+++-+.. ... ..
T Consensus 268 KPdNlLiD~~G-HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~ 346 (550)
T KOG0605|consen 268 KPDNLLIDAKG-HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAY 346 (550)
T ss_pred ChhheeecCCC-CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhh
Confidence 99999999777 899999999842210 000 01
Q ss_pred ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------CchHHHHHH
Q 040656 212 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLG----------TDELNAYLD 281 (332)
Q Consensus 212 ~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~~~ 281 (332)
..+||+.|+|||++.+ ..|+..+|.||||||+||||.|.+|| .+.++.++..+|...-. ++...+++.
T Consensus 347 StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ImyEmLvGyPPF-~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 347 STVGTPDYIAPEVLLG-KGYGKECDWWSLGCIMYEMLVGYPPF-CSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLIT 424 (550)
T ss_pred cccCCccccchHHHhc-CCCCccccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHH
Confidence 2479999999999998 77999999999999999999999999 57777888777776532 356677777
Q ss_pred hcCCCCChhHHH---HhccC--CCCCCCC
Q 040656 282 KYHLELDPQLEA---LVGRK--RVWPIPN 305 (332)
Q Consensus 282 ~~~~~~~~~~~~---~i~~~--~~~~~~~ 305 (332)
++.. ++.-|- .++.+ |||+...
T Consensus 425 rll~--d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 425 RLLC--DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHhc--CHHHhcCcccHHHHhcCCccccC
Confidence 7643 333332 22333 7877544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=322.50 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=187.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCce-EEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEK-CIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+.+...+.+.||+|+||+||++.+ .|.. ||+|++.... .+.+.+|+.+|.++ +||||++++|++.++.. .
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~ 114 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-S 114 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-c
Confidence 456677778899999999999976 5555 9999997543 45899999999999 99999999999965432 6
Q ss_pred ceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC-CeecCCCCC
Q 040656 104 PSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG-IMHRDVKPH 182 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-ivHrdlkp~ 182 (332)
+++||||+++|+|..++...... ...+...+.++++||+||.|||+++ ||||||||+
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~----------------------~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~ 172 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKR----------------------KLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSD 172 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChh
Confidence 89999999999988876331000 0122233467888888999999999 999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.+..++||+|||+++..... ...+...||..|||||++.+ ...|+.++||||||+++|||+||..||. ....
T Consensus 173 NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~-~~~~ 251 (362)
T KOG0192|consen 173 NILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE-DLAP 251 (362)
T ss_pred hEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC-CCCH
Confidence 9999966448999999999877643 33444789999999999985 2679999999999999999999999994 4444
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
......+......+.+ ....++.+..++ ..||+.||+.||+
T Consensus 252 ~~~~~~v~~~~~Rp~~-------p~~~~~~l~~l~------------------------~~CW~~dp~~RP~ 292 (362)
T KOG0192|consen 252 VQVASAVVVGGLRPPI-------PKECPPHLSSLM------------------------ERCWLVDPSRRPS 292 (362)
T ss_pred HHHHHHHHhcCCCCCC-------CccCCHHHHHHH------------------------HHhCCCCCCcCCC
Confidence 4444444432222221 122555555555 4499999999996
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=311.11 Aligned_cols=277 Identities=29% Similarity=0.518 Sum_probs=223.9
Q ss_pred ccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeee
Q 040656 18 YWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKL 92 (332)
Q Consensus 18 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~ 92 (332)
|..+.-....+...+.|..++.||.|++|.|..|.++.+|+.||+|.+.. ...++..+|+.+|+++ +|+||+.+
T Consensus 8 ~~~~~~~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l 86 (359)
T KOG0660|consen 8 YYDYEVFGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGL 86 (359)
T ss_pred ceEEEeeeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceE
Confidence 55555555667777888889999999999999999999999999999862 2347789999999999 79999999
Q ss_pred eeeeec---cCCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHH
Q 040656 93 LDIVRD---QHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL 166 (332)
Q Consensus 93 ~~~~~~---~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 166 (332)
.+++.. .+-.-.|+|+|+|+. +|..++ +.++++....+++|++. ||
T Consensus 87 ~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLr---------------------------gL 138 (359)
T KOG0660|consen 87 LDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILR---------------------------GL 138 (359)
T ss_pred EeecccccccccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHH---------------------------hc
Confidence 999865 334568999999954 444443 33889999999998887 99
Q ss_pred HHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecC---CCcccccccccceeccccccCCCCCCCcccHHHHHHH
Q 040656 167 DYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243 (332)
Q Consensus 167 ~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~i 243 (332)
.|+|+.+|+||||||.|++++.+. .+||+|||+|+.... ....+..+.|.+|+|||++.....|+.+.||||+|||
T Consensus 139 KyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI 217 (359)
T KOG0660|consen 139 KYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCI 217 (359)
T ss_pred chhhcccccccccchhheeeccCC-CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHH
Confidence 999999999999999999999887 589999999998753 3445778999999999999888899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC-----CCCCCCCccccccccccccc
Q 040656 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK-----RVWPIPNNKKLQFCRSSRTS 318 (332)
Q Consensus 244 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~~~~~~ 318 (332)
+.||++|+.-| ++.+..+++..|...+|++....+ ... -++..+..++++ .||.. ......+...++
T Consensus 218 ~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~e~l-~~i---~s~~ar~yi~slp~~p~~~f~~---~fp~a~p~AidL 289 (359)
T KOG0660|consen 218 LAEMLTGKPLF-PGKDYVHQLQLILELLGTPSEEDL-QKI---RSEKARPYIKSLPQIPKQPFSS---IFPNANPLAIDL 289 (359)
T ss_pred HHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCHHHH-HHh---ccHHHHHHHHhCCCCCCCCHHH---HcCCCCHHHHHH
Confidence 99999999665 899999999999999998865433 222 344555566554 23322 222334444588
Q ss_pred CceEEEeCCCCCCC
Q 040656 319 TNICITFSPSGFPF 332 (332)
Q Consensus 319 ~~~cl~~dP~~RP~ 332 (332)
++++|.+||.+|++
T Consensus 290 lekmL~fdP~kRit 303 (359)
T KOG0660|consen 290 LEKMLVFDPKKRIT 303 (359)
T ss_pred HHHHhccCccccCC
Confidence 99999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.86 Aligned_cols=244 Identities=28% Similarity=0.447 Sum_probs=197.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
...+|++.+.||+|+||.|+.|.+..+++.||+|+++.. ..+.+.+|+.+++++..||||+++++++..+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 457899999999999999999999999999999987642 2345778999999995599999999999655
Q ss_pred CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||||+.+|+|.... +++.+.+++.++.|++. |++|+|++||+|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlis---------------------------av~y~H~~gi~HRD 145 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLIS---------------------------AVAYCHSRGIVHRD 145 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHH---------------------------HHHHHHhCCEeeCC
Confidence 4599999999998877764 57888889999998887 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceee-cCCCcccccccccceeccccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||+|||++.+.+.+||+|||++... .......+.+||+.|+|||++.+.. .-+.++||||+|++||.|++|..||..
T Consensus 146 LK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 146 LKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred CCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999977247999999999987 4566778899999999999998854 346999999999999999999999953
Q ss_pred CCCCHHHHHHHHHHh------C-CchHHHHHHhcCCCCChhHHHHhccC--CCCCCC
Q 040656 257 GHDNQDQLVKIARVL------G-TDELNAYLDKYHLELDPQLEALVGRK--RVWPIP 304 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~ 304 (332)
.+......++.+.. . ++....++.++ +..+|..|..+..+ ++|+..
T Consensus 226 -~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~m-L~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 226 -SNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKM-LVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -ccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHH-cCCCcccCCCHHHHhhChhhcc
Confidence 44444444444331 1 33445666665 56666555555555 777765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=322.61 Aligned_cols=211 Identities=25% Similarity=0.433 Sum_probs=189.2
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
....++|.+++.||+|+||.|+++..+.+++.+|||++++.. -+....|..|+....+||.++.++..| ++.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccC
Confidence 335689999999999999999999999999999999998643 345778999999997899999999999 777
Q ss_pred CCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 102 KTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++.||||+.||++..+. +.+++..++.|+.+++. ||.|||++|||||||
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l---------------------------~L~fLH~~~IIYRDl 494 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVL---------------------------GLQFLHENGIIYRDL 494 (694)
T ss_pred CeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHH---------------------------HHHHHHhcCceeeec
Confidence 8999999999999976665 56999999999999987 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
|.+|||+|.+| ++||+|||+++... .+....+++||+.|+|||++.+ +.|+.+.|.|||||+||||+.|+.|| ++.
T Consensus 495 KLdNiLLD~eG-h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gd 571 (694)
T KOG0694|consen 495 KLDNLLLDTEG-HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGD 571 (694)
T ss_pred chhheEEcccC-cEEecccccccccCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCC
Confidence 99999999888 79999999998755 5566788999999999999988 78999999999999999999999999 678
Q ss_pred CCHHHHHHHHHH
Q 040656 259 DNQDQLVKIARV 270 (332)
Q Consensus 259 ~~~~~~~~~~~~ 270 (332)
++.+....|..-
T Consensus 572 dEee~FdsI~~d 583 (694)
T KOG0694|consen 572 DEEEVFDSIVND 583 (694)
T ss_pred CHHHHHHHHhcC
Confidence 888888877653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=306.72 Aligned_cols=272 Identities=27% Similarity=0.443 Sum_probs=210.2
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch-----HHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.+.+.|+++.+|++|+||.||+|+++.+++.||+|.++.... -.-.+|+.+|.++ +||||+.+-.+.++.+-.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccc
Confidence 4466889999999999999999999999999999999974332 2468999999999 899999999999887777
Q ss_pred CceeEEeeecCCCc---eeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDF---KVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..|+|||||+...- ....+++...+++.++.|++. |++|||++.|+||||
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~---------------------------glk~lH~~wilHRDL 203 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLR---------------------------GLKHLHDNWILHRDL 203 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHH---------------------------HHHHHhhceeEeccc
Confidence 89999999986432 222357778888777777776 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
|++|+|+++.| .+|++|||+|+.+... ...+..+-|.+|+|||.+++...|+.+.||||+|||+.||+++.+.| ++.
T Consensus 204 K~SNLLm~~~G-~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf-~G~ 281 (419)
T KOG0663|consen 204 KTSNLLLSHKG-ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF-PGK 281 (419)
T ss_pred chhheeeccCC-cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC-CCC
Confidence 99999999777 7999999999988644 45677789999999999999889999999999999999999998555 899
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCccccccc--ccccccCceEEEeCCCCCCC
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFC--RSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~cl~~dP~~RP~ 332 (332)
...+++.+|.+.+|++.-..|.. + ..-|.....-...+|+-.......... ..-.++++..|.+||.+|-+
T Consensus 282 sE~dQl~~If~llGtPte~iwpg-~--~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t 354 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWPG-Y--SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT 354 (419)
T ss_pred chHHHHHHHHHHhCCCccccCCC-c--cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc
Confidence 99999999999999764332221 1 111111111101123222221111111 22236778888899988843
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.09 Aligned_cols=211 Identities=32% Similarity=0.608 Sum_probs=177.5
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCC-----CCeeeeeeeeeccCCCCc
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGG-----PNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-----~niv~~~~~~~~~~~~~~ 104 (332)
.+|++.+.||+|+||.|-+|.+..+++.||||++++.. ..+.+.|+.+|..+++| -|+|+++++| ...+++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F--~fr~Hl 263 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF--YFRNHL 263 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc--ccccce
Confidence 48999999999999999999999999999999998543 35667899999999644 3999999999 456799
Q ss_pred eeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
|+|+|.+..+.+..+. ..++...++.++.|++. ||.+||..||||+|||
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~---------------------------~L~~L~~l~IIHcDLK 316 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILT---------------------------ALLFLHELGIIHCDLK 316 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeeeccCC
Confidence 9999998876655543 23555555555555554 9999999999999999
Q ss_pred CCCeeecC-CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDH-EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||+.. ....|||+|||+|+..... ...+..++.|+|||++++ .+|+.+.||||||||+.||++| .|++++.+
T Consensus 317 PENILL~~~~r~~vKVIDFGSSc~~~q~--vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~n 392 (586)
T KOG0667|consen 317 PENILLKDPKRSRIKVIDFGSSCFESQR--VYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDN 392 (586)
T ss_pred hhheeeccCCcCceeEEecccccccCCc--ceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCC
Confidence 99999943 3347999999999876532 237789999999999999 7899999999999999999999 57779999
Q ss_pred CHHHHHHHHHHhCCch
Q 040656 260 NQDQLVKIARVLGTDE 275 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~ 275 (332)
+.+++..|...+|.+.
T Consensus 393 e~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 393 EYDQLARIIEVLGLPP 408 (586)
T ss_pred HHHHHHHHHHHhCCCC
Confidence 9999999999999654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=323.74 Aligned_cols=241 Identities=21% Similarity=0.357 Sum_probs=193.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+++.+.+++.||+|.||+||+|.+ .....||+|.++.. ....|.+|+++|++| +|+|||+++++|..+ ..++||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIV 279 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIV 279 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEE
Confidence 467789999999999999999987 45568999999853 447899999999999 999999999999654 368999
Q ss_pred EeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
||||+.|+|..+++.- +.. . ..+.+-+.++.||++||+||+++++|||||..+||||+
T Consensus 280 tE~m~~GsLl~yLr~~-~~~-~--------------------l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~ 337 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR-EGG-L--------------------LNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD 337 (468)
T ss_pred EEecccCcHHHHhhhc-CCC-c--------------------cchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec
Confidence 9999999988887541 110 1 12222345888899999999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCcccccc---cccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKEYNVRV---ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNQDQ 263 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~---~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~~~~ 263 (332)
.+. .+||+|||+|+... +...+... .+..|.|||.+.. ..++.+||||||||+||||+| |+.|+ ++..+.+.
T Consensus 338 ~~~-~vKIsDFGLAr~~~-d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py-~~msn~ev 413 (468)
T KOG0197|consen 338 EDL-VVKISDFGLARLIG-DDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPY-PGMSNEEV 413 (468)
T ss_pred cCc-eEEEcccccccccC-CCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCC-CCCCHHHH
Confidence 666 89999999999443 33333332 3445999999977 789999999999999999998 56665 78888999
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+..+.++++-+.+ ..+++.+-++ +..||+.+|++||+
T Consensus 414 ~~~le~GyRlp~P--------~~CP~~vY~l------------------------M~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 414 LELLERGYRLPRP--------EGCPDEVYEL------------------------MKSCWHEDPEDRPT 450 (468)
T ss_pred HHHHhccCcCCCC--------CCCCHHHHHH------------------------HHHHhhCCcccCCC
Confidence 9999988765543 3455555554 45599999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=311.33 Aligned_cols=197 Identities=26% Similarity=0.466 Sum_probs=166.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++...+.||+|+||.||++...++++..|||.+.... .+.+.+|+.+|.++ +|||||+++|.........++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEee
Confidence 456888999999999999999999999999999986443 45589999999999 69999999997433222368999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||+++|++..+.. .+++..++.++.+++. ||+|||++||+||||||+|
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~---------------------------GL~ylHs~g~vH~DiK~~N 147 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILE---------------------------GLAYLHSKGIVHCDIKPAN 147 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCEeccCcccce
Confidence 99999999999863 4788989988888887 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecC----CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||++..++.+||+|||+++.... ........||+.|||||++..+.....++|||||||++.||+||..||.
T Consensus 148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 99997444799999999987653 1223457899999999999853334469999999999999999999994
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=307.81 Aligned_cols=248 Identities=25% Similarity=0.446 Sum_probs=192.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+.+.|++.+.||.|..++||+|+...+++.||||++.- ...+.+++|+..|+.+ +||||++++..|... ..+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~--~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVD--SELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEec--ceeE
Confidence 67999999999999999999999999999999999962 2347789999999999 999999999999654 5799
Q ss_pred eEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 106 LIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 106 lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+||.+|.+|++.+++ ..+.+..+..+++++++ ||.|||.+|.||||||
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~Lk---------------------------aL~YLH~~G~IHRdvK 153 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLK---------------------------ALDYLHQNGHIHRDVK 153 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHH---------------------------HHHHHHhcCceecccc
Confidence 999999999988875 34667777777777776 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceee-cCCCc----ccccccccceecccc-ccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFY-HPGKE----YNVRVASRYFKGPEL-LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~-~~~~~----~~~~~~t~~y~aPE~-~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
+.|||++.+| .|||+|||.+-.+ ..+.. ++++.||++|||||+ ......|++|+|||||||++.|+.+|..||
T Consensus 154 AgnILi~~dG-~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 154 AGNILIDSDG-TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred cccEEEcCCC-cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 9999999777 7999999975433 32222 256689999999999 455567999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
. .--+..++. ....+.+ |..... ..+......+..++++++..||..||++||+
T Consensus 233 ~-k~pPmkvLl--~tLqn~p--------------p~~~t~-------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt 286 (516)
T KOG0582|consen 233 S-KYPPMKVLL--LTLQNDP--------------PTLLTS-------GLDKDEDKKFSKSFREMIALCLVKDPSKRPT 286 (516)
T ss_pred c-cCChHHHHH--HHhcCCC--------------CCcccc-------cCChHHhhhhcHHHHHHHHHHhhcCcccCCC
Confidence 4 222222221 1111111 111000 0011122234457778889999999999996
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=310.85 Aligned_cols=244 Identities=27% Similarity=0.527 Sum_probs=204.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------------hHHHHHHHHHHHhccCCCCeeeee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNIVKLL 93 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~h~niv~~~ 93 (332)
...|++++.||+|.||.|-+|++..+++.||+|++.+.. .+++.+|+.+|+++ +|+|||+++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence 467999999999999999999999999999999996321 24789999999999 999999999
Q ss_pred eeeeccCCCCceeEEeeecCCCceeec--cc-cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 94 DIVRDQHSKTPSLIFEHVNSTDFKVLY--PT-LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
++..++....+|+|+|||..|.+...- .. +.+.+++.|+..++. ||+|||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~---------------------------GLEYLH 227 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVL---------------------------GLEYLH 227 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHH---------------------------HHHHHH
Confidence 999998889999999999988877663 23 778888888888887 999999
Q ss_pred HcCCeecCCCCCCeeecCCCCeEEEEecccceeecCC------CcccccccccceeccccccCCC---CCCCcccHHHHH
Q 040656 171 SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG------KEYNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLG 241 (332)
Q Consensus 171 ~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~~---~~~~~sDiwSlG 241 (332)
.+|||||||||+|+|++.++ +|||+|||.+..+..+ .......||+.|+|||.+.++. ..+.+.||||+|
T Consensus 228 ~QgiiHRDIKPsNLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 228 YQGIIHRDIKPSNLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred hcCeeccccchhheEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 99999999999999999775 8999999998766322 2234468999999999998732 357899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCCC
Q 040656 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLG--------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIPN 305 (332)
Q Consensus 242 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~ 305 (332)
|+||.|+.|+.||+ +....+...+|....- .+.+.+++.++ ++.+|+.|..+..+ |||....
T Consensus 307 VTLYCllfG~~PF~-~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~l-L~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFF-DDFELELFDKIVNDPLEFPENPEINEDLKDLIKRL-LEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred hhHHHhhhccCCcc-cchHHHHHHHHhcCcccCCCcccccHHHHHHHHHH-hhcChhheeehhhheecceeccC
Confidence 99999999999995 4445566666655422 34566788887 89999999999887 9997554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=322.19 Aligned_cols=191 Identities=30% Similarity=0.597 Sum_probs=171.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccchH-----HHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+. .+++|++|++.+ +||||+.++++| ++..++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esf--Et~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESF--ETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhh--cccceEEE
Confidence 5788999999999999999999999999999999876543 389999999999 999999999999 55678999
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|+||+.| +|..++ ..++++.++.+..+++. ||.|||+.+|+|||+||+|
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVs---------------------------aL~yLhs~rilhrd~kPqn 130 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVS---------------------------ALYYLHSNRILHRDMKPQN 130 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHH---------------------------HHHHHHhcCcccccCCcce
Confidence 9999998 666655 56899999999888887 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||++..+ .+|++|||+|+.+..+.. .+...||+.|||||++.+ ++|+..+|+|||||++||+++|++||+
T Consensus 131 iLl~~~~-~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 131 ILLEKGG-TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred eeecCCC-ceeechhhhhhhcccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCch
Confidence 9999555 799999999998765443 345589999999999986 899999999999999999999999995
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.09 Aligned_cols=240 Identities=23% Similarity=0.417 Sum_probs=208.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.-|++++.||.|+-|.|-+|++..||+.+|||++.+. ....+.+|+.+|+.+ .|||++++|+++ ++..++|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVw--e~~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVW--ENKQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeee--ccCceEE
Confidence 4589999999999999999999999999999999653 235688999999999 999999999999 4457899
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++.||+++|.|.+.+ +.+++.++..+++|++. |+.|+|..+|+||||||+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~---------------------------gv~yCH~~~icHRDLKpE 141 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILD---------------------------GVSYCHAFNICHRDLKPE 141 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHH---------------------------HHHHHhhhcceeccCCch
Confidence 999999999988875 78999999999999988 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+|++..++ |||+|||+|....++....+.||+++|.|||++.+....+.++||||.|||||.|+||..||+ +.+-..
T Consensus 142 NlLLd~~~n-IKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-DdNir~ 219 (786)
T KOG0588|consen 142 NLLLDVKNN-IKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-DDNIRV 219 (786)
T ss_pred hhhhhcccC-EeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-CccHHH
Confidence 999998775 999999999988878888889999999999999997777899999999999999999999994 333344
Q ss_pred HHHHHHHHhC------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCC
Q 040656 263 QLVKIARVLG------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIP 304 (332)
Q Consensus 263 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~ 304 (332)
.+.++.++.. +.+..+++.++ ++++|.-|..++.+ |||..-
T Consensus 220 LLlKV~~G~f~MPs~Is~eaQdLLr~m-l~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 220 LLLKVQRGVFEMPSNISSEAQDLLRRM-LDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred HHHHHHcCcccCCCcCCHHHHHHHHHH-hccCccccccHHHHhhCchhhc
Confidence 5666666533 45667888888 89999988888887 888643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=312.05 Aligned_cols=240 Identities=23% Similarity=0.444 Sum_probs=194.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
....|...++||+|..|.||.|....+++.||||.+... .++-+.+|+.+|+.+ +|+|||.+++.|.-. ..+|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ceeEE
Confidence 457899999999999999999999999999999998632 345688999999999 999999999988433 57999
Q ss_pred EEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 107 IFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 107 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||||++||+|.++.. .+++.....+..+++. ||+|||.+||+|||||.+||
T Consensus 348 VMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~---------------------------aL~fLH~~gIiHrDIKSDnI 400 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTRMTEGQIAAICREILQ---------------------------GLKFLHARGIIHRDIKSDNI 400 (550)
T ss_pred EEeecCCCchhhhhhcccccHHHHHHHHHHHHH---------------------------HHHHHHhcceeeecccccee
Confidence 999999999888863 4677777666666665 99999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++.++ .+||+|||++..+.... ...+.+||++|||||++.. ..|+++.||||||+|++||+-|.+||.. .++ -.
T Consensus 401 LL~~~g-~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln-E~P-lr 476 (550)
T KOG0578|consen 401 LLTMDG-SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENP-LR 476 (550)
T ss_pred EeccCC-cEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC-CCh-HH
Confidence 999777 69999999998776555 5567799999999999977 7899999999999999999999999953 222 23
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+++...+++.+. ....+++.+++.+ ++||..||.+||+
T Consensus 477 AlyLIa~ng~P~lk-----~~~klS~~~kdFL------------------------~~cL~~dv~~Ras 516 (550)
T KOG0578|consen 477 ALYLIATNGTPKLK-----NPEKLSPELKDFL------------------------DRCLVVDVEQRAS 516 (550)
T ss_pred HHHHHhhcCCCCcC-----CccccCHHHHHHH------------------------HHHhhcchhcCCC
Confidence 33344444444431 1123455555544 5599999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=317.72 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=191.3
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeecc------CCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------HSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~------~~~ 102 (332)
...++|++++.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.+ +|+||+++++++... ...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCce
Confidence 3457899999999999999999999899999999988532 33456799999999 999999998876432 122
Q ss_pred CceeEEeeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 103 TPSLIFEHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
.++++|||++++....+. ..++...+.. ++.|++.||+|||++||+|
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~---------------------------~~~qi~~gL~yLH~~~IiH 193 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL---------------------------YSYQLCRALAYIHSKFICH 193 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCEec
Confidence 467899999865322221 1233333333 4445566999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||||+|||++.++..+||+|||+++............+|..|+|||++.+...++.++|||||||++|+|++|..|| .
T Consensus 194 rDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~ 272 (440)
T PTZ00036 194 RDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-S 272 (440)
T ss_pred CCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-C
Confidence 999999999987766799999999987665555556678999999999877567899999999999999999999998 4
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCC---------ChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLEL---------DPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSP 327 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP 327 (332)
+....+.+..+.+.++.+....+.. +.+.. +..++..+ +........+|+..||++||
T Consensus 273 ~~~~~~~~~~i~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~------------p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 273 GQSSVDQLVRIIQVLGTPTEDQLKE-MNPNYADIKFPDVKPKDLKKVF------------PKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHH-hchhhhcccCCccCchhHHHHh------------ccCCCHHHHHHHHHHCCCCh
Confidence 6666777888887777654332221 10100 00111110 00112234578888999999
Q ss_pred CCCCC
Q 040656 328 SGFPF 332 (332)
Q Consensus 328 ~~RP~ 332 (332)
.+||+
T Consensus 340 ~~R~t 344 (440)
T PTZ00036 340 LKRLN 344 (440)
T ss_pred hHCcC
Confidence 99986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=310.50 Aligned_cols=237 Identities=24% Similarity=0.399 Sum_probs=191.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
...|..+++||+|+||.||+|.+..+++.||+|++.- ....++++|+.++..+ .++||.++|+.+.. +..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~--g~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLK--GTKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheee--cccHHH
Confidence 4668889999999999999999999999999999973 3456799999999999 89999999999854 457999
Q ss_pred EEeeecCCCceeeccc---cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|||+.||+...++.. +.+.....++.+++. |+.|||.++.+|||||+.|
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~---------------------------~l~ylH~~~kiHrDIKaan 141 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLK---------------------------GLDYLHSEKKIHRDIKAAN 141 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHH---------------------------Hhhhhhhcceecccccccc
Confidence 9999999998887632 355555555666655 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||+..++ .+||+|||.+-.+..... ..+++||+.|||||++.+ ..|+.++||||||++++||++|.+|+ .+..+..
T Consensus 142 il~s~~g-~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~-s~~hPmr 218 (467)
T KOG0201|consen 142 ILLSESG-DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPH-SKLHPMR 218 (467)
T ss_pred eeEeccC-cEEEEecceeeeeechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCC-cccCcce
Confidence 9999775 799999999877764433 377899999999999986 78999999999999999999999998 3333322
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..|.+ +.+| .....+.+.+++|+..||+.||+.||+
T Consensus 219 vlflIpk----------------~~PP----------------~L~~~~S~~~kEFV~~CL~k~P~~Rps 256 (467)
T KOG0201|consen 219 VLFLIPK----------------SAPP----------------RLDGDFSPPFKEFVEACLDKNPEFRPS 256 (467)
T ss_pred EEEeccC----------------CCCC----------------ccccccCHHHHHHHHHHhhcCcccCcC
Confidence 2111111 1122 122245556678888899999999996
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.94 Aligned_cols=268 Identities=29% Similarity=0.523 Sum_probs=190.6
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~ 78 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEec--CCeE
Confidence 45789999999999999999999998899999999986432 24578899999999 99999999999954 4578
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+++|||+.++.+..+. ..++...+..++.|++ .||+|||++||+||||||
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~---------------------------~al~~lH~~~ivH~dlkp 131 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL---------------------------RGLSYIHQRYILHRDLKP 131 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeecCCCCH
Confidence 9999999765433332 2355555555555555 499999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
+|||++.++ .+||+|||++...... .......+|..|+|||++.+...++.++|||||||++|+|++|..||....+.
T Consensus 132 ~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 132 QNLLISDTG-ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred HHEEECCCC-CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 999999666 7999999998754322 22334567889999999876566889999999999999999999999644444
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcC-CCCChhHHHHhccC---CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYH-LELDPQLEALVGRK---RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+....+.+....+..... ....+..-...... ..|. .........+++..||+.||++||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~dli~~mL~~dp~~R~s 281 (303)
T cd07869 211 QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWN-----KLSYVNHAEDLASKLLQCFPKNRLS 281 (303)
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhh-----ccCCChHHHHHHHHHhccCchhccC
Confidence 556666665555433221111000 00000000000000 0010 1112233457889999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=298.15 Aligned_cols=265 Identities=30% Similarity=0.502 Sum_probs=199.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch-----HHHHHHHHHHHhccCCCC-eeeeeeeeeccC----
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPN-IVKLLDIVRDQH---- 100 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~---- 100 (332)
.+.|+.+++||+|.||+||+|+...+|+.||+|.++.... ....+|+.+++++ +|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence 4668999999999999999999999999999999974322 4568999999999 9999 999999996543
Q ss_pred CCCceeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
...+++||||+.... ...+. .++...++ .++.|++.||+|||+++
T Consensus 89 ~~~l~lvfe~~d~DL-~~ymd~~~~~~~g~~~~~ik---------------------------~~m~Qll~gl~~~H~~~ 140 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDL-KKYMDSLPKKPQGLPPRLIK---------------------------SFMRQLLRGLAFLHSHG 140 (323)
T ss_pred cceEEEEEEeecccH-HHHHHhccccccCCCHHHHH---------------------------HHHHHHHHHHHHHHhCC
Confidence 236889999987533 22221 12222333 45556666999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|+||||||+|||++.++ .+||+|||+|+... +....+...+|.+|+|||++.+...|+...||||+|||+.||++++.
T Consensus 141 IlHRDLKPQNlLi~~~G-~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 141 ILHRDLKPQNLLISSSG-VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred eecccCCcceEEECCCC-cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 99999999999999766 79999999998776 44557788999999999999997789999999999999999999875
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCccccccc---ccccccCceEEEeCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFC---RSSRTSTNICITFSPSG 329 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~cl~~dP~~ 329 (332)
- +++..+.+++..|.+.++++....|..-. .-|..+. ....|........... .+-.+++..||+++|++
T Consensus 220 L-FpG~se~~ql~~If~~lGtP~e~~Wp~v~---~~~~~k~---~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~ 292 (323)
T KOG0594|consen 220 L-FPGDSEIDQLFRIFRLLGTPNEKDWPGVS---SLPDYKA---PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAK 292 (323)
T ss_pred C-CCCCcHHHHHHHHHHHcCCCCccCCCCcc---ccccccc---cCcCCCCccchHHhccccCccHHHHHHHHhccCccc
Confidence 5 58888899999999999987655443221 0011110 1122221111111111 23347888899999999
Q ss_pred CCC
Q 040656 330 FPF 332 (332)
Q Consensus 330 RP~ 332 (332)
|.+
T Consensus 293 R~S 295 (323)
T KOG0594|consen 293 RIS 295 (323)
T ss_pred CcC
Confidence 965
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=300.53 Aligned_cols=265 Identities=25% Similarity=0.463 Sum_probs=191.4
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~ 78 (288)
T cd07871 2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCL 78 (288)
T ss_pred CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeE
Confidence 3467899999999999999999999999999999998632 234678999999999 99999999999854 4578
Q ss_pred eeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||++++ ++...+. .++...+..+ +.|++.||+|||++||+|||||
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~---------------------------~~qi~~aL~~LH~~~ivH~dlk 130 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIF---------------------------MFQLLRGLSYCHKRKILHRDLK 130 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCcccCCCC
Confidence 999999986 4433321 1334444444 4455559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||++.++ .+||+|||+++...... ......++..|+|||++.+...++.++|||||||++|+|++|..|| .+.+
T Consensus 131 p~Nil~~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~ 208 (288)
T cd07871 131 PQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGST 208 (288)
T ss_pred HHHEEECCCC-CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCC
Confidence 9999999666 79999999987654222 2234567889999999876567899999999999999999999998 4556
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC---CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK---RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+.+..+.+..+.+....+.. . ....+....+... .++.. .......+..+++..||++||++||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~dll~~mL~~dp~~R~t 278 (288)
T cd07871 209 VKEELHLIFRLLGTPTEETWPG-I--TSNEEFRSYLFPQYRAQPLIN---HAPRLDTDGIDLLSSLLLYETKSRIS 278 (288)
T ss_pred HHHHHHHHHHHhCCCChHHhhc-c--ccchhhhccccCccCCCchHH---hCCCCCHHHHHHHHHhcCcCcccCCC
Confidence 6667777777666544332211 1 1111111111000 11110 01112223357899999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.31 Aligned_cols=191 Identities=24% Similarity=0.403 Sum_probs=158.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +|+||+++++.+.+ ....++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEcc--CCeEEE
Confidence 3889999999999999999999999999999986322 23567899999999 99999999999854 357899
Q ss_pred EEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||++++++..... .+++..+..+ +.|++.||+|||+.+|+||||||
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~---------------------------~~qi~~~l~~lH~~~iiH~dikp 130 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFY---------------------------AAELCCGLEDLQRERIVYRDLKP 130 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCEEeCCCCH
Confidence 999999998865431 2344444444 44555599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .++|+|||++.............||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 ~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 131 ENILLDDRG-HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred HHEEECCCC-CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 999998666 799999999987654444455678999999999977 678999999999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=304.25 Aligned_cols=213 Identities=27% Similarity=0.514 Sum_probs=170.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC----
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS---- 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---- 101 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++...+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcccc
Confidence 58899999999999999999999999999999998632 235678999999999 99999999999854332
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...+++|||+.++....+...++...+..++.+ ++.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~q---------------------------i~~~L~~LH~~~ivHrDlkp 151 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQ---------------------------MLCGIKHLHSAGIIHRDLKP 151 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHH---------------------------HHHHHHHHHhCCcccCCCCH
Confidence 347899999987654444334555555444444 45599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+||+++.++ .++|+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..
T Consensus 152 ~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~ 228 (359)
T cd07876 152 SNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHI 228 (359)
T ss_pred HHEEECCCC-CEEEecCCCccccccCccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHH
Confidence 999999766 799999999976544444455678899999999877 678999999999999999999999994 55555
Q ss_pred HHHHHHHHHhCCc
Q 040656 262 DQLVKIARVLGTD 274 (332)
Q Consensus 262 ~~~~~~~~~~~~~ 274 (332)
+....+...++.+
T Consensus 229 ~~~~~~~~~~~~~ 241 (359)
T cd07876 229 DQWNKVIEQLGTP 241 (359)
T ss_pred HHHHHHHHhcCCC
Confidence 5666666655543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=299.00 Aligned_cols=202 Identities=23% Similarity=0.434 Sum_probs=163.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence 4799999999999999999999889999999998632 234578899999999 99999999998854 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++|||++++++...+ ..+++.....++.++ +.||+|||++||+||||||+
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~i~H~dlkp~ 130 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI---------------------------VCALEYLHSKEIVYRDLKPE 130 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeeecCCCHH
Confidence 999999999877654 234555554444444 45999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|||++.++ .++|+|||++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+
T Consensus 131 NIli~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~-~~~~~~ 205 (291)
T cd05612 131 NILLDKEG-HIKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFF-DDNPFG 205 (291)
T ss_pred HeEECCCC-CEEEEecCcchhccC--CcccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHH
Confidence 99999666 799999999876542 2234578999999999876 678999999999999999999999994 333334
Q ss_pred HHHHHH
Q 040656 263 QLVKIA 268 (332)
Q Consensus 263 ~~~~~~ 268 (332)
....+.
T Consensus 206 ~~~~i~ 211 (291)
T cd05612 206 IYEKIL 211 (291)
T ss_pred HHHHHH
Confidence 444433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.60 Aligned_cols=191 Identities=24% Similarity=0.440 Sum_probs=161.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++.+.+ ....
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEc--CCEE
Confidence 57899999999999999999999999999999998643 234678999999999 99999999999954 4578
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+++|||+.++++...+ ..+++..+..++.++ +.||+|||++||+||||||
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi---------------------------~~aL~~LH~~~ivH~dlkp 146 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL---------------------------VLAFEYLHSKDIIYRDLKP 146 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeeecCCCH
Confidence 9999999999887654 234555555455554 4599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .++|+|||++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 147 ~NIll~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~ 216 (329)
T PTZ00263 147 ENLLLDNKG-HVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFF 216 (329)
T ss_pred HHEEECCCC-CEEEeeccCceEcCC--CcceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCC
Confidence 999999666 799999999986542 2234578999999999877 678999999999999999999999994
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=292.91 Aligned_cols=264 Identities=27% Similarity=0.494 Sum_probs=184.7
Q ss_pred CCceEEEeecccCCceEEEEEEcc-CCceEEEEEeccc-----chHHHHHHHHHHHhcc--CCCCeeeeeeeeec---cC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVT-NNEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRD---QH 100 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~---~~ 100 (332)
++|++.+.||+|+||.||+|.+.. +++.||+|.++.. ....+.+|+.+++.+. .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999998754 5688999998632 1235667888887763 59999999998752 23
Q ss_pred CCCceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
...+++++|++++ ++..++. .++...+.. ++.|++.||.|||++||+
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~---------------------------i~~qi~~aL~~lH~~~ii 132 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD---------------------------MMFQLLRGLDFLHSHRVV 132 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCee
Confidence 4568999999975 4433321 133333333 445556699999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||||||+|||++.++ .++|+|||++.............+|..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 133 H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f- 209 (290)
T cd07862 133 HRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF- 209 (290)
T ss_pred eCCCCHHHEEEcCCC-CEEEccccceEeccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-
Confidence 999999999999766 799999999987654444455678999999999876 67899999999999999999999998
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+.+..+....+.+...++..... .+.. .... .+................+++..||+.||++||+
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~---~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 280 (290)
T cd07862 210 RGSSDVDQLGKILDVIGLPGEEDWPRDVA--LPRQ---AFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280 (290)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhc--ccch---hccC-CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC
Confidence 45556677777776665443333222110 0000 0000 0000000000112223357888999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=277.08 Aligned_cols=207 Identities=25% Similarity=0.470 Sum_probs=176.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|.||.||+|+..+++..||+|++.+.+ ...+.+|++|...| +||||+++|++|.++ ..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~--~r 96 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS--KR 96 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc--ce
Confidence 4689999999999999999999999999999999986543 35688999999999 999999999999654 67
Q ss_pred ceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 104 PSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.|+++||...|.+...++ .+.+.....|++|+.. ||.|+|.++++|||
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~---------------------------Al~y~h~k~VIhRd 149 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLAN---------------------------ALLYCHLKRVIHRD 149 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHH---------------------------HHHHhccCCcccCC
Confidence 999999999888665543 3666666666666655 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
|||+|+|++..+ .+|++|||.+.... .....+.+||..|.+||+..+ ..++...|+|++|++.||++.|..||. ..
T Consensus 150 iKpenlLlg~~~-~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFe-s~ 225 (281)
T KOG0580|consen 150 IKPENLLLGSAG-ELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFE-SQ 225 (281)
T ss_pred CCHHHhccCCCC-CeeccCCCceeecC-CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchh-hh
Confidence 999999999777 69999999997655 556678899999999999988 789999999999999999999999994 33
Q ss_pred CCHHHHHHHHHH
Q 040656 259 DNQDQLVKIARV 270 (332)
Q Consensus 259 ~~~~~~~~~~~~ 270 (332)
...+...+|.+.
T Consensus 226 ~~~etYkrI~k~ 237 (281)
T KOG0580|consen 226 SHSETYKRIRKV 237 (281)
T ss_pred hhHHHHHHHHHc
Confidence 355666666653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.63 Aligned_cols=208 Identities=24% Similarity=0.430 Sum_probs=179.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||.|.-|+||+|....++..+|+|++.+.. ..+.+.|-+||+.+ +||.++.+|..| +.+..
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~f--et~~~ 151 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASF--ETDKY 151 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhhee--eccce
Confidence 4578999999999999999999999999999999997532 35688899999999 999999999999 55578
Q ss_pred ceeEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 104 PSLIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.|++||||+||+|..+. ..+++..+++|+.+++- ||+|||-.|||+||
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~---------------------------ALEYLHmlGivYRD 204 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLL---------------------------ALEYLHMLGIVYRD 204 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHH---------------------------HHHHHHhhceeecc
Confidence 99999999999998886 35899999999999988 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceee-------cC--------------------------C-C----------------
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFY-------HP--------------------------G-K---------------- 208 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~-------~~--------------------------~-~---------------- 208 (332)
|||+||||..+| +|.|+||.++... .. . .
T Consensus 205 LKPENILvredG-HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~ 283 (459)
T KOG0610|consen 205 LKPENILVREDG-HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPEL 283 (459)
T ss_pred CCcceeEEecCC-cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhh
Confidence 999999999676 8999999875311 00 0 0
Q ss_pred -------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 040656 209 -------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARV 270 (332)
Q Consensus 209 -------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 270 (332)
....++||-.|.|||++.+ ..++.+.|.|+|||++|||+.|..|| .+.++.+++..+...
T Consensus 284 ~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~~ 350 (459)
T KOG0610|consen 284 VAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVGQ 350 (459)
T ss_pred hcCCCCccccccccccccccceeeec-CCCCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhcC
Confidence 1124579999999999988 78999999999999999999999999 577777887777653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=290.31 Aligned_cols=263 Identities=30% Similarity=0.516 Sum_probs=187.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +|+||+++++++.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence 4799999999999999999999999999999998642 235678999999999 99999999999854 457899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|||++++.+..+. ..++...+..++.++ +.||.|||+.+|+||||||+|
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi---------------------------~~~L~~lH~~~i~H~dlkp~N 130 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL---------------------------IKAIHWCHKNDIVHRDIKPEN 130 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCCCHHH
Confidence 99999987765443 234555555555554 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
|+++.++ .++|+|||++....... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..
T Consensus 131 ill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~ 207 (287)
T cd07848 131 LLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEI 207 (287)
T ss_pred EEEcCCC-cEEEeeccCcccccccccccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHH
Confidence 9999666 79999999997654322 2234568889999999877 56899999999999999999999998 444455
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC----cccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN----NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+....++.....+ ... ..++...... ...+.... ...........+++.+||+.||++||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s 277 (287)
T cd07848 208 DQLFTIQKVLGPLPAEQM-KLF--YSNPRFHGLR--FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL 277 (287)
T ss_pred HHHHHHHHhhCCCCHHHH-Hhh--hccchhcccc--cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC
Confidence 555555554443222111 110 0011110000 00000000 000112233468899999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=300.05 Aligned_cols=223 Identities=17% Similarity=0.278 Sum_probs=159.2
Q ss_pred CCCCceEEEeecccCCceEEEEEE-----ccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGIN-----VTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+|+.++.++.+||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 457899999999999999999974 234578999998642 2356889999999998899999999988543
Q ss_pred CCCceeEEeeecCCCceeeccccchh---------hHHHHHHHHHhhcCCcc-------------eee------------
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTAN---------EIRYYIYELLKHAMPRK-------------VII------------ 146 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-------------~~~------------ 146 (332)
....+++|||+++++|..++...... ....-............ ...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 34678999999999987765321100 00000000000000000 000
Q ss_pred ----cCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccce
Q 040656 147 ----MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYF 219 (332)
Q Consensus 147 ----~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y 219 (332)
.....+.+...++.|++.||+|||++||+||||||+|||++.++ .++|+|||+++....... .....++..|
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCccc
Confidence 00011223346778999999999999999999999999999666 799999999976532221 1123445679
Q ss_pred eccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 220 KGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 220 ~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~ 278 (338)
T cd05102 243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYP 278 (338)
T ss_pred cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence 99999876 678999999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=301.60 Aligned_cols=266 Identities=25% Similarity=0.451 Sum_probs=192.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----C
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----S 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~ 101 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++.+ +|+||+++++++.... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccccc
Confidence 47899999999999999999999899999999998632 235677899999999 9999999999885432 2
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...+++|||++++....+...++...+..++. |++.||.|||++||+||||||
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~---------------------------qi~~aL~~LH~~givHrDikp 147 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQMELDHERMSYLLY---------------------------QMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_pred ceeEEEhhhhcccHHHHHhhcCCHHHHHHHHH---------------------------HHHHHHHHHHhCCcccCCCCh
Confidence 35789999998765443333444544444444 445599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+||+++.++ .++|+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..
T Consensus 148 ~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~ 224 (355)
T cd07874 148 SNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYI 224 (355)
T ss_pred HHEEECCCC-CEEEeeCcccccCCCccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHH
Confidence 999999666 799999999986654444455678999999999877 67899999999999999999999999 455555
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCC--------------CCCCCcccccccccccccCceEEEeCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRV--------------WPIPNNKKLQFCRSSRTSTNICITFSP 327 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--------------~~~~~~~~~~~~~~~~~~~~~cl~~dP 327 (332)
+....+...++.+... +..+ ..+.....+.+... +..............++++..||+.||
T Consensus 225 ~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 299 (355)
T cd07874 225 DQWNKVIEQLGTPCPE-FMKK----LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_pred HHHHHHHHHhCCCCHH-HHHh----hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCc
Confidence 6666666655543321 1111 11222222211100 000011111112233588999999999
Q ss_pred CCCCC
Q 040656 328 SGFPF 332 (332)
Q Consensus 328 ~~RP~ 332 (332)
++||+
T Consensus 300 ~~Rps 304 (355)
T cd07874 300 AKRIS 304 (355)
T ss_pred hhcCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=297.70 Aligned_cols=247 Identities=28% Similarity=0.517 Sum_probs=199.8
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch------HHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.....+.|++.+.||.|.||.||+|+...+|+.+|+|++++... ..+.+|+.+|+++..||||+.+++.|.+.
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~- 108 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP- 108 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-
Confidence 33456789999999999999999999999999999999975432 57999999999995599999999999554
Q ss_pred CCCceeEEeeecCCCceeeccc--cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPT--LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
...++|||++.||.+.+.+.. +++.++..++.+++. ++.|||+.||+|||
T Consensus 109 -~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~---------------------------av~~lH~~gvvHrD 160 (382)
T KOG0032|consen 109 -DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILE---------------------------AVKYLHSLGVVHRD 160 (382)
T ss_pred -CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHH---------------------------HHHHHHhCCceecc
Confidence 578999999999988776533 777777776666665 99999999999999
Q ss_pred CCCCCeeecCCC---CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 179 VKPHNVMIDHEQ---QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~---~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||+|+|+.... ..++++|||++............+||+.|+|||++.. ..|+..+||||+|+++|.|++|..||.
T Consensus 161 lKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~ 239 (382)
T KOG0032|consen 161 LKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFW 239 (382)
T ss_pred CCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCc
Confidence 999999996542 3799999999999887666788899999999999876 689999999999999999999999994
Q ss_pred CCCCCHHHHHHHHHHhC----------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLG----------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIPN 305 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~ 305 (332)
+.........+.+.-. +..+.+++..+ +..+|..|-...+. |||....
T Consensus 240 -~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~l-l~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 240 -GETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKL-LEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred -CCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHh-cccCcccCCCHHHHhcCccccCC
Confidence 5555555555555422 33555556555 56666666555555 7776543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=301.42 Aligned_cols=214 Identities=27% Similarity=0.478 Sum_probs=171.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---- 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 100 (332)
..++|.+.+.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++.+ +|+||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 357899999999999999999999999999999998632 235678899999999 9999999999875432
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....++||||++++....+...++...+..++ .|++.||.|||++||+|||||
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~---------------------------~qi~~aL~~LH~~~ivH~Dlk 153 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLL---------------------------YQMLCGIKHLHSAGIIHRDLK 153 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHH---------------------------HHHHHHHHHHhhCCeecCCCC
Confidence 23579999999875444333334444444444 445559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+||+++.++ .++|+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+.
T Consensus 154 p~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~ 230 (364)
T cd07875 154 PSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDH 230 (364)
T ss_pred HHHEEECCCC-cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCH
Confidence 9999999666 799999999986654434455678999999999877 67899999999999999999999999 56666
Q ss_pred HHHHHHHHHHhCCc
Q 040656 261 QDQLVKIARVLGTD 274 (332)
Q Consensus 261 ~~~~~~~~~~~~~~ 274 (332)
.+....+....+.+
T Consensus 231 ~~~~~~~~~~~~~~ 244 (364)
T cd07875 231 IDQWNKVIEQLGTP 244 (364)
T ss_pred HHHHHHHHHhcCCC
Confidence 66777777666654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=295.44 Aligned_cols=265 Identities=29% Similarity=0.512 Sum_probs=184.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC---CCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS---KTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---~~~ 104 (332)
+|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +||||+++++++..... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 599999999999999999999999999999998632 234578999999999 99999999998854322 347
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+++|||+.+ ++...+ ..++......++. |+++||.|||++||+||||||
T Consensus 80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~---------------------------qi~~aL~~LH~~~ivH~dlkp 131 (338)
T cd07859 80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLY---------------------------QLLRALKYIHTANVFHRDLKP 131 (338)
T ss_pred EEEEecCCC-CHHHHHHhcccCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeecCCCCH
Confidence 999999965 444332 2344544444444 445599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+|||++.++ .++|+|||+++....... .....+|..|+|||++.+. ..++.++|||||||++|+|++|..|| .
T Consensus 132 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~ 209 (338)
T cd07859 132 KNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-P 209 (338)
T ss_pred HHeEECCCC-cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-C
Confidence 999999666 799999999875432211 2345789999999987642 46889999999999999999999998 4
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCC-CC-CcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWP-IP-NNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~-~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.+....+..+....+.+.... ...... ...+..+..+.... .. ............+++..||+.||++||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~-~~~i~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 210 GKNVVHQLDLITDLLGTPSPET-ISRVRN---EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCChHHHHHHHHHHhCCCCHHH-HHHhhh---hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 5555555666666555443221 111111 11111111110000 00 0000111223347788899999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=299.42 Aligned_cols=202 Identities=31% Similarity=0.552 Sum_probs=166.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++..+ +|+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence 4699999999999999999999999999999998743 234578899999999 89999999999854 45789
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++|||+++++|..++. .+++..+..++.+++. ||.|||++||+||||||+
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------~l~~lH~~~ivH~dlkp~ 130 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE---------------------------AVDALHELGYIHRDLKPE 130 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCccccCCCHH
Confidence 9999999999887753 3555555555555554 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||+++.++ .++|+|||++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||. ..+..+
T Consensus 131 Nil~~~~~-~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~ 205 (333)
T cd05600 131 NFLIDASG-HIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNE 205 (333)
T ss_pred HEEECCCC-CEEEEeCcCCccccc--ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHH
Confidence 99999666 799999999876543 3345578999999999887 588999999999999999999999994 444444
Q ss_pred HHHHHH
Q 040656 263 QLVKIA 268 (332)
Q Consensus 263 ~~~~~~ 268 (332)
....+.
T Consensus 206 ~~~~i~ 211 (333)
T cd05600 206 TWENLK 211 (333)
T ss_pred HHHHHH
Confidence 444433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=298.32 Aligned_cols=186 Identities=25% Similarity=0.448 Sum_probs=154.7
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++.+.+ ...++++|||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999998742 224577899999999 99999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+ ..+++..+..++.|++. ||+|||++||+||||||+|||++.
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------~L~~lH~~~ivHrDlkp~NIll~~ 130 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVS---------------------------ALGYLHSCDVVYRDLKLENLMLDK 130 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeEeCCCCHHHEEECC
Confidence 999886654 23555555555555554 999999999999999999999996
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 131 ~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 131 DG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred CC-CEEEeeCCCCcccccCCCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCC
Confidence 66 799999999875322 223345678999999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=292.69 Aligned_cols=238 Identities=23% Similarity=0.467 Sum_probs=201.8
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.-.-+|++.+.||+|.||.|-+|+....|+.||||.+++.. .-++.+|++||..| +||||+++|.+|+ +..
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFE--Nkd 126 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFE--NKD 126 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhc--CCc
Confidence 34568999999999999999999999999999999997543 24688999999999 9999999999994 456
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+.+||||..+|.|-+.. +.+++.+++.++.|++. |+.|+|.++++||||
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvS---------------------------AVhYCHknrVvHRDL 179 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVS---------------------------AVHYCHKNRVVHRDL 179 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHH---------------------------HHHHHhhccceeccc
Confidence 789999999999987775 57899999999998887 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|.+|||+|.++ .+||+|||++..+......+++||++.|.+||.+.+...-++..|.||||++||.|+.|..|| .+.+
T Consensus 180 KLENILLD~N~-NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~D 257 (668)
T KOG0611|consen 180 KLENILLDQNN-NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRD 257 (668)
T ss_pred chhheeecCCC-CeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCch
Confidence 99999999777 599999999999988888899999999999999988666689999999999999999999999 5666
Q ss_pred CHHHHHHHHHHhC----CchHHHHHHhcCCCCChhHHHHhccC
Q 040656 260 NQDQLVKIARVLG----TDELNAYLDKYHLELDPQLEALVGRK 298 (332)
Q Consensus 260 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~ 298 (332)
-...+.+|.++-- ++.-...+.+..+-++|+.|..|..+
T Consensus 258 hk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDi 300 (668)
T KOG0611|consen 258 HKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDI 300 (668)
T ss_pred HHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHH
Confidence 6666677766521 12222223333367788888888776
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=306.22 Aligned_cols=229 Identities=20% Similarity=0.338 Sum_probs=180.0
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
..-++.||+|+.|.||+|+. .++.||||.++ +.-..+++.|++| +|+|||.+.|+|. ....+|+|||||..
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----elkETdIKHLRkL-kH~NII~FkGVCt--qsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----ELKETDIKHLRKL-KHPNIITFKGVCT--QSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHh----hhhhhhHHHHHhc-cCcceeeEeeeec--CCceeEEeeecccc
Confidence 34478899999999999965 78999999875 2224678899999 9999999999994 45678999999999
Q ss_pred CCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 114 TDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 114 ~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
|.|...+. .++...+..+.+++.. |+.|||.++|||||||.-||||+.++
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~---------------------------GM~YLH~hKIIHRDLKSPNiLIs~~d 249 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAG---------------------------GMNYLHLHKIIHRDLKSPNILISYDD 249 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhh---------------------------hhHHHHHhhHhhhccCCCceEeeccc
Confidence 98877763 3555555556665554 99999999999999999999999777
Q ss_pred CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 040656 191 QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARV 270 (332)
Q Consensus 191 ~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~ 270 (332)
.|||+|||.++..........++||..|||||++.+ ++++.+.|||||||+||||+||..||. +.+.. .|+=+
T Consensus 250 -~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYk-dVdss----AIIwG 322 (904)
T KOG4721|consen 250 -VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYK-DVDSS----AIIWG 322 (904)
T ss_pred -eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCcc-ccchh----eeEEe
Confidence 799999999988776666778899999999999998 899999999999999999999999993 32221 12222
Q ss_pred hCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 271 LGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.++..+ -.-++.+++..++.++ .+||+-.|.+||+
T Consensus 323 VGsNsL---~LpvPstcP~GfklL~------------------------Kqcw~sKpRNRPS 357 (904)
T KOG4721|consen 323 VGSNSL---HLPVPSTCPDGFKLLL------------------------KQCWNSKPRNRPS 357 (904)
T ss_pred ccCCcc---cccCcccCchHHHHHH------------------------HHHHhcCCCCCcc
Confidence 232221 1122234555555555 5599999999996
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=301.79 Aligned_cols=204 Identities=29% Similarity=0.496 Sum_probs=166.2
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++..+ +|+||+++++.|.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence 4799999999999999999999999999999999742 224578899999999 89999999999954 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||+++++|..++ ..+++..+..++.|++. ||+|||++||+||||||+
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------aL~~lH~~~ivH~Dlkp~ 130 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL---------------------------AIDSIHKLGYIHRDIKPD 130 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEeccCCHH
Confidence 999999999887764 34566666666666655 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc---------------------------------------ccccccccceeccc
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE---------------------------------------YNVRVASRYFKGPE 223 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~---------------------------------------~~~~~~t~~y~aPE 223 (332)
|||++.++ .++|+|||++..+..... ....+||+.|+|||
T Consensus 131 NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 209 (364)
T cd05599 131 NLLLDAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE 209 (364)
T ss_pred HeEECCCC-CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHH
Confidence 99999766 799999999875432110 01236899999999
Q ss_pred cccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 040656 224 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIA 268 (332)
Q Consensus 224 ~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 268 (332)
++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.
T Consensus 210 ~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~-~~~~~~~~~~i~ 252 (364)
T cd05599 210 VFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFC-SDNPQETYRKII 252 (364)
T ss_pred HHcC-CCCCCeeeeecchhHHHHhhcCCCCCC-CCCHHHHHHHHH
Confidence 9876 678999999999999999999999994 444444444443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.86 Aligned_cols=204 Identities=25% Similarity=0.394 Sum_probs=162.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
+|++.+.||+|+||.||+|.+..+++.||+|++++.. ......|..++..+.+|++|+++++++.+ ...+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 5899999999999999999999999999999987421 23456788888888679999999999854 457899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||++++++...+ ..+++..+..++.++ +.||+|||++||+||||||+|
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi---------------------------~~aL~~LH~~~ivHrDlkp~N 131 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEI---------------------------AIGLFFLHSKGIIYRDLKLDN 131 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCEEecCCCHHH
Confidence 99999999886654 234555555555554 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|+||..||. +.+..+
T Consensus 132 ill~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~ 208 (323)
T cd05616 132 VMLDSEG-HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDE 208 (323)
T ss_pred eEECCCC-cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC-CCCHHH
Confidence 9999666 799999999875432 223345578999999999877 678999999999999999999999994 444444
Q ss_pred HHHHHH
Q 040656 263 QLVKIA 268 (332)
Q Consensus 263 ~~~~~~ 268 (332)
....+.
T Consensus 209 ~~~~i~ 214 (323)
T cd05616 209 LFQSIM 214 (323)
T ss_pred HHHHHH
Confidence 444443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.78 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=161.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
+|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+..|..++..+.+|++|+.+++++.+ ....++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 589999999999999999999999999999998642 234577899999999556678889988854 457899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|||++++++...+ ..+++..+..++.|+ +.||+|||++||+||||||+|
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi---------------------------~~al~~lH~~~ivH~dlkp~N 131 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI---------------------------AIGLFFLHSKGIIYRDLKLDN 131 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeEecCCCHHH
Confidence 99999999886654 234455444444444 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.++ .++|+|||++..... ........||..|+|||++.+ ..++.++|||||||++|+|+||..||. +.+..+
T Consensus 132 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~ 208 (324)
T cd05587 132 VMLDAEG-HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDE 208 (324)
T ss_pred eEEcCCC-CEEEeecCcceecCCCCCceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHH
Confidence 9999666 799999999875322 223344578999999999977 678999999999999999999999994 444444
Q ss_pred HHHHHH
Q 040656 263 QLVKIA 268 (332)
Q Consensus 263 ~~~~~~ 268 (332)
....+.
T Consensus 209 ~~~~i~ 214 (324)
T cd05587 209 LFQSIM 214 (324)
T ss_pred HHHHHH
Confidence 444443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=298.92 Aligned_cols=211 Identities=27% Similarity=0.508 Sum_probs=182.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
-++|+.++.+|.|+||.+++++++.....+++|.+.- ..+....+|+.++.++ .|||||.+.+.|+.. +..++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence 3689999999999999999999999999999999862 2334678999999998 999999999999643 34589
Q ss_pred eEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 106 LIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 106 lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++|+|++||++.+.+ ..++++.+..++.|++. |+.|||+++|+|||||
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~---------------------------av~ylH~~~iLHRDlK 133 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILL---------------------------AVNYLHENRVLHRDLK 133 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHH---------------------------HHHHHHhhhhhcccch
Confidence 999999999998875 23667777666666665 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
+.||+++.++ .|+|.|||+|+.+.... ...+..||+.||+||.+.+ .+|+.++|||||||++|||++-+.+| .+.+
T Consensus 134 ~~Nifltk~~-~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~ 210 (426)
T KOG0589|consen 134 CANIFLTKDK-KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASN 210 (426)
T ss_pred hhhhhccccC-ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-Cccc
Confidence 9999999777 58999999999988776 5667899999999999988 78999999999999999999999998 5777
Q ss_pred CHHHHHHHHHHhCC
Q 040656 260 NQDQLVKIARVLGT 273 (332)
Q Consensus 260 ~~~~~~~~~~~~~~ 273 (332)
......++.+....
T Consensus 211 m~~Li~ki~~~~~~ 224 (426)
T KOG0589|consen 211 MSELILKINRGLYS 224 (426)
T ss_pred hHHHHHHHhhccCC
Confidence 77778888876543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=298.73 Aligned_cols=205 Identities=29% Similarity=0.476 Sum_probs=168.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++.++ +|+||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~--~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQD--KLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCeEE
Confidence 5799999999999999999999999999999999642 224578899999999 99999999999954 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||++++++..++ ..+++..+..++.+++. ||+|||++||+||||||+
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------aL~~lH~~givHrDlKp~ 130 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL---------------------------AIDSIHQLGFIHRDIKPD 130 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeEecCCCHH
Confidence 999999999887765 34666666666666655 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC------------------------------------cccccccccceecccccc
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK------------------------------------EYNVRVASRYFKGPELLV 226 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~------------------------------------~~~~~~~t~~y~aPE~~~ 226 (332)
|||++.++ .++|+|||+++...... .....+||..|+|||++.
T Consensus 131 NILi~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 209 (363)
T cd05628 131 NLLLDSKG-HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM 209 (363)
T ss_pred HeEECCCC-CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc
Confidence 99999766 79999999986542110 012347899999999987
Q ss_pred CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 040656 227 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAR 269 (332)
Q Consensus 227 ~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 269 (332)
+ ..++.++|||||||++|||++|..||. +.+..+....+..
T Consensus 210 ~-~~~~~~~DvwSlGvil~ell~G~~Pf~-~~~~~~~~~~i~~ 250 (363)
T cd05628 210 Q-TGYNKLCDWWSLGVIMYEMLIGYPPFC-SETPQETYKKVMN 250 (363)
T ss_pred C-CCCCCchhhhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHc
Confidence 7 678999999999999999999999994 4444555555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=278.04 Aligned_cols=244 Identities=25% Similarity=0.448 Sum_probs=194.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..+.|++.+.||+|.|+.|+++.+..+|+.+|+|++.. ..-+++.+|+.|.+.| +||||+++++.+ +.....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti--~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI--QEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhh--ccccee
Confidence 34789999999999999999999999999999999863 3446789999999999 999999999998 444678
Q ss_pred eeEEeeecCCCceee-cc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVL-YP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++|||++.|+++..- .. .+++..+..++. ||+.+|.|+|.+||||||+||
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~r---------------------------QiLeal~yCH~n~IvHRDvkP 138 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------------------------QILEALAYCHSNGIVHRDLKP 138 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHH---------------------------HHHHHHHHHHhcCceeccCCh
Confidence 999999999886442 22 234444444444 455599999999999999999
Q ss_pred CCeeecC--CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 182 HNVMIDH--EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 182 ~Nilv~~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
+|+++.. .+.-+||+|||+|..+..+.....+.||+.|||||++.. .+|+.++||||-|++||-++.|..||. +.+
T Consensus 139 ~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~ 216 (355)
T KOG0033|consen 139 ENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DED 216 (355)
T ss_pred hheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-Ccc
Confidence 9999943 233689999999999886667778899999999999988 789999999999999999999999993 445
Q ss_pred CHHHHHHHHHHhC----------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCc
Q 040656 260 NQDQLVKIARVLG----------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNN 306 (332)
Q Consensus 260 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~ 306 (332)
.....+.|...-- ++..++++.+| +..+|..|...... |||..+..
T Consensus 217 ~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrM-L~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRM-LTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred HHHHHHHHhccccCCCCcccCcCCHHHHHHHHHH-hccChhhhccHHHHhCCchhcchH
Confidence 5566666665421 34566666666 67777666665444 78876553
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.99 Aligned_cols=205 Identities=21% Similarity=0.405 Sum_probs=165.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC-ceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN-EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~ 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKD--ES 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEe--CC
Confidence 4578999999999999999999866554 68999998632 234678899999999 99999999999954 45
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.++++|||++++++..++ ..+++..+..++.+++ .||.|||+.||+||||
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~---------------------------~aL~~LH~~~ivHrDL 157 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV---------------------------LIFEYLQSLNIVYRDL 157 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEccCC
Confidence 789999999999887665 2355555555555555 4999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
||+|||++.++ .++|+|||++..... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+
T Consensus 158 kp~NILl~~~~-~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~-~~~ 232 (340)
T PTZ00426 158 KPENLLLDKDG-FIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFY-ANE 232 (340)
T ss_pred CHHHEEECCCC-CEEEecCCCCeecCC--CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCC-CCC
Confidence 99999999666 799999999986542 2345678999999999877 678999999999999999999999994 334
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
.......+..
T Consensus 233 ~~~~~~~i~~ 242 (340)
T PTZ00426 233 PLLIYQKILE 242 (340)
T ss_pred HHHHHHHHhc
Confidence 4344444443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=297.78 Aligned_cols=265 Identities=26% Similarity=0.470 Sum_probs=192.9
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC---CCCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---SKTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---~~~~ 104 (332)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +|+||+++++++.... ....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 478999999999999999999899999999998632 235688999999999 9999999999986543 1257
Q ss_pred eeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 105 SLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++++||+.+.....+. ..++...+..++.+++. ||.|||+.|++||||||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~---------------------------aL~~LH~~~ivH~dlkp~ 132 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR---------------------------GLKYLHSAGILHRDIKPG 132 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeeCCCCChH
Confidence 8999998754333222 33555555555555554 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.++ .++|+|||+++...... ......++..|+|||++.+...++.++|||||||++|+|++|..|| .+.+.
T Consensus 133 Nili~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~ 210 (372)
T cd07853 133 NLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSP 210 (372)
T ss_pred HEEECCCC-CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCH
Confidence 99999666 79999999998654322 2233467888999999887556899999999999999999999998 46667
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCC--CCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPI--PNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+...++.+...++.... ...+..+.+. .+... .............+++..||+.||++||+
T Consensus 211 ~~~~~~i~~~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 281 (372)
T cd07853 211 IQQLDLITDLLGTPSLEAMRSAC-----EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS 281 (372)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhh-----HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC
Confidence 77888888887776554432211 1112211111 00000 00001111233457888999999999996
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=294.66 Aligned_cols=193 Identities=23% Similarity=0.435 Sum_probs=158.4
Q ss_pred CceEEEeecccCCceEEEEEEc---cCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+|++++.||+|+||.||+|+.. .+++.||+|++++. ..+.+..|+.++.++.+|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 5899999999999999998763 47899999998632 124577899999999779999999999844 45
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..+++|||++++++...+ ..+++..+..++.+++. ||.|||++||+||||
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------~l~~lH~~~ivHrDl 131 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL---------------------------ALEHLHKLGIVYRDI 131 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcEecCC
Confidence 789999999999887654 33566665555555554 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+|||++.++ .++|+|||+++...... ......||..|+|||++.+...++.++|||||||++|+|++|..||.
T Consensus 132 kp~Nili~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 132 KLENILLDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred CHHHeEECCCC-CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 99999999766 79999999987653322 22345789999999998764557899999999999999999999994
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=288.36 Aligned_cols=268 Identities=25% Similarity=0.441 Sum_probs=188.8
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+..-++|.+.+.||+|+||.||+|++..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++.. ...
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 78 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHT--DKS 78 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEee--CCe
Confidence 34568899999999999999999999889999999998632 224577899999999 99999999999854 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.+++|||+++.....+. ..++...+.. ++.|++.||+|||++||+|||||
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~---------------------------~~~qi~~aL~~lH~~~ivH~dlk 131 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDDCGNIMSMHNVKI---------------------------FLYQILRGLAYCHRRKVLHRDLK 131 (309)
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeecCCCC
Confidence 89999999864322221 1133333333 44455569999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+||+++.++ .++|+|||++....... ......++..|+|||++.+...++.++|||||||++|+|+||..|| .+.+
T Consensus 132 p~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~ 209 (309)
T cd07872 132 PQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGST 209 (309)
T ss_pred HHHEEECCCC-CEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCC
Confidence 9999999666 79999999987654222 2234467888999999876567899999999999999999999998 4555
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCC--CCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPI--PNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+.+..+.+..+.+....+.. .... ..... .. ...+.. .............+++.+||+.||.+||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 279 (309)
T cd07872 210 VEDELHLIFRLLGTPTEETWPG-ISSN--DEFKN-YN-FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279 (309)
T ss_pred hHHHHHHHHHHhCCCCHHHHhh-hcch--hhhhh-hh-cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC
Confidence 5666677777666544332211 1000 00000 00 000000 00000112223357888899999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.48 Aligned_cols=184 Identities=23% Similarity=0.446 Sum_probs=152.5
Q ss_pred ecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++.++ +||||+++++.+.+ ....+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 69999999999999999999999998632 234577899999999 99999999999854 4678999999999
Q ss_pred CCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 114 TDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 114 ~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
+++...+ ..+++..+..++.++ +.||.|||++||+||||||+|||++.++
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~i~HrDlkp~Nili~~~~ 130 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAEL---------------------------LCALENLHKFNVIYRDLKPENILLDYQG 130 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCeEeCCCCHHHeEECCCC
Confidence 9887654 234555555555554 4599999999999999999999999666
Q ss_pred CeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 191 QKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 191 ~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++|+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 -~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~ 194 (312)
T cd05585 131 -HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFY 194 (312)
T ss_pred -cEEEEECcccccCccCCCccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcC
Confidence 7999999998754322 22344578999999999877 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=299.82 Aligned_cols=205 Identities=31% Similarity=0.557 Sum_probs=167.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++..+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence 4799999999999999999999989999999998642 235678899999999 89999999999854 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||++++++..++ ..++...+..++.+++ .||+|||++||+||||||+
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~---------------------------~aL~~LH~~giiH~Dlkp~ 130 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV---------------------------LALDSVHKLGFIHRDIKPD 130 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeeccCCCHH
Confidence 999999999887765 2355555555555555 4999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC------------------------------cccccccccceeccccccCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK------------------------------EYNVRVASRYFKGPELLVDLQDYD 232 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ 232 (332)
|||++.++ .++|+|||++....... ......||..|+|||++.+ ..++
T Consensus 131 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~ 208 (350)
T cd05573 131 NILIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYG 208 (350)
T ss_pred HeEECCCC-CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCC
Confidence 99999766 79999999987654332 1234568999999999877 5789
Q ss_pred CcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 040656 233 YSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAR 269 (332)
Q Consensus 233 ~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 269 (332)
.++|||||||++|+|++|..||. ..........+..
T Consensus 209 ~~~DiwSlG~il~ell~g~~Pf~-~~~~~~~~~~i~~ 244 (350)
T cd05573 209 LECDWWSLGVILYEMLYGFPPFY-SDTLQETYNKIIN 244 (350)
T ss_pred CceeeEecchhhhhhccCCCCCC-CCCHHHHHHHHhc
Confidence 99999999999999999999994 3333444444443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=294.59 Aligned_cols=193 Identities=23% Similarity=0.401 Sum_probs=160.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++|++.+.||+|+||.||++.+..++..+|+|++... ....+.+|+++++++ +|+||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 79 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 79 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence 368899999999999999999999999999999998643 235688999999999 99999999999854 35789
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHrdlkp 181 (332)
++|||+++++|..++. .+++..+..+ +.+++.||.|||++ +|+||||||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------~~~i~~~l~~lH~~~~ivH~dlkp 132 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKV---------------------------SIAVLRGLAYLREKHQIMHRDVKP 132 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHH---------------------------HHHHHHHHHHHhhcCCEEcCCCCh
Confidence 9999999999877652 2344444444 44455599999986 699999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .++|+|||++..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 133 ~Nil~~~~~-~~kl~Dfg~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 133 SNILVNSRG-EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred hhEEEcCCC-cEEEccCcccccccc-cccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 999999666 799999999876532 22344578899999999877 678999999999999999999999993
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=292.76 Aligned_cols=200 Identities=23% Similarity=0.414 Sum_probs=158.8
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHH---hccCCCCeeeeeeeeeccCCCCc
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQ---NLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~---~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++. .+ +||||+++++++.+ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~--~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQT--EDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEc--CCEE
Confidence 78999999999999999999999999999999632 2245667776654 44 79999999999854 4678
Q ss_pred eeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 105 SLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++||||++++++.... ..+++.....++.+++ .||.|||+.||+||||||+
T Consensus 78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~---------------------------~al~~lH~~~ivHrdlkp~ 130 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVV---------------------------LGLQYLHENKIVYRDLKLD 130 (324)
T ss_pred EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeEecCCCHH
Confidence 9999999999876554 2355555555555554 4999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||+++.++ .+||+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||. +.+..
T Consensus 131 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~ 207 (324)
T cd05589 131 NLLLDTEG-FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEE 207 (324)
T ss_pred HeEECCCC-cEEeCcccCCccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHH
Confidence 99999776 799999999875332 223345678999999999877 678999999999999999999999993 33333
Q ss_pred HHHHH
Q 040656 262 DQLVK 266 (332)
Q Consensus 262 ~~~~~ 266 (332)
+....
T Consensus 208 ~~~~~ 212 (324)
T cd05589 208 EVFDS 212 (324)
T ss_pred HHHHH
Confidence 33333
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=285.54 Aligned_cols=191 Identities=26% Similarity=0.442 Sum_probs=158.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+|+.+++++ +|+||+++++.+.+. ...++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCC--CeEEE
Confidence 4899999999999999999998899999999986421 23467899999999 999999999998543 57899
Q ss_pred EEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+|||+.++++...+ ..++...+..++.++ +.||.|||+.|++||||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~ivH~dlkp 130 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI---------------------------TCGLEDLHRERIVYRDLKP 130 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCcEecCCCH
Confidence 99999999886553 124454444444444 4599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+||+++.++ .++|+|||++.............++..|+|||++.+ ..++.++||||||+++|++++|..||.
T Consensus 131 ~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~ 202 (285)
T cd05605 131 ENILLDDYG-HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFR 202 (285)
T ss_pred HHEEECCCC-CEEEeeCCCceecCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCC
Confidence 999999665 799999999987654444445578899999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.74 Aligned_cols=209 Identities=25% Similarity=0.381 Sum_probs=162.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
...+|.+++.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++++ +||||++++++|.. ....++++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTY--NKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEE--CCeeEEEEe
Confidence 3468999999999999999999999999999999753 34578999999999 99999999999854 456899999
Q ss_pred eecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 110 HVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 110 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
++.+..+..+. ..++...+.. ++.|++.||.|||++||+||||||+|||++
T Consensus 164 ~~~~~L~~~l~~~~~l~~~~~~~---------------------------i~~qi~~aL~ylH~~~IvHrDiKP~NIll~ 216 (391)
T PHA03212 164 RYKTDLYCYLAAKRNIAICDILA---------------------------IERSVLRAIQYLHENRIIHRDIKAENIFIN 216 (391)
T ss_pred cCCCCHHHHHHhcCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCcccCCCChHhEEEc
Confidence 98653322221 2234444443 444555699999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCC--CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC------C
Q 040656 188 HEQQKLRLIDWGLAEFYHPG--KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH------D 259 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~------~ 259 (332)
.++ .++|+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||+... +
T Consensus 217 ~~~-~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 217 HPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred CCC-CEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 666 7999999998653221 22334578999999999877 678999999999999999999998886432 2
Q ss_pred CHHHHHHHHHHhCC
Q 040656 260 NQDQLVKIARVLGT 273 (332)
Q Consensus 260 ~~~~~~~~~~~~~~ 273 (332)
....+..+....+.
T Consensus 295 ~~~~l~~i~~~~g~ 308 (391)
T PHA03212 295 SDRQIKLIIRRSGT 308 (391)
T ss_pred hhHHHHHHHHHhcC
Confidence 23445555555443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.24 Aligned_cols=246 Identities=17% Similarity=0.329 Sum_probs=186.3
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
-.+..+...+.+.||+|+||+||+|.+. -.||||+++. ...+.|++|+.++++- .|.||+-+.|+|+.+
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p-- 460 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNP-- 460 (678)
T ss_pred cccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCC--
Confidence 3345678899999999999999999763 5699999973 3457799999999999 999999999999654
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
.+.+|+.+|+|.+|-.++.-.. .+.-+.+. ..++.||++|+.|||.++|||||||.
T Consensus 461 -~~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~--------------------idIAqQiaqGM~YLHAK~IIHrDLKS 516 (678)
T KOG0193|consen 461 -PLAIITQWCEGSSLYTHLHVQE---TKFDMNTT--------------------IDIAQQIAQGMDYLHAKNIIHRDLKS 516 (678)
T ss_pred -ceeeeehhccCchhhhhccchh---hhhhHHHH--------------------HHHHHHHHHhhhhhhhhhhhhhhccc
Confidence 2389999999999877763321 12222222 34788888999999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeec---CCCcccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
.||++.+++ +|||.|||++..-. .........|...|||||++... .+|++.||||||||++|||+||..||.
T Consensus 517 nNIFl~~~~-kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys- 594 (678)
T KOG0193|consen 517 NNIFLHEDL-KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS- 594 (678)
T ss_pred cceEEccCC-cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-
Confidence 999999655 89999999986433 22233344677789999998643 468999999999999999999999994
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.......+..+.+++..++. .+...+.+.++++++ ..||++++++||.
T Consensus 595 i~~~dqIifmVGrG~l~pd~----s~~~s~~pk~mk~Ll------------------------~~C~~~~~~eRP~ 642 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDL----SKIRSNCPKAMKRLL------------------------SDCWKFDREERPL 642 (678)
T ss_pred CCChhheEEEecccccCccc----hhhhccCHHHHHHHH------------------------HHHHhcCcccCcc
Confidence 33333344444554444433 223344555666665 4499999999995
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=284.96 Aligned_cols=263 Identities=28% Similarity=0.489 Sum_probs=184.0
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhcc--CCCCeeeeeeeeecc---CCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ---HSK 102 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~---~~~ 102 (332)
+|++.+.||+|+||.||+|.+..+++.||+|.++... .....+|+.+++++. +|+||+++++++.+. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999986421 234667888877663 699999999988542 234
Q ss_pred CceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 103 TPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
..++++|++.+ ++..++. .+++..+..++.+++ .||.|||+.|++||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~---------------------------~al~~lH~~~ivH~ 132 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---------------------------RGLDFLHANCIVHR 132 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeecC
Confidence 57899999986 3333321 245555555555554 49999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
||||+||+++.++ .++|+|||++.............+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+
T Consensus 133 dikp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~ 209 (288)
T cd07863 133 DLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CG 209 (288)
T ss_pred CCCHHHEEECCCC-CEEECccCccccccCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CC
Confidence 9999999999666 799999999987654444445678889999999876 67899999999999999999999888 44
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+.+.++....+.+....+...... +. ..... ..................+++..||+.||++||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 210 NSEADQLGKIFDLIGLPPEDDWPRDVTL--PR---GAFSP-RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred CCHHHHHHHHHHHhCCCChhhCcccccc--cc---cccCC-CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 5555666666665554333222211100 00 00000 0000000000111222347788899999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.05 Aligned_cols=186 Identities=25% Similarity=0.461 Sum_probs=153.5
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||++.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++.|.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCEEEEEEeCC
Confidence 4689999999999999999999999998642 224567899999999 99999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+ ..+++..+..++.+++ .||+|||++||+||||||+|||++.
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~aL~~LH~~~ivH~Dlkp~NIll~~ 130 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIV---------------------------SALEYLHSRDVVYRDIKLENLMLDK 130 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEecCCCHHHEEEcC
Confidence 999886554 2355555555555554 4999999999999999999999996
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||++..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 131 DG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred CC-CEEecccHHhccccCCCCccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 66 799999999875322 222344578999999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=300.05 Aligned_cols=204 Identities=26% Similarity=0.486 Sum_probs=165.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|.+++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||++++++|.+ ....+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCeeE
Confidence 4799999999999999999999999999999998632 234678899999999 99999999999954 45789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||+++++|..++ ..+++..++.++.|++. ||+|||+.||+||||||+
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~---------------------------aL~~LH~~givHrDlkp~ 130 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL---------------------------AIEAVHKLGFIHRDIKPD 130 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeeccCCCHH
Confidence 999999999987764 34566666666666655 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC------------c------------------------------------ccccc
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK------------E------------------------------------YNVRV 214 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~------------~------------------------------------~~~~~ 214 (332)
|||++.++ .++|+|||+++.+.... . .....
T Consensus 131 NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (377)
T cd05629 131 NILIDRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTV 209 (377)
T ss_pred HEEECCCC-CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccC
Confidence 99999666 79999999986322100 0 01246
Q ss_pred cccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 040656 215 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIA 268 (332)
Q Consensus 215 ~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 268 (332)
||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.
T Consensus 210 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~ 261 (377)
T cd05629 210 GTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFC-SENSHETYRKII 261 (377)
T ss_pred CCccccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCC-CCCHHHHHHHHH
Confidence 8999999999876 678999999999999999999999994 344444444444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=297.50 Aligned_cols=203 Identities=25% Similarity=0.445 Sum_probs=163.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +|+||+++++.+.+ ...++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~~ 77 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY 77 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEec--CCEEE
Confidence 3689999999999999999999999999999998642 234678999999999 99999999999954 45799
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++|||++++++..++ ..+++..++.++.+++. ||.|||+.||+||||||+
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~---------------------------aL~~LH~~givHrDlKp~ 130 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL---------------------------AIESVHKMGFIHRDIKPD 130 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeeecCCcHH
Confidence 999999999887765 33566666666666555 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC------------------------------------------------cccccc
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK------------------------------------------------EYNVRV 214 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~------------------------------------------------~~~~~~ 214 (332)
|||++.++ +++|+|||+++.+.... ......
T Consensus 131 Nili~~~~-~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (381)
T cd05626 131 NILIDLDG-HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209 (381)
T ss_pred HEEECCCC-CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccccccc
Confidence 99999666 79999999875321000 012346
Q ss_pred cccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 040656 215 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267 (332)
Q Consensus 215 ~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 267 (332)
||..|+|||++.+ ..++.++|||||||++|||++|..||.. .+..+....+
T Consensus 210 gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i 260 (381)
T cd05626 210 GTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLA-PTPTETQLKV 260 (381)
T ss_pred CCccccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcC-CCHHHHHHHH
Confidence 8999999999877 6789999999999999999999999953 3333333333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=291.15 Aligned_cols=197 Identities=24% Similarity=0.434 Sum_probs=156.0
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. .......|..++....+||||+++++++.. ....+++|||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998742 223455677777766589999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
++++|...+ ..+++..+..++.|+ +.||+|||+.||+||||||+||+++.
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi---------------------------~~al~~LH~~~ivH~dlkp~Nill~~ 131 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEI---------------------------ICGLQFLHKKGIIYRDLKLDNVLLDK 131 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCEEeCCCCHHHeEECC
Confidence 999886654 235555555555554 45999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 040656 189 EQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~ 266 (332)
++ .++|+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....
T Consensus 132 ~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~ 207 (316)
T cd05592 132 DG-HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDS 207 (316)
T ss_pred CC-CEEEccCcCCeECCCCCCccccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHH
Confidence 66 7999999999764322 23345578999999999877 678999999999999999999999994 3443333333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=299.27 Aligned_cols=204 Identities=24% Similarity=0.441 Sum_probs=164.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +|+||+++++.|.+ ...++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~--~~~~~ 77 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLY 77 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEe--CCEEE
Confidence 3699999999999999999999999999999998642 234678899999999 99999999999954 45789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||++++++..++ ..+++..++.++.|++. ||.|||++||+||||||+
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~---------------------------al~~lH~~~ivHrDlKp~ 130 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC---------------------------AVESVHKMGFIHRDIKPD 130 (382)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeecCCCCHH
Confidence 999999999887765 23556656665665555 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCC------------------------------------------------Ccccccc
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPG------------------------------------------------KEYNVRV 214 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~------------------------------------------------~~~~~~~ 214 (332)
|||++.++ .++|+|||++..+... .......
T Consensus 131 NILl~~~g-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (382)
T cd05625 131 NILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV 209 (382)
T ss_pred HEEECCCC-CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 99999666 7999999987532100 0012246
Q ss_pred cccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 040656 215 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIA 268 (332)
Q Consensus 215 ~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 268 (332)
||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.
T Consensus 210 gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~ 261 (382)
T cd05625 210 GTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFL-AQTPLETQMKVI 261 (382)
T ss_pred cCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCC-CCCHHHHHHHHH
Confidence 8999999999877 678999999999999999999999994 444444444444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=290.92 Aligned_cols=198 Identities=25% Similarity=0.411 Sum_probs=158.1
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|++++. ....+..|..++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 4689999999999999999999999998642 234567888888887689999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+ ..+++..+..++.+++ .||+|||++||+||||||+|||++.
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~---------------------------~~L~~lH~~~ivH~dlkp~NIli~~ 131 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEIT---------------------------SALMFLHDKGIIYRDLKLDNVLLDH 131 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEeCCCCHHHeEECC
Confidence 999887654 2355555555555554 4999999999999999999999996
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 267 (332)
++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+
T Consensus 132 ~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i 208 (320)
T cd05590 132 EG-HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAI 208 (320)
T ss_pred CC-cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHH
Confidence 66 799999999875432 223344578999999999876 678999999999999999999999994 34333444433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.47 Aligned_cols=197 Identities=28% Similarity=0.442 Sum_probs=175.9
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch------HHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+-.....|..-+.||+|+||+|+-|....+|+.+|+|.+.+... ....+|-.+|.++ +.+.||.+-..| ++
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAf--eT 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAF--ET 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeee--cC
Confidence 44456789999999999999999999999999999999864322 3467899999999 889999998888 44
Q ss_pred CCCceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
...+|+|+..|+||+|..++. .+++..+.+|+.+++. ||++||+.+||
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~c---------------------------GLehlH~~~iV 309 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIIC---------------------------GLEHLHRRRIV 309 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHh---------------------------hHHHHHhccee
Confidence 567999999999999998862 5889999999999987 99999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||||+|||+|..| +++|+|+|+|..+..++.....+||.+|||||++.+ ..|++..|.|||||++|||+.|+.||.
T Consensus 310 YRDLKPeNILLDd~G-hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 310 YRDLKPENILLDDHG-HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred eccCChhheeeccCC-CeEeeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchh
Confidence 999999999999555 899999999999988888888899999999999988 569999999999999999999999993
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.84 Aligned_cols=197 Identities=23% Similarity=0.374 Sum_probs=160.2
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC--
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS-- 101 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-- 101 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++..+ +|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccC
Confidence 3458999999999999999999999999999999998632 235678899999999 99999999887743221
Q ss_pred ----CCceeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 102 ----KTPSLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 102 ----~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
..++++|||+++++|...+. .+++..+..++.++ +.||.|||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ql---------------------------l~aL~~lH 160 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV---------------------------LLAVHHVH 160 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHH---------------------------HHHHHHHH
Confidence 13679999999998876542 24455554444444 45999999
Q ss_pred HcCCeecCCCCCCeeecCCCCeEEEEecccceeecCC---CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHH
Q 040656 171 SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 171 ~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~el 247 (332)
+.+|+||||||+|||++.++ .+||+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|
T Consensus 161 ~~~IiHrDLKP~NILl~~~~-~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeL 238 (496)
T PTZ00283 161 SKHMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYEL 238 (496)
T ss_pred hCCEecCCCCHHHEEEeCCC-CEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999666 7999999999765422 12234578999999999977 6789999999999999999
Q ss_pred HhCCCCCC
Q 040656 248 IFRKEPFF 255 (332)
Q Consensus 248 ltg~~pf~ 255 (332)
++|..||.
T Consensus 239 ltG~~Pf~ 246 (496)
T PTZ00283 239 LTLKRPFD 246 (496)
T ss_pred HHCCCCCC
Confidence 99999993
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=292.00 Aligned_cols=186 Identities=25% Similarity=0.452 Sum_probs=153.6
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++.+.+ ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999998642 234678899999999 99999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+ ..+++..+..++.+++ .||+|||++||+||||||+|||++.
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~---------------------------~aL~~LH~~~ivHrDikp~NIll~~ 130 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIV---------------------------SALDYLHSGKIVYRDLKLENLMLDK 130 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeEecccCHHHeEECC
Confidence 999876554 2355555555555554 4999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .+||+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 ~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 131 DG-HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred CC-cEEEecCcCCccCCCcccccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCC
Confidence 66 7999999998753322 22334578999999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=291.17 Aligned_cols=216 Identities=31% Similarity=0.627 Sum_probs=169.4
Q ss_pred ccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..|...++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPAT 87 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccc
Confidence 3445578999999999999999999999999999999998642 234577899999999 9999999999885322
Q ss_pred ----CCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 101 ----SKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 101 ----~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
....+++++++ ++++..+. ..++...+..++.|++ .||.|||++||
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~---------------------------~aL~~LH~~~i 139 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLL---------------------------RGLKYIHSAGI 139 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCe
Confidence 23467888887 44554443 2355555555555554 59999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
+||||||+||+++.++ .++|+|||+++.... ......+|..|+|||++.+...++.++|||||||++|+|++|..||
T Consensus 140 vHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 140 IHRDLKPSNVAVNEDC-ELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred ecccCChhhEEECCCC-CEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999666 799999999986542 2345578999999999877567899999999999999999999998
Q ss_pred CCCCCCHHHHHHHHHHhCCc
Q 040656 255 FYGHDNQDQLVKIARVLGTD 274 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~ 274 (332)
.+.+..+.+..+....+.+
T Consensus 217 -~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 217 -PGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred -CCCCHHHHHHHHHHHhCCC
Confidence 4555556666666555443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=291.73 Aligned_cols=245 Identities=24% Similarity=0.458 Sum_probs=205.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.-|.+.+.||+|.|++|-+|++.-+|+.||||++.+.. ..++-+|+..|+.+ +||||+++|++...+ -.+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQ--TKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQ--TKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhccc--ceEEE
Confidence 45899999999999999999999999999999997543 35688999999999 999999999999554 46899
Q ss_pred EEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|+|.-.+|++.++. ..+.+..++.|+.|++. |+.|+|+..+|||||||+
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~---------------------------AI~YCHqLHVVHRDLKPE 147 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVH---------------------------AISYCHQLHVVHRDLKPE 147 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHH---------------------------HHHHHhhhhhhcccCCcc
Confidence 99999999988764 45778888888888887 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+.+...-+-|||.|||++..+.+++..++.||+..|-|||++++...-.++.||||||+|||.|++|+.||. ..++.+
T Consensus 148 NVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq-eANDSE 226 (864)
T KOG4717|consen 148 NVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ-EANDSE 226 (864)
T ss_pred eeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc-cccchh
Confidence 9999877778999999999999999999999999999999999997767789999999999999999999995 555667
Q ss_pred HHHHHHHHhCC------chHHHHHHhcCCCCChhHHHHhccC--CCCCCCCccc
Q 040656 263 QLVKIARVLGT------DELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKK 308 (332)
Q Consensus 263 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~ 308 (332)
.+..|+++--+ ..-++++..| +--+|+.|..++.+ .+|.+.....
T Consensus 227 TLTmImDCKYtvPshvS~eCrdLI~sM-LvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 227 TLTMIMDCKYTVPSHVSKECRDLIQSM-LVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhhhhcccccCchhhhHHHHHHHHHH-HhcCchhhccHHHHhccccccCCCCC
Confidence 77777765322 2334555555 55667777777666 7776655433
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=294.17 Aligned_cols=208 Identities=26% Similarity=0.416 Sum_probs=166.4
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~ 116 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DK 116 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence 3567899999999999999999999999999999998632 224577899999999 99999999999854 46
Q ss_pred CceeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
..++||||+++++|..++. .+++.....++. |++.||+|||++||+|||||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~---------------------------qi~~aL~~LH~~~ivHrDLk 169 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTA---------------------------EVVLALDAIHSMGFIHRDVK 169 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeeccCCC
Confidence 7899999999999877653 244444444444 44559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~---~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+|||++.++ .++|+|||++....... ......||..|+|||++.+. ..++.++|||||||++|+|++|..||.
T Consensus 170 p~NILl~~~~-~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 170 PDNMLLDKSG-HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred HHHEEEcCCC-CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 9999999666 79999999997654322 22345789999999998652 247899999999999999999999994
Q ss_pred CCCCCHHHHHHHH
Q 040656 256 YGHDNQDQLVKIA 268 (332)
Q Consensus 256 ~~~~~~~~~~~~~ 268 (332)
+.+.......+.
T Consensus 249 -~~~~~~~~~~i~ 260 (370)
T cd05596 249 -ADSLVGTYSKIM 260 (370)
T ss_pred -CCCHHHHHHHHH
Confidence 333334444444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=297.21 Aligned_cols=203 Identities=25% Similarity=0.453 Sum_probs=163.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +|+||+++++.|.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCEEE
Confidence 4799999999999999999999999999999998632 235678999999999 99999999999954 46799
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++|||++++++..++. .+++..+..++.|++ .||+|||++||+||||||+
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~---------------------------~al~~lH~~~ivHrDlkp~ 130 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELT---------------------------CAIESVHKMGFIHRDIKPD 130 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEeCCCCHH
Confidence 9999999999877652 345555555555555 4999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCC--------------------------------------------Ccccccccccc
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPG--------------------------------------------KEYNVRVASRY 218 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~--------------------------------------------~~~~~~~~t~~ 218 (332)
|||++.++ .++|+|||++..+... .......||..
T Consensus 131 Nill~~~~-~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 209 (376)
T cd05598 131 NILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209 (376)
T ss_pred HEEECCCC-CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcc
Confidence 99999666 7999999997532100 00113468999
Q ss_pred eeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 040656 219 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267 (332)
Q Consensus 219 y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 267 (332)
|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+
T Consensus 210 y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i 256 (376)
T cd05598 210 YIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFL-ADTPAETQLKV 256 (376)
T ss_pred ccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCC-CCCHHHHHHHH
Confidence 999999877 678999999999999999999999994 34444443333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=293.36 Aligned_cols=187 Identities=26% Similarity=0.486 Sum_probs=155.8
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+..|..++..+.+||||++++++|.+ ...++++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999999742 224578899999998789999999999954 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++..++ ..+++..+..++.+++. ||.|||++||+||||||+||+++.
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~---------------------------~l~~lH~~~ivH~dlkp~Nili~~ 131 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISL---------------------------ALNFLHERGIIYRDLKLDNVLLDA 131 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEecCCCHHHeEECC
Confidence 999886554 34566666655555554 999999999999999999999996
Q ss_pred CCCeEEEEecccceee-cCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||+++.. ..........||..|+|||++.+ ..++.++|+|||||++|+|++|..||.
T Consensus 132 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 132 EG-HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CC-CEEECcCccccccccCCCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcc
Confidence 66 7999999998753 22333445678999999999877 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=292.61 Aligned_cols=253 Identities=19% Similarity=0.306 Sum_probs=187.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
++|.--..||+|+||.||+|.. .++..||||.++... ..+|.+|+.++.++ +|||+++++|+|.+... ..++|+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~-~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEGGE-HRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecCCc-eEEEEE
Confidence 5777788999999999999986 455999999887533 56799999999999 79999999999975432 689999
Q ss_pred eeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC---CeecCCCCCCee
Q 040656 109 EHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG---IMHRDVKPHNVM 185 (332)
Q Consensus 109 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---ivHrdlkp~Nil 185 (332)
||++.|+|..++..-... ...|..+..|++++|+||+|||... |+|||||+.|||
T Consensus 152 Eym~nGsL~d~L~~~~~~----------------------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGE----------------------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred EccCCCCHHHHhCCCCCC----------------------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 999999998876432211 1256667789999999999999754 999999999999
Q ss_pred ecCCCCeEEEEecccceeecC-CCccccc-ccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--CCH
Q 040656 186 IDHEQQKLRLIDWGLAEFYHP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNQ 261 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~--~~~ 261 (332)
+|.+. .+||+|||+|+.... ....... .||..|+|||+... ...+.++||||||+++.|++||+.|..... ...
T Consensus 210 LD~~~-~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~ 287 (361)
T KOG1187|consen 210 LDEDF-NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL 287 (361)
T ss_pred ECCCC-CEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence 99666 799999999976543 3333333 79999999999876 578999999999999999999998875432 122
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCC--CCC--hhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHL--ELD--PQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+.........+.++++.... ..+ ..+.. .-.+...|++.+|++||+
T Consensus 288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~---------------------~~~~a~~C~~~~~~~RP~ 341 (361)
T KOG1187|consen 288 SLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKK---------------------LAELALRCLRPDPKERPT 341 (361)
T ss_pred cHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHH---------------------HHHHHHHHcCcCCCcCcC
Confidence 233333333333333333332211 111 01111 225677799999999995
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.90 Aligned_cols=192 Identities=24% Similarity=0.365 Sum_probs=157.3
Q ss_pred CCceEEEeecccCCceEEEEEEccC-CceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTN-NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..|.+.+.||+|+||.||+|....+ ++.||+|.+.... ...+.+|+.+++.+ +||||+++++.|.. ....++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~--~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKS--DDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEE--CCEEEEE
Confidence 3499999999999999999988777 7889999764322 34577899999999 99999999999954 4578999
Q ss_pred EeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 108 FEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
|||+++++|...+. .+++.....++ .|++.||.|||+++|+|||||
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~---------------------------~qi~~aL~~lH~~~ivHrDlk 196 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLF---------------------------YQIVLALDEVHSRKMMHRDLK 196 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHH---------------------------HHHHHHHHHHHhCCEEECCcC
Confidence 99999999866432 23444444444 455559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+|||++.++ .++|+|||+++....... ....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 197 p~NIll~~~~-~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~ 272 (478)
T PTZ00267 197 SANIFLMPTG-IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK 272 (478)
T ss_pred HHhEEECCCC-cEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 9999999666 799999999987643221 334578999999999877 678999999999999999999999994
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.78 Aligned_cols=234 Identities=22% Similarity=0.350 Sum_probs=170.8
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. .......|..++....+|+||+++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 4699999999999999999999999998742 234566788888776689999999999954 46789999999
Q ss_pred cCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
.++++...+. .++...+..++. |++.||+|||++||+||||||+||+++.
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~---------------------------qi~~~l~~lH~~~ivHrDlkp~Nil~~~ 131 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAA---------------------------EIVCGLQFLHSKGIIYRDLKLDNVMLDR 131 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeEecCCCHHHeEECC
Confidence 9988765542 344444444444 4455999999999999999999999996
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 267 (332)
++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+
T Consensus 132 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~-~~~~~~~~~~~ 208 (316)
T cd05620 132 DG-HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFH-GDDEDELFESI 208 (316)
T ss_pred CC-CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHH
Confidence 66 799999999875322 223345678999999999877 678999999999999999999999994 33333333333
Q ss_pred HHHhC------CchHHHHHHhcCCCCChhHHHHhc-cC--CCCCCC
Q 040656 268 ARVLG------TDELNAYLDKYHLELDPQLEALVG-RK--RVWPIP 304 (332)
Q Consensus 268 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~i~-~~--~~~~~~ 304 (332)
..... +....+++.++ +..+|..|..+. .+ |+|+..
T Consensus 209 ~~~~~~~~~~~~~~~~~li~~~-l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 209 RVDTPHYPRWITKESKDILEKL-FERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HhCCCCCCCCCCHHHHHHHHHH-ccCCHHHcCCChHHHHcCCCcCC
Confidence 22111 12334445444 455555554331 22 566544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=290.06 Aligned_cols=187 Identities=27% Similarity=0.490 Sum_probs=154.3
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+..|+.++.++.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998742 224577899998887789999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+ ..+++.....++.+++ .||+|||++||+||||||+||+++.
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~---------------------------~~l~~lH~~~ivH~Dikp~Nili~~ 131 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEIS---------------------------LALNYLHERGIIYRDLKLDNVLLDS 131 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeeeCCCCHHHEEECC
Confidence 999886553 2355555555555554 5999999999999999999999997
Q ss_pred CCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||+++... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 132 ~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 132 EG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CC-CEEEeeCCccccccCCCCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCc
Confidence 66 79999999987532 2223345678999999999877 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=284.37 Aligned_cols=214 Identities=20% Similarity=0.356 Sum_probs=155.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc----------------CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCe
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT----------------NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNI 89 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni 89 (332)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++... ....+.+|+.++.++ +||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCe
Confidence 45789999999999999999997532 3347999998643 235688999999999 99999
Q ss_pred eeeeeeeeccCCCCceeEEeeecCCCceeeccccc--hhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHH
Q 040656 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLT--ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALD 167 (332)
Q Consensus 90 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 167 (332)
+++++++.+. ...+++|||+.++++..++.... ....... .............+.+...++.|++.||.
T Consensus 82 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 82 IRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGN-------DAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred eEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccc-------cccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999653 56899999999988766542210 0000000 00000000011122233467788888999
Q ss_pred HHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHH
Q 040656 168 YCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244 (332)
Q Consensus 168 ~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il 244 (332)
|||+.||+||||||+|||++.++ .++|+|||+++........ ....++..|+|||++.+ ..++.++||||||+++
T Consensus 153 ~lH~~~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l 230 (304)
T cd05096 153 YLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTL 230 (304)
T ss_pred HHHHCCccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHH
Confidence 99999999999999999999665 7999999999765433221 12244677999999876 5789999999999999
Q ss_pred HHHHh--CCCCCC
Q 040656 245 AGMIF--RKEPFF 255 (332)
Q Consensus 245 ~ellt--g~~pf~ 255 (332)
|+|++ +..||.
T Consensus 231 ~el~~~~~~~p~~ 243 (304)
T cd05096 231 WEILMLCKEQPYG 243 (304)
T ss_pred HHHHHccCCCCCC
Confidence 99986 566773
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.81 Aligned_cols=187 Identities=26% Similarity=0.457 Sum_probs=151.3
Q ss_pred EEeecccCCceEEEEEEc---cCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 37 VRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++.||+|+||.||+|... .+++.||+|+++.. ....+.+|+.+++.+ +||||+++++.|.. ....++
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~l 77 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQT--GGKLYL 77 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEec--CCeEEE
Confidence 368999999999999763 46889999998642 123567899999999 99999999999854 457899
Q ss_pred EEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|||++++++...+. .+.+..+..++.++ +.||.|||++||+||||||+|
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~ivH~dlkp~N 130 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEI---------------------------SLALEHLHQQGIIYRDLKPEN 130 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCCCHHH
Confidence 999999998766542 24444444444444 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||++.++ .++|+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~ 201 (323)
T cd05584 131 ILLDAQG-HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFT 201 (323)
T ss_pred eEECCCC-CEEEeeCcCCeecccCCCcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCC
Confidence 9999666 7999999998754322 22344578999999999877 668899999999999999999999994
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=287.03 Aligned_cols=204 Identities=24% Similarity=0.382 Sum_probs=162.0
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
+|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+..|..++..+.+|++|+++++++.+ ...+++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 478999999999999999999999999999998642 124567788999888667888889998854 357899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||++++++...+ ..+++..+..++.+++ .||.|||++||+||||||+|
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~---------------------------~al~~lH~~~ivHrDikp~N 131 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS---------------------------VGLFFLHRRGIIYRDLKLDN 131 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeeccCCCHHH
Confidence 99999999886654 3355555555555554 59999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.++ .++|+|||++...... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+...
T Consensus 132 ill~~~~-~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~ 208 (323)
T cd05615 132 VMLDSEG-HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDE 208 (323)
T ss_pred eEECCCC-CEEEeccccccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC-CCCHHH
Confidence 9999666 7999999998754322 22334568999999999876 678999999999999999999999994 333333
Q ss_pred HHHHHH
Q 040656 263 QLVKIA 268 (332)
Q Consensus 263 ~~~~~~ 268 (332)
....+.
T Consensus 209 ~~~~i~ 214 (323)
T cd05615 209 LFQSIM 214 (323)
T ss_pred HHHHHH
Confidence 444433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.65 Aligned_cols=193 Identities=23% Similarity=0.408 Sum_probs=156.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+++++.+ +|+||+++++++.+ ...+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEE
Confidence 46799999999999999999999889999999998643 235688999999999 99999999999844 457899
Q ss_pred EEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 107 IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
++||+.++++.... ...+..+.. ++.|++.||+|||++||+||||||+|||+
T Consensus 150 v~e~~~~~~L~~~~-~~~~~~~~~---------------------------i~~qi~~aL~~LH~~~ivHrDlkp~NIll 201 (353)
T PLN00034 150 LLEFMDGGSLEGTH-IADEQFLAD---------------------------VARQILSGIAYLHRRHIVHRDIKPSNLLI 201 (353)
T ss_pred EEecCCCCcccccc-cCCHHHHHH---------------------------HHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 99999998875432 123333333 44455569999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCC-cccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+.++ .++|+|||++....... ......||..|+|||++... ...+.++|||||||++|||++|..||.
T Consensus 202 ~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 202 NSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred cCCC-CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 9666 79999999998764322 23445789999999987431 234579999999999999999999995
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=288.71 Aligned_cols=199 Identities=24% Similarity=0.376 Sum_probs=157.4
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+..|.+++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 4689999999999999899999999998642 223467788999887689999999999954 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+ ..+++..+..++.+ ++.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~q---------------------------i~~aL~~LH~~~ivHrDikp~Nill~~ 131 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAE---------------------------VTLALMFLHRHGVIYRDLKLDNILLDA 131 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 999876543 23444444444444 455999999999999999999999997
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 267 (332)
++ .++|+|||++..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||. ..+..+....+
T Consensus 132 ~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i 208 (321)
T cd05591 132 EG-HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESI 208 (321)
T ss_pred CC-CEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHH
Confidence 66 799999999875432 223344578999999999876 678999999999999999999999994 34444444443
Q ss_pred H
Q 040656 268 A 268 (332)
Q Consensus 268 ~ 268 (332)
.
T Consensus 209 ~ 209 (321)
T cd05591 209 L 209 (321)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=287.53 Aligned_cols=187 Identities=24% Similarity=0.406 Sum_probs=153.7
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+..|..++..+.+||||+++++++.+ ...++++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998742 234567889999888789999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++.... ..+++.....++.+++ .||.|||+++|+||||||+||+++.
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~---------------------------~~l~~LH~~~ivH~dlkp~Nill~~ 131 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIV---------------------------LGLQFLHERGIIYRDLKLDNVLLDS 131 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeEccCCCHHHeEECC
Confidence 999876554 2355555555555554 4999999999999999999999997
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||++..... ........+|..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 132 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 132 EG-HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred CC-cEEecccCCCeecCcCCCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 66 799999999875322 222334578999999999877 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.25 Aligned_cols=211 Identities=22% Similarity=0.461 Sum_probs=161.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhcc-----CCCCeeeeeeeeeccCCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLC-----GGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-----~h~niv~~~~~~~~~~~~~ 103 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......|+.++..+. +|.+++.++++|... ..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cce
Confidence 47899999999999999999999899999999999642 2345667888877772 244688888888643 347
Q ss_pred ceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlk 180 (332)
++++|+++.+..+..+. ..++...+..++. |++.||.|||+ .||+|||||
T Consensus 207 ~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~---------------------------qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIF---------------------------QTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred EEEEEeccCCCHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhcCCeecCCCC
Confidence 89999988554333222 2345554444444 44559999998 599999999
Q ss_pred CCCeeecCCCC---------------eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHH
Q 040656 181 PHNVMIDHEQQ---------------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 245 (332)
Q Consensus 181 p~Nilv~~~~~---------------~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ 245 (332)
|+|||++.++. .+||+|||.+.... .......||..|+|||++.+ ..++.++|||||||++|
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIY 336 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHH
Confidence 99999985542 49999999875432 23345688999999999987 67999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 040656 246 GMIFRKEPFFYGHDNQDQLVKIARVLGT 273 (332)
Q Consensus 246 elltg~~pf~~~~~~~~~~~~~~~~~~~ 273 (332)
||++|..|| .+.+..+.+..+...++.
T Consensus 337 elltG~~pf-~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 337 ELYTGKLLY-DTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred HHHhCCCCC-CCCChHHHHHHHHHHcCC
Confidence 999999998 455566666666666654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.80 Aligned_cols=187 Identities=27% Similarity=0.501 Sum_probs=156.3
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++.++.+|+||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999999742 224577899999998789999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+ ..+++..+..++.+++. ||+|||++||+||||||+|||++.
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~---------------------------al~~lH~~~ivHrDlkp~Nili~~ 131 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICI---------------------------ALNFLHERGIIYRDLKLDNVLLDA 131 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeccCCCHHHEEEeC
Confidence 999886553 34666666665555554 999999999999999999999996
Q ss_pred CCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||+++... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 132 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 132 DG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred CC-CEEEeccccceeccCCCCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCC
Confidence 66 79999999987532 2333445678999999999877 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=294.24 Aligned_cols=204 Identities=28% Similarity=0.492 Sum_probs=166.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++..+ +|+||+++++.+.+ ....+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 4799999999999999999999999999999998632 234678899999999 99999999999844 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||++++++..++ ..+++..+..++.+++. ||+|||++||+||||||+
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------~L~~lH~~givHrDLkp~ 130 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL---------------------------AIDAIHQLGFIHRDIKPD 130 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEccCCCHH
Confidence 999999999887765 34566666666666655 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC------------------------------------cccccccccceecccccc
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK------------------------------------EYNVRVASRYFKGPELLV 226 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~------------------------------------~~~~~~~t~~y~aPE~~~ 226 (332)
|||++.++ .++|+|||++....... .....+||..|+|||++.
T Consensus 131 NIli~~~~-~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 209 (360)
T cd05627 131 NLLLDAKG-HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM 209 (360)
T ss_pred HEEECCCC-CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc
Confidence 99999666 79999999986432110 012346899999999987
Q ss_pred CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 040656 227 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIA 268 (332)
Q Consensus 227 ~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~ 268 (332)
+ ..++.++|||||||++|||++|..||. +.+.......+.
T Consensus 210 ~-~~~~~~~DiwSlGvilyel~tG~~Pf~-~~~~~~~~~~i~ 249 (360)
T cd05627 210 Q-TGYNKLCDWWSLGVIMYEMLIGYPPFC-SETPQETYRKVM 249 (360)
T ss_pred C-CCCCCcceeccccceeeecccCCCCCC-CCCHHHHHHHHH
Confidence 7 678999999999999999999999994 444444444444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=291.33 Aligned_cols=239 Identities=24% Similarity=0.369 Sum_probs=179.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeEE
Confidence 4799999999999999999999999999999998743 234578899999998 99999999999854 45789
Q ss_pred eEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+||||+++++|..++. .+++..+..++.+++ .||.|||+.+|+||||||
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~---------------------------~aL~~lH~~~i~H~Dlkp 130 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV---------------------------LAIHSVHQMGYVHRDIKP 130 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEcccCch
Confidence 9999999998877652 345555555555554 499999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccC-----CCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
+|||++.++ .++|+|||++......... ....+|..|+|||++.. ...++.++|||||||++|+|++|..||
T Consensus 131 ~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf 209 (330)
T cd05601 131 ENVLIDRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209 (330)
T ss_pred HheEECCCC-CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC
Confidence 999999666 7999999999876533322 23468899999999863 246789999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhC----------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLG----------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIP 304 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~ 304 (332)
. ..........+..... +..+.+++.++ +. +|..|..+.++ |||+..
T Consensus 210 ~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~l-l~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 210 H-EGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSL-LC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred C-CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHH-cc-ChhhCCCHHHHhCCCCcCC
Confidence 4 3333344444433211 22334555544 22 45555544444 666654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=286.16 Aligned_cols=211 Identities=24% Similarity=0.525 Sum_probs=158.9
Q ss_pred EEeecccCCceEEEEEEc--cCCceEEEEEecccc-hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 37 VRKVGRGKYSEVFEGINV--TNNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
.++||+|+||.||+|.+. .+++.+|+|.++... ...+.+|+.+++++ +||||+++++.+.+......++++||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 368999999999999864 467899999986433 35678999999999 99999999999977666678999999876
Q ss_pred CCceeec-----------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 114 TDFKVLY-----------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 114 ~~l~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
.....+. ..++...+. .++.|++.||.|||++||+||||||+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~---------------------------~i~~qi~~al~~LH~~~ivHrDlkp~ 137 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVK---------------------------SLLYQILDGIHYLHANWVLHRDLKPA 137 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHH---------------------------HHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence 4322211 013333333 34555666999999999999999999
Q ss_pred CeeecC---CCCeEEEEecccceeecCCC----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDH---EQQKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~---~~~~vkL~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||++. ..+.+||+|||+++...... ......+|..|+|||++.+...++.++|||||||++|+|++|..||.
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred HEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999942 33479999999997654321 22345788999999998875668999999999999999999999995
Q ss_pred CCCC--------CHHHHHHHHHHhCCch
Q 040656 256 YGHD--------NQDQLVKIARVLGTDE 275 (332)
Q Consensus 256 ~~~~--------~~~~~~~~~~~~~~~~ 275 (332)
.... ..+.+..+....+.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (317)
T cd07868 218 CRQEDIKTSNPYHHDQLDRIFNVMGFPA 245 (317)
T ss_pred CCcccccccccccHHHHHHHHHhcCCCC
Confidence 3222 1344555666555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=288.37 Aligned_cols=193 Identities=23% Similarity=0.411 Sum_probs=159.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++|++.++||+|+||.||+|.+..++..+|+|+++.. ....+.+|+++++++ +|+||++++++|.+ ...++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE--CCEEE
Confidence 468899999999999999999999999999999998642 235688999999999 89999999999965 35789
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHrdlkp 181 (332)
++|||+++++|..++. .++...+..++ .+++.||.|||+. +++||||||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~---------------------------~~l~~~l~~lH~~~~ivH~dlkp 132 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVS---------------------------IAVIKGLTYLREKHKIMHRDVKP 132 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHH---------------------------HHHHHHHHHHHhcCCEEecCCCh
Confidence 9999999999877652 23444444444 4455599999985 799999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .++|+|||++..... .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.
T Consensus 133 ~Nili~~~~-~~kL~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 133 SNILVNSRG-EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred hhEEEcCCC-CEEEeeCCcchhhhh-hccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999666 799999999875432 22334568889999999876 678999999999999999999999994
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=290.74 Aligned_cols=222 Identities=19% Similarity=0.292 Sum_probs=159.2
Q ss_pred CCCCceEEEeecccCCceEEEEEE-----ccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGIN-----VTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.. ..++..||+|+++.. ..+.+.+|+.++..+.+||||++++++|.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 356899999999999999999864 345678999998642 235678999999999789999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccc----------hhhHHHHHH-------------HHHhhcCCccee------------
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLT----------ANEIRYYIY-------------ELLKHAMPRKVI------------ 145 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~-------------~~~~~~~~~~~~------------ 145 (332)
....+++|||+++|+|..++.... ......+.. ............
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 457899999999999877653211 000000000 000000000000
Q ss_pred ----------------ecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc
Q 040656 146 ----------------IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE 209 (332)
Q Consensus 146 ----------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~ 209 (332)
......+.....++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSN 269 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCccc
Confidence 000112233456788999999999999999999999999999655 799999999986543322
Q ss_pred cc---ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 210 YN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 210 ~~---~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
.. ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~ 318 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYP 318 (375)
T ss_pred ccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 11 1234556999999877 678999999999999999998 888884
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=270.74 Aligned_cols=195 Identities=25% Similarity=0.486 Sum_probs=173.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-------c----hHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-------K----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
-..|+-.+.||.|..++|-++.+..++..+|+|++... . .+.-.+|+.||+++..||+|+++.+++ +
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence 36788889999999999999999999999999998621 1 234678999999999999999999999 5
Q ss_pred CCCCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
.+...++|+|.|+.|.|.+.+. .++++..+.++++++. |++|||.++|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfe---------------------------gVeylHa~~IVH 146 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFE---------------------------GVEYLHARNIVH 146 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHH---------------------------HHHHHHHhhhhh
Confidence 5568899999999999888763 4789999999999988 999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC-----CCCCCcccHHHHHHHHHHHHhCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~sDiwSlG~il~elltg~ 251 (332)
|||||+|||++.+. .++|+|||+++.+.++......|||++|.|||.+.+. ..|+...|+||+|+|+|.++.|.
T Consensus 147 RDLKpENILlddn~-~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 147 RDLKPENILLDDNM-NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred cccChhheeecccc-ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 99999999999665 7999999999999999999999999999999998653 45889999999999999999999
Q ss_pred CCCC
Q 040656 252 EPFF 255 (332)
Q Consensus 252 ~pf~ 255 (332)
.||.
T Consensus 226 pPFw 229 (411)
T KOG0599|consen 226 PPFW 229 (411)
T ss_pred Cchh
Confidence 9994
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=291.30 Aligned_cols=209 Identities=27% Similarity=0.442 Sum_probs=166.8
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
....++|++.+.||+|+||.||+|.+..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++.+.+ .
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~ 115 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--D 115 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--C
Confidence 33468999999999999999999999999999999998632 224567899999998 99999999999854 4
Q ss_pred CCceeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
...+++|||+++++|..++. .+++..+..++.++ +.||+|||++||+||||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi---------------------------~~aL~~LH~~~ivHrDL 168 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV---------------------------VLALDAIHSMGFIHRDV 168 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCEEeCCC
Confidence 67899999999998877653 34455454445544 45999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCC---CCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+|||++.++ .++|+|||++....... ......||..|+|||++.+.. .++.++|||||||++|+|++|..||
T Consensus 169 kp~NIll~~~~-~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 169 KPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CHHHEEECCCC-CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 99999999666 79999999998764322 223457899999999986522 3789999999999999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 040656 255 FYGHDNQDQLVKIA 268 (332)
Q Consensus 255 ~~~~~~~~~~~~~~ 268 (332)
. +.+.......+.
T Consensus 248 ~-~~~~~~~~~~i~ 260 (371)
T cd05622 248 Y-ADSLVGTYSKIM 260 (371)
T ss_pred C-CCCHHHHHHHHH
Confidence 4 333334444444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=290.57 Aligned_cols=222 Identities=22% Similarity=0.288 Sum_probs=157.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC-----CceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|++... +..||+|+++... ...+.+|+.+++.+.+|+||+++++.|.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 356899999999999999999986433 3579999986432 34678999999999789999999999854
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHH-------------HHHH--hh-----------------------cCC-
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYI-------------YELL--KH-----------------------AMP- 141 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~-------------~~~~--~~-----------------------~~~- 141 (332)
....+++|||++++++..++............ .... .. ...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 45789999999999887665221100000000 0000 00 000
Q ss_pred -------cceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCccc---
Q 040656 142 -------RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN--- 211 (332)
Q Consensus 142 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~--- 211 (332)
..........+.+.+.++.|++.||.|||++||+||||||+|||++.++ .++|+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeecc
Confidence 0000000011222356788999999999999999999999999999555 79999999987654332211
Q ss_pred ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 212 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 212 ~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 273 ~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 273 NARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred CCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 1234556999999876 678999999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=284.48 Aligned_cols=187 Identities=22% Similarity=0.395 Sum_probs=152.1
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. .......|..++....+||||+++++++.+ ...++++|||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 4689999999999999999999999998742 224466788888776599999999999854 45789999999
Q ss_pred cCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++...+. .++......++. |++.||.|||+.||+||||||+|||++.
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~---------------------------qi~~al~~LH~~~ivHrdikp~Nil~~~ 131 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAA---------------------------EIICGLQFLHSKGIVYRDLKLDNILLDT 131 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeEeCCCCHHHEEECC
Confidence 9998876652 244444444444 4555999999999999999999999996
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||++..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 132 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 132 DG-HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred CC-CEEEccCCcceECCCCCCceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 66 799999999875432 223345578999999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=290.02 Aligned_cols=186 Identities=25% Similarity=0.458 Sum_probs=152.7
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++.. ....+..|+.+++.+ +|+||+++++.+.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 4689999999999999999999999998742 224567899999999 99999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCCCCCeeec
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKPHNVMID 187 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlkp~Nilv~ 187 (332)
+++++...+ ..+++..+..++.+++ .||.|||+ .||+||||||+|||++
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~---------------------------~aL~~lH~~~~ivHrDikp~NIll~ 130 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIV---------------------------SALDYLHSEKNVVYRDLKLENLMLD 130 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhcCCEEecCCCCCeEEEC
Confidence 999876554 2355555555555554 59999997 7999999999999999
Q ss_pred CCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 131 KDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred CCC-CEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCC
Confidence 666 799999999875432 222334578999999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=278.96 Aligned_cols=265 Identities=28% Similarity=0.454 Sum_probs=188.2
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|+||.||+|.+..+|+.||+|.++.. ....+.+|+.+++++ +|+||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS--DKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc--CCceEEE
Confidence 589999999999999999999999999999998632 124577899999999 99999999999954 4578999
Q ss_pred EeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
+||+.++.+..+. ..++...+..+ +.|+++||.|||+.|++||||||+||
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~---------------------------~~qi~~al~~LH~~~i~H~dl~~~ni 130 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSF---------------------------MFQLLKGLAFCHSHNVLHRDLKPQNL 130 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHH---------------------------HHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 9999864333221 22444444444 44555599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
+++.++ .++|+|||++....... ......++..|+|||.+.+...++.++|||||||++|+|+||..||+.+.+..+.
T Consensus 131 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~ 209 (284)
T cd07839 131 LINKNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209 (284)
T ss_pred EEcCCC-cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH
Confidence 999766 79999999987654322 2233466788999999877556799999999999999999999998777766666
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+..+.+..+.+....+.... ...+............|.. .........++++..||+.||.+||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~t 274 (284)
T cd07839 210 LKRIFRLLGTPTEESWPGVS-KLPDYKPYPMYPATTSLVN---VVPKLNSTGRDLLQNLLVCNPVQRIS 274 (284)
T ss_pred HHHHHHHhCCCChHHhHHhh-hcccccccCCCCCcchhhh---hcccCCHHHHHHHHHHhcCChhhcCC
Confidence 66666665543322221100 0000000000000011110 01122334457889999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=278.18 Aligned_cols=185 Identities=26% Similarity=0.400 Sum_probs=151.2
Q ss_pred ecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
||+|+||+||++.+..+++.+|+|.+.... ...+..|+.+++.+ +|+||+++++++.. ....+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 699999999999999999999999986421 24567899999999 99999999998854 4568999999999
Q ss_pred CCceeec-------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 114 TDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 114 ~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
+++...+ ..+++..+..++. |++.||.|||+++|+||||||+||++
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~---------------------------qi~~~l~~lH~~~i~H~dlkp~Nili 130 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTA---------------------------QIISGLEHLHQRRIIYRDLKPENVLL 130 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 9886543 1244444444444 45559999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 131 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 131 DNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred CCCC-CEEEeeCccceecCCCCccccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9665 799999999976643332 234578889999999987 6789999999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=310.21 Aligned_cols=198 Identities=27% Similarity=0.488 Sum_probs=161.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++++.||+|+||.||+|.+..++..+|+|++... ....+..|+.+++++ +||||++++++|.+.....++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEE
Confidence 47899999999999999999999999999999998632 235688999999999 999999999999776666789
Q ss_pred eEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc------
Q 040656 106 LIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ------ 172 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------ 172 (332)
+||||+++++|..++. .+++..+..++. ||+.||.|||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~---------------------------QIL~ALaYLHs~g~~~~~ 143 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR---------------------------QLLHALAYCHNLKDGPNG 143 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHH---------------------------HHHHHHHHHHhccccccc
Confidence 9999999998876542 244444444444 455599999984
Q ss_pred -CCeecCCCCCCeeecCC----------------CCeEEEEecccceeecCCCcccccccccceeccccccCC-CCCCCc
Q 040656 173 -GIMHRDVKPHNVMIDHE----------------QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYS 234 (332)
Q Consensus 173 -~ivHrdlkp~Nilv~~~----------------~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~ 234 (332)
+|+||||||+|||++.+ ...++|+|||++.............+|+.|+|||++.+. ..++.+
T Consensus 144 k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~K 223 (1021)
T PTZ00266 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223 (1021)
T ss_pred CCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCch
Confidence 49999999999999632 124899999999876544444556789999999998642 457899
Q ss_pred ccHHHHHHHHHHHHhCCCCCCC
Q 040656 235 LDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 235 sDiwSlG~il~elltg~~pf~~ 256 (332)
+|||||||++|+|+||..||..
T Consensus 224 SDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 224 SDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred hHHHHHHHHHHHHHHCCCCCCc
Confidence 9999999999999999999953
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=290.75 Aligned_cols=209 Identities=27% Similarity=0.442 Sum_probs=167.7
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++.+.||+|+||.||+|.+..+++.+|+|++++. ....+.+|+.+++.+ +||||+++++.+.+ ..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~ 116 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DK 116 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CC
Confidence 3458899999999999999999999999999999998632 234577899999999 99999999999954 46
Q ss_pred CceeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
..++||||+++++|..++. .+++.....++.+++ .||+|||++||+|||||
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil---------------------------~aL~~LH~~~IvHrDLK 169 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV---------------------------LALDAIHSMGLIHRDVK 169 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEecCCC
Confidence 7899999999999877653 345555555555554 49999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCC---CCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+|||++.++ .+||+|||++....... ......||..|+|||++.+.. .++.++|||||||++|+|++|..||.
T Consensus 170 p~NILl~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 170 PDNMLLDKHG-HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred HHHEEECCCC-CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 9999999666 79999999998764322 223557999999999986532 37889999999999999999999994
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
+.+.......+..
T Consensus 249 -~~~~~~~~~~i~~ 261 (370)
T cd05621 249 -ADSLVGTYSKIMD 261 (370)
T ss_pred -CCCHHHHHHHHHh
Confidence 3344444555543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.32 Aligned_cols=186 Identities=26% Similarity=0.485 Sum_probs=149.2
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHH-HHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~-l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||+|+||.||+|.+..+++.||+|++.... ...+..|... ++.+ +||||+++++.+.+ ....+++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 46899999999999999999999999986421 2344555554 4667 99999999999854 4578999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
++++++...+ ..+++.....++.+++ .||.|||++||+||||||+|||++
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~givH~dikp~NIll~ 130 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIA---------------------------SALGYLHSLNIIYRDLKPENILLD 130 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEeCCCCHHHeEEC
Confidence 9999886654 2345555555555554 599999999999999999999999
Q ss_pred CCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++ .++|+|||++..... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 131 SQG-HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred CCC-cEEEeccCCCcccccCCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCC
Confidence 666 799999999875322 223344578999999999877 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=280.01 Aligned_cols=212 Identities=31% Similarity=0.612 Sum_probs=165.4
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++.+ ....
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~--~~~~ 79 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSL 79 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEec--CCeE
Confidence 3457899999999999999999999889999999998632 234678899999999 99999999999954 4578
Q ss_pred eeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++++||+.+ ++...+ ..++...+..+ +.|+++||+|||+.|++|+|||
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~---------------------------~~qi~~aL~~lH~~~i~H~dlk 131 (301)
T cd07873 80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLF---------------------------LFQLLRGLNYCHRRKVLHRDLK 131 (301)
T ss_pred EEEEecccc-CHHHHHHhcCCCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCeeCCCCC
Confidence 999999985 333322 12334444444 4455559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+||+++.++ .++|+|||++....... ......++..|+|||++.+...++.++||||||+++|+|++|..|| ...+
T Consensus 132 p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f-~~~~ 209 (301)
T cd07873 132 PQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF-PGST 209 (301)
T ss_pred HHHEEECCCC-cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC-CCCC
Confidence 9999999666 79999999987543222 2233456788999999876566889999999999999999999998 3445
Q ss_pred CHHHHHHHHHHhCC
Q 040656 260 NQDQLVKIARVLGT 273 (332)
Q Consensus 260 ~~~~~~~~~~~~~~ 273 (332)
..+....+.+..+.
T Consensus 210 ~~~~~~~~~~~~~~ 223 (301)
T cd07873 210 VEEQLHFIFRILGT 223 (301)
T ss_pred HHHHHHHHHHHcCC
Confidence 55555556555444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=286.61 Aligned_cols=197 Identities=24% Similarity=0.455 Sum_probs=153.2
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHH-HHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||+|+||.||+|.+..+++.||+|++.... ...+..|.. +++.+ +|+||+++++++.+ ....+++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEc--CCeEEEEEeC
Confidence 46999999999999999999999999986421 223444444 45667 99999999999854 4578999999
Q ss_pred ecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
++++++...+. .+.+..+..++.+++ .||.|||++||+||||||+|||++
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~---------------------------~~L~~lH~~giiHrDlkp~Nili~ 130 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIA---------------------------SALGYLHSLNIVYRDLKPENILLD 130 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEecCCCHHHeEEC
Confidence 99998876542 344555555555554 599999999999999999999999
Q ss_pred CCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 040656 188 HEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~ 266 (332)
.++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....
T Consensus 131 ~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~ 207 (325)
T cd05602 131 SQG-HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDN 207 (325)
T ss_pred CCC-CEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC-CCCHHHHHHH
Confidence 666 799999999875432 223345578999999999877 678999999999999999999999994 3333343333
Q ss_pred H
Q 040656 267 I 267 (332)
Q Consensus 267 ~ 267 (332)
+
T Consensus 208 i 208 (325)
T cd05602 208 I 208 (325)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=277.33 Aligned_cols=192 Identities=24% Similarity=0.408 Sum_probs=158.5
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.|++.+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+|+.+++++ +|+||+.+++.+.+ ....++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEec--CCEEEE
Confidence 4788999999999999999999999999999986321 23467899999999 99999999999854 457899
Q ss_pred EEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+|||++++++...+. .++...+..++. |++.||.|||+.+|+||||||
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~---------------------------qi~~~l~~lH~~~iiH~dikp 130 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA---------------------------EICCGLEDLHQERIVYRDLKP 130 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCEEeCCCCH
Confidence 999999998866542 244444444444 445599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+||+++.++ .++|+|||++.............++..|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 131 ~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 131 ENILLDDHG-HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred HHEEECCCC-CEEEeeccceeecCCCccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 999999666 699999999876654444444578899999999877 6789999999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.60 Aligned_cols=191 Identities=26% Similarity=0.412 Sum_probs=158.0
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.|+..+.||+|+||.||+|.+..+++.+|+|.++... ...+.+|+++++++ +|+||+++++.+.. ....++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence 3788899999999999999999999999999986422 23467899999999 99999999998854 457899
Q ss_pred EEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||++++++..... .++...+..++.+ ++.||.|||+.||+||||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~q---------------------------l~~~l~~lH~~~iiH~dikp 130 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE---------------------------ILCGLEDLHRENTVYRDLKP 130 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHH---------------------------HHHHHHHHHhCCeeecCCCH
Confidence 999999988765431 2445555444444 45599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+||+++.++ .++|+|||++.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 131 ~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~ 202 (285)
T cd05632 131 ENILLDDYG-HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFR 202 (285)
T ss_pred HHEEECCCC-CEEEecCCcceecCCCCcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 999999665 799999999876544434445578899999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.92 Aligned_cols=257 Identities=21% Similarity=0.359 Sum_probs=195.4
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEcc-----CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
-..+.+....+.||+|.||.||+|.-.. ....||||.++.. ...+|++|++++..| +|||||+++|+|..
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCRE 560 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEcc
Confidence 3356778889999999999999987432 3467999999843 456899999999999 99999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
+..+++|||||..|+|..++......... ... +.+ .....+..+.+.++.|||.||.||-++.+||||
T Consensus 561 --~~P~~MvFEYm~~GDL~eFLra~sP~a~~-----~~~-g~~----~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRD 628 (774)
T KOG1026|consen 561 --GDPLCMVFEYMDHGDLHEFLRARSPKADK-----LAS-GQD----TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRD 628 (774)
T ss_pred --CCeeEEEEEecccccHHHHHHhhCCcccc-----ccC-CCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccc
Confidence 45789999999999999987332211100 000 111 012234556678999999999999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCccccc---ccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|..+|+||..+- .|||+|||+++..-..+-.... .-..+||+||.+.- ..|+.+||||||||+|||+++ |..||
T Consensus 629 LATRNCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 629 LATRNCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred hhhhhceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc
Confidence 999999999555 8999999999865422221111 22466999999988 689999999999999999997 88898
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+.++++.+..+.- + ..+.+.++++..++.. ||+..|++||+
T Consensus 707 -~glSn~EVIe~i~~g~l-------L-~~Pe~CP~~vY~LM~~------------------------CW~~~P~~RPs 751 (774)
T KOG1026|consen 707 -YGLSNQEVIECIRAGQL-------L-SCPENCPTEVYSLMLE------------------------CWNENPKRRPS 751 (774)
T ss_pred -cccchHHHHHHHHcCCc-------c-cCCCCCCHHHHHHHHH------------------------HhhcCcccCCC
Confidence 57778888877776322 1 1224566777776644 99999999996
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=278.43 Aligned_cols=241 Identities=17% Similarity=0.246 Sum_probs=176.1
Q ss_pred CCCCceEE--EeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeec--c
Q 040656 30 DQEDYEVV--RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRD--Q 99 (332)
Q Consensus 30 ~~~~y~~~--~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~ 99 (332)
+.++++.. ..||+|++|.||+|.. +++.||+|.++... .+.+.+|+.+++++ +||||+++++++.+ +
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVD 92 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEeccc
Confidence 33444444 5789999999999976 78999999987432 24567999999999 99999999999876 4
Q ss_pred CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeecC
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRD 178 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHrd 178 (332)
+....+++|||+++++|..++..-.. ..+...+.++.+++.||.+||+. +++|||
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~------------------------~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrd 148 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEKD------------------------LSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCCC------------------------CChhHHHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 44578999999999988776522100 11222345667777799999984 999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|||+||+++.++ .+||+|||+++..... .....++..|+|||++.+. ..++.++|||||||++|||++|..||. +
T Consensus 149 lkp~nill~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~-~ 224 (283)
T PHA02988 149 LTSVSFLVTENY-KLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-N 224 (283)
T ss_pred CChhhEEECCCC-cEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC-C
Confidence 999999999666 7999999998765322 2234678889999998652 468999999999999999999999994 3
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+....+........ .....++.++++ +.+||+.||++||+
T Consensus 225 ~~~~~~~~~i~~~~~~~~-------~~~~~~~~l~~l------------------------i~~cl~~dp~~Rps 268 (283)
T PHA02988 225 LTTKEIYDLIINKNNSLK-------LPLDCPLEIKCI------------------------VEACTSHDSIKRPN 268 (283)
T ss_pred CCHHHHHHHHHhcCCCCC-------CCCcCcHHHHHH------------------------HHHHhcCCcccCcC
Confidence 333333333322111110 111334444444 45699999999996
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=289.13 Aligned_cols=196 Identities=28% Similarity=0.458 Sum_probs=156.5
Q ss_pred EeecccCCceEEEEEE---ccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 38 RKVGRGKYSEVFEGIN---VTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
+.||+|+||.||++.+ ..+++.+|+|+++.. ....+.+|+++++++ +||||+++++++.+ ...+++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCEEEEEEc
Confidence 6799999999999875 357899999998742 234567899999999 99999999999954 457899999
Q ss_pred eecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 110 HVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 110 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|++++++...+ ..+++..+..++.+++ .||+|||+.||+||||||+||++
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~---------------------------~~l~~lH~~~i~H~dlkp~Nil~ 131 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELA---------------------------LALDHLHSLGIIYRDLKPENILL 131 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCEecCCCCHHHeEE
Confidence 99998876654 2355555555555555 49999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 040656 187 DHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~ 265 (332)
+.++ .++|+|||++...... .......||..|+|||.+.+ ..++.++|||||||++|+|++|..||. ..+..+...
T Consensus 132 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~-~~~~~~~~~ 208 (318)
T cd05582 132 DEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMT 208 (318)
T ss_pred CCCC-cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC-CCCHHHHHH
Confidence 9666 7999999998765433 23344578999999999876 678999999999999999999999994 333333333
Q ss_pred H
Q 040656 266 K 266 (332)
Q Consensus 266 ~ 266 (332)
.
T Consensus 209 ~ 209 (318)
T cd05582 209 M 209 (318)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.79 Aligned_cols=184 Identities=27% Similarity=0.401 Sum_probs=150.5
Q ss_pred ecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
||+|+||.||++....+++.+|+|.+.... ......|+++++++ +||||+++++.+.+ ....+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 699999999999999999999999986321 23456799999999 99999999999854 4678999999999
Q ss_pred CCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 114 TDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 114 ~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++..... .+....+. .++.|++.||+|||+.|++||||||+||+++.
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~---------------------------~~~~qi~~al~~lH~~~ivH~dikp~Nili~~ 130 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVI---------------------------HYSAQITCGILHLHSMDIVYRDMKPENVLLDD 130 (277)
T ss_pred CCHHHHHHhccccCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCEEEccCChHhEEEcC
Confidence 98765431 12222222 34556666999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||++.............++..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 ~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 131 QG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred CC-CEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 66 799999999887654444445578889999999877 568999999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=288.69 Aligned_cols=195 Identities=23% Similarity=0.368 Sum_probs=155.1
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.....+|++.+.||+|+||.||+|.+..+++.||+|+... .....|+.+++++ +|+||+++++++.. ....+++
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 135 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVS--GAITCMV 135 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEe--CCeeEEE
Confidence 3345679999999999999999999988999999998542 3346799999999 99999999999854 3568999
Q ss_pred EeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
+|++.+..+..+. ..++...+.. ++.|++.||.|||++||+||||||+||
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~aL~~LH~~~ivHrDlkp~Ni 188 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALI---------------------------IEKQILEGLRYLHAQRIIHRDVKTENI 188 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 9999764433322 1234444433 445555699999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|++.++ .++|+|||++.............||..|+|||++.+ ..++.++|||||||++|||+++..|++..
T Consensus 189 ll~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 189 FINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred EECCCC-CEEEecCccccccccCcccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 999666 699999999875443333445678999999999877 67899999999999999999977666443
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=285.07 Aligned_cols=213 Identities=28% Similarity=0.516 Sum_probs=168.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----C
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----S 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~ 101 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +|+||++++++|.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcccc
Confidence 58899999999999999999999999999999998532 234677899999999 9999999999885432 2
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...++++|++.+.....+...++......++.+ ++.||+|||+.|++||||||
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~q---------------------------l~~aL~~LH~~gi~H~dlkp 146 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ---------------------------MLCGIKHLHSAGIIHRDLKP 146 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHH---------------------------HHHHHHHHHhCCeeeCCCCH
Confidence 357999999976433333223455544444444 45599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+||+++.++ .++|+|||++.............++..|+|||.+.+ ..++.++|||||||++|+|++|..|| ...+..
T Consensus 147 ~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf-~~~~~~ 223 (353)
T cd07850 147 SNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLF-PGTDHI 223 (353)
T ss_pred HHEEECCCC-CEEEccCccceeCCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCC-CCCCHH
Confidence 999999766 799999999987654433344567888999999877 67899999999999999999999998 455555
Q ss_pred HHHHHHHHHhCCc
Q 040656 262 DQLVKIARVLGTD 274 (332)
Q Consensus 262 ~~~~~~~~~~~~~ 274 (332)
.....+...++.+
T Consensus 224 ~~~~~~~~~~~~~ 236 (353)
T cd07850 224 DQWNKIIEQLGTP 236 (353)
T ss_pred HHHHHHHHhcCCC
Confidence 6666666655543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=274.61 Aligned_cols=194 Identities=16% Similarity=0.309 Sum_probs=153.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEc---cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.++|++.+.||+|+||.||+|... ..+..||+|.++... ...+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 79 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GN 79 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CC
Confidence 4578999999999999999999764 456789999987432 24678899999999 99999999999854 46
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++||||++++++..++. .++...+..+ +.+++.||+|||++|++|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~---------------------------~~~i~~al~~lH~~~iiH~d 132 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM---------------------------LPGLASGMKYLSEMGYVHKG 132 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHH---------------------------HHHHHHHHHHHHHCCEeecc
Confidence 7899999999998876642 2344444444 44555599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCccc--ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||+||+++.++ .++++|||.+.......... ...++..|+|||.+.+ ..++.++|||||||++||+++ |..||.
T Consensus 133 ikp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 133 LAAHKVLVNSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccHhhEEEcCCC-cEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 999999999666 79999999875432221111 1234567999999876 678999999999999999775 999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=285.45 Aligned_cols=197 Identities=24% Similarity=0.463 Sum_probs=154.2
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHH-HHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKI-LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~-l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||+|+||.||+|.+..+++.+|+|++... ....+..|..+ ++.+ +||||+++++.+.. ....+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEec--CCEEEEEEcC
Confidence 4689999999999999999999999998632 22345556554 5556 99999999999854 4578999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
++++++...+ ..+++..+..++.+++ .||.|||+.||+||||||+|||++
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~al~~lH~~givH~Dlkp~NIll~ 130 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIA---------------------------SALGYLHSINIVYRDLKPENILLD 130 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeeecCCCHHHeEEC
Confidence 9999876554 2355555555555555 499999999999999999999999
Q ss_pred CCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 040656 188 HEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~ 266 (332)
.++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....
T Consensus 131 ~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~ 207 (325)
T cd05604 131 SQG-HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDN 207 (325)
T ss_pred CCC-CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCC-CCCHHHHHHH
Confidence 666 799999999875322 223345578999999999877 678999999999999999999999994 3443444443
Q ss_pred H
Q 040656 267 I 267 (332)
Q Consensus 267 ~ 267 (332)
+
T Consensus 208 ~ 208 (325)
T cd05604 208 I 208 (325)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=283.76 Aligned_cols=186 Identities=24% Similarity=0.468 Sum_probs=149.0
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHH-HHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||+|+||.||+|.+..+++.||+|++.... ...+..|.. +++.+ +|+||+++++.+.+ ....+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCEEEEEEcC
Confidence 46999999999999999999999999986321 233455554 46667 99999999999854 4578999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
++++++...+ ..+++..+..++.+++ .||.|||+.||+||||||+||+++
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~L~~lH~~~ivH~Dlkp~NIll~ 130 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVA---------------------------SAIGYLHSLNIIYRDLKPENILLD 130 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEeccCCHHHeEEC
Confidence 9999876544 2345555555555554 599999999999999999999999
Q ss_pred CCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++ .++|+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 131 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 131 SQG-HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred CCC-CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCC
Confidence 766 799999999875322 222344578999999999876 678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=280.27 Aligned_cols=191 Identities=24% Similarity=0.532 Sum_probs=149.1
Q ss_pred EeecccCCceEEEEEEcc--CCceEEEEEecccc-hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCC
Q 040656 38 RKVGRGKYSEVFEGINVT--NNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST 114 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 114 (332)
.+||+|+||.||+|.... ++..||+|.++... ...+.+|+.+++++ +||||+++++++........++++||+.++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 579999999999998643 56889999986433 34678999999999 999999999998766667789999998865
Q ss_pred Cceeecc-----------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 115 DFKVLYP-----------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 115 ~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
.+..+.. .++...+ ..++.|++.||.|||+.+|+||||||+|
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~---------------------------~~i~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMV---------------------------KSLLYQILDGIHYLHANWVLHRDLKPAN 138 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHH---------------------------HHHHHHHHHHHHHHHhCCEEcCCCCHHH
Confidence 3322210 1222222 2455666779999999999999999999
Q ss_pred eeec---CCCCeEEEEecccceeecCCC----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 184 VMID---HEQQKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 184 ilv~---~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|++. .+.+.++|+|||+++...... ......+|..|+|||++.+...++.++|||||||++|+|+||..||..
T Consensus 139 il~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 139 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred EEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9994 233479999999998654322 123446788999999987755689999999999999999999999953
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=286.72 Aligned_cols=216 Identities=23% Similarity=0.322 Sum_probs=159.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC-----CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN-----NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
++++|.+++.||+|+||.||+|.+... +..||+|+++.. ....+.+|+.++.++..||||+++++++.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 468899999999999999999986432 346999999642 235688999999999559999999999944
Q ss_pred CCCceeEEeeecCCCceeeccccchhh-----------------------HH-H--------------------------
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANE-----------------------IR-Y-------------------------- 130 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~-----------------------~~-~-------------------------- 130 (332)
....+++|||+++++|..++....... .. .
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 467899999999999876542110000 00 0
Q ss_pred ----------------------------HHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 131 ----------------------------YIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 131 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
-+.+.+.. .........+...++.|++.||.|||+.+|+||||||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSD------DGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHh------cccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 00000000 00001223334568889999999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 267 Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 267 NVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred hEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 99999655 799999999986543222 122345677999999876 678999999999999999997 888984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=282.97 Aligned_cols=205 Identities=27% Similarity=0.453 Sum_probs=164.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||++.+..+++.||+|++.+. ....+.+|+.++..+ +|+||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEec--CCeEE
Confidence 5799999999999999999999999999999998632 234578899999998 99999999999954 46799
Q ss_pred eEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+||||+++++|..++. .+++..+..++.|++. ||+|||++||+||||||
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~---------------------------~l~~lH~~~ivH~dlkp 130 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL---------------------------AIDSVHQLGYVHRDIKP 130 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeEECCCCH
Confidence 9999999999877652 3556666666666555 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .++|+|||++........ .....||..|+|||++.. ...++.++|||||||++|+|++|..||.
T Consensus 131 ~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 131 DNVLLDKNG-HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred HHEEECCCC-CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 999998666 799999999876543322 223468999999999863 2457889999999999999999999994
Q ss_pred CCCCCHHHHHHHH
Q 040656 256 YGHDNQDQLVKIA 268 (332)
Q Consensus 256 ~~~~~~~~~~~~~ 268 (332)
+....+....+.
T Consensus 210 -~~~~~~~~~~i~ 221 (331)
T cd05597 210 -AESLVETYGKIM 221 (331)
T ss_pred -CCCHHHHHHHHH
Confidence 333334444443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.69 Aligned_cols=239 Identities=27% Similarity=0.446 Sum_probs=180.4
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch------HHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
....+.|.-++.||+|+||.||.|++..+.+.||||.++-..+ .++..|+..|+++ .|||+|.+-|+|..++
T Consensus 22 ~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~- 99 (948)
T KOG0577|consen 22 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREH- 99 (948)
T ss_pred CCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccc-
Confidence 3344668889999999999999999999999999999874322 4688999999999 9999999999996553
Q ss_pred CCceeEEeeecCCC---ceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTD---FKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..|+|||||-|.- +..+..++.+.++. .+..+.++||+|||+.+.||||
T Consensus 100 -TaWLVMEYClGSAsDlleVhkKplqEvEIA---------------------------Ai~~gaL~gLaYLHS~~~IHRD 151 (948)
T KOG0577|consen 100 -TAWLVMEYCLGSASDLLEVHKKPLQEVEIA---------------------------AITHGALQGLAYLHSHNRIHRD 151 (948)
T ss_pred -hHHHHHHHHhccHHHHHHHHhccchHHHHH---------------------------HHHHHHHHHHHHHHHhhHHhhh
Confidence 5799999997632 11122344443333 2444556699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||..|||++..+ .|||+|||.|.... ..++++||++|||||+++.+ ..|+-++|||||||+++|+.-+++|++.
T Consensus 152 iKAGNILLse~g-~VKLaDFGSAsi~~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 152 IKAGNILLSEPG-LVKLADFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred ccccceEecCCC-eeeeccccchhhcC---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 999999999555 89999999998754 44678999999999998654 4699999999999999999999999862
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+--|.+ + .+|.+. ...-...++.|++.||+.-|++||+
T Consensus 228 -MNAMSALYHIAQ---N-------------esPtLq---------------s~eWS~~F~~Fvd~CLqKipqeRpt 271 (948)
T KOG0577|consen 228 -MNAMSALYHIAQ---N-------------ESPTLQ---------------SNEWSDYFRNFVDSCLQKIPQERPT 271 (948)
T ss_pred -chHHHHHHHHHh---c-------------CCCCCC---------------CchhHHHHHHHHHHHHhhCcccCCc
Confidence 222223322322 1 111110 0111223357888999999999996
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=272.35 Aligned_cols=261 Identities=29% Similarity=0.525 Sum_probs=181.2
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|++|.||+|++..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee--CCeEEEE
Confidence 589999999999999999999889999999998632 235688999999999 89999999999954 4578999
Q ss_pred EeeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 108 FEHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 108 ~e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+||+++ ++.... ..++...+..++.+ ++.||.|||+.|++|+||||
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~q---------------------------i~~~L~~lH~~~i~H~dl~p 129 (285)
T cd07861 78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQ---------------------------ILQGILFCHSRRVLHRDLKP 129 (285)
T ss_pred EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHH---------------------------HHHHHHHHHhCCeeecCCCH
Confidence 999985 333332 22444444444444 45599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
+||+++.++ .++|+|||++....... ......++..|+|||.+.+...++.++||||||+++|+|+||..||. +...
T Consensus 130 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~ 207 (285)
T cd07861 130 QNLLIDNKG-VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSE 207 (285)
T ss_pred HHEEEcCCC-cEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCH
Confidence 999999666 79999999987654222 22334567889999998765667899999999999999999999984 3344
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC--cccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN--NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+....+......+ ... ...+..+... ..|.... ...........+++.+||+.||++||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 275 (285)
T cd07861 208 IDQLFRIFRILGTPTEDVW-PGV--TSLPDYKNTF---PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275 (285)
T ss_pred HHHHHHHHHHhCCCChhhh-hcc--hhhHHHHhhc---cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC
Confidence 4444444443332211111 000 0000111111 1111100 001112233347788899999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=272.39 Aligned_cols=209 Identities=34% Similarity=0.637 Sum_probs=167.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++.+.||+|++|.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +|+|++++++++.+ ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRR--KRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEee--CCEEEE
Confidence 4799999999999999999999889999999998532 224578999999999 89999999999854 457899
Q ss_pred EEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
++||++++.+..+.. .++...+..++.+++ .||+|||+.|++|+||||+|
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~---------------------------~~l~~LH~~~i~H~dl~p~n 130 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTL---------------------------QAVNFCHKHNCIHRDVKPEN 130 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCceecCCChhh
Confidence 999999887766542 355555555555555 49999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+++.++ .++|+|||++....... ......++..|+|||.+.+...++.++|+||||+++|+|++|..||. +..+.+
T Consensus 131 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~-~~~~~~ 208 (286)
T cd07847 131 ILITKQG-QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP-GKSDVD 208 (286)
T ss_pred EEEcCCC-cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC-CCChHH
Confidence 9999666 79999999998765433 22334577889999998765568899999999999999999999984 455555
Q ss_pred HHHHHHHHhC
Q 040656 263 QLVKIARVLG 272 (332)
Q Consensus 263 ~~~~~~~~~~ 272 (332)
....+....+
T Consensus 209 ~~~~~~~~~~ 218 (286)
T cd07847 209 QLYLIRKTLG 218 (286)
T ss_pred HHHHHHHHhC
Confidence 5555554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=275.30 Aligned_cols=191 Identities=21% Similarity=0.379 Sum_probs=158.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++.+... ...+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence 4689999999999999999999999999999998632 235688999999999 999999999999653 567899
Q ss_pred EeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
+||++++++... ..+++..+..++.+ ++.||.|||+.||+|+||||+||+++
T Consensus 78 ~e~~~~~~l~~~-~~~~~~~~~~~~~q---------------------------i~~~l~~lH~~~i~H~dlkp~Nill~ 129 (279)
T cd06619 78 TEFMDGGSLDVY-RKIPEHVLGRIAVA---------------------------VVKGLTYLWSLKILHRDVKPSNMLVN 129 (279)
T ss_pred EecCCCCChHHh-hcCCHHHHHHHHHH---------------------------HHHHHHHHHHCCEeeCCCCHHHEEEC
Confidence 999999887543 23445444444444 45599999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
.++ .++|+|||++..... .......+|..|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus 130 ~~~-~~~l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 130 TRG-QVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCC-CEEEeeCCcceeccc-ccccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 766 799999999876542 23344578889999999877 6789999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.39 Aligned_cols=270 Identities=24% Similarity=0.434 Sum_probs=189.8
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.++... .....+|+.+++++ +|+||+++++++.+.....
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCe
Confidence 35688999999999999999999999999999999986322 23456899999999 9999999999997665567
Q ss_pred ceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.++++||+.+ ++..++ ..++......++ .|++.||.|||+.|++||||
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~---------------------------~qi~~~l~~lH~~~i~H~dl 134 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM---------------------------LQLLRGLQYLHENFIIHRDL 134 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHH---------------------------HHHHHHHHHHHhCCeecCCC
Confidence 8999999975 333222 224444444444 45555999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||+||+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++||||||+++|+|++|..|| .+.
T Consensus 135 ~p~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~ 212 (309)
T cd07845 135 KVSNLLLTDKG-CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGK 212 (309)
T ss_pred CHHHEEECCCC-CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCC
Confidence 99999999666 79999999998765332 2233345777999999876566899999999999999999999998 456
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+..+.+..+....+.+....+.. . ...+..........++...............+++..||++||++||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 283 (309)
T cd07845 213 SEIEQLDLIIQLLGTPNESIWPG-F--SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT 283 (309)
T ss_pred CHHHHHHHHHHhcCCCChhhchh-h--hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC
Confidence 66667777776655432211100 0 00000000000001111100011112333457889999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=269.26 Aligned_cols=192 Identities=25% Similarity=0.441 Sum_probs=157.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
++|.+.+.||+|++|.||.|.+..+++.+|+|.+... ....+.+|+.+++++ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDD--ET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccC--Ce
Confidence 5799999999999999999999889999999998632 124578899999999 999999999999544 58
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++++|+++++++...+. .++......++.+ ++.||.+||+.|++|+||+
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~---------------------------l~~~l~~lH~~~i~H~dl~ 131 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ---------------------------ILEGVEYLHSNMIVHRDIK 131 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHH---------------------------HHHHHHHHHhCCeecCCCC
Confidence 999999999988766542 2444444444444 4559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||.++........ ....++..|+|||.+.+ ..++.++||||||+++|++++|..||.
T Consensus 132 p~nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 132 GANILRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred HHHEEEcCCC-CEEEeecccceeccccccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 9999999665 7999999998765432211 23457788999999987 568999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=286.44 Aligned_cols=186 Identities=25% Similarity=0.422 Sum_probs=149.8
Q ss_pred ecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhcc--CCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
||+|+||.||+|.+..+++.||+|++.... ......|..++.+.. +||||+.+++.+.+ ...++++|||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 699999999999999999999999986321 123456777777664 79999999999854 45789999999
Q ss_pred cCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
.++++...+ ..+++..+..++.|++ .||+|||++||+||||||+|||++.
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil---------------------------~al~~LH~~~ivHrDlkp~Nili~~ 131 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELV---------------------------LALEHLHKYDIVYRDLKPENILLDA 131 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEeccCCHHHeEECC
Confidence 998876554 2355555555555555 4999999999999999999999996
Q ss_pred CCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||++..... ........||..|+|||++.+...++.++|||||||++|+|++|..||.
T Consensus 132 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 132 TG-HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred CC-CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 66 799999999875432 2233456789999999998765568999999999999999999999994
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=274.71 Aligned_cols=256 Identities=18% Similarity=0.304 Sum_probs=177.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCC-----ceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++|++.+.||+|+||.||+|.....+ ..|++|.++... ...+.+|+.++.++ +||||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC--C
Confidence 467999999999999999999875554 679999986432 35688999999999 99999999999854 3
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...++++||++++++..++.......... .. .............+...++.|++.||+|||++|++|+||||
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~----~~----~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp 152 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVG----AE----SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA 152 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccc----cc----cccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccc
Confidence 56899999999988766542210000000 00 00000000011222335666777799999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 257 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~ 257 (332)
+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +
T Consensus 153 ~Nil~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~-~ 229 (283)
T cd05048 153 RNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYY-G 229 (283)
T ss_pred ceEEEcCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCC-C
Confidence 999999665 799999999876532221 223355778999999876 578999999999999999998 999984 3
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+....+...... ......++.+..++ ..||+.||.+||+
T Consensus 230 ~~~~~~~~~i~~~~~~--------~~~~~~~~~~~~l~------------------------~~c~~~~p~~Rp~ 272 (283)
T cd05048 230 FSNQEVIEMIRSRQLL--------PCPEDCPARVYALM------------------------IECWNEIPARRPR 272 (283)
T ss_pred CCHHHHHHHHHcCCcC--------CCcccCCHHHHHHH------------------------HHHccCChhhCcC
Confidence 3333333322221100 11123445555554 5599999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=291.95 Aligned_cols=201 Identities=26% Similarity=0.466 Sum_probs=171.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccC----CCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----SKT 103 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~ 103 (332)
.-+...+.||+|+||.||+++++.+|+.||||.+++ ...+.+-+|+++|++| +|+|||++.++-.+.. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccccc
Confidence 346777899999999999999999999999999975 3456788999999999 7999999999865544 556
Q ss_pred ceeEEeeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 104 PSLIFEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
..++||||.+|+|...+.. +++..+..++..+.. ||.|||.+||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~---------------------------al~~LrEn~IvHR 144 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVS---------------------------ALRHLRENGIVHR 144 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHH---------------------------HHHHHHHcCceec
Confidence 7899999999999988743 666666666665555 9999999999999
Q ss_pred CCCCCCeeecC--CCC-eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 178 DVKPHNVMIDH--EQQ-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 178 dlkp~Nilv~~--~~~-~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||||.||++.. ++. .-||+|||.|+....+..+++..||..|.+||++.....|+...|.|||||++|+.+||..||
T Consensus 145 DlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF 224 (732)
T KOG4250|consen 145 DLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF 224 (732)
T ss_pred cCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence 99999999842 232 458999999999998888999999999999999985578999999999999999999999999
Q ss_pred CCCCCC
Q 040656 255 FYGHDN 260 (332)
Q Consensus 255 ~~~~~~ 260 (332)
-+...+
T Consensus 225 ~p~~~p 230 (732)
T KOG4250|consen 225 IPFGGP 230 (732)
T ss_pred CcCCCc
Confidence 655444
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=288.08 Aligned_cols=211 Identities=22% Similarity=0.375 Sum_probs=163.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC----ceEEEEEecc------cchHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN----EKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
..++-.+.++||+|.||+||+|.....+ ..||+|..+- ....++.+|.++|+++ +||||++++|+..++
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLE 233 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC
Confidence 3566677799999999999999876543 2389999873 2346789999999999 999999999998654
Q ss_pred CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..++++||+|.||+|..+++..... ....++..+..+.|.||+|||+++++||||
T Consensus 234 --~Pl~ivmEl~~gGsL~~~L~k~~~~-----------------------v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDI 288 (474)
T KOG0194|consen 234 --EPLMLVMELCNGGSLDDYLKKNKKS-----------------------LPTLEKLRFCYDAARGLEYLHSKNCIHRDI 288 (474)
T ss_pred --CccEEEEEecCCCcHHHHHHhCCCC-----------------------CCHHHHHHHHHHHHhHHHHHHHCCCcchhH
Confidence 4689999999999998887543220 112223345555566999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCccc-ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 257 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~ 257 (332)
..+|+|++.++ .+||+|||+++.-....... ...-+..|+|||.+.. ..|++++|||||||++||+++ |..|| ++
T Consensus 289 AARNcL~~~~~-~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g 365 (474)
T KOG0194|consen 289 AARNCLYSKKG-VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PG 365 (474)
T ss_pred hHHHheecCCC-eEEeCccccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CC
Confidence 99999999655 68999999987533111111 1134467999999988 589999999999999999998 78887 67
Q ss_pred CCCHHHHHHHHH
Q 040656 258 HDNQDQLVKIAR 269 (332)
Q Consensus 258 ~~~~~~~~~~~~ 269 (332)
....+...++..
T Consensus 366 ~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 366 MKNYEVKAKIVK 377 (474)
T ss_pred CCHHHHHHHHHh
Confidence 777777777743
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=277.21 Aligned_cols=211 Identities=16% Similarity=0.247 Sum_probs=152.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCce--EEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.-++|++.+.||+|+||.||+|.+..++.. +++|.++.. ....+.+|++++.++.+|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 346899999999999999999998777654 577766532 234678899999999789999999999843 467
Q ss_pred ceeEEeeecCCCceeeccccc---hhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYPTLT---ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++++||++++++..++..-. ..... +... .........+...++.|++.||+|||++|++|||||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~-------~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlk 151 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAF----AIAN-------STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 151 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccc----cccc-------cccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 899999999988766542100 00000 0000 000001112233456666779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+|||++.++ .++|+|||++..............+..|+|||++.+ ..++.++|||||||++|+|+| |..||.
T Consensus 152 p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 152 ARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred hheEEecCCC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 9999999666 799999999864321111122233556999998866 568999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=269.71 Aligned_cols=195 Identities=26% Similarity=0.551 Sum_probs=158.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|+...+++.||+|.++.. ....+.+|+++++.+ +||||+++++.+.+. ...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence 5799999999999999999999899999999987531 224578899999999 999999999998543 5789
Q ss_pred eEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 106 LIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
+++||++++++..+... ++...+. .++.+++.||+|||+++++|+|
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~i~~~l~~LH~~~i~H~d 131 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVW---------------------------KYFVQLCSAVEHMHSRRVMHRD 131 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHH---------------------------HHHHHHHHHHHHHhhCCeeCCC
Confidence 99999999887665421 2333333 3455566699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|||+||+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 132 l~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 132 IKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCHHHEEEcCCC-CEEECccccceeccchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 999999999766 699999999876643222 223467788999999876 56889999999999999999999999544
Q ss_pred C
Q 040656 258 H 258 (332)
Q Consensus 258 ~ 258 (332)
.
T Consensus 210 ~ 210 (267)
T cd08228 210 K 210 (267)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.43 Aligned_cols=258 Identities=26% Similarity=0.488 Sum_probs=185.7
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
|++.+.||+|+||.||+|.+..+++.+|+|.++... .....+|+.++.++.+|+|++++++++.+.....+++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 788999999999999999998899999999986421 2234578999999866999999999997654467899999
Q ss_pred eecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 110 HVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 110 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|++++.+..+.. .++...+..++. |++.||+|||+.|++||||+|+||++
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~---------------------------qi~~~L~~LH~~~i~H~dl~p~ni~l 133 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMY---------------------------QLLKSLDHMHRNGIFHRDIKPENILI 133 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCceecccCHHHEEE
Confidence 998654433321 244444444444 45559999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~ 266 (332)
+. +.++|+|||.+.............++..|+|||.+.....++.++|||||||++|+|++|..|| .+.+..+.+..
T Consensus 134 ~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~ 210 (282)
T cd07831 134 KD--DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAK 210 (282)
T ss_pred cC--CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHH
Confidence 96 4799999999987654444445567888999998765466789999999999999999999998 45555666666
Q ss_pred HHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCc-------ccccccccccccCceEEEeCCCCCCC
Q 040656 267 IARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN-------KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-------~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+.+... +........ ...+..+.. ..........+++.+||+.+|++||+
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 272 (282)
T cd07831 211 IHDVLGTPDAE-VLKKFRKSR----------HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272 (282)
T ss_pred HHHHcCCCCHH-HHHhhcccc----------cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC
Confidence 66655443221 111110000 001100000 00122344458889999999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=269.58 Aligned_cols=191 Identities=33% Similarity=0.602 Sum_probs=159.1
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccchH-----HHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
|++++.||+|+||.||++.+..+++.+|+|++...... ...+|+.+++++ +|+||+++++++.+ ....+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence 78999999999999999999999999999999754432 234599999999 99999999999965 45788999
Q ss_pred eeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 109 EHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 109 e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
|++.++++..++ ..++...+..++.+++ +||.+||+.+++|+||||+||+
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~L~~Lh~~~i~H~dikp~NIl 130 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQIL---------------------------EALAYLHSKGIVHRDIKPENIL 130 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHH---------------------------HHHHHHHHTTEEESSBSGGGEE
T ss_pred ccccccccccccccccccccccccccccccc---------------------------cccccccccccccccccccccc
Confidence 999998877654 3355555555555555 4999999999999999999999
Q ss_pred ecCCCCeEEEEecccceee-cCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||.+... ..........++..|+|||++.....++.++|+||||+++++|++|..||.
T Consensus 131 ~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~ 200 (260)
T PF00069_consen 131 LDENG-EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE 200 (260)
T ss_dssp ESTTS-EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred ccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99555 7999999999764 223344556788899999998733688999999999999999999999995
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=268.73 Aligned_cols=193 Identities=20% Similarity=0.389 Sum_probs=155.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+..+|.+.+.||+|+||.||+|....+++.||+|+++... ...+.+|+.+++.+ +|+||+++++++.. ....+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcC--CCCcEEE
Confidence 4567999999999999999999998899999999987433 35688999999999 99999999999854 4578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||++++++..++.. ++...... ++.|+++||+|||++|++||||||+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~---------------------------~~~ql~~~l~~lH~~~i~H~dlkp~ 133 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLY---------------------------MATQISSAMEYLEKKNFIHRDLAAR 133 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEeecccCcc
Confidence 999999888765421 33333333 4455566999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCccc--ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
||+++.++ .++|+|||.+.......... ....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 134 nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 134 NCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred eEEEcCCC-cEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99998666 79999999987654322111 1223456999998876 678999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=266.00 Aligned_cols=242 Identities=20% Similarity=0.333 Sum_probs=187.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+.++.+.+..||+|+.|.||++++..+|...|||.+.. .+.++++..+.++.+..+.|.|++.+|+|.... ..+
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHH
Confidence 45677889999999999999999999999999999963 345778889998888756899999999997543 345
Q ss_pred eEEeeec---CCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH-HcCCeecCCCC
Q 040656 106 LIFEHVN---STDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH-SQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~ivHrdlkp 181 (332)
+.||.|. ...+....+.+++.-+..+...+++ ||.||. .+||+|||+||
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~---------------------------AL~YLKeKH~viHRDvKP 220 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVK---------------------------ALYYLKEKHGVIHRDVKP 220 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHH---------------------------HHHHHHHhcceeecccCc
Confidence 6666654 3344444566777666666666555 999996 56899999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
+|||+|..+ .+||+|||++-.+......+...|.+.|||||.+--. ..|+-++||||||++++||.||+.||.....
T Consensus 221 SNILlDe~G-niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 221 SNILLDERG-NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred cceEEccCC-CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 999999777 6999999999877766667777899999999988432 4588999999999999999999999965556
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFP 331 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP 331 (332)
+.+++.++.... +|.+..- ..|.+.+.+|+..||+.|+.+||
T Consensus 300 dFe~ltkvln~e----------------PP~L~~~--------------~gFSp~F~~fv~~CL~kd~r~RP 341 (391)
T KOG0983|consen 300 DFEVLTKVLNEE----------------PPLLPGH--------------MGFSPDFQSFVKDCLTKDHRKRP 341 (391)
T ss_pred cHHHHHHHHhcC----------------CCCCCcc--------------cCcCHHHHHHHHHHhhcCcccCc
Confidence 667777666511 1111110 01455555677889999999999
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=267.48 Aligned_cols=192 Identities=21% Similarity=0.395 Sum_probs=154.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.++||+|+||.||+|.. .++..||+|.+... ..+.+.+|+.+++++ +|+||+++++.+.+ ....+++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYII 79 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEE
Confidence 468899999999999999999986 56678999988643 346789999999999 99999999998843 4568999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|+++++++..++.. ++.... ..++.+++.||+|||+.+++||||||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~---------------------------~~~~~~l~~~l~~LH~~~i~H~dl~p~ 132 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKL---------------------------IDFSAQIAEGMAYIERKNYIHRDLRAA 132 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHH---------------------------HHHHHHHHHHHHHHHHCCeeccccchh
Confidence 999999887665422 222222 234556667999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
||+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 133 nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 133 NVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred hEEecCCC-cEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 99999666 799999999987543221 122234567999999876 568899999999999999998 88888
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=301.14 Aligned_cols=206 Identities=24% Similarity=0.386 Sum_probs=160.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.++||+|+||.||+|++..+++.||+|+++.. ..+++.+|++++.++ +||||+++++++.+ ....+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d--~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSD--GDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEee--CCEEE
Confidence 5899999999999999999999999999999998632 235688999999999 99999999999854 45789
Q ss_pred eEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 106 LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
++|||++++++..++........ ..... .....+.....++.|+++||+|||++||+||||||+||+
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~--l~e~~-----------~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNIL 145 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKES--LSKEL-----------AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNIL 145 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccc--cchhh-----------hcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEE
Confidence 99999999988776532110000 00000 000011222456778888999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-------------------cccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
++.++ .++|+|||+++...... ......||..|+|||++.+ ..++.++|||||||++||
T Consensus 146 Ld~dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyE 223 (932)
T PRK13184 146 LGLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQ 223 (932)
T ss_pred EcCCC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHH
Confidence 99666 69999999997652110 0112468999999999877 678999999999999999
Q ss_pred HHhCCCCCC
Q 040656 247 MIFRKEPFF 255 (332)
Q Consensus 247 lltg~~pf~ 255 (332)
|+||..||.
T Consensus 224 LLTG~~PF~ 232 (932)
T PRK13184 224 MLTLSFPYR 232 (932)
T ss_pred HHHCCCCCC
Confidence 999999994
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.75 Aligned_cols=192 Identities=18% Similarity=0.342 Sum_probs=152.4
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.+.++|++.++||+|+||.||+|.+..+ ..||+|.++.. ..+.+.+|+++++++ +|+||+++++.+.. ...++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~l 77 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYI 77 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEE
Confidence 3567899999999999999999987544 56999998742 346789999999999 89999999988732 35799
Q ss_pred EEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+|||++++++..++.. ++...... ++.+++.||++||+.+++||||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~aL~~lH~~~i~H~dl~p 130 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVD---------------------------MAAQIASGMAYVERMNYVHRDLRA 130 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCccccccCc
Confidence 9999999887766532 23333333 444555699999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
+||+++.++ .++|+|||.+......... ....++..|+|||+..+ ..++.++||||||+++|+++| |..||
T Consensus 131 ~Nill~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~ 204 (262)
T cd05071 131 ANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY 204 (262)
T ss_pred ccEEEcCCC-cEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999665 7999999999766433221 12235567999998866 568999999999999999999 77777
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=273.21 Aligned_cols=213 Identities=35% Similarity=0.648 Sum_probs=165.5
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+..++|++.+.||+|++|.||+|....+++.||+|.+... ....+.+|+++++++ +|+||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~ 78 (291)
T cd07844 2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTL 78 (291)
T ss_pred CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeE
Confidence 3458899999999999999999999889999999998632 124567899999999 99999999999854 4678
Q ss_pred eeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++|+||+.+ ++..++ ..++...+..++.+++ +||.|||+.+++|||||
T Consensus 79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~---------------------------~al~~lH~~~i~H~dl~ 130 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---------------------------RGLAYCHQRRVLHRDLK 130 (291)
T ss_pred EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeecccCC
Confidence 999999986 554433 1244445555555544 59999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+||+++.++ .++|+|||+++...... ......++..|+|||++.+...++.++||||||+++|+|++|..||.....
T Consensus 131 p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 209 (291)
T cd07844 131 PQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209 (291)
T ss_pred HHHEEEcCCC-CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999766 79999999986543211 122234677899999987656688999999999999999999999954443
Q ss_pred CHHHHHHHHHHhCC
Q 040656 260 NQDQLVKIARVLGT 273 (332)
Q Consensus 260 ~~~~~~~~~~~~~~ 273 (332)
..+.+..+.+..+.
T Consensus 210 ~~~~~~~~~~~~~~ 223 (291)
T cd07844 210 VEDQLHKIFRVLGT 223 (291)
T ss_pred HHHHHHHHHHhcCC
Confidence 45555556555544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=266.60 Aligned_cols=204 Identities=25% Similarity=0.462 Sum_probs=176.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
-++|+.++.||+|.||.|.+|+.+.+++.+|+|++++. +-.+-..|-++|+.. .||.+..+-..| +....+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF--Qt~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF--QTQDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh--ccCceE
Confidence 37899999999999999999999999999999999753 234567899999998 999999998888 666789
Q ss_pred eeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
|.||||.+||.|..++. .+++...++|-.+++. ||.|||+++||+||||.
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvs---------------------------AL~YLHs~~ivYRDlKL 296 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVS---------------------------ALGYLHSRNIVYRDLKL 296 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHH---------------------------HhhhhhhCCeeeeechh
Confidence 99999999999988874 4888889999888887 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceee-cCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
+|+|+|.++ ++||+|||+++.- ..+....++|||+.|.|||++.. ..|+.+.|.|.+|+++|||++|+.||+ ..+.
T Consensus 297 ENLlLDkDG-HIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFy-n~dh 373 (516)
T KOG0690|consen 297 ENLLLDKDG-HIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFY-NKDH 373 (516)
T ss_pred hhheeccCC-ceEeeecccchhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccc-ccch
Confidence 999999777 7999999999753 34456678899999999999977 789999999999999999999999994 3443
Q ss_pred HHHHHHH
Q 040656 261 QDQLVKI 267 (332)
Q Consensus 261 ~~~~~~~ 267 (332)
...+..|
T Consensus 374 ~kLFeLI 380 (516)
T KOG0690|consen 374 EKLFELI 380 (516)
T ss_pred hHHHHHH
Confidence 3333333
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=273.67 Aligned_cols=212 Identities=17% Similarity=0.244 Sum_probs=152.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCc--eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|....++. .+++|.++.. ....+.+|+.++.++.+||||+++++++.+ ...++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 579999999999999999998866664 4688887632 224688899999999779999999999844 45689
Q ss_pred eEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 106 LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+++||++++++..++..-....... ... ................++.|++.||+|||++|++||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~----~~~----~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 151 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDP----AFA----KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVL 151 (297)
T ss_pred EEEEecCCCcHHHHHHhcccccccc----ccc----cccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEE
Confidence 9999999888766542100000000 000 00000001122223456667778999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
++.++ .++|+|||++..............+..|+|||+..+ ..++.++|||||||++|+|++ |..||.
T Consensus 152 l~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 152 VGENL-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred ECCCC-eEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 98665 799999999864321111111223456999999876 678999999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=266.17 Aligned_cols=204 Identities=17% Similarity=0.324 Sum_probs=157.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||.||++.. ..+..+|+|.++.. ....+.+|+.+++++ +||||+++++++.. ....+++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEcc--CCCEEEE
Confidence 457899999999999999999976 45568999987643 346788999999999 99999999999844 4578999
Q ss_pred EeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||++++++...+.. ++..... .++.+++.||+|||++|++||||||+|
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~---------------------------~~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLL---------------------------SMCQDVCEGMEYLERNSFIHRDLAARN 130 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCccccccCcce
Confidence 999999887765421 2333333 344556669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDN 260 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~ 260 (332)
|+++.++ .++|+|||.++........ ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..+.
T Consensus 131 i~i~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~-~~~~ 207 (256)
T cd05114 131 CLVSSTG-VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFE-KKSN 207 (256)
T ss_pred EEEcCCC-eEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCC-CCCH
Confidence 9999665 7999999998765322221 12234567999999876 678999999999999999999 888883 3333
Q ss_pred HHHHHHH
Q 040656 261 QDQLVKI 267 (332)
Q Consensus 261 ~~~~~~~ 267 (332)
.+....+
T Consensus 208 ~~~~~~i 214 (256)
T cd05114 208 YEVVEMI 214 (256)
T ss_pred HHHHHHH
Confidence 3333333
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=288.81 Aligned_cols=192 Identities=23% Similarity=0.359 Sum_probs=153.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
..+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++++ +|+||+++++++.. ....++++++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~--~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVV--GGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEEEEEEc
Confidence 457999999999999999999999999999999643 34467899999999 99999999999854 3567999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
+.+..+..+. ..++...+. .++.|++.||.|||++||+||||||+|||++
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~---------------------------~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVT---------------------------AVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 8654332221 123333333 4555566699999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
.++ .++|+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|||++|..|++..
T Consensus 295 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 295 GPE-DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred CCC-CEEEcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 666 699999999986543221 123468999999999977 67899999999999999999998777543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=275.66 Aligned_cols=193 Identities=20% Similarity=0.380 Sum_probs=153.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCce----EEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
...+|++.+.||+|+||.||+|.+..+++. ||+|+++.. ....+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC--
Confidence 356799999999999999999987666554 899998632 235688899999999 999999999998542
Q ss_pred CCceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
..++++++++++++...+.. ++.... +.++.|++.||+|||++||+||
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~---------------------------~~~~~qi~~~L~~LH~~~iiH~ 133 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYL---------------------------LNWCVQIAKGMNYLEERRLVHR 133 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHH---------------------------HHHHHHHHHHHHHHHhcCeecc
Confidence 46899999999887665422 222222 2455667779999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCccc---ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||||+||+++.++ .++|+|||+++......... ....+..|+|||.+.+ ..++.++||||||+++|||++ |..|
T Consensus 134 dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p 211 (316)
T cd05108 134 DLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKP 211 (316)
T ss_pred ccchhheEecCCC-cEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 9999999999666 79999999998765333221 1233567999999876 678999999999999999997 8988
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 212 ~~ 213 (316)
T cd05108 212 YD 213 (316)
T ss_pred CC
Confidence 83
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.45 Aligned_cols=212 Identities=31% Similarity=0.539 Sum_probs=163.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++|.+.+.||+|+||.||+|....+++.+|+|+++... ...+.+|+.+++.+ +|+||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~~ 79 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHT--KETLT 79 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEec--CCeEE
Confidence 3478999999999999999999998899999999986422 23578899999999 99999999999854 45789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+++||+.++.+..+. ..++...+..++ .|++.||+|||+.||+|+||||+
T Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~---------------------------~qi~~~L~~lH~~~i~H~dlkp~ 132 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHPGGLHPYNVRLFM---------------------------FQLLRGLAYIHGQHILHRDLKPQ 132 (291)
T ss_pred EEEecccCCHHHHHHhCCCCCCHHHHHHHH---------------------------HHHHHHHHHHHhCCcccCCCChH
Confidence 999999754433322 123333444344 45555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||+++.++ .++|+|||+++..... .......++..|+|||.+.+...++.++||||||+++|+|++|..||....+..
T Consensus 133 Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~ 211 (291)
T cd07870 133 NLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF 211 (291)
T ss_pred HEEEcCCC-cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH
Confidence 99999666 7999999998754322 122334567889999998764567889999999999999999999996544444
Q ss_pred HHHHHHHHHhC
Q 040656 262 DQLVKIARVLG 272 (332)
Q Consensus 262 ~~~~~~~~~~~ 272 (332)
+.+..+....+
T Consensus 212 ~~~~~~~~~~~ 222 (291)
T cd07870 212 EQLEKIWTVLG 222 (291)
T ss_pred HHHHHHHHHcC
Confidence 55555555444
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.97 Aligned_cols=195 Identities=26% Similarity=0.409 Sum_probs=155.0
Q ss_pred CCc-eEEEeecccCCceEEEEE----EccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 32 EDY-EVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 32 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
++| .+.+.||+|+||.||++. ...++..||+|+++.. ....+.+|+++++++ +||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 455 999999999999998764 3356788999998742 245678999999999 999999999988665555
Q ss_pred CceeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
..+++|||++++++..+.. .++......++.+ ++.||.|||+++++|||||
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~---------------------------l~~~l~~lH~~~i~H~dlk 134 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---------------------------ICEGMAYLHSQHYIHRDLA 134 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCeeccccC
Confidence 6899999999998877642 3445544444444 4559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+||+++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 135 p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 135 ARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred hheEEEcCCC-cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 9999999665 799999999876543221 112234566999999876 5789999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=278.92 Aligned_cols=205 Identities=26% Similarity=0.435 Sum_probs=164.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||++....+++.+|+|++.+. ....+..|+.++..+ +|+||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQD--ENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCEEE
Confidence 5799999999999999999999999999999998632 123477899999998 99999999999854 45789
Q ss_pred eEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+||||++++++..++. .+++..+..++.+++. ||.|||+.||+||||||
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~---------------------------al~~lH~~~iiHrDlkp 130 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI---------------------------AIDSVHQLHYVHRDIKP 130 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEecCCCH
Confidence 9999999999877752 3455555555555554 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .++|+|||++........ .....||..|+|||++.+ ...++.++|||||||++|||++|..||.
T Consensus 131 ~Nili~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 131 DNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred HHEEECCCC-CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 999999666 799999999876533222 223578999999999863 2457899999999999999999999994
Q ss_pred CCCCCHHHHHHHH
Q 040656 256 YGHDNQDQLVKIA 268 (332)
Q Consensus 256 ~~~~~~~~~~~~~ 268 (332)
..+..+....+.
T Consensus 210 -~~~~~~~~~~i~ 221 (332)
T cd05623 210 -AESLVETYGKIM 221 (332)
T ss_pred -CCCHHHHHHHHh
Confidence 344444444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=278.71 Aligned_cols=223 Identities=17% Similarity=0.266 Sum_probs=157.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.+++|++.+.||+|+||.||+|... .+++.||+|+++.. ..+.+.+|+.++.++.+|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 4578999999999999999999643 34578999998632 2245778999999997899999999988543
Q ss_pred CCCceeEEeeecCCCceeeccccchhh----HHHHHHHHH--hhcCCc-------------------------------c
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANE----IRYYIYELL--KHAMPR-------------------------------K 143 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~----~~~~~~~~~--~~~~~~-------------------------------~ 143 (332)
...+++++||++++++..++....... ......... ...... .
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 356789999999998876542111000 000000000 000000 0
Q ss_pred eeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---cccccccccee
Q 040656 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFK 220 (332)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~ 220 (332)
-...-...+.....++.|++.||+|||++||+||||||+|||++.++ .++|+|||++..+..... .....++..|+
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 00000112222345677889999999999999999999999999665 799999999976543221 12234456799
Q ss_pred ccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 221 GPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 221 aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 243 aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~ 277 (337)
T cd05054 243 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYP 277 (337)
T ss_pred CcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence 9999877 678999999999999999998 998983
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=285.93 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=182.1
Q ss_pred CCCceEEEeecccCCceEEEEEEc--cCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV--TNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
..+|++++.||+|+||.||+|... ..++.||+|.+... ....+|+.+++++ +|+||+++++.+.. ....+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRW--KSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEee--CCEEEEEe
Confidence 457999999999999999998753 35678999988642 3457899999999 99999999999854 35789999
Q ss_pred eeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 109 EHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 109 e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|++.+..+..+. ..++...+..++. |++.||.|||++||+||||||+|||+
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~---------------------------ql~~aL~~LH~~givHrDlkp~Nill 218 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQR---------------------------RLLEALAYLHGRGIIHRDVKTENIFL 218 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCccccCCCHHHEEE
Confidence 998754333221 2344444444444 45559999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--CH
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NQ 261 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~--~~ 261 (332)
+.++ .++|+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++|..||+.... ..
T Consensus 219 ~~~~-~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 219 DEPE-NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred cCCC-CEEEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 9666 799999999876543221 234578999999999876 6789999999999999999999999964332 34
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC-----CCCCCCCc-ccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK-----RVWPIPNN-KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~~-~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+..+.+.++..... ..............+. .++..+.. ....+.....+++..||.+||++||+
T Consensus 297 ~~l~~i~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps 368 (392)
T PHA03207 297 SQLRSIIRCMQVHPLE-----FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS 368 (392)
T ss_pred HHHHHHHHHhccCccc-----cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC
Confidence 4555566554432211 0011111111111111 11111100 01112233457788999999999996
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.62 Aligned_cols=213 Identities=17% Similarity=0.314 Sum_probs=154.0
Q ss_pred CCCceEEEeecccCCceEEEEEEc----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.++|++.+.||+|+||.||+|... ..+..+++|.++.. ....+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec--CC
Confidence 467999999999999999999853 45578999998632 225688999999999 99999999999854 35
Q ss_pred CceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
..+++|||++++++..++......... .....................++.+++.||.|||++|++||||||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDV-------GCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCcc-------ccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 689999999998876654110000000 0000000000000111122346667778999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
||+++.++ .++|+|||+++....... .....++..|+|||++.+ ..++.++|+||||+++|||++ |..||.
T Consensus 154 nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 154 NILIGEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred eEEEcCCC-cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 99999666 799999999976543221 222345667999999876 568999999999999999998 888884
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=270.31 Aligned_cols=196 Identities=27% Similarity=0.462 Sum_probs=159.3
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++.+... ...+
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~--~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSR--EKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC--CEEE
Confidence 3457899999999999999999999899999999998643 234578899999999 999999999998543 5789
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+++||++++++..++. .++......++.+ ++.||.|||+.||+||||+|+
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~q---------------------------i~~~l~~lH~~~i~H~dl~p~ 135 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE---------------------------TLQGLAYLHSKGKMHRDIKGA 135 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCccccCCCHH
Confidence 9999999988876542 3444444444444 455999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++ .++|+|||++....... ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.
T Consensus 136 nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 136 NILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred HEEECCCC-CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 99998666 69999999988654222 2234567888999998742 2457889999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=275.82 Aligned_cols=267 Identities=26% Similarity=0.482 Sum_probs=186.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC---CCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---SKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---~~~ 103 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++++...+ ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccce
Confidence 47899999999999999999999999999999998632 234578899999999 8999999999875432 235
Q ss_pred ceeEEeeecCCCceeec-cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 104 PSLIFEHVNSTDFKVLY-PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
.++++|++.+.....+. ..+++..+..++.+++ .||++||+.||+||||||+
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~---------------------------~aL~~LH~~~ivH~dlkp~ 135 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL---------------------------RGLKYIHSANVLHRDLKPS 135 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeeccCCCHH
Confidence 78999999763322222 2355555555555554 5999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||+++.++ .++|+|||++........ .....++..|+|||.+.+...++.++||||||+++|+|++|..|| .+.
T Consensus 136 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f-~~~ 213 (336)
T cd07849 136 NLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-PGK 213 (336)
T ss_pred HEEECCCC-CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCC
Confidence 99999666 799999999876543221 123467888999998766566899999999999999999999998 455
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCc---ccccccccccccCceEEEeCCCCCCC
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN---KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.......+...++.+...++ ... .+...+..++.. +...... ..........+++..||+.||++||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 285 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDL-NCI---ISLRARNYIKSL-PFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT 285 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHH-HHh---hchhhhhHHhhc-CcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC
Confidence 555556666655554332221 111 011111111110 0000000 00112333457888899999999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=278.18 Aligned_cols=205 Identities=26% Similarity=0.435 Sum_probs=164.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||++.+..+++.||+|+++.. ....+.+|..++..+ +|+||+++++.+.+ ....+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 5799999999999999999999999999999998642 123477889999988 99999999999954 46789
Q ss_pred eEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+||||+++++|..++. .+++..+..++.+++ .||.|||++||+||||||
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~---------------------------~~L~~lH~~~iiHrDlkp 130 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV---------------------------LAIHSIHQLHYVHRDIKP 130 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeeeccCch
Confidence 9999999999887652 345555555555554 499999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .++|+|||++......... ....||..|+|||++.+. ..++.++|||||||++|+|++|..||.
T Consensus 131 ~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 131 DNVLLDMNG-HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred HHEEEcCCC-CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 999999666 7999999999776533322 234689999999988642 357889999999999999999999994
Q ss_pred CCCCCHHHHHHHH
Q 040656 256 YGHDNQDQLVKIA 268 (332)
Q Consensus 256 ~~~~~~~~~~~~~ 268 (332)
..+..+....+.
T Consensus 210 -~~~~~~~~~~i~ 221 (331)
T cd05624 210 -AESLVETYGKIM 221 (331)
T ss_pred -CCCHHHHHHHHH
Confidence 333344444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=270.81 Aligned_cols=210 Identities=21% Similarity=0.357 Sum_probs=157.2
Q ss_pred CCCceEEEeecccCCceEEEEEEcc-----CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++|.+.+.||+|+||.||+|.... +++.||+|.++.. ....+.+|+++++++ +|+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC--
Confidence 5679999999999999999997643 3578999998743 235788999999999 999999999998553
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...+++|||++++++..++......... .. ................++.+++.|+.+||++|++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~--~~--------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp 150 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAF--LK--------SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLAT 150 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhh--hc--------ccccccccccHHHHHHHHHHHHHHHHHHhhCCeecccccc
Confidence 6789999999999887765321110000 00 0000000011122234666777799999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+||+++.++ .++|+|||.+........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 151 ~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 151 RNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred ceEEEcCCC-eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 999999666 799999999876532221 122345677999999877 678999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.22 Aligned_cols=242 Identities=20% Similarity=0.377 Sum_probs=194.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.+.+..+..+||-|.||.||.|++++..-.||||.++.. ..++|+.|..+|+.+ +|||+++++|+|. ++...|+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT--~EpPFYIi 341 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT--HEPPFYII 341 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhc--cCCCeEEE
Confidence 467789999999999999999999999999999999854 457899999999999 9999999999994 44678999
Q ss_pred EeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
+|||..|.|.+.+......++..++. +.|+.||.+|++||..+++|||||..+|+||.
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvL----------------------lyMAtQIsSaMeYLEkknFIHRDLAARNCLVg 399 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVL----------------------LYMATQISSAMEYLEKKNFIHRDLAARNCLVG 399 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHH----------------------HHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc
Confidence 99999888877765443333222111 35788889999999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCccccc---ccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNQDQ 263 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~~~~ 263 (332)
.+. .||++|||+++++..+. ++.- ....-|.|||.+.- ..++-++|||+||++|||+.| |..|| ++.+-..+
T Consensus 400 Enh-iVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqV 475 (1157)
T KOG4278|consen 400 ENH-IVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQV 475 (1157)
T ss_pred ccc-eEEeeccchhhhhcCCc-eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHH
Confidence 655 89999999999876433 3222 23455999999866 678999999999999999987 77776 78777777
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
...+...++.+.+ ..++|..-.++ ..||+|+|++||+
T Consensus 476 Y~LLEkgyRM~~P--------eGCPpkVYeLM------------------------raCW~WsPsDRPs 512 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGP--------EGCPPKVYELM------------------------RACWNWSPSDRPS 512 (1157)
T ss_pred HHHHhccccccCC--------CCCCHHHHHHH------------------------HHHhcCCcccCcc
Confidence 6666665554332 45666666655 4499999999996
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=270.97 Aligned_cols=238 Identities=19% Similarity=0.289 Sum_probs=175.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
++.+|.+.+.||+|+||.||++... .++..+|+|.++... .+.+.+|+++++++ +|+||+++++++.+ .
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 4678999999999999999999752 345679999986432 35688999999999 89999999999854 4
Q ss_pred CCceeEEeeecCCCceeeccc----------------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHH
Q 040656 102 KTPSLIFEHVNSTDFKVLYPT----------------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQA 165 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 165 (332)
..+++++||++++++..++.. ++.... ..++.|++.|
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~---------------------------~~~~~ql~~a 132 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM---------------------------LHIAQQIAAG 132 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHH---------------------------HHHHHHHHHH
Confidence 678999999999887665421 233333 3455566669
Q ss_pred HHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHH
Q 040656 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 242 (332)
Q Consensus 166 l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~ 242 (332)
|+|||++|++||||||+||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++|||||||
T Consensus 133 L~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~ 210 (288)
T cd05093 133 MVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGV 210 (288)
T ss_pred HHHHHhCCeeecccCcceEEEccCC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHH
Confidence 9999999999999999999999666 799999999875532221 122234667999999876 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCce
Q 040656 243 MFAGMIF-RKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNI 321 (332)
Q Consensus 243 il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (332)
++|+|++ |..||. .....+....+...... ......++.+. +++.+
T Consensus 211 il~~l~t~g~~p~~-~~~~~~~~~~i~~~~~~--------~~~~~~~~~l~------------------------~li~~ 257 (288)
T cd05093 211 VLWEIFTYGKQPWY-QLSNNEVIECITQGRVL--------QRPRTCPKEVY------------------------DLMLG 257 (288)
T ss_pred HHHHHHhCCCCCCC-CCCHHHHHHHHHcCCcC--------CCCCCCCHHHH------------------------HHHHH
Confidence 9999998 888883 33333333333221100 00112333344 44566
Q ss_pred EEEeCCCCCCC
Q 040656 322 CITFSPSGFPF 332 (332)
Q Consensus 322 cl~~dP~~RP~ 332 (332)
||+.||.+||+
T Consensus 258 ~l~~~p~~Rpt 268 (288)
T cd05093 258 CWQREPHMRLN 268 (288)
T ss_pred HccCChhhCCC
Confidence 99999999996
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=263.11 Aligned_cols=191 Identities=24% Similarity=0.459 Sum_probs=157.3
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|.+.+.||+|++|.||+|....+++.|++|.+.. .....+.+|+++++++ +|+||+++++.+.+ ...++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD--KGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc--CCEEEEE
Confidence 58899999999999999999999999999999863 2345688999999999 99999999999854 3578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||++++++..++.. ++..... .++.+++.||.|||+.|++|+||||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------~i~~~l~~al~~lH~~~i~h~dl~~~ 130 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVW---------------------------RFFIQILLGLAHLHSKKILHRDIKSL 130 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCcccCCCCcc
Confidence 999999887665422 2222222 34555666999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++ .++|+|||+++....... .....++..|+|||+..+ ..++.++|+||||+++++|++|..||.
T Consensus 131 nili~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 202 (256)
T cd08529 131 NLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFD 202 (256)
T ss_pred eEEEeCCC-CEEEcccccceeccCccchhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 99999666 799999999886653322 233467888999999877 568899999999999999999999994
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=267.19 Aligned_cols=261 Identities=27% Similarity=0.476 Sum_probs=189.2
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|++|.||+|.+..+++.|++|++.... ...+.+|+.+++++ +|+||+++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence 5899999999999999999998899999999986432 35788999999999 89999999999854 4678999
Q ss_pred EeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|++ ++++..++ ..++...+..++.+++ .||+|||+.|++|+||||+|
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~---------------------------~~l~~lH~~~i~H~dl~p~n 129 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLL---------------------------KGVAYMHANGIMHRDLKPAN 129 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeecCCcCHHH
Confidence 9999 88876654 2345555555555555 49999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
|+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++||||||+++++|++|..|| .+..+.
T Consensus 130 i~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~ 207 (286)
T cd07832 130 LLISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF-PGENDI 207 (286)
T ss_pred EEEcCCC-cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc-CCCCHH
Confidence 9999765 79999999987665332 2334568888999999876556789999999999999999996665 555566
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC---CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK---RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+..+....+.+....+..-. +.. ......... .+|... .........+++..||+.+|++||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLT--SLP-DYNKITFPESKPIPLEEI---FPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhcc--Ccc-hhhcccCCCCCcchHHHh---CCCccHHHHHHHHHHhccChhhCCC
Confidence 6666666665554332222110 000 000000000 011000 0011133357889999999999996
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=266.22 Aligned_cols=191 Identities=23% Similarity=0.425 Sum_probs=157.0
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+|++.+.||.|+||.||++.+..+++.+|+|.++.. ..+.+.+|+.+++.+ +|+||+++++.+.+ ...+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEE
Confidence 589999999999999999999999999999998532 235678899999999 99999999999854 46789999
Q ss_pred eeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||++++++..... .+++.....++. +++.||.+||++|++|+||||+|
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~---------------------------~i~~al~~lH~~~i~H~dl~p~n 130 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFV---------------------------QMCLGVQHIHEKRVLHRDIKSKN 130 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHH---------------------------HHHHHHHHHhhCCcccCCCCcce
Confidence 9999988765432 234444444444 45559999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+++.++ .++|+|||.+........ .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.
T Consensus 131 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~ 201 (255)
T cd08219 131 IFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQ 201 (255)
T ss_pred EEECCCC-cEEEcccCcceeecccccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCC
Confidence 9998666 799999999876643222 234567888999999876 568999999999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=264.52 Aligned_cols=193 Identities=17% Similarity=0.324 Sum_probs=153.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||.||.|... .+..+|+|.++... ...+.+|+.+++++ +||||+++++++.. ....+++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK--QRPIYIV 77 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEcc--CCCcEEE
Confidence 4678999999999999999999763 45569999887432 45789999999999 89999999999854 3568999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||+.++++..++. .++...+.. ++.+++.||+|||+.|++|+||||+|
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLE---------------------------MCKDVCEGMAYLESKQFIHRDLAARN 130 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeeccccCcce
Confidence 99999988776542 233333333 44555569999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCccc--ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||.++......... ...++..|+|||...+ ..++.++||||||+++|+|++ |..||.
T Consensus 131 ili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~ 203 (256)
T cd05113 131 CLVDDQG-CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE 203 (256)
T ss_pred EEEcCCC-CEEECCCccceecCCCceeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 9999665 79999999987654332211 1234567999999876 568899999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=263.26 Aligned_cols=192 Identities=24% Similarity=0.422 Sum_probs=159.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|++|.||+|....+++.+|+|.+... ....+.+|+++++++ +|+|++++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence 589999999999999999999999999999998632 245688999999999 99999999998843 4578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|+++++++..++.. +++..+..++. +++.+|++||++|++|+||+|+
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~---------------------------~i~~~l~~lh~~~i~h~dl~~~ 130 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFV---------------------------QILLALHHVHTKLILHRDLKTQ 130 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeecCCCCHH
Confidence 999999887765421 34444444444 4455999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++..++|+|||.+.............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 131 nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~ 202 (256)
T cd08220 131 NILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFE 202 (256)
T ss_pred HEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcc
Confidence 999987766789999999987654444444567888999999876 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=268.90 Aligned_cols=269 Identities=28% Similarity=0.441 Sum_probs=189.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+.++|++.+.||+|+||.||+|.+..+++.+++|.++... ...+.+|+.+++++ +||||+++++++.+.+....
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcE
Confidence 3468999999999999999999998899999999986322 23467899999999 89999999999876655789
Q ss_pred eeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++++||+.+ ++..++. .++......++ .|++.||+|||+.|++|+|||
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~---------------------------~qi~~aL~~LH~~~i~H~dl~ 133 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM---------------------------LQLLSGVAHLHDNWILHRDLK 133 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHH---------------------------HHHHHHHHHHHHCCeeeccCC
Confidence 999999985 4433321 24444444444 455559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+||+++.++ .++|+|||++...... .......++..|+|||.+.+...++.++|+||||+++++|++|..||. ...
T Consensus 134 p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~-~~~ 211 (293)
T cd07843 134 TSNLLLNNRG-ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKS 211 (293)
T ss_pred HHHEEECCCC-cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC-CCC
Confidence 9999999666 7999999998866543 223344567889999998765567899999999999999999999984 455
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCccccc--ccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQ--FCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+...++....+.+....+..-....... ..... ..++......... ......+++..||+.||++||+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t 283 (293)
T cd07843 212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAK--KKTFT-KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283 (293)
T ss_pred hHHHHHHHHHHhCCCchHHHHHhhccchhc--ccccc-cccchhhhccccccCCChHHHHHHHHHhccCccccCC
Confidence 556666666655544332222111000000 00000 0000000000000 2333457889999999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=269.56 Aligned_cols=198 Identities=25% Similarity=0.436 Sum_probs=159.3
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.....+.|++++.||+|+||.||+|.+..+++.+++|++.... ...+.+|+.+++.+ +|+||+++++.+.. ...
T Consensus 7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 83 (292)
T cd06644 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYW--DGK 83 (292)
T ss_pred ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEe--CCe
Confidence 3445678999999999999999999998899999999986433 35678899999999 89999999999854 357
Q ss_pred ceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++|||++++++..+. ..++...+..++.++ +.+|.+||+.+++||||
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql---------------------------~~~l~~lH~~~i~H~dl 136 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM---------------------------LEALQYLHSMKIIHRDL 136 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHH---------------------------HHHHHHHhcCCeeecCC
Confidence 89999999999876543 224455444444444 45999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+||+++.++ .++|+|||.+...... .......++..|+|||++.+ ...++.++|+|||||++|+|++|..||
T Consensus 137 kp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 215 (292)
T cd06644 137 KAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 215 (292)
T ss_pred CcceEEEcCCC-CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCC
Confidence 99999998665 7999999988654322 22234567888999999853 234678999999999999999999998
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 216 ~ 216 (292)
T cd06644 216 H 216 (292)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.67 Aligned_cols=207 Identities=19% Similarity=0.360 Sum_probs=153.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+. .++..||+|.++.. ....+.+|+.+++.+ +|+||+++++++. .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~--~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVS--Q 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEc--C
Confidence 4678999999999999999998753 23567999998532 234578999999999 9999999999984 3
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....+++|||++++++..++.......... .......+.....++.+++.||.|||+.|++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlk 146 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENN--------------PVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLA 146 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCcccccc--------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcc
Confidence 457899999999988776543211100000 000000111123456677779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+||+++.++ .++|+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 147 p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~ 223 (277)
T cd05062 147 ARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ 223 (277)
T ss_pred hheEEEcCCC-CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999666 7999999998754322211 11234667999999876 678999999999999999999 677873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=265.51 Aligned_cols=198 Identities=20% Similarity=0.387 Sum_probs=151.7
Q ss_pred ceEEEeecccCCceEEEEEEccC---CceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----C
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----S 101 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~ 101 (332)
|.+.+.||+|+||.||.|....+ +..||+|.++.. ....+.+|+..++.+ +|+||+++++++.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987543 478999998742 124688999999999 9999999999875432 2
Q ss_pred CCceeEEeeecCCCceeecc---------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 102 KTPSLIFEHVNSTDFKVLYP---------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
...++++||++++++...+. .++..... .++.|++.||.|||+.
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~---------------------------~~~~~i~~aL~~lH~~ 132 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL---------------------------KFMVDIALGMEYLSNR 132 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHH---------------------------HHHHHHHHHHHHHHhC
Confidence 34789999999998766541 12333233 3555666699999999
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt 249 (332)
+++||||||+||+++.++ .++|+|||+++........ .....+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 133 ~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~ 210 (273)
T cd05035 133 NFIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIAT 210 (273)
T ss_pred CeeccccchheEEECCCC-eEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHh
Confidence 999999999999999665 7999999999866433221 11234567999999866 678999999999999999999
Q ss_pred -CCCCCCCCCCCHH
Q 040656 250 -RKEPFFYGHDNQD 262 (332)
Q Consensus 250 -g~~pf~~~~~~~~ 262 (332)
|..|| .+..+.+
T Consensus 211 ~g~~p~-~~~~~~~ 223 (273)
T cd05035 211 RGQTPY-PGVENHE 223 (273)
T ss_pred CCCCCC-CCCCHHH
Confidence 77777 3443333
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=267.87 Aligned_cols=190 Identities=25% Similarity=0.483 Sum_probs=159.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||++.+..+++.+|+|+++.. ....+.+|+++++++ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence 4799999999999999999999889999999998632 235688899999999 89999999999854 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++|||++++++...+ ..++......++.++ +.||.+||+.|++|+||+|+
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi---------------------------l~~l~~lH~~~i~H~dl~p~ 130 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV---------------------------VLALEYLHSLDIVYRDLKPE 130 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCEecCCCCHH
Confidence 999999988876664 234555554444544 45999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++ .++|+|||++...... .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.
T Consensus 131 nili~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 131 NLLLDSDG-YIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred HEEECCCC-CEEEeeCCCccccCCC--CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999666 7999999998776433 334467888999999876 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=262.91 Aligned_cols=193 Identities=21% Similarity=0.389 Sum_probs=154.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|++|.||+|.. .+++.||+|.++.. ..+.+.+|+.+++++ +|+||+++++++.. ....+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL--EEPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEec--CCCeeee
Confidence 467899999999999999999986 45678999998743 346788999999999 89999999999854 4578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|+++++++..+... ++......+ +.+++.||.+||+.|++||||||+
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~---------------------------~~~i~~~l~~lH~~~i~H~dl~p~ 132 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDM---------------------------AAQVASGMAYLEAQNYIHRDLAAR 132 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCeeeccCCcc
Confidence 999998888766422 334444444 444555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
||+++.++ .++|+|||++......... .....+..|+|||+..+ ..++.++|+||||+++++|++ |..||.
T Consensus 133 Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 206 (261)
T cd05068 133 NVLVGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYP 206 (261)
T ss_pred eEEEcCCC-CEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 99999666 7999999999876522211 11122346999998876 678999999999999999999 888883
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=270.90 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=175.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc-----CCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+..+|++.+.||+|+||.||+|.... .+..||+|+++... ...+.+|+.++..+ +|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~- 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE- 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC-
Confidence 34678999999999999999998654 35789999987432 24578899999999 999999999998543
Q ss_pred CCCceeEEeeecCCCceeeccc-cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPT-LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
...++++||+.++++..++.. ........ ................+.++.|++.||.|||++||+||||
T Consensus 81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dl 150 (283)
T cd05091 81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGS---------TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDL 150 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCccccc---------cccccccccccCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 468999999998877665421 00000000 0000000000112223456677888999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
||+||+++.++ .++|+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.
T Consensus 151 kp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 151 ATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred chhheEecCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 99999998665 699999999876542221 122344667999999876 568999999999999999998 777773
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+....+...... ....+.++.+.. ++..||+.+|.+||+
T Consensus 229 -~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~~------------------------li~~cl~~~p~~RP~ 272 (283)
T cd05091 229 -GYSNQDVIEMIRNRQVL--------PCPDDCPAWVYT------------------------LMLECWNEFPSRRPR 272 (283)
T ss_pred -CCCHHHHHHHHHcCCcC--------CCCCCCCHHHHH------------------------HHHHHhCCCcccCCC
Confidence 33333333333321110 011233344444 445699999999996
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=268.53 Aligned_cols=193 Identities=27% Similarity=0.513 Sum_probs=159.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|++.+.||.|++|.||+|.+..+++.|++|.+... ..+.+.+|+.+++.+ +|+||+++++.+.+ ...++++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--CceEEEE
Confidence 46799999999999999999999899999999998632 345688999999999 99999999999854 4578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++++++..+.. .++......++.++ +.||++||+.|++|+||||+||+
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l---------------------------~~al~~LH~~~i~H~dL~p~Nil 147 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCREC---------------------------LQALEFLHANQVIHRDIKSDNVL 147 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCcccCCCCHHHEE
Confidence 99999998877642 24444444444444 45999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++|++++|..||.
T Consensus 148 i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 148 LGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred ECCCC-CEEEccCccchhcccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99666 799999999876543322 233467888999999876 668899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=275.78 Aligned_cols=267 Identities=27% Similarity=0.487 Sum_probs=189.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC---CC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---SK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---~~ 102 (332)
..+|.+.+.||+|+||.||+|++..+++.||+|.++.. ....+.+|+.+++.+ +|+||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence 46799999999999999999999999999999998632 234677899999999 9999999999885432 23
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..++++||+.+ ++...+ ..++...+..++.+++ .||.|||+++++||||
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~---------------------------~aL~~LH~~~i~H~dl 134 (337)
T cd07858 83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLL---------------------------RGLKYIHSANVLHRDL 134 (337)
T ss_pred cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCEecCCC
Confidence 57999999975 333322 3355555555555555 4999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||+||+++.++ .++|+|||++...... .......++..|+|||.+.+...++.++|+|||||++|+|++|..|| .+.
T Consensus 135 kp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~ 212 (337)
T cd07858 135 KPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGK 212 (337)
T ss_pred CHHHEEEcCCC-CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCC
Confidence 99999999766 7999999998765433 22334567888999998865456889999999999999999999998 444
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.......+....+.+...++ . .-.++..+..+.+. .+................+++..||+.||++||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps 284 (337)
T cd07858 213 DYVHQLKLITELLGSPSEEDL-G---FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT 284 (337)
T ss_pred ChHHHHHHHHHHhCCCChHHh-h---hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC
Confidence 545555555555554332221 0 11112222222211 1111111111123344458888999999999996
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=267.15 Aligned_cols=195 Identities=23% Similarity=0.377 Sum_probs=160.2
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|+..+.||.|++|.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|+||++++++|.+.....++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 4799999999999999999999889999999998642 235688999999999 89999999999876666678999
Q ss_pred EeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 108 FEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
|||++++++..++.. ++...+ ..++.++++||.|||+.|++|+||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~---------------------------~~i~~~i~~~L~~lH~~~i~H~dl~ 132 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVL---------------------------GKIAESVLKGLSYLHSRKIIHRDIK 132 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHH---------------------------HHHHHHHHHHHHHHHHCCcccCCCC
Confidence 999999887655321 222222 3456666779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|+||+++.++ .++|+|||++....... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 133 ~~nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 133 PSNILLTRKG-QVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred HHHEEEecCC-eEEEeeccccccccccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999666 79999999986543222 223456788999999876 67899999999999999999999999543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=270.20 Aligned_cols=194 Identities=25% Similarity=0.529 Sum_probs=155.9
Q ss_pred CceEEEeecccCCceEEEEEEcc--CCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVT--NNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ...+.+|+.++.++ +||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 58999999999999999999887 78999999987521 35678899999999 99999999999977655789
Q ss_pred eeEEeeecCCCceeec-------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 105 SLIFEHVNSTDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
++|+|++++..+..+. ..+++..+.. ++.|++.||.|||+.+|+||
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~---------------------------i~~qi~~~l~~lH~~~i~h~ 132 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS---------------------------LLWQILNGVHYLHSNWVLHR 132 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHH---------------------------HHHHHHHHHHHHHhCCEeeC
Confidence 9999999864433221 1233444444 44455559999999999999
Q ss_pred CCCCCCeeecC----CCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh
Q 040656 178 DVKPHNVMIDH----EQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 178 dlkp~Nilv~~----~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt 249 (332)
||||+||+++. ++ .++|+|||++........ .....++..|+|||++.+...++.++||||||+++++|++
T Consensus 133 dlkp~Nil~~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 133 DLKPANILVMGEGPERG-VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred CCCHHHEEEcCCCCccc-eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999986 44 799999999876543221 2234677889999998775668899999999999999999
Q ss_pred CCCCCC
Q 040656 250 RKEPFF 255 (332)
Q Consensus 250 g~~pf~ 255 (332)
|..||.
T Consensus 212 ~~~~~~ 217 (316)
T cd07842 212 LEPIFK 217 (316)
T ss_pred cCCCCc
Confidence 999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=266.18 Aligned_cols=210 Identities=33% Similarity=0.603 Sum_probs=161.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++.+.||+|++|.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++.+ ...+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEec--CCeEEE
Confidence 5799999999999999999999889999999998632 225678999999999 99999999999954 467899
Q ss_pred EEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|+||+++.....+... +....+. .++.|++.||+|||+++++|+||+|+
T Consensus 79 v~e~~~~~l~~~~~~~~~~~~~~~~~~---------------------------~~~~qi~~aL~~LH~~~i~H~dl~p~ 131 (294)
T PLN00009 79 VFEYLDLDLKKHMDSSPDFAKNPRLIK---------------------------TYLYQILRGIAYCHSHRVLHRDLKPQ 131 (294)
T ss_pred EEecccccHHHHHHhCCCCCcCHHHHH---------------------------HHHHHHHHHHHHHHhCCeeCCCCCcc
Confidence 9999975332222111 1222222 34455566999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||+++.++..++|+|||++....... ......++..|+|||.+.+...++.++||||||+++|+|+||..||. ..+..
T Consensus 132 nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~-~~~~~ 210 (294)
T PLN00009 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP-GDSEI 210 (294)
T ss_pred eEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHH
Confidence 99998666679999999997654322 22334567889999998765568899999999999999999999984 34444
Q ss_pred HHHHHHHHHhC
Q 040656 262 DQLVKIARVLG 272 (332)
Q Consensus 262 ~~~~~~~~~~~ 272 (332)
+.+.++....+
T Consensus 211 ~~~~~~~~~~~ 221 (294)
T PLN00009 211 DELFKIFRILG 221 (294)
T ss_pred HHHHHHHHHhC
Confidence 55555544444
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=267.14 Aligned_cols=209 Identities=33% Similarity=0.586 Sum_probs=164.5
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+++++++ +|+||+++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence 4799999999999999999999888999999997532 234678899999999 99999999999954 467899
Q ss_pred EEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
++||++++.+..+.. .++..... .++.|++.||+|||+.|++|+||+|+|
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~---------------------------~~~~~i~~~l~~LH~~~i~h~~l~p~n 130 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVR---------------------------KYLFQILRGIEFCHSHNIIHRDIKPEN 130 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 999999877665432 23333333 345555669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+++.++ .++|+|||++....... ......++..|+|||++.+...++.++||||||+++++|++|..|| ......+
T Consensus 131 i~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~ 208 (286)
T cd07846 131 ILVSQSG-VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDID 208 (286)
T ss_pred EEECCCC-cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHH
Confidence 9999666 79999999987654332 2234467888999999876556789999999999999999999887 3444445
Q ss_pred HHHHHHHHhC
Q 040656 263 QLVKIARVLG 272 (332)
Q Consensus 263 ~~~~~~~~~~ 272 (332)
....+....+
T Consensus 209 ~~~~~~~~~~ 218 (286)
T cd07846 209 QLYHIIKCLG 218 (286)
T ss_pred HHHHHHHHhC
Confidence 5555554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=266.16 Aligned_cols=212 Identities=30% Similarity=0.573 Sum_probs=161.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC---CC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS---KT 103 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---~~ 103 (332)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++.+.+|+||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999889999999997632 124678899999999778999999998854322 23
Q ss_pred ceeEEeeecCCCceeecc--------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 104 PSLIFEHVNSTDFKVLYP--------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
.++++||+++. +...+. .+++..+. .++.|++.||.|||++|++
T Consensus 81 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~qi~~~L~~LH~~~i~ 132 (295)
T cd07837 81 LYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIK---------------------------SFMYQLLKGVAHCHKHGVM 132 (295)
T ss_pred EEEEeeccCcC-HHHHHHHhcccCCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCee
Confidence 78999999863 333221 12333333 3455566699999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||||+|+||+++.+++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++|+|++|..||
T Consensus 133 H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 212 (295)
T cd07837 133 HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212 (295)
T ss_pred ecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999745589999999987654222 2233356778999998876556899999999999999999999998
Q ss_pred CCCCCCHHHHHHHHHHhC
Q 040656 255 FYGHDNQDQLVKIARVLG 272 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~ 272 (332)
. +.........+....+
T Consensus 213 ~-~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 213 P-GDSELQQLLHIFKLLG 229 (295)
T ss_pred C-CCCHHHHHHHHHHHhC
Confidence 4 4444445555544433
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=266.44 Aligned_cols=193 Identities=19% Similarity=0.367 Sum_probs=153.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc----eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
..++|++.+.||+|+||+||+|.+..+++ .||+|+++.. ....+.+|+.+++.+ +|+||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---
Confidence 46789999999999999999998776666 4899998632 235678899999999 99999999999854
Q ss_pred CCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++++++++++++..++. .++...... ++.|++.||+|||+++++||
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~---------------------------~~~qi~~~L~~lH~~~iiH~ 133 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN---------------------------WCVQIAKGMSYLEEVRLVHR 133 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeecc
Confidence 34689999999988766542 233333333 44556669999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCccc---ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||||+||+++.++ .++|+|||+++......... ...++..|+|||...+ ..++.++|||||||++|||++ |..|
T Consensus 134 dlkp~Nil~~~~~-~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p 211 (279)
T cd05109 134 DLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ccccceEEEcCCC-cEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999999998665 79999999998765332211 1234567999999876 678999999999999999998 8888
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 212 ~~ 213 (279)
T cd05109 212 YD 213 (279)
T ss_pred CC
Confidence 83
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=262.60 Aligned_cols=202 Identities=20% Similarity=0.398 Sum_probs=156.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.. ..+..+|+|.++.. ....+.+|+.+++++ +|+|++++++++.. ...+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEe-cCCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEE
Confidence 467899999999999999999976 46677999998642 346789999999999 99999999998732 357899
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||++++++..++. .++...... ++.+++.||+|||+.+++||||||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~al~~lH~~~i~H~di~p~ 131 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVD---------------------------MAAQVAAGMAYIERMNYIHRDLRSA 131 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCcccCCCccc
Confidence 99999988776542 133333444 4445555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
||+++.++ .++|+|||.+......... ....++..|+|||...+ ..++.++|+||||+++|+|++ |..||. +.+
T Consensus 132 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~ 208 (260)
T cd05070 132 NILVGDGL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMN 208 (260)
T ss_pred eEEEeCCc-eEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCC-CCC
Confidence 99999655 7999999999765432211 11234556999998866 678999999999999999999 788873 333
Q ss_pred CHHHHHH
Q 040656 260 NQDQLVK 266 (332)
Q Consensus 260 ~~~~~~~ 266 (332)
..+....
T Consensus 209 ~~~~~~~ 215 (260)
T cd05070 209 NREVLEQ 215 (260)
T ss_pred HHHHHHH
Confidence 3333333
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=262.42 Aligned_cols=193 Identities=20% Similarity=0.385 Sum_probs=154.2
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
...++|+++++||+|+||.||+|.. .+++.+|+|.+... ....+.+|+.+++++ +|+||+++++++.+ ...++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEE
Confidence 3568899999999999999999985 56788999998643 346789999999999 99999999998733 45899
Q ss_pred EEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++|++.++++..++. .++...... ++.+++.||+|||+.|++||||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------i~~~i~~al~~LH~~~i~H~dl~p 130 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLID---------------------------MAAQIAEGMAFIERKNYIHRDLRA 130 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHH---------------------------HHHHHHHHHHHHhcCCeecccccH
Confidence 999999988766542 133333333 444555699999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+||+++.++ .++|+|||++........ .....++..|+|||++.. ..++.++||||||+++|++++ |..||.
T Consensus 131 ~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 131 ANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred HhEEEcCCC-CEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 999999666 799999999876542221 122345567999998866 568899999999999999999 999983
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=263.85 Aligned_cols=194 Identities=26% Similarity=0.504 Sum_probs=160.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|++.+.||+|+||.||+|....+++.+++|++... ..+.+.+|+++++++ +|+||+++++.+.+ ...++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEe--CCEEEEE
Confidence 57899999999999999999999888999999998743 346788999999999 99999999999854 3568999
Q ss_pred EeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||++++++..+. ..+++..+..++.+ ++.||.|||+++++|+||+|+|
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~q---------------------------l~~~l~~lh~~~i~h~dl~p~n 131 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRE---------------------------TLKGLAYLHETGKIHRDIKGAN 131 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHH---------------------------HHHHHHHHHhCCceecCCChhh
Confidence 9999998887754 23455544444444 4559999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+++.++ .++|+|||.+....... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||.
T Consensus 132 i~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 132 ILLTEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred EEECCCC-CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999666 69999999987654322 23345678889999998662 267889999999999999999999994
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=269.14 Aligned_cols=193 Identities=25% Similarity=0.488 Sum_probs=159.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..+|++.+.||+|+||.||+|++..+++.+++|.+... ....+.+|+.+++.+ .|+|++++++.+.+ ....++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEe--CCEEEEe
Confidence 47899999999999999999998889999999998642 235678899999998 99999999999854 4578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++++++..+.. .++...... ++.|++.||+|||+.||+||||||+||+
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~---------------------------i~~ql~~aL~~LH~~gi~H~dLkp~Nil 148 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAA---------------------------VCRECLQALEFLHSNQVIHRDIKSDNIL 148 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 99999998877652 234443333 4445556999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 149 l~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~ 217 (296)
T cd06654 149 LGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (296)
T ss_pred EcCCC-CEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 98666 79999999987554322 2234467888999999876 668899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=288.13 Aligned_cols=195 Identities=23% Similarity=0.416 Sum_probs=166.2
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCC
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST 114 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 114 (332)
-.||+|.||+||.|++..+....|||.+.... ..-+..|+.+.++| .|.||++++|.+ ..+..+-+.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~--senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSV--SENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhcc--CCCCeEEEEeecCCCC
Confidence 46999999999999999999999999996433 24578999999999 999999999998 4456788999999999
Q ss_pred Cceeec----ccc--chhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 115 DFKVLY----PTL--TANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 115 ~l~~~~----~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+|..++ +++ .+....+|.+|++. ||.|||.+.|||||||-+|+||+.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILe---------------------------GLkYLHen~IVHRDIKGDNVLvNT 710 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILE---------------------------GLKYLHENKIVHRDIKGDNVLVNT 710 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHH---------------------------HhhhhhhcceeeccccCCcEEEee
Confidence 999887 445 56667788888877 999999999999999999999987
Q ss_pred CCCeEEEEecccceeecCCC-cccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 189 EQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
-.+.+||+|||.++.+.... ...++.||..|||||++-.+ ..|+.++|||||||++.||.||++||..-..+..
T Consensus 711 ySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 711 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred ccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 77799999999998775443 34567899999999999654 4599999999999999999999999965444433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=281.50 Aligned_cols=205 Identities=25% Similarity=0.454 Sum_probs=175.8
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
-+.||+|.||+||-|.+.++|+.||||++.+ .....+.+|+.||+++ +||.|+.+...|+ +....++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~E--T~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFE--TPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeec--CCceEEEEehhh
Confidence 3789999999999999999999999999964 3446789999999999 9999999999994 456789999999
Q ss_pred cCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 112 NSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 112 ~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
.|..|.-++ +++++..-++++.|++. ||.|||.++|+|+||||+|+|+.
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~---------------------------ALr~LH~knIvHCDLKPENVLLa 698 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILV---------------------------ALRYLHFKNIVHCDLKPENVLLA 698 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHH---------------------------HHHHhhhcceeeccCCchheeec
Confidence 998877765 56777777777777766 99999999999999999999996
Q ss_pred CCC--CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 040656 188 HEQ--QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265 (332)
Q Consensus 188 ~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~ 265 (332)
... -.+||+|||+|+++.......+.+||+.|.|||++.+ +.|...-|+||+|+|+|--++|-.||..+.+-.++++
T Consensus 699 s~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ 777 (888)
T KOG4236|consen 699 SASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ 777 (888)
T ss_pred cCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhh
Confidence 432 2689999999999987777788899999999999988 8899999999999999999999999987776666655
Q ss_pred HHHHHhC
Q 040656 266 KIARVLG 272 (332)
Q Consensus 266 ~~~~~~~ 272 (332)
.-.-.+.
T Consensus 778 NAaFMyP 784 (888)
T KOG4236|consen 778 NAAFMYP 784 (888)
T ss_pred ccccccC
Confidence 5443333
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=267.06 Aligned_cols=209 Identities=36% Similarity=0.643 Sum_probs=164.4
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc--------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+|++.+.||+|++|.||+|.+..+++.|++|.++... ...+..|+++++++ +|+||+++++++.+ ...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence 5889999999999999999998899999999986432 23467899999999 89999999999965 4678
Q ss_pred eeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++|+||+ ++++..++. .++...+..+ +.|+++||.|||++|++|+||+
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~---------------------------~~qi~~al~~lH~~~i~H~dl~ 129 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSY---------------------------MLMTLRGLEYLHSNWILHRDLK 129 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCeeecCCC
Confidence 9999999 777666542 2344444444 4455569999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+||+++.++ .++|+|||++....... ......++..|+|||.+.+...++.++|+|||||++++|++|..|| .+.+
T Consensus 130 p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~-~~~~ 207 (298)
T cd07841 130 PNNLLIASDG-VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL-PGDS 207 (298)
T ss_pred hhhEEEcCCC-CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc-cCCc
Confidence 9999999666 79999999998765332 2233456778999998866567889999999999999999996555 5555
Q ss_pred CHHHHHHHHHHhCCc
Q 040656 260 NQDQLVKIARVLGTD 274 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~ 274 (332)
..+.+.++....+.+
T Consensus 208 ~~~~~~~~~~~~~~~ 222 (298)
T cd07841 208 DIDQLGKIFEALGTP 222 (298)
T ss_pred cHHHHHHHHHHcCCC
Confidence 666666665554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=267.55 Aligned_cols=208 Identities=18% Similarity=0.305 Sum_probs=154.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC----------------ceEEEEEeccc----chHHHHHHHHHHHhccCCCCe
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN----------------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNI 89 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni 89 (332)
..++|++++.||+|+||.||+|.....+ ..||+|.+... ..+.+.+|+.+++++ +|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCE
Confidence 4578999999999999999998875533 46899998643 245688899999999 99999
Q ss_pred eeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHH
Q 040656 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYC 169 (332)
Q Consensus 90 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 169 (332)
+++++++.+ ....++++|++.++++..++.......... ..............++.|++.||+||
T Consensus 82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~al~~L 146 (296)
T cd05051 82 ARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGL-------------ACNSKSLSFSTLLYMATQIASGMRYL 146 (296)
T ss_pred eEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccc-------------cccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 999999854 367899999999988766542211000000 00000011112234556667799999
Q ss_pred HHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 170 HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 170 H~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
|+.|++||||||+||+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++|||||||++|+
T Consensus 147 H~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~e 224 (296)
T cd05051 147 ESLNFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWE 224 (296)
T ss_pred HHcCccccccchhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHH
Confidence 999999999999999999665 799999999876543221 122345677999999876 568999999999999999
Q ss_pred HHh--CCCCCC
Q 040656 247 MIF--RKEPFF 255 (332)
Q Consensus 247 llt--g~~pf~ 255 (332)
|++ +..||.
T Consensus 225 l~~~~~~~p~~ 235 (296)
T cd05051 225 ILTLCREQPYE 235 (296)
T ss_pred HHhcCCCCCCC
Confidence 998 677773
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=263.61 Aligned_cols=194 Identities=19% Similarity=0.363 Sum_probs=154.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC---CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.++|++.+.||+|+||.||+|....+ ...||+|.++.. ....+.+|+.+++++ +|+||+++++.+.+ ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 78 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SR 78 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CC
Confidence 457899999999999999999987544 457999998643 235678899999999 99999999999844 45
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++++|+++++++..++. .++...+.. ++.+++.||+|||+.+|+|+|
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~Lh~~~i~H~d 131 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVG---------------------------MLRGIASGMKYLSEMNYVHRD 131 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCcccCC
Confidence 6899999999998876642 233444433 444555699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCC-cccc--cccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~--~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+||+++.++ .++|+|||++....... .... ..++..|+|||.+.+ ..++.++||||||+++|++++ |..||
T Consensus 132 i~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~ 209 (266)
T cd05033 132 LAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred CCcceEEEcCCC-CEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCC
Confidence 999999999666 79999999998764221 1111 233567999999876 678999999999999999998 99998
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 210 ~ 210 (266)
T cd05033 210 W 210 (266)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=298.73 Aligned_cols=218 Identities=20% Similarity=0.373 Sum_probs=167.8
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCc-----eEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNE-----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
.+++.-++.+.||+|.||+||.|....... .||+|.++. .+..+|.+|..+|..+ +||||++++|++-+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD- 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC-
Confidence 457888999999999999999998654433 499999874 3456899999999999 99999999999966
Q ss_pred CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
....++++|||.+|+|..++..-...... ........-+.++++||+|+.||+++++|||||
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~-----------------~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL 828 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQ-----------------PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL 828 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCC-----------------CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence 46789999999999998876432111000 011122223358889999999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCccccc---ccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg-~~pf~ 255 (332)
..+|+|++... .|||+|||+|+.+....-.... .-...|||||.+.. ..++.++|||||||++||++|. ..||
T Consensus 829 AaRNCLL~~~r-~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY- 905 (1025)
T KOG1095|consen 829 AARNCLLDERR-VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPY- 905 (1025)
T ss_pred hhhheeecccC-cEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCC-
Confidence 99999999775 7999999999854422221111 11245999999987 7899999999999999999994 5555
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
++.++.+++.-...
T Consensus 906 ~~~~n~~v~~~~~~ 919 (1025)
T KOG1095|consen 906 PSRSNFEVLLDVLE 919 (1025)
T ss_pred CCcchHHHHHHHHh
Confidence 78888777665544
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=270.28 Aligned_cols=191 Identities=25% Similarity=0.421 Sum_probs=158.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||+|+||.||++.+..++..+|+|.++.. ....+.+|+++++++ +||||+++++.|.+ ...++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCEEEEE
Confidence 4699999999999999999999899999999998633 234578899999999 99999999999954 4578999
Q ss_pred EeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlkp~N 183 (332)
+||+++++|..++. .+++.....++.++ ++||.|||+ .+++||||||+|
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i---------------------------~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAV---------------------------LRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHhhCCEEECCCChHH
Confidence 99999998877652 34555555555554 459999997 589999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+++.++ .++|+|||++..... .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.
T Consensus 131 il~~~~~-~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 131 ILVNSRG-EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred EEEecCC-cEEEccCCCcccccc-cccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9999665 799999999865532 22344578889999999866 668899999999999999999999984
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=280.38 Aligned_cols=194 Identities=27% Similarity=0.508 Sum_probs=154.9
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
++...|+++++||+||.+.||++.. .+.+.+|+|.+.. ....-+.+|+..|.+|.+|.+||+++++-+. +..
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~ 434 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGY 434 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--Cce
Confidence 4567899999999999999999986 4445566665432 2234589999999999999999999999754 468
Q ss_pred ceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
+|+|||+-+. +|..++. ..+...++.|.+|++. ++.++|.+||||.||
T Consensus 435 lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~---------------------------aV~~IH~~gIVHSDL 486 (677)
T KOG0596|consen 435 LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLL---------------------------AVKTIHQHGIVHSDL 486 (677)
T ss_pred EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHH---------------------------HHHHHHHhceeecCC
Confidence 9999998654 4444442 2333466677777665 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCC----------CCCCcccHHHHHHHHHH
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~sDiwSlG~il~e 246 (332)
||.|+|+- .| ++||+|||+|..+..+... ...+||..||+||.+..+. ..+.+|||||||||||+
T Consensus 487 KPANFLlV-kG-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq 564 (677)
T KOG0596|consen 487 KPANFLLV-KG-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ 564 (677)
T ss_pred CcccEEEE-ee-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence 99999997 55 8999999999987755543 3458999999999986542 15789999999999999
Q ss_pred HHhCCCCCC
Q 040656 247 MIFRKEPFF 255 (332)
Q Consensus 247 lltg~~pf~ 255 (332)
|+.|+.||.
T Consensus 565 MvYgktPf~ 573 (677)
T KOG0596|consen 565 MVYGKTPFG 573 (677)
T ss_pred HHhcCCchH
Confidence 999999994
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=265.90 Aligned_cols=200 Identities=23% Similarity=0.419 Sum_probs=152.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+..|+.++.+..+|+||+++++++.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 4799999999999999999999999999999998643 224556677765554499999999999854 3568999
Q ss_pred EeeecCCCceeec-------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeecCC
Q 040656 108 FEHVNSTDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDV 179 (332)
Q Consensus 108 ~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHrdl 179 (332)
+||+++. +..++ ..+++..+.. ++.|++.||+|||++ +++||||
T Consensus 79 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~---------------------------~~~qi~~~l~~lH~~~~i~h~dl 130 (283)
T cd06617 79 MEVMDTS-LDKFYKKVYDKGLTIPEDILGK---------------------------IAVSIVKALEYLHSKLSVIHRDV 130 (283)
T ss_pred hhhhccc-HHHHHHHhccCCCCCCHHHHHH---------------------------HHHHHHHHHHHHhhcCCeecCCC
Confidence 9999753 22221 1233444434 445555699999997 9999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||+||+++.++ .++|+|||.+.........+...++..|+|||.+.+. ..++.++|+||||+++|+|++|..||..
T Consensus 131 kp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 131 KPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred CHHHEEECCCC-CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 99999999666 7999999998765433333345678889999987542 3468899999999999999999999954
Q ss_pred CCCCHH
Q 040656 257 GHDNQD 262 (332)
Q Consensus 257 ~~~~~~ 262 (332)
.....+
T Consensus 210 ~~~~~~ 215 (283)
T cd06617 210 WKTPFQ 215 (283)
T ss_pred cccCHH
Confidence 333333
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=264.37 Aligned_cols=208 Identities=35% Similarity=0.652 Sum_probs=160.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|++|.||+|++..+++.||+|.++.. ....+.+|+++++++ +|+||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence 489999999999999999999889999999998632 224688999999999 99999999999854 4578999
Q ss_pred EeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||+.+ ++..++ ..++...+.. ++.+++.||+|||+.+++|+||+|+
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~---------------------------~~~~i~~~l~~lh~~~i~H~~l~p~ 129 (284)
T cd07860 78 FEFLHQ-DLKKFMDASPLSGIPLPLIKS---------------------------YLFQLLQGLAFCHSHRVLHRDLKPQ 129 (284)
T ss_pred eecccc-CHHHHHHhCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeecCCCCHH
Confidence 999964 443332 1233333333 4455566999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||+++.++ .++|+|||++....... ......++..|+|||.+.+...++.++||||||+++|+|+||..||. +.+..
T Consensus 130 nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~ 207 (284)
T cd07860 130 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEI 207 (284)
T ss_pred HEEECCCC-CEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHH
Confidence 99999666 79999999987554322 22334567789999988765557889999999999999999999984 44444
Q ss_pred HHHHHHHHHhCC
Q 040656 262 DQLVKIARVLGT 273 (332)
Q Consensus 262 ~~~~~~~~~~~~ 273 (332)
+....+.+..+.
T Consensus 208 ~~~~~~~~~~~~ 219 (284)
T cd07860 208 DQLFRIFRTLGT 219 (284)
T ss_pred HHHHHHHHHhCC
Confidence 455555554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=263.12 Aligned_cols=228 Identities=20% Similarity=0.355 Sum_probs=167.0
Q ss_pred eecccCCceEEEEEE--ccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 39 KVGRGKYSEVFEGIN--VTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
.||+|+||.||+|.+ ..++..+|+|+++.. ..+.+.+|+.+++.+ +|+||+++++++.+ ...++++||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence 589999999999864 456789999998633 235688999999999 99999999998743 3578999999
Q ss_pred cCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++..++. .++...... ++.|++.||++||++|++||||||+||+++.
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~---------------------------i~~qi~~al~~lH~~~i~H~dlkp~nill~~ 130 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITE---------------------------LVHQVSMGMKYLEETNFVHRDLAARNVLLVT 130 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCEeecccchhhEEEcC
Confidence 9988866542 234444444 4445555999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNQDQ 263 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~~~~ 263 (332)
++ .++|+|||++......... ....++..|+|||.+.. ..++.++|+||||+++|||++ |..||. +....+.
T Consensus 131 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~ 207 (257)
T cd05116 131 QH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEV 207 (257)
T ss_pred CC-eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHH
Confidence 65 7999999998765433221 11233467999998865 578899999999999999998 898984 3333333
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
...+...... ......++.+.+++ ..||+.||++||+
T Consensus 208 ~~~i~~~~~~--------~~~~~~~~~l~~li------------------------~~~~~~~p~~Rp~ 244 (257)
T cd05116 208 TQMIESGERM--------ECPQRCPPEMYDLM------------------------KLCWTYGVDERPG 244 (257)
T ss_pred HHHHHCCCCC--------CCCCCCCHHHHHHH------------------------HHHhccCchhCcC
Confidence 3333221100 01123445555554 5599999999996
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=274.31 Aligned_cols=223 Identities=18% Similarity=0.304 Sum_probs=158.3
Q ss_pred CCCCceEEEeecccCCceEEEEEE-----ccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGIN-----VTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+|+.++.++.+|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 467899999999999999999974 346789999998642 2345788999999997899999999988543
Q ss_pred CCCceeEEeeecCCCceeeccccch-------------------hhHHHHHHHHHhhcC---------------------
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTA-------------------NEIRYYIYELLKHAM--------------------- 140 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~--------------------- 140 (332)
....+++|||+++++|..++..... ......+........
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 3467899999999998766421100 000000000000000
Q ss_pred ---CcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccc
Q 040656 141 ---PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRV 214 (332)
Q Consensus 141 ---~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~ 214 (332)
..+........+.....++.|++.||+|||++||+||||||+||+++.++ .++|+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCC
Confidence 00000000112333456788999999999999999999999999999666 7999999998765322211 1123
Q ss_pred cccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 215 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 215 ~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.
T Consensus 243 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 283 (343)
T cd05103 243 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 283 (343)
T ss_pred CCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4566999999876 678999999999999999997 888883
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=291.23 Aligned_cols=206 Identities=23% Similarity=0.367 Sum_probs=163.9
Q ss_pred ccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeee-
Q 040656 22 ESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVR- 97 (332)
Q Consensus 22 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~- 97 (332)
.+..++.+ .-+++|.+.|.+|||+.||+|.....+..||+|.+-.. ....+.+|+.+|++|..|+|||.+++...
T Consensus 28 ~G~~~~Vg-~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 28 VGQTFTVG-SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CceEEEEC-CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 33444444 67899999999999999999999888899999987432 34568999999999988999999999321
Q ss_pred ---ccC-CCCceeEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHH
Q 040656 98 ---DQH-SKTPSLIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDY 168 (332)
Q Consensus 98 ---~~~-~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 168 (332)
+.. .....++||||.++.|.+++ ..+++.++..|+.++.. |+++
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~---------------------------AVa~ 159 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCE---------------------------AVAA 159 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHH---------------------------HHHH
Confidence 122 35678999999988877765 34778888777777766 9999
Q ss_pred HHHcC--CeecCCCCCCeeecCCCCeEEEEecccceeecCCC-c---------ccccccccceeccccc--cCCCCCCCc
Q 040656 169 CHSQG--IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-E---------YNVRVASRYFKGPELL--VDLQDYDYS 234 (332)
Q Consensus 169 LH~~~--ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~---------~~~~~~t~~y~aPE~~--~~~~~~~~~ 234 (332)
||..+ |||||||-+|||++.++ ..||||||.++-..... . .-...-|+.|+|||++ -.+.+.+.|
T Consensus 160 mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK 238 (738)
T KOG1989|consen 160 MHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK 238 (738)
T ss_pred HhcCCCccchhhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch
Confidence 99998 99999999999999777 79999999986432221 1 1123567889999987 233678999
Q ss_pred ccHHHHHHHHHHHHhCCCCCCC
Q 040656 235 LDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 235 sDiwSlG~il~elltg~~pf~~ 256 (332)
+|||+|||+||-|+....||..
T Consensus 239 sDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 239 SDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred hHHHHHHHHHHHHHHhCCCcCc
Confidence 9999999999999999999953
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=261.20 Aligned_cols=193 Identities=19% Similarity=0.342 Sum_probs=152.2
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
...++|++.+.||+|++|.||+|.... +..+|+|.+... ....+.+|+.+++++ .|+|++++++++.. ...++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYI 77 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEE
Confidence 456789999999999999999998744 456999987643 335788999999999 99999999998732 45789
Q ss_pred EEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+|||+.++++..++.. ++...... ++.+++.||+|||+.|++|+||||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~al~~lH~~~i~H~dl~~ 130 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVD---------------------------MAAQIADGMAYIERMNYIHRDLRA 130 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEeecccCc
Confidence 9999999887665422 22333333 444555699999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+||+++.++ .++|+|||.+......... ....++..|+|||...+ ..++.++||||||+++|+|++ |..||.
T Consensus 131 ~Nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 131 ANILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred ceEEEcCCC-eEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999665 7999999999766433211 12235567999998876 668999999999999999999 888883
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=262.52 Aligned_cols=195 Identities=25% Similarity=0.434 Sum_probs=158.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+++|++.+.||+|+||.||.|.+..++..||+|.+... ....+.+|+.+++++ +|+||+++++.+.+....
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMER 79 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCc
Confidence 36799999999999999999999999999999987521 124678899999999 999999999988665556
Q ss_pred CceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++++||++++++...+. .++...... ++.+++.||++||+.+++|+||
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lH~~~i~H~dl 132 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSYGALTENVTRK---------------------------YTRQILEGVSYLHSNMIVHRDI 132 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEecCCC
Confidence 6889999999988776542 233333333 3445556999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+||+++.++ .++|+|||.+...... .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.
T Consensus 133 ~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 133 KGANILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred CHHHEEecCCC-CEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 99999999666 7999999998754321 12233467888999999876 678999999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=264.61 Aligned_cols=236 Identities=19% Similarity=0.362 Sum_probs=177.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|++.+.||+|+||.||+|.+.. ++.+++|+++... ...+..|+.+++.+ +|+||+++++++.+ ....+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSV--GEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEec--CCCeEEE
Confidence 4679999999999999999999866 8999999987433 45788999999999 99999999999854 4578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||++++++..++.. ++...... ++.+++.||.|||++|++|+||+|+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~~i~~al~~lH~~~i~h~dl~~~ 133 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLID---------------------------MACQVAEGMAYLEEQNSIHRDLAAR 133 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeeccccCcc
Confidence 999999988776532 33333333 4445555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~ 260 (332)
||+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+.
T Consensus 134 nilv~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~-~~~~ 210 (261)
T cd05148 134 NILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYP-GMNN 210 (261)
T ss_pred eEEEcCCc-eEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-cCCH
Confidence 99999665 799999999876542221 122344567999999876 678999999999999999998 888883 3333
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+...... ......++.+.++ +..||+.||++||+
T Consensus 211 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~------------------------i~~~l~~~p~~Rpt 250 (261)
T cd05148 211 HEVYDQITAGYRM--------PCPAKCPQEIYKI------------------------MLECWAAEPEDRPS 250 (261)
T ss_pred HHHHHHHHhCCcC--------CCCCCCCHHHHHH------------------------HHHHcCCCchhCcC
Confidence 3344433321111 0112334444444 45599999999996
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=266.12 Aligned_cols=197 Identities=25% Similarity=0.436 Sum_probs=159.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----CCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----SKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~ 104 (332)
.+.|++.+.||+|+||.||+|....+++.+|+|+++.. ....+.+|+.+++++.+|+||+++++.+.... ....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 46799999999999999999999999999999998643 34578899999999877999999999986532 2357
Q ss_pred eeEEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 105 SLIFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
++++||++++++..++.. +++.... .++.|++.||+|||+++|+|+||
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~---------------------------~~~~qi~~~l~~LH~~~ivh~dl 137 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIA---------------------------YICREILRGLSHLHQHKVIHRDI 137 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCCccCCC
Confidence 899999999888776432 2333333 34455666999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+||+++.++ .++|+|||++...... .......++..|+|||++.+. ..++.++|||||||++|+|++|..||
T Consensus 138 ~~~nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~ 216 (272)
T cd06637 138 KGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216 (272)
T ss_pred CHHHEEECCCC-CEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999766 6999999998765422 223345688889999998532 35788999999999999999999999
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 217 ~ 217 (272)
T cd06637 217 C 217 (272)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.30 Aligned_cols=192 Identities=28% Similarity=0.439 Sum_probs=155.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|++|.||.+.+..+++.+|+|.+... ..+.+.+|+++++++ +|+|++++++.+... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence 589999999999999999999889999999998632 234678899999999 999999999887432 3457899
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|+++++++...+. .++...... ++.+++.|+++||+.|++|+||||+
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~---------------------------~~~~l~~~l~~lH~~~i~H~di~p~ 131 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVE---------------------------WFVQIAMALQYLHEKHILHRDLKTQ 131 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeeccCCCch
Confidence 99999988765542 233443433 4445556999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++ .++|+|||++....... ......++..|+|||++.+ ..++.++|+||||++++++++|..||.
T Consensus 132 nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 132 NVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred hEEEecCC-cEEEecccceEEecccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 99999666 79999999988664322 2234467888999999877 678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=264.40 Aligned_cols=209 Identities=36% Similarity=0.614 Sum_probs=165.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++.+.||+|+||.||+|.+..+++.|++|.++.. ..+.+.+|+++++++ +|+||+++++.+.+ ....++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence 4799999999999999999999889999999998632 246788999999999 89999999999955 457899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
++||++++.+..+. ..++......++. +++.||.|||+.+++|+||+|+|
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~---------------------------~i~~~l~~LH~~~i~H~dl~~~n 130 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIW---------------------------QLLQAIAYCHSHNIIHRDIKPEN 130 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeecCCCCHHH
Confidence 99999987765543 2244444444444 44559999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
|+++.++ .++|+|||.+....... ......++..|+|||++.+...++.++|+||||+++|+|++|..||. +....
T Consensus 131 i~~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~ 208 (288)
T cd07833 131 ILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP-GDSDI 208 (288)
T ss_pred eEECCCC-CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC-CCCHH
Confidence 9999665 79999999987765433 33445678889999999874478999999999999999999998884 34444
Q ss_pred HHHHHHHHHhC
Q 040656 262 DQLVKIARVLG 272 (332)
Q Consensus 262 ~~~~~~~~~~~ 272 (332)
+.+..+....+
T Consensus 209 ~~~~~~~~~~~ 219 (288)
T cd07833 209 DQLYLIQKCLG 219 (288)
T ss_pred HHHHHHHHHhC
Confidence 44444444333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=264.10 Aligned_cols=194 Identities=20% Similarity=0.394 Sum_probs=154.8
Q ss_pred CCCceEEEeecccCCceEEEEE----EccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..+|++.+.||+|+||.||+|. ...+++.||+|.++... .+.+.+|+++++++ +|+||+++++++...+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence 4689999999999999999987 34578899999986433 34688999999999 9999999999876555567
Q ss_pred ceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
+++++||++++++..++. .++...... ++.|++.||+|||++|++||||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~---------------------------~~~~l~~aL~~LH~~~i~H~dl 134 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLL---------------------------YASQICKGMEYLGSKRYVHRDL 134 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCceeccC
Confidence 899999999998877652 133343333 4445556999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+||+++.++ .++|+|||++......... ....++..|+|||.+.+ ..++.++||||||++++||++|..|+
T Consensus 135 kp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~ 211 (284)
T cd05081 135 ATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKS 211 (284)
T ss_pred CHhhEEECCCC-eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcC
Confidence 99999999666 7999999999865433221 11123445999999876 67899999999999999999988776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=264.96 Aligned_cols=198 Identities=27% Similarity=0.474 Sum_probs=158.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeec---cCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRD---QHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~---~~~~~~ 104 (332)
..++|++.+.||+|+||.||+|.+..+++.+|+|+++... ...+.+|+.+++.+.+|+||+++++++.. +++..+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 3578999999999999999999999999999999986432 35678899999999679999999998743 334578
Q ss_pred eeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 105 SLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
+++|||+++++|..++. .+++..+. .++.|+++||.|||+.+++||
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------------------------~~~~~i~~~l~~lH~~~i~H~ 148 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIA---------------------------YILHEALMGLQHLHVNKTIHR 148 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHH---------------------------HHHHHHHHHHHHHHhCCcccc
Confidence 99999999998866432 12222232 344556669999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~ 252 (332)
||||+||+++.++ .++|+|||++....... ......++..|+|||++... ..++.++|||||||++|+|++|..
T Consensus 149 dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 149 DVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred CCCHHhEEECCCC-CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 9999999999766 69999999987654322 22344688889999987532 347889999999999999999999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 228 p~~ 230 (286)
T cd06638 228 PLA 230 (286)
T ss_pred CCC
Confidence 984
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=266.72 Aligned_cols=212 Identities=17% Similarity=0.294 Sum_probs=155.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
+.++|.+.++||+|+||.||++... .++..+++|.++.. ....+.+|+++++.+ +|+||+++++++.+ .
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTE--G 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEec--C
Confidence 4578999999999999999998642 34668999988643 235789999999999 99999999999854 3
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...++++||++++++..++........ .... . ...........+...++.|++.|++|||+.|++||||||
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~--~~~~----~---~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp 150 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAK--ILAG----G---EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLAT 150 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchh--hhcc----c---ccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccH
Confidence 568999999999988766532111000 0000 0 000000012223345666777899999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 151 ~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 151 RNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred hhEEEcCCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 999999655 799999999876543221 112234567999999877 678999999999999999998 888884
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=266.95 Aligned_cols=193 Identities=22% Similarity=0.429 Sum_probs=156.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++++.||+|+||.||+|.+..+++.+|+|.++.. ....+.+|+.+++++ +|+||+++++.+.. ...++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence 4799999999999999999999889999999988632 134688899999999 99999999998854 4678999
Q ss_pred EeeecCCCceeecc------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCC
Q 040656 108 FEHVNSTDFKVLYP------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVK 180 (332)
Q Consensus 108 ~e~~~~~~l~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlk 180 (332)
+||++++++..++. .+++..+..++.+++ .||.|||+ .+++|+|||
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~---------------------------~~l~~LH~~~~i~H~dl~ 130 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVV---------------------------KGLKFLKEEHNIIHRDVK 130 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHH---------------------------HHHHHHHhcCCEeeCCCC
Confidence 99999998766542 345555555555554 49999997 599999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCC-----CCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||.+...... ......++..|+|||.+.+.. .++.++|+|||||++|+|++|..||.
T Consensus 131 p~nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 131 PTNVLVNGNG-QVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred HHHEEECCCC-CEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 9999999755 7999999998765322 223345777899999985422 35789999999999999999999994
Q ss_pred C
Q 040656 256 Y 256 (332)
Q Consensus 256 ~ 256 (332)
.
T Consensus 209 ~ 209 (286)
T cd06622 209 P 209 (286)
T ss_pred C
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=255.48 Aligned_cols=201 Identities=21% Similarity=0.309 Sum_probs=162.4
Q ss_pred ccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeecc---
Q 040656 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--- 99 (332)
Q Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 99 (332)
..+.+.+||++.++||+|||+-||++....++..+|+|.+.. ...+...+|++..+++ +|||+++++++...+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKD 93 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhcc
Confidence 456688999999999999999999999999999999999864 3456789999999999 999999999886432
Q ss_pred CCCCceeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
.+...|++++|...|++.+... .+++.....++. ++.+||++||+.
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~---------------------------gic~gL~~lH~~ 146 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFL---------------------------GICRGLEALHEK 146 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHH---------------------------HHHHHHHHHhcc
Confidence 2345899999999998776542 345555444444 445599999999
Q ss_pred C--CeecCCCCCCeeecCCCCeEEEEecccceeecCC----------CcccccccccceeccccccCC--CCCCCcccHH
Q 040656 173 G--IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG----------KEYNVRVASRYFKGPELLVDL--QDYDYSLDMW 238 (332)
Q Consensus 173 ~--ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~----------~~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiw 238 (332)
. +.||||||.|||++.++ .++|.|||.++..... +.......|..|+|||.+... ...+.++|||
T Consensus 147 ~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIW 225 (302)
T KOG2345|consen 147 EPPYAHRDIKPANILLSDSG-LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIW 225 (302)
T ss_pred CCcccccCCCcceeEecCCC-ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchh
Confidence 8 99999999999999656 7999999998654311 122344678889999998542 3467999999
Q ss_pred HHHHHHHHHHhCCCCCC
Q 040656 239 SLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 239 SlG~il~elltg~~pf~ 255 (332)
||||++|+|+.|..||.
T Consensus 226 SLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 226 SLGCTLYAMMFGESPFE 242 (302)
T ss_pred hhhHHHHHHHHcCCcch
Confidence 99999999999999994
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=258.88 Aligned_cols=191 Identities=23% Similarity=0.410 Sum_probs=157.6
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++++.||.|+||.||.+....+++.+++|.+... ....+.+|+.+++++ +|+||+++++++.+ ...++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeEEEE
Confidence 599999999999999999999999999999987532 235688999999999 99999999999965 3578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||++++++...+.. ++...... ++.+++.||.|||+.|++|+||+|+
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lh~~~i~h~dl~p~ 130 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLW---------------------------YLFQIVSAVSYIHKAGILHRDIKTL 130 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCccccCCChH
Confidence 999999887765422 33333333 4445556999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++ .++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.
T Consensus 131 ni~~~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08221 131 NIFLTKAG-LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFD 202 (256)
T ss_pred hEEEeCCC-CEEECcCcceEEcccccccccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence 99999666 79999999988764333 2334567889999999876 557899999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=264.90 Aligned_cols=206 Identities=17% Similarity=0.328 Sum_probs=156.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC-----CceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|..... +..||+|.+.... ...+.+|+.+++.+ +|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-- 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVST-- 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC--
Confidence 467899999999999999999987543 3789999986432 34678899999999 99999999999854
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....++++||+++++|..++......... ........+.....++.|++.||.|||+.+++|||||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~ 146 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAEN--------------NPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLA 146 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhh--------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccC
Confidence 46789999999988877665321110000 0000001122233466677789999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|+||+++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|++++ |..||
T Consensus 147 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~ 222 (277)
T cd05032 147 ARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY 222 (277)
T ss_pred hheEEEcCCC-CEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCC
Confidence 9999999766 799999999875543221 123345678999999876 568999999999999999998 88887
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=266.77 Aligned_cols=213 Identities=16% Similarity=0.258 Sum_probs=154.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC-----CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN-----NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||++..... ...+|+|.++.. ....+.+|+.+++++.+|+||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 457899999999999999999987543 378999998642 224578899999999779999999999843
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
...++++|||++++++..++..........-... ...............++.|++.||+|||+.+|+|||||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD--------PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCcccccccc--------ccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 4578999999999987766532110000000000 00000001122233466677779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|+||+++.++ .++|+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|++++ |..||
T Consensus 160 p~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~ 235 (293)
T cd05053 160 ARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY 235 (293)
T ss_pred eeeEEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCC
Confidence 9999999665 799999999986543221 111234456999999866 678999999999999999997 88888
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=266.12 Aligned_cols=193 Identities=26% Similarity=0.530 Sum_probs=157.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|.+.+.||+|+||.||+|....+++.+++|.+... ....+.+|+.+++.+ +|+||+++++.+.+ ....+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEe--CCeEE
Confidence 5789999999999999999998889999999987531 235678899999999 99999999999854 35789
Q ss_pred eEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 106 LIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
+++|+++++++..++.. +++..... ++.+++.||+|||++|++|+|
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~LH~~~i~H~d 131 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWK---------------------------YFVQLCSALEHMHSRRVMHRD 131 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeecCC
Confidence 99999999887665421 23333333 444556699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||+||+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 132 l~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 132 IKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCHHHEEEcCCC-CEEECcchhhhccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999666 799999999876543222 233467888999999876 6788999999999999999999999953
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=263.84 Aligned_cols=191 Identities=19% Similarity=0.365 Sum_probs=147.7
Q ss_pred ceEEEeecccCCceEEEEEEccCCc--eEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc----CCC
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNE--KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----HSK 102 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----~~~ 102 (332)
|.+.+.||+|+||.||+|....++. .+|+|.++.. ....+.+|+.+++.+ +|+||+++++.+... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCC
Confidence 4577899999999999998866665 6999987632 235688899999999 999999999976432 123
Q ss_pred CceeEEeeecCCCceeecc---------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 103 TPSLIFEHVNSTDFKVLYP---------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
..++++||+.++++..++. .++..... .++.|++.||+|||+++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~i~~~l~~lH~~~ 132 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV---------------------------KFMTDIASGMEYLSSKS 132 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHH---------------------------HHHHHHHHHHHHHHHCC
Confidence 5789999999988765431 12233233 34556666999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF- 249 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt- 249 (332)
|+||||||+||+++.++ .++|+|||+++....... .....++..|+|||...+ ..++.++||||||+++|+|++
T Consensus 133 i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 133 FIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred eeccccchhheEEcCCC-CEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999998666 799999999886643321 112245567999999876 678999999999999999999
Q ss_pred CCCCC
Q 040656 250 RKEPF 254 (332)
Q Consensus 250 g~~pf 254 (332)
|..||
T Consensus 211 g~~p~ 215 (272)
T cd05075 211 GQTPY 215 (272)
T ss_pred CCCCC
Confidence 77887
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=289.30 Aligned_cols=207 Identities=27% Similarity=0.490 Sum_probs=172.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.+-|+|+..||.|.||.||+|..+.++-..|.|++... ...++.-|++||..+ +||+|+++++.|+-+ +.++++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~e--nkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFE--NKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhcc--CceEEE
Confidence 35678899999999999999999989999999998754 346788999999999 899999999987544 579999
Q ss_pred EeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
.|+|.||-...+. ..+++.....+-++++ .||.|||+++|||||||..|
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~l---------------------------dALn~LHs~~iIHRDLKAGN 160 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVL---------------------------DALNWLHSQNIIHRDLKAGN 160 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHH---------------------------HHHHHHhhcchhhhhccccc
Confidence 9999999876653 3455655555555554 49999999999999999999
Q ss_pred eeecCCCCeEEEEecccceee-cCCCcccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||++.+| .|+|+|||.+... ...+...++.||++|||||++.+. .+|+.++|||||||+|+||..+.+|- +..
T Consensus 161 iL~TldG-dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-hel 238 (1187)
T KOG0579|consen 161 ILLTLDG-DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HEL 238 (1187)
T ss_pred eEEEecC-cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-ccc
Confidence 9999888 5999999986443 333456778999999999998664 57999999999999999999999775 677
Q ss_pred CCHHHHHHHHH
Q 040656 259 DNQDQLVKIAR 269 (332)
Q Consensus 259 ~~~~~~~~~~~ 269 (332)
++..++.++.+
T Consensus 239 npMRVllKiaK 249 (1187)
T KOG0579|consen 239 NPMRVLLKIAK 249 (1187)
T ss_pred chHHHHHHHhh
Confidence 77777777765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=262.18 Aligned_cols=193 Identities=19% Similarity=0.344 Sum_probs=152.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+..+|++.+.||+|+||.||+|.+. ++..+|+|++... ....+.+|+++++++ +|+||+++++++.+ ....+++
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--CCceEEE
Confidence 3467999999999999999999874 5678999998643 345788999999999 99999999999843 4578999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|+++++++..++. .++...... ++.|++.||++||+.|++||||||+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLD---------------------------MCSDVCEAMEYLESNGFIHRDLAARN 130 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCcccccccHhh
Confidence 99999988766542 233333333 44455569999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCccc--ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||.++......... ...++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.
T Consensus 131 i~i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 203 (256)
T cd05059 131 CLVGEDN-VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE 203 (256)
T ss_pred EEECCCC-cEEECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence 9999666 79999999987654222111 1123346999999877 678999999999999999999 788884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=268.02 Aligned_cols=208 Identities=19% Similarity=0.339 Sum_probs=152.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccC--------------CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTN--------------NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKL 92 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~ 92 (332)
..+|++.+.||+|+||.||+|....+ ...||+|.++.. ....+.+|+++++++ +|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 46899999999999999999876432 235899998643 234688999999999 99999999
Q ss_pred eeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
++++.. ....+++|||+.++++..++............. ......+.+...++.+++.||.|||+.
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------------~~~~~~~~~~~~i~~~i~~al~~lH~~ 148 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHAN------------NIPSVSIANLLYMAVQIASGMKYLASL 148 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccc------------cCCcccHHHHHHHHHHHHHHHHHHHhc
Confidence 999854 457899999999998876542110000000000 000011222234667778899999999
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt 249 (332)
|++||||||+||+++.++ .++|+|||++......... ....++..|+|||.+.+ ..++.++|+||||+++++|++
T Consensus 149 ~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~ 226 (295)
T cd05097 149 NFVHRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFT 226 (295)
T ss_pred CeeccccChhhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHH
Confidence 999999999999999665 7999999998765432211 12234667999999876 568999999999999999988
Q ss_pred --CCCCCC
Q 040656 250 --RKEPFF 255 (332)
Q Consensus 250 --g~~pf~ 255 (332)
+..||.
T Consensus 227 ~~~~~p~~ 234 (295)
T cd05097 227 LCKEQPYS 234 (295)
T ss_pred cCCCCCCc
Confidence 666773
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=281.26 Aligned_cols=237 Identities=22% Similarity=0.423 Sum_probs=188.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC----CceEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN----NEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++...+.++||.|.||.||.|+.... .-.||||..++ ...+.|..|..+|+++ +||||++++|+|.+
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e--- 462 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE--- 462 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---
Confidence 356677888999999999999987543 23589999874 3467899999999999 99999999999975
Q ss_pred CCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...|+|||.++-|.|..+++ .++...+..|..|+.. ||+|||++++|||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~t---------------------------alaYLeSkrfVHR 515 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICT---------------------------ALAYLESKRFVHR 515 (974)
T ss_pred cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHH---------------------------HHHHHHhhchhhh
Confidence 35899999999999888764 3555555555555554 9999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccc--cceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVAS--RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t--~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
||..+||||.... .|||+|||+++.+....-.....+. .-|||||.+.- ..++.+||||-||+++||++. |..||
T Consensus 516 DIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf 593 (974)
T KOG4257|consen 516 DIAARNILVSSPQ-CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF 593 (974)
T ss_pred hhhhhheeecCcc-eeeecccchhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc
Confidence 9999999998665 7999999999988755443333333 34999999865 789999999999999999875 88898
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+.+++..+..+-+.+. ++.++|.+-.+. .+||.+||.+||.
T Consensus 594 -qgvkNsDVI~~iEnGeRlP~--------P~nCPp~LYslm------------------------skcWayeP~kRPr 638 (974)
T KOG4257|consen 594 -QGVKNSDVIGHIENGERLPC--------PPNCPPALYSLM------------------------SKCWAYEPSKRPR 638 (974)
T ss_pred -ccccccceEEEecCCCCCCC--------CCCCChHHHHHH------------------------HHHhccCcccCCc
Confidence 57777787777666443333 256677666555 4599999999994
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=266.38 Aligned_cols=212 Identities=21% Similarity=0.344 Sum_probs=155.8
Q ss_pred CCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..+|.+.+.||+|+||.||+|... .++..+++|.++... .+.+.+|+++++++ +|+||+++++++.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CC
Confidence 457999999999999999999753 345669999986433 35688999999999 99999999999854 45
Q ss_pred CceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
..+++|||++++++..++......... +.. ...........+...+.++.+++.||+|||++|++||||||+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~-----~~~---~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMI-----LVD---GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCccccc-----ccc---cccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 789999999999887665221100000 000 000000000122233456667777999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|+| |..||.
T Consensus 153 Nil~~~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 153 NCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred eEEEccCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999666 799999999875532221 122345677999999877 678999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=266.12 Aligned_cols=194 Identities=26% Similarity=0.482 Sum_probs=159.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++.+.+ ....+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe--CCEEEEE
Confidence 468999999999999999999998999999999987432 24578899999999 99999999999854 4578999
Q ss_pred EeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
+||++++++..++ +.+++..+..++.+++ .||.|||+.|++|+||||+||
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~---------------------------~~l~~lH~~~i~H~dlkp~ni 137 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETL---------------------------QGLYYLHSKGKMHRDIKGANI 137 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeecCCCCHHHE
Confidence 9999999887764 2355555555555554 499999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-cccccccccceecccccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+++.++ .++|+|||.+....... ......++..|+|||++. ....++.++|+|||||++|+|++|..||.
T Consensus 138 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 138 LLTDNG-HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred EECCCC-CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 999666 69999999987654222 223446888999999874 22457889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=262.93 Aligned_cols=194 Identities=20% Similarity=0.371 Sum_probs=153.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc---eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.++|++.+.||+|+||.||+|....++. .+|+|.++.. ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 78 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SK 78 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence 35789999999999999999998764443 7999998642 235688999999999 99999999999854 45
Q ss_pred CceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++|||++++++..++.. ++..... .++.+++.||++||+.+++|||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~---------------------------~i~~~i~~~l~~lH~~~i~h~d 131 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLV---------------------------GMLRGIASGMKYLSDMGYVHRD 131 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCEeehh
Confidence 78999999999987766422 2333333 3445556699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
|||+||+++.++ .++|+|||++......... ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..|
T Consensus 132 lkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p 209 (267)
T cd05066 132 LAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERP 209 (267)
T ss_pred hchhcEEECCCC-eEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCC
Confidence 999999998666 7999999998765432221 11123457999999876 578999999999999999886 9999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 210 ~~ 211 (267)
T cd05066 210 YW 211 (267)
T ss_pred cc
Confidence 84
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=261.78 Aligned_cols=191 Identities=26% Similarity=0.494 Sum_probs=154.6
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc------------hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+|.+...||+|++|.||+|.+..+++.+|+|.+.... .+.+.+|+.+++++ +|+||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLD-- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Confidence 4788899999999999999988889999999885321 14578899999999 99999999999854
Q ss_pred CCCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
....++++||++++++..++. .++......+ +.+++.||++||+.|++||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~---------------------------~~~l~~~l~~lH~~~ivH~ 130 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF---------------------------VRQILKGLNYLHNRGIIHR 130 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHH---------------------------HHHHHHHHHHHHhcCcccc
Confidence 457899999999988766652 2344444444 4455559999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCC-------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
||+|+||+++.++ .++|+|||.++...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus 131 di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 131 DIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred cCCHHHEEEcCCC-CEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhC
Confidence 9999999998665 79999999987654221 1122357788999999876 5688999999999999999999
Q ss_pred CCCCC
Q 040656 251 KEPFF 255 (332)
Q Consensus 251 ~~pf~ 255 (332)
..||.
T Consensus 209 ~~p~~ 213 (267)
T cd06628 209 KHPFP 213 (267)
T ss_pred CCCCC
Confidence 99994
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=263.81 Aligned_cols=197 Identities=28% Similarity=0.505 Sum_probs=158.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccC---CCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---SKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---~~~~~ 105 (332)
.++|.+.+.||+|+||.||+|....+++.+|+|++... ....+.+|+.+++++.+|+|++++++++...+ ....+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 57799999999999999999999899999999998643 24567889999999878999999999986432 24689
Q ss_pred eEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 106 LIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
+++||++++++..+.. .+++..+.. ++.|++.||++||+.+++|+|
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~---------------------------~~~qi~~al~~lH~~~ivH~d 153 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISY---------------------------ILYGALLGLQHLHNNRIIHRD 153 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeeccC
Confidence 9999999998866542 233333333 444555699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCC----CCCCcccHHHHHHHHHHHHhCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~sDiwSlG~il~elltg~~p 253 (332)
|||+||+++.++ .++|+|||++....... ......++..|+|||.+.... .++.++|||||||++|+|++|..|
T Consensus 154 lkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p 232 (291)
T cd06639 154 VKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232 (291)
T ss_pred CCHHHEEEcCCC-CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCC
Confidence 999999998666 69999999987654322 223346788899999876532 367899999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 233 ~~ 234 (291)
T cd06639 233 LF 234 (291)
T ss_pred CC
Confidence 84
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=263.72 Aligned_cols=192 Identities=25% Similarity=0.468 Sum_probs=160.2
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||.|++|.||+|.+..+++.+|+|++.... ...+.+|+.+++.+ +|+||+++++.+.+. ..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEEC--CeEEEE
Confidence 47899999999999999999998899999999986432 34678999999999 899999999998544 678999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+|+++++++..+.. .++...+..++.++ +.||.+||+.+++|+||+|+||+
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql---------------------------~~~l~~lh~~~i~h~dl~p~ni~ 130 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREV---------------------------LLGLEYLHEEGKIHRDIKAANIL 130 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCcccCCCCHHHEE
Confidence 99999988876653 34555555444444 45999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||.++..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 131 i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 131 LSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred ECCCC-CEEEcccccceeecccccccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99766 7999999999877543 22344567888999999877 558999999999999999999999994
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=259.89 Aligned_cols=193 Identities=27% Similarity=0.538 Sum_probs=158.5
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecc------cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||+|....+++.||+|.++. ...+.+.+|+++++++ +|+|++++++.+.+. ...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIEN--NELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecC--CeEE
Confidence 579999999999999999999988999999998852 1245788999999999 999999999998553 5789
Q ss_pred eEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 106 LIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
++|||++++++..++.. ++...+.. ++.++++||.+||+.|++|+|
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lh~~~i~h~d 131 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWK---------------------------YFVQLCSALEHMHSKRIMHRD 131 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHH---------------------------HHHHHHHHHHHHHhCCEecCC
Confidence 99999999888765422 23333333 445556699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+|+||+++.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 132 l~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 132 IKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred cChhhEEECCCC-cEEEeccceeeeccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 999999999666 79999999987654322 2233467888999999876 6789999999999999999999999953
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=261.25 Aligned_cols=193 Identities=30% Similarity=0.514 Sum_probs=159.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|+||.||+|.+..+++.+|+|+++.. ..+.+..|+.+++++ +|+||+++++.+........+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998632 235678899999999 99999999998876666678999
Q ss_pred EeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH-----HcCCe
Q 040656 108 FEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH-----SQGIM 175 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-----~~~iv 175 (332)
+||++++++..++.. ++...... ++.+++.||.+|| +.+++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~---------------------------~~~~i~~~l~~lH~~~~~~~~i~ 132 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWR---------------------------ILTQLLLALYECHNRSDPGNTVL 132 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHH---------------------------HHHHHHHHHHHHhcCccccCcce
Confidence 999999887766422 33333333 4455566999999 88999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
|+||+|+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||
T Consensus 133 h~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~ 210 (265)
T cd08217 133 HRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPF 210 (265)
T ss_pred ecCCCHHHEEEecCC-CEEEecccccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcc
Confidence 999999999999665 799999999887654433 344568888999999877 56889999999999999999999999
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 211 ~ 211 (265)
T cd08217 211 T 211 (265)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=274.47 Aligned_cols=268 Identities=28% Similarity=0.489 Sum_probs=187.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. .....+.+|+.+++++.+|+||++++++|...+...++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4789999999999999999999988899999998743 22345778999999998899999999998666566789
Q ss_pred eEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 106 LIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+++|++++ ++..... .+...... .++.|++.||+|||+.||+||||||+|
T Consensus 86 lv~e~~~~-~L~~~~~~~~~~~~~~~---------------------------~i~~qi~~~L~~LH~~~i~H~dl~p~n 137 (337)
T cd07852 86 LVFEYMET-DLHAVIRANILEDVHKR---------------------------YIMYQLLKALKYIHSGNVIHRDLKPSN 137 (337)
T ss_pred EEeccccc-CHHHHHhcCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 99999975 4433321 22332222 345566669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+
T Consensus 138 ill~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~ 215 (337)
T cd07852 138 ILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PG 215 (337)
T ss_pred EEEcCCC-cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CC
Confidence 9999766 79999999987654322 2233467888999998876566889999999999999999999998 45
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+.+....+....+.....+ +..+. .+.....+... ..................+++..||+.||++||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps 288 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPSAED-IESIK---SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT 288 (337)
T ss_pred CChHHHHHHHHHHhCCCCHHH-HHHHH---hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC
Confidence 555556666655544322111 11110 01111111111 0000000000012233357788899999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.97 Aligned_cols=205 Identities=20% Similarity=0.394 Sum_probs=161.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.. .+++.+|+|.+.. ...+.+.+|+.+++++ +|+||+++++++.+ ....+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEE-cCCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeec--CCceEEE
Confidence 568999999999999999999986 4567899999874 3456789999999999 89999999999844 3568999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|+++++++..++. .++...+..++.+++ .|+.|||+++++|+||||+
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~---------------------------~al~~lh~~~i~h~di~p~ 132 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA---------------------------EGMAYLESRNYIHRDLAAR 132 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCcccCCcchh
Confidence 99999988876652 244444455555544 4999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
||+++.++ .++|+|||.+......... .....+..|+|||.+.+ ..++.++|+||||++++++++ |..|| .+.+
T Consensus 133 nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~ 209 (261)
T cd05034 133 NILVGENL-VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMT 209 (261)
T ss_pred eEEEcCCC-CEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCC
Confidence 99999666 7999999998766432111 11233457999999876 678999999999999999998 88888 3444
Q ss_pred CHHHHHHHH
Q 040656 260 NQDQLVKIA 268 (332)
Q Consensus 260 ~~~~~~~~~ 268 (332)
.......+.
T Consensus 210 ~~~~~~~~~ 218 (261)
T cd05034 210 NREVLEQVE 218 (261)
T ss_pred HHHHHHHHH
Confidence 444444443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.01 Aligned_cols=191 Identities=18% Similarity=0.375 Sum_probs=152.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.++|.+.+.||+|+||.||++.. .+..+++|.++... .+.+.+|+.+++++ +|+|++++++++... ....++++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~ 79 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 79 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEE
Confidence 457899999999999999999965 58889999987543 45688999999999 999999999976433 34679999
Q ss_pred eeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||++++++..++.. ++...+.. ++.+++.||+|||++|++||||||+|
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~lH~~~i~H~dlkp~n 132 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLK---------------------------FSLDVCEAMEYLEANNFVHRDLAARN 132 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEeccccchhe
Confidence 99999887765421 23333333 44455569999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||++....... .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 133 il~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 133 VLVSEDN-VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred EEEcCCC-cEEecCCccceeccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999666 79999999987654222 22344567999999866 678999999999999999997 898883
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=260.72 Aligned_cols=186 Identities=24% Similarity=0.435 Sum_probs=147.3
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+++++++ +|+||+++++++.+ ....++++||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 4689999999999999889999999987532 235689999999999 99999999999854 4578999999999
Q ss_pred CCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCC
Q 040656 114 TDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE 189 (332)
Q Consensus 114 ~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~ 189 (332)
+++..++. .++...+.. ++.|+++||.|||++|++||||||+||+++.+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~---------------------------~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 130 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQ---------------------------MVENAAAGMEYLESKHCIHRDLAARNCLVTEK 130 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCccccccchheEEEcCC
Confidence 88876642 233333333 44455569999999999999999999999966
Q ss_pred CCeEEEEecccceeecCCCccc---ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 190 QQKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 190 ~~~vkL~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+ .++|+|||.+.......... ....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.
T Consensus 131 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 131 N-VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred C-cEEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 6 79999999987543221111 1122346999999876 568999999999999999998 888873
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=265.31 Aligned_cols=193 Identities=26% Similarity=0.458 Sum_probs=155.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+-|++.+.||+|+||.||+|.+..++..+++|.+.... ...+.+|+++++.+ +|+||+++++.+.. ....++++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEee--CCEEEEEE
Confidence 34788999999999999999998899999999986432 35678899999999 99999999999854 35789999
Q ss_pred eeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||++++++..++ ..++...+..++. |+++||.|||+.|++||||||+||
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~---------------------------qi~~~L~~LH~~~i~H~dlkp~ni 134 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCK---------------------------QTLEALNYLHENKIIHRDLKAGNI 134 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeeecCCCcccE
Confidence 999998876653 2244444444444 445599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCC-CcccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+++.++ .++|+|||++...... .......++..|+|||++.. ...++.++|+|||||++|+|++|..||.
T Consensus 135 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 135 LFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred EEccCC-CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 998666 7999999998654322 12234567888999998742 2457789999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=271.86 Aligned_cols=210 Identities=30% Similarity=0.560 Sum_probs=162.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC-----
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS----- 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~----- 101 (332)
...+|++.+.||.|+||.||+|.+..+++.||+|.+... ..+.+.+|+++++++ +|+||+++++.+.....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccc
Confidence 358899999999999999999999999999999998643 345688999999999 99999999987754322
Q ss_pred -------CCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 102 -------KTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 102 -------~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
...++++||+++ ++...+ ..+++..+..++.++ ++||.|||+.
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi---------------------------~~aL~~LH~~ 133 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQL---------------------------LRGLKYIHSA 133 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHhC
Confidence 246899999975 443332 234555555555554 4599999999
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
|++||||||+||+++.++..++|+|||.+........ .....++..|+|||.+.+...++.++|||||||++|+|+
T Consensus 134 givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~ 213 (342)
T cd07854 134 NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213 (342)
T ss_pred CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence 9999999999999987766799999999876532211 122356788999998766566889999999999999999
Q ss_pred hCCCCCCCCCCCHHHHHHHHH
Q 040656 249 FRKEPFFYGHDNQDQLVKIAR 269 (332)
Q Consensus 249 tg~~pf~~~~~~~~~~~~~~~ 269 (332)
+|..||. +....+....+..
T Consensus 214 ~g~~pf~-~~~~~~~~~~~~~ 233 (342)
T cd07854 214 TGKPLFA-GAHELEQMQLILE 233 (342)
T ss_pred hCCCCCC-CCCHHHHHHHHHH
Confidence 9999994 4444444444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=267.51 Aligned_cols=207 Identities=18% Similarity=0.321 Sum_probs=152.4
Q ss_pred CCCceEEEeecccCCceEEEEEEc----------------cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV----------------TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIV 90 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv 90 (332)
.++|++.+.||+|+||.||++... .+...+|+|+++.. ....+.+|+.+++.+ +|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 467999999999999999998532 23457999998743 235688999999999 999999
Q ss_pred eeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
++++++.+. ...++++||++++++..++......... .........+.+...++.|++.||+|||
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~i~~al~~lH 147 (296)
T cd05095 83 RLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAA-------------EKADVVTISYSTLIFMATQIASGMKYLS 147 (296)
T ss_pred eEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCccccc-------------ccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 999998543 5689999999998887654221100000 0000000111223456677778999999
Q ss_pred HcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHH
Q 040656 171 SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 171 ~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~el 247 (332)
+.|++||||||+||+++.++ .++|+|||++......... .....+..|+|||...+ ..++.++|+|||||++|||
T Consensus 148 ~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el 225 (296)
T cd05095 148 SLNFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEI 225 (296)
T ss_pred HCCeecccCChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHH
Confidence 99999999999999998655 7999999998765432211 11233567999998766 5789999999999999999
Q ss_pred Hh--CCCCCC
Q 040656 248 IF--RKEPFF 255 (332)
Q Consensus 248 lt--g~~pf~ 255 (332)
++ |..||.
T Consensus 226 ~~~~~~~p~~ 235 (296)
T cd05095 226 LTLCKEQPYS 235 (296)
T ss_pred HHhCCCCCcc
Confidence 98 778883
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=261.55 Aligned_cols=192 Identities=26% Similarity=0.467 Sum_probs=157.6
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc---------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+|+..+.||+|++|.||++....+++.+|+|+++... ...+.+|+.+++++ +|+||+++++++. +...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--~~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATC--EDSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceec--cCCe
Confidence 4788899999999999999998999999999986322 35688999999999 9999999999984 4467
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++++||++++++..++. .+++..+..++. |++.||++||++|++|+||+
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------------------------ql~~al~~LH~~~i~H~~i~ 130 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE---------------------------QLLRGLSYLHENQIIHRDVK 130 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeecCCCC
Confidence 899999999998876652 234444444444 45559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++..++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||++++++++|..||.
T Consensus 131 ~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred HHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999987765799999999876543211 123457788999999876 678999999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=261.59 Aligned_cols=194 Identities=25% Similarity=0.418 Sum_probs=157.2
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
-+|++.+.||+|+||.||+|.+..++..|++|.++.. ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 4689999999999999999999889999999987532 224578899999999 8999999999986655567
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++++|+++++++...+. .++...... ++.|++.||++||+.+++|+||+
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~---------------------------~~~qi~~~l~~LH~~~i~H~~l~ 133 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRK---------------------------YTRQILEGMSYLHSNMIVHRDIK 133 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeeeCCCC
Confidence 889999999888766542 234443333 34455569999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCC----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++...... .......++..|+|||.+.+ ..++.++|+|||||++|++++|..||.
T Consensus 134 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 134 GANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred HHHEEECCCC-CEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 9999998666 7999999998754321 11123457788999999877 678999999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=263.37 Aligned_cols=205 Identities=17% Similarity=0.288 Sum_probs=153.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc-----CCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|.+.+.||+|++|.||+|.+.. ++..|++|.++... ...+.+|+.+++++ +|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC-
Confidence 34779999999999999999999876 67889999886322 34688899999999 999999999988543
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
...+++|||++++++..++........ ......+.....++.|++.||+|||+++++|||||
T Consensus 82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 143 (277)
T cd05036 82 -LPRFILLELMAGGDLKSFLRENRPRPE-----------------RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIA 143 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHHhCCCCC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 467999999999888765421100000 00000111122355666779999999999999999
Q ss_pred CCCeeecCCC--CeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 181 PHNVMIDHEQ--QKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 181 p~Nilv~~~~--~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|+||+++.++ ..++|+|||+++........ .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 144 p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf 222 (277)
T cd05036 144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222 (277)
T ss_pred hheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 9999997543 35899999998765322111 11223456999999876 568999999999999999997 88888
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 223 ~ 223 (277)
T cd05036 223 P 223 (277)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=288.89 Aligned_cols=216 Identities=22% Similarity=0.316 Sum_probs=151.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCC-ceEEEE------------------Eecc--cchHHHHHHHHHHHhccCCCCe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNN-EKCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNI 89 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK------------------~~~~--~~~~~~~~E~~~l~~l~~h~ni 89 (332)
.++|++++.||+|+||.||+|...... ...+.| .++. .....+.+|+.+++++ +|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence 368999999999999999998653222 222222 1111 1224578999999999 99999
Q ss_pred eeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHH
Q 040656 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYC 169 (332)
Q Consensus 90 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 169 (332)
+++++++.+. ...+++++++.+..+..+.............. +...++.|++.||.||
T Consensus 226 v~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~--------------------~~~~i~~ql~~aL~yL 283 (501)
T PHA03210 226 LKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK--------------------QTRAIMKQLLCAVEYI 283 (501)
T ss_pred CcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHH--------------------HHHHHHHHHHHHHHHH
Confidence 9999999554 56789999886544333221100000000011 1123666777799999
Q ss_pred HHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHH
Q 040656 170 HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 170 H~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~el 247 (332)
|++||+||||||+|||++.++ .+||+|||+++.+..... .....||..|+|||++.+ ..++.++|||||||++|||
T Consensus 284 H~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 284 HDKKLIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDM 361 (501)
T ss_pred HhCCeecCCCCHHHEEECCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999666 799999999987653322 234578999999999877 6789999999999999999
Q ss_pred HhCCCCCCCCC--CCHHHHHHHHHHh
Q 040656 248 IFRKEPFFYGH--DNQDQLVKIARVL 271 (332)
Q Consensus 248 ltg~~pf~~~~--~~~~~~~~~~~~~ 271 (332)
++|..++.... .....+.++...+
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99886543322 2334455555443
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=265.66 Aligned_cols=198 Identities=26% Similarity=0.458 Sum_probs=158.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeecc----CCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----HSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----~~~~ 103 (332)
..+.|++.+.||+|+||.||+|.+..+++.+|+|++... ....+..|+.++.++.+|+||+++++++... ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 457899999999999999999999999999999998643 3356788999999987899999999998542 2456
Q ss_pred ceeEEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 104 PSLIFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
++++|||++++++..++.. +++..+.. ++.|++.||.|||+.|++|+|
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~qi~~al~~LH~~~ivH~d 146 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY---------------------------ICREILRGLAHLHAHKVIHRD 146 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCcccCC
Confidence 8999999999887766522 23333333 344556699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|+|+||+++.++ .++|+|||.+...... .......++..|+|||.+.. ...++.++|+||||+++|+|++|..|
T Consensus 147 l~~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p 225 (282)
T cd06636 147 IKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225 (282)
T ss_pred CCHHHEEECCCC-CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence 999999999666 7999999998754321 22334568888999998753 24578899999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 226 ~~ 227 (282)
T cd06636 226 LC 227 (282)
T ss_pred cc
Confidence 95
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=267.91 Aligned_cols=193 Identities=26% Similarity=0.482 Sum_probs=159.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..+|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++.+ +|+||+++++.+.. ....+++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEEEe
Confidence 48899999999999999999999889999999998632 335678899999999 99999999999854 4578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++++++..+.. .++......++. +++.||.+||+.|++||||||+||+
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~l~~~L~~LH~~~i~H~dL~p~Nil 147 (297)
T cd06656 95 MEYLAGGSLTDVVTETCMDEGQIAAVCR---------------------------ECLQALDFLHSNQVIHRDIKSDNIL 147 (297)
T ss_pred ecccCCCCHHHHHHhCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCcccCCCCHHHEE
Confidence 99999998877642 234444444444 4455999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.
T Consensus 148 i~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 148 LGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred ECCCC-CEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99666 799999999876543322 233467888999999877 678899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=267.73 Aligned_cols=195 Identities=23% Similarity=0.376 Sum_probs=153.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|.+.+.||+|+||.||+|... .++..+|+|.++... .+.+.+|+.+++++.+|+||+++++.+..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 4578999999999999999998752 345589999886432 34688999999999779999999999854
Q ss_pred CCCceeEEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
....++++||+.++++..++.. ++...... ++.+++.||.|||+++++
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~---------------------------i~~~i~~~l~~lH~~~iv 163 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS---------------------------FSYQVAKGMAFLASKNCI 163 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCee
Confidence 3568999999999887765422 33444444 444555699999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RK 251 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~ 251 (332)
|+||||+||+++.++ .++|+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.
T Consensus 164 H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 164 HRDLAARNVLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred hhhhccceEEEcCCC-eEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCC
Confidence 999999999998555 7999999998765433221 12244667999999876 568999999999999999998 89
Q ss_pred CCCC
Q 040656 252 EPFF 255 (332)
Q Consensus 252 ~pf~ 255 (332)
.||.
T Consensus 242 ~p~~ 245 (302)
T cd05055 242 NPYP 245 (302)
T ss_pred CCcC
Confidence 8984
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=260.01 Aligned_cols=184 Identities=19% Similarity=0.385 Sum_probs=144.1
Q ss_pred eecccCCceEEEEEEc--cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeec
Q 040656 39 KVGRGKYSEVFEGINV--TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVN 112 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~ 112 (332)
.||+|+||.||+|... .++..||+|+++... .+.+.+|+.+++++ +|+||+++++++.. ...+++|||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999998764 445679999986432 35688999999999 99999999998742 36799999999
Q ss_pred CCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 113 STDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 113 ~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
++++..++. .++...+.. ++.|++.||.|||++|++||||||+||+++.
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~ 130 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVE---------------------------LMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhcCeeecccchheEEEcC
Confidence 998876542 234444443 4445556999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
++ .++|+|||++......... ....++..|+|||.+.+ ..++.++||||||+++|++++ |..||.
T Consensus 131 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 131 QH-YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred CC-cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 65 7999999998755433221 11123467999999876 678999999999999999996 999984
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=262.71 Aligned_cols=197 Identities=25% Similarity=0.453 Sum_probs=159.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----CCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----SKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~ 104 (332)
.++|++.+.||+|++|.||+|.+..+++.+++|+++.. ....+.+|+.+++++..|+||+++++++.+.. ...+
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 47899999999999999999999888999999998743 34678899999999977999999999986533 3458
Q ss_pred eeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 105 SLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
++++||++++++..+.. .++...+.. ++.|++.||.|||+.+++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~---------------------------~~~ql~~al~~lH~~~i~H~ 137 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY---------------------------ILRETLRGLAYLHENKVIHR 137 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHhcCCcccC
Confidence 99999999988766542 233333333 44555669999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~ 252 (332)
||+|+||+++.++ .++|+|||.+....... ......++..|+|||++... ..++.++||||||+++|++++|..
T Consensus 138 ~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 216 (275)
T cd06608 138 DIKGQNILLTKNA-EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216 (275)
T ss_pred CCCHHHEEEccCC-eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCC
Confidence 9999999999665 79999999987654322 22345678889999987542 346789999999999999999999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 217 p~~ 219 (275)
T cd06608 217 PLC 219 (275)
T ss_pred Ccc
Confidence 994
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=265.08 Aligned_cols=192 Identities=24% Similarity=0.458 Sum_probs=155.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|+||.||++.+..+++.|++|.+.... ...+.+|+.+++.+ +|+||+++++.+.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence 46999999999999999999999999999999986432 34677899999999 99999999999854 45789
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+++||++++++..++. .+++..+..++.+++ .||.|||+.+++||||||+
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~---------------------------~~l~~lH~~~i~H~dl~p~ 130 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETV---------------------------LALEYLHNYGIVHRDLKPD 130 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCccccCCchH
Confidence 9999999998877652 344554444444444 5999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC----------------cccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK----------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
||+++.++ .++|+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 131 NIll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~e 208 (305)
T cd05609 131 NLLITSMG-HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYE 208 (305)
T ss_pred HEEECCCC-CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHH
Confidence 99999665 79999999886321000 0112346778999999876 678999999999999999
Q ss_pred HHhCCCCCC
Q 040656 247 MIFRKEPFF 255 (332)
Q Consensus 247 lltg~~pf~ 255 (332)
+++|..||.
T Consensus 209 l~~g~~pf~ 217 (305)
T cd05609 209 FLVGCVPFF 217 (305)
T ss_pred HHhCCCCCC
Confidence 999999994
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=263.74 Aligned_cols=206 Identities=18% Similarity=0.359 Sum_probs=155.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc----CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT----NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
+.++|.+.+.||+|+||.||+|.+.. ++..|++|.++.. ....+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-G 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-C
Confidence 56899999999999999999998765 3688999988632 235688999999999 999999999987543 3
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...++++++++++++..++........ .........+.+.++.+++.||+|||+.+++||||||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p 145 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEA----------------NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAA 145 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhcccccc----------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCH
Confidence 567899999998887665422100000 0000011112234556667799999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+||+++.++ .++|+|||+++.+...... ....++..|+|||++.+ ..++.++||||||+++|++++ |..||.
T Consensus 146 ~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 146 RNCVIDEEL-QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred hhEEEcCCC-cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 999998665 7999999999765432211 12345667999999876 678999999999999999999 999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=264.38 Aligned_cols=207 Identities=19% Similarity=0.352 Sum_probs=153.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+.++|++.+.||+|+||.||+|... ..+..||+|.++... ...+.+|+.+++.+ +|+||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK-- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 5789999999999999999998754 234589999876332 24578899999999 89999999999854
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....+++|||+++++|..++......... ....+...+.....++.|++.||.|||+++|+|||||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dik 146 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAEN--------------NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLA 146 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhcccccc--------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCC
Confidence 35689999999999887765321110000 0000000111123456677779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+||+++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.
T Consensus 147 p~nili~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~ 223 (288)
T cd05061 147 ARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQ 223 (288)
T ss_pred hheEEEcCCC-cEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999666 799999999875432221 111234567999999876 678999999999999999998 787883
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=266.58 Aligned_cols=194 Identities=24% Similarity=0.459 Sum_probs=159.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|++++.||.|+||.||+|.+..++..+|+|+++... ...+.+|+++++++ +|+||+++++.+.+ ....+++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEec--CCeEEEE
Confidence 478999999999999999999988889999999986432 34688899999999 89999999999854 4578999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||++++++..++. .+++..+..++.+++ .||.|||+.||+|+||||+|
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~---------------------------~~l~~lh~~~i~h~dl~p~n 133 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQML---------------------------EALNFLHSHKVIHRDLKAGN 133 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCcccCCCChhh
Confidence 99999998877652 355555555555555 49999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+++.++ .++|+|||.+...... .......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.
T Consensus 134 ili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~ 209 (280)
T cd06611 134 ILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209 (280)
T ss_pred EEECCCC-CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence 9999666 7999999987654322 22234567888999998752 2456789999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.64 Aligned_cols=193 Identities=19% Similarity=0.361 Sum_probs=152.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCc---eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..+|++.+.||+|+||.||+|....+++ .||+|+++.. ....+..|+.+++++ +||||+++++++. +...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~--~~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVT--KSRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEEC--CCCc
Confidence 4579999999999999999999876665 5999998643 235788999999999 9999999999984 3457
Q ss_pred ceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.++++||++++++..++.. ++..... .++.|++.||+|||++|++|+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------------------------~i~~~l~~al~~lH~~g~~H~dl 132 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLV---------------------------GMLRGIAAGMKYLSEMNYVHRDL 132 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCEeeccc
Confidence 8999999999887665422 2333333 34455566999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcc---cccc---cccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRV---ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~---~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
||+||+++.++ .++|+|||.+......... .... .+..|+|||.+.+ ..++.++||||||+++||+++ |..
T Consensus 133 ~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 133 AARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred ChheEEEcCCC-cEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCC
Confidence 99999998655 7999999998765432221 1111 1346999999876 678999999999999999886 999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 211 p~~ 213 (269)
T cd05065 211 PYW 213 (269)
T ss_pred CCC
Confidence 984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.41 Aligned_cols=210 Identities=27% Similarity=0.438 Sum_probs=179.5
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.++++|++++.||+|+||.|..++++.+++.+|.|++++. ...-|..|-.+|..- +.+=|+.++..| ++..
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAF--QD~~ 148 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAF--QDER 148 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHh--cCcc
Confidence 4679999999999999999999999999999999999753 234588888888877 788899999999 6668
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
++|+||||++||++..++ ..+++..+++|+.+++- ||.-||+.|+|||||
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVl---------------------------AldslH~mgyVHRDi 201 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVL---------------------------ALDSLHSMGYVHRDI 201 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHH---------------------------HHHHHHhccceeccC
Confidence 999999999999998886 34889999999999987 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~p 253 (332)
||+|||+|..| ++||+|||.+-.+..+. .+...+||+.|.+||++... ..|+..+|.||+||++|||+.|..|
T Consensus 202 KPDNvLld~~G-HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP 280 (1317)
T KOG0612|consen 202 KPDNVLLDKSG-HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP 280 (1317)
T ss_pred CcceeEecccC-cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence 99999999777 89999999987665333 24566999999999998532 4589999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 040656 254 FFYGHDNQDQLVKIARV 270 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~ 270 (332)
|+ ...-.++..+|+..
T Consensus 281 FY-adslveTY~KIm~h 296 (1317)
T KOG0612|consen 281 FY-ADSLVETYGKIMNH 296 (1317)
T ss_pred ch-HHHHHHHHHHHhch
Confidence 95 33345566666654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=272.74 Aligned_cols=190 Identities=21% Similarity=0.234 Sum_probs=149.5
Q ss_pred EEEeeccc--CCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 36 VVRKVGRG--KYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 36 ~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+++.||+| +|++||++.+..+++.||+|.++.. ....+++|+.+++.+ +||||++++++|..+ ...++|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--NELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--CEEEEEE
Confidence 56789999 7889999999999999999998642 124577899999999 999999999999554 5689999
Q ss_pred eeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||++++++..++. .++...+..++. |++.||.|||+++|+||||||+|
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~---------------------------qi~~~L~~LH~~~iiH~dlkp~N 131 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQ---------------------------GVLKALDYIHHMGYVHRSVKASH 131 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCEecCCCChhh
Confidence 9999998876642 244444444444 44559999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCC-C-------cccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPG-K-------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~-~-------~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
|+++.++ .++++||+.+...... . ......++..|+|||++.+. ..++.++|||||||++|+|++|..||
T Consensus 132 il~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 210 (327)
T cd08227 132 ILISVDG-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210 (327)
T ss_pred EEEecCC-cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999666 7999999864332111 1 01123456779999998653 35889999999999999999999999
Q ss_pred CC
Q 040656 255 FY 256 (332)
Q Consensus 255 ~~ 256 (332)
..
T Consensus 211 ~~ 212 (327)
T cd08227 211 KD 212 (327)
T ss_pred CC
Confidence 53
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.71 Aligned_cols=192 Identities=18% Similarity=0.343 Sum_probs=150.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCc----eEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.++|++.+.||+|+||.||+|....+++ .+++|.+.... ..++..|+..+.++ .|+||+++++++.+ .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence 4689999999999999999999877766 47777775321 24567788888888 99999999998743 3
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++++||++++++..++. .++...+.. ++.|++.||+|||+++++|||
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~~l~~lH~~~iiH~d 134 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN---------------------------WCVQIAKGMYYLEEHRMVHRN 134 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCEeccc
Confidence 5688999999988876652 233333333 445556699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+||+++.++ .++|+|||.++....... .....++..|+|||.+.+ ..++.++||||||+++||+++ |..||
T Consensus 135 lkp~nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 135 LAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred cCcceEEEcCCC-cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999665 799999999986643322 122345667999999876 578999999999999999998 99898
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 213 ~ 213 (279)
T cd05111 213 A 213 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.29 Aligned_cols=192 Identities=25% Similarity=0.495 Sum_probs=160.6
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
+|++.+.||.|+||.||+|.+..+++.||+|++... ..+.+.+|+++++++ +||||+++++.+.+ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence 589999999999999999999889999999998632 246788999999999 99999999999844 467899
Q ss_pred EEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
++||+.++++...+. .+++.....++.++ ++||.|||+.+++|+||+|+|
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i---------------------------~~~l~~lh~~~i~h~dl~~~n 130 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI---------------------------VLALEYLHSKGIIHRDIKPDN 130 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHH---------------------------HHHHHHHHhCCeeccCCCHHH
Confidence 999999998876642 34555454444444 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+++.++ .++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 131 il~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 131 ILLDEQG-HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred eEEcCCC-CEEEeecccccccCCCccccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 9999666 799999999877654434445567888999999876 5689999999999999999999999953
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=262.50 Aligned_cols=203 Identities=16% Similarity=0.235 Sum_probs=146.4
Q ss_pred EeecccCCceEEEEEEccCCc--eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|....++. .+++|.++.. ....+.+|+.++.++.+||||+++++++.. ....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 368999999999999877765 4688887632 235688899999999889999999999854 45689999999
Q ss_pred cCCCceeeccccc---hhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLYPTLT---ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++..++.... ..... .. ...........+...++.+++.||+|||+.|++||||||+||+++.
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~--~~---------~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~ 147 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAF--AI---------ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 147 (270)
T ss_pred CCCcHHHHHHhcccccccccc--cc---------ccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC
Confidence 9988766542100 00000 00 0000000112223446667777999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
++ .++|+|||++..............+..|+|||++.. ..++.++||||||+++|+|++ |..||.
T Consensus 148 ~~-~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 148 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred CC-eEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 66 799999999853221111112233556999998866 678999999999999999997 999983
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.49 Aligned_cols=213 Identities=17% Similarity=0.307 Sum_probs=153.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-------cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-------TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
..++|.+.+.||+|+||.||+|.+. .....+|+|.++... ...+.+|+.+++++.+|+||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4578999999999999999999753 234579999987432 24678899999999679999999999854
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
....++++||++++++..++......... ..... .........+.+...++.|++.||.|||++|++|||
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~-~~~~~-------~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPD-YTFDI-------TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCccc-ccccc-------cCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 35689999999999877654221100000 00000 000000011222334666777899999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+||+++.++ .++|+|||.++....... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 160 lkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 160 LAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred ccceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 999999999666 799999999976542211 111223456999999876 678999999999999999999 88888
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=264.27 Aligned_cols=215 Identities=28% Similarity=0.572 Sum_probs=165.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---- 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 100 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+++++++ +||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhh
Confidence 357899999999999999999999889999999998632 224577899999999 9999999999886543
Q ss_pred ----CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 101 ----SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 101 ----~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
...+++++||++++.+..+. ..++...+..++. |++.||+|||+.|
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~---------------------------qi~~aL~~LH~~~ 136 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK---------------------------QLLEGLNYCHKKN 136 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCC
Confidence 23789999999874433322 1244444444444 4455999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCC
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~ 251 (332)
|+|+||||+||+++.++ .++|+|||.+........ .....++..|+|||.+.+...++.++|||||||++++|++|.
T Consensus 137 i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 137 FLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred eecCCCCHHHEEECCCC-cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999666 799999999876643321 222345677999998876556789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhCCc
Q 040656 252 EPFFYGHDNQDQLVKIARVLGTD 274 (332)
Q Consensus 252 ~pf~~~~~~~~~~~~~~~~~~~~ 274 (332)
.||. .....+.+..+.+..+.+
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 216 PIFQ-ANQELAQLELISRLCGSP 237 (302)
T ss_pred CCCC-CCChHHHHHHHHHHhCCC
Confidence 9984 444555666666655443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=268.46 Aligned_cols=264 Identities=29% Similarity=0.525 Sum_probs=188.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc--CCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HSKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~ 103 (332)
.++|++.+.||+|+||.||+|....+++.||+|.+... ....+.+|+.+++++ +|+||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 47899999999999999999999999999999998642 235677899999999 899999999988543 3356
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++++||+.+ ++..++ ..++...+..++.+ ++.||+|||+.|++|||||
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~q---------------------------i~~aL~~LH~~~ivH~dlk 134 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQ---------------------------LLRGLKYIHSANVIHRDLK 134 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCeecCCCC
Confidence 8999999975 444433 23445545444444 4559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++........ .....++..|+|||.+.+...++.++||||||+++|+|++|..||
T Consensus 135 p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf- 212 (334)
T cd07855 135 PSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF- 212 (334)
T ss_pred HHHEEEcCCC-cEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-
Confidence 9999999666 799999999876543221 123467888999999866566899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC-----CCCCCCCcccccccccccccCceEEEeCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK-----RVWPIPNNKKLQFCRSSRTSTNICITFSPSGF 330 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R 330 (332)
.+.+....+..+....+.+... .+... .....+..++.. .+|.. ..........+++..||+.||++|
T Consensus 213 ~~~~~~~~~~~~~~~~g~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 213 PGKNYVHQLKLILSVLGSPSEE-VLNRI---GSDRVRKYIQNLPRKQPVPWSK---IFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred CCCChHHHHHHHHHHhCCChhH-hhhhh---chhhHHHHHhhcccCCCCCHHH---HcccCCHHHHHHHHHHccCChhhC
Confidence 4555555566556555543221 11111 011112222111 11110 001123444578889999999999
Q ss_pred CC
Q 040656 331 PF 332 (332)
Q Consensus 331 P~ 332 (332)
|+
T Consensus 286 pt 287 (334)
T cd07855 286 IT 287 (334)
T ss_pred cC
Confidence 96
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=260.53 Aligned_cols=209 Identities=34% Similarity=0.615 Sum_probs=163.6
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
|++.+.||+|++|.||+|....+++.+|+|.++.. ....+.+|+++++++ +|+|++++++++.+......++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 78899999999999999999888999999999743 234678899999999 899999999998654346789999
Q ss_pred eeecCCCceeec-c---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLY-P---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||+++ ++..+. . .++...+.. ++.+++.||++||+.|++|+||+|+||
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~---------------------------i~~~i~~al~~LH~~~~~h~dl~p~ni 131 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKC---------------------------YMKQLLEGLQYLHSNGILHRDIKGSNI 131 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 99975 433332 1 233333333 445556699999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++||||||+++++|++|..||. ..+...
T Consensus 132 l~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~ 209 (287)
T cd07840 132 LINNDG-VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELE 209 (287)
T ss_pred EEcCCC-CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHH
Confidence 999666 79999999988765433 23334567789999987765568899999999999999999999984 444455
Q ss_pred HHHHHHHHhCC
Q 040656 263 QLVKIARVLGT 273 (332)
Q Consensus 263 ~~~~~~~~~~~ 273 (332)
.+..+....+.
T Consensus 210 ~~~~~~~~~~~ 220 (287)
T cd07840 210 QLEKIFELCGS 220 (287)
T ss_pred HHHHHHHHhCC
Confidence 55555555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.42 Aligned_cols=199 Identities=23% Similarity=0.412 Sum_probs=159.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++.+.||+|++|.||+|.+..+++.+|+|.+... ..+.+..|+++++++ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence 4799999999999999999999888999999998643 234688899999999 89999999999844 45789
Q ss_pred eEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 106 LIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||+.++++..++. .+++.....++ .|+++||+|||+.|++|+|||
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~---------------------------~qi~~~l~~lH~~~i~H~dlk 130 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYA---------------------------AEVLLALEYLHLLGIVYRDLK 130 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHH---------------------------HHHHHHHHHHHHCCeeccCCC
Confidence 9999999998877653 23444444444 455559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc------------------------------ccccccccceeccccccCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE------------------------------YNVRVASRYFKGPELLVDLQD 230 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~ 230 (332)
|+||+++.++ .++|+|||++........ .....|+..|+|||++.+ ..
T Consensus 131 p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~ 208 (316)
T cd05574 131 PENILLHESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DG 208 (316)
T ss_pred hHHeEEcCCC-CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CC
Confidence 9999999766 799999998764422110 112357788999999877 56
Q ss_pred CCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 231 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 231 ~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
++.++||||||+++|+|++|..||. +.+....
T Consensus 209 ~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~ 240 (316)
T cd05574 209 HGSAVDWWTLGILLYEMLYGTTPFK-GSNRDET 240 (316)
T ss_pred CCchHHHHHHHHHHHHHhhCCCCCC-CCchHHH
Confidence 8999999999999999999999994 3433333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=258.44 Aligned_cols=194 Identities=19% Similarity=0.363 Sum_probs=152.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc---eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...+|+..+.||+|+||.||+|....++. .+++|.++.. ....+.+|+++++++ +|+||+++.+++.+ ..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 79 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTK--FK 79 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEcc--CC
Confidence 34679999999999999999998866554 7999998643 235688999999999 99999999999844 45
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++|||++++++..++. .++...... ++.+++.|+.|||+.|++|||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~al~~lH~~~i~H~d 132 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVG---------------------------MLRGIAAGMKYLSDMNYVHRD 132 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeeccc
Confidence 7899999999998876642 233333443 444555599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc--c--ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY--N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~--~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
|||+||+++.++ .++|+|||++......... . ....+..|+|||++.+ ..++.++|||||||++|++++ |..|
T Consensus 133 lkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p 210 (268)
T cd05063 133 LAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERP 210 (268)
T ss_pred cchhhEEEcCCC-cEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999666 7999999998765432211 1 1122346999999876 568999999999999999997 9999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 211 ~~ 212 (268)
T cd05063 211 YW 212 (268)
T ss_pred CC
Confidence 84
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=268.66 Aligned_cols=209 Identities=32% Similarity=0.631 Sum_probs=161.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----C
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----S 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~ 101 (332)
..+|.+.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ .|+||+++++++.... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCC
Confidence 47899999999999999999999889999999998632 124578899999999 9999999999985432 1
Q ss_pred CCceeEEeeecCCCceeec-cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLY-PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
...++++|++.. ++.... ..++...+..++.+ ++.||+|||+.+++|||||
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~q---------------------------i~~aL~~LH~~~i~H~dlk 144 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQ---------------------------MLCGLKYIHSAGIIHRDLK 144 (342)
T ss_pred ceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCcccCCCC
Confidence 345899998864 333322 23455554444444 4559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+||+++.++ .++|+|||+++... .......++..|+|||.+.+...++.++|||||||++|+|++|..||. +.+.
T Consensus 145 p~NIll~~~~-~~kL~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~ 220 (342)
T cd07879 145 PGNLAVNEDC-ELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDY 220 (342)
T ss_pred HHHEEECCCC-CEEEeeCCCCcCCC--CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCH
Confidence 9999999766 79999999987543 222344678889999998764568899999999999999999999994 4444
Q ss_pred HHHHHHHHHHhC
Q 040656 261 QDQLVKIARVLG 272 (332)
Q Consensus 261 ~~~~~~~~~~~~ 272 (332)
...+..+....+
T Consensus 221 ~~~~~~~~~~~~ 232 (342)
T cd07879 221 LDQLTQILKVTG 232 (342)
T ss_pred HHHHHHHHHhcC
Confidence 455555555444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.39 Aligned_cols=222 Identities=22% Similarity=0.337 Sum_probs=158.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|.+.+.||+|+||.||+|++. .++..||+|+++... ...+.+|+.++.++..|+||+++++.+..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 4577999999999999999999853 345689999997432 24678899999999459999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHH------HHHh-------------------------------------
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY------ELLK------------------------------------- 137 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~------~~~~------------------------------------- 137 (332)
....++++||+.+++|..++............. +...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 357899999999999877653211100000000 0000
Q ss_pred -----------------------------hcCCccee--ecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 138 -----------------------------HAMPRKVI--IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 138 -----------------------------~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
.....+.. ......+...+.++.|++.||+|||+.+++||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 00000000 00011222345677899999999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..||.
T Consensus 273 ~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 273 CEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred eCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 9655 799999999976532221 122346678999999876 678999999999999999998 888883
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.20 Aligned_cols=193 Identities=25% Similarity=0.431 Sum_probs=158.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.+.|+..+.||+|+||.||.|.+..++..||+|+++.. ....+.+|+.+++++ .|+||+++++.+.+ ....++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--GTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEEE
Confidence 35688999999999999999999889999999998632 235688999999999 99999999999854 457899
Q ss_pred EEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 107 IFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 107 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
++||++++++..++. .++...+..++. +++.||++||+.+++|+||+|+||
T Consensus 80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~---------------------------~l~~~l~~lh~~~ivH~dl~p~Ni 132 (277)
T cd06640 80 IMEYLGGGSALDLLRAGPFDEFQIATMLK---------------------------EILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred EEecCCCCcHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCccCcCCChhhE
Confidence 999999998776542 244444444444 445599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.
T Consensus 133 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 133 LLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred EEcCCC-CEEEcccccceeccCCccccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 999665 799999999876543332 233457788999999876 568999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=266.12 Aligned_cols=212 Identities=18% Similarity=0.314 Sum_probs=153.5
Q ss_pred CCCceEEEeecccCCceEEEEEEcc-------CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVT-------NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.++.. ....+.+|+.+++++.+|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 4689999999999999999997533 2356999998743 224577899999999789999999999854
Q ss_pred CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
....++++||++++++..++............ ...........+.+...++.|++.||+|||+.|++||||
T Consensus 96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 166 (307)
T cd05098 96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCY--------NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDL 166 (307)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCccccccc--------ccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 35689999999998877665321100000000 000000001122233456777788999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
||+||+++.++ .++|+|||.++........ ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||
T Consensus 167 kp~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 167 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred cHHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999666 7999999998765422111 11223457999999876 678999999999999999998 77887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=264.72 Aligned_cols=193 Identities=23% Similarity=0.409 Sum_probs=158.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||+|++|.||+|.+..+++.+++|.+... ....+.+|+++++++ +|+||+++++.+... ...+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecC--CEEEEE
Confidence 4688899999999999999999889999999998643 235688999999999 799999999998554 678999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlkp~ 182 (332)
+|+++++++..++. .++...... ++.+++.||++||+ .|++|+||||+
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lH~~~~i~H~dl~~~ 130 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGK---------------------------IAVAVLKGLTYLHEKHKIIHRDVKPS 130 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHH---------------------------HHHHHHHHHHHHcCCCCeecCCCCHH
Confidence 99999888877653 233443333 44455569999999 99999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
||+++.++ .++|+|||.+........ ....++..|+|||.+.+ ..++.++||||||+++++|++|..||...
T Consensus 131 ni~~~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 131 NILVNSRG-QIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HEEECCCC-CEEEeecccchhhHHHHh-hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 99999765 799999999865532222 22667888999999877 57899999999999999999999999544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=259.72 Aligned_cols=237 Identities=22% Similarity=0.410 Sum_probs=173.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC---CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.++|.+.+.||+|+||.||+|.+... ...|++|..... ..+.+.+|+.+++++ +|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---N 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---C
Confidence 467899999999999999999987544 356899987643 235688999999999 99999999999854 3
Q ss_pred CceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||+++++++..++.. ++......+ +.+++.||.|||+.+++|+|
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~---------------------------~~~l~~~l~~lH~~~~~H~d 132 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILY---------------------------SYQLSTALAYLESKRFVHRD 132 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCeeccc
Confidence 46899999999888776532 334433333 44555599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||+||+++.++ .++|+|||++......... ....++..|+|||.+.. ..++.++||||||+++|++++ |..||.
T Consensus 133 l~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 133 IAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred cChheEEEecCC-CeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999666 7999999998765433221 11223456999998866 678999999999999999986 999984
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+....+...... ......++.++++ +.+||+.+|.+||+
T Consensus 211 -~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l------------------------i~~~l~~~P~~Rpt 254 (270)
T cd05056 211 -GVKNNDVIGRIENGERL--------PMPPNCPPTLYSL------------------------MTKCWAYDPSKRPR 254 (270)
T ss_pred -CCCHHHHHHHHHcCCcC--------CCCCCCCHHHHHH------------------------HHHHcCCChhhCcC
Confidence 33333333333221100 0112333444444 45699999999996
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=262.66 Aligned_cols=213 Identities=16% Similarity=0.265 Sum_probs=151.7
Q ss_pred CceEEEeecccCCceEEEEEEcc-----CCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+|++.+.||+|+||.||+|.... ....+++|.+.... ...+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCC
Confidence 48899999999999999998643 23579999876322 34688999999999 99999999999854 456
Q ss_pred ceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcce----eecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV----IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.++++||+.++++..++...........-. . ....+. ...........+.++.|++.||.|||+.+++||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di 153 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGS---D-GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCcccccccc---c-cccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 899999999988876542210000000000 0 000000 00000112223456778888999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
||+||+++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++++|++ |..||
T Consensus 154 kp~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 154 AARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 99999998655 799999999876532221 112234567999998866 678999999999999999998 88888
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=267.77 Aligned_cols=269 Identities=27% Similarity=0.473 Sum_probs=184.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC----
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH---- 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 100 (332)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ...+.+|+++++.+ +|+||+++++++.+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 3589999999999999999999998899999999985321 23568899999999 9999999999875432
Q ss_pred --CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 101 --SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 101 --~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
...++++++|+.+.....+. ..++...+..++.++ ++||+|||++|++
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l---------------------------~~al~~lH~~~i~ 137 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL---------------------------LEGINYLHENHIL 137 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCee
Confidence 23578999998764333222 235555555555555 4599999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCc------------ccccccccceeccccccCCCCCCCcccHHHHHHH
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~i 243 (332)
|+||||+||+++.++ .++|+|||++........ .+...++..|+|||.+.+...++.++||||||++
T Consensus 138 H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i 216 (311)
T cd07866 138 HRDIKAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCV 216 (311)
T ss_pred cCCCCHHHEEECCCC-CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHH
Confidence 999999999999666 799999999875432211 1223567789999998765568899999999999
Q ss_pred HHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC-cccccccccccccCceE
Q 040656 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN-NKKLQFCRSSRTSTNIC 322 (332)
Q Consensus 244 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~c 322 (332)
+|+|++|..|| .+.+.......+....+......+.... .. +...... ......... ...........+++..|
T Consensus 217 l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~ 291 (311)
T cd07866 217 FAEMFTRRPIL-QGKSDIDQLHLIFKLCGTPTEETWPGWR--SL-PGCEGVH-SFTNYPRTLEERFGKLGPEGLDLLSKL 291 (311)
T ss_pred HHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhchhhh--hc-ccccccc-cCCCCCccHHHHcccCChhHHHHHHHH
Confidence 99999999888 4555555566666555433222111100 00 0000000 000000000 00011223345789999
Q ss_pred EEeCCCCCCC
Q 040656 323 ITFSPSGFPF 332 (332)
Q Consensus 323 l~~dP~~RP~ 332 (332)
|+.||++||+
T Consensus 292 l~~~p~~R~t 301 (311)
T cd07866 292 LSLDPYKRLT 301 (311)
T ss_pred cccCcccCcC
Confidence 9999999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.03 Aligned_cols=193 Identities=26% Similarity=0.496 Sum_probs=160.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.++|++.+.||+|+||.||+|....+++.+++|.++... ...+.+|+.+++++ +|+||+++++.+.+ ....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCcEEEEEe
Confidence 468999999999999999999988889999999987433 56789999999999 99999999999854 367899999
Q ss_pred eecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+++++++..++. .++......++.++ +.||.|||+.+++|+||+|+||+
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l---------------------------~~~l~~lh~~~i~H~dl~~~ni~ 131 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQT---------------------------LKGLEYLHSNKKIHRDIKAGNIL 131 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCcccCCCCcceEE
Confidence 999988876642 23444444444444 45999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||.+....... ......++..|+|||++.+ ..++.++||||||+++++|++|..||.
T Consensus 132 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~ 200 (256)
T cd06612 132 LNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYS 200 (256)
T ss_pred ECCCC-cEEEcccccchhcccCccccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99766 79999999987654332 2233457788999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=259.27 Aligned_cols=207 Identities=31% Similarity=0.641 Sum_probs=161.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+|++.+.||.|++|.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++.+.+ ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEee--CCcEEEEE
Confidence 589999999999999999999889999999998643 235677899999999 99999999999955 35789999
Q ss_pred eeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 109 EHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 109 e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
||+++ ++..++ ..++...+.. ++.|++.||.|||+.|++||||||+
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~---------------------------~~~qi~~~l~~lH~~~i~h~dl~p~ 129 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKS---------------------------FTYQLLKGIAFCHENRVLHRDLKPQ 129 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHH---------------------------HHHHHHHHHHHHHHCCeeeCCCCHH
Confidence 99986 333322 1234444444 4445555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||+++.++ .++|+|||++....... ......++..|++||.+.+...++.++|+||||+++|++++|..||. +.+..
T Consensus 130 ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~ 207 (284)
T cd07836 130 NLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP-GTNNE 207 (284)
T ss_pred HEEECCCC-cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCcH
Confidence 99999665 79999999987543221 22334567889999998765567899999999999999999999984 45555
Q ss_pred HHHHHHHHHhC
Q 040656 262 DQLVKIARVLG 272 (332)
Q Consensus 262 ~~~~~~~~~~~ 272 (332)
+....+.....
T Consensus 208 ~~~~~~~~~~~ 218 (284)
T cd07836 208 DQLLKIFRIMG 218 (284)
T ss_pred HHHHHHHHHhC
Confidence 56566555444
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.57 Aligned_cols=212 Identities=33% Similarity=0.534 Sum_probs=160.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC-----
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----- 100 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----- 100 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++++ +||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 47899999999999999999999889999999998532 123567899999999 9999999999885432
Q ss_pred -CCCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 -SKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 -~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....++++||+.+.....+.. .++...+.. ++.|++.||+|||++|++|
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~al~~lH~~~i~H 142 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK---------------------------VMKMLLNGLYYIHRNKILH 142 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeec
Confidence 234689999987633222211 234444444 4445556999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~ 251 (332)
+||||+||+++.++ .++|+|||++........ .....++..|+|||.+.+...++.++||||||+++|+|++|.
T Consensus 143 ~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~ 221 (310)
T cd07865 143 RDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRS 221 (310)
T ss_pred cCCCHHHEEECCCC-cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCC
Confidence 99999999999666 799999999876542221 123456778999998876555789999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhC
Q 040656 252 EPFFYGHDNQDQLVKIARVLG 272 (332)
Q Consensus 252 ~pf~~~~~~~~~~~~~~~~~~ 272 (332)
.||. +.+.......+....+
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 222 PIMQ-GNTEQHQLTLISQLCG 241 (310)
T ss_pred CCCC-CCCHHHHHHHHHHHhC
Confidence 8884 4444445554554433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=268.67 Aligned_cols=268 Identities=25% Similarity=0.456 Sum_probs=186.3
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC--
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH-- 100 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 100 (332)
|...++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++++....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 91 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence 44568999999999999999999999889999999998642 134577899999999 9999999999885432
Q ss_pred --CCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 --SKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 --~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....+++++++ ++++..+. ..++......+ +.|++.||.|||+.||+|
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i---------------------------~~qi~~aL~~LH~~~ivH 143 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFL---------------------------IYQILRGLKYIHSADIIH 143 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHH---------------------------HHHHHHHHHHHHHCCeee
Confidence 23456777766 45554433 22444444444 445555999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||||+||+++.++ .++|+|||++.... .......++..|+|||.+.+...++.++|||||||++|+|++|..|| .
T Consensus 144 ~dlkp~NIll~~~~-~~kl~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~ 219 (345)
T cd07877 144 RDLKPSNLAVNEDC-ELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-P 219 (345)
T ss_pred cCCChHHEEEcCCC-CEEEeccccccccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC-C
Confidence 99999999999766 79999999987543 22334567888999998866456889999999999999999999998 4
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCC--CCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPI--PNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+....+..+.+..+.+.. ......... ..+..+........ .............+++..|++.||.+||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 293 (345)
T cd07877 220 GTDHIDQLKLILRLVGTPGA-ELLKKISSE---SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 293 (345)
T ss_pred CCCHHHHHHHHHHHhCCCCH-HHHhhcccH---hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC
Confidence 55555556666665543322 222222111 11122211100000 00000112233457888899999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=264.48 Aligned_cols=213 Identities=17% Similarity=0.310 Sum_probs=156.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-------cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-------TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
..++|.+.+.||+|+||.||+|... ..+..+|+|.++.. ....+.+|+.+++.+.+|+||+++++.+..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4688999999999999999999742 23457999998632 235688999999999789999999999854
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
....+++|||++++++..++........ .+...+.. .......+.+...++.|++.||.|||++|++|||
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGM-EYSYDIAR-------VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCccc-cccccccc-------CCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 3578999999999887766522110000 00000000 0001112333456777888899999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+||+++.++ .++|+|||.++....... .....++..|+|||++.+ ..++.++||||||+++|++++ |..||
T Consensus 163 lkp~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~ 240 (304)
T cd05101 163 LAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 240 (304)
T ss_pred cccceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999998665 799999999986643221 122234567999999876 678999999999999999998 77777
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=256.02 Aligned_cols=190 Identities=19% Similarity=0.378 Sum_probs=154.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||.||+|.. .++.||+|.++... .+++.+|+.+++.+ +|+||+++++++.+ ....+++
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 78 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIV 78 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEE
Confidence 467899999999999999999975 58899999997543 46788999999999 89999999999854 4678999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|+++++++..++. .++...... ++.|++.||.|||++|++|+||||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~qi~~~l~~lh~~~i~H~di~p~ 131 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLG---------------------------FALDVCEGMEYLEEKNFVHRDLAAR 131 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCccchhcccc
Confidence 99999888776642 233444444 4445556999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
||+++.++ .++|+|||.+....... .....+..|+|||.+.+ ..++.++||||||++++++++ |..||.
T Consensus 132 Nili~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 132 NVLVSEDL-VAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred eEEEeCCC-CEEEccccccccccccc--ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 99999666 79999999987653221 22334566999999876 568899999999999999997 998983
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=260.85 Aligned_cols=207 Identities=39% Similarity=0.676 Sum_probs=162.9
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
|++.+.||+|++|.||+|....+++.+++|.++... ...+.+|+.+++++ +|+||+++++++.+ ....++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhcc--CCCEEEEE
Confidence 678899999999999999998899999999986432 35678899999999 89999999999854 46789999
Q ss_pred eeecCCCceeec-c---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLY-P---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||+++ ++...+ . .++...+.. ++.+++.||.+||+.+++|+||||+||
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~LH~~~i~H~dl~p~ni 129 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKS---------------------------YLYQLLQGLAFCHSHGILHRDLKPENL 129 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence 99976 333322 1 234444444 444555599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++|+|++|..|| ++.+..+.
T Consensus 130 li~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~ 207 (283)
T cd05118 130 LINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQ 207 (283)
T ss_pred EECCCC-cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHH
Confidence 999666 79999999987765443 2333467778999999877447899999999999999999999888 45555566
Q ss_pred HHHHHHHhCC
Q 040656 264 LVKIARVLGT 273 (332)
Q Consensus 264 ~~~~~~~~~~ 273 (332)
+..+....+.
T Consensus 208 ~~~~~~~~~~ 217 (283)
T cd05118 208 LFKIFRTLGT 217 (283)
T ss_pred HHHHHHHcCC
Confidence 6666555444
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=256.40 Aligned_cols=192 Identities=18% Similarity=0.340 Sum_probs=152.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||++.. ..+..+++|.++... ...+.+|+.+++++ +|+||+++++.+.+ ...+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEE
Confidence 468999999999999999999975 456779999886432 35688999999999 99999999998854 467999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||++++++..++.. ++...+.. ++.+++.||.+||+.|++|+||||+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~aL~~lH~~~i~H~dl~p~ 131 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLID---------------------------FSAQIAEGMAFIEQRNYIHRDLRAA 131 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHH---------------------------HHHHHHHHHHHHHhCCccccccCcc
Confidence 999999887766432 22222233 4455566999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
||+++.++ .++|+|||.+........ .....++..|+|||++.. ..++.++|+||||+++|++++ |..||.
T Consensus 132 ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 132 NILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred eEEEcCCC-cEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 99998666 799999999876543221 112234566999999876 578999999999999999999 888883
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=261.79 Aligned_cols=216 Identities=19% Similarity=0.316 Sum_probs=156.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+.++|++.+.||+|+||.||+|.+. .++..+|+|+++... ...+.+|+.+++++ .|+||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~-- 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV-- 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence 4678999999999999999999864 367889999986432 35688899999999 99999999999854
Q ss_pred CCCceeEEeeecCCCceeeccccch---hhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTA---NEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
....++++||++++++..++..... ........+... ...-.......+.+.++.+++.||.+||+++++||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~ 154 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK-----CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR 154 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCcccccccccccccccc-----ccccccccCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 4578999999999887766532111 000000000000 00000001122234577778889999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||||+||+++.++ .++|+|||.+........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..|
T Consensus 155 dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 155 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred cccHhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999998666 799999999876543221 112234566999999876 578999999999999999997 7788
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 233 ~~ 234 (288)
T cd05050 233 YY 234 (288)
T ss_pred CC
Confidence 84
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=263.76 Aligned_cols=238 Identities=24% Similarity=0.422 Sum_probs=168.3
Q ss_pred eEEEeecccCCceEEEEEEc----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 35 EVVRKVGRGKYSEVFEGINV----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.+.+.||.|.||.||+|... ..+..|+||.++.. ..+.+.+|++.+.++ +||||+++++++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence 57899999999999999886 45678999999642 246789999999999 99999999999963 345899
Q ss_pred EEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 107 IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|+||+++++|...+...... .....+.+.++.|++.||+|||+++++|++|+++||++
T Consensus 79 v~e~~~~g~L~~~L~~~~~~----------------------~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill 136 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKE----------------------PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL 136 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTT----------------------TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE
T ss_pred cccccccccccccccccccc----------------------cccccccccccccccccccccccccccccccccccccc
Confidence 99999998887765322000 01122233466677779999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNQD 262 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~~~ 262 (332)
+.++ .+||+|||++......... ........|+|||.+.. ..++.++||||||+++||+++ |..|| ...+..+
T Consensus 137 ~~~~-~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~ 213 (259)
T PF07714_consen 137 DSNG-QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEE 213 (259)
T ss_dssp ETTT-EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHH
T ss_pred cccc-ccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc-ccccccc
Confidence 9666 8999999999876322221 22345667999999877 568999999999999999999 67887 3444444
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+.+.... ......+..+..++ ..||+.||++||+
T Consensus 214 ~~~~~~~~~~~--------~~~~~~~~~~~~li------------------------~~C~~~~p~~RPs 251 (259)
T PF07714_consen 214 IIEKLKQGQRL--------PIPDNCPKDIYSLI------------------------QQCWSHDPEKRPS 251 (259)
T ss_dssp HHHHHHTTEET--------TSBTTSBHHHHHHH------------------------HHHT-SSGGGS--
T ss_pred ccccccccccc--------eeccchhHHHHHHH------------------------HHHcCCChhhCcC
Confidence 44444321111 01123444555555 5599999999996
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=255.60 Aligned_cols=193 Identities=26% Similarity=0.462 Sum_probs=157.6
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+|+..+.||+|++|.||+|....+++.|++|.+... ..+.+.+|+.+++.+ +|+||+++++++.+ ...+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEec--CCeE
Confidence 578889999999999999998889999999998642 235688999999999 99999999999854 4578
Q ss_pred eeEEeeecCCCceeeccc---cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++++||++++++..++.. ++...... ++.|++.||++||+.|++|+||+|
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~lH~~~i~H~dl~~ 130 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRL---------------------------YTRQILLGLEYLHDRNTVHRDIKG 130 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCcccCCCCH
Confidence 999999999887666432 33333333 344555699999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+||+++.++ .++|+|||.+.............++..|+|||.+.....++.++|+||||+++|++++|..||..
T Consensus 131 ~ni~~~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 131 ANILVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred HHEEECCCC-CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 999999666 79999999987765444344556888899999986633388999999999999999999999943
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=258.20 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=196.6
Q ss_pred CCceEE-EeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeecc--CCCCceeEE
Q 040656 32 EDYEVV-RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~~~lv~ 108 (332)
++|.+- +.||-|-.|.|-.|.++.+++.+|+|++.. ..+..+|+++......|+|||.++++|.+. ....+.+||
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 566654 569999999999999999999999999864 345579999999988999999999998653 344577899
Q ss_pred eeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|.|+||.|.... +.+++.++..+++++.. |+.|||+.+|.||||||+|
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~---------------------------Av~~lH~~nIAHRDlKpEN 191 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGL---------------------------AVRYLHSMNIAHRDLKPEN 191 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHH---------------------------HHHHHHhcchhhccCChhh
Confidence 999999987765 34888888887777766 9999999999999999999
Q ss_pred eeecC--CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC--
Q 040656 184 VMIDH--EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-- 259 (332)
Q Consensus 184 ilv~~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~-- 259 (332)
+|... .+..+||+|||+|+.-.......+.+.|++|.|||++-. +.|+...|+||+|+++|-|++|.+||+....
T Consensus 192 LLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 192 LLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred eeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence 99953 334689999999997665666677899999999999855 7899999999999999999999999964332
Q ss_pred -CHHHHHHHHHHhC----------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccc
Q 040656 260 -NQDQLVKIARVLG----------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQF 311 (332)
Q Consensus 260 -~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 311 (332)
+-..-.+|..+.- +...++++.++ +...|..|-.|+.. +||........+.
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~L-Lkt~PteRlTI~~~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKL-LKTEPTERLTIEEVMDHPWINQYEAVPQT 334 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHH-hcCCchhheeHHHhhcCchhcccccCCCC
Confidence 1222233332211 23555666665 77788888888777 8888776554444
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=258.92 Aligned_cols=193 Identities=24% Similarity=0.473 Sum_probs=158.5
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||.|+||.||+|....++..+++|+++.. ....+.+|+++++.+ +|+||+++++.+.. ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee--CCEEEEE
Confidence 4799999999999999999998889999999998632 346788999999999 99999999998854 4578999
Q ss_pred EeeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 108 FEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+|+++++++...+.. +++..+..++.+ ++.||++||+.|++|+||+|
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~q---------------------------l~~al~~lh~~~i~h~~l~p 130 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE---------------------------VLKGLEYLHSNGQIHRDIKA 130 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHH---------------------------HHHHHHHHHhCCeecCCCCH
Confidence 999999887766422 344444444444 45599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc-----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY-----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+||+++.++ .++|+|||++......... ....++..|+|||++.....++.++|+||||+++++|++|..||.
T Consensus 131 ~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 131 GNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred HhEEEcCCC-CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 999999665 7999999998665433221 334678889999998774478999999999999999999999994
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=264.85 Aligned_cols=211 Identities=26% Similarity=0.511 Sum_probs=173.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCC-----CeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-----NIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-----niv~~~~~~~~~~~~ 102 (332)
...+|.++..+|+|.||.|-.+.+..++..||+|+++.. ..+...-|+++++++..+. -++++.++| +-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hccC
Confidence 468999999999999999999999999999999999854 3466788999999995432 467777888 4457
Q ss_pred CceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
+.|+|+|.+.......+. .+++-..++.+.+|++. ++++||+.+++|.|
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~---------------------------sv~fLh~~kl~HTD 217 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLE---------------------------SVAFLHDLKLTHTD 217 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHH---------------------------HHHHHHhcceeecC
Confidence 899999998654443332 34777777777777776 99999999999999
Q ss_pred CCCCCeeecCC-------------------CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHH
Q 040656 179 VKPHNVMIDHE-------------------QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWS 239 (332)
Q Consensus 179 lkp~Nilv~~~-------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwS 239 (332)
|||+|||+... ...|+++|||.|+..... .++.+.|..|+|||++++ .+++.++||||
T Consensus 218 LKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg-LGwS~pCDvWS 294 (415)
T KOG0671|consen 218 LKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG-LGWSQPCDVWS 294 (415)
T ss_pred CChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheec-cCcCCccCcee
Confidence 99999998421 114899999999876433 356789999999999999 78999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 040656 240 LGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273 (332)
Q Consensus 240 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 273 (332)
+||||+|+.||...| +..++.+.+.-+.+.+|+
T Consensus 295 iGCIL~ElytG~~LF-qtHen~EHLaMMerIlGp 327 (415)
T KOG0671|consen 295 IGCILVELYTGETLF-QTHENLEHLAMMERILGP 327 (415)
T ss_pred eeeEEEEeeccceec-ccCCcHHHHHHHHHhhCC
Confidence 999999999999988 677788888777777773
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=255.66 Aligned_cols=191 Identities=23% Similarity=0.445 Sum_probs=155.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|+||.||.+....+++.+|+|.++.. ....+.+|+.+++++ +|+||+++++++.+ ....+++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence 589999999999999999999899999999998632 235688999999999 99999999999854 4678999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||+.++++..... .++...... ++.|++.||.+||++|++|+||+|+
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lh~~~i~h~~l~~~ 130 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILD---------------------------WFVQICLALKHVHDRKILHRDIKSQ 130 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEecCCCCHH
Confidence 99999888765442 123333333 3445556999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++ .++|+|||.+........ .....++..|+|||++.+ ...+.++|+||||++++++++|..||.
T Consensus 131 nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 131 NIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred HEEEcCCC-CEEEeeccceeecCcchhhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 99998666 799999999876543222 223457788999999876 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=276.10 Aligned_cols=239 Identities=26% Similarity=0.390 Sum_probs=188.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
..+.|++...+|.|+||+|-.+.+..+++..++|++... ..+.++|+.++....+|+||+++++.+.+ ..+.++|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence 468899999999999999999999999999999999754 55678899999998899999999999944 578999999
Q ss_pred eecCCCceeeccc--cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 110 HVNSTDFKVLYPT--LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 110 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
.+.++.+...... .....+..++.++ +.|+.|||++|++||||||+|||++
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~l---------------------------v~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAEL---------------------------VSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHH---------------------------HHHHHHHHhcCeeecCCChhheeec
Confidence 9998775554321 1112333444444 4599999999999999999999995
Q ss_pred CCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~ 267 (332)
.+.+.++|+|||.++..... ..+.+-|..|.|||++.. ..|++++|+||||++||+|++|+.||.......+....+
T Consensus 450 ~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 450 GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 34447999999999876544 445577888999999985 889999999999999999999999996544442333332
Q ss_pred HHH----hCCchHHHHHHhcCCCCChhHHHHhccC--CCCC
Q 040656 268 ARV----LGTDELNAYLDKYHLELDPQLEALVGRK--RVWP 302 (332)
Q Consensus 268 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~ 302 (332)
... .-++..++++.++ +.++|..|-.+.++ ++|.
T Consensus 527 ~~~~~s~~vS~~AKdLl~~L-L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQL-LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCCccccccCHHHHHHHHHh-ccCChhhCcChhhhccCcch
Confidence 222 1145677777777 78888888888777 8887
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=259.57 Aligned_cols=193 Identities=20% Similarity=0.370 Sum_probs=153.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc----eEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
...+|++.+.||+|+||.||+|....+++ .+|+|.++... ...+.+|+.+++++ +|+||+++++++.+
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---
Confidence 35789999999999999999998766554 58999876432 35688999999999 99999999999865
Q ss_pred CCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++++||++++++...+. .++...... ++.|++.||+|||+.+++||
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~---------------------------~~~qi~~~l~~LH~~~i~H~ 133 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN---------------------------WCVQIAKGMSYLEEKRLVHR 133 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEEec
Confidence 57899999999988876642 233444433 44455569999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccc---cccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||||+||+++.++ .++|+|||.++.......... ..++..|+|||.+.. ..++.++|+||||+++||+++ |..|
T Consensus 134 di~p~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p 211 (279)
T cd05057 134 DLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ccCcceEEEcCCC-eEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCC
Confidence 9999999998666 799999999987653322211 123456999998865 678899999999999999998 9999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 212 ~~ 213 (279)
T cd05057 212 YE 213 (279)
T ss_pred CC
Confidence 84
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=265.88 Aligned_cols=262 Identities=30% Similarity=0.517 Sum_probs=188.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC---CCCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---SKTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---~~~~ 104 (332)
+|++.+.||+|++|.||+|....+++.||+|.+... ..+.+.+|+.+++.+ +|+||+++++++.+.. ....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 689999999999999999999888999999998642 235788999999999 8999999999986542 2367
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+++++|+++ ++...+ ..+++..+..++.++ +.||++||+.||+|+||||
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l---------------------------~~~l~~LH~~gi~H~dlkp 131 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQI---------------------------LRGLKYLHSANVIHRDLKP 131 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCeecCCCCH
Confidence 999999885 333332 134444444445544 4599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCC----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
+||+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+
T Consensus 132 ~nili~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~ 209 (330)
T cd07834 132 SNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PG 209 (330)
T ss_pred HHEEEcCCC-CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CC
Confidence 999999765 79999999998765443 2334467888999999987447899999999999999999999998 45
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC-----CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK-----RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+....+....+.+....+.. ...+.....+... .+|... .........+++..||+.+|.+||+
T Consensus 210 ~~~~~~~~~i~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt 282 (330)
T cd07834 210 RDYIDQLNLIVEVLGTPSEEDLKF----ITSEKARNYLKSLPKKPKKPLSKL---FPGASPEAIDLLEKMLVFDPKKRIT 282 (330)
T ss_pred CCHHHHHHHHHHhcCCCChhHhhh----ccccchhhHHhhcccCCcchhHHh---cccCCHHHHHHHHHHccCChhhCCC
Confidence 555666666666655443322111 0111111111111 111100 0112233357888899999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=256.38 Aligned_cols=195 Identities=26% Similarity=0.432 Sum_probs=158.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--------cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+++|++.+.||+|+||.||+|.+..+++.||+|.+.. .....+.+|+++++++ +|+||+++++.+.+....
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEK 79 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCC
Confidence 3689999999999999999999999999999998742 1224688899999999 999999999998765556
Q ss_pred CceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++++|+++++++...+. .++......++. +++.||.|||+.|++|+||
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~---------------------------~i~~al~~LH~~~i~H~dl 132 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR---------------------------QILQGVSYLHSNMIVHRDI 132 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCEecCCC
Confidence 7889999999988766542 234444444444 4455999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+||+++.++ .++|+|||.++..... .......++..|+|||.+.+ ..++.++|+||||+++|++++|..||.
T Consensus 133 ~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 133 KGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred CHHHEEEcCCC-CEEECccccccccccccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999666 7999999998765321 11223467888999999877 568899999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=265.58 Aligned_cols=192 Identities=21% Similarity=0.420 Sum_probs=156.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.|.....||+|+||.||++....++..||+|.+... ..+.+.+|+.+++++ +|+||+++++.+.. ....++++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence 5566678899999999999998889999999998642 235688999999999 99999999999854 45789999
Q ss_pred eeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 109 EHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 109 e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
||++++++..++ ..++......++.+ ++.||.|||+++++||||||+||++
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~q---------------------------i~~~l~~LH~~~ivH~dlkp~Nill 151 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLS---------------------------VLRALSYLHNQGVIHRDIKSDSILL 151 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCEeecCCCHHHEEE
Confidence 999998887664 23444444444444 4559999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++||+++|..||.
T Consensus 152 ~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 152 TSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred cCCC-CEEEccCcchhhcccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9666 79999999986543222 2234567888999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=266.40 Aligned_cols=194 Identities=22% Similarity=0.411 Sum_probs=158.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+.++|++.+.||+|+||+||++.+..+++.+|+|++... ..+.+.+|+++++.+ +|+||+++++.+.+. ..++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEE
Confidence 357899999999999999999999889999999987532 235788999999999 999999999999544 6789
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlkp 181 (332)
+++||++++++..+.. .++......+ +.+++.||.|||+ .+++||||+|
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~---------------------------~~~i~~~l~~LH~~~~i~H~dl~p 132 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKI---------------------------AVAVVEGLTYLYNVHRIMHRDIKP 132 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHH---------------------------HHHHHHHHHHHHHhcCeeccCCCH
Confidence 9999999998876542 2344444444 4445559999997 5899999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+||+++.++ .++|+|||++..... .......++..|+|||++.+ ..++.++|+|||||++|++++|..||..
T Consensus 133 ~nil~~~~~-~~~l~d~gl~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 133 SNILVNSRG-QIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred HHEEECCCC-cEEEccCCcccchhh-hccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 999999665 799999999865432 22234568889999999876 5788999999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=264.11 Aligned_cols=194 Identities=22% Similarity=0.416 Sum_probs=152.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.++|+..+.||+|+||.||++.+..+++.+|+|.+... ....+.+|+.++.++..|+||+++++++.. ....++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 35677889999999999999999999999999998642 235678999999999569999999998854 356789
Q ss_pred EEeeecCCCceeec--------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeec
Q 040656 107 IFEHVNSTDFKVLY--------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHR 177 (332)
Q Consensus 107 v~e~~~~~~l~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHr 177 (332)
++|++... +..+. ..+++..+. .++.+++.||+|||+. +++||
T Consensus 81 ~~e~~~~~-l~~l~~~~~~~~~~~l~~~~~~---------------------------~i~~~i~~~l~~lh~~~~i~H~ 132 (288)
T cd06616 81 CMELMDIS-LDKFYKYVYEVLKSVIPEEILG---------------------------KIAVATVKALNYLKEELKIIHR 132 (288)
T ss_pred EEecccCC-HHHHHHHHHHhhcCCCCHHHHH---------------------------HHHHHHHHHHHHHhhcCCeecc
Confidence 99998642 11111 123333333 3455566699999975 99999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||||+||+++.++ .++|+|||++.............++..|+|||++.+. ..++.++||||||+++|+|++|..||.
T Consensus 133 dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 133 DVKPSNILLDRNG-NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred CCCHHHEEEccCC-cEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 9999999999666 7999999998765433333444678889999998764 368899999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=264.13 Aligned_cols=192 Identities=27% Similarity=0.451 Sum_probs=156.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.|...+.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++.+.+ ....+++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEE
Confidence 4578889999999999999999889999999998632 234688999999999 89999999999854 4578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++++++...+. .+++..+.. ++.+++.|+.|||+++++|+||+|+||+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~lH~~~ivH~dl~p~ni~ 133 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIAT---------------------------ILREILKGLDYLHSERKIHRDIKAANVL 133 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHH---------------------------HHHHHHHHHHHHhcCCeeccCCChheEE
Confidence 99999988766542 234444433 3445556999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 134 i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 134 LSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred EeCCC-CEEEccccccccccCcchhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 99666 79999999987654322 1223457788999999877 578899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=259.17 Aligned_cols=260 Identities=30% Similarity=0.549 Sum_probs=180.7
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
|++.+.||.|++|.||+|.+..++..||+|++... ....+.+|+++++++ +|+|++++++++.+ ....++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheecc--CCeEEEEE
Confidence 67889999999999999999889999999998632 235678899999999 89999999999854 46789999
Q ss_pred eeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||+++ ++..++. .+++..+.. ++.|++.||+|||+.+++|+||+|+|
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~---------------------------~~~~i~~~L~~lH~~~~~H~dl~p~n 129 (283)
T cd07835 78 EFLDL-DLKKYMDSSPLTGLDPPLIKS---------------------------YLYQLLQGIAYCHSHRVLHRDLKPQN 129 (283)
T ss_pred eccCc-CHHHHHhhCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence 99864 4444331 233433333 44555569999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+++.++ .++|+|||.+....... ......++..|+|||++.+...++.++|+||||+++|+|++|..||. ..+...
T Consensus 130 il~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~ 207 (283)
T cd07835 130 LLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP-GDSEID 207 (283)
T ss_pred EEEcCCC-cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHH
Confidence 9999755 79999999987553222 22333567789999988765567899999999999999999999984 444445
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC--cccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN--NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+.+..+.+....+.. ....+.......+ |.... ...........+++.+||+.||++||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 273 (283)
T cd07835 208 QLFRIFRTLGTPDEDVWPG---VTSLPDYKPTFPK---WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273 (283)
T ss_pred HHHHHHHHhCCCChHHhhh---hhhchhhhhhccc---ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC
Confidence 5555555444332211100 0011111111111 11000 001111223346788899999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.50 Aligned_cols=187 Identities=16% Similarity=0.297 Sum_probs=145.2
Q ss_pred EeecccCCceEEEEEEccCCc-------eEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 38 RKVGRGKYSEVFEGINVTNNE-------KCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~-------~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.||+|+||.||+|.+...+. .+++|.+.... .+.+.+|+.+++.+ +||||+++++++... ...+++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCG--DESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeC--CCcEEE
Confidence 468999999999998755443 48888876432 34678899999999 999999999998643 568999
Q ss_pred EeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||++++++..++.. ++..... .++.|++.||+|||++||+||||||+|
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~---------------------------~~~~qi~~~l~~lH~~~iiH~dlkp~n 130 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKL---------------------------EVAKQLAWALHFLEDKGLTHGNVCAKN 130 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999988776532 2333333 345566669999999999999999999
Q ss_pred eeecCCCCe-------EEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 184 VMIDHEQQK-------LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 184 ilv~~~~~~-------vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+++.++.. ++++|||.+..... .....++..|+|||++.+...++.++||||||+++|+|++|..+++.
T Consensus 131 ili~~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 131 VLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred EEEecccccccCCCceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 999866532 79999998865432 22346778899999997756689999999999999999999644433
Q ss_pred C
Q 040656 257 G 257 (332)
Q Consensus 257 ~ 257 (332)
.
T Consensus 208 ~ 208 (258)
T cd05078 208 A 208 (258)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=260.81 Aligned_cols=193 Identities=25% Similarity=0.402 Sum_probs=154.6
Q ss_pred CCceEEEeecccCCceEEEEEE----ccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGIN----VTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.-|.+++.||+|+||.||+|.. ..++..||+|.++.. ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence 4579999999999999999874 457889999998633 235688999999999 9999999999987655567
Q ss_pred ceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++|||+++++|..++.. ++...... ++.+++.||+|||++|++||||
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~---------------------------i~~~i~~aL~~lH~~gi~H~dl 135 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLK---------------------------YAVQICKGMDYLGSRQYVHRDL 135 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeeeccc
Confidence 8999999999998776521 33333333 4445556999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|+++..|.
T Consensus 136 kp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 136 AARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred chheEEEcCCC-CEEECCCccccccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCC
Confidence 99999999666 799999999876543322 122345667999999876 57889999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=255.12 Aligned_cols=185 Identities=19% Similarity=0.398 Sum_probs=146.3
Q ss_pred EeecccCCceEEEEEEccCC---ceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVTNN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
++||+|+||.||+|....++ ..+|+|.++... .+.+.+|+.+++.+ .|+||+++++++.. ...++++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence 47999999999999875555 789999987432 35688999999999 99999999998743 357999999
Q ss_pred ecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
++++++..++. .++...... ++.|++.||++||+.+++|+||||+||+++
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~---------------------------~~~qi~~~l~~lh~~~i~H~di~p~nili~ 129 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKE---------------------------LAHQVAMGMAYLESKHFVHRDLAARNVLLV 129 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHH---------------------------HHHHHHHHHHHHhhcCeeccCcccceEEEc
Confidence 99988776652 234444444 444555699999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCccc----ccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
.++ .++|+|||+++......... ...++..|+|||.+.+ ..++.++||||||+++|++++ |..||.
T Consensus 130 ~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~ 200 (257)
T cd05060 130 NRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG 200 (257)
T ss_pred CCC-cEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence 666 79999999988664333211 1122456999999876 678999999999999999998 899984
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=261.31 Aligned_cols=201 Identities=20% Similarity=0.263 Sum_probs=140.7
Q ss_pred ccCCCCCCceEEEeecccCCceEEEEEEccC---CceEEEEEecccchH--------------HHHHHHHHHHhccCCCC
Q 040656 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPVKKK--------------KIKREIKILQNLCGGPN 88 (332)
Q Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~~--------------~~~~E~~~l~~l~~h~n 88 (332)
+.....++|.+.+.||+|+||.||+|....+ +..+|+|+....... ....+...+..+ .|+|
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~ 84 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLG 84 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCC
Confidence 3445668999999999999999999998776 667788864321110 111223334455 7999
Q ss_pred eeeeeeeeeccCCC--CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHH
Q 040656 89 IVKLLDIVRDQHSK--TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDL 163 (332)
Q Consensus 89 iv~~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (332)
++++++.+...... ..+++++++.... .... ...+...+ ..++.|++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---------------------------~~i~~qi~ 136 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENT-KEIFKRIKCKNKKLI---------------------------KNIMKDML 136 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCH-HHHHHhhccCCHHHH---------------------------HHHHHHHH
Confidence 99999876433221 2244555443221 1111 11222222 24566677
Q ss_pred HHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCC--------cccccccccceeccccccCCCCCCCcc
Q 040656 164 QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSL 235 (332)
Q Consensus 164 ~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~s 235 (332)
.||+|||+++|+||||||+|||++.++ .++|+|||+++.+.... ......||..|+|||+..+ ..++.++
T Consensus 137 ~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~ 214 (294)
T PHA02882 137 TTLEYIHEHGISHGDIKPENIMVDGNN-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRG 214 (294)
T ss_pred HHHHHHHhCCeecCCCCHHHEEEcCCC-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHH
Confidence 799999999999999999999998665 79999999998664221 1123468999999999876 6789999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCC
Q 040656 236 DMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 236 DiwSlG~il~elltg~~pf~~~ 257 (332)
|||||||+++||++|..||...
T Consensus 215 DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 215 DLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred HHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999543
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=265.67 Aligned_cols=212 Identities=17% Similarity=0.303 Sum_probs=154.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccC-------CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTN-------NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
..+|++.+.||+|+||.||+|.+... +..+|+|.++.. ....+.+|+.+++++.+|+||+++++.+..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 46799999999999999999976432 236899988642 235688999999999789999999999854
Q ss_pred CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
....++++||++++++..++.......... ....+ ........+.+...++.|++.||+|||++|++||||
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~----~~~~~----~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl 160 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDY----SFDTC----KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCccccc----ccccc----cCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 457899999999988766543211000000 00000 000001122233456778888999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
||+||+++.++ .++|+|||+++........ ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 161 kp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 161 AARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred ccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 99999999666 7999999998765432211 11233456999999877 678999999999999999998 77887
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=256.85 Aligned_cols=190 Identities=25% Similarity=0.455 Sum_probs=154.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc---------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+|.+.+.||+|+||.||+|.. .+++.+|+|.++.. ....+.+|+++++++ +|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeec--CCe
Confidence 478899999999999999976 57889999988632 124588899999999 89999999999954 367
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++++||++++++..++. .+++..+..++.+++ .||++||+.+++|+||+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~i~H~dl~ 129 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---------------------------DGVAYLHNNCVVHRDIK 129 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCcccCCcC
Confidence 899999999998877652 345555555555555 49999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCC-------CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPG-------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|+||+++.++ .++|+|||.+...... .......++..|+|||++.+ ..++.++|+||||+++|++++|..|
T Consensus 130 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p 207 (265)
T cd06631 130 GNNVMLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPP 207 (265)
T ss_pred HHhEEECCCC-eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCc
Confidence 9999999666 7999999988654211 11223467888999999876 5688999999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 208 ~~ 209 (265)
T cd06631 208 LA 209 (265)
T ss_pred cc
Confidence 94
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.61 Aligned_cols=268 Identities=27% Similarity=0.498 Sum_probs=185.1
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC-
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS- 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 101 (332)
|...++|.+.+.||+|+||.||+|.+..++..||+|.+... ....+.+|+.+++++ +|+||+++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccc
Confidence 44468899999999999999999999899999999998532 234678999999999 99999999998854322
Q ss_pred ---CCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 102 ---KTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 102 ---~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...+++++++ ++++..+. ..++...+..++. |++.||+|||+.||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~---------------------------qi~~al~~LH~~gi~H 141 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVY---------------------------QMLKGLKYIHAAGIIH 141 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeec
Confidence 2358999998 55554443 2445554444444 4455999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||||+||+++.++ .++|+|||++..... ......++..|+|||.+.+...++.++|+||||+++|++++|..||.
T Consensus 142 ~dlkp~Nill~~~~-~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~- 217 (343)
T cd07880 142 RDLKPGNLAVNEDC-ELKILDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK- 217 (343)
T ss_pred CCCCHHHEEEcCCC-CEEEeeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-
Confidence 99999999999666 799999999876532 22334667889999998764568899999999999999999999994
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCC--CcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIP--NNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.+.......+........ .++........ ....+......... ............+++..|++.||++||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t 291 (343)
T cd07880 218 GHDHLDQLMEIMKVTGTPS-KEFVQKLQSED---AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT 291 (343)
T ss_pred CCCHHHHHHHHHHhcCCCC-HHHHHhhcchh---HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC
Confidence 4444445555544433321 12222221111 11111111000000 0000112222347788899999999996
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=258.77 Aligned_cols=193 Identities=27% Similarity=0.475 Sum_probs=157.4
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhcc--CCCCeeeeeeeeeccCCCCcee
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~~~l 106 (332)
.|++.+.||+|+||.||+|.+..+++.+|+|.++.. ..+.+.+|+.+++++. .|+|++++++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 478899999999999999999899999999998532 3356889999999994 39999999999854 457899
Q ss_pred EEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 107 IFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 107 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
++||++++++..++. .+++..+.. ++.+++.||.+||+.|++|+||+|+||
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~---------------------------i~~~i~~~l~~lh~~~i~H~dl~p~ni 132 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISV---------------------------IIREVLVALKYIHKVGVIHRDIKAANI 132 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCcccCCcCHHHE
Confidence 999999988766542 233333333 444555699999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+++.++ .++|+|||.+........ .....++..|+|||.+.+...++.++|+||||+++|+|++|..||.
T Consensus 133 ~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 203 (277)
T cd06917 133 LVTNTG-NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203 (277)
T ss_pred EEcCCC-CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence 999655 799999999887654332 2344688889999998765667899999999999999999999994
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=265.28 Aligned_cols=266 Identities=28% Similarity=0.481 Sum_probs=185.7
Q ss_pred CceEEEeecccCCceEEEEEEccC--CceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeec--cCCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTN--NEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRD--QHSKT 103 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~ 103 (332)
+|++.+.||+|+||.||++.+..+ +..||+|.++.. ..+.+.+|+.+++++.+|+||+++++.+.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999998877 889999998632 134678899999999679999999987532 22245
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.+++++++.+ ++...+ ..++...+..++.++ +.||+|||+.|++|||||
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi---------------------------~~aL~~LH~~givH~dlk 132 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQI---------------------------LCGLKYIHSANVLHRDLK 132 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCcccCCCC
Confidence 6788888764 343332 234455555445544 459999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||.+........ .....++..|+|||++.+...++.++|+||||+++|++++|..||
T Consensus 133 p~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf- 210 (332)
T cd07857 133 PGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF- 210 (332)
T ss_pred HHHeEEcCCC-CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-
Confidence 9999999666 799999999976542221 223467888999998766567899999999999999999999888
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC--cccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN--NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
...+....+..+...++.+... .+..+ ..+.....+.....+.... ...........+++..||+.||++||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t 285 (332)
T cd07857 211 KGKDYVDQLNQILQVLGTPDEE-TLSRI---GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285 (332)
T ss_pred CCCCHHHHHHHHHHHhCCCCHH-HHHhh---hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC
Confidence 4555566777777777654332 12111 1111111111111111000 000111233457889999999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=255.73 Aligned_cols=194 Identities=23% Similarity=0.370 Sum_probs=154.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.......||+|+||.||+|.+..++..|++|.+... ..+.+.+|+.+++++ +|+||+++++++.. ....++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSE--NGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeecc--CCEEEEEE
Confidence 3344456899999999999998889999999998643 335688999999999 99999999999854 45789999
Q ss_pred eeecCCCceeeccc----c--chhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 109 EHVNSTDFKVLYPT----L--TANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 109 e~~~~~~l~~~~~~----~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
||+++++|..++.. + +..... .++.|++.||+|||++||+||||||+
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~---------------------------~~~~qi~~al~~lH~~~i~h~dl~p~ 137 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTII---------------------------FYTKQILEGLKYLHDNQIVHRDIKGD 137 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHH---------------------------HHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 99999888766421 1 222222 34456667999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.+.+.++|+|||.+........ .....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||.
T Consensus 138 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred HEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 999986556899999999876542222 2334578889999998553 247899999999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=256.96 Aligned_cols=192 Identities=26% Similarity=0.480 Sum_probs=154.2
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----c--------hHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----K--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~--------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
+|.+.+.||+|+||.||+|....+++.+|+|.++.. . .+.+.+|+.+++.+ +|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETT- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEecc-
Confidence 588899999999999999998889999999987521 0 13577899999999 99999999999854
Q ss_pred CCCCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....++++||++++++...+. .++......++.+ ++.||.+||+.+++|
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~q---------------------------i~~~l~~lH~~~i~H 131 (272)
T cd06629 80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ---------------------------VLEGLAYLHSKGILH 131 (272)
T ss_pred -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHH---------------------------HHHHHHHHhhCCeee
Confidence 457899999999998876652 2444444444444 455999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCC-CCCCcccHHHHHHHHHHHHhCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~sDiwSlG~il~elltg~~ 252 (332)
+||+|+||+++.++ .++|+|||++....... ......++..|+|||.+.... .++.++|+||||++++++++|..
T Consensus 132 ~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 210 (272)
T cd06629 132 RDLKADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210 (272)
T ss_pred cCCChhhEEEcCCC-eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence 99999999999665 79999999987543211 123346778899999986632 47899999999999999999999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 211 p~~ 213 (272)
T cd06629 211 PWS 213 (272)
T ss_pred CCc
Confidence 984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=255.11 Aligned_cols=192 Identities=25% Similarity=0.511 Sum_probs=157.0
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|.+.+.||+|+||.||+|....++..+|+|.+... ..+.+.+|+.+++++ +|+||+++++.+.+ ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence 589999999999999999999999999999998632 345678999999999 99999999999844 4678999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||++++++...+.. +++..+..++ .++++||.|||+.+++|+||||+
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~---------------------------~~l~~~l~~lh~~~i~H~dl~~~ 130 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWF---------------------------VQISLGLKHIHDRKILHRDIKSQ 130 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHH---------------------------HHHHHHHHHHHHCCcccccCCHH
Confidence 999999887665422 3344344444 44555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++..++|+|||.+........ .....++..|+|||...+ ..++.++|+||||++++++++|..||.
T Consensus 131 nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 203 (257)
T cd08225 131 NIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFE 203 (257)
T ss_pred HEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999987765679999999876543322 223457888999998876 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=256.02 Aligned_cols=261 Identities=28% Similarity=0.472 Sum_probs=185.4
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
|.+.+.||+|++|.||+|....+++.|++|.+... ......+|+..+.++..|+|++++++++.+ ....+++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 67899999999999999999888999999998643 223456799999999349999999999855 567899999
Q ss_pred eecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 110 HVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 110 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
++ ++++...+. .++...+. .++.|++.+|.|||++|++|+||+|+||
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~~l~~Lh~~~i~H~dl~~~ni 130 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIR---------------------------SIIYQILQGLAHIHKHGFFHRDLKPENL 130 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHH---------------------------HHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 99 444433321 22333333 3455556699999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~ 264 (332)
+++.++ .++|+|||.+.............++..|+|||++.+...++.++|+||||+++++|++|..|| +.....+..
T Consensus 131 ~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~ 208 (283)
T cd07830 131 LVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQL 208 (283)
T ss_pred EEcCCC-CEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHH
Confidence 999665 799999999987654444455677888999998866566899999999999999999999888 455556666
Q ss_pred HHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcc---cccccccccccCceEEEeCCCCCCC
Q 040656 265 VKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNK---KLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.++....+.+....+........ ... ...+....... ..........++..||+.||++||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt 273 (283)
T cd07830 209 YKICSVLGTPTKQDWPEGYKLAS--KLG----FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273 (283)
T ss_pred HHHHHhcCCCChhhhhhHhhhhc--ccc----ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC
Confidence 66666655544332222211000 000 00000000000 0011233458889999999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=273.45 Aligned_cols=244 Identities=24% Similarity=0.483 Sum_probs=199.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
..|.+...||+|.|+.|.+|++..++..||+|++.+. ....+.+|+++|..+ +||||++++.+.. ....+++
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~--t~~~lyl 132 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIE--TEATLYL 132 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeee--ecceeEE
Confidence 5699999999999999999999999999999999753 234588999999999 9999999999984 4568999
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||+.++.+.+.+ +++.+..++.++.|++. |++|+|+++|+|||||++|
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vs---------------------------aveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVS---------------------------AVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHH---------------------------HHHHHhhcceeccccchhh
Confidence 99999999888775 56777888888888877 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
||++.+. .+||+|||++..+..+....+.+|++.|.|||+..+....++.+|+||+|+++|.|+.|..||. +.+-.+.
T Consensus 186 ilL~~~m-nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-G~~lk~L 263 (596)
T KOG0586|consen 186 ILLDENM-NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-GQNLKEL 263 (596)
T ss_pred ccccccc-ceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-Ccccccc
Confidence 9999777 5999999999999877788899999999999999997777899999999999999999999994 2221111
Q ss_pred HHHHHH----H--hCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCccc
Q 040656 264 LVKIAR----V--LGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKK 308 (332)
Q Consensus 264 ~~~~~~----~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~ 308 (332)
-..... . +.+.+-.+++.++ +-+.|..+..++++ ++|.....+.
T Consensus 264 r~rvl~gk~rIp~~ms~dce~lLrk~-lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFYMSCDCEDLLRKF-LVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cchheeeeecccceeechhHHHHHHh-hccCccccCCHHHhhhhcccchhhhh
Confidence 111111 1 1133444556655 56777777777776 7787555444
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=254.43 Aligned_cols=186 Identities=22% Similarity=0.422 Sum_probs=151.9
Q ss_pred EeecccCCceEEEEEEccC---CceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVTN---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||+|+||.||+|..... +..+++|+++... ...+.+|+..++.+ +|+||+++++++.+ ....++++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999998765 8999999987432 46788999999999 79999999999854 5678999999
Q ss_pred ecCCCceeeccc------------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 111 VNSTDFKVLYPT------------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 111 ~~~~~l~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
++++++..++.. +++.....++. ++++||++||+++++|+|
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~l~~al~~lH~~~i~H~d 130 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI---------------------------QIAKGMEYLASKKFVHRD 130 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHH---------------------------HHHHHHHHHHcCCcccCc
Confidence 999988776532 34444444444 445599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||
T Consensus 131 i~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 131 LAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred cCcceEEECCCC-cEEEcccccccccccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 999999999766 79999999998765432 2233456778999999877 578999999999999999999 58888
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 209 ~ 209 (262)
T cd00192 209 P 209 (262)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=258.37 Aligned_cols=185 Identities=27% Similarity=0.425 Sum_probs=150.9
Q ss_pred ecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
||+|+||.||+|.+..+++.||+|++... ....+..|+++++++ +||||+++++.+.. ....++++||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 68999999999999889999999998532 123467899999999 89999999999854 4578999999999
Q ss_pred CCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 114 TDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 114 ~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++...+. .+++..+..++.++ +.||.|||+.|++|+||+|+||+++.
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql---------------------------~~~l~~lH~~~i~H~di~p~Nil~~~ 130 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQI---------------------------ICGLEHLHQRRIVYRDLKPENVLLDD 130 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCcccCCCCHHHEEECC
Confidence 88876541 34444444444554 45999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
++ .++|+|||.+.............++..|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus 131 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 131 HG-NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred CC-CEEEccCcchhhhccCCccccccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 66 799999999876544333344567778999999877 5589999999999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=254.56 Aligned_cols=189 Identities=19% Similarity=0.379 Sum_probs=151.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.++|++.+.||+|+||.||++. .+++.+|+|.++.. ....+.+|+.+++++ +|+|++++++++.. ...++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~~~~~v~ 77 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH---NGLYIVM 77 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC---CCcEEEE
Confidence 34779999999999999999985 47889999998643 446788999999999 99999999999854 2479999
Q ss_pred eeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||+.++++..++.. ++..... .++.|++.||.|||+.|++||||||+|
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------~~~~qi~~al~~lH~~~~~H~dl~p~n 130 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLL---------------------------QFSLDVAEGMEYLESKKLVHRDLAARN 130 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHH---------------------------HHHHHHHHHHHHHHhCCeeccccCcce
Confidence 99999887766422 2222222 345566669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||++...... ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.
T Consensus 131 ili~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 199 (254)
T cd05083 131 ILVSEDG-VAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199 (254)
T ss_pred EEEcCCC-cEEECCCccceecccc--CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 9999666 7999999998764322 122234567999998876 578999999999999999997 888883
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=257.98 Aligned_cols=187 Identities=25% Similarity=0.422 Sum_probs=146.2
Q ss_pred eecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhc--cCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 39 KVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
.||+|+||.||++.+..+++.+|+|++.+.. .....+|..+++.+ .+|+||+.+++.+.. ....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 4899999999999998899999999986321 12334454444443 268999999999854 3578999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
++++++...+ ..++...+..++.+++ .||.|||+.+++||||||+||+++
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~---------------------------~al~~lH~~~ivH~dikp~Nil~~ 131 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEII---------------------------LGLEHMHNRFVVYRDLKPANILLD 131 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCcCCCCCCHHHEEEC
Confidence 9999886654 2355555555555554 499999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
.++ .++|+|||++...... ......++..|+|||.+.+...++.++|+|||||++|+|++|..||..
T Consensus 132 ~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 132 EHG-HVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred CCC-CEEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 666 7999999998755422 223346888999999986545688999999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=271.14 Aligned_cols=210 Identities=24% Similarity=0.429 Sum_probs=187.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++++++..||-|+||.|-++........+|+|++++. ..+++..|-.||... ..+.|+++|..|.+ +..
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~ky 494 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKY 494 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chh
Confidence 346788999999999999999876555556999998743 446788999999999 79999999999955 468
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.|++||-|-||.+-.++ +.+.+...+++..-++. |++|||++|||+||||
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~E---------------------------AfeYLH~k~iIYRDLK 547 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLE---------------------------AFEYLHRKGIIYRDLK 547 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHH---------------------------HHHHHHhcCceeccCC
Confidence 99999999999988876 67899999998888877 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+|+|++.++ -+||.|||+|+.+..+....+++||+.|.|||++++ ..++.++|.||||+++|||++|.+|| .+.++
T Consensus 548 PENllLd~~G-y~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dp 624 (732)
T KOG0614|consen 548 PENLLLDNRG-YLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDP 624 (732)
T ss_pred hhheeeccCC-ceEEeehhhHHHhccCCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCch
Confidence 9999999887 599999999999999999999999999999999998 78999999999999999999999998 78888
Q ss_pred HHHHHHHHHHhC
Q 040656 261 QDQLVKIARVLG 272 (332)
Q Consensus 261 ~~~~~~~~~~~~ 272 (332)
......|.+++.
T Consensus 625 mktYn~ILkGid 636 (732)
T KOG0614|consen 625 MKTYNLILKGID 636 (732)
T ss_pred HHHHHHHHhhhh
Confidence 888888888755
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=255.08 Aligned_cols=184 Identities=20% Similarity=0.301 Sum_probs=142.0
Q ss_pred EeecccCCceEEEEEEcc------------CCceEEEEEecccch---HHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 38 RKVGRGKYSEVFEGINVT------------NNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~------------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.||+|+||.||+|.... ....+++|++..... ..+.+|+.+++.+ +||||+++++++.+. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~--~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRD--V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--C
Confidence 468999999999997532 223689998764332 3677889999999 999999999998543 5
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++++||++++++..++. .++..... .++.|+++||+|||+++|+|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~---------------------------~i~~qi~~~l~~lH~~~ivH~d 130 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF---------------------------KVAKQLASALSYLEDKDLVHGN 130 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHH---------------------------HHHHHHHHHHHHhhhCCeECCC
Confidence 6799999999988765542 13333333 3555666799999999999999
Q ss_pred CCCCCeeecCCCC------eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH-hCC
Q 040656 179 VKPHNVMIDHEQQ------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRK 251 (332)
Q Consensus 179 lkp~Nilv~~~~~------~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell-tg~ 251 (332)
|||+|||++.++. .++++|||++...... ....++..|+|||.+.....++.++|||||||++|+|+ +|.
T Consensus 131 lkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~ 207 (262)
T cd05077 131 VCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207 (262)
T ss_pred CCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 9999999975442 3899999998654322 23457778999998875567899999999999999998 577
Q ss_pred CCC
Q 040656 252 EPF 254 (332)
Q Consensus 252 ~pf 254 (332)
.||
T Consensus 208 ~p~ 210 (262)
T cd05077 208 IPL 210 (262)
T ss_pred CCC
Confidence 776
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=253.75 Aligned_cols=193 Identities=27% Similarity=0.473 Sum_probs=156.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|.+.+.||+|+||.||+|....+++.+++|+++.. ....+.+|+++++++ +|+||+++++.+.+ ....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence 589999999999999999998889999999998743 235688999999999 99999999998743 4578999
Q ss_pred EeeecCCCceeeccc---cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
+||++++++..+... ++...... ++.+++.||.|||+.|++|+||+|+||
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~---------------------------i~~~i~~~l~~lh~~~i~H~dl~~~ni 130 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRV---------------------------YTLQLLEGLAYLHSHGIVHRDIKPANI 130 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHH---------------------------HHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 999999988776422 33333333 444555699999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~--~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+++.++ .++|+|||.+........ .....++..|+|||++.+.. .++.++||||||++++++++|..||..
T Consensus 131 l~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 131 FLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred EECCCC-CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 999755 799999999876543222 11245678899999987632 278999999999999999999999953
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=271.50 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=190.1
Q ss_pred ccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeee
Q 040656 22 ESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVR 97 (332)
Q Consensus 22 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 97 (332)
+...++.-.++...++++||+|.||+|.+|.. ..+..||+|.++.. .+.+|.+|+++|.+| +||||+.++|+|.
T Consensus 528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~ 605 (807)
T KOG1094|consen 528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCV 605 (807)
T ss_pred cCcchhhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeee
Confidence 55666667789999999999999999999974 56799999999854 346799999999999 9999999999996
Q ss_pred ccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 98 DQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
.+ ..+|+|+||++.|+|..++..-...++ -.. .-+.++.||++||+||.+.++|||
T Consensus 606 ~D--ePicmI~EYmEnGDLnqFl~aheapt~--~t~--------------------~~vsi~tqiasgmaYLes~nfVHr 661 (807)
T KOG1094|consen 606 QD--DPLCMITEYMENGDLNQFLSAHELPTA--ETA--------------------PGVSICTQIASGMAYLESLNFVHR 661 (807)
T ss_pred cC--CchHHHHHHHhcCcHHHHHHhccCccc--ccc--------------------hhHHHHHHHHHHHHHHHhhchhhc
Confidence 54 468999999999999887633211110 000 113477888889999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCccc---ccccccceeccccccCCCCCCCcccHHHHHHHHHHHH--hCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI--FRKE 252 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell--tg~~ 252 (332)
||.+.|+|++.+. ++||+|||+++-+-.+.... ..+-...|||||.+.. ..++.+||+|+||+++||++ +...
T Consensus 662 d~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~ 739 (807)
T KOG1094|consen 662 DLATRNCLVDGEF-TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQ 739 (807)
T ss_pred cccccceeecCcc-cEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhC
Confidence 9999999999777 79999999998654333221 2244677999999887 68999999999999999985 4788
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
||. ...+.+..+.....+........+.+. .-++..+- +++..||+.|.++||+
T Consensus 740 Py~-~lt~e~vven~~~~~~~~~~~~~l~~P-~~cp~~ly------------------------elml~Cw~~es~~RPs 793 (807)
T KOG1094|consen 740 PYS-QLTDEQVVENAGEFFRDQGRQVVLSRP-PACPQGLY------------------------ELMLRCWRRESEQRPS 793 (807)
T ss_pred chh-hhhHHHHHHhhhhhcCCCCcceeccCC-CcCcHHHH------------------------HHHHHHhchhhhcCCC
Confidence 983 333444444444433333222222221 22333333 3345699999999996
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=264.36 Aligned_cols=212 Identities=30% Similarity=0.517 Sum_probs=162.2
Q ss_pred CCCCceE-EEeecccCCceEEEEEEccCCceEEEEEecccch-----------------HHHHHHHHHHHhccCCCCeee
Q 040656 30 DQEDYEV-VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNIVK 91 (332)
Q Consensus 30 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~~h~niv~ 91 (332)
..++|.. .+.||+|+||.||+|.+..+++.||+|+++.... ..+.+|+++++++ +|+||++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~ 84 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMG 84 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceee
Confidence 3567864 5779999999999999988999999999864221 1467899999999 9999999
Q ss_pred eeeeeeccCCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHH
Q 040656 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDY 168 (332)
Q Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 168 (332)
+++++.. ....+++||++.+ ++...+ ..++......+ +.|++.||++
T Consensus 85 ~~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~---------------------------~~ql~~aL~~ 134 (335)
T PTZ00024 85 LVDVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI---------------------------LLQILNGLNV 134 (335)
T ss_pred eeEEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHH---------------------------HHHHHHHHHH
Confidence 9999854 4578999999975 443332 12444444444 4455559999
Q ss_pred HHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCC---------------CcccccccccceeccccccCCCCCCC
Q 040656 169 CHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDY 233 (332)
Q Consensus 169 LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~ 233 (332)
||+.|++|+||+|+||+++.++ .++|+|||.+...... .......++..|+|||.+.+...++.
T Consensus 135 LH~~~i~H~dl~~~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 213 (335)
T PTZ00024 135 LHKWYFMHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHF 213 (335)
T ss_pred HHhCCeecccccHHHeEECCCC-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCc
Confidence 9999999999999999999666 7999999998765411 11122345778999999876556799
Q ss_pred cccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 040656 234 SLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTD 274 (332)
Q Consensus 234 ~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 274 (332)
++|+|||||++|+|++|..|| .+.++.+.+..+....+.+
T Consensus 214 ~~Dv~slG~~l~el~tg~~p~-~~~~~~~~~~~i~~~~~~~ 253 (335)
T PTZ00024 214 AVDMWSVGCIFAELLTGKPLF-PGENEIDQLGRIFELLGTP 253 (335)
T ss_pred HHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence 999999999999999999998 4555556666666655543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.24 Aligned_cols=189 Identities=26% Similarity=0.418 Sum_probs=150.8
Q ss_pred CCceEEEee--cccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 32 EDYEVVRKV--GRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 32 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
++|++.+.+ |+|+||.||++....++..+|+|+++...... .|+.....+.+|+||+++++.|... ...+++||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--hhHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence 456676666 99999999999999999999999986432222 2344444344799999999999554 47899999
Q ss_pred eecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 110 HVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 110 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|+++++|..++. .+++..+..++.|++ +||.+||+.|++||||||+||++
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~---------------------------~~l~~lH~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLV---------------------------EALNDLHKHNIIHNDIKLENVLY 142 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeeeCCCCHHHEEE
Confidence 999998877642 355555555555555 49999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+.++..++|+|||.+...... ....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred eCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 976657999999998765422 23467888999999877 668999999999999999999999995
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=251.86 Aligned_cols=185 Identities=23% Similarity=0.403 Sum_probs=145.3
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
+.||+|+||.||+|.. .++..+|+|.++... ...+.+|+.+++++ +|+||+++++++.+ ....+++|||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 4689999999999985 578899999986432 34688999999999 99999999999854 3568999999999
Q ss_pred CCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCC
Q 040656 114 TDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE 189 (332)
Q Consensus 114 ~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~ 189 (332)
+++...+.. +....... +..+++.+|.|+|++|++||||||+||+++.+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~ 129 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVK---------------------------FALDAAAGMAYLESKNCIHRDLAARNCLVGEN 129 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeeecccChheEEEcCC
Confidence 987765421 23333333 34455569999999999999999999999866
Q ss_pred CCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 190 QQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 190 ~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
+ .++|+|||++......... ....++..|+|||++.+ ..++.++||||||+++|++++ |..||.
T Consensus 130 ~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~ 196 (250)
T cd05085 130 N-VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP 196 (250)
T ss_pred C-eEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence 5 7999999998754322211 11233456999999876 568899999999999999998 888983
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=262.87 Aligned_cols=292 Identities=24% Similarity=0.393 Sum_probs=212.3
Q ss_pred ccCCCCCc--cccccccccCCCC-CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccC
Q 040656 11 NVHRPRDY--WDYESLTVQWGDQ-EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCG 85 (332)
Q Consensus 11 ~~~~~~~~--~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~ 85 (332)
....|.+| .+|+...+..... .+|-+.++||.|.|++||+|.+..+.+.||+|+.+.. ..+....|+++|++++.
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence 34567777 8899999988877 9999999999999999999999999999999999743 34667889999999864
Q ss_pred C-------CCeeeeeeeee--ccCCCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCc
Q 040656 86 G-------PNIVKLLDIVR--DQHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152 (332)
Q Consensus 86 h-------~niv~~~~~~~--~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (332)
+ .+||++++.|. +.++.+.|+|+|++....|..+. +.++-..++.+.+|++.
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~--------------- 198 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLT--------------- 198 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHH---------------
Confidence 3 48999999985 46788999999999887776663 44666666666666555
Q ss_pred ccchhhHHhHHHHHHHHHHc-CCeecCCCCCCeeecCCCC----------------------------------------
Q 040656 153 MENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQ---------------------------------------- 191 (332)
Q Consensus 153 ~~~~~~~~~i~~~l~~LH~~-~ivHrdlkp~Nilv~~~~~---------------------------------------- 191 (332)
||.|||.+ ||||.||||+|||+....-
T Consensus 199 ------------GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s 266 (590)
T KOG1290|consen 199 ------------GLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMS 266 (590)
T ss_pred ------------HHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccc
Confidence 99999965 8999999999999731000
Q ss_pred --------------------------------------------------------------------------------
Q 040656 192 -------------------------------------------------------------------------------- 191 (332)
Q Consensus 192 -------------------------------------------------------------------------------- 191 (332)
T Consensus 267 ~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~ 346 (590)
T KOG1290|consen 267 KSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNN 346 (590)
T ss_pred hhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCcccccccc
Confidence
Q ss_pred ---------------------------------------------eEEEEecccceeecCCCcccccccccceecccccc
Q 040656 192 ---------------------------------------------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 226 (332)
Q Consensus 192 ---------------------------------------------~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 226 (332)
++||+|||-|+... ..++.-..|+.|+|||++.
T Consensus 347 ~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVll 424 (590)
T KOG1290|consen 347 TSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLL 424 (590)
T ss_pred ccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceee
Confidence 05666666666542 3345556888999999999
Q ss_pred CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHHHHhCCchHHHHHHhcCCC---CChhHHHHhccC
Q 040656 227 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNQDQLVKIARVLGTDELNAYLDKYHLE---LDPQLEALVGRK 298 (332)
Q Consensus 227 ~~~~~~~~sDiwSlG~il~elltg~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~~ 298 (332)
+ ..|++.+||||++|++|||+||...|.+.. .+.+.+..|+..++.-...-.+...... -......-|+++
T Consensus 425 G-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~L 503 (590)
T KOG1290|consen 425 G-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRL 503 (590)
T ss_pred c-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceeccccc
Confidence 9 789999999999999999999999996432 2456788888888753322111111000 001112223445
Q ss_pred CCCCCCCcccc------cccccccccCceEEEeCCCCCCC
Q 040656 299 RVWPIPNNKKL------QFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 299 ~~~~~~~~~~~------~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+|.-...... .....+.+|+.=+|+++|++||+
T Consensus 504 K~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 504 KPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred CCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 67753322211 12223347777799999999996
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.35 Aligned_cols=194 Identities=19% Similarity=0.401 Sum_probs=153.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc-----CCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+.++|++.+.||+|+||.||+|+... ..+.+++|.+.... ...+.+|+++++++ +|+||+++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 79 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE-- 79 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--
Confidence 45889999999999999999998643 34679999986432 35689999999999 99999999999854
Q ss_pred CCCceeEEeeecCCCceeeccc------------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHH
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPT------------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDY 168 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 168 (332)
....+++|||+++++|..++.. ++...... ++.|++.||.|
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~---------------------------~~~~l~~~l~~ 132 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA---------------------------LCTQIALGMDH 132 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHH---------------------------HHHHHHHHHHH
Confidence 4568999999999888766422 33333333 44455569999
Q ss_pred HHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 169 CHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 169 LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
||+.+|+||||||+||+++.++ .++++|||.+....... ......++..|+|||.+.+ ...+.++||||||+++|+
T Consensus 133 LH~~~i~H~dlkp~Nili~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~ 210 (275)
T cd05046 133 LSNARFVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWE 210 (275)
T ss_pred hhhcCcccCcCccceEEEeCCC-cEEEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHH
Confidence 9999999999999999999766 69999999886443211 1223355667999998876 567899999999999999
Q ss_pred HHh-CCCCCC
Q 040656 247 MIF-RKEPFF 255 (332)
Q Consensus 247 llt-g~~pf~ 255 (332)
+++ |..||.
T Consensus 211 l~~~~~~p~~ 220 (275)
T cd05046 211 VFTQGELPFY 220 (275)
T ss_pred HHhCCCCCcc
Confidence 998 778884
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=252.97 Aligned_cols=193 Identities=25% Similarity=0.460 Sum_probs=161.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||+|++|.||+|.+..+++.|++|++... ....+.+|+..+.++ +|+|++++++.+.. ...++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcc--CCeEEEE
Confidence 3689999999999999999999889999999998754 246789999999999 89999999999854 4678999
Q ss_pred EeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlkp~N 183 (332)
+||++++++..++. .+++.....++.+ +++|+.+||+ .+++|+||+|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~---------------------------l~~~l~~lh~~~~~~H~~l~~~n 130 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQ---------------------------ILKGLDYLHTKRHIIHRDIKPSN 130 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHH---------------------------HHHHHHHHhccCCCccCCCCHHH
Confidence 99999998877653 3444444444444 4559999999 999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcc-cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+++.++ .++|+|||.+......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 131 i~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~ 202 (264)
T cd06623 131 LLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLP 202 (264)
T ss_pred EEECCCC-CEEEccCccceecccCCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999666 7999999998876543332 24567888999999876 5788999999999999999999999943
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=274.14 Aligned_cols=239 Identities=22% Similarity=0.386 Sum_probs=194.8
Q ss_pred ccccccCCCCCCc-eEEEeecccCCceEEEEEEccCCceEEEEEecc-------cchHHHHHHHHHHHhccCCCCeeeee
Q 040656 22 ESLTVQWGDQEDY-EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-------VKKKKIKREIKILQNLCGGPNIVKLL 93 (332)
Q Consensus 22 ~~~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~~h~niv~~~ 93 (332)
.+..++-....+| +.-+.||+|.|-+||+|.+..+|-.||--.++. ....++..|+.+|+.| +|+||+++|
T Consensus 29 ~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy 107 (632)
T KOG0584|consen 29 ESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFY 107 (632)
T ss_pred cccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeee
Confidence 3344455555666 566889999999999999999998888665541 2347899999999999 999999999
Q ss_pred eeeeccCCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 94 DIVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
+++.+.+...+.+|+|.+..|+|.... +.+.-+-++.|..|+++ ||.|||
T Consensus 108 ~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILk---------------------------GL~yLH 160 (632)
T KOG0584|consen 108 DSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILK---------------------------GLVYLH 160 (632)
T ss_pred eheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHH---------------------------Hhhhhh
Confidence 999988888899999999999998886 34556666666666666 999999
Q ss_pred HcC--CeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 171 SQG--IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 171 ~~~--ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
++. |+|||||-+||+|+.+.+.|||.|+|+|+.... .......||+.|||||++. ..|+...||||||+++.||+
T Consensus 161 s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-s~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMv 237 (632)
T KOG0584|consen 161 SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-SHAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMV 237 (632)
T ss_pred cCCCCccccccccceEEEcCCcCceeecchhHHHHhhc-cccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHH
Confidence 885 999999999999998888999999999987653 3334479999999999986 47999999999999999999
Q ss_pred hCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC
Q 040656 249 FRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK 298 (332)
Q Consensus 249 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 298 (332)
|+..||.....+.....++..+..+..+ .+. .+|+++.+|.+.
T Consensus 238 T~eYPYsEC~n~AQIYKKV~SGiKP~sl----~kV---~dPevr~fIekC 280 (632)
T KOG0584|consen 238 TSEYPYSECTNPAQIYKKVTSGIKPAAL----SKV---KDPEVREFIEKC 280 (632)
T ss_pred hccCChhhhCCHHHHHHHHHcCCCHHHh----hcc---CCHHHHHHHHHH
Confidence 9999998888888888888776554433 222 477777777553
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=262.23 Aligned_cols=193 Identities=22% Similarity=0.407 Sum_probs=157.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+..|+....||+|+||.||+|.+..+++.||+|++.. ...+.+.+|+.+++.+ +||||+++++.+.. ....+++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLV--GEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheee--CCeEEEE
Confidence 3556677789999999999999988999999999853 2345688999999999 99999999999854 4578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++++++..+.. .++......+ +.|++.||++||+.|++|+||||+||+
T Consensus 97 ~e~~~~~~L~~~~~~~~~~~~~~~~~---------------------------~~qi~~~L~~LH~~~ivH~dl~p~Nil 149 (297)
T cd06659 97 MEFLQGGALTDIVSQTRLNEEQIATV---------------------------CESVLQALCYLHSQGVIHRDIKSDSIL 149 (297)
T ss_pred EecCCCCCHHHHHhhcCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCeecCCCCHHHeE
Confidence 99999988776542 2344444444 445555999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++++|++|..||.
T Consensus 150 l~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 150 LTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred EccCC-cEEEeechhHhhcccccccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99666 79999999986543222 2234568889999999876 578999999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.39 Aligned_cols=266 Identities=25% Similarity=0.475 Sum_probs=197.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCc----eEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..|+++..||+|.+|.||+|..++++. .+|+|.++... ....-+|+.+++.+ +|+|++.+..+|..- ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-Cc
Confidence 679999999999999999997665543 78999987442 24567899999999 999999999998643 56
Q ss_pred CceeEEeeecCCCceeec-------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 103 TPSLIFEHVNSTDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
..++++||.+...+..+. ..++...++.+++|++. |+.|||++=|+
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~---------------------------Gv~YLH~NWvl 154 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILD---------------------------GVHYLHSNWVL 154 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHh---------------------------hhHHHhhhhee
Confidence 899999999887655442 23555566666666665 99999999999
Q ss_pred ecCCCCCCeeecCC---CCeEEEEecccceeecCCC----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 176 HRDVKPHNVMIDHE---QQKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 176 Hrdlkp~Nilv~~~---~~~vkL~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
||||||.||||..+ .++|||+|||+++.+...- .....+-|.+|+|||.+++..-|+.+.||||.|||+.||+
T Consensus 155 HRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL 234 (438)
T KOG0666|consen 155 HRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL 234 (438)
T ss_pred eccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence 99999999999755 2489999999999876432 2344578999999999999888999999999999999999
Q ss_pred hCCCCCCCC--------CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCC--------CCccccc
Q 040656 249 FRKEPFFYG--------HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPI--------PNNKKLQ 310 (332)
Q Consensus 249 tg~~pf~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~--------~~~~~~~ 310 (332)
|..+.|... .-..+++..|...+|.+...+|..- ..-|+....++.. +.|.. ...-..
T Consensus 235 tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~l---kk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~- 310 (438)
T KOG0666|consen 235 TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDL---KKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKD- 310 (438)
T ss_pred ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhh---hhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCC-
Confidence 998777321 1135678899999998766655431 2224444444333 22221 111111
Q ss_pred ccccccccCceEEEeCCCCCCC
Q 040656 311 FCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 311 ~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
++--.++.++|++||-+|-+
T Consensus 311 --~~a~~LL~klL~yDP~kRIt 330 (438)
T KOG0666|consen 311 --PSALDLLQKLLTYDPIKRIT 330 (438)
T ss_pred --chHHHHHHHHhccCchhhcc
Confidence 11226677899999998853
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=260.69 Aligned_cols=191 Identities=30% Similarity=0.489 Sum_probs=152.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|.+.+.||+|+||.||+|....+++.||+|++... ....+.+|+++++.+ +||||+++++++.+. ...
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~--~~~ 90 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLRE--HTA 90 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeC--CeE
Confidence 46799999999999999999999889999999998532 124678999999999 999999999999653 568
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++++||+.+.....+. ..++...+.. ++.|++.||.|||+.|++|+||+|
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~---------------------------~~~ql~~~L~~LH~~~i~H~dl~p 143 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAA---------------------------ICHGALQGLAYLHSHERIHRDIKA 143 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCceecCCCc
Confidence 9999999864322221 2234444443 444555599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+||+++.++ .++|+|||++...... ....++..|+|||++.+ ...++.++||||||+++|+|++|..||.
T Consensus 144 ~nIl~~~~~-~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 144 GNILLTEPG-TVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred ccEEECCCC-CEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 999999666 7999999998764322 33467788999998753 2458899999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=255.67 Aligned_cols=192 Identities=27% Similarity=0.451 Sum_probs=156.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+-|.+.+.||+|+||.||+|.+..+++.+|+|++... ....+.+|+.++.++ +|+||+++++.+.+ +...+++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe--CCeEEEE
Confidence 4478899999999999999998889999999997632 235688999999999 99999999999854 3578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++++++..++. .++...+..++. +++.++.+||+.|++|+||+|+||+
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~---------------------------~l~~~l~~lh~~~i~h~dl~p~Ni~ 133 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILR---------------------------EILKGLDYLHSEKKIHRDIKAANVL 133 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHccCCeecCCCCHHhEE
Confidence 99999988776643 234444444444 4455999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.
T Consensus 134 i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 134 LSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred ECCCC-CEEEeecccceecccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99666 79999999987654322 2233467788999999876 567899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=251.22 Aligned_cols=193 Identities=18% Similarity=0.377 Sum_probs=153.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+..+|++.+.||+|+||.||+|.+. .+..+|+|.++.. ....+.+|+++++++ .|+|++++++++.. ....+++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEcc--CCceEEE
Confidence 3568999999999999999999874 4678999998643 346789999999999 99999999999854 3568999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+||+.++++..++. .++...+..++. +++.|+++||+.+++|+||||+|
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~---------------------------~l~~~l~~lH~~~i~h~dl~p~n 130 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCL---------------------------DVCEGMAYLESSNVIHRDLAARN 130 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCccccccccce
Confidence 99999988766542 234444444444 44559999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||.
T Consensus 131 i~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 131 CLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred EEEcCCC-eEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9998555 799999999876532211 112234567999999876 578899999999999999998 898884
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=234.01 Aligned_cols=214 Identities=34% Similarity=0.646 Sum_probs=180.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.+|.-+++||+|.+|+||+|+..++++.||+|.++-.. .....+|+-+++.+ +|.||+++++.... .+.+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs--dkkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc--CceeEE
Confidence 35778899999999999999999999999999986332 24578999999999 99999999998743 456899
Q ss_pred EEeeecCCC---ceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTD---FKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|+|+|.... +..+.+.+..+.++.++.|++. ||.+.|++++.||||||+|
T Consensus 79 vfe~cdqdlkkyfdslng~~d~~~~rsfmlqllr---------------------------gl~fchshnvlhrdlkpqn 131 (292)
T KOG0662|consen 79 VFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLR---------------------------GLGFCHSHNVLHRDLKPQN 131 (292)
T ss_pred eHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHh---------------------------hhhhhhhhhhhhccCCcce
Confidence 999997533 2222345666666666666655 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
+|++.++ .+||+|||+++.+.... ..+..+-|.+|++|.++-+..-|+...|+||-|||+.|+.....|.+++.+-.+
T Consensus 132 llin~ng-elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd 210 (292)
T KOG0662|consen 132 LLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_pred EEeccCC-cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH
Confidence 9999776 79999999999876544 456678899999999999988899999999999999999998889999999999
Q ss_pred HHHHHHHHhCCchH
Q 040656 263 QLVKIARVLGTDEL 276 (332)
Q Consensus 263 ~~~~~~~~~~~~~~ 276 (332)
++.+|.+.++++.-
T Consensus 211 qlkrif~~lg~p~e 224 (292)
T KOG0662|consen 211 QLKRIFRLLGTPTE 224 (292)
T ss_pred HHHHHHHHhCCCcc
Confidence 99999999986543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=258.02 Aligned_cols=194 Identities=19% Similarity=0.275 Sum_probs=141.3
Q ss_pred EeecccCCceEEEEEEcc--CCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVT--NNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.... ....+++|.+.... ...+.+|+.+++.+ +|+||+++++.+.+ ....+++|||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeC
Confidence 368999999999986432 34578888775322 24578899999999 99999999999854 45789999999
Q ss_pred cCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCC
Q 040656 112 NSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191 (332)
Q Consensus 112 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~ 191 (332)
+++++..++........... .......++.|++.||+|||+++|+||||||+||+++.++
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~-------------------~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~- 137 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMA-------------------QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL- 137 (269)
T ss_pred CCCcHHHHHHhccccccccc-------------------cHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-
Confidence 99988776522111000000 0001123556667799999999999999999999999666
Q ss_pred eEEEEecccceeecCCCc---ccccccccceeccccccC------CCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 192 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 192 ~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~------~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
.++|+|||++........ .....++..|+|||++.. ...++.++|||||||++|+|++ |..||
T Consensus 138 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (269)
T cd05042 138 SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210 (269)
T ss_pred cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC
Confidence 799999999865432221 122244567999998743 2356889999999999999999 67777
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=259.72 Aligned_cols=193 Identities=26% Similarity=0.476 Sum_probs=158.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|.+.+.||+|+||.||++....++..+++|.+... ....+.+|+.+++++ +||||+++++.+.+ ....++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLV--GDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeee--CCcEEEE
Confidence 47899999999999999999998889999999998532 235688899999999 89999999999854 3578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++++++..+.. .++...+..++. +++.||.+||++|++|+||+|+||+
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~---------------------------~l~~al~~LH~~gi~H~dL~p~Nil 147 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCR---------------------------ECLQALEFLHSNQVIHRDIKSDNIL 147 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCEeeccCCHHHEE
Confidence 99999998877653 234444444444 4455999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.
T Consensus 148 i~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~ 216 (293)
T cd06647 148 LGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (293)
T ss_pred EcCCC-CEEEccCcceecccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99666 799999998875543322 233467788999999876 568899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=251.79 Aligned_cols=189 Identities=22% Similarity=0.438 Sum_probs=153.1
Q ss_pred ceEEEeecccCCceEEEEEEccCC----ceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+++.+.||.|+||.||+|.+...+ ..||+|+++... .+.+..|+.+++.+ +|+||+++++.+.+. ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeE
Confidence 467899999999999999987766 899999997433 45788999999999 999999999998543 5789
Q ss_pred eEEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 106 LIFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++||+++++++..++.. ++......++.+ ++.||++||+.+++|+|||
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~q---------------------------l~~~l~~lh~~~~~h~dl~ 130 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQ---------------------------IARGMEYLESKNFIHRDLA 130 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHH---------------------------HHHHHHHHhcCCeeecccc
Confidence 99999999888766532 444444444444 4559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccc--cccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|+||+++.++ .++|+|||++........... ..++..|+|||.+.+ ..++.++|+||||+++++|++ |..||
T Consensus 131 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~ 205 (258)
T smart00219 131 ARNCLVGENL-VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY 205 (258)
T ss_pred cceEEEccCC-eEEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 9999999666 799999999977654322221 235678999999855 678999999999999999998 67776
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=263.65 Aligned_cols=267 Identities=25% Similarity=0.496 Sum_probs=186.6
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC--
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS-- 101 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-- 101 (332)
.-.++|++.+.||+|++|.||+|.+..+++.||+|++... ....+.+|+.+++++ .|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhcccccc
Confidence 3467899999999999999999999889999999998632 234577899999999 99999999998754322
Q ss_pred --CCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 --KTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 --~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++++|++. +++..+. ..++...+..++.++ +.||.+||+.||+||
T Consensus 91 ~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql---------------------------~~aL~~LH~~gi~H~ 142 (343)
T cd07851 91 DFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQI---------------------------LRGLKYIHSAGIIHR 142 (343)
T ss_pred ccccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecC
Confidence 34789999984 4544433 234555554444444 559999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
||+|+||+++.++ .++|+|||++...... .....++..|+|||.+.+...++.++||||||+++|++++|..||. +
T Consensus 143 dlkp~Nill~~~~-~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~ 218 (343)
T cd07851 143 DLKPSNIAVNEDC-ELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-G 218 (343)
T ss_pred CCCHHHeEECCCC-CEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-C
Confidence 9999999999665 7999999998765422 3344678889999998664567899999999999999999999983 4
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC--cccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN--NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+..+....+.+. ..+..+... ......+.....-.... ...........+++..||+.||++||+
T Consensus 219 ~~~~~~~~~i~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt 291 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPD-EELLQKISS---ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT 291 (343)
T ss_pred CChHHHHHHHHHhcCCCC-HHHHhhccc---hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC
Confidence 455555666555544322 223333211 11111111110000000 000112333457888899999999996
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=257.90 Aligned_cols=196 Identities=22% Similarity=0.408 Sum_probs=157.4
Q ss_pred CCCceEEEeecccCCceEEEEEEc----cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV----TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.+.|++.+.||+|+||.||+|... .+++.+|+|+++... ...+.+|+.+++.+ .|+||+++++++......
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence 467899999999999999999854 347899999997433 45789999999999 999999999998765567
Q ss_pred CceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++++||++++++..++.. ++...... ++.+++.||++||+.|++|+|
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~---------------------------~~~~l~~aL~~lH~~~i~H~d 134 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL---------------------------FSSQICKGMDYLGSQRYIHRD 134 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHH---------------------------HHHHHHHHHHHHHhCCeecCC
Confidence 88999999999888766532 33333333 445556699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
|||+||+++.++ .++|+|||.+......... ....++..|+|||.+.+ ..++.++||||||+++++|++|..|+
T Consensus 135 l~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~ 212 (284)
T cd05038 135 LAARNILVESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPS 212 (284)
T ss_pred CCHHhEEEcCCC-CEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCc
Confidence 999999999665 7999999999876532221 11234456999999876 57899999999999999999999998
Q ss_pred CC
Q 040656 255 FY 256 (332)
Q Consensus 255 ~~ 256 (332)
..
T Consensus 213 ~~ 214 (284)
T cd05038 213 QS 214 (284)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=256.31 Aligned_cols=193 Identities=22% Similarity=0.418 Sum_probs=154.3
Q ss_pred CceEEEeecccCCceEEEEEEc---cCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+|++.+.||.|+||.||.|... .+++.||+|+++.. ..+.+.+|+.++.++.+|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4899999999999999999864 47899999998632 235678899999999779999999999844 45
Q ss_pred CceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..++++||++++++...+. .++...+..++. |++.||.+||+.|++||||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~---------------------------qi~~al~~lH~~~i~H~dl 131 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSG---------------------------EIVLALEHLHKLGIIYRDI 131 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeeccCC
Confidence 7889999999988766542 244444443333 4555999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|+||+++.++ +++|+|||++....... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||.
T Consensus 132 ~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 132 KLENILLDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred CHHHeEECCCC-CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 99999999766 79999999987654322 12234678889999998652 246789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=254.37 Aligned_cols=195 Identities=17% Similarity=0.243 Sum_probs=144.2
Q ss_pred EeecccCCceEEEEEEc--cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINV--TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|... .++..+|+|.++.. ....+.+|+.+++++ +||||+++++.+.+ ....+++|||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36899999999999753 34567999988643 224688899999999 99999999999854 35689999999
Q ss_pred cCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCC
Q 040656 112 NSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191 (332)
Q Consensus 112 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~ 191 (332)
+++++..++......... .........++.|++.||+|||+.+++||||||+||+++.++
T Consensus 78 ~~g~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~- 137 (269)
T cd05087 78 PLGDLKGYLRSCRKAELM-------------------TPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL- 137 (269)
T ss_pred CCCcHHHHHHHhhhcccc-------------------cccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-
Confidence 998887664221100000 000111124566777799999999999999999999999665
Q ss_pred eEEEEecccceeecCCCc---ccccccccceeccccccCC------CCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 192 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 192 ~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~------~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
.++|+|||.+........ .....++..|+|||++.+. ..++.++|+||||+++|+|++ |..||.
T Consensus 138 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 138 TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 799999999865432221 1223566779999988542 135789999999999999996 999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=260.84 Aligned_cols=265 Identities=29% Similarity=0.466 Sum_probs=183.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.. ...+.+.+|+.+++.+ .||||++++++|... ....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCcE
Confidence 46789999999999999999999999999999998753 1245678899999999 999999999988543 3467
Q ss_pred eeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 105 SLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++++|++.+ ++..++. .++......+ +.|++.||.+||+.+++||||+|+
T Consensus 86 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~---------------------------~~ql~~aL~~LH~~~iiH~dl~p~ 137 (328)
T cd07856 86 YFVTELLGT-DLHRLLTSRPLEKQFIQYF---------------------------LYQILRGLKYVHSAGVVHRDLKPS 137 (328)
T ss_pred EEEeehhcc-CHHHHHhcCCCCHHHHHHH---------------------------HHHHHHHHHHHHhCCcccCCCCHH
Confidence 899999854 4444432 2333333333 445555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||+++.++ .++|+|||.+.... .......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .......
T Consensus 138 Nili~~~~-~~~l~dfg~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f-~~~~~~~ 213 (328)
T cd07856 138 NILINENC-DLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF-PGKDHVN 213 (328)
T ss_pred HEeECCCC-CEEeCccccccccC--CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHH
Confidence 99999665 79999999987543 22234467788999998766567899999999999999999999998 3444444
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC-CCCCCCCc-ccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK-RVWPIPNN-KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~-~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+.+.++.+. .++....... ...+.+... .....+.. ..........+++..||+.+|++||+
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t 281 (328)
T cd07856 214 QFSIITDLLGTPP-DDVINTICSE---NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS 281 (328)
T ss_pred HHHHHHHHhCCCC-HHHHHhccch---hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC
Confidence 4444555444322 1122111001 111111111 00100000 00112234457788899999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=249.54 Aligned_cols=196 Identities=29% Similarity=0.489 Sum_probs=161.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|.+.+.||+|++|.||+|....+++.+++|++.... ...+.+|+.+++++ +|+||+++++.+.+......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 4888999999999999999998899999999987543 56788999999999 89999999999865433678999
Q ss_pred EeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
+|+++++++..++. .++......++. +++.||+|||+.+++|+||+|+||
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~---------------------------~l~~~l~~lh~~~~~h~dl~p~ni 132 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTR---------------------------QILEGLAYLHSNGIVHRDIKGANI 132 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCccccCCCHHHE
Confidence 99999888776642 334444444444 445599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
+++.++ .++|+|||.+........ .....++..|+|||...+ ...+.++||||||+++++|++|..||....
T Consensus 133 ~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 133 LVDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred EEcCCC-CEEEcccccEEecccccccccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999765 799999999887764442 344577888999999876 558999999999999999999999995433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=253.20 Aligned_cols=186 Identities=26% Similarity=0.476 Sum_probs=153.6
Q ss_pred ecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
||.|++|.||+|++..+++.+++|++... ..+.+.+|+.+++++ +|+||+++++.+.+ ....++++||+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 68999999999999888999999998632 235688999999999 99999999999854 4678999999999
Q ss_pred CCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 114 TDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 114 ~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
+++..++. .++...+..++.+ +++||+|||+++++|+||+|+||+++.++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~---------------------------i~~~l~~lH~~~~~h~dl~~~nilv~~~~ 130 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIAC---------------------------VVLAFEYLHNRGIIYRDLKPENLLLDSNG 130 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHH---------------------------HHHHHHHHhhCCcccCCCCHHHEEEcCCC
Confidence 98877653 2444444444444 45599999999999999999999999766
Q ss_pred CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 191 QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 191 ~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
.++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 131 -~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 131 -YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred -CEEEeeCCcccccCcccccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 799999999987654433334567888999999866 66899999999999999999999999543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=259.28 Aligned_cols=193 Identities=19% Similarity=0.351 Sum_probs=151.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc----eEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
..++|+..+.||+|+||.||+|.+..+++ .+|+|.+.... ...+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC--
Confidence 45789999999999999999998877776 46888876432 23578899999999 999999999998542
Q ss_pred CCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
..++++++++++++..... .++...+. .++.|++.||.|||+++|+||
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~---------------------------~~~~qi~~~L~~LH~~~ivH~ 133 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLL---------------------------NWCVQIAKGMMYLEERRLVHR 133 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHH---------------------------HHHHHHHHHHHHHhhcCeecc
Confidence 4578999999888766542 12333333 344556669999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||||+||+++.++ .+||+|||+++........ ....++..|+|||.+.+ ..++.++||||||+++||+++ |..|
T Consensus 134 dikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 134 DLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred ccccceeeecCCC-ceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999998665 7999999999865433221 12234567999999876 678999999999999999997 8888
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 212 ~~ 213 (303)
T cd05110 212 YD 213 (303)
T ss_pred CC
Confidence 83
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=255.02 Aligned_cols=193 Identities=21% Similarity=0.419 Sum_probs=155.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+..|...+.||+|++|.||++.+..+++.+++|.++.. ..+.+.+|+.+++.+ +|+||+++++++.. ....+++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v 94 (285)
T cd06648 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVV 94 (285)
T ss_pred hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEE
Confidence 34577778999999999999998889999999988532 335678999999999 99999999998854 4578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||+.++++...+. .++...+..++ .|++.||++||+.|++||||+|+||+
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~---------------------------~ql~~~l~~lH~~~i~H~dl~p~Nil 147 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVC---------------------------LAVLKALSFLHAQGVIHRDIKSDSIL 147 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHH---------------------------HHHHHHHHHHHhCCeecCCCChhhEE
Confidence 99999988876542 23344444444 44555999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 148 ~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 148 LTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred EcCCC-cEEEcccccchhhccCCcccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 99666 79999999876543222 1223467888999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=253.14 Aligned_cols=208 Identities=32% Similarity=0.628 Sum_probs=160.0
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhcc--CCCCeeeeeeeeeccCC---CC
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQHS---KT 103 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~---~~ 103 (332)
|++.+.||+|+||.||+|.+..+++.+|+|.++.. ....+.+|+.+++++. .|+|++++++++.+.+. ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78899999999999999999888999999998632 1235667888887773 59999999999865432 23
Q ss_pred ceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 104 PSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.++++|++.+ ++..++. .++..... .++.++++||.+||+.+++|+|
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~---------------------------~~~~~i~~al~~LH~~~i~h~~ 132 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIK---------------------------DLMRQLLRGVDFLHSHRIVHRD 132 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHH---------------------------HHHHHHHHHHHHHHHCCeeecc
Confidence 8899999875 3333221 13333333 4555666699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
|+|+||+++.++ .++|+|||.+.............++..|+|||++.+ ..++.++|+|||||++|+|++|..|| .+.
T Consensus 133 l~~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~ 209 (287)
T cd07838 133 LKPQNILVTSDG-QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGT 209 (287)
T ss_pred CChhhEEEccCC-CEEEeccCcceeccCCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCC
Confidence 999999999775 799999999987654444444567888999999877 66899999999999999999998887 445
Q ss_pred CCHHHHHHHHHHhC
Q 040656 259 DNQDQLVKIARVLG 272 (332)
Q Consensus 259 ~~~~~~~~~~~~~~ 272 (332)
...+....+.....
T Consensus 210 ~~~~~~~~~~~~~~ 223 (287)
T cd07838 210 SEADQLDKIFDVIG 223 (287)
T ss_pred ChHHHHHHHHHHcC
Confidence 55555666655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=256.25 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=181.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++.+-+..||.|+||+|++-.++.+|+..|||.++. .+.+++..|.+...+-.+.|||+++||.+-.+ .-.|
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcW 139 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCW 139 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--Ccee
Confidence 45667778999999999999999999999999999973 34577889999888887899999999986444 3468
Q ss_pred eEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH-HcCCeecCCCCCCe
Q 040656 106 LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH-SQGIMHRDVKPHNV 184 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~ivHrdlkp~Ni 184 (332)
+.||.|.- ++.. +..++..+.+...+.+++- .+.+-.+.||.||- ..+|+|||+||+||
T Consensus 140 iCMELMd~-SlDk---------lYk~vy~vq~~~ipE~Ilg----------~ItvatV~AL~yLK~~lkiIHRDvKPSNI 199 (361)
T KOG1006|consen 140 ICMELMDI-SLDK---------LYKRVYSVQKSRIPENILG----------HITVATVDALDYLKEELKIIHRDVKPSNI 199 (361)
T ss_pred eeHHHHhh-hHHH---------HHHHHHHHHhccCcHhhhh----------heeeeehhHHHHHHHHhhhhhccCChhhe
Confidence 89998863 2222 2333333332111111110 22333456999996 55899999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++..| .|||+|||++-.+...-..+.-.|...|||||.+.... .|.-+||+||||++|+|+.||..|+..-. .+
T Consensus 200 Lldr~G-~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---sv 275 (361)
T KOG1006|consen 200 LLDRHG-DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---SV 275 (361)
T ss_pred EEecCC-CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---HH
Confidence 999777 69999999987665444555668889999999986544 48999999999999999999999983211 24
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
++++......+.+ -..+..+...++.+...|++.|+..|-++||.
T Consensus 276 feql~~Vv~gdpp------------------------~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk 320 (361)
T KOG1006|consen 276 FEQLCQVVIGDPP------------------------ILLFDKECVHYSFSMVRFINTCLIKDRSDRPK 320 (361)
T ss_pred HHHHHHHHcCCCC------------------------eecCcccccccCHHHHHHHHHHhhcccccCcc
Confidence 4444433222111 11111222345666678889999999999994
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=252.67 Aligned_cols=191 Identities=21% Similarity=0.409 Sum_probs=144.2
Q ss_pred EeecccCCceEEEEEEcc---CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVT---NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||+|+||.||+|.... .+..||+|.+... ....+.+|+.+++.+ +||||+++++++... ....++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence 468999999999998643 3457999987532 235678899999999 999999999976433 3457899999
Q ss_pred ecCCCceeecccc----chhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 111 VNSTDFKVLYPTL----TANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 111 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
+.++++..++... ...... .++.++++||+|||+.+++||||||+||++
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~---------------------------~~~~~i~~~l~~lH~~~i~H~dlk~~nili 131 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLI---------------------------GFGLQVAKGMEYLASKKFVHRDLAARNCML 131 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHH---------------------------HHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence 9999887765321 122222 345566779999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCC-----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
+.++ .++|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|||++|..|++...+
T Consensus 132 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 132 DESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred cCCC-cEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9666 79999999987543221 1112244667999999876 6789999999999999999996655444433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=252.20 Aligned_cols=184 Identities=27% Similarity=0.461 Sum_probs=147.7
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||+|.+..+++.||+|+++... ...+..|..++....+|+|++++++.+.. ...+++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 56899999999999998899999999986432 12345565555554489999999999954 45789999999
Q ss_pred cCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
+++++..++. .++...+..++.++ ++||.|||+.+++|+||+|+||+++.
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi---------------------------~~aL~~lH~~~i~H~dl~p~nil~~~ 132 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEV---------------------------VLGVEDLHQRGIIHRDIKPENLLIDQ 132 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCCCHHHeEECC
Confidence 9999877653 34555555555554 45999999999999999999999996
Q ss_pred CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .++|+|||++..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 133 ~~-~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 133 TG-HLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred CC-cEEEeecccceeccc---cccCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 66 799999999875432 233457788999999877 458999999999999999999999994
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=257.39 Aligned_cols=196 Identities=21% Similarity=0.379 Sum_probs=152.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+..|+.++.+...|+||+++++++.+ ....+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEE
Confidence 457899999999999999999999888999999998643 234566788777777569999999999954 45789
Q ss_pred eEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCC
Q 040656 106 LIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVK 180 (332)
Q Consensus 106 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlk 180 (332)
+++|++.+ .+..+. ..++..... .++.+++.||+|||+ .||+||||+
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~---------------------------~i~~~i~~~l~~lH~~~~i~H~dl~ 142 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILG---------------------------KMTVAIVKALHYLKEKHGVIHRDVK 142 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHH---------------------------HHHHHHHHHHHHHHhhCCEecCCCc
Confidence 99999864 333222 123333333 355566669999997 599999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+||+++.++ .++|+|||++.............++..|+|||.+.+. ..++.++|+||||+++|+|++|..||..
T Consensus 143 p~nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 143 PSNILLDASG-NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred HHHEEEcCCC-CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 9999999665 7999999998765433333444577789999998653 2378899999999999999999999943
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=251.51 Aligned_cols=265 Identities=28% Similarity=0.429 Sum_probs=199.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEec-----ccchHHHHHHHHHHHhccCCCCeeeeeeeeecc-----
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----- 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----- 99 (332)
..+.|+-..++|+|.||+||+|+..++++.||+|.+- ........+|+.+|+.+ +|+|++.+.++|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcc
Confidence 3567999999999999999999999999999988753 12235678999999999 999999998887442
Q ss_pred -CCCCceeEEeeecCCCc---eeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 100 -HSKTPSLIFEHVNSTDF---KVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 100 -~~~~~~lv~e~~~~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
....+++||.+|+.... .....+++..+...+++.++. ||.|+|+..|+
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~---------------------------GL~~iHr~kil 146 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMN---------------------------GLYYIHRNKIL 146 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHH---------------------------HHHHHHHhhHH
Confidence 23347899999986443 333356777777777777776 99999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCC-----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
|||+|+.|+|++.++ .++|+|||+++.+.... ..+..+.|.+|++||.+.+...|+++.|||.-||++.||.||
T Consensus 147 HRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtr 225 (376)
T KOG0669|consen 147 HRDMKAANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTR 225 (376)
T ss_pred hhcccHhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHcc
Confidence 999999999999666 89999999997664322 245567799999999999988999999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHhCCchHH--------HHHHhcCCC-CChh-HHHHhccCCCCCCCCcccccccccccccCc
Q 040656 251 KEPFFYGHDNQDQLVKIARVLGTDELN--------AYLDKYHLE-LDPQ-LEALVGRKRVWPIPNNKKLQFCRSSRTSTN 320 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (332)
.+.+ .+..+..++..|...+|+.... ++...+.++ ++.. .+.+-.++.|+-. +... .++++
T Consensus 226 spim-qgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~k----d~~a----~dLle 296 (376)
T KOG0669|consen 226 SPIM-QGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVK----DDEA----LDLLE 296 (376)
T ss_pred Cccc-cCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccC----ChhH----HHHHH
Confidence 8655 7888888999999888853222 222222222 1111 1111111233322 2223 37889
Q ss_pred eEEEeCCCCCCC
Q 040656 321 ICITFSPSGFPF 332 (332)
Q Consensus 321 ~cl~~dP~~RP~ 332 (332)
+.+.+||.+||.
T Consensus 297 ~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 297 KLLKLDPTKRID 308 (376)
T ss_pred HHhccCcccCcc
Confidence 999999999984
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=246.52 Aligned_cols=191 Identities=34% Similarity=0.600 Sum_probs=159.4
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
+|++.+.||+|++|.||++.+..+++.+++|++... ....+.+|+++++++ .|+|++++++.+... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence 488999999999999999999888999999998643 346789999999999 899999999998543 57899999
Q ss_pred eecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
|++++++..++. .++......++.++ +.||.+||+.|++|+||+|+||+
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i---------------------------~~~l~~lh~~~i~h~dl~p~ni~ 130 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKEL---------------------------LKGLEYLHSNGIIHRDIKAANIL 130 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHH---------------------------HHHHHHhhcCCEecCCCCHHHEE
Confidence 999888777642 33444444444444 45999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++ .++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++++|++|..||.
T Consensus 131 i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 131 LTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred EccCC-eEEEeeccccccccccccccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99665 799999999877654433345577888999999876 558899999999999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=259.38 Aligned_cols=192 Identities=24% Similarity=0.429 Sum_probs=167.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.+-|.++++||+|+||.||+|.++++|+.+|+|.+.. ....++..|+.+|+++ +.++++++||.+-. ..-+|+|||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVME 108 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVME 108 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeehh
Confidence 4679999999999999999999999999999999874 3457899999999999 99999999997632 235899999
Q ss_pred eecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
||..|+..++. ..+.+.+...++...++ ||+|||..+-+|||||..|||
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLK---------------------------GL~YLH~~~KIHRDIKAGNIL 161 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLK---------------------------GLQYLHDLKKIHRDIKAGNIL 161 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHh---------------------------HHHHHHHHHHHHhhcccccEE
Confidence 99999988775 46788888878887777 999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
++.++ +.||+|||.|-.+.. ....++..||+.|||||++.. -.|..++||||||++..||..|++||
T Consensus 162 LNT~G-~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPY 229 (502)
T KOG0574|consen 162 LNTDG-IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPY 229 (502)
T ss_pred Ecccc-hhhhhhccccchhhhhHHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCc
Confidence 99777 799999999866542 234567789999999999976 57899999999999999999999998
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=248.29 Aligned_cols=184 Identities=23% Similarity=0.440 Sum_probs=145.3
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
+.||.|+||.||+|.+.. ++.|++|.++.. ....+.+|+.+++++ +|+||+++++++.+ ....++++|++.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 468999999999999866 999999998642 235788999999999 99999999999854 4578999999999
Q ss_pred CCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCC
Q 040656 114 TDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE 189 (332)
Q Consensus 114 ~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~ 189 (332)
+++..++.. ++...... ++.+++.||.+||+++++||||+|+||+++.+
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~lH~~~i~h~di~p~nili~~~ 129 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQ---------------------------MSLDAAAGMEYLESKNCIHRDLAARNCLVGEN 129 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEehhhcCcceEEEcCC
Confidence 887665421 23333333 44455669999999999999999999999966
Q ss_pred CCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 190 QQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 190 ~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
+ .++|+|||.+......... .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||
T Consensus 130 ~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~ 196 (251)
T cd05041 130 N-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPY 196 (251)
T ss_pred C-cEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCC
Confidence 6 7999999998755422111 11223456999999876 578999999999999999999 77777
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=256.47 Aligned_cols=211 Identities=25% Similarity=0.377 Sum_probs=179.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch------HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
...+|..+..||+|+||.|.+|..+.+.+.+|||++++.-. +--..|-++|....+-|.+++++..| ++-..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhh
Confidence 45789999999999999999999999999999999985321 12345777777776788999999999 44467
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++.||||+.||+|.... +.+.+..+..|+.++.. ||-+||++||++||||
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiai---------------------------gLFFLh~kgIiYRDLK 477 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAI---------------------------GLFFLHSKGIIYRDLK 477 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHH---------------------------HhhhhhcCCeeeeecc
Confidence 99999999999988775 56778888888887766 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
.+|+|++.++ ++||+|||+++.-. .+....+++||+.|+|||++.- ++|+...|.||+|++||||+.|+.|| .+.+
T Consensus 478 LDNvmLd~eG-HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeD 554 (683)
T KOG0696|consen 478 LDNVMLDSEG-HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGED 554 (683)
T ss_pred ccceEeccCC-ceEeeecccccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCC
Confidence 9999999887 79999999997643 3445677899999999999988 89999999999999999999999999 5778
Q ss_pred CHHHHHHHHHHhC
Q 040656 260 NQDQLVKIARVLG 272 (332)
Q Consensus 260 ~~~~~~~~~~~~~ 272 (332)
+.+.+..|.....
T Consensus 555 E~elF~aI~ehnv 567 (683)
T KOG0696|consen 555 EDELFQAIMEHNV 567 (683)
T ss_pred HHHHHHHHHHccC
Confidence 8888888877543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=249.81 Aligned_cols=190 Identities=19% Similarity=0.285 Sum_probs=147.4
Q ss_pred EeecccCCceEEEEEEcc-CC--ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVT-NN--EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~-~~--~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||+|++|.||+|.+.. ++ ..||+|.++.. ..+.+.+|+.+++++ +|+||+++++.+.+ ...++++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence 468999999999998755 33 36999998753 235788999999999 99999999999865 578999999
Q ss_pred ecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 111 VNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 111 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
++++++...+...... ...+...+.++.|++.||++||++|++|+||||+||+++.++
T Consensus 77 ~~~~~L~~~l~~~~~~----------------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~ 134 (257)
T cd05040 77 APLGSLLDRLRKDALG----------------------HFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD 134 (257)
T ss_pred cCCCcHHHHHHhcccc----------------------cCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC
Confidence 9988876654221100 001112234556667799999999999999999999999776
Q ss_pred CeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 191 QKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 191 ~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++++|++ |..||.
T Consensus 135 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 135 -KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred -EEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 799999999877643221 112345677999999876 678999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=252.74 Aligned_cols=184 Identities=15% Similarity=0.235 Sum_probs=141.0
Q ss_pred eecccCCceEEEEEEccC------------------------CceEEEEEecccc---hHHHHHHHHHHHhccCCCCeee
Q 040656 39 KVGRGKYSEVFEGINVTN------------------------NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVK 91 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~~~~------------------------~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~ 91 (332)
.||+|+||.||+|....+ ...|++|++.... ...+.+|+.+++.+ +|+||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 589999999999874321 1358899886432 24577889999999 9999999
Q ss_pred eeeeeeccCCCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHH
Q 040656 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALD 167 (332)
Q Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 167 (332)
+++++.+ ....++||||++++++..++. .++..... .++.|++.||+
T Consensus 81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~---------------------------~i~~qi~~~l~ 131 (274)
T cd05076 81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI---------------------------TVAQQLASALS 131 (274)
T ss_pred EEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHH---------------------------HHHHHHHHHHH
Confidence 9999854 356899999999998766542 23333333 35556667999
Q ss_pred HHHHcCCeecCCCCCCeeecCCC------CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHH
Q 040656 168 YCHSQGIMHRDVKPHNVMIDHEQ------QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241 (332)
Q Consensus 168 ~LH~~~ivHrdlkp~Nilv~~~~------~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG 241 (332)
|||+++|+||||||+||+++..+ ..++++|||.+...... ....++..|+|||.+.+...++.++||||||
T Consensus 132 ~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG 208 (274)
T cd05076 132 YLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFG 208 (274)
T ss_pred HHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHH
Confidence 99999999999999999997432 14899999987543221 2235677799999887656689999999999
Q ss_pred HHHHHHH-hCCCCCC
Q 040656 242 CMFAGMI-FRKEPFF 255 (332)
Q Consensus 242 ~il~ell-tg~~pf~ 255 (332)
+++||++ +|..||.
T Consensus 209 ~~l~el~~~g~~p~~ 223 (274)
T cd05076 209 TTLLEICFDGEVPLK 223 (274)
T ss_pred HHHHHHHhCCCCCcc
Confidence 9999985 6888884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=253.48 Aligned_cols=197 Identities=23% Similarity=0.360 Sum_probs=146.7
Q ss_pred EeecccCCceEEEEEEccCC------ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 38 RKVGRGKYSEVFEGINVTNN------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.||+|+||.||+|...... +.+|+|.+... ....+.+|+.+++.+ +||||+++++++.+ ....+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecC--CCCeEEE
Confidence 36899999999999875433 68999987532 345788999999999 99999999999854 3568999
Q ss_pred EeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
+||++++++...+..-..... ......+.+...++.+++.||+|||+.+++|+||||+||+++
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERF-----------------GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVS 140 (269)
T ss_pred EeccCCCcHHHHHHHhhhccc-----------------CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEe
Confidence 999999887665422000000 000011222234666777799999999999999999999998
Q ss_pred CCC----CeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 188 HEQ----QKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 188 ~~~----~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
.++ ..++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.
T Consensus 141 ~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 141 EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred cCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 544 2699999999875532221 112244567999999876 578999999999999999998 999983
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=252.36 Aligned_cols=192 Identities=21% Similarity=0.385 Sum_probs=147.0
Q ss_pred ceEEEeecccCCceEEEEEEcc---CCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC---
Q 040656 34 YEVVRKVGRGKYSEVFEGINVT---NNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK--- 102 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~--- 102 (332)
|.+.+.||+|+||.||+|.... +++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 6778899999999999998543 5789999998642 234688999999999 999999999988543221
Q ss_pred -CceeEEeeecCCCceeecc---------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 103 -TPSLIFEHVNSTDFKVLYP---------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 103 -~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
..+++++|+.++++..++. .++.... ..++.|++.||+|||++
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~---------------------------~~~~~~i~~~l~~lH~~ 132 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL---------------------------VRFMIDIASGMEYLSSK 132 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHH---------------------------HHHHHHHHHHHHHHHhC
Confidence 2467889998887654431 1222222 34566667799999999
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt 249 (332)
||+||||||+||+++.++ .++|+|||+++....... .....++..|++||.+.. ..++.++||||||+++|+|++
T Consensus 133 ~i~H~dikp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 133 NFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred CEeecccchhhEEEcCCC-CEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhh
Confidence 999999999999998665 799999999876543221 122234567999998876 678899999999999999999
Q ss_pred -CCCCCC
Q 040656 250 -RKEPFF 255 (332)
Q Consensus 250 -g~~pf~ 255 (332)
|..||.
T Consensus 211 ~g~~p~~ 217 (273)
T cd05074 211 RGQTPYA 217 (273)
T ss_pred CCCCCCC
Confidence 777773
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=248.90 Aligned_cols=190 Identities=25% Similarity=0.476 Sum_probs=156.3
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|++|.||++.+..+++.+++|.++.. ....+.+|+.+++++ +|+||+++++++.+. ...+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDG--NKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccC--CEEEEE
Confidence 589999999999999999999889999999998632 234577899999999 899999999998543 678999
Q ss_pred EeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 108 FEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+||++++++...+.. ++...+. .++.+++.||++||+.|++|+||+
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~al~~lh~~~i~h~~l~ 130 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIW---------------------------RIFIQLLRGLQALHEQKILHRDLK 130 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHH---------------------------HHHHHHHHHHHHHhhCCcccCCCC
Confidence 999999887665422 2233333 345556669999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++...... ......++..|++||.+.+ ..++.++|+||||+++++|++|..||.
T Consensus 131 ~~ni~~~~~~-~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 131 SANILLVAND-LVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred cceEEEecCC-cEEEeeccchhhhccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999765 7999999998766543 3333467788999999876 678899999999999999999999993
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=251.11 Aligned_cols=192 Identities=23% Similarity=0.489 Sum_probs=154.1
Q ss_pred CceEEEeecccCCceEEEEEEcc-CCceEEEEEeccc-------------chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVT-NNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
.|++.+.||+|+||.||+|.... +++.+|+|.+... ...++.+|+.++.+..+|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 6789999987521 123467788888764499999999999854
Q ss_pred cCCCCceeEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
....++++||++++++..++.. ++...+ +.++.+++.||.+||+
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~---------------------------~~~~~~l~~~l~~lh~ 131 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---------------------------WNIFVQMVLALRYLHK 131 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHH---------------------------HHHHHHHHHHHHHhcc
Confidence 4678999999999887665421 222222 3455566679999996
Q ss_pred -cCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 172 -QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 172 -~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
.+++|+||+|+||+++.++ .++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus 132 ~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g 209 (269)
T cd08528 132 EKRIVHRDLTPNNIMLGEDD-KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTL 209 (269)
T ss_pred CCceeecCCCHHHEEECCCC-cEEEecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhC
Confidence 6899999999999999766 799999999987654444445578888999999876 6689999999999999999999
Q ss_pred CCCCC
Q 040656 251 KEPFF 255 (332)
Q Consensus 251 ~~pf~ 255 (332)
..||.
T Consensus 210 ~~p~~ 214 (269)
T cd08528 210 QPPFY 214 (269)
T ss_pred CCccc
Confidence 99984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.28 Aligned_cols=192 Identities=30% Similarity=0.486 Sum_probs=152.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..+.|...+.||+|+||.||++++..++..+|+|.+... ....+.+|+.+++++ +|+|++++++++.+. ..
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~ 99 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE--HT 99 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--Ce
Confidence 345689999999999999999999889999999998632 124678899999999 999999999998553 56
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++++||+.+..+..+. ..++...... ++.+++.||.|||+.|++||||+
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~---------------------------i~~~i~~~l~~lH~~~i~H~dL~ 152 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHKKPLQEVEIAA---------------------------ITHGALQGLAYLHSHNMIHRDIK 152 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhcCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCcccCCCC
Confidence 89999999864322221 1233333333 34455569999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++..... .....++..|+|||.+.. ...++.++||||||+++|+|++|..||.
T Consensus 153 p~Nil~~~~~-~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 153 AGNILLTEPG-QVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred cccEEECCCC-CEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999998666 799999998865432 234467888999999742 2457899999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=249.30 Aligned_cols=184 Identities=17% Similarity=0.276 Sum_probs=145.5
Q ss_pred EeecccCCceEEEEEEccCC----------ceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 38 RKVGRGKYSEVFEGINVTNN----------EKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~----------~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+.||+|+||.||+|.+..++ ..+++|+++... ...+.+|+.+++++ +|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence 46899999999999987666 358888876433 46788999999999 99999999998855 4579
Q ss_pred eEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+++||++++++..++. .++...... ++.|++.||.|||++||+||||||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------~~~~i~~~l~~LH~~~i~H~dlkp 129 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLD---------------------------VAKQLASALHYLEDKKLVHGNVCG 129 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHH---------------------------HHHHHHHHHHHHhhCCeecccCcc
Confidence 9999999999876653 233333333 444556699999999999999999
Q ss_pred CCeeecCCCC------eEEEEecccceeecCCCcccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 182 HNVMIDHEQQ------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 182 ~Nilv~~~~~------~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
+||+++.++. .++|+|||++..... .....++..|+|||++.+. ..++.++||||||++++++++ |..|
T Consensus 130 ~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p 206 (259)
T cd05037 130 KNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP 206 (259)
T ss_pred ceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCC
Confidence 9999986541 599999999876543 2233566679999998774 368899999999999999999 5667
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 207 ~~ 208 (259)
T cd05037 207 LS 208 (259)
T ss_pred cc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=252.09 Aligned_cols=193 Identities=31% Similarity=0.560 Sum_probs=156.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|.+.+.||+|+||.||+|....+++.|++|++... ....+..|+.+++++..|+||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 4799999999999999999999889999999998642 235678899999999339999999999854 45789
Q ss_pred eEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++||++.++++...+. .++......++. |++.||.+||+.|++|+||+|+
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~---------------------------ql~~~l~~Lh~~~~~H~dl~~~ 131 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAA---------------------------EILLALEYLHSKGIIHRDLKPE 131 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeeecCCCHH
Confidence 9999999988876652 344444444444 4455999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC---------------------cccccccccceeccccccCCCCCCCcccHHHHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK---------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~---------------------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG 241 (332)
||+++.++ .++|+|||++....... ......++..|+|||+..+ ..++.++|+||||
T Consensus 132 ni~i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG 209 (280)
T cd05581 132 NILLDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALG 209 (280)
T ss_pred HeEECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHH
Confidence 99999666 79999999987554222 1123356788999998876 5688999999999
Q ss_pred HHHHHHHhCCCCCC
Q 040656 242 CMFAGMIFRKEPFF 255 (332)
Q Consensus 242 ~il~elltg~~pf~ 255 (332)
++++++++|..||.
T Consensus 210 ~~l~~l~~g~~p~~ 223 (280)
T cd05581 210 CIIYQMLTGKPPFR 223 (280)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999999994
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=244.42 Aligned_cols=190 Identities=24% Similarity=0.454 Sum_probs=159.0
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
.+.||+|.++.|--|....++..+|||++.++ .+.++.+|++++.+...|+||++++++|+++ ...|+|||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccC
Confidence 36799999999999999999999999999764 3578999999999998999999999999654 568999999999
Q ss_pred CCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 114 TDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 114 ~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
|.+..+. ..+++.++..+++++.. ||.+||.+||.||||||+|||....+
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~---------------------------aLdFlH~kgIAHRDlKPENiLC~~pn 213 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIAS---------------------------ALDFLHTKGIAHRDLKPENILCESPN 213 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHH---------------------------HHHHHhhcCcccccCCccceeecCCC
Confidence 9977765 45888888888887766 99999999999999999999996443
Q ss_pred C--eEEEEecccceeecCCCc--------ccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 191 Q--KLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 191 ~--~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
. -|||+||.+..-...... ..+.+|+..|||||++.- ...|+.+.|.||||+|+|-|++|..||.
T Consensus 214 ~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 214 KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 2 379999988754432221 234578888999998732 1358899999999999999999999993
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=245.61 Aligned_cols=191 Identities=27% Similarity=0.536 Sum_probs=157.8
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|.+.+.||+|+||.||++.+..++..+++|++... ....+.+|+++++.+ +|+|++++.+.+.+. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecC--CEEEEE
Confidence 589999999999999999999889999999998642 345688999999999 899999999998543 678999
Q ss_pred EeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 108 FEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+|+++++++...+.. ++...+. .++.++++||.+||+.|++|+||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------------------------~i~~~i~~~l~~lh~~~~~H~dl~ 130 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQIL---------------------------DWFVQLCLALKYLHSRKILHRDIK 130 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHH---------------------------HHHHHHHHHHHHHHhCCEecccCC
Confidence 999999887665422 3333333 345555669999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||.+....... ......++..|+|||...+ ..++.++|+||||+++++|++|..||.
T Consensus 131 ~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~ 204 (258)
T cd08215 131 PQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFE 204 (258)
T ss_pred hHHeEEcCCC-cEEECCccceeecccCcceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCC
Confidence 9999999665 79999999987665433 2233467888999998876 568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=258.93 Aligned_cols=182 Identities=21% Similarity=0.233 Sum_probs=141.2
Q ss_pred CCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCcee
Q 040656 44 KYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKV 118 (332)
Q Consensus 44 ~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 118 (332)
++|.||.+....+++.||+|+++.. ....+.+|+.+++.+ +|+||+++++++.+. ...++++||++++++..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVD--SELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecC--CeEEEEEeccCCCCHHH
Confidence 4455566666679999999998643 235789999999999 899999999998543 56899999999998876
Q ss_pred ecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeE
Q 040656 119 LYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193 (332)
Q Consensus 119 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~v 193 (332)
++. .+++.....++. |+++||.|||+++|+||||||+||+++.++ .+
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~---------------------------~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~ 140 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILK---------------------------DVLNALDYIHSKGFIHRSVKASHILLSGDG-KV 140 (314)
T ss_pred HHHHhcccCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeecCCCCcceEEEecCC-ce
Confidence 643 234444444444 445599999999999999999999999666 79
Q ss_pred EEEecccceeecCCCc--------ccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 194 RLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 194 kL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+|+|||.+........ .....++..|+|||++.+. ..++.++|+|||||++++|++|..||..
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred EEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999998865432211 1233566779999998653 3578999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=248.79 Aligned_cols=260 Identities=30% Similarity=0.523 Sum_probs=183.6
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
|++.+.||+|++|.||+|....+++.+|+|++... ..+.+..|+.+++++ +|+|++++++++.+ ....++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhc--CCceEEEe
Confidence 67889999999999999999889999999998743 135677899999999 89999999999854 36789999
Q ss_pred eeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|++++ ++..++. .++...+..+ +.+++.||++||+.|++||||+|+||
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~---------------------------~~~i~~~l~~LH~~~i~H~~l~~~ni 129 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSI---------------------------MYQLLRGLAYCHSHRILHRDLKPQNI 129 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHH---------------------------HHHHHHHHHHHHHCCcccCCCChheE
Confidence 99985 5544432 2344444444 44555599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++||||||++++++++|..|| ......+.
T Consensus 130 ~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~ 207 (282)
T cd07829 130 LINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQ 207 (282)
T ss_pred EEcCCC-CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHH
Confidence 999665 79999999987654332 2233455677999999877557899999999999999999999888 44445556
Q ss_pred HHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCc--ccccccccccccCceEEEeCCCCCCC
Q 040656 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN--KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.++....+.+....+..-. ... ...... ..|..... ..........+++..||+.||++||+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~ 272 (282)
T cd07829 208 LFKIFQILGTPTEESWPGVT--KLP-DYKPTF---PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272 (282)
T ss_pred HHHHHHHhCCCcHHHHHhhc--ccc-cccccc---cccCccchHHhcccccHHHHHHHHHhhccCcccCCC
Confidence 66666655543322221110 000 000000 01110000 00111233457889999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=254.67 Aligned_cols=192 Identities=29% Similarity=0.452 Sum_probs=151.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.+.|...+.||+|+||.||+|++..+++.+++|.+... ....+.+|+++++.+ +|+|++++++++.+. ...
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~ 96 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE--HTA 96 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEE
Confidence 35588889999999999999999889999999998632 124578899999999 899999999998553 568
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++++||+.+..+..+. ..++......+ +.|++.||.|||+.|++|+||+|
T Consensus 97 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~---------------------------~~qi~~al~~LH~~gi~H~dl~p 149 (313)
T cd06633 97 WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---------------------------THGALQGLAYLHSHNMIHRDIKA 149 (313)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHH---------------------------HHHHHHHHHHHHHCCeecCCCCh
Confidence 9999999764332221 12333333333 44555599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+||+++.++ .++|+|||++.... ......++..|+|||.+.. ...++.++||||||+++|+|++|..||..
T Consensus 150 ~nili~~~~-~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 150 GNILLTEPG-QVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred hhEEECCCC-CEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999666 79999999886432 2234567888999999743 24578899999999999999999999843
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.07 Aligned_cols=187 Identities=26% Similarity=0.419 Sum_probs=146.6
Q ss_pred eecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhc--cCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 39 KVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
.||+|+||.||+|.+..+++.||+|++.... ......|..+++.+ ..|+||+++++.+.+ ....++++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4799999999999998899999999986421 12234444433332 279999999999854 3578999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
+.++++...+ ..+++..+..++.+++. ||+|||+.+++||||||+||+++
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~---------------------------~l~~lH~~~i~H~di~p~nili~ 131 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIIL---------------------------GLEHMHNRFVVYRDLKPANILLD 131 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCEEcCCCCHHHEEEC
Confidence 9999886654 23555555555555554 99999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
.++ .++|+|||++...... ......++..|+|||++.+...++.++||||+|+++|+|++|..||..
T Consensus 132 ~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~ 198 (278)
T cd05606 132 EHG-HVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (278)
T ss_pred CCC-CEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 665 7999999998755422 223457888999999987645689999999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=269.67 Aligned_cols=213 Identities=20% Similarity=0.328 Sum_probs=167.1
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCC---ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.+..+...+.|+||+|+||+|++|.+...+ -.||||+++.. ...+|.+|+.+|.+| +|+|++++||+..+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc--
Confidence 345577888999999999999999876543 46999999743 457899999999999 99999999999866
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
..+.+|||.++.|+|.+.+.. ... ..++...+ +.++.|||.||.||.++++|||||.
T Consensus 183 -qp~mMV~ELaplGSLldrLrk--a~~-~~llv~~L-------------------cdya~QiA~aM~YLeskrlvHRDLA 239 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRK--AKK-AILLVSRL-------------------CDYAMQIAKAMQYLESKRLVHRDLA 239 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhh--ccc-cceeHHHH-------------------HHHHHHHHHHHHHHhhhhhhhhhhh
Confidence 357899999999998776643 011 11111122 2466677779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccc----cccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRV----ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~----~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
.+|+|+.... .|||+|||+.+-+..+....... -...|+|||.+.. ..++.+||||+||+++|||+| |..||
T Consensus 240 ARNlllaspr-tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW- 316 (1039)
T KOG0199|consen 240 ARNLLLASPR-TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW- 316 (1039)
T ss_pred hhhheecccc-eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-
Confidence 9999998655 79999999998876554433222 2334999999877 689999999999999999997 78999
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
.+....+.+..+..
T Consensus 317 ~G~~g~qIL~~iD~ 330 (1039)
T KOG0199|consen 317 VGCRGIQILKNIDA 330 (1039)
T ss_pred CCCCHHHHHHhccc
Confidence 56666666666553
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=250.75 Aligned_cols=193 Identities=27% Similarity=0.425 Sum_probs=152.8
Q ss_pred CceEEEeecccCCceEEEEEEc---cCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+|++.+.||+|++|.||++... .+++.||+|+++.. ..+.+.+|+.++.++.+|+||+++++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 4899999999999999998753 46788999998632 23457889999999977999999999884 345
Q ss_pred CceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..++++||+.++++...+. .++...+..++. |+++||.+||+.+++||||
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~---------------------------ql~~~l~~lH~~~~~H~dl 131 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIA---------------------------EIVLALDHLHQLGIIYRDI 131 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHH---------------------------HHHHHHHHHHHCCeeccCC
Confidence 7899999999988766542 234444444444 4455999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|+||+++.++ .++|+|||++........ .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.
T Consensus 132 ~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 132 KLENILLDSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CHHHeEECCCC-CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 99999999665 799999999876543322 12345788899999986532 36889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=275.17 Aligned_cols=229 Identities=19% Similarity=0.348 Sum_probs=184.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC---ceEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN---EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.....|.+.||.|.||+|++|+.+..+ ..||||.+|. ..+.+|+.|..||.++ +||||+++.|+. ....
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVV--Tks~ 703 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVV--TKSK 703 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEE--ecCc
Confidence 4566789999999999999999877666 4799999984 3456799999999999 999999999998 4445
Q ss_pred CceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
...+|+|||+.|.|+.++.....+ +-..|+ +.|...|+.|+.||-+.++|||||..+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGq---ftviQL--------------------VgMLrGIAsGMkYLsdm~YVHRDLAAR 760 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQ---FTVIQL--------------------VGMLRGIASGMKYLSDMNYVHRDLAAR 760 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCc---eEeehH--------------------HHHHHHHHHHhHHHhhcCchhhhhhhh
Confidence 678899999999999987443321 112233 347778889999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC--ccccccc--ccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 257 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~--t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~ 257 (332)
||||+.+- .+|++|||+++.+..+. ..++..| ..+|.|||.+.- ..++.+|||||+||++||.++ |..|| =+
T Consensus 761 NILVNsnL-vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPY-Wd 837 (996)
T KOG0196|consen 761 NILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPY-WD 837 (996)
T ss_pred heeeccce-EEEeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcc-cc
Confidence 99999555 89999999999876443 2233333 356999999977 789999999999999999765 89997 47
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHh
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALV 295 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 295 (332)
..+++++..+.+.++-+.+ .+++..+-.++
T Consensus 838 mSNQdVIkaIe~gyRLPpP--------mDCP~aL~qLM 867 (996)
T KOG0196|consen 838 MSNQDVIKAIEQGYRLPPP--------MDCPAALYQLM 867 (996)
T ss_pred cchHHHHHHHHhccCCCCC--------CCCcHHHHHHH
Confidence 7789999999998876554 46666666655
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=257.95 Aligned_cols=188 Identities=19% Similarity=0.267 Sum_probs=144.7
Q ss_pred Eeeccc--CCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 38 RKVGRG--KYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
+.||.| +||.||+|.+..+++.||+|+++... .+.+.+|+.+++.+ +|+||++++++|.. ....++++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTT--GSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEec--CCceEEEEec
Confidence 456766 89999999999999999999986322 35678899999888 99999999999954 4578999999
Q ss_pred ecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 111 VNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 111 ~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+.++++..++.. +++..+.. ++.|++.||+|||+.|++||||||+||+
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~---------------------------~~~qi~~aL~~lH~~~ivHrDlkp~Nil 133 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGN---------------------------ILFGALRGLNYLHQNGYIHRNIKASHIL 133 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999887765432 33333333 4445566999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-c-------ccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-E-------YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~-------~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
++.++ .++++||+.+....... . .....++..|+|||++.+. ..++.++|||||||++|+|++|..||..
T Consensus 134 l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 134 ISGDG-LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred EeCCC-cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99666 79999997543221111 0 0112345569999998763 3478999999999999999999999943
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=246.50 Aligned_cols=204 Identities=16% Similarity=0.266 Sum_probs=143.7
Q ss_pred EeecccCCceEEEEEEccC--CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTN--NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~--~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.||+|+||.||++..... ...+++|.++.. ....+.+|+.+++.+ +||||+++++.+.+ ....+++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVE--AIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecC--CCccEEEEecC
Confidence 3689999999999864332 345667766532 235788999999999 99999999999954 45789999999
Q ss_pred cCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCC
Q 040656 112 NSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191 (332)
Q Consensus 112 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~ 191 (332)
++++|..++......... ........++.|++.||+|||+.+++||||||+|||++.++
T Consensus 78 ~~~~L~~~l~~~~~~~~~--------------------~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~- 136 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRN--------------------SQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL- 136 (268)
T ss_pred CCCcHHHHHHhhhccccc--------------------ccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-
Confidence 998877654221000000 00001123556677799999999999999999999998665
Q ss_pred eEEEEecccceeecCCC---cccccccccceeccccccCC------CCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCH
Q 040656 192 KLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNQ 261 (332)
Q Consensus 192 ~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~------~~~~~~sDiwSlG~il~elltg-~~pf~~~~~~~ 261 (332)
.++|+|||++....... ......++..|+|||++... ..++.++||||||+++|||+++ ..|| ......
T Consensus 137 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~ 215 (268)
T cd05086 137 TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDR 215 (268)
T ss_pred cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC-CCCCHH
Confidence 79999999875422111 12334677889999987431 2457899999999999999975 5566 344443
Q ss_pred HHHHH
Q 040656 262 DQLVK 266 (332)
Q Consensus 262 ~~~~~ 266 (332)
+.+..
T Consensus 216 ~~~~~ 220 (268)
T cd05086 216 EVLNH 220 (268)
T ss_pred HHHHH
Confidence 44443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=250.28 Aligned_cols=195 Identities=28% Similarity=0.503 Sum_probs=160.1
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
...+.|++.+.||+|++|.||+|.+..++..+++|+++... ...+.+|+++++.+ +|+|++++++.+... ...++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEEE
Confidence 34577999999999999999999998889999999997544 56788999999999 999999999998654 57899
Q ss_pred EEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++||++++++..++. .++...... ++.+++.||.+||+.|++|+||+|+
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~---------------------------i~~~i~~~L~~lH~~gi~H~dl~p~ 145 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAY---------------------------VCREVLQGLEYLHSQNVIHRDIKSD 145 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeeeCCCChh
Confidence 999999888877653 234444433 4445556999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.++ .++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 146 ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 146 NILLSKDG-SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred hEEEcCCC-CEEECccchhhhhccchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 99999666 79999999876543222 1233456778999999876 678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.21 Aligned_cols=193 Identities=25% Similarity=0.457 Sum_probs=159.9
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++.-..+||.|.||.||-|....+|+..|+|.++-+ ..+.+.+|..++..+ .|||++++||+-++ ....++.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvH--Rekv~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVH--REKVYIF 1312 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeec--HHHHHHH
Confidence 344558899999999999999999999999998732 235688999999999 99999999999744 3567999
Q ss_pred EeeecCCCceeeccc---cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||||.+|++..++.. ..+.-.+.|..|++. |++|||++|||||||||.||
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~---------------------------gla~LH~~gIVHRDIK~aNI 1365 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLE---------------------------GLAYLHEHGIVHRDIKPANI 1365 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHH---------------------------HHHHHHhcCceecCCCccce
Confidence 999999999998743 233334455555554 99999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-----cccccccccceeccccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+++.++ .+|+.|||.|..+.... ......||+.|||||++.+.. ....++|||||||+..||+||+.||..
T Consensus 1366 ~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1366 LLDFNG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred eeecCC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 999666 89999999998776443 234568999999999997753 467899999999999999999999943
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=252.76 Aligned_cols=192 Identities=21% Similarity=0.407 Sum_probs=155.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
..|+....||+|+||.||++....+++.||+|.+.. .....+.+|+.+++.+ +|+||+++++.+.. ....++++
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 96 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVM 96 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEe--CCEEEEEE
Confidence 445556789999999999999988999999999753 2345688999999999 89999999999854 45789999
Q ss_pred eeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 109 EHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 109 e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
||++++++..+. ..++......++.++ +.||++||+.|++|+||+|+||++
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql---------------------------~~~l~~lH~~givH~dl~p~Nilv 149 (292)
T cd06657 97 EFLEGGALTDIVTHTRMNEEQIAAVCLAV---------------------------LKALSVLHAQGVIHRDIKSDSILL 149 (292)
T ss_pred ecCCCCcHHHHHhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCCCHHHEEE
Confidence 999998877654 234444444444444 459999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+.++ .++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 150 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 150 THDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred CCCC-CEEEcccccceecccccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9665 79999999886553222 2233467888999998866 668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=243.20 Aligned_cols=191 Identities=28% Similarity=0.541 Sum_probs=157.6
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+|++++.++ .|+|++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIET--SDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEe--CCEEEEE
Confidence 5899999999999999999998899999999986432 35688999999999 89999999999854 3578999
Q ss_pred EeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
+|+++++++..+.. .+++.....++ .|++.||.+||+.|++|+||+|+||
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~---------------------------~~i~~~l~~lH~~~i~H~dl~p~ni 130 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYV---------------------------YQVLQGLAYLHEQGVIHRDIKAANI 130 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHH---------------------------HHHHHHHHHHhhCCcccCCCCHHHE
Confidence 99999988776542 24444444444 4455599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||.
T Consensus 131 ~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~ 200 (254)
T cd06627 131 LTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYY 200 (254)
T ss_pred EECCCC-CEEEeccccceecCCCcccccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 999655 799999999987653332 234467888999999876 458899999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=253.08 Aligned_cols=192 Identities=30% Similarity=0.483 Sum_probs=152.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..+.|...+.||+|+||.||+|++..+++.+++|.+... ...++.+|+++++.+ +|+|++++++++.+. ..
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--Ce
Confidence 456688999999999999999999889999999998531 124577899999999 999999999998653 56
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++++||+.+.....+. ..++...+..++.+ ++.|+.|||+.+++||||+
T Consensus 90 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~---------------------------l~~~l~~LH~~~i~H~dl~ 142 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG---------------------------ALQGLAYLHSHNMIHRDVK 142 (308)
T ss_pred eEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHH---------------------------HHHHHHHHHhCCcccCCCC
Confidence 89999999754322221 22444444444444 4459999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++...... ....++..|+|||.+.+ ...++.++|||||||++|+|++|..||.
T Consensus 143 p~nil~~~~~-~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 143 AGNILLSEPG-LVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred HHhEEECCCC-cEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 9999998665 7999999998765432 33467888999998753 2457889999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=244.58 Aligned_cols=190 Identities=25% Similarity=0.462 Sum_probs=150.9
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+|.+.+.||+|+||.||++.+..++..+++|+++.. ....+..|+.+++++ +||||+++++++.+. ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLER--DAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcC--Cce
Confidence 689999999999999999998777777777776521 223566789999999 999999999998543 568
Q ss_pred eeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 105 SLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
++++||++++++..++. .+++.... .++.|++.||.+||+.|++|+
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~~~l~~lH~~~i~h~ 130 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVC---------------------------EWFIQLLLGVHYMHQRRILHR 130 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHH---------------------------HHHHHHHHHHHHHHHcCcccc
Confidence 99999999988765542 23333333 345555669999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+|+||+++ ++ .++|+|||.+........ .....++..|+|||...+ ..++.++|+||||+++|+|++|..||.
T Consensus 131 ~l~~~nili~-~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 131 DLKAKNIFLK-NN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CCChhheEee-cC-CEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999997 44 599999999876643322 234467788999998865 567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=237.97 Aligned_cols=195 Identities=26% Similarity=0.500 Sum_probs=174.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
...+|.+++.||+|+++.|.+++.+++.+.+|+|++++. ...-++.|-.+.....+||.++-++.+| +++..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccce
Confidence 357899999999999999999999999999999999742 1233678888888888999999999999 55678
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++|.||++||+|..+.+ .++++.+++|..++.- ||.|||++||++||||
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~l---------------------------al~flh~rgiiyrdlk 378 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICL---------------------------ALNFLHERGIIYRDLK 378 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHH---------------------------HHHHHhhcCeeeeecc
Confidence 999999999999988763 5899999999999876 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceee-cCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.+|+|++.++ ++||.|+|+++.- .++...++++||+.|.|||.+.+ ..|++..|.|+||++++||+.|+.||.
T Consensus 379 ldnvlldaeg-hikltdygmcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 379 LDNVLLDAEG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ccceEEccCC-ceeecccchhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcc
Confidence 9999999888 7999999998753 45566788999999999999988 789999999999999999999999994
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=245.32 Aligned_cols=184 Identities=30% Similarity=0.528 Sum_probs=149.4
Q ss_pred ecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
||+|+||.||++.+..+++.+++|++... ....+.+|+.+++++ .|+||+++++.+. .....++++|++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQ--GKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHhee--cCcEEEEEEecCCC
Confidence 68999999999999888999999998643 235688899999999 8999999999884 34678999999999
Q ss_pred CCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 114 TDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 114 ~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
+++..++. .+++.....++. |+++||++||+.|++|+||+|+||+++.++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~---------------------------qi~~~L~~lH~~~i~H~di~~~nil~~~~~ 130 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIA---------------------------EIVLALEYLHSNGIIHRDLKPDNILIDSNG 130 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHH---------------------------HHHHHHHHHHHcCeecCCCCHHHeEEcCCC
Confidence 88766542 344444444444 445599999999999999999999999766
Q ss_pred CeEEEEecccceeecCCC---------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 191 QKLRLIDWGLAEFYHPGK---------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 191 ~~vkL~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++|+|||++....... ......++..|+|||.... ...+.++|+||||++++++++|..||.
T Consensus 131 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 131 -HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred -CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 79999999986543221 1223456778999999876 558899999999999999999999994
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=259.77 Aligned_cols=210 Identities=25% Similarity=0.451 Sum_probs=175.8
Q ss_pred cccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeee
Q 040656 21 YESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLD 94 (332)
Q Consensus 21 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~ 94 (332)
|..+....++.+-|..++.||-|.||+|.++....+...+|.|.+++. .-.+++.|-.||... +.+=||++|.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyy 696 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYY 696 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEE
Confidence 344555667778899999999999999999998889999999998642 235678899999998 8999999999
Q ss_pred eeeccCCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 95 IVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
.| +++..+|+||+|.+||++..++ +-|.+..+++|+.++.. |+++.|.
T Consensus 697 SF--QDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltc---------------------------AiesVHk 747 (1034)
T KOG0608|consen 697 SF--QDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTC---------------------------AIESVHK 747 (1034)
T ss_pred Ee--ccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHH---------------------------HHHHHHh
Confidence 99 5567899999999999987775 67889999999999987 9999999
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccceeec---------CCCc---------------------------------
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH---------PGKE--------------------------------- 209 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~---------~~~~--------------------------------- 209 (332)
.|+|||||||+|||||.+| +|||.|||+++-+. .+..
T Consensus 748 mGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~ 826 (1034)
T KOG0608|consen 748 MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRI 826 (1034)
T ss_pred ccceecccCccceEEccCC-ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhh
Confidence 9999999999999999777 79999999985321 0000
Q ss_pred -ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 210 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 210 -~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
....+||..|+|||++.. ..|+.-+|.||.|+|||||+.|+.||. +..+.+.
T Consensus 827 ~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~-~~tp~~t 879 (1034)
T KOG0608|consen 827 LAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFL-ADTPGET 879 (1034)
T ss_pred hhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCcc-CCCCCcc
Confidence 012469999999999988 679999999999999999999999994 4444443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=275.47 Aligned_cols=219 Identities=27% Similarity=0.427 Sum_probs=148.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc---
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP--- 104 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~--- 104 (332)
.+|+.++.||+||||.||+++.+-+|+.+|||.+.-. ...++.+|+..+.+| +|||||+++..+...+....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccccc
Confidence 5689999999999999999999999999999998632 235689999999999 99999999986643211100
Q ss_pred -------------------eeEEeeecC-------------CCceee--------------------------c------
Q 040656 105 -------------------SLIFEHVNS-------------TDFKVL--------------------------Y------ 120 (332)
Q Consensus 105 -------------------~lv~e~~~~-------------~~l~~~--------------------------~------ 120 (332)
.++.+.-.. ++.... .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 000000000 000000 0
Q ss_pred c------------------ccchh-------hHHHHHHHHHhhcCCcceeecCCC--CcccchhhHHhHHHHHHHHHHcC
Q 040656 121 P------------------TLTAN-------EIRYYIYELLKHAMPRKVIIMPGE--GLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 121 ~------------------~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
+ ...+. ...+|-+++......+...-.+.. ...+.|.+..+|+.||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 00000 000111111111111111111122 24557889999999999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeec-------------------CCCcccccccccceeccccccCCC--CCC
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DYD 232 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--~~~ 232 (332)
||||||||.||+++.++ .|||.|||+|+... .....+..+||..|+|||++.+.. .|+
T Consensus 718 iIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999776 69999999997621 001235568999999999998866 699
Q ss_pred CcccHHHHHHHHHHHHhCCCCCC
Q 040656 233 YSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 233 ~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++|||||||++|||+. ||.
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~ 816 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFG 816 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCC
Confidence 99999999999999994 663
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=243.32 Aligned_cols=219 Identities=29% Similarity=0.561 Sum_probs=179.1
Q ss_pred eEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC---CCcee
Q 040656 35 EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS---KTPSL 106 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---~~~~l 106 (332)
+--+-||-|.||+||.+++.++|+.||.|.+.+. ..+++-+|+.++..+ +|.|++..+++....+- ..+|+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHH
Confidence 3346799999999999999999999999998643 457889999999999 99999999887633221 12466
Q ss_pred EEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 107 IFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 107 v~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
++|.|....-..+. +.++...++-+++|++. ||.|||+.+|.||||||.|+
T Consensus 135 ~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILR---------------------------GLKYLHsA~ILHRDIKPGNL 187 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVSPQALTPDHVKVFVYQILR---------------------------GLKYLHTANILHRDIKPGNL 187 (449)
T ss_pred HHHHHHhhhhheeccCCCCCcchhhhhHHHHHh---------------------------hhHHHhhcchhhccCCCccE
Confidence 77777654433332 45777777777777766 99999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|++.+. .+||+|||+++....++. .+..+-|.+|+|||.+.+...|+.+.||||+|||+.|++-++..| ....+.+
T Consensus 188 LVNSNC-vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF-QAq~Piq 265 (449)
T KOG0664|consen 188 LVNSNC-ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF-QAAGPIE 265 (449)
T ss_pred EeccCc-eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh-hccChHH
Confidence 999776 899999999987765543 344578899999999999888999999999999999999888777 6888999
Q ss_pred HHHHHHHHhCCchHHHHHHhc
Q 040656 263 QLVKIARVLGTDELNAYLDKY 283 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~ 283 (332)
++.-|.+.+|++...++....
T Consensus 266 QL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 266 QLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred HHHHHHHHhCCCcHHHHHHHh
Confidence 999999999998877665443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=257.13 Aligned_cols=218 Identities=27% Similarity=0.478 Sum_probs=181.2
Q ss_pred ccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch--HHHHHHHHHHHhccC-----CCCeeeeeeee
Q 040656 24 LTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLCG-----GPNIVKLLDIV 96 (332)
Q Consensus 24 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~-----h~niv~~~~~~ 96 (332)
..+...-..+|++....|+|=||+|-+|.+...|+.||||++.+.+. +.-+.|++||++|.. --|+++++..|
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 34444456899999999999999999999999999999999986443 556899999999943 24889999888
Q ss_pred eccCCCCceeEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 97 RDQHSKTPSLIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
.+.+++|+|||.+.-+.-..+. -.+.-..++.|+.|++- ||.+|-.
T Consensus 504 --~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLfl---------------------------ALklLK~ 554 (752)
T KOG0670|consen 504 --KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFL---------------------------ALKLLKK 554 (752)
T ss_pred --hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHH---------------------------HHHHHHh
Confidence 6678999999987654332221 12556667777777776 9999999
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCC
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~ 251 (332)
.||+|.||||+||||+.....+||||||.|.... ....+.+..+..|.|||++++ .+|+...|+||+||+|||+.||+
T Consensus 555 c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~-eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGk 632 (752)
T KOG0670|consen 555 CGVLHADIKPDNILVNESKNILKLCDFGSASFAS-ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGK 632 (752)
T ss_pred cCeeecccCccceEeccCcceeeeccCccccccc-cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccc
Confidence 9999999999999999888889999999998765 444566777889999999999 78999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhCC
Q 040656 252 EPFFYGHDNQDQLVKIARVLGT 273 (332)
Q Consensus 252 ~pf~~~~~~~~~~~~~~~~~~~ 273 (332)
..| ++..+.+.+..++..-|+
T Consensus 633 IlF-pG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 633 ILF-PGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eec-CCCCcHHHHHHHHHhcCC
Confidence 888 899998988888887664
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=226.45 Aligned_cols=209 Identities=19% Similarity=0.386 Sum_probs=168.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEec----ccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..+++..++.||+|++|.|-+-++..+|...|+|.++ .+..++..+|+.+..+...+|.++.+||.+.++ ...+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEE
Confidence 3466778899999999999999999999999999986 345678899999988877899999999987544 4578
Q ss_pred eEEeeecCCCceeec-------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeec
Q 040656 106 LIFEHVNSTDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHR 177 (332)
Q Consensus 106 lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHr 177 (332)
+.||.|.. ++..++ +..++.-+..++.++++ ||.|||++ .++||
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~---------------------------al~~L~~kL~vIHR 173 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVH---------------------------ALEFLHSKLSVIHR 173 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHH---------------------------HHHHHHHHhhhhhc
Confidence 99998863 333332 23455555555555554 99999976 89999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC---CCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
|+||.|||++.++ +||++|||++-.+...-..+...|...|||||.+... ..|+.+|||||||++++||.++..||
T Consensus 174 DvKPsNiLIn~~G-qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 174 DVKPSNILINYDG-QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred cCCcceEEEccCC-cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 9999999999777 7999999999877655555556788899999988543 35899999999999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 040656 255 FYGHDNQDQLVKIAR 269 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~ 269 (332)
.....+.+++.++..
T Consensus 253 ~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 253 ESWGTPFQQLKQVVE 267 (282)
T ss_pred cccCCHHHHHHHHhc
Confidence 877777777766654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=251.94 Aligned_cols=195 Identities=21% Similarity=0.313 Sum_probs=156.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhc-cCCCCeeeeeeeeecc--CCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQ--HSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~~~~~~~~~--~~~~~~lv 107 (332)
....++.+.+|+|.||+||+|. -.++.||||++....+..+++|-.|.... ..|+||+++++.-... ....+++|
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 5678899999999999999995 47799999999988889999998887763 2799999999875332 24578999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc---------CCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ---------GIMH 176 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---------~ivH 176 (332)
++|.+.|+|.+++. ..+-.++.. ++.-+++||+|||.. .|+|
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cr---------------------------ia~SmarGLa~LHee~p~~d~~Kp~IaH 339 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCR---------------------------IAESMARGLAHLHEELPRGDHHKPPIAH 339 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHH---------------------------HHHHHHHHHHHhcccCCcCCCCCCcccc
Confidence 99999999888763 234444444 444455699999953 5999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCC-----CcccHHHHHHHHHHHH
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYD-----YSLDMWSLGCMFAGMI 248 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~-----~~sDiwSlG~il~ell 248 (332)
||||.+||||.+|. ..-|+|||+|..+..+... ...+||.+|||||++.+.-.+. .+.||||+|.++|||+
T Consensus 340 RDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 340 RDLKSKNVLVKNDL-TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred ccccccceEEccCC-cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999776 7999999999988765543 3468999999999997743333 4799999999999999
Q ss_pred hCCCCCC
Q 040656 249 FRKEPFF 255 (332)
Q Consensus 249 tg~~pf~ 255 (332)
++..-++
T Consensus 419 SRC~~~~ 425 (534)
T KOG3653|consen 419 SRCTDAD 425 (534)
T ss_pred hhccccc
Confidence 9865553
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=265.18 Aligned_cols=198 Identities=25% Similarity=0.497 Sum_probs=166.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--cchHHHHHHHHHHHhccCCCCeeeeeeeeecc---CCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---HSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---~~~~~ 104 (332)
..+-|++.+.||.|.+|.||+++...+++.+|+|+... ...+++..|.++++.+++|||++.++++|.-. .+..+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 34679999999999999999999999999999999864 34577889999999999999999999988532 34579
Q ss_pred eeEEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 105 SLIFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
|+|||+|.+|+..++... +.+....+++.+. +.|+.+||...++|||+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~---------------------------lrgl~HLH~nkviHRDi 149 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREI---------------------------LRGLAHLHNNKVIHRDI 149 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHH---------------------------HHHHHHHhhcceeeecc
Confidence 999999999998887643 3444444444444 44999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCC----CCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~----~~~~sDiwSlG~il~elltg~~pf 254 (332)
|-.|||++.++ .|||+|||.+..+... ....++.||+.|||||++.+.+. |+.++|+||||++..||.-|.+|+
T Consensus 150 kG~NiLLT~e~-~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl 228 (953)
T KOG0587|consen 150 KGQNVLLTENA-EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL 228 (953)
T ss_pred cCceEEEeccC-cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence 99999999777 6999999998776533 34567799999999999987643 678999999999999999999998
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 229 ~ 229 (953)
T KOG0587|consen 229 C 229 (953)
T ss_pred c
Confidence 4
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=237.70 Aligned_cols=184 Identities=28% Similarity=0.494 Sum_probs=151.0
Q ss_pred ecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
||.|+||.||.+....+++.+++|+++.. ....+..|+.+++++ .|+||+++++.+. .....+++||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQ--TEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHee--cCCeeEEEEecCCC
Confidence 68999999999999888999999998643 234688999999999 8999999999984 45678999999988
Q ss_pred CCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 114 TDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 114 ~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
+++...+. .++......++.+ +++||.+||+.+++|+||+|+||+++.++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~q---------------------------i~~~l~~lh~~~~~H~~l~p~ni~~~~~~ 130 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAE---------------------------IVLALEYLHSLGIIYRDLKPENILLDADG 130 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCceecCCCcceEEEcCCC
Confidence 88766542 2444444444444 45599999999999999999999999666
Q ss_pred CeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 191 QKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 191 ~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++|+|||.+...... .......++..|+|||...+ ...+.++|+||||+++|++++|..||.
T Consensus 131 -~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~ 194 (250)
T cd05123 131 -HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFY 194 (250)
T ss_pred -cEEEeecCcceecccCCCcccCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 7999999998776533 23344567888999999876 567899999999999999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=247.36 Aligned_cols=195 Identities=20% Similarity=0.291 Sum_probs=153.6
Q ss_pred ccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHh-ccCCCCeeeeeeeeecc--CCC
Q 040656 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQN-LCGGPNIVKLLDIVRDQ--HSK 102 (332)
Q Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~-l~~h~niv~~~~~~~~~--~~~ 102 (332)
+|..-.....+.+.||+|.||+||+|.+ .|+.||||++.......+.+|.+|.+. +-+|+||+.+++.-... .--
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3444457789999999999999999965 899999999998888889999998877 23899999998864222 223
Q ss_pred CceeEEeeecCCCceeeccc--cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc--------
Q 040656 103 TPSLIFEHVNSTDFKVLYPT--LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-------- 172 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-------- 172 (332)
.+++|++|.+.|+|.+++.+ ++.+.... +++-+|.||++||..
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~tv~~~~ml~---------------------------LalS~AsGLaHLH~eI~GTqgKP 335 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNTVTTEGMLK---------------------------LALSIASGLAHLHMEIVGTQGKP 335 (513)
T ss_pred EEEEeeecccCCcHHHHHhhccCCHHHHHH---------------------------HHHHHhhhHHHHHHHHhcCCCCc
Confidence 58999999999999998755 33333333 444556699999943
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeecCC-----CcccccccccceeccccccCCCC---C--CCcccHHHHHH
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQD---Y--DYSLDMWSLGC 242 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~---~--~~~sDiwSlG~ 242 (332)
.|.|||||..||||..++ ..-|+|+|+|...... ...+..+||.+|||||++...-. + -..+||||||.
T Consensus 336 aIAHRDlKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgL 414 (513)
T KOG2052|consen 336 AIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGL 414 (513)
T ss_pred hhhccccccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHH
Confidence 499999999999999766 7999999999766543 23567799999999999855311 1 14899999999
Q ss_pred HHHHHHhC
Q 040656 243 MFAGMIFR 250 (332)
Q Consensus 243 il~elltg 250 (332)
++||++.+
T Consensus 415 VlWEiarR 422 (513)
T KOG2052|consen 415 VLWEIARR 422 (513)
T ss_pred HHHHHHHH
Confidence 99999854
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=268.37 Aligned_cols=141 Identities=29% Similarity=0.490 Sum_probs=117.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|.+.++||+|+||.||+|.+..+++.||+|+++... ...+..|+.++..+ +|+||+++++.+.. ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEE--CCEE
Confidence 478999999999999999999998899999999986432 25688899999999 99999999988844 4578
Q ss_pred eeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||||+.+++|..++. .+....+..++. |++.||.|||+++|+||||||
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~---------------------------qil~aL~yLH~~gIiHrDLKP 132 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS---------------------------EVALALDYLHRHGIIHRDLKP 132 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCEEeCCccH
Confidence 99999999998877652 344444444444 445599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccce
Q 040656 182 HNVMIDHEQQKLRLIDWGLAE 202 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~ 202 (332)
+|||++.++ .++|+|||+++
T Consensus 133 ~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 133 DNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred HHEEEcCCC-CEEEEeCCCCc
Confidence 999999666 79999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=282.34 Aligned_cols=189 Identities=22% Similarity=0.335 Sum_probs=149.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+.|...+.||+|+||.||+|....++..||+|.++... .....|+++++++ +||||+++++++.+. ...++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-cccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCC
Confidence 34666788999999999999988899999999986432 2234678999999 999999999999654 5689999999
Q ss_pred cCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH---HcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH---SQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~ivHrdlkp~Nilv~~ 188 (332)
+++++..++..++...... ++.++++||+||| +.+|+||||||+||+++.
T Consensus 766 ~~g~L~~~l~~l~~~~~~~---------------------------i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~ 818 (968)
T PLN00113 766 EGKNLSEVLRNLSWERRRK---------------------------IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818 (968)
T ss_pred CCCcHHHHHhcCCHHHHHH---------------------------HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC
Confidence 9999887776555444433 4555566999999 669999999999999986
Q ss_pred CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
++ ..++. ||.+..... .....+|..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 819 ~~-~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 819 KD-EPHLR-LSLPGLLCT---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred CC-ceEEE-ecccccccc---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 55 45554 665443221 122367889999999876 67999999999999999999999999543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=259.61 Aligned_cols=219 Identities=20% Similarity=0.232 Sum_probs=140.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC----CceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeee----ccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN----NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR----DQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~~ 101 (332)
..++|++.+.||+|+||.||+|++..+ +..||+|.++.........+.. +.+. .+.++..+...+. ..+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~-~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRA-CPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhh-chhhHHHHHHhhhcccccccC
Confidence 457899999999999999999999888 8999999886433222211111 2222 2223333322221 1345
Q ss_pred CCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
...++++||+.++++..++..... ...+.+.+... .................++.|++.||.|||+++|+||||||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~---~~~v~~~l~~~-~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEF---PYNVEPYLLGK-VQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCC---chhHHHHhccc-hhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 678999999999988776532110 01111111100 00000000000001125777889999999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCC---------------------CCCCcccHH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDMW 238 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~sDiw 238 (332)
+|||++.+++.+||+|||+++.+.... ......+++.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999998655589999999997654322 224457889999999654311 133466999
Q ss_pred HHHHHHHHHHhCCCCC
Q 040656 239 SLGCMFAGMIFRKEPF 254 (332)
Q Consensus 239 SlG~il~elltg~~pf 254 (332)
||||++|||+++..|+
T Consensus 364 SlGviL~el~~~~~~~ 379 (566)
T PLN03225 364 SAGLIFLQMAFPNLRS 379 (566)
T ss_pred HHHHHHHHHHhCcCCC
Confidence 9999999999876554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=237.41 Aligned_cols=176 Identities=19% Similarity=0.299 Sum_probs=140.2
Q ss_pred cCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeec--
Q 040656 43 GKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY-- 120 (332)
Q Consensus 43 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-- 120 (332)
|.+|.||+|.+..+++.+|+|.++... ...+|...+... .||||+++++++.+ ....+++|||++++++...+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986432 334455555555 79999999999854 45789999999999886654
Q ss_pred -cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecc
Q 040656 121 -PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199 (332)
Q Consensus 121 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg 199 (332)
..++......++.+++ +||.|||++|++||||||+||+++.++ .++++|||
T Consensus 79 ~~~l~~~~~~~~~~ql~---------------------------~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~ 130 (237)
T cd05576 79 FLNIPEECVKRWAAEMV---------------------------VALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFS 130 (237)
T ss_pred hcCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeccc
Confidence 2345555555555554 499999999999999999999999776 69999999
Q ss_pred cceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 200 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 200 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
.+..... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..|+
T Consensus 131 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~ 182 (237)
T cd05576 131 RWSEVED--SCDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLV 182 (237)
T ss_pred chhcccc--ccccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchh
Confidence 8765432 2233455677999998865 56889999999999999999999887
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=252.46 Aligned_cols=206 Identities=26% Similarity=0.462 Sum_probs=174.6
Q ss_pred cccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------hHHHHHHHHHHHhcc--C
Q 040656 19 WDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------KKKIKREIKILQNLC--G 85 (332)
Q Consensus 19 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~--~ 85 (332)
..+........+-.+|..++.+|+|+||.|++|.++++...|++|.+.+.+ ...+..|+.||..+. .
T Consensus 548 e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~s 627 (772)
T KOG1152|consen 548 EGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHS 627 (772)
T ss_pred cccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcC
Confidence 344555666667788999999999999999999999999999999987532 234678999999993 2
Q ss_pred CCCeeeeeeeeeccCCCCceeEEeeec-CCCceee---ccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHh
Q 040656 86 GPNIVKLLDIVRDQHSKTPSLIFEHVN-STDFKVL---YPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVW 161 (332)
Q Consensus 86 h~niv~~~~~~~~~~~~~~~lv~e~~~-~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (332)
|+||++++++|++ ..+++++||-.. +-+|.++ ..++.+.++..+++|+..
T Consensus 628 H~NIlKlLdfFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~a------------------------ 681 (772)
T KOG1152|consen 628 HENILKLLDFFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVA------------------------ 681 (772)
T ss_pred ccchhhhhheeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHh------------------------
Confidence 9999999999955 467889998874 4344443 367889999999999887
Q ss_pred HHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHH
Q 040656 162 DLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241 (332)
Q Consensus 162 i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG 241 (332)
|+++||+.||||||||-+|++++.+| -+||+|||.+.... ...+..+.||..|.|||++.+....+..-|||++|
T Consensus 682 ---gi~hlh~~~ivhrdikdenvivd~~g-~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalg 756 (772)
T KOG1152|consen 682 ---GIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALG 756 (772)
T ss_pred ---ccccccccCceecccccccEEEecCC-eEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhh
Confidence 99999999999999999999999776 79999999987655 55667889999999999998876778999999999
Q ss_pred HHHHHHHhCCCCCC
Q 040656 242 CMFAGMIFRKEPFF 255 (332)
Q Consensus 242 ~il~elltg~~pf~ 255 (332)
++||.++....||+
T Consensus 757 illytivykenpyy 770 (772)
T KOG1152|consen 757 ILLYTIVYKENPYY 770 (772)
T ss_pred heeeEEEeccCCCc
Confidence 99999999999985
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=242.05 Aligned_cols=220 Identities=33% Similarity=0.631 Sum_probs=192.4
Q ss_pred CCCceEEEeecccCCceEEEEEEcc---CCceEEEEEec-ccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVT---NNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.+.|.++++||+|+|++||++.... ..+.||+|.+. .....++.+|++.|..+..+.||+.+.+.+.. ....++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence 3669999999999999999998777 78899999986 45668899999999999999999999999954 457899
Q ss_pred EEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 107 IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|+||++...+..++..++-..++.|+..++. ||+++|.+||||||+||.|+|.
T Consensus 113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~---------------------------Al~~~h~~GIvHRDiKpsNFL~ 165 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLK---------------------------ALAHLHKNGIVHRDIKPSNFLY 165 (418)
T ss_pred EecccCccCHHHHHhcCCHHHHHHHHHHHHH---------------------------HhhhhhccCccccCCCcccccc
Confidence 9999999999999999999999999999998 9999999999999999999999
Q ss_pred cCCCCeEEEEecccceeec-----------------C--CC--------------------------cccccccccceec
Q 040656 187 DHEQQKLRLIDWGLAEFYH-----------------P--GK--------------------------EYNVRVASRYFKG 221 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~-----------------~--~~--------------------------~~~~~~~t~~y~a 221 (332)
+...++-.|+|||+|.... . +. ......||++|+|
T Consensus 166 n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa 245 (418)
T KOG1167|consen 166 NRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA 245 (418)
T ss_pred ccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc
Confidence 9888889999999985110 0 00 0012368999999
Q ss_pred cccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHH
Q 040656 222 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAY 279 (332)
Q Consensus 222 PE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (332)
||++......+++.||||.|+|+..++++..||+...++.+.+..+....+...+...
T Consensus 246 PEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~ 303 (418)
T KOG1167|consen 246 PEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKC 303 (418)
T ss_pred hHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHH
Confidence 9999887788999999999999999999999999999999999999999997766643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=257.39 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=180.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEc----c---CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV----T---NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~----~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
++++..+.+.||+|.||.|++|.-. . ....||||.++.. ..+.+..|+++|+.+.+|+||+.++|.+..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3556688889999999999988632 1 2567999998742 346789999999999999999999999965
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeec--CCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM--PGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...+++++||+..|++..++...... ..+.... .... .......-+.++.||+.|++||++.+++|
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~-------~~~~~~~---~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vH 441 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVT-------ESIDGSG---VFPNERDALTTKDLLSFAYQIANGMEYLASVPCVH 441 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhcccc-------ccccccC---CCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 56789999999999988776332200 0000000 0000 00122223468889999999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCccccc--cc--ccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR--VA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RK 251 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~--~~--t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~ 251 (332)
|||..+|||+..+. .+|++|||+|+........... .+ ...|||||.+.. ..|+.+|||||||++|||++| |.
T Consensus 442 RDLAaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 442 RDLAARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred hhhhhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCC
Confidence 99999999999655 8999999999876544433222 22 234999999987 789999999999999999998 56
Q ss_pred CCCCCCCC-CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCC
Q 040656 252 EPFFYGHD-NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGF 330 (332)
Q Consensus 252 ~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R 330 (332)
.|| ++.. ..+....+..+...+.+ ..++++.-. ++..||+.+|++|
T Consensus 520 ~PY-p~~~~~~~l~~~l~~G~r~~~P--------~~c~~eiY~------------------------iM~~CW~~~p~~R 566 (609)
T KOG0200|consen 520 TPY-PGIPPTEELLEFLKEGNRMEQP--------EHCSDEIYD------------------------LMKSCWNADPEDR 566 (609)
T ss_pred CCC-CCCCcHHHHHHHHhcCCCCCCC--------CCCCHHHHH------------------------HHHHHhCCCcccC
Confidence 666 5533 33333333332222111 223333333 3456999999999
Q ss_pred CC
Q 040656 331 PF 332 (332)
Q Consensus 331 P~ 332 (332)
|+
T Consensus 567 P~ 568 (609)
T KOG0200|consen 567 PT 568 (609)
T ss_pred CC
Confidence 96
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=232.23 Aligned_cols=268 Identities=25% Similarity=0.485 Sum_probs=210.4
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeecc---
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--- 99 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 99 (332)
+....+|.-+..+|.|.- .|-.|-+.-.+++||+|.... ...++..+|...+..+ .|+||++++.+|.-.
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccH
Confidence 334578999999999998 778888888999999998752 2346788999999999 999999999998543
Q ss_pred -CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 100 -HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 100 -~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.....++|||+|....-....-.+..+..+.++.|.+. |+.|||+.||+|||
T Consensus 91 ~~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~---------------------------~ik~lhs~~IihRd 143 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDANLCQVILMELDHETISYILYQMLC---------------------------GIKHLHSAGIIHRD 143 (369)
T ss_pred HHHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHH---------------------------HHHHHHhcceeecc
Confidence 22357899999988776666667778888888888877 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
|||+||++..+. .+|+.|||+|+.....-..+..+.|+.|.|||++.++. +.+.+||||+||++.||++|..-| ++.
T Consensus 144 LkPsnivv~~~~-~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf-~g~ 220 (369)
T KOG0665|consen 144 LKPSNIVVNSDC-TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLF-PGK 220 (369)
T ss_pred cCcccceecchh-heeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEe-cCc
Confidence 999999999777 79999999998765443556778999999999999965 999999999999999999999887 699
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--------------CCCCCCCcccccccccccccCceEEE
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--------------RVWPIPNNKKLQFCRSSRTSTNICIT 324 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~~~~~~~~~~~~cl~ 324 (332)
+..++..++.+.+++++.. +.+++ .|..+..++.. -.|..........|...++++.++|-
T Consensus 221 d~idQ~~ki~~~lgtpd~~-F~~qL----~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLv 295 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPS-FMKQL----QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLV 295 (369)
T ss_pred hHHHHHHHHHHHhcCCCHH-HHHHh----hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhc
Confidence 9999999999999987643 33332 22222222211 12222222233445555788889999
Q ss_pred eCCCCCCC
Q 040656 325 FSPSGFPF 332 (332)
Q Consensus 325 ~dP~~RP~ 332 (332)
.+|++|-+
T Consensus 296 i~pe~Ris 303 (369)
T KOG0665|consen 296 IDPEKRIS 303 (369)
T ss_pred cChhhccc
Confidence 99999953
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=239.86 Aligned_cols=204 Identities=25% Similarity=0.458 Sum_probs=167.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEec--ccc--------hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~--------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.++|.++.+||+|||++||+|.+...++.||||+-. +.. -+..-+|..|.+.| +||.||++|++|.-.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeecc
Confidence 378999999999999999999999999999999942 211 14467899999999 9999999999996433
Q ss_pred CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc--CCe
Q 040656 101 SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ--GIM 175 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~iv 175 (332)
...|-|+|||+|++|...+ ..+++++++.++++++. ||.||... -||
T Consensus 541 -dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVn---------------------------AL~YLNEikpPII 592 (775)
T KOG1151|consen 541 -DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVN---------------------------ALKYLNEIKPPII 592 (775)
T ss_pred -ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHH---------------------------HHHHHhccCCCee
Confidence 4689999999999998876 45889999999999887 99999865 599
Q ss_pred ecCCCCCCeeecC--CCCeEEEEecccceeecCCCc--------ccccccccceeccccccCC---CCCCCcccHHHHHH
Q 040656 176 HRDVKPHNVMIDH--EQQKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGC 242 (332)
Q Consensus 176 Hrdlkp~Nilv~~--~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~---~~~~~~sDiwSlG~ 242 (332)
|-||||.|||+.. ..+.+||.|||+++++..+.. .....||.+|.+||.+.-+ ...+.+.||||+|+
T Consensus 593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV 672 (775)
T KOG1151|consen 593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV 672 (775)
T ss_pred eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence 9999999999953 234799999999998764322 2335799999999987543 34789999999999
Q ss_pred HHHHHHhCCCCCCCCCCCHHH
Q 040656 243 MFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 243 il~elltg~~pf~~~~~~~~~ 263 (332)
|+|..+.|+-||.......+.
T Consensus 673 IFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 673 IFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred hhhhhhccCCCCCCchhHHHH
Confidence 999999999999654444443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=217.08 Aligned_cols=181 Identities=34% Similarity=0.610 Sum_probs=148.9
Q ss_pred CCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceee
Q 040656 44 KYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL 119 (332)
Q Consensus 44 ~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 119 (332)
+||.||+|....+++.+++|++.... .+.+.+|++.++++ +|+|++++++.+... ...++++|+++++++..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 58999999998889999999987433 57889999999999 999999999998543 568999999999877666
Q ss_pred ccc---cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEE
Q 040656 120 YPT---LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLI 196 (332)
Q Consensus 120 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~ 196 (332)
+.. ++...... ++.+++.++.+||+.+++|+||+|+||+++.++ .++|+
T Consensus 78 ~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~ 129 (244)
T smart00220 78 LKKRGRLSEDEARF---------------------------YARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLA 129 (244)
T ss_pred HHhccCCCHHHHHH---------------------------HHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEc
Confidence 432 23333333 444555699999999999999999999999665 79999
Q ss_pred ecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 197 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 197 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||.+.............++..|++||...+ ..++.++|+||||++++++++|..||..
T Consensus 130 d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 130 DFGLARQLDPGGLLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred cccceeeeccccccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999987765444455677888999999875 5678899999999999999999999843
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=237.03 Aligned_cols=222 Identities=18% Similarity=0.299 Sum_probs=147.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEc----------------cCCceEEEEEecccch---H--------------HHHHH
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV----------------TNNEKCIIKILKPVKK---K--------------KIKRE 76 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vavK~~~~~~~---~--------------~~~~E 76 (332)
+.++|++.++||+|+||.||+|... ..++.||+|.++.... . ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4689999999999999999998642 2446799999863221 1 23346
Q ss_pred HHHHHhccCCCCe-----eeeeeeeecc------CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcC-Ccce
Q 040656 77 IKILQNLCGGPNI-----VKLLDIVRDQ------HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM-PRKV 144 (332)
Q Consensus 77 ~~~l~~l~~h~ni-----v~~~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 144 (332)
+.++.++ +|.++ +.++++|... .....++|+||+++++|..++...... ....+.+.+.... ....
T Consensus 223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~-~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGP-FPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCC-CcchHHHHHhcCCchhhh
Confidence 7777777 45443 5666766432 234579999999999988876431110 0011111111111 1111
Q ss_pred eecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCccccc--ccccceecc
Q 040656 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGP 222 (332)
Q Consensus 145 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~--~~t~~y~aP 222 (332)
.......+.....++.+++.+|.|||+.+|+||||||+|||++.++ .++|+|||++............ .+|+.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1111122333456777889999999999999999999999999766 7999999999765433222222 346789999
Q ss_pred ccccCCCC-------------------C--CCcccHHHHHHHHHHHHhCCC-CC
Q 040656 223 ELLVDLQD-------------------Y--DYSLDMWSLGCMFAGMIFRKE-PF 254 (332)
Q Consensus 223 E~~~~~~~-------------------~--~~~sDiwSlG~il~elltg~~-pf 254 (332)
|.+..... + ....||||+||++++|++|.. ||
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 98754211 1 134799999999999999875 55
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=219.12 Aligned_cols=211 Identities=18% Similarity=0.324 Sum_probs=163.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeee-eeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDI-VRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~-~~~~~~~~~~lv 107 (332)
.+.|.|.+.||+|.||.+-+|.+..++..+++|.+... ..++|.+|...--.|..|.||+.-|+. | ++...++.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF--qt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF--QTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh--hcCceEEEe
Confidence 36799999999999999999999999999999998643 457899999888888889999998764 5 444578889
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+||++.|+|..-.. .+.+...+.+..|++ +||.|||++++||||||.+|||
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~---------------------------SAi~fMHsknlVHRdlK~eNiL 153 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLL---------------------------SAIEFMHSKNLVHRDLKAENIL 153 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHH---------------------------HHHHHhhccchhhcccccceEE
Confidence 99999999877653 344444455555554 4999999999999999999999
Q ss_pred e-cCCCCeEEEEecccceeecCCCcccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 186 I-DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 186 v-~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
+ +.+..+|||+|||.++..... -.....+..|.+||.+... ....+.+|+|.|||++|.++||..||..+...
T Consensus 154 if~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~ 231 (378)
T KOG1345|consen 154 IFDADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM 231 (378)
T ss_pred EecCCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence 8 456669999999998764322 1222344558899986432 22568999999999999999999999754444
Q ss_pred HHHHHHHHHHhC
Q 040656 261 QDQLVKIARVLG 272 (332)
Q Consensus 261 ~~~~~~~~~~~~ 272 (332)
......+.+..+
T Consensus 232 d~~Y~~~~~w~~ 243 (378)
T KOG1345|consen 232 DKPYWEWEQWLK 243 (378)
T ss_pred CchHHHHHHHhc
Confidence 444555555444
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=240.95 Aligned_cols=190 Identities=19% Similarity=0.350 Sum_probs=152.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCc----eEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.....++||+|.||+||+|.+...++ +||+|++.. .....+..|+.+|.++ +|||++++++++... .+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---hH
Confidence 35566889999999999998866654 688888753 2356899999999999 999999999999653 38
Q ss_pred eeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.+|+++++.|.|.++.+. +..+.+. ....||++||.|||.++++||||.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lL---------------------------nw~~QIAkgM~YLe~qrlVHrdLa 825 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLL---------------------------NWCYQIAKGMKYLEEQRLVHRDLA 825 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHH---------------------------HHHHHHHHHHHHHHhcchhhhhhh
Confidence 899999999998877533 2223332 355566779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcc-ccccc--ccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEY-NVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~-~~~~~--t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
.+|+||..-+ .+|+.|||+++....+... ....| ...|||=|.+.. ..|+.++|||||||++||++| |..|++
T Consensus 826 aRNVLVksP~-hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 826 ARNVLVKSPN-HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred hhheeecCCC-eEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 9999999555 8999999999988755443 22222 355999998877 789999999999999999997 888873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-31 Score=246.75 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=188.7
Q ss_pred ceEEEeecccCCc-eEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeec
Q 040656 34 YEVVRKVGRGKYS-EVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVN 112 (332)
Q Consensus 34 y~~~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~ 112 (332)
|.-.+.+|.|+.| .||+|.. .++.||||.+-.......++|+..|+.-..|||||++++.- ++....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence 3444668999987 6789965 78899999986666678899999999998899999999875 55678899999987
Q ss_pred CCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCC---
Q 040656 113 STDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE--- 189 (332)
Q Consensus 113 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~--- 189 (332)
... .++...- .. +... ..-...+.+..|+++||++||+.+||||||||+||||+..
T Consensus 587 ~sL-~dlie~~-~~-------d~~~------------~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~ 645 (903)
T KOG1027|consen 587 CSL-QDLIESS-GL-------DVEM------------QSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSAD 645 (903)
T ss_pred hhH-HHHHhcc-cc-------chhh------------cccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCC
Confidence 532 2221110 00 0000 0002334566677789999999999999999999999762
Q ss_pred C-CeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCCCHHH
Q 040656 190 Q-QKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNQDQ 263 (332)
Q Consensus 190 ~-~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg-~~pf~~~~~~~~~ 263 (332)
+ .+++|+|||+++.+..++. .....||.+|+|||++.. ..-+.+.||+||||++|+.++| .+||.. ..+.
T Consensus 646 ~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd---~~~R 721 (903)
T KOG1027|consen 646 GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGD---SLER 721 (903)
T ss_pred cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCc---hHHh
Confidence 2 4789999999998876654 234578999999999987 5567799999999999999986 899942 2222
Q ss_pred HHHHHHHhC-------Cc--hHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccC
Q 040656 264 LVKIARVLG-------TD--ELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTST 319 (332)
Q Consensus 264 ~~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~ 319 (332)
...|..... .+ .+.+++.++ .+.+|+.|..+... ||++....+...+.++..+-+
T Consensus 722 ~~NIl~~~~~L~~L~~~~d~eA~dLI~~m-l~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRv 787 (903)
T KOG1027|consen 722 QANILTGNYTLVHLEPLPDCEAKDLISRM-LNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRV 787 (903)
T ss_pred hhhhhcCccceeeeccCchHHHHHHHHHh-cCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhh
Confidence 233333211 22 566788887 78888888888777 999999988888887765443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=207.35 Aligned_cols=192 Identities=32% Similarity=0.589 Sum_probs=156.9
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
|.+.+.||+|++|.||++....+++.+++|.+... ..+.+.+|++.++++ .|+|++++++.+.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeec--CCceEEEEe
Confidence 67889999999999999998888999999999754 356788999999999 99999999998854 356899999
Q ss_pred eecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
+++++++..+... ++...... ++.+++.++.+||+.+++|+|++|.||+
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lh~~~i~h~di~~~ni~ 130 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARF---------------------------YLRQILEALEYLHSLGIVHRDLKPENIL 130 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9998887766532 33333333 3444455999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
++.++ .++|+|||.+....... ......++..|++||...+...++.++|+||||+++++|++|..||..
T Consensus 131 v~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 131 LGMDG-LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EcCCC-CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99665 79999999998775443 334456777899999874436788899999999999999999999943
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=236.23 Aligned_cols=196 Identities=27% Similarity=0.473 Sum_probs=164.2
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..+++|+++..+|+|.+|.||+|+++.+++..|+|+++-. .-+-+++|+-+++.. +|+||+.+++.+.. ...++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr--~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLR--RDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhh--hcCcE
Confidence 3568999999999999999999999999999999999732 335578999999998 99999999998843 35689
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+.||||.+|++.+++ +.+++....+.-++.+. ||+|||+.|-+|||||-.
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~---------------------------gl~ylhs~gk~hRdiKGa 141 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---------------------------GLKYLHSQGKIHRDIKGA 141 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhc---------------------------cchhhhcCCccccccccc
Confidence 999999999999987 45666666665666555 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++..+ .+|++|||.+-.+.. -.....+.||++|||||+..- ...|...+|||++|+...|+.--+.|.+
T Consensus 142 nilltd~g-DvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 142 NILLTDEG-DVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred ceeecccC-ceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 99999666 699999998765542 234567899999999998632 1458899999999999999998888864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=211.96 Aligned_cols=247 Identities=17% Similarity=0.284 Sum_probs=181.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC-----CceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.+++++..-.+-+|.||.||.|.+.+. .+.|.+|.++... -..+..|.-.+.-+ +|||+.++.+++.. +
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie-~ 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIE-D 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEee-c
Confidence 356788889999999999999966433 3456677765322 24577888888888 89999999998864 3
Q ss_pred CCCceeEEeeecCCCceeeccccc---hhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLT---ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++.++.++..+.|..++.... ..-++.+. -.+-+.++.|++.|++|||++|+||.
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvt-------------------t~qlV~masQla~am~hlh~~~ViHk 420 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVT-------------------TIQLVLMASQLAMAMEHLHNHGVIHK 420 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchh-------------------HHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 456788889888888777653100 00011000 11123578889999999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||..+|++++ +.-++||+|=.+++.+.+..-. .....+..||+||.+.+ ..|+.++|+||||+++|||+| |+.|
T Consensus 421 DiAaRNCvId-d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~P 498 (563)
T KOG1024|consen 421 DIAARNCVID-DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLP 498 (563)
T ss_pred hhhhhcceeh-hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999 4458999999998876544321 12234556999999988 789999999999999999998 7888
Q ss_pred CCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+ ...|+.+....+.++++-.++ -+++.++-..+ --||..+|++||+
T Consensus 499 y-aeIDPfEm~~ylkdGyRlaQP--------~NCPDeLf~vM------------------------acCWallpeeRPs 544 (563)
T KOG1024|consen 499 Y-AEIDPFEMEHYLKDGYRLAQP--------FNCPDELFTVM------------------------ACCWALLPEERPS 544 (563)
T ss_pred c-cccCHHHHHHHHhccceecCC--------CCCcHHHHHHH------------------------HHHHhcCcccCCC
Confidence 7 678888888888877665443 23444444433 2299999999996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=191.40 Aligned_cols=178 Identities=33% Similarity=0.590 Sum_probs=143.3
Q ss_pred ecccCCceEEEEEEccCCceEEEEEecccch----HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCC
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD 115 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~ 115 (332)
||+|++|.||++....+++.+++|++..... ..+.+|+..++.+ .|++++++++++... ...++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 6899999999999877799999999976543 6799999999999 899999999998543 57899999999888
Q ss_pred ceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCC
Q 040656 116 FKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191 (332)
Q Consensus 116 l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~ 191 (332)
+..++.. ++...... ++.++++++.+||+.|++|+||+|.||+++..++
T Consensus 78 l~~~~~~~~~~~~~~~~~~---------------------------~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~ 130 (215)
T cd00180 78 LKDLLKENEGKLSEDEILR---------------------------ILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG 130 (215)
T ss_pred HHHHHHhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC
Confidence 7766532 33333333 4445556999999999999999999999997234
Q ss_pred eEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHH
Q 040656 192 KLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 192 ~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~el 247 (332)
.++|+|||.+....... ......+...|++||........+.++|+|++|++++++
T Consensus 131 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 131 KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 79999999998665332 123345677799999987633788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=190.72 Aligned_cols=221 Identities=20% Similarity=0.367 Sum_probs=174.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEec-ccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.-.|.++++||+|+||+.+.|....++++||||.-. +.+...+..|....+.|...++|..+|.+. +++.+-.+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhh
Confidence 356999999999999999999999999999999975 345568899999999998889999988775 67778889999
Q ss_pred eecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
.+.. +|.++. ..++.+++..++.|++. -++++|++.+|+|||||+|+|
T Consensus 105 LLGP-SLEDLFD~CgR~FSvKTV~miA~Qmi~---------------------------rie~vH~k~LIYRDIKPdNFL 156 (449)
T KOG1165|consen 105 LLGP-SLEDLFDLCGRRFSVKTVAMIAKQMIT---------------------------RIEYVHEKDLIYRDIKPDNFL 156 (449)
T ss_pred hhCc-CHHHHHHHhcCcccHHhHHHHHHHHHH---------------------------HHHHHHhcceeecccCcccee
Confidence 8754 333332 56788888877777776 999999999999999999999
Q ss_pred ecC----CCCeEEEEecccceeecCCC--------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 186 IDH----EQQKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 186 v~~----~~~~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|.. +.+.|.++|||+|+.+.... +..+..||..||+-....+ ...+.+.|+-|||-++++++-|..|
T Consensus 157 IGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 157 IGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred ecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCc
Confidence 964 23368999999998764332 2345679999999998888 6789999999999999999999999
Q ss_pred CCC--CCCCHHHHHHHHHHhCCchHHHHHHh
Q 040656 254 FFY--GHDNQDQLVKIARVLGTDELNAYLDK 282 (332)
Q Consensus 254 f~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (332)
|.. ...+.+..++|...-+.-.+.+++..
T Consensus 236 WQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g 266 (449)
T KOG1165|consen 236 WQGLKADTNKEKYEKIGETKRSTPIEVLCEG 266 (449)
T ss_pred cccccCcchHHHHHHhccccccCCHHHHHhc
Confidence 942 22344555565554444444444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=181.01 Aligned_cols=201 Identities=23% Similarity=0.383 Sum_probs=156.6
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.....+|.++++||+|+||.+|.|.....|+.||+|+-+.. ....+..|..+...|.....|..+..++ .+..+-.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc--ccccccee
Confidence 34468899999999999999999999999999999998643 3456888999988885566777776666 44467789
Q ss_pred EEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
||+.+.. +|.++. ..++-+++..++.|++. -++|+|.++++||||||+
T Consensus 89 VMdLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~---------------------------RiEyvH~r~fiHRDIKPd 140 (341)
T KOG1163|consen 89 VMDLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLS---------------------------RIEYVHLRNFIHRDIKPD 140 (341)
T ss_pred eeeccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHH---------------------------HHHHHHhhccccccCCcc
Confidence 9998754 444432 45666666666666665 999999999999999999
Q ss_pred CeeecC--CCCeEEEEecccceeecCCC--------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 183 NVMIDH--EQQKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 183 Nilv~~--~~~~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|+|..- ...++.|+|||+|+.+.... ......||..|.+-....+ ...+.+.|+-|+|.++..+--|..
T Consensus 141 NFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~L 219 (341)
T KOG1163|consen 141 NFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSL 219 (341)
T ss_pred ceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCC
Confidence 999842 33479999999998664222 2344578999988776665 567889999999999999999999
Q ss_pred CCCCCCCC
Q 040656 253 PFFYGHDN 260 (332)
Q Consensus 253 pf~~~~~~ 260 (332)
||. +...
T Consensus 220 PWQ-glka 226 (341)
T KOG1163|consen 220 PWQ-GLKA 226 (341)
T ss_pred ccc-ccch
Confidence 994 4443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.6e-25 Score=197.36 Aligned_cols=169 Identities=18% Similarity=0.237 Sum_probs=124.7
Q ss_pred CCCceEEEeecccCCceEEEEEEcc-CCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeee-eeeeeeccC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVT-NNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVK-LLDIVRDQH 100 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~-~~~~~~~~~ 100 (332)
.++|.+.+.||+|+||+||+|++.. +++.+|+|.+... ....+.+|+++++++ .|+|+++ +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~----- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT----- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc-----
Confidence 4679999999999999999998766 6778899986422 234689999999999 8999885 4432
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC-
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV- 179 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl- 179 (332)
...+++|||+++++|.... . .. ... ++.+++++|.+||+.||+||||
T Consensus 91 -~~~~LVmE~~~G~~L~~~~-~--~~-~~~---------------------------~~~~i~~aL~~lH~~gIiHrDL~ 138 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR-P--HG-DPA---------------------------WFRSAHRALRDLHRAGITHNDLA 138 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC-c--cc-hHH---------------------------HHHHHHHHHHHHHHCCCeeCCCC
Confidence 2479999999998875221 0 01 112 3344556999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcc---------cccccccceeccccccCCC-----CCCCcccHH
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---------NVRVASRYFKGPELLVDLQ-----DYDYSLDMW 238 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~-----~~~~~sDiw 238 (332)
||+|||++.++ .++|+|||+|+.+...... ....++..|+|||.+...+ ..+..+|-|
T Consensus 139 KP~NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 139 KPQNWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CcceEEEcCCC-CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999998665 7999999999876533211 2345677789999874421 134456666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=186.67 Aligned_cols=193 Identities=22% Similarity=0.341 Sum_probs=146.9
Q ss_pred CceEEEeecccCCceEEEEEEccCC-ceEEEEEecccch---HHHHHHHHHHHhccC---CCCeeeeeeeeeccCCCCce
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNN-EKCIIKILKPVKK---KKIKREIKILQNLCG---GPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~---~~~~~E~~~l~~l~~---h~niv~~~~~~~~~~~~~~~ 105 (332)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+...... ..+..|..++..+.. .+++..+++... ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 8999999999999999999986664 6789998764322 268899999999842 358888888774 2344668
Q ss_pred eEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 106 LIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 106 lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+||+.+.. +|.++. +.++..++. .++.|++.+|++||+.|++|||||
T Consensus 98 iVM~l~G~-sL~dl~~~~~~~~fs~~T~l---------------------------~ia~q~l~~l~~lH~~G~iHRDiK 149 (322)
T KOG1164|consen 98 IVMSLLGP-SLEDLRKRNPPGRFSRKTVL---------------------------RIAIQNLNALEDLHSKGFIHRDIK 149 (322)
T ss_pred EEEeccCc-cHHHHHHhCCCCCcCHhHHH---------------------------HHHHHHHHHHHHHHhcCcccCCcC
Confidence 88887654 333332 234444444 455555669999999999999999
Q ss_pred CCCeeecCCC----CeEEEEecccce--eecCCC--------c-ccccccccceeccccccCCCCCCCcccHHHHHHHHH
Q 040656 181 PHNVMIDHEQ----QKLRLIDWGLAE--FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 245 (332)
Q Consensus 181 p~Nilv~~~~----~~vkL~Dfg~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ 245 (332)
|+|+++.... ..+.|.|||+++ .+.... . ...+.||..|+++.+..+ ...+.+.|+||++.++.
T Consensus 150 p~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~ 228 (322)
T KOG1164|consen 150 PENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLL 228 (322)
T ss_pred HHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHH
Confidence 9999997553 469999999998 321111 1 223459999999998776 77899999999999999
Q ss_pred HHHhCCCCCC
Q 040656 246 GMIFRKEPFF 255 (332)
Q Consensus 246 elltg~~pf~ 255 (332)
++..|..||.
T Consensus 229 el~~g~LPW~ 238 (322)
T KOG1164|consen 229 ELLKGSLPWE 238 (322)
T ss_pred HHhcCCCCCc
Confidence 9999999994
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=215.73 Aligned_cols=139 Identities=13% Similarity=0.181 Sum_probs=95.7
Q ss_pred CCeeeeeeeeec-----cCCCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchh
Q 040656 87 PNIVKLLDIVRD-----QHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQD 157 (332)
Q Consensus 87 ~niv~~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (332)
.||..++++|.. .+...++.++|++.+ +|..++. .++...+..++.|+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi---------------------- 89 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQI---------------------- 89 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHH----------------------
Confidence 567777776611 122346677887644 5555542 24555555555555
Q ss_pred hHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC------------------CeEEEEecccceeecCCC-----------
Q 040656 158 ISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ------------------QKLRLIDWGLAEFYHPGK----------- 208 (332)
Q Consensus 158 ~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~------------------~~vkL~Dfg~a~~~~~~~----------- 208 (332)
++||.|||++||+||||||+|||++..+ ..+|++|||+++......
T Consensus 90 -----~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~ 164 (793)
T PLN00181 90 -----VEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVK 164 (793)
T ss_pred -----HHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccc
Confidence 4599999999999999999999996322 246666777665321100
Q ss_pred ------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 209 ------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 209 ------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
......+|+.|||||++.+ ..++.++|||||||++|||++|..|+
T Consensus 165 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~ 215 (793)
T PLN00181 165 KQPFPMKQILAMEMSWYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSR 215 (793)
T ss_pred cCCCcccccccCCCcceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCch
Confidence 0011357888999999877 67899999999999999999988776
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-23 Score=168.62 Aligned_cols=86 Identities=27% Similarity=0.417 Sum_probs=71.4
Q ss_pred hhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCccc
Q 040656 157 DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 236 (332)
Q Consensus 157 ~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sD 236 (332)
.++.|++.||.|||+.+ ||+|||++.++ .+++ ||.+....... ..+|..|+|||++.+ ..++.++|
T Consensus 21 ~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~~-~~~~~~~D 86 (176)
T smart00750 21 AVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQG-QSYTEKAD 86 (176)
T ss_pred HHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc----CCCcccccChHHhcC-CCCcchhh
Confidence 34445555999999998 99999998665 6888 99988754322 267899999999977 67899999
Q ss_pred HHHHHHHHHHHHhCCCCCCC
Q 040656 237 MWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 237 iwSlG~il~elltg~~pf~~ 256 (332)
||||||++|||+||..||..
T Consensus 87 iwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 87 IYSLGITLYEALDYELPYNE 106 (176)
T ss_pred HHHHHHHHHHHHhCCCCccc
Confidence 99999999999999999953
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=171.20 Aligned_cols=192 Identities=13% Similarity=0.169 Sum_probs=133.4
Q ss_pred ccccccCCCCCccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hH---H------HH
Q 040656 7 YADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KK---K------IK 74 (332)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~------~~ 74 (332)
+.+.++=.+.+-.+|+..--.. -..+|++++.||.|+||.||++.. ++..+|+|++.+.. .. . +.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~-l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e 83 (232)
T PRK10359 7 IKGYTVFYKDNDNKYKEIFDDF-LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYE 83 (232)
T ss_pred ccceEEEecCCcccHHHHHHHH-hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHH
Confidence 3344443344333343322222 368999999999999999999654 57789999996321 11 1 57
Q ss_pred HHHHHHHhccCCCCeeeeeeeeeccC------CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecC
Q 040656 75 REIKILQNLCGGPNIVKLLDIVRDQH------SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148 (332)
Q Consensus 75 ~E~~~l~~l~~h~niv~~~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (332)
+|+..+.++ .|++|....+++.... ....+++|||++|.++.++. ..++
T Consensus 84 ~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----------------------- 138 (232)
T PRK10359 84 NLIVQTDRV-RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----------------------- 138 (232)
T ss_pred HHHHHHHHH-HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-hccH-----------------------
Confidence 899999999 9999999998865432 23578999999998875542 1111
Q ss_pred CCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC
Q 040656 149 GEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 228 (332)
Q Consensus 149 ~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 228 (332)
....++++++..+|+.|++|||++|.||+++.++ ++|+|||..+.......... .+..
T Consensus 139 --------~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg~~~~~~e~~a~d~-----------~vle- 196 (232)
T PRK10359 139 --------DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLSGKRCTAQRKAKDR-----------IDLE- 196 (232)
T ss_pred --------HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECCCcccccchhhHHH-----------HHHH-
Confidence 1222445599999999999999999999998655 99999998865432211110 2222
Q ss_pred CCCCCcccHHHHHHHHHHHH
Q 040656 229 QDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 229 ~~~~~~sDiwSlG~il~ell 248 (332)
..++.++|+||||+++..+.
T Consensus 197 r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 197 RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hHhcccccccceeEeehHHH
Confidence 34668999999999876543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=173.06 Aligned_cols=190 Identities=33% Similarity=0.586 Sum_probs=153.7
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCC-CeeeeeeeeeccCCCCcee
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~~~l 106 (332)
|.+.+.||.|+||.||.+.+. ..+++|.+... ....+.+|+.++..+ .|+ +|+++.+.+.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~--~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQD--EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEec--CCEEEE
Confidence 789999999999999999875 88899998642 245688999999999 555 89999999833 334799
Q ss_pred EEeeecCCCceeecc------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 107 IFEHVNSTDFKVLYP------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 107 v~e~~~~~~l~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++++.++.+..+.. .+.......++.+++. ++.++|+.+++|||+|
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~l~~~H~~~~~hrd~k 128 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS---------------------------ALEYLHSKGIIHRDIK 128 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeeccCCC
Confidence 999999988875432 3455555555555554 8999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-------cccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-------EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~ 251 (332)
|+||+++..+..++++|||.+....... ......+|..|+|||.+.+. ...+...|+||+|++++++++|.
T Consensus 129 p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred HHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999999666469999999998654333 23566899999999998763 47889999999999999999999
Q ss_pred CCCCC
Q 040656 252 EPFFY 256 (332)
Q Consensus 252 ~pf~~ 256 (332)
.||..
T Consensus 209 ~p~~~ 213 (384)
T COG0515 209 PPFEG 213 (384)
T ss_pred CCCCC
Confidence 99743
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=159.25 Aligned_cols=183 Identities=17% Similarity=0.135 Sum_probs=131.5
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccch-------HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-------KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
..+.+.|++|+||+|+.+.. .+.+++.+.++.... ..+.+|+++|++|.+|++++.++++. ..++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~l 75 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHL 75 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEE
Confidence 34678999999999998754 788888777763221 25789999999997778899998862 3589
Q ss_pred EEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC-CCCCee
Q 040656 107 IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV-KPHNVM 185 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl-kp~Nil 185 (332)
+|+|+.|.+|..... ... ..++ .+++++|.++|++||+|||| ||.|||
T Consensus 76 vmeyI~G~~L~~~~~---~~~-~~~~---------------------------~qi~~~L~~lH~~GIvHrDL~kp~NIL 124 (218)
T PRK12274 76 DRSYLAGAAMYQRPP---RGD-LAYF---------------------------RAARRLLQQLHRCGVAHNDLAKEANWL 124 (218)
T ss_pred EEeeecCccHHhhhh---hhh-HHHH---------------------------HHHHHHHHHHHHCcCccCCCCCcceEE
Confidence 999999887643321 111 1222 34455999999999999999 799999
Q ss_pred ecCCCCeEEEEecccceeecCCCcc----c----------ccccccceeccccccCCCCCC-CcccHHHHHHHHHHHHhC
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGKEY----N----------VRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~~~----~----------~~~~t~~y~aPE~~~~~~~~~-~~sDiwSlG~il~elltg 250 (332)
++.++ .++|+|||++......... . -...++.|++|+.-......+ .+.+.++.|+.+|.++|+
T Consensus 125 v~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~ 203 (218)
T PRK12274 125 VQEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTR 203 (218)
T ss_pred EcCCC-CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhc
Confidence 98666 7999999999865533310 0 012455566666543333445 455666999999999999
Q ss_pred CCCCCC
Q 040656 251 KEPFFY 256 (332)
Q Consensus 251 ~~pf~~ 256 (332)
..|...
T Consensus 204 ~~~~~~ 209 (218)
T PRK12274 204 RVLHWE 209 (218)
T ss_pred cCCccc
Confidence 988743
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-22 Score=174.63 Aligned_cols=136 Identities=19% Similarity=0.269 Sum_probs=91.8
Q ss_pred cchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCC---eEEEEecccceeec-------CCCcccccccccceeccc
Q 040656 154 ENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ---KLRLIDWGLAEFYH-------PGKEYNVRVASRYFKGPE 223 (332)
Q Consensus 154 ~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~---~vkL~Dfg~a~~~~-------~~~~~~~~~~t~~y~aPE 223 (332)
....+..|+++|+.|||++||.|||+|.+|||+.-++. .+.++|||++---. .........|+...||||
T Consensus 342 ~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 342 TGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 34456677788999999999999999999999943322 57899999864221 112234456777899999
Q ss_pred cccCCCCC-----CCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhcc
Q 040656 224 LLVDLQDY-----DYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297 (332)
Q Consensus 224 ~~~~~~~~-----~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 297 (332)
+....... -.++|.|+.|.+.||++....||+......-. .+.++..++ .-+...++|..++++..
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~----~r~Yqe~qL----Palp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD----TRTYQESQL----PALPSRVPPVARQLVFD 492 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec----hhhhhhhhC----CCCcccCChHHHHHHHH
Confidence 87553221 25899999999999999999999642211111 111333332 23445677888887743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=159.38 Aligned_cols=133 Identities=20% Similarity=0.255 Sum_probs=96.1
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccch------------HH-----------------HHHHHHHHHhccCCC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------------KK-----------------IKREIKILQNLCGGP 87 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~-----------------~~~E~~~l~~l~~h~ 87 (332)
...||+|+||.||+|.+. +|+.||+|+++.... .+ ...|+.++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 467999999999999985 899999999964311 11 23499999999 666
Q ss_pred CeeeeeeeeeccCCCCceeEEeeecCCCceee-c--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHH
Q 040656 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL-Y--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQ 164 (332)
Q Consensus 88 niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 164 (332)
++....... . ...+++|||++++++... + ..++...+..++ .|++.
T Consensus 80 ~v~~p~~~~--~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~---------------------------~qi~~ 128 (190)
T cd05147 80 GIPCPEPIL--L--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELY---------------------------LQVIQ 128 (190)
T ss_pred CCCCCcEEE--e--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHH---------------------------HHHHH
Confidence 663322221 1 123899999998765432 1 234444444444 44455
Q ss_pred HHHHH-HHcCCeecCCCCCCeeecCCCCeEEEEecccceee
Q 040656 165 ALDYC-HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204 (332)
Q Consensus 165 ~l~~L-H~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~ 204 (332)
+|.++ |+.||+||||||+|||++ ++ .++|+|||+|...
T Consensus 129 ~L~~l~H~~giiHrDlkP~NIli~-~~-~v~LiDFG~a~~~ 167 (190)
T cd05147 129 IMRILYQDCRLVHADLSEYNLLYH-DG-KLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHhCCcccCCCCHHHEEEE-CC-cEEEEEccccccC
Confidence 99999 799999999999999998 44 6999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-22 Score=190.40 Aligned_cols=193 Identities=27% Similarity=0.406 Sum_probs=149.6
Q ss_pred eEEEeecccCCceEEEEEEccCCceEEEEEec----ccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 35 EVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
...+.+|.|.+|.|+.+......+.++.|.+. ... ...+..|+-+-..+ .|+|++..+..+.+.. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~--~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEID--GIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcc--cch
Confidence 56678899999988888777777666666543 111 12256677777778 8999988777664332 223
Q ss_pred eEEeeecCCCceeec-c--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY-P--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
-.|||+++ ++..++ . .+...++..+++|++. |+.|+|+.||.|||+|++
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~---------------------------Gv~y~h~~GiahrdlK~e 449 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLR---------------------------GVKYLHSMGLAHRDLKLE 449 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHH---------------------------HHHHHHhcCceeccCccc
Confidence 33999999 665554 2 5788888888888887 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|++++..+ .+||+|||.+..+...-. ....+|+..|+|||++.+...-....||||.|++++.|.+|+.||...
T Consensus 450 nll~~~~g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 450 NLLVTENG-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred cEEEecCC-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 99999776 799999999877653322 345689999999999988666678999999999999999999999544
Q ss_pred CC
Q 040656 258 HD 259 (332)
Q Consensus 258 ~~ 259 (332)
..
T Consensus 529 ~~ 530 (601)
T KOG0590|consen 529 KK 530 (601)
T ss_pred cc
Confidence 33
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=153.43 Aligned_cols=134 Identities=17% Similarity=0.184 Sum_probs=98.1
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccc-----------------------------hHHHHHHHHHHHhccCCC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGGP 87 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h~ 87 (332)
.+.||+|++|.||+|.+. +|+.||+|+++... ......|...+.++ .|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 468999999999999876 89999999987431 01235788999999 788
Q ss_pred CeeeeeeeeeccCCCCceeEEeeecCCCceee-c--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHH
Q 040656 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL-Y--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQ 164 (332)
Q Consensus 88 niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 164 (332)
++.....+... ..+++|||++++.+... + ..++...... ++.+++.
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~---------------------------i~~~l~~ 128 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEE---------------------------LYEQVVE 128 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHH---------------------------HHHHHHH
Confidence 77443333221 24899999998743221 1 1233333333 4445556
Q ss_pred HHHHHHH-cCCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 165 ALDYCHS-QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 165 ~l~~LH~-~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
++.++|+ .||+||||||+||+++ ++ .++|+|||+++...
T Consensus 129 ~l~~lH~~~givHrDlkP~NIll~-~~-~~~liDFG~a~~~~ 168 (190)
T cd05145 129 QMRRLYQEAGLVHGDLSEYNILYH-DG-KPYIIDVSQAVELD 168 (190)
T ss_pred HHHHHHHhCCEecCCCChhhEEEE-CC-CEEEEEcccceecC
Confidence 9999999 9999999999999998 55 79999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-21 Score=161.52 Aligned_cols=238 Identities=19% Similarity=0.262 Sum_probs=163.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
-+++.++.+|.+...|+.|+|++ .|..++.|+++. ....+|..|.-.++.+ .||||+++++.|. ...++.
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacn--sppnlv 263 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACN--SPPNLV 263 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhcc--CCCCce
Confidence 35567888999999999999976 566777788763 2346789999999999 9999999999994 446889
Q ss_pred eEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC--CeecCCCCCC
Q 040656 106 LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHRDVKPHN 183 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--ivHrdlkp~N 183 (332)
++..||+.++|...+..-+. +++ .-.+.+.+++++++|++|||+.. |..--|+...
T Consensus 264 ~isq~mp~gslynvlhe~t~------------------vvv----d~sqav~faldiargmaflhslep~ipr~~lns~h 321 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTS------------------VVV----DHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH 321 (448)
T ss_pred EeeeeccchHHHHHHhcCcc------------------EEE----ecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence 99999998886555432111 111 11234568888899999999874 4455688899
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+++|.+- +.+|+ ++-+++... .......+.||+||.+..... --.++|+|||++++||+.|+..|| .+..+.
T Consensus 322 vmidedl-taris-mad~kfsfq---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf-adlspm 395 (448)
T KOG0195|consen 322 VMIDEDL-TARIS-MADTKFSFQ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF-ADLSPM 395 (448)
T ss_pred EEecchh-hhhee-cccceeeee---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc-ccCCch
Confidence 9998554 34432 222222110 112345677999999876322 236899999999999999999999 455566
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.-.++.- +.++...+|....-+. .+++.|++.||.+||-
T Consensus 396 ecgmkial-----------eglrv~ippgis~hm~--------------------klm~icmnedpgkrpk 435 (448)
T KOG0195|consen 396 ECGMKIAL-----------EGLRVHIPPGISRHMN--------------------KLMNICMNEDPGKRPK 435 (448)
T ss_pred hhhhhhhh-----------ccccccCCCCccHHHH--------------------HHHHHHhcCCCCcCCC
Confidence 65555442 3333444443332221 3456799999999993
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=177.96 Aligned_cols=181 Identities=27% Similarity=0.372 Sum_probs=145.6
Q ss_pred ecccCCceEEEEE---EccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 40 VGRGKYSEVFEGI---NVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 40 lg~G~~g~V~~~~---~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
+|.|+||.|+++. ....+.-+|.|+.++. .+.....|-.++..+..||.++.++..| +....+++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhhc
Confidence 6899999999754 2345677888887632 1224567888888886799999999998 5556789999999
Q ss_pred cCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 112 NSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 112 ~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
.++++...+. .+.+.....+..+.+- +++++|+.+|+|||+|++||+++.
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaL---------------------------ald~lh~l~iiyrd~k~enilld~ 132 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELAL---------------------------ALDHLHKLGIAYRDYKLENVLLLL 132 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHH---------------------------HHhhcchhHHHHhcccccceeecc
Confidence 9988777652 3556666666666654 999999999999999999999997
Q ss_pred CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+| ++++.|||.++..-..+.. +||..|||||++. .+..++|.||||+++|+|+||..||..
T Consensus 133 ~G-hi~~tdfglske~v~~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 133 EG-HIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cC-ccccCCchhhhHhHhhhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 77 7999999999875433322 8999999999986 468899999999999999999999953
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-20 Score=181.54 Aligned_cols=196 Identities=25% Similarity=0.463 Sum_probs=134.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
..++|+.++.+-.|++|.||.++++.+.+.+|.|+=+ ...+.+- ++... ..|.++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk---q~lilRn--ilt~a-~npfvv------------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK---QNLILRN--ILTFA-GNPFVV------------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccc---cchhhhc--ccccc-CCccee-------------------
Confidence 4578999999999999999999999999999995421 1111111 11111 222222
Q ss_pred eecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 110 HVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 110 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|+-..++ +.++.. ++.+++|||+.||+|||+||+|.+|
T Consensus 136 ----gDc~tllk~~g~lPvd-----------------------------------mvla~Eylh~ygivhrdlkpdnllI 176 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVD-----------------------------------MVLAVEYLHSYGIVHRDLKPDNLLI 176 (1205)
T ss_pred ----chhhhhcccCCCCcch-----------------------------------hhHHhHhhccCCeecCCCCCCccee
Confidence 2211121 112211 1238999999999999999999999
Q ss_pred cCCCCeEEEEecccceeecCCC--------------c--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 187 DHEQQKLRLIDWGLAEFYHPGK--------------E--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~~~~~~--------------~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
+.-+ ++|+.|||+++...... . ....+||+.|.|||++.. +.|+...|.|++|+|+||++.|
T Consensus 177 T~mG-hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVg 254 (1205)
T KOG0606|consen 177 TSMG-HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVG 254 (1205)
T ss_pred eecc-cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHhee
Confidence 9777 79999999876421110 0 122389999999999988 7899999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC
Q 040656 251 KEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK 298 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 298 (332)
..||+ +..+.+.+..+..... .|.++ ....+++.+++++++
T Consensus 255 cvpff-Gdtpeelfg~visd~i-----~wpE~-dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 255 CVPFF-GDTPEELFGQVISDDI-----EWPEE-DEALPPEAQDLIEQL 295 (1205)
T ss_pred eeecc-CCCHHHHHhhhhhhhc-----ccccc-CcCCCHHHHHHHHHH
Confidence 99995 4445555555554322 23333 245666677666655
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=180.28 Aligned_cols=193 Identities=20% Similarity=0.358 Sum_probs=142.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhcc--CCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..+.|.|-+.||+|+||.||+|...+ |+.||+|+-++...=+|.-=.+++.+|. --+.|..+.....-.+ .-+++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN--ASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCC--cceee
Confidence 35889999999999999999999766 9999999987543222222222333331 0123333333322232 34789
Q ss_pred EeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
++|.+.|+|..+.. .+++..+..++.+++. .+++||..+|||+||||+|+
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~---------------------------ive~lH~~~IIHgDiKPDNf 825 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLR---------------------------IVEHLHAMGIIHGDIKPDNF 825 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHH---------------------------HHHHHHhcceecccCCccee
Confidence 99999999888764 3555556666666655 99999999999999999999
Q ss_pred eecC------CCCeEEEEecccceee---cCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 185 MIDH------EQQKLRLIDWGLAEFY---HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 185 lv~~------~~~~vkL~Dfg~a~~~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|+.. +..-++|+|||.+-.+ ..+..+...++|..+-++|+..| .++++.+|.|.|+.+++-|+.|...
T Consensus 826 ll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 826 LLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9942 2224899999998543 44456677788999999999988 8899999999999999999999644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.1e-20 Score=159.20 Aligned_cols=203 Identities=21% Similarity=0.317 Sum_probs=115.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccC---------CCCeeeeeeee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCG---------GPNIVKLLDIV 96 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~---------h~niv~~~~~~ 96 (332)
..+...+.||.|+++.||.+++..+++.+|+|++... ..+.+.+|.-....+.. |-.++.-++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3467889999999999999999999999999998522 22445555544433311 11111111211
Q ss_pred eccC----------CC-----CceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHh
Q 040656 97 RDQH----------SK-----TPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVW 161 (332)
Q Consensus 97 ~~~~----------~~-----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (332)
.-+. .. +.+++|+-+.+ ++..+. ..+..... . ....+..-+..+..|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~---------~~l~~~~~---~-----~~~l~~~arl~lT~Q 153 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLV---------EALFSRAQ---T-----HSPLAFAARLSLTVQ 153 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHH---------HHHHHHTT---T-----SHHHHHHHHHHHHHH
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHH---------HHHhhccc---c-----cchhHHHHHHHHHHH
Confidence 1010 00 12334443322 222211 11110000 0 000001112345567
Q ss_pred HHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC-------CCCCCc
Q 040656 162 DLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYS 234 (332)
Q Consensus 162 i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~ 234 (332)
+++.+++||+.|++|+||+|+|++++.+| .+.|.||+...... ........+..|.+||..... ..++.+
T Consensus 154 ~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~ 230 (288)
T PF14531_consen 154 MIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFA 230 (288)
T ss_dssp HHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HH
T ss_pred HHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeec
Confidence 78899999999999999999999999877 69999998765533 222223445668889876442 246889
Q ss_pred ccHHHHHHHHHHHHhCCCCCC
Q 040656 235 LDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 235 sDiwSlG~il~elltg~~pf~ 255 (332)
.|.|+||+++|.|.++..||.
T Consensus 231 ~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 231 TDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp HHHHHHHHHHHHHHHSS-STC
T ss_pred cCHHHHHHHHHHHHHccCCCC
Confidence 999999999999999999994
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=150.36 Aligned_cols=136 Identities=19% Similarity=0.285 Sum_probs=97.2
Q ss_pred EEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhcc----CCCCeeeeeeeeeccCC-CC-cee
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQHS-KT-PSL 106 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~~~~-~~-~~l 106 (332)
-.+.||+|+||.||. +..++.. +||++... ..+.+.+|+.+++.+. .||||+++++++.+..+ .. ..+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 347899999999995 5666665 68887643 4567899999999994 37999999999976532 22 336
Q ss_pred EEee--ecCCCceeeccc--cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHH-HHHHHcCCeecCCCC
Q 040656 107 IFEH--VNSTDFKVLYPT--LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL-DYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~--~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~LH~~~ivHrdlkp 181 (332)
|+|| +.+++|..++.. +.+. ..++.+++ .++ +|||+++|+||||||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L---------------------------~~l~~yLh~~~IvhrDlKp 133 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLL---------------------------KKLKRYLLDNRIVTMELKP 133 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHH---------------------------HHHHHHHHHCCEeecCCCH
Confidence 8999 446777666532 2221 22333433 366 899999999999999
Q ss_pred CCeeecCC---CCeEEEEe-ccccee
Q 040656 182 HNVMIDHE---QQKLRLID-WGLAEF 203 (332)
Q Consensus 182 ~Nilv~~~---~~~vkL~D-fg~a~~ 203 (332)
+|||++.. +..++|+| ||....
T Consensus 134 ~NILl~~~~~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 134 QNILCQRISESEVIPVVCDNIGESTF 159 (210)
T ss_pred HHEEEeccCCCCCcEEEEECCCCcce
Confidence 99999742 23799999 454433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=147.20 Aligned_cols=137 Identities=15% Similarity=0.169 Sum_probs=101.3
Q ss_pred CCceEEEeecccCCceEEEEE-EccCCceEEEEEecccc---------------------------hHHHHHHHHHHHhc
Q 040656 32 EDYEVVRKVGRGKYSEVFEGI-NVTNNEKCIIKILKPVK---------------------------KKKIKREIKILQNL 83 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vavK~~~~~~---------------------------~~~~~~E~~~l~~l 83 (332)
.-|.+.+.||+|++|.||+|. +..+|+.||+|+++... ...+..|..++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 458999999999999999998 66789999999986321 01256899999999
Q ss_pred cCCC--CeeeeeeeeeccCCCCceeEEeeecCCCceeec-cc--cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhh
Q 040656 84 CGGP--NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY-PT--LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDI 158 (332)
Q Consensus 84 ~~h~--niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (332)
.+. .+.++++. . ..++|||++++.++.... .. ........ +
T Consensus 108 -~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~---------------------------i 153 (237)
T smart00090 108 -YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFE---------------------------L 153 (237)
T ss_pred -HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHH---------------------------H
Confidence 442 23333432 1 248999999998765543 11 12222223 4
Q ss_pred HHhHHHHHHHHHHcC-CeecCCCCCCeeecCCCCeEEEEecccceee
Q 040656 159 SVWDLQALDYCHSQG-IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204 (332)
Q Consensus 159 ~~~i~~~l~~LH~~~-ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~ 204 (332)
+.+++.++.+||+.| ++||||||+||+++ ++ .++|+|||.+...
T Consensus 154 ~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~-~i~LiDFg~a~~~ 198 (237)
T smart00090 154 YDDILEEMRKLYKEGELVHGDLSEYNILVH-DG-KVVIIDVSQSVEL 198 (237)
T ss_pred HHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC-CEEEEEChhhhcc
Confidence 455566999999999 99999999999998 54 7999999998754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.2e-19 Score=170.54 Aligned_cols=188 Identities=22% Similarity=0.372 Sum_probs=128.2
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHH---HHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKI---KREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~---~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+|...+.||++.|=.|.+|.+. .|. |+||++-+.. ...+ ..|++ ..+.++||++++..+.+. ....|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t--~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVT--DKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHh--hHHHH
Confidence 6888899999999999999763 344 8899985432 1222 33344 334489999999877532 34556
Q ss_pred eEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 106 LIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 106 lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|=+|.....++.+. ..+..-+.+. +++|++.||.-+|..||+|+|||.+|
T Consensus 98 lvRqyvkhnLyDRlSTRPFL~~iEKkW---------------------------iaFQLL~al~qcH~~gVcHGDIKsEN 150 (1431)
T KOG1240|consen 98 LVRQYVKHNLYDRLSTRPFLVLIEKKW---------------------------IAFQLLKALSQCHKLGVCHGDIKSEN 150 (1431)
T ss_pred HHHHHHhhhhhhhhccchHHHHHHHHH---------------------------HHHHHHHHHHHHHHcCccccccccce
Confidence 666666655544442 2233333444 44455559999999999999999999
Q ss_pred eeecCCCCeEEEEecccceee--cCC--Ccccccccc----cceeccccccCCC---------C-CCCcccHHHHHHHHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFY--HPG--KEYNVRVAS----RYFKGPELLVDLQ---------D-YDYSLDMWSLGCMFA 245 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~--~~~--~~~~~~~~t----~~y~aPE~~~~~~---------~-~~~~sDiwSlG~il~ 245 (332)
||++.=+ .+.|+||..-+.. ..+ ..++.+..| ..|.|||...... . .+++-||+|+||+++
T Consensus 151 ILiTSWN-W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVia 229 (1431)
T KOG1240|consen 151 ILITSWN-WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIA 229 (1431)
T ss_pred EEEeeec-hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHH
Confidence 9999666 5999999875422 111 122333333 2399999875421 1 468899999999999
Q ss_pred HHHh-CCCCC
Q 040656 246 GMIF-RKEPF 254 (332)
Q Consensus 246 ellt-g~~pf 254 (332)
|+++ |.+||
T Consensus 230 ELf~Eg~PlF 239 (1431)
T KOG1240|consen 230 ELFLEGRPLF 239 (1431)
T ss_pred HHHhcCCCcc
Confidence 9987 56666
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=138.59 Aligned_cols=131 Identities=25% Similarity=0.349 Sum_probs=100.0
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc-----------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
+.||+|++|.||+|.. .+..+++|+..... ...+.+|+.++..+ .|+++.....++.+. ...++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDP--ENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeC--CCCEE
Confidence 5789999999999976 77889999865211 23577899999999 788877665555333 45789
Q ss_pred EEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 107 IFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 107 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
+|||++|+++..+...... ... .++.+++.+|.++|+.+++|+|++|.|||+
T Consensus 77 v~e~~~G~~L~~~~~~~~~-~~~---------------------------~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~ 128 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM-EEL---------------------------ELSREIGRLVGKLHSAGIIHGDLTTSNMIL 128 (211)
T ss_pred EEEEeCCcCHHHHHHhccH-HHH---------------------------HHHHHHHHHHHHHHhCCcccCCCCcccEEE
Confidence 9999999887665433221 222 344455569999999999999999999999
Q ss_pred cCCCCeEEEEeccccee
Q 040656 187 DHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 187 ~~~~~~vkL~Dfg~a~~ 203 (332)
+ ++ .++|+|||.+..
T Consensus 129 ~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 129 S-GG-KIYLIDFGLAEF 143 (211)
T ss_pred E-CC-CEEEEECCcccC
Confidence 8 44 699999998865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.5e-17 Score=135.89 Aligned_cols=134 Identities=17% Similarity=0.318 Sum_probs=99.6
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccc-------------------------hHHHHHHHHHHHhccCCC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP 87 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~~l~~h~ 87 (332)
-|.+.+.||+|+||.||++.. .+++.||+|+++... ......|..++..+ .++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHc
Confidence 488889999999999999986 479999999865321 11356788888888 666
Q ss_pred C--eeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHH
Q 040656 88 N--IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQA 165 (332)
Q Consensus 88 n--iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 165 (332)
+ +...++. ...+++||+++++++..+... .... .++.+++.+
T Consensus 94 ~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~---------------------------~~~~~i~~~ 137 (198)
T cd05144 94 GFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPE---------------------------EVLDEILEE 137 (198)
T ss_pred CCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHH---------------------------HHHHHHHHH
Confidence 4 3333332 245899999999887654321 1122 234455569
Q ss_pred HHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 166 l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
+.++|+.|++||||||+||+++.++ .++|+|||.+....
T Consensus 138 l~~lh~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~~~~ 176 (198)
T cd05144 138 IVKAYKHGIIHGDLSEFNILVDDDE-KIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHCCCCcCCCCcccEEEcCCC-cEEEEECCccccCC
Confidence 9999999999999999999998655 79999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-17 Score=152.58 Aligned_cols=152 Identities=20% Similarity=0.266 Sum_probs=110.7
Q ss_pred HhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHH
Q 040656 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISV 160 (332)
Q Consensus 81 ~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (332)
+.+ .|.|+.+++|.+.+. ...+.|.+||..|++.+.+..-..+. .......+..
T Consensus 2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~-----------------------d~~F~~s~~r 55 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKL-----------------------DYFFILSFIR 55 (484)
T ss_pred ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCc-----------------------cHHHHHHHHH
Confidence 456 899999999999765 67899999999999888764311111 1111123445
Q ss_pred hHHHHHHHHHHcCC-eecCCCCCCeeecCCCCeEEEEecccceeecCC---CcccccccccceeccccccCCC--C----
Q 040656 161 WDLQALDYCHSQGI-MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ--D---- 230 (332)
Q Consensus 161 ~i~~~l~~LH~~~i-vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~--~---- 230 (332)
+++.||+|+|...| .|+.|+..|.+++ ..+.+||+|||+....... .......-...|.|||.+.+.. .
T Consensus 56 di~~Gl~ylh~s~i~~hg~l~s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~ 134 (484)
T KOG1023|consen 56 DISKGLAYLHNSPIGYHGALKSSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESA 134 (484)
T ss_pred HHHHHHHHHhcCcceeeeeeccccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccccc
Confidence 55669999998766 8999999999999 5568999999998765421 1111112234499999987631 1
Q ss_pred CCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 231 YDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 231 ~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
.+.++|+||||++++|++++..||.....
T Consensus 135 ~~~~gdiYs~~ii~~ei~~r~~~~~~~~~ 163 (484)
T KOG1023|consen 135 LTQKGDIYSFGIIMYEILFRSGPFDLRNL 163 (484)
T ss_pred ccccCCeehHHHHHHHHHhccCccccccc
Confidence 46789999999999999999999965433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=151.09 Aligned_cols=146 Identities=17% Similarity=0.326 Sum_probs=104.7
Q ss_pred cccccccccCCCC----CCceEEEeecccCCceEEEEEEccCCceEEEEEec-cc----------chHHHHHHHHHHHhc
Q 040656 19 WDYESLTVQWGDQ----EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-PV----------KKKKIKREIKILQNL 83 (332)
Q Consensus 19 ~~~~~~~~~~~~~----~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~----------~~~~~~~E~~~l~~l 83 (332)
|+.......|... ..|...+.||+|+||.||++... +..+++|+.. +. ...++.+|++++..+
T Consensus 316 ~~~~ev~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 393 (535)
T PRK09605 316 FRTDEVEVTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA 393 (535)
T ss_pred CccccceeeeccccccccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh
Confidence 4444444445433 34566899999999999998763 3344444321 10 124578899999999
Q ss_pred cCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHH
Q 040656 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDL 163 (332)
Q Consensus 84 ~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (332)
.|++++....++.+. ...+++|||++++++...+. ... .++.+++
T Consensus 394 -~~~~i~~p~~~~~~~--~~~~lv~E~~~g~~L~~~l~-----~~~---------------------------~~~~~i~ 438 (535)
T PRK09605 394 -RRAGVPTPVIYDVDP--EEKTIVMEYIGGKDLKDVLE-----GNP---------------------------ELVRKVG 438 (535)
T ss_pred -cccCCCeeEEEEEeC--CCCEEEEEecCCCcHHHHHH-----HHH---------------------------HHHHHHH
Confidence 899988766655432 35689999999988765432 111 2445566
Q ss_pred HHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 164 QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 164 ~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
++|.+||+.|++||||||+|||++ ++ .++|+|||+++.
T Consensus 439 ~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~ 476 (535)
T PRK09605 439 EIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKY 476 (535)
T ss_pred HHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCccccc
Confidence 699999999999999999999994 44 699999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=131.62 Aligned_cols=127 Identities=19% Similarity=0.309 Sum_probs=93.2
Q ss_pred eecccCCceEEEEEEccCCceEEEEEeccc-----------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 39 KVGRGKYSEVFEGINVTNNEKCIIKILKPV-----------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.||+|+||.||++.. .+..+++|+.... ...++.+|++++..+ .|+++.....++.+. ...+++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDP--DNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEEC--CCCEEE
Confidence 479999999999974 6788999986421 124567899999999 666544333333222 346899
Q ss_pred EeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
||+++|+++......... . ++.+++.+|.++|+.|++|+|++|.||+++
T Consensus 76 ~e~~~g~~l~~~~~~~~~----~---------------------------~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~ 124 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND----E---------------------------LLREIGRLVGKLHKAGIVHGDLTTSNIIVR 124 (199)
T ss_pred EEEECCccHHHHHhhcHH----H---------------------------HHHHHHHHHHHHHHCCeecCCCCcceEEEE
Confidence 999999887654321100 2 344555699999999999999999999998
Q ss_pred CCCCeEEEEeccccee
Q 040656 188 HEQQKLRLIDWGLAEF 203 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~ 203 (332)
++ .++++|||++..
T Consensus 125 -~~-~~~liDfg~a~~ 138 (199)
T TIGR03724 125 -DD-KLYLIDFGLGKY 138 (199)
T ss_pred -CC-cEEEEECCCCcC
Confidence 44 799999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=126.09 Aligned_cols=133 Identities=19% Similarity=0.322 Sum_probs=89.8
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccch-----HH----------------------HHHHHHHHHhccCC-CC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-----KK----------------------IKREIKILQNLCGG-PN 88 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~----------------------~~~E~~~l~~l~~h-~n 88 (332)
.+.||+|+||.||+|.+. +++.||+|+++.... .. ...|...+.++..+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999875 899999999864211 11 13455566665222 12
Q ss_pred eeeeeeeeeccCCCCceeEEeeecCCCceee-ccccch-hhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHH
Q 040656 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL-YPTLTA-NEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL 166 (332)
Q Consensus 89 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 166 (332)
+.+.++. ...+++||+++++.+... +..... ... ..++.+++.++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~~~~---------------------------~~~~~~~~~~l 127 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLLEDP---------------------------EELYDQILELM 127 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhcccH---------------------------HHHHHHHHHHH
Confidence 3333332 235899999998553211 111111 222 34555566699
Q ss_pred HHHHH-cCCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 167 DYCHS-QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 167 ~~LH~-~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
.++|. .+|+|+||||+||+++ ++ .++|+|||.+....
T Consensus 128 ~~lh~~~~ivH~Dl~p~Nili~-~~-~~~liDfg~a~~~~ 165 (187)
T cd05119 128 RKLYREAGLVHGDLSEYNILVD-DG-KVYIIDVPQAVEID 165 (187)
T ss_pred HHHhhccCcCcCCCChhhEEEE-CC-cEEEEECccccccc
Confidence 99999 9999999999999999 55 69999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.3e-15 Score=128.10 Aligned_cols=134 Identities=17% Similarity=0.274 Sum_probs=94.4
Q ss_pred Eeec-ccCCceEEEEEEccCCceEEEEEeccc----------------chHHHHHHHHHHHhccCCCCe--eeeeeeeec
Q 040656 38 RKVG-RGKYSEVFEGINVTNNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNI--VKLLDIVRD 98 (332)
Q Consensus 38 ~~lg-~G~~g~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~ 98 (332)
..|| .||.|+||.+.. .+..+++|.+... ...++.+|+.++.++ .|+++ +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4576 888899998865 4788999887421 124578899999999 77774 556665433
Q ss_pred cCCC--CceeEEeeecC-CCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 99 QHSK--TPSLIFEHVNS-TDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 99 ~~~~--~~~lv~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
.... ..++|+|++++ .++..++..... ......+++++|.+||+.||+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l-----------------------------~~~~~~~i~~~l~~lH~~GI~ 164 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPL-----------------------------SEEQWQAIGQLIARFHDAGVY 164 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCC-----------------------------CHHHHHHHHHHHHHHHHCCCC
Confidence 2221 23599999987 455544321110 011234556699999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceee
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~ 204 (332)
||||||.|||++.++ .++|+|||.++..
T Consensus 165 HrDlkp~NILv~~~~-~v~LIDfg~~~~~ 192 (239)
T PRK01723 165 HADLNAHNILLDPDG-KFWLIDFDRGELR 192 (239)
T ss_pred CCCCCchhEEEcCCC-CEEEEECCCcccC
Confidence 999999999998666 7999999988753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.8e-15 Score=118.19 Aligned_cols=132 Identities=21% Similarity=0.294 Sum_probs=101.0
Q ss_pred EEEeecccCCceEEEEEEccCCceEEEEEecccc-hHHHHHHHHHHHhccCC-CCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
+++.||+|.++.||++.. .+..+++|..+... ...+..|+.++..+.++ .++++++.++.. ....++++|++.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCC
Confidence 457899999999999976 34789999986543 35789999999999444 688888887743 3568999999998
Q ss_pred CCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc---CCeecCCCCCCeeecCCC
Q 040656 114 TDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ---GIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 114 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~ivHrdlkp~Nilv~~~~ 190 (332)
..+..+ +......+.. +++++++.+|.. +++|+|++|.||+++..+
T Consensus 78 ~~~~~~----~~~~~~~~~~---------------------------~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~ 126 (155)
T cd05120 78 ETLDEV----SEEEKEDIAE---------------------------QLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126 (155)
T ss_pred eecccC----CHHHHHHHHH---------------------------HHHHHHHHHhCCCceEEEecCCCcceEEEECCc
Confidence 776544 2222223333 344599999984 799999999999999644
Q ss_pred CeEEEEeccccee
Q 040656 191 QKLRLIDWGLAEF 203 (332)
Q Consensus 191 ~~vkL~Dfg~a~~ 203 (332)
.++++|||.+..
T Consensus 127 -~~~l~Df~~~~~ 138 (155)
T cd05120 127 -ILGIIDWEYAGY 138 (155)
T ss_pred -EEEEEecccccC
Confidence 799999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-16 Score=145.57 Aligned_cols=119 Identities=20% Similarity=0.394 Sum_probs=92.4
Q ss_pred CceeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++++.|+.|....|.+++. +..+..-...+. ....|++.|+.| ++.+|+|+|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~-----------------------~~~~q~~~~~~y---k~~ihrdlk 383 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLML-----------------------DIFKQIAPAVEY---KGLIHRDLK 383 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHH-----------------------HHHHhhccchhh---ccchhhhcc
Confidence 5788899998888888873 222222222222 234455568888 999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt 249 (332)
|.||....++ .+||.|||+.+...... ..+...||..||+||.+.+ +.|+.++||||||++|+|+++
T Consensus 384 p~nif~~~d~-q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 384 PSNIFFSDDD-QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred ccccccccch-hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH
Confidence 9999998666 79999999987665443 3455689999999999988 789999999999999999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.5e-16 Score=149.42 Aligned_cols=244 Identities=22% Similarity=0.366 Sum_probs=173.7
Q ss_pred CCCceEEEeecccCCceEEEEEEc-cCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV-TNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
...|.+.+.||+|+|+.|-.+... .....+|.|.+... .......|..+-..+..|+|++.+++...+ ....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSY 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Cccc
Confidence 466888899999999999887653 33445666666532 224456688888888559999999998744 4567
Q ss_pred eeEEeeecCCCceeec-c----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH-HcCCeecC
Q 040656 105 SLIFEHVNSTDFKVLY-P----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH-SQGIMHRD 178 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~ivHrd 178 (332)
++++++..++++.... . ..+...+..++.++.. ++.|+| ..++.|+|
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s---------------------------~l~~~H~~~~~~h~~ 149 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNS---------------------------GLSYLHPENGVTHRD 149 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhcc---------------------------CccccCcccccccCC
Confidence 8899998888766654 1 3455666677777766 999999 99999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecC-CCc---cccccc-ccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHP-GKE---YNVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
+||+|.+++..+..++++|||+|+.+.. ... ....+| +..|+|||...+........|+||.|+++..+++|..|
T Consensus 150 ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 150 IKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred CCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 9999999996663689999999987765 222 234477 89999999988755678999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHhC----------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLG----------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIP 304 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~ 304 (332)
+............+...-. .....+++.++ +...+..+..++.+ ++|...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~-l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 230 WDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKI-LKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccccccceeecccccccccCccccCChhhhhccccc-ccCCchhccccccccccccccc
Confidence 9644333222222111110 12333444444 23566677777666 677655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.3e-12 Score=120.60 Aligned_cols=138 Identities=15% Similarity=0.254 Sum_probs=90.7
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccchHH-------------------------------------------HH
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-------------------------------------------IK 74 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------------~~ 74 (332)
+.||+|++|.||+|+. .+|+.||||+.++.-.+. +.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999985 578999999986432211 33
Q ss_pred HHHHHHHhcc---CCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccc-hhhHHHHHHHHHhhcCCcceeecCCC
Q 040656 75 REIKILQNLC---GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLT-ANEIRYYIYELLKHAMPRKVIIMPGE 150 (332)
Q Consensus 75 ~E~~~l~~l~---~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (332)
+|...+.++. .+.+-+.+-.++.+- ....+++|||++|.++......-. ......
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~-------------------- 260 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLDRKA-------------------- 260 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCCHHH--------------------
Confidence 4555555542 223333443333221 124689999999998876532100 001111
Q ss_pred CcccchhhHHhHHH-HHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 151 GLMENQDISVWDLQ-ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 151 ~~~~~~~~~~~i~~-~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
++..++. .+..+|..|++|+|++|.||+++.++ +++++|||++..+.
T Consensus 261 -------ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 261 -------LAENLARSFLNQVLRDGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred -------HHHHHHHHHHHHHHhCCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 2222222 46778999999999999999998665 79999999997765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.9e-12 Score=103.90 Aligned_cols=127 Identities=20% Similarity=0.197 Sum_probs=90.8
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST 114 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 114 (332)
++.|+.|.++.||++.. .+..+++|+..... ...+..|+.+++.+.+...+.+++... . ...++|||++++.
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~--~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--P--ETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C--CCCeEEEEecCCC
Confidence 46789999999999875 47889999976443 245688999999984333334455543 2 2347999999998
Q ss_pred CceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC-----eecCCCCCCeeecCC
Q 040656 115 DFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI-----MHRDVKPHNVMIDHE 189 (332)
Q Consensus 115 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i-----vHrdlkp~Nilv~~~ 189 (332)
.+.... ........+ ++++|+.||+.++ +|+|++|.||+++ +
T Consensus 77 ~l~~~~-----~~~~~~~~~---------------------------l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 77 ELLTED-----FSDPENLEK---------------------------IAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred cccccc-----ccCHHHHHH---------------------------HHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 765430 011122233 3459999999885 9999999999998 4
Q ss_pred CCeEEEEeccccee
Q 040656 190 QQKLRLIDWGLAEF 203 (332)
Q Consensus 190 ~~~vkL~Dfg~a~~ 203 (332)
+ .++++||+.+..
T Consensus 124 ~-~~~liDf~~a~~ 136 (170)
T cd05151 124 G-RLWLIDWEYAGM 136 (170)
T ss_pred C-eEEEEecccccC
Confidence 4 699999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-11 Score=102.48 Aligned_cols=133 Identities=18% Similarity=0.265 Sum_probs=90.4
Q ss_pred EeecccCCceEEEEEEcc------CCceEEEEEecccc-------------------------hHHH----HHHHHHHHh
Q 040656 38 RKVGRGKYSEVFEGINVT------NNEKCIIKILKPVK-------------------------KKKI----KREIKILQN 82 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~-------------------------~~~~----~~E~~~l~~ 82 (332)
..||.|.-+.||.|.... .+..+|+|+.+... .+.+ .+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 35799999986210 1112 379999999
Q ss_pred ccCC-CCeeeeeeeeeccCCCCceeEEeeecCCCcee-ecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhh
Q 040656 83 LCGG-PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKV-LYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDI 158 (332)
Q Consensus 83 l~~h-~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (332)
+... -++...+++ ..-+++||++.+..+.. .+. .++......+..+
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~------------------------ 132 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQ------------------------ 132 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHH------------------------
Confidence 8443 355666654 23589999998754321 111 1222223333334
Q ss_pred HHhHHHHHHHH-HHcCCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 159 SVWDLQALDYC-HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 159 ~~~i~~~l~~L-H~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
++.+|..+ |..|++|+||++.|||+. ++ .+.++|||.+....
T Consensus 133 ---i~~~l~~l~H~~glVHGDLs~~NIL~~-~~-~v~iIDF~qav~~~ 175 (197)
T cd05146 133 ---VLSMMKQLYKECNLVHADLSEYNMLWH-DG-KVWFIDVSQSVEPT 175 (197)
T ss_pred ---HHHHHHHHHHhCCeecCCCCHHHEEEE-CC-cEEEEECCCceeCC
Confidence 34488888 899999999999999997 44 59999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.8e-12 Score=118.65 Aligned_cols=145 Identities=12% Similarity=0.279 Sum_probs=90.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccchH-----------------------------------------
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK----------------------------------------- 71 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------------- 71 (332)
.|+. +.||+|++|.||+|+...+|+.||||+.++.-.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4666 7899999999999998777999999999743111
Q ss_pred --HHHHHHHHHHhcc---CCCCeeeeeeeeeccCCCCceeEEeeecCCCceeecccc-chhhHHHHHHHHHhhcCCccee
Q 040656 72 --KIKREIKILQNLC---GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTL-TANEIRYYIYELLKHAMPRKVI 145 (332)
Q Consensus 72 --~~~~E~~~l~~l~---~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 145 (332)
++.+|...+.++. .+.+.+.+-.++.+- ....+++|||+.|+.+.++..-- ...+...+....+.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~-------- 270 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE-------- 270 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--------
Confidence 1334444444442 233334443433221 13458999999998876531100 00011111111111
Q ss_pred ecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC---CeEEEEecccceeec
Q 040656 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ---QKLRLIDWGLAEFYH 205 (332)
Q Consensus 146 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~---~~vkL~Dfg~a~~~~ 205 (332)
.-+.-+...|++|+|++|.||+++.++ ++++++|||++..+.
T Consensus 271 ------------------~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 271 ------------------VFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------------------HHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 123345578999999999999998654 379999999987664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.9e-11 Score=111.22 Aligned_cols=179 Identities=20% Similarity=0.325 Sum_probs=120.6
Q ss_pred ceEEEeecccCCceEE-EEEEccCCceEEEEEecccch---HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 34 YEVVRKVGRGKYSEVF-EGINVTNNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~-~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
|.+ +..+-++.+ +| .|..+.++.+|.|++.+.... ....+-++.|+.+ +||||+++++.++. +..+|+|+|
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~--~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEE--EGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcc--cCceEEEee
Confidence 444 444444443 44 466678889999999875443 5577889999999 99999999999844 458899999
Q ss_pred eecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH-HcCCeecCCCCCCeeecC
Q 040656 110 HVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH-SQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 110 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~ivHrdlkp~Nilv~~ 188 (332)
.+..-. ..+..+....+..-+ .||+.||.+|| +.+++|++|..+.++|+.
T Consensus 90 rV~Pl~--~~lk~l~~~~v~~Gl---------------------------~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~ 140 (690)
T KOG1243|consen 90 RVRPLE--TVLKELGKEEVCLGL---------------------------FQILAALSFLNDDCNLVHGNVCKDSVFVNE 140 (690)
T ss_pred ccccHH--HHHHHhHHHHHHHHH---------------------------HHHHHHHHHHhccCCeeeccEeeeeEEEcC
Confidence 875421 122222233333333 45556999997 668999999999999997
Q ss_pred CCCeEEEEecccceeecCCCcc-cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
.| ..||.+|.++......... ....--..|..|+.+.. -+...|.|-|||++++++.|
T Consensus 141 ~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 141 SG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred CC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 77 6999999987654322211 11111122556654321 12457999999999999988
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2e-11 Score=113.54 Aligned_cols=195 Identities=21% Similarity=0.196 Sum_probs=144.1
Q ss_pred CCCCceEEEeecc--cCCceEEEEEE--ccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGR--GKYSEVFEGIN--VTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
....+.+.+.+|+ |++|.||.+.. ......+|+|.-+. ....+-.+|.....++..|+|.++.+..+ +.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~ 189 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EG 189 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--cc
Confidence 3567888899999 99999998876 77888999998432 12344567888888887899999977777 44
Q ss_pred CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHH----HHHHHHHcC
Q 040656 101 SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQ----ALDYCHSQG 173 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~LH~~~ 173 (332)
...+++-+|.+........- ..+++..+..++. +..+ |+.++|+..
T Consensus 190 ~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~---------------------------~~~~~~~~al~~~hs~~ 242 (524)
T KOG0601|consen 190 SGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLR---------------------------DWLSRDVTALSHLHSNN 242 (524)
T ss_pred CCcceeeeccccchhHHhhhcccccCCchhhhhHHh---------------------------hhhhcccccccccCCCc
Confidence 56788888888743322221 2244444333333 3333 999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCCccc-cc-----ccccceeccccccCCCCCCCcccHHHHHHHHHHH
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYN-VR-----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~-~~-----~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~el 247 (332)
++|-|+||+||+...+....++.|||+...+....... .. .+...|++||+..+ -++..+|++|+|.++.+.
T Consensus 243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~ 320 (524)
T KOG0601|consen 243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEA 320 (524)
T ss_pred ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhh
Confidence 99999999999998773478999999988776444211 11 45566999999876 679999999999999999
Q ss_pred HhCCCCCC
Q 040656 248 IFRKEPFF 255 (332)
Q Consensus 248 ltg~~pf~ 255 (332)
.++..++.
T Consensus 321 ~l~~~~~~ 328 (524)
T KOG0601|consen 321 ILGSHLPS 328 (524)
T ss_pred Hhhccccc
Confidence 88877663
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.8e-10 Score=89.00 Aligned_cols=127 Identities=18% Similarity=0.306 Sum_probs=87.5
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecc-c----------chHHHHHHHHHHHhccCC-CCeeeeeeeeeccCCCCce
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKP-V----------KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~----------~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~~~ 105 (332)
..+++|+-+.++.+.. -+.++++|.-.+ . ...+..+|..++.++..- -+...++++. + ....
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~--~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P--DNGL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C--CCCE
Confidence 3578899999998854 455678887432 1 124577899999987321 2333344432 3 3568
Q ss_pred eEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 106 LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
++|||.+|..+.+.+.... ..+...+-. -+.-||..||+|+||.++||+
T Consensus 76 I~me~I~G~~lkd~l~~~~----~~~~r~vG~---------------------------~vg~lH~~givHGDLTtsNiI 124 (204)
T COG3642 76 IVMEYIEGELLKDALEEAR----PDLLREVGR---------------------------LVGKLHKAGIVHGDLTTSNII 124 (204)
T ss_pred EEEEEeCChhHHHHHHhcc----hHHHHHHHH---------------------------HHHHHHhcCeecCCCccceEE
Confidence 9999999988776553321 222333322 567899999999999999999
Q ss_pred ecCCCCeEEEEeccccee
Q 040656 186 IDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~ 203 (332)
+..+ .+.++|||++..
T Consensus 125 l~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 125 LSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EeCC--cEEEEECCcccc
Confidence 9844 399999999974
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.4e-10 Score=99.08 Aligned_cols=150 Identities=21% Similarity=0.240 Sum_probs=98.0
Q ss_pred HHhccCCCCeeeeeeeeecc---CCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccch
Q 040656 80 LQNLCGGPNIVKLLDIVRDQ---HSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQ 156 (332)
Q Consensus 80 l~~l~~h~niv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (332)
+-++ .|.||++++.++.+. +.....+++|||..+++..++++..........+..-
T Consensus 121 llql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wk-------------------- 179 (458)
T KOG1266|consen 121 LLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWK-------------------- 179 (458)
T ss_pred HHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHH--------------------
Confidence 4444 699999999998663 3345678999999999988876533332222222111
Q ss_pred hhHHhHHHHHHHHHHcC--CeecCCCCCCeeecCCCCeEEEEecccceeecCC-----C-cccccccccceeccccccCC
Q 040656 157 DISVWDLQALDYCHSQG--IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG-----K-EYNVRVASRYFKGPELLVDL 228 (332)
Q Consensus 157 ~~~~~i~~~l~~LH~~~--ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-----~-~~~~~~~t~~y~aPE~~~~~ 228 (332)
....||++||.|||+.. |+|+++..+.|++.+++ .+|+.- +-....+.. . ......+-++|.|||.=..
T Consensus 180 kw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~- 256 (458)
T KOG1266|consen 180 KWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT- 256 (458)
T ss_pred HHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcc-
Confidence 23345555999999874 99999999999999666 466431 111111100 0 1111234566889987443
Q ss_pred CCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 229 QDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 229 ~~~~~~sDiwSlG~il~elltg~~p 253 (332)
-.-+.++|||+||+...+|..+..-
T Consensus 257 tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 257 TNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred cccccchhhhhhhHHHHHHHHheec
Confidence 3457899999999999999887643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.2e-09 Score=88.62 Aligned_cols=165 Identities=19% Similarity=0.295 Sum_probs=95.4
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCC-CCeeeeeeeeeccC-CCCceeEEeee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGG-PNIVKLLDIVRDQH-SKTPSLIFEHV 111 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~-~~~~~lv~e~~ 111 (332)
+.|+.|..+.||++.. .+|+.+++|+..... ...+..|.++++.+..+ .++.+++.+..... ....+++||++
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 6789999999999876 335889999976432 45789999999999432 34566666653321 12568999999
Q ss_pred cCCCceeec--cccchhhHHHHH----HHHHhhcCCcceeecC-CCC--ccc-chhhHH--------------hHHHHHH
Q 040656 112 NSTDFKVLY--PTLTANEIRYYI----YELLKHAMPRKVIIMP-GEG--LME-NQDISV--------------WDLQALD 167 (332)
Q Consensus 112 ~~~~l~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-~~~--~~~-~~~~~~--------------~i~~~l~ 167 (332)
+|..+.... ..++......+. ..+...+......... ... ... ...+.. .+...+.
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 998877754 233333322222 2222221111000000 000 000 000000 0111222
Q ss_pred HHH-------HcCCeecCCCCCCeeecCC-CCeEEEEeccccee
Q 040656 168 YCH-------SQGIMHRDVKPHNVMIDHE-QQKLRLIDWGLAEF 203 (332)
Q Consensus 168 ~LH-------~~~ivHrdlkp~Nilv~~~-~~~vkL~Dfg~a~~ 203 (332)
.+. ...++|+|+.|.||+++.+ ++.+.++||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 222 3468999999999999863 33688999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.5e-09 Score=85.84 Aligned_cols=123 Identities=24% Similarity=0.393 Sum_probs=77.0
Q ss_pred eEEEEEEccCCceEEEEEecccc-----------------------------hHHHHHHHHHHHhccCC-CCeeeeeeee
Q 040656 47 EVFEGINVTNNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNIVKLLDIV 96 (332)
Q Consensus 47 ~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h-~niv~~~~~~ 96 (332)
.||.|.. ..+..+|+|+.+... ....++|.+.|.++... -++.+.+.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 677899999976210 12367899999999443 2566666553
Q ss_pred eccCCCCceeEEeeec--CCCceeeccc-cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHH-HHHc
Q 040656 97 RDQHSKTPSLIFEHVN--STDFKVLYPT-LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDY-CHSQ 172 (332)
Q Consensus 97 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-LH~~ 172 (332)
.-++||||++ |..+..+... +.......+..+++. .+.. +|..
T Consensus 80 ------~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~---------------------------~~~~~~~~~ 126 (188)
T PF01163_consen 80 ------RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILE---------------------------EIIKMLHKA 126 (188)
T ss_dssp ------TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHH---------------------------HHHHHHHCT
T ss_pred ------CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHH---------------------------HHHHHHHhc
Confidence 2489999999 6555443322 123444445555443 4444 5899
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
||+|+||.+.|||++.+ .+.++|||.+....
T Consensus 127 givHGDLs~~NIlv~~~--~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG--KVYIIDFGQAVDSS 157 (188)
T ss_dssp TEEESS-STTSEEEETT--CEEE--GTTEEETT
T ss_pred CceecCCChhhEEeecc--eEEEEecCcceecC
Confidence 99999999999999844 59999999987644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.2e-09 Score=85.22 Aligned_cols=137 Identities=20% Similarity=0.265 Sum_probs=90.6
Q ss_pred EEEeecccCCceEEEEEEccCCceEEEEEecc-c----------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-V----------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~----------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++.+-+|.-+.|+++.+ .|+.++||.-.. . .+++..+|...+.++ .--.|..-.-+|.|. +.-
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~--~~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDT--YGG 85 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEec--CCC
Confidence 678889999999999965 889988887532 1 235678899999987 322333222233232 445
Q ss_pred eeEEeeecCCC-ceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 105 SLIFEHVNSTD-FKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 105 ~lv~e~~~~~~-l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
+++||+.+|.+ +..+.. .-...... ..++..|=+.+.-||..+|+|+||
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~--------------------------~~~~~~iG~~igklH~ndiiHGDL 139 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGL--------------------------AELARRIGELIGKLHDNDIIHGDL 139 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhH--------------------------HHHHHHHHHHHHHhhhCCeecccc
Confidence 89999998722 222211 11111110 123333334788999999999999
Q ss_pred CCCCeeecCCCCeE--EEEeccccee
Q 040656 180 KPHNVMIDHEQQKL--RLIDWGLAEF 203 (332)
Q Consensus 180 kp~Nilv~~~~~~v--kL~Dfg~a~~ 203 (332)
..+||++..+++.+ .++|||++..
T Consensus 140 TTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 140 TTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cccceEEecCCCcCceEEEeecchhc
Confidence 99999998776654 8999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-10 Score=114.30 Aligned_cols=207 Identities=20% Similarity=0.269 Sum_probs=139.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..+.+.+++-+-+|++|.++.+.-..++...+.|+.... .......+-.++-.. .+|-++.....+ .....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP 878 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP 878 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence 457789999999999999998876566655555554321 111222222222222 344444433332 33456
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
..++++|.+++++...+. ...++..+.++..+.. ++++||+..+.|+|++
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vq---------------------------s~e~L~s~~r~h~~~~ 931 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQ---------------------------SLESLHSSLRKHRDLK 931 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHh---------------------------hhhccccchhhccccc
Confidence 789999998887766653 3445555555555554 8999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCC--------------------------------CcccccccccceeccccccCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPG--------------------------------KEYNVRVASRYFKGPELLVDL 228 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~--------------------------------~~~~~~~~t~~y~aPE~~~~~ 228 (332)
|+|++...++ +.++.|||........ .......+|+.|.+||.+.+
T Consensus 932 p~~~l~~~~g-h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg- 1009 (1205)
T KOG0606|consen 932 PDSLLIAYDG-HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG- 1009 (1205)
T ss_pred ccchhhcccC-CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-
Confidence 9999998776 6899999843211100 00112367888999999988
Q ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 040656 229 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAR 269 (332)
Q Consensus 229 ~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~ 269 (332)
...+..+|.|++|++++|.++|..||. .......+..+..
T Consensus 1010 ~~hgs~ad~~~~g~~l~e~l~g~pp~n-a~tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 1010 RRHGSAADWWSSGVCLFEVLTGIPPFN-AETPQQIFENILN 1049 (1205)
T ss_pred ccCCCcchhhhhhhhhhhhhcCCCCCC-Ccchhhhhhcccc
Confidence 678899999999999999999999984 4444455544443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.1e-10 Score=104.24 Aligned_cols=193 Identities=19% Similarity=0.123 Sum_probs=135.2
Q ss_pred CCCceEEEeecccCCceEEEEEEc-cCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV-TNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..+|-.+..||.|.|+.|+.+... .++..+++|.+.+. ....-..|+.+...+..|.+++.....+.. ..+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccc
Confidence 477999999999999999987644 67888999987642 223345677777777778888887665532 2344
Q ss_pred eeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 105 SLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
++=.||+.+++..... .+.+++. --..+.+..+++.++.++|+..++|+|+||+||
T Consensus 342 ~ip~e~~~~~s~~l~~----------~~~~~~d--------------~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni 397 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS----------VTSQMLD--------------EDPRLRLTAQILTALNVIHSKLFVHLDVKPSNI 397 (524)
T ss_pred cCchhhhcCcchhhhh----------HHHHhcC--------------cchhhhhHHHHHhccccccchhhhcccccccce
Confidence 5778888877654432 1222221 112234555666799999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCCccccccccccee-ccccccCCCCCCCcccHHHHHHHHHHHHhCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFK-GPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~sDiwSlG~il~elltg~ 251 (332)
++.+++...++.|||..+.+. -......+..+++ ..|.+.....+..++|++|||..+.+.+++.
T Consensus 398 ~i~~~~~~~~~~~~~~~t~~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 398 LISNDGFFSKLGDFGCWTRLA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred eeccchhhhhccccccccccc--eecccccccccccccchhhccccccccccccccccccccccccCc
Confidence 999765567899999886422 1122233344445 3555555577899999999999999988876
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.5e-08 Score=84.27 Aligned_cols=135 Identities=21% Similarity=0.353 Sum_probs=96.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecc-------c------------------chHHHHHHHHHHHhccCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-------V------------------KKKKIKREIKILQNLCGG 86 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~------------------~~~~~~~E~~~l~~l~~h 86 (332)
.-+.++..||-|.-|.||.|.. ..+.++|+|.=+. . .+...++|.++|++|...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred hHHhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 3467889999999999999986 5789999998431 0 112368899999999322
Q ss_pred -CCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHH
Q 040656 87 -PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQA 165 (332)
Q Consensus 87 -~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 165 (332)
-.+.+-+++ +.-.++||+.+|..|.... +..+....++..++. .
T Consensus 170 G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~---------------------------~ 214 (304)
T COG0478 170 GVKVPKPIAW------NRHAVVMEYIEGVELYRLR--LDVENPDEILDKILE---------------------------E 214 (304)
T ss_pred CCCCCCcccc------ccceeeeehcccceeeccc--CcccCHHHHHHHHHH---------------------------H
Confidence 245555544 3458999999997766553 134444444444443 4
Q ss_pred HHHHHHcCCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 166 LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 166 l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
+...-..|+||+|+++=||+++.++ .+.++||-.+..
T Consensus 215 ~~~~~~~GiVHGDlSefNIlV~~dg-~~~vIDwPQ~v~ 251 (304)
T COG0478 215 VRKAYRRGIVHGDLSEFNILVTEDG-DIVVIDWPQAVP 251 (304)
T ss_pred HHHHHHcCccccCCchheEEEecCC-CEEEEeCccccc
Confidence 4444489999999999999999776 599999976643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-07 Score=83.08 Aligned_cols=127 Identities=17% Similarity=0.153 Sum_probs=79.3
Q ss_pred eEEEEEEccCCceEEEEEecccc--------------hHHHHHHHHHHHhccCCCCee--eeeeeeeccC---CCCceeE
Q 040656 47 EVFEGINVTNNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIV--KLLDIVRDQH---SKTPSLI 107 (332)
Q Consensus 47 ~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv--~~~~~~~~~~---~~~~~lv 107 (332)
.|.+.. -.|+.+.+|...... ...+.+|...+.++ ...+|. ....+.+... ...-++|
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 355543 356778888654222 11377899888887 322322 2333332211 2346799
Q ss_pred EeeecCC-Cceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 108 FEHVNST-DFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 108 ~e~~~~~-~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+|++++. ++.++... ........ +..+++..+.-||..||+|+|+++
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~---------------------------ll~~la~~i~~LH~~Gi~HgDL~~ 166 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRM---------------------------LIKRVATMVRDMHAAGINHRDCYI 166 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHH---------------------------HHHHHHHHHHHHHHCcCccCCCCh
Confidence 9999875 55554321 11122223 333445599999999999999999
Q ss_pred CCeeecC------CCCeEEEEeccccee
Q 040656 182 HNVMIDH------EQQKLRLIDWGLAEF 203 (332)
Q Consensus 182 ~Nilv~~------~~~~vkL~Dfg~a~~ 203 (332)
.|||++. ++..+.|+||+.+..
T Consensus 167 ~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 167 CHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred hhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999974 234799999998853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.2e-08 Score=86.09 Aligned_cols=200 Identities=14% Similarity=0.152 Sum_probs=122.4
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeee----eeccCC-CCceeEE
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDI----VRDQHS-KTPSLIF 108 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~----~~~~~~-~~~~lv~ 108 (332)
....+.||+|+.+.+|-. ..-...+-|++.+.....-.+-+..|.....||-+..-+.| ..+.+. .-+.++|
T Consensus 13 i~~gr~LgqGgea~ly~l---~e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 13 IPPGRPLGQGGEADLYTL---GEVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred cCCCccccCCccceeeec---chhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 345578999999999953 22244556887654444334445555555456643331111 111111 1245556
Q ss_pred eeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC
Q 040656 109 EHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188 (332)
Q Consensus 109 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~ 188 (332)
..+.+..-...+ +....+..-.+...|...+.++..++.+.+.||..|.+-+|++++|+||+.
T Consensus 90 P~v~g~~pI~~~-----------------y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd 152 (637)
T COG4248 90 PKVSGKEPIHMI-----------------YSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSD 152 (637)
T ss_pred ccCCCccchhhh-----------------cCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeec
Confidence 655543211111 000111111222344444566667778999999999999999999999995
Q ss_pred CCCeEEEEecccceeecCCCcccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhC-CCCC
Q 040656 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFR-KEPF 254 (332)
Q Consensus 189 ~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg-~~pf 254 (332)
++ .|.|.|=..-.....+.-....+|...|.+||.-.- +...+...|.+.||+++|+++.| .+||
T Consensus 153 ~~-~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPy 222 (637)
T COG4248 153 DS-KVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222 (637)
T ss_pred Cc-eEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCC
Confidence 55 799998554333333444455678889999997531 12346899999999999999887 8898
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.7e-08 Score=94.37 Aligned_cols=89 Identities=17% Similarity=0.354 Sum_probs=68.8
Q ss_pred HHHHHHHHc-CCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcc-----cc-----cccccceeccccccCCCCCC
Q 040656 164 QALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY-----NV-----RVASRYFKGPELLVDLQDYD 232 (332)
Q Consensus 164 ~~l~~LH~~-~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~-----~~-----~~~t~~y~aPE~~~~~~~~~ 232 (332)
.|+.++|.. ++||++|.|++|.++..+ ..||++|+++......... .. ......|.|||++.. ...+
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~~ 187 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTNT 187 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cccc
Confidence 499999965 899999999999999766 6899999987655432221 11 123455999999877 6678
Q ss_pred CcccHHHHHHHHHHHHhCCCCC
Q 040656 233 YSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 233 ~~sDiwSlG~il~elltg~~pf 254 (332)
.++|++|||+.+|.+..|..+.
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i 209 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSI 209 (700)
T ss_pred ccccceeeeeEEEEEecCCcch
Confidence 9999999999999998554454
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=79.46 Aligned_cols=178 Identities=13% Similarity=0.169 Sum_probs=120.1
Q ss_pred CceEEEEEEccCCceEEEEEe---cccchHHHHHHHHHHHhccCCCCeeeeeeeeecc--CCCCceeEEeeecCCC-cee
Q 040656 45 YSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HSKTPSLIFEHVNSTD-FKV 118 (332)
Q Consensus 45 ~g~V~~~~~~~~~~~vavK~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~~~lv~e~~~~~~-l~~ 118 (332)
..+.|+|....+|..+++|.+ +.....+...-++..+++ .|.|+|++.++|... +...+++|++|.++.. |-+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 357899999999999999998 333344556678888999 999999999988532 3456889999987532 222
Q ss_pred ec-cccchhhHHHHHHHHHhhcCCcceeecCCCCccc--chhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEE
Q 040656 119 LY-PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLME--NQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195 (332)
Q Consensus 119 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL 195 (332)
+. ...+.- ..........+...++ -|.++.|+..||.++|+.|+.-+-|.|.+||++.+. +++|
T Consensus 368 ~~F~~~~~t------------~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIri 434 (655)
T KOG3741|consen 368 LYFANPPFT------------KRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRI 434 (655)
T ss_pred HHccCCccc------------cccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEE
Confidence 21 110000 0000011111112222 357777777899999999999999999999998665 7999
Q ss_pred EecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 196 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
+..|+......+.. |.+.+ -.+-|.=.||.++..|.||..-
T Consensus 435 S~C~i~Dvl~~d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 435 SGCGIMDVLQEDPT-------------EPLES----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ecccceeeecCCCC-------------cchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence 98888776553320 11222 2356889999999999999543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.9e-06 Score=68.20 Aligned_cols=137 Identities=15% Similarity=0.249 Sum_probs=86.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch------------HHHHHHHHHHHhcc--CCCCeeeeeeee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------------KKIKREIKILQNLC--GGPNIVKLLDIV 96 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~E~~~l~~l~--~h~niv~~~~~~ 96 (332)
..+|.+.+.+-......|.+.. -.++.+++|..++... ....+++..+.++. .-.....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678999999988888887764 4778999999764321 11233444444441 122222222222
Q ss_pred eccC---CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 97 RDQH---SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 97 ~~~~---~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
.-.. ....+++|||++|..+..... +++. ....+ ++++.-+|+.|
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-i~e~----~~~ki---------------------------~~~ikqlH~~G 155 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-IDED----LAEKI---------------------------VEAIKQLHKHG 155 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-cCHH----HHHHH---------------------------HHHHHHHHHcC
Confidence 1111 123468999999987766531 1211 11222 34899999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
++|+|..|.|++++ ++ .++++||+..+.
T Consensus 156 ~~HGD~hpgNFlv~-~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 156 FYHGDPHPGNFLVS-NN-GIRIIDTQGKRM 183 (229)
T ss_pred CccCCCCcCcEEEE-CC-cEEEEECccccc
Confidence 99999999999998 44 399999986643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.1e-06 Score=69.25 Aligned_cols=132 Identities=14% Similarity=0.225 Sum_probs=85.9
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccch----------------------HH-----HHHHHHHHHhccC-CCCe
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----------------------KK-----IKREIKILQNLCG-GPNI 89 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------~~-----~~~E~~~l~~l~~-h~ni 89 (332)
-.|.+|.-+.||+|.. ..+..+|+|+++.... .+ ..+|+..|+++.. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3667788889999864 6789999999873210 00 3457777887732 2233
Q ss_pred eeeeeeeeccCCCCceeEEeeecCC-Cceeeccccc--hhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHH
Q 040656 90 VKLLDIVRDQHSKTPSLIFEHVNST-DFKVLYPTLT--ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL 166 (332)
Q Consensus 90 v~~~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 166 (332)
.+-+.+. .-.++||++... .....+...+ .++...+..+++. .+
T Consensus 133 P~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~---------------------------~~ 179 (268)
T COG1718 133 PEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVE---------------------------YM 179 (268)
T ss_pred CCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHH---------------------------HH
Confidence 3334432 348999999765 3333333332 2134444444443 66
Q ss_pred HHHH-HcCCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 167 DYCH-SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 167 ~~LH-~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
.-|- ..++||+||+.=|||+. ++ .+.++|||.|....
T Consensus 180 ~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~QaV~~~ 217 (268)
T COG1718 180 RRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHhcCcccccchhhheEEE-CC-eEEEEECccccccC
Confidence 6664 48999999999999998 55 69999999987544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.5e-06 Score=69.14 Aligned_cols=148 Identities=17% Similarity=0.209 Sum_probs=89.5
Q ss_pred cccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEec---------ccchHHHHHHHHHHHhccCC-CCee
Q 040656 21 YESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK---------PVKKKKIKREIKILQNLCGG-PNIV 90 (332)
Q Consensus 21 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~~h-~niv 90 (332)
++....+|.+.-+. |.||-|-|+.... .|+.+-+|.-. +-....+.+|...+.+|... -.+.
T Consensus 13 ~w~~~~~wve~pN~------~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP 84 (216)
T PRK09902 13 WWATEGDWVEEPNY------RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVP 84 (216)
T ss_pred HHhCCCceecCCCc------CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence 34445555544433 4578888887643 33456666643 23456799999999998431 1233
Q ss_pred eee--eeeeccCCCCceeEEeeecC-CCceeeccc--c---chhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhH
Q 040656 91 KLL--DIVRDQHSKTPSLIFEHVNS-TDFKVLYPT--L---TANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWD 162 (332)
Q Consensus 91 ~~~--~~~~~~~~~~~~lv~e~~~~-~~l~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 162 (332)
+.. +.-.........+|+|-+++ .+|..++.. . +.... ..+...+
T Consensus 85 ~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k---------------------------~~il~~v 137 (216)
T PRK09902 85 KIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVR---------------------------QAMLKAV 137 (216)
T ss_pred ccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHH---------------------------HHHHHHH
Confidence 333 11111223346788886653 344433311 1 22222 2344445
Q ss_pred HHHHHHHHHcCCeecCCCCCCeeecCCCC-eEEEEeccccee
Q 040656 163 LQALDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDWGLAEF 203 (332)
Q Consensus 163 ~~~l~~LH~~~ivHrdlkp~Nilv~~~~~-~vkL~Dfg~a~~ 203 (332)
+.+++-||+.|+.|+|+.+.||+++.++. .+.++||.-++.
T Consensus 138 a~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 138 ALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 56999999999999999999999985542 499999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.4e-06 Score=73.51 Aligned_cols=108 Identities=24% Similarity=0.338 Sum_probs=69.6
Q ss_pred hHHHHHHHHHHHhccC-CCCeeeeeeeeeccCC--CCceeEEeeecCC-Cceeeccc---cchhhHHHHHHHHHhhcCCc
Q 040656 70 KKKIKREIKILQNLCG-GPNIVKLLDIVRDQHS--KTPSLIFEHVNST-DFKVLYPT---LTANEIRYYIYELLKHAMPR 142 (332)
Q Consensus 70 ~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~--~~~~lv~e~~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~~~~~ 142 (332)
..+..+|...+.+|.. .-.+...+.+.+.... ...++|+|++++. ++..++.. ........++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll---------- 124 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELL---------- 124 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHH----------
Confidence 3467888888777732 1123344444432221 2347899998874 45555432 2222223333
Q ss_pred ceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC--CeEEEEecccceee
Q 040656 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ--QKLRLIDWGLAEFY 204 (332)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~--~~vkL~Dfg~a~~~ 204 (332)
.+++..++-||..||+|+|+++.|||++.++ ..+.++||+.++..
T Consensus 125 -----------------~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 125 -----------------RALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred -----------------HHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 3444589999999999999999999998654 36899999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.4e-06 Score=68.62 Aligned_cols=130 Identities=18% Similarity=0.316 Sum_probs=86.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecc-cchHHHHHHHHHHHhccCCCCee-eeeeeeeccCCCCceeEEe
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV-KLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv-~~~~~~~~~~~~~~~lv~e 109 (332)
...++.+.||+|.+|.||++.+ .+..+|+|+-+. ..+..+..|++++..+ .-.++. ++|.+- . ..+.||
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil-~g~~~~p~vy~yg--~----~~i~me 92 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEIL-AGEGVTPEVYFYG--E----DFIRME 92 (201)
T ss_pred hhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHh-hhcCCCceEEEec--h----hhhhhh
Confidence 3456778899999999999965 677899999764 4456799999999999 544444 455553 2 245599
Q ss_pred eecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC-C-Ceeec
Q 040656 110 HVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP-H-NVMID 187 (332)
Q Consensus 110 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp-~-Nilv~ 187 (332)
|..|..|.........+.+ ..++. .---|-..||-|..|.- . |+++.
T Consensus 93 ~i~G~~L~~~~~~~~rk~l----~~vlE---------------------------~a~~LD~~GI~H~El~~~~k~vlv~ 141 (201)
T COG2112 93 YIDGRPLGKLEIGGDRKHL----LRVLE---------------------------KAYKLDRLGIEHGELSRPWKNVLVN 141 (201)
T ss_pred hhcCcchhhhhhcccHHHH----HHHHH---------------------------HHHHHHHhccchhhhcCCceeEEec
Confidence 9998776554322222222 22222 32334567888888763 3 45554
Q ss_pred CCCCeEEEEeccccee
Q 040656 188 HEQQKLRLIDWGLAEF 203 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~ 203 (332)
++ .+.|+||..|+.
T Consensus 142 -~~-~~~iIDFd~At~ 155 (201)
T COG2112 142 -DR-DVYIIDFDSATF 155 (201)
T ss_pred -CC-cEEEEEccchhh
Confidence 54 699999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.2e-05 Score=62.84 Aligned_cols=125 Identities=21% Similarity=0.252 Sum_probs=84.5
Q ss_pred CCceEEEeecccCC-ceEEEEEEccCCceEEEEEecc---c---------------------chHHHHHHHHHHHhccC-
Q 040656 32 EDYEVVRKVGRGKY-SEVFEGINVTNNEKCIIKILKP---V---------------------KKKKIKREIKILQNLCG- 85 (332)
Q Consensus 32 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~---~---------------------~~~~~~~E~~~l~~l~~- 85 (332)
.+++.++.||.|.. |.||++.. .|+.+|+|+++. . ....|..|.+...+|..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999965 788999999431 0 01236778888777733
Q ss_pred -CCCe--eeeeeeeeccC----------------CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceee
Q 040656 86 -GPNI--VKLLDIVRDQH----------------SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146 (332)
Q Consensus 86 -h~ni--v~~~~~~~~~~----------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (332)
+.++ ++++|++.-.. .....+|.|+.+... .+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~----------------------- 165 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PL----------------------- 165 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------cc-----------------------
Confidence 3455 88888873210 001123444443322 11
Q ss_pred cCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccc
Q 040656 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201 (332)
Q Consensus 147 ~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a 201 (332)
...-+.+|++-+..+|..||+-+|+++.|.. ++ +|+|||.+
T Consensus 166 --------~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G---~lvDfs~~ 206 (207)
T PF13095_consen 166 --------QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG---KLVDFSSS 206 (207)
T ss_pred --------chhHHHHHHHHHHHHHHCCeeeccCcccccc---CC---EEEecccC
Confidence 1123334455888999999999999999987 22 78999864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.7e-06 Score=77.31 Aligned_cols=138 Identities=14% Similarity=0.265 Sum_probs=87.7
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccchH-------------------------------------------HHH
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK-------------------------------------------KIK 74 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------------------------------------~~~ 74 (332)
+-|++++=|.||+|+. .+|+.||||+..+.-.+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5689999999999986 45999999998642111 144
Q ss_pred HHHHHHHhcc---CCCCeeeeeeeeeccCCCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCC
Q 040656 75 REIKILQNLC---GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPG 149 (332)
Q Consensus 75 ~E~~~l~~l~---~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (332)
+|...+.++. +...-+.+-.++-+- ...-.++|||+.|..+.+.. .. ...+...+...++.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~------------ 275 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVR------------ 275 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHH------------
Confidence 5555555542 222223333333211 13458999999998777763 22 12222222222222
Q ss_pred CCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeec
Q 040656 150 EGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 150 ~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~ 205 (332)
..+..+=..|++|.|..|.||+++.++ ++.+.|||+...+.
T Consensus 276 --------------~f~~q~~~dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~ 316 (517)
T COG0661 276 --------------AFLRQLLRDGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD 316 (517)
T ss_pred --------------HHHHHHHhcCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence 123344458999999999999999776 79999999986654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.7e-05 Score=67.84 Aligned_cols=80 Identities=16% Similarity=0.350 Sum_probs=56.4
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCC-Ceeeeeeeeecc-CCCCceeEEeeecC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQ-HSKTPSLIFEHVNS 113 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~-~~~~~~lv~e~~~~ 113 (332)
++.|+.|..+.||++... +..+++|..... ....+..|..+++.+..+. .+.+++...... .....+++|+++++
T Consensus 2 i~~l~~G~~n~~~~v~~~--~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--DGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEET--TSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEEC--CcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578899999999998753 368999998655 4567889999999985442 245566543222 22346889999999
Q ss_pred CCcee
Q 040656 114 TDFKV 118 (332)
Q Consensus 114 ~~l~~ 118 (332)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.4e-05 Score=66.92 Aligned_cols=72 Identities=24% Similarity=0.376 Sum_probs=50.9
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCC-CeeeeeeeeeccCCCCceeEEeeecCCC
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQHSKTPSLIFEHVNSTD 115 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~~~lv~e~~~~~~ 115 (332)
+.||+|..+.||+. .+..+++|..... ......+|.++++.+.... .+.+.+++..+ .....++||+++|..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCCcc
Confidence 67899999999974 2556788987653 3456899999999984322 24556666532 344678999999964
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.7e-05 Score=65.93 Aligned_cols=78 Identities=21% Similarity=0.232 Sum_probs=54.1
Q ss_pred EeecccCC-ceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCc
Q 040656 38 RKVGRGKY-SEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDF 116 (332)
Q Consensus 38 ~~lg~G~~-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l 116 (332)
+.|-.|.. +.||+... .+..+.+|...........+|+.+++.+..+--+.+++++... ....++||++++|..+
T Consensus 4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCCccH
Confidence 34455555 78998853 3478888987654345678899999998655445566666533 2457899999999877
Q ss_pred eee
Q 040656 117 KVL 119 (332)
Q Consensus 117 ~~~ 119 (332)
...
T Consensus 80 ~~~ 82 (244)
T cd05150 80 AAL 82 (244)
T ss_pred hHh
Confidence 654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.6e-05 Score=73.08 Aligned_cols=134 Identities=18% Similarity=0.262 Sum_probs=84.9
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccch----------------------------------------HHHHHHH
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----------------------------------------KKIKREI 77 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------------------------------~~~~~E~ 77 (332)
+-||..+.|.||+|+- .+|+.||||+-++.-. -+|.+|.
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5689999999999986 4599999999653210 0245555
Q ss_pred HHHHhcc---CCCC------eeeeeeeeeccCCCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcce
Q 040656 78 KILQNLC---GGPN------IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKV 144 (332)
Q Consensus 78 ~~l~~l~---~h~n------iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 144 (332)
+...++. .|-+ |.+++-.+. ..-.++|||++|..+.++. .......+...+.+.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~--------- 312 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA--------- 312 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH---------
Confidence 5444432 3444 333433331 2458999999998877763 112222211111111
Q ss_pred eecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecC---CCCeEEEEecccceeec
Q 040656 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH---EQQKLRLIDWGLAEFYH 205 (332)
Q Consensus 145 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~---~~~~vkL~Dfg~a~~~~ 205 (332)
.++-+-..|++|+|-.|.||++.. .+..+.+.|||+.....
T Consensus 313 --------------------~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 313 --------------------YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --------------------HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 123334678999999999999984 34579999999976554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00018 Score=60.06 Aligned_cols=138 Identities=20% Similarity=0.386 Sum_probs=85.6
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccc-------------------hHHHHHHHHHHHhcc-----CCCCeeee
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNIVKL 92 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~niv~~ 92 (332)
...||+|+.-.||. ........||+..... .+...+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999995 2556667789987655 456777877766662 27899999
Q ss_pred eeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
+|+. +++..+.+|+|.....+-. ...++..++++ +.... .+...+-+-..+|-+.
T Consensus 83 ~G~v--eT~~G~Glv~e~I~d~dG~------~s~TL~~~l~~----------------~~~~~-~~~~~L~~f~~~l~~~ 137 (199)
T PF10707_consen 83 YGFV--ETNLGLGLVVELIRDADGN------ISPTLEDYLKE----------------GGLTE-ELRQALDEFKRYLLDH 137 (199)
T ss_pred eEEE--ecCCceEEEEEEEECCCCC------cCccHHHHHHc----------------CCccH-HHHHHHHHHHHHHHHc
Confidence 9998 4456678899987543210 01111111110 00000 1111111245678889
Q ss_pred CCeecCCCCCCeeecCCC--C-eEEEEe-cccce
Q 040656 173 GIMHRDVKPHNVMIDHEQ--Q-KLRLID-WGLAE 202 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~--~-~vkL~D-fg~a~ 202 (332)
+|+.+|++|.||++...+ . .+.|+| ||...
T Consensus 138 ~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 138 HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred CCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 999999999999995432 2 567776 45443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.9e-06 Score=81.45 Aligned_cols=188 Identities=15% Similarity=0.144 Sum_probs=127.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCC-eeeeeeeeeccCCCCceeEEee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPN-IVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~~~~~lv~e~ 110 (332)
.-+...+-+++|+.+.+++.+...+...+ .+.+.-. ....-++++|.++ +||| .+..++-+ +.+...++.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d~--~~E~~~~i~~~i 315 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLEDY--DGEDYLWIPMRI 315 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCcccccccC--Ccccccchhhhh
Confidence 44667778899999999998765554444 6665422 4556789999999 9999 44443333 444577888999
Q ss_pred ecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCC
Q 040656 111 VNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQ 190 (332)
Q Consensus 111 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~ 190 (332)
+.++.-.......++..+..+.... +...-..+++++|+.-=+|+| ||+..+ +
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~----------------------~~r~et~~l~~l~~~~~~~~d----~~l~s~-~ 368 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAY----------------------PLRKETRPLAELHSSYKVHRD----NILGSE-E 368 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhh----------------------hhhhhcccccccccccccCcc----cccccc-c
Confidence 8877211111112222211111111 111112488999988778888 888874 3
Q ss_pred CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 191 QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 191 ~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
..++.||+....+......++..+++.++|||+... ..+....|.||+|.-..++.-|-.|-
T Consensus 369 -~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 369 -EVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -ccccccccCCcccCcccccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCC
Confidence 589999999877765556677889999999998766 67889999999998777777776553
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.0002 Score=63.83 Aligned_cols=160 Identities=13% Similarity=0.162 Sum_probs=87.8
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCC-Ceeeeeeeeec----cCCCCceeEEeee
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QHSKTPSLIFEHV 111 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~----~~~~~~~lv~e~~ 111 (332)
++.+..|....+|+... .+..+++|+........+..|+.++..+..+. .+.+.+....+ ......+.+++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 56777788789998753 44578999987655567788999998884332 23344332110 1123467899999
Q ss_pred cCCCceeeccccchhhHHHHHHHHHhhcCCcc-eeec-CCC---Cccc----------chhhHHhHHHHHHHHHH-----
Q 040656 112 NSTDFKVLYPTLTANEIRYYIYELLKHAMPRK-VIIM-PGE---GLME----------NQDISVWDLQALDYCHS----- 171 (332)
Q Consensus 112 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~---~~~~----------~~~~~~~i~~~l~~LH~----- 171 (332)
+|..+... +......+...+...+.... .... ... .+.. .......+..++..+..
T Consensus 97 ~G~~~~~~----~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 97 AGEHLTRP----TAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred CCCCCCCC----CHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99876541 22222222222222111100 0000 000 0000 00111112234444442
Q ss_pred --cCCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 172 --QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 172 --~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
.+++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 4799999999999998543 568999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00027 Score=71.99 Aligned_cols=82 Identities=18% Similarity=0.260 Sum_probs=57.2
Q ss_pred EEEeecccCCceEEEEEEccCC--ceEEEEEeccc----chHHHHHHHHHHHhccCCCCe--eeeeeeeeccC-CCCcee
Q 040656 36 VVRKVGRGKYSEVFEGINVTNN--EKCIIKILKPV----KKKKIKREIKILQNLCGGPNI--VKLLDIVRDQH-SKTPSL 106 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~--~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~~~-~~~~~l 106 (332)
-++.++.|.++.+|+......+ ..+++|..... ....+.+|..+++.+..|.++ .+++.++.+.. ....++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4677899999999987653322 46777775421 235688999999999546554 67777775432 235789
Q ss_pred EEeeecCCCce
Q 040656 107 IFEHVNSTDFK 117 (332)
Q Consensus 107 v~e~~~~~~l~ 117 (332)
|||+++|..+.
T Consensus 122 VME~v~G~~~~ 132 (822)
T PLN02876 122 IMEYLEGRIFV 132 (822)
T ss_pred EEEecCCcccC
Confidence 99999987544
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00038 Score=59.78 Aligned_cols=75 Identities=17% Similarity=0.273 Sum_probs=49.5
Q ss_pred EEeecccCCceEEEEEEcc-CCceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 37 VRKVGRGKYSEVFEGINVT-NNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
++.|..|-...+|++.... .++.+++|+...... ....+|+.+++.+..+.-..++++.+ + -.+++||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~----~~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--Q----NGLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--C----CcEEEEeeCC
Confidence 4567778888999886422 257898998754322 23457999999885444444555543 2 1479999998
Q ss_pred CCce
Q 040656 114 TDFK 117 (332)
Q Consensus 114 ~~l~ 117 (332)
..+.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 6654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00091 Score=57.55 Aligned_cols=77 Identities=10% Similarity=0.146 Sum_probs=48.8
Q ss_pred EeecccCCc-eEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCC--CeeeeeeeeeccCC-CCceeEEeeec
Q 040656 38 RKVGRGKYS-EVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGP--NIVKLLDIVRDQHS-KTPSLIFEHVN 112 (332)
Q Consensus 38 ~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~~~~~~~~~~~-~~~~lv~e~~~ 112 (332)
+.|+.|+.. .||+. +..+++|+.+.. ....+.+|.+++..+..+- .+..+++.....+. ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 567777776 58875 235778886543 3457899999999884331 23334443322211 24588999999
Q ss_pred CCCceee
Q 040656 113 STDFKVL 119 (332)
Q Consensus 113 ~~~l~~~ 119 (332)
|..+...
T Consensus 78 G~~l~~~ 84 (235)
T cd05155 78 GETATAA 84 (235)
T ss_pred CCCCCcc
Confidence 9887654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0016 Score=58.11 Aligned_cols=84 Identities=8% Similarity=0.156 Sum_probs=60.7
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCC--CCeeeeeeeeecc-CCCCceeEE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQ-HSKTPSLIF 108 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~-~~~~~~lv~ 108 (332)
.-.-.+.||.|..+.||.... .+..+.+|..+.. ....+..|.+.++.+..+ -.+.++++++.+. .....++||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344567899999999998743 3335777886542 456899999999998554 3677788776542 234579999
Q ss_pred eeecCCCcee
Q 040656 109 EHVNSTDFKV 118 (332)
Q Consensus 109 e~~~~~~l~~ 118 (332)
|++++..+..
T Consensus 93 E~i~G~~~~~ 102 (297)
T PRK10593 93 ERLRGVSVEA 102 (297)
T ss_pred eccCCEecCC
Confidence 9999977654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.001 Score=58.03 Aligned_cols=151 Identities=18% Similarity=0.102 Sum_probs=79.8
Q ss_pred ecccCCceEEEEEEccCCceEEEEEecccch---HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCc
Q 040656 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDF 116 (332)
Q Consensus 40 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l 116 (332)
+..|-.+.+|+.. .+++.+++|....... -...+|..+++.+..+.-..+++... + .++|+|+++|..+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence 4557778999875 4677888998653221 24578999999985442233344433 2 3789999998765
Q ss_pred eeeccccchhhHHHHHHHHHhhcCCcceeecCCCCccc----------chhhHHhHHHHHHHHHH--------cCCeecC
Q 040656 117 KVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLME----------NQDISVWDLQALDYCHS--------QGIMHRD 178 (332)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~i~~~l~~LH~--------~~ivHrd 178 (332)
...... .......++..+...+...... ....... ...+...+...+..+-. ..++|+|
T Consensus 76 ~~~~~~-~~~~~~~la~~l~~lH~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 76 TLDQFV-ALDLLLELAALLHQLHSQPRFG--YPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccc-CchhHHHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 542100 1111222222222222211100 0000000 00000011111222211 2589999
Q ss_pred CCCCCeeecCCCCeEEEEeccccee
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
+.|.||+++.++ +.++||+.+..
T Consensus 153 l~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC--CEEEeccccCc
Confidence 999999998554 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0033 Score=56.43 Aligned_cols=165 Identities=13% Similarity=0.129 Sum_probs=85.3
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCC-Ceeeeeeeee----ccCCCCceeE
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGP-NIVKLLDIVR----DQHSKTPSLI 107 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~-niv~~~~~~~----~~~~~~~~lv 107 (332)
..-++.++.|....+|++.. ++..+++|+.... ....+..|.+++..|..+. ++.+++.... ..-....+++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ceeccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 44467778887789998753 3446788987543 3456677888888873221 2334433211 1112346889
Q ss_pred EeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecC---CCCccc------------chhhHHhHHHHHHHHH--
Q 040656 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP---GEGLME------------NQDISVWDLQALDYCH-- 170 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------------~~~~~~~i~~~l~~LH-- 170 (332)
+++++|......... ....+...+..+-.....-...... ...+.. +......+.+.++++.
T Consensus 102 ~e~i~G~~~~~~~~~-~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 102 VEFLQGLSVGRPTAM-HCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEeCCCCCCCCCCHH-HHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 999998765421100 0111222222221111000000000 000000 0011111223444443
Q ss_pred -----HcCCeecCCCCCCeeecCCCCeEEEEecccce
Q 040656 171 -----SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202 (332)
Q Consensus 171 -----~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~ 202 (332)
..+++|+|+.+.|++++.++ .+.++||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 26899999999999998654 56899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00012 Score=64.66 Aligned_cols=145 Identities=19% Similarity=0.317 Sum_probs=94.9
Q ss_pred cccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEec-------ccc------------------hHHH
Q 040656 19 WDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-------PVK------------------KKKI 73 (332)
Q Consensus 19 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-------~~~------------------~~~~ 73 (332)
+||--...-.....-+.++..||-|.-+.||.+.+ ..|++.++|.=+ +.. +-..
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 44433333333445688999999999999999876 567888888732 100 1124
Q ss_pred HHHHHHHHhccCCCC-eeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCc
Q 040656 74 KREIKILQNLCGGPN-IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152 (332)
Q Consensus 74 ~~E~~~l~~l~~h~n-iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (332)
.+|...|+.|..|.. +.+.++. +.-++|||++.+-.+.....-.....+. ..++.
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v~d~~~ly---~~lm~--------------- 213 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH------NRHCVVMELVDGYPLRQVRHVEDPPTLY---DDLMG--------------- 213 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc------cceeeHHHhhcccceeeeeecCChHHHH---HHHHH---------------
Confidence 678888888844432 2233333 3458899999887776654333333222 22221
Q ss_pred ccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccc
Q 040656 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201 (332)
Q Consensus 153 ~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a 201 (332)
-+--|..+|+||+|.+-=||+++.++ +++++||-..
T Consensus 214 ------------~Iv~la~~GlIHgDFNEFNimv~dd~-~i~vIDFPQm 249 (465)
T KOG2268|consen 214 ------------LIVRLANHGLIHGDFNEFNIMVKDDD-KIVVIDFPQM 249 (465)
T ss_pred ------------HHHHHHHcCceecccchheeEEecCC-CEEEeechHh
Confidence 34557789999999999999999655 7999999653
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0016 Score=58.21 Aligned_cols=76 Identities=18% Similarity=0.197 Sum_probs=50.0
Q ss_pred EEeecccCCceEEEEEEcc------CCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 37 VRKVGRGKYSEVFEGINVT------NNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
++.|..|-...||++.... .++.+++|+.... ......+|..++..+..+.-..++++.+. . ..|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cchh
Confidence 3455557777899876432 2578999997643 22457889999999855443445566552 1 4589
Q ss_pred eeecCCCcee
Q 040656 109 EHVNSTDFKV 118 (332)
Q Consensus 109 e~~~~~~l~~ 118 (332)
++++|..+..
T Consensus 77 e~i~G~~l~~ 86 (302)
T cd05156 77 EFIPSRTLTT 86 (302)
T ss_pred heeCCCcCCH
Confidence 9999876543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0017 Score=60.08 Aligned_cols=75 Identities=16% Similarity=0.252 Sum_probs=53.4
Q ss_pred EEEeecccCCceEEEEEEccCCceEEEEEecc----------cchHHHHHHHHHHHhccCC--CCeeeeeeeeeccCCCC
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~ 103 (332)
-.+.||.|.+..||++....+++.++||.-.+ ....+...|.+.|+.+..+ .++.+++.+- + ..
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~ 105 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--EL 105 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CC
Confidence 34778999999999998754446899998431 1345678888888887443 3566777763 2 34
Q ss_pred ceeEEeeecCC
Q 040656 104 PSLIFEHVNST 114 (332)
Q Consensus 104 ~~lv~e~~~~~ 114 (332)
.++|||++++.
T Consensus 106 ~~lVME~L~~~ 116 (401)
T PRK09550 106 AVTVMEDLSDH 116 (401)
T ss_pred CEEEEecCCCc
Confidence 68999999863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0025 Score=57.48 Aligned_cols=135 Identities=19% Similarity=0.293 Sum_probs=86.6
Q ss_pred eEEEeecccCCceEEEEEEccCCceEEEEEecccc-------------------------hH--H--HHHHHHHHHhccC
Q 040656 35 EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-------------------------KK--K--IKREIKILQNLCG 85 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------------~~--~--~~~E~~~l~~l~~ 85 (332)
++-.+|..|.-+.||.|.. ..|..+|||++++.- ++ + ...|+..|.++ +
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N 224 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence 4556788999999999985 677889999987320 01 1 34578888888 4
Q ss_pred CCCeeeeeeeeeccCCCCceeEEeeecCCCcee-ecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhH
Q 040656 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKV-LYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWD 162 (332)
Q Consensus 86 h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 162 (332)
...|. +-.-..- ..-.|||+++....... .+. .++...+..+-.+++
T Consensus 225 ~aGIP-~PePIlL---k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v-------------------------- 274 (520)
T KOG2270|consen 225 NAGIP-CPEPILL---KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCV-------------------------- 274 (520)
T ss_pred hcCCC-CCCceee---ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHH--------------------------
Confidence 44432 2222111 13478999997544332 222 233333333333333
Q ss_pred HHHHHHH-HHcCCeecCCCCCCeeecCCCCeEEEEecccceee
Q 040656 163 LQALDYC-HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204 (332)
Q Consensus 163 ~~~l~~L-H~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~ 204 (332)
.-+.-| |..++||.||.-=|+|+. +| .+.++|-+.+...
T Consensus 275 -~~MR~lY~~c~LVHADLSEfN~Lyh-dG-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 275 -RIMRRLYQKCRLVHADLSEFNLLYH-DG-KLYIIDVSQSVEH 314 (520)
T ss_pred -HHHHHHHHHhceeccchhhhhheEE-CC-EEEEEEccccccC
Confidence 255555 678999999999999997 55 7999998877543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0037 Score=56.39 Aligned_cols=79 Identities=8% Similarity=0.144 Sum_probs=46.7
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCC-CCeeeeeee----eeccCCCCceeEEeee
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI----VRDQHSKTPSLIFEHV 111 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~----~~~~~~~~~~lv~e~~ 111 (332)
.+.++.|....+|+... ++..+++|++.......+..|..++..|..+ -.+.+.+.. ....-....+++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 45677787789998753 3346889987633445566677777777322 112233321 1111123468999999
Q ss_pred cCCCce
Q 040656 112 NSTDFK 117 (332)
Q Consensus 112 ~~~~l~ 117 (332)
+|....
T Consensus 105 ~G~~~~ 110 (319)
T PRK05231 105 EGKWPR 110 (319)
T ss_pred CCCCCC
Confidence 987643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0018 Score=53.67 Aligned_cols=102 Identities=23% Similarity=0.228 Sum_probs=71.4
Q ss_pred HHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcc
Q 040656 74 KREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLM 153 (332)
Q Consensus 74 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (332)
..|.-+++.+...+++++++|+| ...++.|+...+++......+ .+. ....|.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C------G~~~v~E~~~~~~~~~~~~~l---------~~~------------~~~~w~ 59 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC------GRFYVVEYVGAGSLYGIYRPL---------SQF------------LQSPWE 59 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC------CCEEEEEeecCcccccccccc---------ccc------------cccCHH
Confidence 45888888895557999999998 237789999876543211000 000 112444
Q ss_pred cchhhHHhHHHHHHHHHH---cCCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 154 ENQDISVWDLQALDYCHS---QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 154 ~~~~~~~~i~~~l~~LH~---~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
.+..++.++++.+.+++. ..+.-+|++++|+-++.++ ++|++|...+..
T Consensus 60 ~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~ 111 (188)
T PF12260_consen 60 QRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV 111 (188)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence 556677777779999976 3488899999999999655 799999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.012 Score=53.18 Aligned_cols=161 Identities=22% Similarity=0.239 Sum_probs=85.6
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCe-----eeeeeeeeccCCC--CceeEEe
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNI-----VKLLDIVRDQHSK--TPSLIFE 109 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~~~~~~~--~~~lv~e 109 (332)
..|.+ .-..||+... .+..+++|+.... ....+..|...++.|..+.-- ...-|-....-.. ...-+++
T Consensus 32 ~~l~s-~eN~~f~~~~--~~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 32 RGLNS-EENSNFRVQT--EDGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccccc-ccCceEEEEe--cCCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 33444 5567898764 3334499999875 667888999999998554222 2222211111122 6678999
Q ss_pred eecCCCcee-eccccchhhHHHHHHHHHhhcCCcc---eee--cCCC-----------CcccchhhHHhHHHHHHHHHH-
Q 040656 110 HVNSTDFKV-LYPTLTANEIRYYIYELLKHAMPRK---VII--MPGE-----------GLMENQDISVWDLQALDYCHS- 171 (332)
Q Consensus 110 ~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~-----------~~~~~~~~~~~i~~~l~~LH~- 171 (332)
+++|..+.. ... -....+...+..+-....... -.. .... ...........+...+..+.+
T Consensus 109 ~l~G~~~~~~~~~-~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 109 YLPGRPLERDDNA-EQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred ecCCcCcCCCCcH-HHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 999988874 210 011112222222211111100 000 0000 111122233333344444442
Q ss_pred -------cC--CeecCCCCCCeeecCCCCeEEEEecccce
Q 040656 172 -------QG--IMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202 (332)
Q Consensus 172 -------~~--ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~ 202 (332)
.+ +||+|+.|.||+++.++..+-++||+.+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 99999999999998665347899999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.04 Score=50.29 Aligned_cols=80 Identities=16% Similarity=0.174 Sum_probs=50.3
Q ss_pred CCCceEEEeecccCCceEEEEEEcc----CCceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVT----NNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.+...+.. |-.|-...+|++.... +++.+++|+...... -.-.+|..+++.+..+.--.++++.+ ++
T Consensus 36 ~~~~~i~~-l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~---- 108 (344)
T PLN02236 36 DEALQVIP-LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PN---- 108 (344)
T ss_pred cCcEEEEE-cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CC----
Confidence 34455554 4448888999886422 246899998764321 12367999999985544444566666 22
Q ss_pred eeEEeeecCCCce
Q 040656 105 SLIFEHVNSTDFK 117 (332)
Q Consensus 105 ~lv~e~~~~~~l~ 117 (332)
..|.+|+++..+.
T Consensus 109 g~v~efi~g~~l~ 121 (344)
T PLN02236 109 GRVEEFIHARTLS 121 (344)
T ss_pred ceEEEeeCCCCCC
Confidence 2589998775543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.028 Score=50.38 Aligned_cols=29 Identities=24% Similarity=0.595 Sum_probs=24.9
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccce
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~ 202 (332)
.+++|+|+.+.||+++. + .+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 47899999999999985 4 58999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.046 Score=49.58 Aligned_cols=79 Identities=18% Similarity=0.294 Sum_probs=49.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccC---CceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.+...+....| |-...+|++..... +..|++|+...... -.-.+|..+++.+..+.--.++++++ ++ .
T Consensus 14 ~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~----G 86 (330)
T PLN02421 14 DSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GN----G 86 (330)
T ss_pred cCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CC----c
Confidence 35566666555 77778898764322 24789998754222 23468999999985443334566665 22 2
Q ss_pred eEEeeecCCCc
Q 040656 106 LIFEHVNSTDF 116 (332)
Q Consensus 106 lv~e~~~~~~l 116 (332)
+|.+|+++..+
T Consensus 87 ~i~~fi~g~~l 97 (330)
T PLN02421 87 MIQSFINARTL 97 (330)
T ss_pred EeehhhcCCCC
Confidence 58888877654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.2 Score=44.90 Aligned_cols=167 Identities=16% Similarity=0.277 Sum_probs=88.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEec-----ccchHHHHHHHHHHHhccCC-CCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~~~ 105 (332)
....+++.+-.|-...+|.... +++.+++. .. .....+..+|..+++.+..- --+...++.|.+..-...+
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCCceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 4455566664444445555543 37778888 32 12335678899999987331 2233445566433224679
Q ss_pred eEEeeecCCCceeeccccch------hhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhH-----------------
Q 040656 106 LIFEHVNSTDFKVLYPTLTA------NEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWD----------------- 162 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i----------------- 162 (332)
.||+++.|............ ..+..++.++-...+....... ...-...-.+..+.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g-~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPG-KPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCC-ccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99999999644443322221 2333444444332211000000 00000011111111
Q ss_pred HHHHHHHHHc--------CCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 163 LQALDYCHSQ--------GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 163 ~~~l~~LH~~--------~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
.....+++.+ .++|+|+.+.|++++.++ .+=++||+.+..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence 1233445432 589999999999999777 488999999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.022 Score=51.12 Aligned_cols=30 Identities=17% Similarity=0.303 Sum_probs=26.0
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
+++|+|+.++|+|++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999998665 589999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.034 Score=46.88 Aligned_cols=140 Identities=16% Similarity=0.132 Sum_probs=64.1
Q ss_pred CceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHH
Q 040656 57 NEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYE 134 (332)
Q Consensus 57 ~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~ 134 (332)
++.|++++.... ..-.-..|..+++.+..+..-.++++.+.+ ..+.+|+++..+.... -........++..
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~------g~v~e~i~g~~l~~~~-~~~~~~~~~iA~~ 74 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN------GRVEEFIEGRTLSPED-FRNPEILKRIAKL 74 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT------EEEEE--SSEE--CGG-GGSHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC------CcEEEEecccccChhh-ccChHHHHHHHHH
Confidence 467888887644 334567889999988666556677777622 4677998766543321 0111223333333
Q ss_pred HHhhcCCcceeecCCCCc-------------------ccchhhH----HhHHHHHHHHH--------HcCCeecCCCCCC
Q 040656 135 LLKHAMPRKVIIMPGEGL-------------------MENQDIS----VWDLQALDYCH--------SQGIMHRDVKPHN 183 (332)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~-------------------~~~~~~~----~~i~~~l~~LH--------~~~ivHrdlkp~N 183 (332)
+...+....-.......+ ....... ..+..-+..+. ...+.|+|+.+.|
T Consensus 75 l~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~N 154 (211)
T PF01633_consen 75 LAKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGN 154 (211)
T ss_dssp HHHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGG
T ss_pred HHHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCcccc
Confidence 333222211000000000 0000000 00111122222 1357899999999
Q ss_pred eeecCCCCeEEEEeccccee
Q 040656 184 VMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~ 203 (332)
||++..++.++++||..|..
T Consensus 155 il~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 155 ILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEETSSSSCEEE--GTT-EE
T ss_pred EEeccCCCeEEEecHHHHhh
Confidence 99933444799999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.02 Score=52.74 Aligned_cols=77 Identities=18% Similarity=0.243 Sum_probs=52.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecc---------cchHHHHHHHHHHHhccCC-C-CeeeeeeeeeccC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---------VKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQH 100 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~ 100 (332)
+.+. .+.||.|.-..||++....+++.++||.-.+ -...+..-|.+.|+.+... | .+.+++.+- +
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~- 105 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--S- 105 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--c-
Confidence 4444 7788999999999998744467899998531 1235677788888876432 3 455566552 2
Q ss_pred CCCceeEEeeecC
Q 040656 101 SKTPSLIFEHVNS 113 (332)
Q Consensus 101 ~~~~~lv~e~~~~ 113 (332)
....++||+++.
T Consensus 106 -e~~~~vMEdL~~ 117 (409)
T PRK12396 106 -VMNCCVMEDLSD 117 (409)
T ss_pred -HHhhHHHHhCcc
Confidence 245778998854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.09 Score=48.66 Aligned_cols=81 Identities=17% Similarity=0.138 Sum_probs=50.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCC-c-----eEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNN-E-----KCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~-----~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.+..++. .|..|-...+|++...... . .|.+++..... --+-.+|..+++.+..+..-.++++.+.
T Consensus 50 ~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----- 123 (383)
T PTZ00384 50 PEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----- 123 (383)
T ss_pred cccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC-----
Confidence 3445555 4444888899988643221 2 25555432211 1234679999999966666677888872
Q ss_pred CceeEEeeecCCCcee
Q 040656 103 TPSLIFEHVNSTDFKV 118 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~ 118 (332)
-+++.|+++|..+..
T Consensus 124 -~g~l~efIeGr~l~~ 138 (383)
T PTZ00384 124 -DFTIQEWVEGNTMGI 138 (383)
T ss_pred -CEEEEEEeccccCCh
Confidence 268999999876543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.039 Score=50.25 Aligned_cols=71 Identities=17% Similarity=0.290 Sum_probs=46.9
Q ss_pred eecccCCceEEEEEEccCCceEEEEEecc----------cchHHHHHHHHHHHhccCC-C-CeeeeeeeeeccCCCCcee
Q 040656 39 KVGRGKYSEVFEGINVTNNEKCIIKILKP----------VKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~~~l 106 (332)
.||.|.-..||++....+++.++||.-.+ -...+..-|.+.|+..... | .+.+++.+- + ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~--e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--T--EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--c--cccee
Confidence 57999999999998643346899998531 1224566788888776432 3 455566553 2 24568
Q ss_pred EEeeecC
Q 040656 107 IFEHVNS 113 (332)
Q Consensus 107 v~e~~~~ 113 (332)
+||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.15 Score=45.18 Aligned_cols=77 Identities=14% Similarity=0.185 Sum_probs=48.8
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhcc--CCCCeeeeeeeeeccCCCCceeEEeee
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
-+-.+.++.|.-+.+|+.. .+++.+.+|+-.......+..|.+-|+.|. ..-.+.+++++.... ...++++|++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEee
Confidence 4556778888999999875 678889999987666678999999998883 234566677776433 3459999999
Q ss_pred cCC
Q 040656 112 NST 114 (332)
Q Consensus 112 ~~~ 114 (332)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.19 Score=52.66 Aligned_cols=79 Identities=15% Similarity=0.240 Sum_probs=46.0
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCC------CCeeeee-ee----eeccCC-CCc
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGG------PNIVKLL-DI----VRDQHS-KTP 104 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h------~niv~~~-~~----~~~~~~-~~~ 104 (332)
+.|+ |..-.+|+.. ..++..+++|+.+.. .......|...+..|..+ |.+++.. |- ..+.++ ...
T Consensus 31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEE-eCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 5565 4557788875 356778999999754 333455666777766432 2333321 11 111111 145
Q ss_pred eeEEeeecCCCcee
Q 040656 105 SLIFEHVNSTDFKV 118 (332)
Q Consensus 105 ~lv~e~~~~~~l~~ 118 (332)
+.+++|.+|..+..
T Consensus 109 vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 109 LRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEeccCCCcHHh
Confidence 67899999977654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.55 Score=41.43 Aligned_cols=31 Identities=32% Similarity=0.670 Sum_probs=25.2
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
.++|+|+.|.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999985443456999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.25 Score=44.70 Aligned_cols=76 Identities=13% Similarity=0.165 Sum_probs=43.5
Q ss_pred eecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCC-Ceeeee---eeeeccCCCCceeEEeeec
Q 040656 39 KVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLL---DIVRDQHSKTPSLIFEHVN 112 (332)
Q Consensus 39 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~~~---~~~~~~~~~~~~lv~e~~~ 112 (332)
.|+ +.-..||+... .++..+++|+.++. ....+..|...+..|..+. .++... |-....-+...+.++++.+
T Consensus 33 ~l~-s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 33 ALN-SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred eec-cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 344 33457888753 56678999998643 3566788988888874321 112211 1000011234567888888
Q ss_pred CCCc
Q 040656 113 STDF 116 (332)
Q Consensus 113 ~~~l 116 (332)
|...
T Consensus 111 G~~~ 114 (325)
T PRK11768 111 GRAP 114 (325)
T ss_pred CCCC
Confidence 7654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.34 Score=45.01 Aligned_cols=73 Identities=15% Similarity=0.232 Sum_probs=50.7
Q ss_pred EEEeecccCCceEEEEEEccCCceEEEEEecc----------cchHHHHHHHHHHHhccC--CCCeeeeeeeeeccCCCC
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----------VKKKKIKREIKILQNLCG--GPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~--h~niv~~~~~~~~~~~~~ 103 (332)
..+.||.|....||+... .+..++||.-.. -...+-..|...|+.+.. ..++.+++.++.+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 477889999999999865 456788998541 123445566777776632 2477788888743 3
Q ss_pred ceeEEeeecCC
Q 040656 104 PSLIFEHVNST 114 (332)
Q Consensus 104 ~~lv~e~~~~~ 114 (332)
.+++||+++++
T Consensus 110 ~vlvME~L~~~ 120 (418)
T PLN02756 110 ALIGMRYLEPP 120 (418)
T ss_pred CEEEEeecCCc
Confidence 58899999773
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.076 Score=54.69 Aligned_cols=150 Identities=15% Similarity=0.208 Sum_probs=90.7
Q ss_pred HHHHHHHhccCCCCeeeeeeeeecc-CCC-CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCC
Q 040656 75 REIKILQNLCGGPNIVKLLDIVRDQ-HSK-TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPG 149 (332)
Q Consensus 75 ~E~~~l~~l~~h~niv~~~~~~~~~-~~~-~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (332)
.|...+.+. .|+|+..++.+-... ... ...+..+++...++...+ ...+...++.+..+...
T Consensus 231 ~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~------------ 297 (1351)
T KOG1035|consen 231 IELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLE------------ 297 (1351)
T ss_pred HHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhh------------
Confidence 456667777 899999988875322 111 122345556555554443 34566666666666665
Q ss_pred CCcccchhhHHhHHHHHHHHHHcCCeecCCCCC---CeeecCCCCeEEEE--ecccceeecCCCcccccccccceecccc
Q 040656 150 EGLMENQDISVWDLQALDYCHSQGIMHRDVKPH---NVMIDHEQQKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPEL 224 (332)
Q Consensus 150 ~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~---Nilv~~~~~~vkL~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~ 224 (332)
|++++|+....|.-|... +-.++.++ .+... ||+................+.-+.++|.
T Consensus 298 ---------------GL~~~h~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~ 361 (1351)
T KOG1035|consen 298 ---------------GLAYLHSLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADED 361 (1351)
T ss_pred ---------------hHHHHHHhccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccc
Confidence 999999986655554444 33333333 34444 7777765553333333334444667776
Q ss_pred ccCCCC--CCCcccHHHHHHHHHHHHhCCCCC
Q 040656 225 LVDLQD--YDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 225 ~~~~~~--~~~~sDiwSlG~il~elltg~~pf 254 (332)
... .. .+...|+|.+|.....+..|..+-
T Consensus 362 ~~~-~~~~~~r~~dL~~lgll~~~~~~~~~i~ 392 (1351)
T KOG1035|consen 362 LKE-NTAKKSRLTDLWCLGLLLLQLSQGEDIS 392 (1351)
T ss_pred ccc-ccchhhhhhHHHHHHHHHhhhhhcCccc
Confidence 643 22 334579999999999998876554
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.08 Score=50.10 Aligned_cols=44 Identities=23% Similarity=0.394 Sum_probs=33.4
Q ss_pred chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCC
Q 040656 69 KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST 114 (332)
Q Consensus 69 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 114 (332)
....+.....+++.+ .|+|....+++-...+. ...+|+|++...
T Consensus 25 ~s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~-r~IVV~e~~~~S 68 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSL-QHDNLCQYLDFSRGKHE-RVIVVMEHYTMS 68 (725)
T ss_pred cHHHHhhhhHHHHhh-cCccceeeEeeecCccc-eEEEEehhhccc
Confidence 445667778888888 99999999988766554 477889987643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.0027 Score=66.55 Aligned_cols=153 Identities=10% Similarity=-0.063 Sum_probs=97.2
Q ss_pred HHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeec-c---ccch--hhHHHHHHHHHhhcCCcceee
Q 040656 73 IKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY-P---TLTA--NEIRYYIYELLKHAMPRKVII 146 (332)
Q Consensus 73 ~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~---~~~~--~~~~~~~~~~~~~~~~~~~~~ 146 (332)
...|...++.. .|+++...+.-.....+...+..++++.+|.+...+ . ..+. +.......++.
T Consensus 1276 ll~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvs---------- 1344 (2724)
T KOG1826|consen 1276 LLSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVS---------- 1344 (2724)
T ss_pred hhhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHH----------
Confidence 33444455556 788887766655444455567778888777665543 1 1111 11111111110
Q ss_pred cCCCCcccchhhHHhHHHHHHHHHHc-----CCeecCCCCCCeeecCCCCeEEEEecccceeecCCC-ccccccccccee
Q 040656 147 MPGEGLMENQDISVWDLQALDYCHSQ-----GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFK 220 (332)
Q Consensus 147 ~~~~~~~~~~~~~~~i~~~l~~LH~~-----~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~ 220 (332)
+....-.|+. -.+|++||+-|-++..+. .+++.++|+.+...+.. ......+++.|+
T Consensus 1345 ----------------vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v 1407 (2724)
T KOG1826|consen 1345 ----------------VLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYV 1407 (2724)
T ss_pred ----------------HhccchhhhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHH
Confidence 1133333322 268999999999998666 69999999999443332 334457778888
Q ss_pred ccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 221 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 221 aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
+|+.... -.++.++|+|+.|+.+|+.--|..+|
T Consensus 1408 ~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1408 LQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 8887655 45777899999999999988777666
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.78 Score=48.01 Aligned_cols=79 Identities=8% Similarity=0.156 Sum_probs=44.4
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCC---CCeeeeeee--------eeccCCCCc
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGG---PNIVKLLDI--------VRDQHSKTP 104 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h---~niv~~~~~--------~~~~~~~~~ 104 (332)
...|+++. -.+|+... ++..+++|+.... ....+..|...+..|... -.+.+.+-. .........
T Consensus 36 ~~~L~s~~-d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~ 112 (972)
T PRK06149 36 LTELGSQQ-DRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLR 112 (972)
T ss_pred EEecCCcC-cceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEE
Confidence 35565433 36787653 3357888998743 345677788888777443 122222211 111122345
Q ss_pred eeEEeeecCCCcee
Q 040656 105 SLIFEHVNSTDFKV 118 (332)
Q Consensus 105 ~lv~e~~~~~~l~~ 118 (332)
+.+++|++|..+..
T Consensus 113 vrL~~~l~G~~~~~ 126 (972)
T PRK06149 113 VRLLDYLPGQPLTR 126 (972)
T ss_pred EEEEEecCCccccc
Confidence 67899999876543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.1 Score=48.04 Aligned_cols=54 Identities=26% Similarity=0.375 Sum_probs=35.1
Q ss_pred EeecccCCceEEEEEE---------------ccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeee
Q 040656 38 RKVGRGKYSEVFEGIN---------------VTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 91 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~---------------~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~ 91 (332)
.-||+|+=+.||+|.. ..+.+.||+|+..+.-.+.+.....+|.....-+|+++
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP 263 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVP 263 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcC
Confidence 4689999999998752 23456799999976655555555555554433334333
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.07 E-value=0.029 Score=42.70 Aligned_cols=45 Identities=18% Similarity=0.396 Sum_probs=38.6
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhc
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNL 83 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l 83 (332)
+-||+|+-|.||+|+. .+|+.||||+.++.-...+...+.+++.+
T Consensus 17 ~PlasASiaQVh~a~l-~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 17 EPLASASIAQVHRARL-KDGEEVAVKVQRPGIEEQIEADLRILRRL 61 (119)
T ss_pred chhhheehhhheeeee-cccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence 5689999999999985 45999999999887777888888888776
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.42 Score=40.48 Aligned_cols=86 Identities=21% Similarity=0.277 Sum_probs=56.4
Q ss_pred hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCC
Q 040656 70 KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149 (332)
Q Consensus 70 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (332)
..-+..+..++.++ -.|+++.. .+...+.++.|.|-.... ...-.+.. -+
T Consensus 102 ~~~y~nky~v~Arm---hGilrL~N----Dn~~~yGvIlE~Cy~~~i---------~~~N~i~a-gi------------- 151 (308)
T PF07387_consen 102 DALYFNKYRVFARM---HGILRLKN----DNNYKYGVILERCYKIKI---------NFSNFITA-GI------------- 151 (308)
T ss_pred hhhhhhhhhHHHHh---hheeEeec----CCCceeEEEEeeccCccc---------chhHHHHH-hH-------------
Confidence 45678888898887 25666652 344557788888753211 11111111 01
Q ss_pred CCcccchhhHHhHHHHHHHHHH--cCCeecCCCCCCeeecCCCCeEEEEeccc
Q 040656 150 EGLMENQDISVWDLQALDYCHS--QGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200 (332)
Q Consensus 150 ~~~~~~~~~~~~i~~~l~~LH~--~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~ 200 (332)
.+|...|+ .+.+|+|-+|+|||-|..| -+||.|-+.
T Consensus 152 --------------~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~ 189 (308)
T PF07387_consen 152 --------------KDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVC 189 (308)
T ss_pred --------------HHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhh
Confidence 26777784 4699999999999999777 599999764
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 332 | ||||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-128 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-127 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-127 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-127 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-127 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-127 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-126 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-126 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-126 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-126 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-109 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-109 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-109 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-109 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-109 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-109 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-109 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-109 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-109 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-108 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-108 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-108 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-108 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-108 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-108 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-103 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-102 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-24 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-22 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-22 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-22 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-22 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-21 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-21 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-21 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-21 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-21 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-21 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-21 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-21 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-21 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-21 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-21 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-21 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-21 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-21 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-21 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-21 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-21 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-20 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-20 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-20 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-20 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-20 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-20 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-20 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-20 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-19 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-18 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-12 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-12 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-04 |
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 454 bits (1169), Expect = e-162
Identities = 208/298 (69%), Positives = 242/298 (81%), Gaps = 27/298 (9%)
Query: 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI 61
SRARVY DVN HRPR+YWDYES V+WG+Q+DY++VRK+GRGKYSEVFE IN+TNNEK +
Sbjct: 6 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 65
Query: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP 121
+KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVN+TDFK LY
Sbjct: 66 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 125
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
TLT +IR+Y+YE+LK ALDYCHS GIMHRDVKP
Sbjct: 126 TLTDYDIRFYMYEILK---------------------------ALDYCHSMGIMHRDVKP 158
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
HNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLG
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKR 299
CM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DKY++ELDP+ ++GR
Sbjct: 219 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 276
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 9e-52
Identities = 73/251 (29%), Positives = 119/251 (47%), Gaps = 42/251 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKL 92
Y + +G G + V++ + E IK +L+ K+ RE++I++ L NIV+L
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQIMRKL-DHCNIVRL 112
Query: 93 LDIVRDQHSKTPS----LIFEHVNSTDFKVLYP------TLTANEIRYYIYELLKHAMPR 142
K L+ ++V T ++V TL ++ Y+Y+L +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR----- 167
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+L Y HS GI HRD+KP N+++D + L+L D+G A+
Sbjct: 168 ----------------------SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
G+ + SRY++ PEL+ DY S+D+WS GC+ A ++ + P F G D
Sbjct: 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD 264
Query: 263 QLVKIARVLGT 273
QLV+I +VLGT
Sbjct: 265 QLVEIIKVLGT 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-51
Identities = 75/253 (29%), Positives = 123/253 (48%), Gaps = 41/253 (16%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 90
+ Y + +G G + VF+ V ++E I K+L+ K+ RE++I++ + PN+V
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHPNVV 95
Query: 91 KLLDIVRDQHSKTPS----LIFEHVNSTDFKVL--YP----TLTANEIRYYIYELLKHAM 140
L K L+ E+V T ++ Y T+ I+ Y+Y+LL+
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR--- 152
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+L Y HS GI HRD+KP N+++D L+LID+G
Sbjct: 153 ------------------------SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188
Query: 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
A+ G+ + SRY++ PEL+ +Y ++D+WS GC+ A ++ + P F G
Sbjct: 189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESG 247
Query: 261 QDQLVKIARVLGT 273
DQLV+I +VLGT
Sbjct: 248 IDQLVEIIKVLGT 260
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-49
Identities = 77/270 (28%), Positives = 122/270 (45%), Gaps = 41/270 (15%)
Query: 13 HRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK 72
H D + + + E YE + VG G Y V + N IK K
Sbjct: 6 HHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK 65
Query: 73 -IK----REIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPT-LT 124
+K REIK+L+ L N+V LL++ + K L+FE V+ T L +P L
Sbjct: 66 MVKKIAMREIKLLKQLRH-ENLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLD 122
Query: 125 ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184
++ Y+++++ + +CHS I+HRD+KP N+
Sbjct: 123 YQVVQKYLFQII---------------------------NGIGFCHSHNIIHRDIKPENI 155
Query: 185 MIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
++ ++L D+G A PG+ Y+ VA+R+++ PELLV Y ++D+W++GC+
Sbjct: 156 LVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCL 214
Query: 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
M F EP F G + DQL I LG
Sbjct: 215 VTEM-FMGEPLFPGDSDIDQLYHIMMCLGN 243
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-49
Identities = 72/259 (27%), Positives = 116/259 (44%), Gaps = 57/259 (22%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIK 78
E YE + K+G G Y VF+ N + IK K REI+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54
Query: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPT-LTANEIRYYIYEL 135
+L+ L PN+V LL++ R + L+FE+ + T L Y + + ++ ++
Sbjct: 55 MLKQLKH-PNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L QA+++CH +HRDVKP N++I ++L
Sbjct: 112 L---------------------------QAVNFCHKHNCIHRDVKPENILITKHSV-IKL 143
Query: 196 IDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
D+G A P Y+ VA+R+++ PELLV Y +D+W++GC+FA ++ P
Sbjct: 144 CDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL-SGVPL 202
Query: 255 FYGHDNQDQLVKIARVLGT 273
+ G + DQL I + LG
Sbjct: 203 WPGKSDVDQLYLIRKTLGD 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-48
Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 58/260 (22%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIK 78
+ YE + K+G G Y VF+ N +E V K+++ REI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53
Query: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYE 134
+L+ L NIV+L D++ T L+FE D K L ++ ++++
Sbjct: 54 LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 135 LLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
LLK L +CHS+ ++HRD+KP N++I+ + L+
Sbjct: 110 LLK---------------------------GLGFCHSRNVLHRDLKPQNLLINRNGE-LK 141
Query: 195 LIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
L ++GLA + P + Y+ V + +++ P++L + Y S+DMWS GC+FA + P
Sbjct: 142 LANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
Query: 254 FFYGHDNQDQLVKIARVLGT 273
F G+D DQL +I R+LGT
Sbjct: 202 LFPGNDVDDQLKRIFRLLGT 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-48
Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 44/257 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK--ILKPVKKKKIKREIKILQNLCGGPNI 89
+ ++V R G+G + V G + IK I P + + + ++ L L PNI
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNI 81
Query: 90 VKLLDIVRDQHSKTPS-----LIFEHVNSTDFKVL--YP----TLTANEIRYYIYELLKH 138
V+L + ++ E+V T + Y I+ ++++L++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR- 140
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCH--SQGIMHRDVKPHNVMIDHEQQKLRLI 196
++ H S + HRD+KPHNV+++ L+L
Sbjct: 141 --------------------------SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 197 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
D+G A+ P + + SRY++ PEL+ Q Y ++D+WS+GC+FA M+ + P F
Sbjct: 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFR 233
Query: 257 GHDNQDQLVKIARVLGT 273
G ++ QL +I RVLG
Sbjct: 234 GDNSAGQLHEIVRVLGC 250
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-47
Identities = 69/265 (26%), Positives = 122/265 (46%), Gaps = 61/265 (23%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------RE 76
+ Y + K+G G Y EV++ I+ NE V K+I+ RE
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIRE 83
Query: 77 IKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIY 133
+ +L+ L NI++L ++ H LIFE+ D K P ++ I+ ++Y
Sbjct: 84 VSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYA-ENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 134 ELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQK- 192
+L+ +++CHS+ +HRD+KP N+++
Sbjct: 140 QLIN---------------------------GVNFCHSRRCLHRDLKPQNLLLSVSDASE 172
Query: 193 ---LRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248
L++ D+GLA + P +++ + + +++ PE+L+ + Y S+D+WS+ C++A M+
Sbjct: 173 TPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 249 FRKEPFFYGHDNQDQLVKIARVLGT 273
K P F G DQL KI VLG
Sbjct: 233 -MKTPLFPGDSEIDQLFKIFEVLGL 256
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-47
Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 60/260 (23%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIK 78
E Y + K+G G Y V++ N + KKI+ REI
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG---------ETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYE 134
IL+ L NIVKL D++ + L+FEH+ D K L L + + ++ +
Sbjct: 53 ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 135 LLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
LL + YCH + ++HRD+KP N++I+ E + L+
Sbjct: 109 LLN---------------------------GIAYCHDRRVLHRDLKPQNLLINREGE-LK 140
Query: 195 LIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
+ D+GLA + P ++Y + + +++ P++L+ + Y ++D+WS+GC+FA M+ P
Sbjct: 141 IADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTP 199
Query: 254 FFYGHDNQDQLVKIARVLGT 273
F G DQL++I R+LGT
Sbjct: 200 LFPGVSEADQLMRIFRILGT 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-47
Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 72/284 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 91
+ Y + + +G G + V E ++ + ++ +K + + K RE+ I++ L NI+K
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLD-HVNIIK 64
Query: 92 LLDIVRDQHSKTPS------------------------------------LIFEHVNSTD 115
L+D + P +I E+V T
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 116 FKVLYP------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYC 169
KVL ++ N I YIY+L + A+ +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFR---------------------------AVGFI 157
Query: 170 HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 229
HS GI HRD+KP N++++ + L+L D+G A+ P + + SR+++ PEL++
Sbjct: 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAT 217
Query: 230 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
+Y S+D+WS+GC+F +I K P F G + DQLV+I +++GT
Sbjct: 218 EYTPSIDLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGT 260
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 60/263 (22%)
Query: 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------R 75
G E Y+ + KVG G Y V++ + + V K+I+ R
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQG---------RIVALKRIRLDAEDEGIPSTAIR 68
Query: 76 EIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYY 131
EI +L+ L PNIV L+D++ + T L+FE + D K + L ++I+ Y
Sbjct: 69 EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFM-EKDLKKVLDENKTGLQDSQIKIY 124
Query: 132 IYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191
+Y+LL+ + +CH I+HRD+KP N++I+ +
Sbjct: 125 LYQLLR---------------------------GVAHCHQHRILHRDLKPQNLLINSDGA 157
Query: 192 KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250
L+L D+GLA + P + Y V + +++ P++L+ + Y S+D+WS+GC+FA MI
Sbjct: 158 -LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
Query: 251 KEPFFYGHDNQDQLVKIARVLGT 273
K P F G + DQL KI +LGT
Sbjct: 217 K-PLFPGVTDDDQLPKIFSILGT 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 73/259 (28%), Positives = 125/259 (48%), Gaps = 58/259 (22%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK------------REIKI 79
E Y + K+G G Y+ V++G + + V K+I+ RE+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYEL 135
L++L NIV L DI+ + S T L+FE+++ D K + + ++ ++++L
Sbjct: 54 LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L + L YCH Q ++HRD+KP N++I+ + L+L
Sbjct: 110 L---------------------------RGLAYCHRQKVLHRDLKPQNLLINERGE-LKL 141
Query: 196 IDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
D+GLA P K Y+ V + +++ P++L+ DY +DMW +GC+F M + P
Sbjct: 142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR-PL 200
Query: 255 FYGHDNQDQLVKIARVLGT 273
F G ++QL I R+LGT
Sbjct: 201 FPGSTVEEQLHFIFRILGT 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 67/269 (24%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK----------------R 75
YE V ++G G Y V++ + + V K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60
Query: 76 EIKILQNLCGG--PNIVKLLDIVRDQHSKTPS---LIFEHVNSTDFKVL-----YPTLTA 125
E+ +L+ L PN+V+L+D+ + L+FEHV D + P L A
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPA 119
Query: 126 NEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185
I+ + + L+ LD+ H+ I+HRD+KP N++
Sbjct: 120 ETIKDLMRQFLR---------------------------GLDFLHANCIVHRDLKPENIL 152
Query: 186 IDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMF 244
+ ++L D+GLA Y V + +++ PE+L LQ Y +DMWS+GC+F
Sbjct: 153 VTSGGT-VKLADFGLARIYSYQMALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIF 209
Query: 245 AGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
A M FR++P F G+ DQL KI ++G
Sbjct: 210 AEM-FRRKPLFCGNSEADQLGKIFDLIGL 237
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-46
Identities = 70/263 (26%), Positives = 126/263 (47%), Gaps = 61/263 (23%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK------------REIKI 79
++ + K+G G Y+ V++G+N T V K++K REI +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV--------NSTDFKVLYPTLTANEIRYY 131
++ L NIV+L D++ ++ T L+FE + +S L N ++Y+
Sbjct: 57 MKELKH-ENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 132 IYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ 191
++LL+ L +CH I+HRD+KP N++I+ Q
Sbjct: 114 QWQLLQ---------------------------GLAFCHENKILHRDLKPQNLLINKRGQ 146
Query: 192 KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250
L+L D+GLA + P ++ V + +++ P++L+ + Y S+D+WS GC+ A MI
Sbjct: 147 -LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-T 204
Query: 251 KEPFFYGHDNQDQLVKIARVLGT 273
+P F G ++++QL I ++GT
Sbjct: 205 GKPLFPGTNDEEQLKLIFDIMGT 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 79/256 (30%), Positives = 128/256 (50%), Gaps = 48/256 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK--------REIKILQNL 83
+ YE + +G G+++ V++ + N+ IK +K + + K REIK+LQ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 84 CGGPNIVKLLDIVRDQHSKTP-SLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKH 138
PNI+ LLD K+ SL+F+ + TD +V+ LT + I+ Y+ L+
Sbjct: 70 SH-PNIIGLLDAF---GHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQ- 123
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
L+Y H I+HRD+KP+N+++D L+L D+
Sbjct: 124 --------------------------GLEYLHQHWILHRDLKPNNLLLDENGV-LKLADF 156
Query: 199 GLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
GLA F P + Y +V +R+++ PELL + Y +DMW++GC+ A ++ R PF G
Sbjct: 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPG 215
Query: 258 HDNQDQLVKIARVLGT 273
+ DQL +I LGT
Sbjct: 216 DSDLDQLTRIFETLGT 231
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-45
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 63/266 (23%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIK 78
+ YE V ++G G Y +VF+ ++ N + V K+++ RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63
Query: 79 ILQNLCGG--PNIVKLLDIVRDQHSKTPS---LIFEHVNSTDFKVL-----YPTLTANEI 128
+L++L PN+V+L D+ + + L+FEHV D P + I
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 129 RYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188
+ +++LL+ LD+ HS ++HRD+KP N+++
Sbjct: 123 KDMMFQLLR---------------------------GLDFLHSHRVVHRDLKPQNILVTS 155
Query: 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGM 247
Q ++L D+GLA Y V + +++ PE+L LQ Y +D+WS+GC+FA M
Sbjct: 156 SGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM 212
Query: 248 IFRKEPFFYGHDNQDQLVKIARVLGT 273
FR++P F G + DQL KI V+G
Sbjct: 213 -FRRKPLFRGSSDVDQLGKILDVIGL 237
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 74/270 (27%), Positives = 114/270 (42%), Gaps = 67/270 (24%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK-------------REIK 78
YE + K+G+G + EVF+ + +K V KK+ REIK
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68
Query: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPS------LIFEHVNSTDFKVL----YPTLTANEI 128
ILQ L N+V L++I R + S L+F+ D L T +EI
Sbjct: 69 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEI 126
Query: 129 RYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188
+ + LL L Y H I+HRD+K NV+I
Sbjct: 127 KRVMQMLLN---------------------------GLYYIHRNKILHRDMKAANVLITR 159
Query: 189 EQQKLRLIDWGLAEFYH-----PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
+ L+L D+GLA + Y RV + +++ PELL+ +DY +D+W GC+
Sbjct: 160 DGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218
Query: 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
A M + + P G+ Q QL I+++ G+
Sbjct: 219 MAEM-WTRSPIMQGNTEQHQLALISQLCGS 247
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-42
Identities = 70/270 (25%), Positives = 127/270 (47%), Gaps = 43/270 (15%)
Query: 14 RPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK-- 70
R + ++ + W + Y VG G Y V I+ + EK IK + +P +
Sbjct: 6 RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65
Query: 71 --KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS----LIFEHVNSTDFKVLYPTLT 124
K+ RE+ +L+++ N++ LLD+ S L+ + + K++ +
Sbjct: 66 FAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS 124
Query: 125 ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184
+I+Y +Y++LK L Y HS G++HRD+KP N+
Sbjct: 125 EEKIQYLVYQMLK---------------------------GLKYIHSAGVVHRDLKPGNL 157
Query: 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
++ E +L+++D+GLA Y V +R+++ PE+++ Y+ ++D+WS+GC+
Sbjct: 158 AVN-EDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCI 213
Query: 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
A M+ K F G D DQL +I +V G
Sbjct: 214 MAEMLTGK-TLFKGKDYLDQLTQILKVTGV 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-42
Identities = 61/260 (23%), Positives = 108/260 (41%), Gaps = 49/260 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 90
Y ++ +G G VF ++ +++ IK + P K REIKI++ L NIV
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP-------------TLTANEIRYYIYELLK 137
K+ +I+ S+ + ++ L R ++Y+LL+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
L Y HS ++HRD+KP N+ I+ E L++ D
Sbjct: 132 ---------------------------GLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164
Query: 198 WGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
+GLA P + + +++++ P LL+ +Y ++DMW+ GC+FA M+ K
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-T 223
Query: 254 FFYGHDNQDQLVKIARVLGT 273
F G +Q+ I +
Sbjct: 224 LFAGAHELEQMQLILESIPV 243
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 68/270 (25%), Positives = 123/270 (45%), Gaps = 57/270 (21%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 86
YE+V+K+G+G Y V++ I+ E +K I + ++ REI IL L G
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY-PTLTANEIRYYIYELLKHAMPRKVI 145
NIV LL+++R + + L+F+++ + V+ L +Y +Y+L+K
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIK-------- 120
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
+ Y HS G++HRD+KP N++++ + +++ D+GL+ +
Sbjct: 121 -------------------VIKYLHSGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFV 160
Query: 206 PGKEYNVR----------------------VASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
+ VA+R+++ PE+L+ Y +DMWSLGC+
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
++ K P F G +QL +I V+
Sbjct: 221 LGEILCGK-PIFPGSSTMNQLERIIGVIDF 249
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-40
Identities = 67/253 (26%), Positives = 123/253 (48%), Gaps = 44/253 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 86
Y ++ VG G Y V ++ K IK + +P + K+ RE+++L+++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83
Query: 87 PNIVKLLDIVRDQHSKTPS----LIFEHVNSTDFKVLYP-TLTANEIRYYIYELLKHAMP 141
N++ LLD+ + L+ + + K++ L + I++ +Y++LK
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK---- 139
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 140 -----------------------GLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLA 175
Query: 202 EFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
Y V +R+++ PE++++ Y ++D+WS+GC+ A MI K F G D+
Sbjct: 176 RQADSEMTGY---VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDH 231
Query: 261 QDQLVKIARVLGT 273
DQL +I +V GT
Sbjct: 232 LDQLKEIMKVTGT 244
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 61/270 (22%), Positives = 118/270 (43%), Gaps = 40/270 (14%)
Query: 13 HRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK- 70
R +++ E + + Y+ ++ +G G V + IK + +P +
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ 65
Query: 71 ---KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS----LIFEHVNSTDFKVLYPTL 123
K+ RE+ +++ + NI+ LL++ Q S ++ E +++ +V+ L
Sbjct: 66 THAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 124 TANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183
+ Y +Y++L + + HS GI+HRD+KP N
Sbjct: 125 DHERMSYLLYQMLC---------------------------GIKHLHSAGIIHRDLKPSN 157
Query: 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
+++ L+++D+GLA V +RY++ PE+++ Y ++D+WS+GC+
Sbjct: 158 IVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCI 215
Query: 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
MI F G D+ DQ K+ LGT
Sbjct: 216 MGEMIKGG-VLFPGTDHIDQWNKVIEQLGT 244
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 49/279 (17%)
Query: 14 RPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--- 70
+ + + Q Y V R + G Y V G++ I ++ V
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63
Query: 71 ----------KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS---LIFEHVNSTDFK 117
K++ REI++L + PNI+ L DI L+ E + + +
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 118 VLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174
V++ ++ I+Y++Y +L L H G+
Sbjct: 123 VIHDQRIVISPQHIQYFMYHILL---------------------------GLHVLHEAGV 155
Query: 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 234
+HRD+ P N+++ + + + D+ LA V R+++ PEL++ + +
Sbjct: 156 VHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL 214
Query: 235 LDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
+DMWS GC+ A M RK F G +QL KI V+GT
Sbjct: 215 VDMWSAGCVMAEMFNRK-ALFRGSTFYNQLNKIVEVVGT 252
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 66/267 (24%), Positives = 121/267 (45%), Gaps = 49/267 (18%)
Query: 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KKIKREIKILQ 81
+ + D+++ +G G Y V + E IK ++P K + REIKIL+
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPS---LIFEHVNSTDFKVLYP-TLTANEIRYYIYELLK 137
+ NI+ + +I R + + +I E + + +V+ L+ + I+Y+IY+ L+
Sbjct: 65 HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
A+ H ++HRD+KP N++I+ L++ D
Sbjct: 124 ---------------------------AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCD 155
Query: 198 WGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246
+GLA N VA+R+++ PE+++ Y ++D+WS GC+ A
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215
Query: 247 MIFRKEPFFYGHDNQDQLVKIARVLGT 273
+ R+ P F G D + QL+ I ++GT
Sbjct: 216 LFLRR-PIFPGRDYRHQLLLIFGIIGT 241
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 63/251 (25%), Positives = 121/251 (48%), Gaps = 44/251 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 88
Y+ + VG G Y V + + +K L + K+ RE+++L+++ N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-EN 89
Query: 89 IVKLLDIVRDQHSKTPS----LIFEHVNSTDFKVLYP-TLTANEIRYYIYELLKHAMPRK 143
++ LLD+ S L+ + + ++ LT + +++ IY++L+
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR------ 143
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
L Y HS I+HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 144 ---------------------GLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARH 181
Query: 204 YHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
Y VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ D
Sbjct: 182 TADEMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHID 237
Query: 263 QLVKIARVLGT 273
QL I R++GT
Sbjct: 238 QLKLILRLVGT 248
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 42/254 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 87
Y + +G G Y V + N + IK + P + ++ REIKIL
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE 85
Query: 88 NIVKLLDIVRDQHSKTPS---LIFEHVNSTDFKVLY-PTLTANEIRYYIYELLKHAMPRK 143
NI+ + DI+R + ++ + + + +K+L L+ + I Y++Y++L+
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR------ 139
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
L Y HS ++HRD+KP N++++ L++ D+GLA
Sbjct: 140 ---------------------GLKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARV 177
Query: 204 YHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
P ++ VA+R+++ PE++++ + Y S+D+WS+GC+ A M+ + P F G
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKH 236
Query: 260 NQDQLVKIARVLGT 273
DQL I +LG+
Sbjct: 237 YLDQLNHILGILGS 250
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 61/273 (22%), Positives = 118/273 (43%), Gaps = 46/273 (16%)
Query: 13 HRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK- 70
++ E + + Y+ ++ +G G V + + IK + +P +
Sbjct: 43 KVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ 102
Query: 71 ---KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS----LIFEHVNSTDFKVLYPTL 123
K+ RE+ +++ + NI+ LL++ Q + L+ E +++ +V+ L
Sbjct: 103 THAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 124 TANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183
+ Y +Y++L + + HS GI+HRD+KP N
Sbjct: 162 DHERMSYLLYQMLC---------------------------GIKHLHSAGIIHRDLKPSN 194
Query: 184 VMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240
+++ L+++D+GLA Y V +RY++ PE+++ Y ++D+WS+
Sbjct: 195 IVVK-SDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILG-MGYKENVDIWSV 249
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273
GC+ M+ K F G D DQ K+ LGT
Sbjct: 250 GCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGT 281
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 60/281 (21%), Positives = 115/281 (40%), Gaps = 74/281 (26%)
Query: 31 QEDYEVVR-KVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK---------REIKIL 80
++ +E KVGRG Y V++ + + K+I+ REI +L
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIALL 72
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL------------YPTLTANEI 128
+ L PN++ L + + L+F++ D + L +
Sbjct: 73 RELKH-PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 129 RYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188
+ +Y++L + Y H+ ++HRD+KP N+++
Sbjct: 131 KSLLYQILD---------------------------GIHYLHANWVLHRDLKPANILVMG 163
Query: 189 EQQK---LRLIDWGLA-EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
E + +++ D G A F P K + V + +++ PELL+ + Y ++D+W++G
Sbjct: 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 223
Query: 242 CMFAGMIFRKEPFFYGHD---------NQDQLVKIARVLGT 273
C+FA ++ EP F+ + DQL +I V+G
Sbjct: 224 CIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 57/269 (21%), Positives = 99/269 (36%), Gaps = 54/269 (20%)
Query: 21 YESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIK-ILKPVKKKKIKRE 76
++S++V+ Y +++++G G S+VF+ +N K + + E
Sbjct: 20 FQSMSVK---GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 77 IKILQNLCGG-PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPTLTANEIRYYIY 133
I L L I++L D + ++ E N L ++ E + Y
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 134 ELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193
+L +A+ H GI+H D+KP N +I L
Sbjct: 135 NML---------------------------EAVHTIHQHGIVHSDLKPANFLIV--DGML 165
Query: 194 RLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL----------QDYDYSLDMWSL 240
+LID+G+A P V+ V + + PE + D+ D+WSL
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 241 GCMFAGMIFRKEPFFYGHDNQDQLVKIAR 269
GC+ M + K PF + +L I
Sbjct: 226 GCILYYMTYGKTPFQQIINQISKLHAIID 254
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 55/256 (21%), Positives = 93/256 (36%), Gaps = 51/256 (19%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNE---KCI-IKILKPVKKKKIKREIKILQNLCGG- 86
Y +++++G G S+VF+ +N K + ++ + EI L L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPTLTANEIRYYIYELLKHAMPRKV 144
I++L D + ++ E N L ++ E + Y +L
Sbjct: 69 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML-------- 118
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+A+ H GI+H D+KP N +I L+LID+G+A
Sbjct: 119 -------------------EAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQM 157
Query: 205 HPGKEYNVR---VASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRK 251
P V+ V + + PE + D D+WSLGC+ M + K
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 252 EPFFYGHDNQDQLVKI 267
PF + +L I
Sbjct: 218 TPFQQIINQISKLHAI 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 62/260 (23%), Positives = 108/260 (41%), Gaps = 46/260 (17%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 88
D+E + +G+G + +V + N ++ IK ++ K I E+ +L +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL-YPTLTANEIRYYIYELLKHAMPRKVIIM 147
+V+ ++ + + ST F + Y + I+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEY--CENGTLYDLIHS------------- 108
Query: 148 PGEGLMENQDISVWD-----LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
E L + +D W L+AL Y HSQGI+HRD+KP N+ ID E + +++ D+GLA+
Sbjct: 109 --ENLNQQRD-EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAK 164
Query: 203 FYHPGKEYNVRVASRYFKG---------------PELLVDLQDYDYSLDMWSLGCMFAGM 247
H + + E+L Y+ +DM+SLG +F M
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 248 IFRKEPFFYGHDNQDQLVKI 267
I+ PF G + + L K+
Sbjct: 225 IY---PFSTGMERVNILKKL 241
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-34
Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 37/244 (15%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 85
E Y+ V+K+G G Y EV + + + IKI + K+ E+ +L+ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
PNI+KL D D+ + L+ E + L+ + R E+ + ++V
Sbjct: 95 HPNIMKLYDFFEDKRNY--YLVMECYKGGE---LFDEIIH---RMKFNEVDAAVIIKQV- 145
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWGLAEF 203
L + Y H I+HRD+KP N++++ + ++++D+GL+
Sbjct: 146 -----------------LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ K+ R+ + Y+ PE+L + YD D+WS+G + ++ P F G +Q+
Sbjct: 189 FENQKKMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEI 245
Query: 264 LVKI 267
L K+
Sbjct: 246 LRKV 249
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 46/250 (18%), Positives = 96/250 (38%), Gaps = 38/250 (15%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 90
D++ + +G G + +VF+ + + + +IK +K +K +RE+K L L NIV
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYI----------YELLKHAM 140
++ + + + +I + ++
Sbjct: 68 HYNGC------------WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR- 114
Query: 141 PRKVIIMPGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
GE L + Q +DY HS+ +++RD+KP N+ + +Q +++ D
Sbjct: 115 -------RGEKLDKVL-ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKIGD 165
Query: 198 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
+GL + + + PE + QDY +D+++LG + A ++ + F
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET 224
Query: 258 HDNQDQLVKI 267
L
Sbjct: 225 SKFFTDLRDG 234
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 77/330 (23%), Positives = 128/330 (38%), Gaps = 99/330 (30%)
Query: 13 HRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK- 70
H + W + YE+ +G G Y V E + IK IL+ +
Sbjct: 34 HSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL 93
Query: 71 ---KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS---LIFEHVNSTDF-KVLY--P 121
K+I REI IL L ++VK+LDIV + + ++ E + +DF K+
Sbjct: 94 IDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPV 151
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
LT I+ +Y LL + Y HS GI+HRD+KP
Sbjct: 152 YLTELHIKTLLYNLLV---------------------------GVKYVHSAGILHRDLKP 184
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVR---------------------------- 213
N +++ + +++ D+GLA + N +
Sbjct: 185 ANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 214 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPFFYGHD---- 259
V +R+++ PEL++ ++Y ++D+WS+GC+FA ++ + P F G
Sbjct: 244 VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPL 303
Query: 260 ----------------NQDQLVKIARVLGT 273
N+DQL I +LGT
Sbjct: 304 SPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 55/258 (21%), Positives = 91/258 (35%), Gaps = 51/258 (19%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKI-LKPVKKKKIKREIKILQNLCG-G 86
Y +++++G G S+VF+ +N K + + EI L L
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPTLTANEIRYYIYELLKHAMPRKV 144
I++L D + ++ E N L ++ E + Y +L
Sbjct: 116 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNML-------- 165
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+A+ H GI+H D+KP N +I L+LID+G+A
Sbjct: 166 -------------------EAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQM 204
Query: 205 HPGKEYNVR---VASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRK 251
P V+ V + + PE + D D+WSLGC+ M + K
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 252 EPFFYGHDNQDQLVKIAR 269
PF + +L I
Sbjct: 265 TPFQQIINQISKLHAIID 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 52/272 (19%), Positives = 100/272 (36%), Gaps = 36/272 (13%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 87
+ + +G+G + VF G + + IK+ + + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
NIVKL I + ++ LI E LY L Y + E V+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGS---LYTVLEEPSNAYGLPE--SEF--LIVL-- 118
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI---DHEQQKLRLIDWGLAEFY 204
+D+ + +++ GI+HR++KP N+M + Q +L D+G A
Sbjct: 119 --------RDV----VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 205 HPGKEYNVRVASRYFKGPELL-------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
+++ + + P++ + Y ++D+WS+G F PF
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDP 289
+ + +++ A E P
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-33
Identities = 59/231 (25%), Positives = 90/231 (38%), Gaps = 58/231 (25%)
Query: 30 DQEDYEVVRKV-GRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 88
+DY+V +V G G +V + N EK +K+L+ K +RE+++ P+
Sbjct: 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPH 116
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY-------ELLKHAMP 141
IV+++D+ Y L A I EL
Sbjct: 117 IVRIVDV------------------------YENLYAGRKCLLIVMECLDGGELFSRIQD 152
Query: 142 RKVI---------IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ- 191
R IM + I +A+ Y HS I HRDVKP N++ ++
Sbjct: 153 RGDQAFTEREASEIM--------KSI----GEAIQYLHSINIAHRDVKPENLLYTSKRPN 200
Query: 192 -KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
L+L D+G A+ + Y+ PE+L + YD S DMWSLG
Sbjct: 201 AILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLG 250
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 38/245 (15%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLC 84
+ Y+ R +G+G + EV + ++C +K++ K+ + RE+++L+ L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
PNI+KL + D+ L+ E + L+ + + R E A ++
Sbjct: 84 DHPNIMKLYEFFEDKGYF--YLVGEVYTGGE---LFDEIIS---RKRFSE--VDA--ARI 131
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWGLAE 202
I + + L + Y H I+HRD+KP N++++ + +R+ID+GL+
Sbjct: 132 I----------RQV----LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ K+ ++ + Y+ PE+L YD D+WS G + ++ P F G + D
Sbjct: 178 HFEASKKMKDKIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYD 234
Query: 263 QLVKI 267
L K+
Sbjct: 235 ILKKV 239
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 40/248 (16%)
Query: 31 QEDYEVVRKV-GRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 89
+DY++ ++V G G +V E + +KC +K+L K ++E+ GGP+I
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 90 VKLLDIVRDQHSKTPS--LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
V +LD+ + H +I E + + L+ + + + E + A +++
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQERGDQAF-TE--REA--AEIM-- 134
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ--KLRLIDWGLAEFYH 205
+DI A+ + HS I HRDVKP N++ +++ L+L D+G A+
Sbjct: 135 --------RDI----GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 206 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNQ 261
+ Y+ PE+L + YD S DMWSLG + G P FY + Q
Sbjct: 183 QNALQTP-CYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQ 235
Query: 262 DQLVKIAR 269
+ R
Sbjct: 236 AISPGMKR 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 59/248 (23%), Positives = 110/248 (44%), Gaps = 45/248 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 85
E Y +V +G+G + EV + + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
PNI+KL +I+ D S ++ E + L+ + R E A ++I
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIK---RKRFSE--HDA--ARII 127
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWGLAEF 203
+ + + Y H I+HRD+KP N++++ + +++ID+GL+
Sbjct: 128 ----------KQV----FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHD 259
+ + R+ + Y+ PE+L YD D+WS G + +G P FYG +
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKN 226
Query: 260 NQDQLVKI 267
D L ++
Sbjct: 227 EYDILKRV 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 52/255 (20%), Positives = 96/255 (37%), Gaps = 39/255 (15%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 87
+ + +G+G + VF G + + IK+ + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
NIVKL I + ++ LI E LY L Y + E V+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGS---LYTVLEEPSNAYGLPE--SEF--LIVL-- 118
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH---EQQKLRLIDWGLAEFY 204
+D+ + +++ GI+HR++KP N+M Q +L D+G A
Sbjct: 119 --------RDV----VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 205 HPGKEYNVRVASRYFKGPELL-------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF--- 254
+++ + + P++ + Y ++D+WS+G F PF
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 255 FYGHDNQDQLVKIAR 269
N++ + KI
Sbjct: 227 EGPRRNKEVMYKIIT 241
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 55/270 (20%), Positives = 108/270 (40%), Gaps = 35/270 (12%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--------PVKKKKIKREIKILQN 82
Q+ Y + +G+G Y V I IKI+ P ++IK E+++++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKHA 139
L PNI +L ++ D+ L+ E + D ++ + + + +
Sbjct: 85 LHH-PNIARLYEVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 140 MPRKVIIMPGEGLMENQDISVWD-------------LQALDYCHSQGIMHRDVKPHNVMI 186
P + ++ + AL Y H+QGI HRD+KP N +
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 187 DH-EQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDMWS 239
+ +++L+D+GL++ ++ + + YF PE+L + Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 240 LGCMFAGMIFRKEPFFYGHDNQDQLVKIAR 269
G + ++ P F G ++ D + ++
Sbjct: 262 AGVLLHLLLMGAVP-FPGVNDADTISQVLN 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 50/248 (20%), Positives = 94/248 (37%), Gaps = 43/248 (17%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPN 88
E Y + +GRG++ V + ++ + + K + K + +K+EI IL N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
I+ L + +IFE ++ ++ + I
Sbjct: 63 ILHLHESFESMEELV--MIFEFISGL-------------------DIFER------INTS 95
Query: 149 GEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVM-IDHEQQKLRLIDWGLAEFYH 205
L E + +S +AL + HS I H D++P N++ +++I++G A
Sbjct: 96 AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 206 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNQ 261
PG + + + + PE+ + DMWSLG + +G+ F NQ
Sbjct: 156 PGDNFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGI-----NPFLAETNQ 209
Query: 262 DQLVKIAR 269
+ I
Sbjct: 210 QIIENIMN 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 49/256 (19%), Positives = 101/256 (39%), Gaps = 54/256 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGG 86
+ + RK+G G + +V ++ + +IK + V ++I+ EI++L++L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNS-------TDFKVLYPTLTANEIRYYIYELLKHA 139
PNI+K+ ++ D H+ ++ E + L+ + + +++
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM--- 134
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLID 197
AL Y HSQ ++H+D+KP N++ +++ID
Sbjct: 135 ------------------------NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 198 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEP 253
+GLAE + + + + PE+ +D + D+WS G + G
Sbjct: 171 FGLAELFKSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGC-----L 223
Query: 254 FFYGHDNQDQLVKIAR 269
F G ++ K
Sbjct: 224 PFTGTSLEEVQQKATY 239
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 51/245 (20%), Positives = 84/245 (34%), Gaps = 56/245 (22%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCG 85
Q+ ++ + ++G G Y EVF+ + + +K P + + E+ + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY------ELLKHA 139
P V+L + Y+ L +H
Sbjct: 116 HPCCVRLEQAWEEGG----------------------------ILYLQTELCGPSLQQH- 146
Query: 140 MPRKVIIMPGEGLMENQDISVWD-----LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
G L E Q VW L AL + HSQG++H DVKP N+ + + +
Sbjct: 147 -----CEAWGASLPEAQ---VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CK 197
Query: 195 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
L D+GL V+ + PELL Y + D++SLG + E
Sbjct: 198 LGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELP 255
Query: 255 FYGHD 259
G
Sbjct: 256 HGGEG 260
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 49/272 (18%), Positives = 100/272 (36%), Gaps = 45/272 (16%)
Query: 9 DVNVHRPRDYWDYESLTVQWGD-QEDYEVVRKVGRGKYSEVFEGINVTNNEKC---IIKI 64
D V + + + ++ + Y++ ++G G + V +
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 65 LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLT 124
K+ +++EI+ + L P +V L D D + +I+E ++
Sbjct: 193 PHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV--MIYEFMSGG---------- 239
Query: 125 ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPH 182
EL + + + E++ + + L + H +H D+KP
Sbjct: 240 ---------ELFEK------VADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 284
Query: 183 NVMI-DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
N+M +L+LID+GL P + V + F PE+ + + Y DMWS+G
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVG 343
Query: 242 C----MFAGMIFRKEPFFYGHDNQDQLVKIAR 269
+ +G+ F G ++ + L +
Sbjct: 344 VLSYILLSGL-----SPFGGENDDETLRNVKS 370
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 59/275 (21%), Positives = 107/275 (38%), Gaps = 49/275 (17%)
Query: 9 DVNVHRPRDYWDYESLTVQWGDQED-YEVVRKVGRGKYSEVFEGINVTNNEKC---IIKI 64
D + + + V+ G D Y+++ ++G G + V + I
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 65 LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLT 124
P+ K +K EI I+ L P ++ L D D++ LI E
Sbjct: 87 PYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMV--LILE--------------- 128
Query: 125 ANEIRYYIY--ELLKHAMPRKVIIMPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVK 180
++ EL I + E + I+ + L + H I+H D+K
Sbjct: 129 ------FLSGGELFDR------IAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIK 176
Query: 181 PHNVMI-DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWS 239
P N+M + +++ID+GLA +P + V A+ F PE++ D + + DMW+
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWA 235
Query: 240 LGC----MFAGMIFRKEPFFYGHDNQDQLVKIARV 270
+G + +G+ F G D+ + L + R
Sbjct: 236 IGVLGYVLLSGL-----SPFAGEDDLETLQNVKRC 265
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 91/303 (30%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 86
++Y + +GRG Y V+ + + IK + + + K+I REI IL L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84
Query: 87 PNIVKLLDIVRDQHSKTPS---LIFEHVNSTDF-KVLYP--TLTANEIRYYIYELLKHAM 140
I++L D++ ++ E + +D K+ LT I+ +Y LL
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLL--- 140
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
++ H GI+HRD+KP N +++ + +++ D+GL
Sbjct: 141 ------------------------GENFIHESGIIHRDLKPANCLLN-QDCSVKVCDFGL 175
Query: 201 AEFYHPGKEYNVR-----------------------VASRYFKGPELLVDLQDYDYSLDM 237
A + K+ N+ V +R+++ PEL++ ++Y S+D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 238 WSLGCMFAGMI----------FRKEPFFYG-----------------HDNQDQLVKIARV 270
WS GC+FA ++ + P F G N+DQL I +
Sbjct: 236 WSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI 295
Query: 271 LGT 273
+GT
Sbjct: 296 IGT 298
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 57/261 (21%), Positives = 104/261 (39%), Gaps = 50/261 (19%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 87
D+E ++ +GRG + VFE N ++ IK ++ + ++K+ RE+K L L P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYEL-----LKHAMPR 142
IV+ + ++++ + S+ LY I +L LK M
Sbjct: 64 GIVRYFNAWLEKNTTE-----KLQPSSPKVYLY-------I---QMQLCRKENLKDWMNG 108
Query: 143 KVIIMPGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+ E LQ A+++ HS+G+MHRD+KP N+ + +++ D+G
Sbjct: 109 R----CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFG 163
Query: 200 LA-------EFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAG 246
L E G PE + Y + +D++SLG +
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFE 222
Query: 247 MIFRKEPFFYGHDNQDQLVKI 267
+++ PF + L +
Sbjct: 223 LLY---PFSTQMERVRTLTDV 240
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 57/259 (22%), Positives = 108/259 (41%), Gaps = 54/259 (20%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----------------PVKKKKIKR 75
E Y VRK+G G Y EV + + IK++K ++I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 76 EIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYI 132
EI +L++L PNI+KL D+ D+ L+ E + + + +
Sbjct: 96 EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 133 YELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQ 190
++L + Y H I+HRD+KP N++++ +
Sbjct: 153 KQIL---------------------------SGICYLHKHNIVHRDIKPENILLENKNSL 185
Query: 191 QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250
++++D+GL+ F+ + R+ + Y+ PE+L + Y+ D+WS G + ++
Sbjct: 186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCG 243
Query: 251 KEPFFYGHDNQDQLVKIAR 269
P F G ++QD + K+ +
Sbjct: 244 YPP-FGGQNDQDIIKKVEK 261
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 48/248 (19%), Positives = 99/248 (39%), Gaps = 39/248 (15%)
Query: 33 DYEVVRKVGRGKYSE-VFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 91
+ +G G V+ G+ +N +K + P RE+++L+ PN+++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEG 151
+D+ + + E +T + + E + + + L+ P ++
Sbjct: 83 YFCTEKDRQFQ--YIAIELCAATLQEYV-------EQKDFAHLGLE---PITLL------ 124
Query: 152 LMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ----KLRLIDWGLAEFYHPG 207
Q L + HS I+HRD+KPHN++I K + D+GL + G
Sbjct: 125 ----QQT----TSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 208 KEYNVR----VASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
+ R + + PE+L + ++ Y++D++S GC+F +I F +
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236
Query: 262 DQLVKIAR 269
+ +
Sbjct: 237 QANILLGA 244
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 62/252 (24%), Positives = 120/252 (47%), Gaps = 47/252 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 86
YEV++ +G+G + +V + + ++ +K+++ K+ ++ EI+IL++L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 87 PNIVKLLDIVRDQHSKTPSLIF-EHVNSTDFKVLYPTLTANEIRYYIYELLK----HAMP 141
N++ +L+ + F H+ T F++L L YEL+K
Sbjct: 159 MNVIHMLE----------NFTFRNHICMT-FELLSMNL---------YELIKKNKFQGFS 198
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI-DHEQQKLRLIDWGL 200
++ + + LQ LD H I+H D+KP N+++ + +++ID+G
Sbjct: 199 LPLV----------RKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
+ + H + Y + SR+++ PE+++ Y +DMWSLGC+ A + P G D
Sbjct: 249 SCYEH-QRVYTY-IQSRFYRAPEVILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDE 304
Query: 261 QDQLVKIARVLG 272
DQL + +LG
Sbjct: 305 GDQLACMIELLG 316
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 57/259 (22%), Positives = 109/259 (42%), Gaps = 55/259 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK---------PVKKKKIKREIKILQ 81
++ Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKH 138
+ N++ L D+ ++ LI E V+ DF +L+ E +I ++L
Sbjct: 71 QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQIL-- 125
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI---DHEQQKLRL 195
++Y H++ I H D+KP N+M+ + ++L
Sbjct: 126 -------------------------DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRK 251
ID+GLA G E+ + F PE++ + + DMWS+G + +G
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGA---- 215
Query: 252 EPFFYGHDNQDQLVKIARV 270
F G Q+ L I V
Sbjct: 216 -SPFLGDTKQETLANITSV 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 50/257 (19%), Positives = 101/257 (39%), Gaps = 52/257 (20%)
Query: 31 QEDYEVVRKV-GRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLC 84
Y + K GRGK++ V + I+ + ++ K + +I EI +L+
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-F----KVLYPTLTANEIRYYIYELLKHA 139
P ++ L ++ + LI E+ + F L ++ N++ I
Sbjct: 87 SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLI------- 137
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLID 197
K I L+ + Y H I+H D+KP N+++ + ++++D
Sbjct: 138 ---KQI-----------------LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 198 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG----CMFAGMIFRKEP 253
+G++ E + + + PE+L + + DMW++G +
Sbjct: 178 FGMSRKIGHACELREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHT-----S 231
Query: 254 FFYGHDNQDQLVKIARV 270
F G DNQ+ + I++V
Sbjct: 232 PFVGEDNQETYLNISQV 248
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 58/253 (22%), Positives = 96/253 (37%), Gaps = 46/253 (18%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVKKKKIKREIKILQNLCGGPN 88
+E+ ++G G + V I+ E K + L P +++ EI+I++ L PN
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPN 73
Query: 89 IVKLLDIVRDQHSKTPS----LIFEHVNSTD-FKVL-----YPTLTANEIRYYIYELLKH 138
+V ++ P+ L E+ D K L L IR +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL------ 127
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLI 196
DI AL Y H I+HRD+KP N+++ ++ ++I
Sbjct: 128 -----------------SDI----SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166
Query: 197 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
D G A+ G+ V + + PELL + + Y ++D WS G + I P F
Sbjct: 167 DLGYAKELDQGELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FL 224
Query: 257 GHDNQDQLVKIAR 269
+ Q R
Sbjct: 225 PNWQPVQWHGKVR 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 49/251 (19%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 87
+ Y + +GRG + EV + + K + + K+EI+I+++L P
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
NI++L + D L+ E + V ++ + ++L
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVL-------- 116
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWGLAE 202
A+ YCH + HRD+KP N + L+LID+GLA
Sbjct: 117 -------------------SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGH 258
+ PGK +V + Y+ P++L Y D WS G + G P F
Sbjct: 158 RFKPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGY-----PPFSAP 210
Query: 259 DNQDQLVKIAR 269
+ + ++KI
Sbjct: 211 TDSEVMLKIRE 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 34/256 (13%), Positives = 71/256 (27%), Gaps = 19/256 (7%)
Query: 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL------KPVKKKKIKREIKILQN 82
+ ++V + G S VF +V E +K+ + +++
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYEL------- 135
L G + + D R + +
Sbjct: 119 L-LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY-LLLMPAASVDLEL 176
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L + + EG++ ++ ++ S+G++H P N+ I + + L L
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LML 235
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
D + G + E L + ++L+ W LG + PF
Sbjct: 236 GDVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 255 FYGHDNQDQLVKIARV 270
K +
Sbjct: 294 GLVTPGIKGSWKRPSL 309
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 56/253 (22%), Positives = 106/253 (41%), Gaps = 51/253 (20%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 85
E Y +V +G+G + EV + + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKHAMPR 142
PNI+KL +I+ D S ++ E D + + ++ I ++
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF------ 131
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH--EQQKLRLIDWGL 200
+ Y H I+HRD+KP N++++ + +++ID+GL
Sbjct: 132 ---------------------SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFY 256
+ + + R+ + Y+ PE+L YD D+WS G + +G P FY
Sbjct: 171 STCFQQNTKMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGT-----PPFY 223
Query: 257 GHDNQDQLVKIAR 269
G + D L ++
Sbjct: 224 GKNEYDILKRVET 236
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 60/255 (23%), Positives = 105/255 (41%), Gaps = 47/255 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 86
EDYEV+ +G G Y + ++ + + K + +K+ + E+ +L+ L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PNIV+ D + D+ + T ++ E+ D + ++
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGD----------------LASVITKGTKE---- 104
Query: 147 MPGEGLMENQDISVWD-----LQALDYCHSQG-----IMHRDVKPHNVMIDHEQQKLRLI 196
+ L E V AL CH + ++HRD+KP NV +D +Q ++L
Sbjct: 105 --RQYLDEEF---VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLG 158
Query: 197 DWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
D+GLA + + V + Y+ PE + Y+ D+WSLGC+ + PF
Sbjct: 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT 217
Query: 256 YGHDNQDQLV-KIAR 269
+Q +L KI
Sbjct: 218 --AFSQKELAGKIRE 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 52/292 (17%), Positives = 106/292 (36%), Gaps = 58/292 (19%)
Query: 1 MSRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC 60
M + + + R Y+ + + D + Y ++K+G G +S V + +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVII---DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFY 57
Query: 61 IIKIL---KPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS--LIFEHVNSTD 115
+K + + +++ +RE + + PNI++L+ + L+
Sbjct: 58 ALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116
Query: 116 -------FKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDY 168
K LT ++I + + + + L+
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGIC---------------------------RGLEA 149
Query: 169 CHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASR----------Y 218
H++G HRD+KP N+++ E Q L+D G E + + +
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQ-PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 219 FKGPELLVDLQDY---DYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267
++ PE L +Q + D D+WSLGC+ M+F + P+ D +
Sbjct: 209 YRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 44/257 (17%), Positives = 93/257 (36%), Gaps = 46/257 (17%)
Query: 34 YEVVRKVGRGKYSEV-FEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 92
+ +G G V F+G +K + EIK+L PN+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
+ E N ++ + + +L K P ++
Sbjct: 75 YCSETTDRFL--YIALELCNLNLQDLV----ESKNVSDENLKLQKEYNPISLL------- 121
Query: 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID------------HEQQKLRLIDWGL 200
+ I + + HS I+HRD+KP N+++ E ++ + D+GL
Sbjct: 122 ---RQI----ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 201 AEFYHPGKEY-----NVRVASRYFKGPELLVDLQD------YDYSLDMWSLGCMFAGMIF 249
+ G+ N + ++ PELL + + S+D++S+GC+F ++
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 250 RKEPFFYGHDNQDQLVK 266
+ + F +++ +
Sbjct: 235 KGKHPFGDKYSRESNII 251
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 51/233 (21%), Positives = 93/233 (39%), Gaps = 50/233 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------------PVKKKKIKREIK 78
E+YE +GRG S V I+ ++ +KI+ ++ +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYEL 135
IL+ + G PNI++L D L+F+ + D+ TL+ E R + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L + + H I+HRD+KP N+++D + ++L
Sbjct: 134 L---------------------------EVICALHKLNIVHRDLKPENILLD-DDMNIKL 165
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELL-----VDLQDYDYSLDMWSLGCM 243
D+G + PG++ + + PE++ + Y +DMWS G +
Sbjct: 166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 52/227 (22%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---------KPVKKKKIKREIKILQNL 83
Y+V +G G + V+ GI V++N IK + + ++ E+ +L+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 84 C-GGPNIVKLLDIVRDQHSKTPS---LIFEHVNST----DFKVLYPTLTANEIRYYIYEL 135
G +++LLD + P LI E DF L R + +++
Sbjct: 104 SSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L +A+ +CH+ G++HRD+K N++ID + +L+L
Sbjct: 159 L---------------------------EAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
ID+G Y +R + PE + Y S +WSLG
Sbjct: 192 IDFGSGALLKDTV-YTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLG 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 59/259 (22%), Positives = 110/259 (42%), Gaps = 55/259 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK---------PVKKKKIKREIKILQ 81
++ Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKH 138
+ PNI+ L D+ ++ LI E V+ DF +L+ E +I ++L
Sbjct: 71 QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQIL-- 125
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI---DHEQQKLRL 195
++Y H++ I H D+KP N+M+ + ++L
Sbjct: 126 -------------------------DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRK 251
ID+GLA G E+ + F PE++ + + DMWS+G + +G
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGA---- 215
Query: 252 EPFFYGHDNQDQLVKIARV 270
F G Q+ L I V
Sbjct: 216 -SPFLGDTKQETLANITAV 233
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 56/259 (21%), Positives = 107/259 (41%), Gaps = 55/259 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK---------PVKKKKIKREIKILQ 81
+ Y+ ++G G+++ V + + + K +K V ++ I+RE+ IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKH 138
+ PN++ L ++ ++ LI E V DF +LT E ++ ++L
Sbjct: 70 EI-QHPNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQIL-- 124
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI---DHEQQKLRL 195
+ Y HS I H D+KP N+M+ + + ++++
Sbjct: 125 -------------------------NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRK 251
ID+GLA G E+ + F PE++ + + DMWS+G + +G
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGA---- 214
Query: 252 EPFFYGHDNQDQLVKIARV 270
F G Q+ L ++ V
Sbjct: 215 -SPFLGDTKQETLANVSAV 232
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 59/261 (22%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK---------PVKKKKIKREIKILQ 81
++ YE+ ++G G+++ V + ++ K +K V +++I+RE+ IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST-----DFKVLYPTLTANEIRYYIYELL 136
+ PNI+ L DI ++ LI E V + DF +LT +E ++ ++L
Sbjct: 64 EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 137 KHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI---DHEQQKL 193
+ Y HS+ I H D+KP N+M+ + ++
Sbjct: 119 ---------------------------DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151
Query: 194 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIF 249
+LID+G+A G E+ + F PE++ + + DMWS+G + +G
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGA-- 208
Query: 250 RKEPFFYGHDNQDQLVKIARV 270
F G Q+ L I+ V
Sbjct: 209 ---SPFLGETKQETLTNISAV 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 50/223 (22%), Positives = 102/223 (45%), Gaps = 41/223 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 85
++Y+V ++G+G +S V ++ T + KI L +K++RE +I + L
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKHAMPR 142
PNIV+L D ++++ L+F+ V + V + + + I ++L
Sbjct: 88 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL------ 138
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWGL 200
+++ YCHS GI+HR++KP N+++ + ++L D+GL
Sbjct: 139 ---------------------ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
A + + ++ + + PE+L Y +D+W+ G +
Sbjct: 178 AIEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVI 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-29
Identities = 55/265 (20%), Positives = 105/265 (39%), Gaps = 70/265 (26%)
Query: 31 QEDYEV---VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGP 87
+ Y++ + +G G +S + ++ +N+ +KI+ + ++EI L+ G P
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY-------ELLKHAM 140
NIVKL + +F +++ ++ EL +
Sbjct: 67 NIVKLHE------------VFH----------------DQLHTFLVMELLNGGELFERIK 98
Query: 141 PRK-------VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-- 191
+K IM + + + A+ + H G++HRD+KP N++ E
Sbjct: 99 KKKHFSETEASYIM--------RKL----VSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146
Query: 192 KLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAG 246
++++ID+G A P + + ++ PELL + YD S D+WSLG M +G
Sbjct: 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSG 205
Query: 247 MIFRKEPFFYGHDNQDQLVKIARVL 271
F HD ++
Sbjct: 206 Q-----VPFQSHDRSLTCTSAVEIM 225
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 49/236 (20%), Positives = 100/236 (42%), Gaps = 58/236 (24%)
Query: 31 QEDYEVVRKV-GRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGG 86
++ Y++ V G G ++ V IN+ +++ +KI+ + ++ RE+++L G
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRK--- 143
N+++L++ ++ L+FE + +L H R+
Sbjct: 71 RNVLELIEFFEEEDRF--YLVFEKMRGG-------------------SILSHIHKRRHFN 109
Query: 144 ----VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ--KLRLID 197
+++ QD+ ALD+ H++GI HRD+KP N++ +H Q +++ D
Sbjct: 110 ELEASVVV--------QDV----ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 198 WGLAEFYHPGKEYNV--------RVASRYFKGPELL----VDLQDYDYSLDMWSLG 241
+ L + + S + PE++ + YD D+WSLG
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 55/251 (21%), Positives = 104/251 (41%), Gaps = 46/251 (18%)
Query: 31 QEDYEVVRK--VGRGKYSEVFEGINVTNNEKC---IIKILKPVKKKKIKREIKILQNLCG 85
Y V + +G G++ +V + K IIK K+++K EI ++ L
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-D 144
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
N+++L D ++ L+ E+V+ EL I
Sbjct: 145 HANLIQLYDAFESKNDIV--LVMEYVDGG-------------------ELFDR------I 177
Query: 146 IMPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVM-IDHEQQKLRLIDWGLAE 202
I L E I + + + H I+H D+KP N++ ++ + +++++ID+GLA
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGH 258
Y P ++ V + F PE++ + + DMWS+G + +G+ F G
Sbjct: 238 RYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGL-----SPFLGD 291
Query: 259 DNQDQLVKIAR 269
++ + L I
Sbjct: 292 NDAETLNNILA 302
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 50/221 (22%), Positives = 101/221 (45%), Gaps = 41/221 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 85
++Y+V ++G+G +S V ++ T + KI L +K++RE +I + L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKHAMPR 142
PNIV+L D ++++ L+F+ V + V + + + I ++L
Sbjct: 65 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL------ 115
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWGL 200
+++ YCHS GI+HR++KP N+++ + ++L D+GL
Sbjct: 116 ---------------------ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154
Query: 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
A + + ++ + + PE+L Y +D+W+ G
Sbjct: 155 AIEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACG 194
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--------PVKKKKIKREIKILQN 82
++ YE+ +G+G +S V IN ++ +KI+ + + +KRE I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY-ELLKHAMP 141
L P+IV+LL+ ++FE ++ D L + ++Y E A
Sbjct: 83 L-KHPHIVELLETYSSDGML--YMVFEFMDGAD---LCFEIVKRADAGFVYSE--AVA-- 132
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWG 199
+ + I L+AL YCH I+HRDVKPH V++ ++L +G
Sbjct: 133 SHYM----------RQI----LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178
Query: 200 LA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
+A + G RV + +F PE++ + Y +D+W G +
Sbjct: 179 VAIQLGESGLVAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVI 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 48/229 (20%), Positives = 93/229 (40%), Gaps = 49/229 (21%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK-----------KIKREIKIL 80
+ Y+ +GRG S V ++ + +KI++ ++ +RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLK 137
+ + G P+I+ L+D L+F+ + D+ L+ E R + LL
Sbjct: 154 RQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL- 210
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
+A+ + H+ I+HRD+KP N+++D + ++RL D
Sbjct: 211 --------------------------EAVSFLHANNIVHRDLKPENILLD-DNMQIRLSD 243
Query: 198 WGLAEFYHPGKEYNVRVASRYFKGPELL-----VDLQDYDYSLDMWSLG 241
+G + PG++ + + PE+L Y +D+W+ G
Sbjct: 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 50/246 (20%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNI 89
+ +EV ++GRG S V+ + +K + K V KK ++ EI +L L PNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNI 110
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNST-----DFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
+KL +I SL+ E V T D V + + + ++L
Sbjct: 111 IKLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQIL-------- 158
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH--EQQKLRLIDWGLAE 202
+A+ Y H GI+HRD+KP N++ L++ D+GL++
Sbjct: 159 -------------------EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGH 258
+ + PE+L Y +DMWS+G + G FY
Sbjct: 200 IVEHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGF-----EPFYDE 253
Query: 259 DNQDQL 264
+
Sbjct: 254 RGDQFM 259
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 54/256 (21%), Positives = 97/256 (37%), Gaps = 58/256 (22%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-----------KPVKKKKIKREIKI 79
+++Y + + +G G EV +K I+I+ + ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS---TDFKVLYPTLTANEIRYYIYELL 136
L+ L P I+K+ + + ++ E + D V L + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 KHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLR 194
A+ Y H GI+HRD+KP NV++ E ++
Sbjct: 250 ---------------------------LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 282
Query: 195 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGC----MFAGMI 248
+ D+G ++ + + PE+LV + Y+ ++D WSLG +G
Sbjct: 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY- 341
Query: 249 FRKEPFFYGHDNQDQL 264
P F H Q L
Sbjct: 342 ----PPFSEHRTQVSL 353
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 54/229 (23%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---------KPVKKKKIKREIKILQNL 83
+Y + +G+G + VF G +T+ + IK++ E+ +L +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 84 CGG---PNIVKLLDIVRDQHSKTPS---LIFEHVNST----DFKVLYPTLTANEIRYYIY 133
G P +++LLD +T L+ E D+ L R +
Sbjct: 92 GAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 134 ELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193
+++ A+ +CHS+G++HRD+K N++ID +
Sbjct: 147 QVV---------------------------AAIQHCHSRGVVHRDIKDENILIDLRRGCA 179
Query: 194 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
+LID+G H Y +R + PE + Y +WSLG
Sbjct: 180 KLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISR-HQYHALPATVWSLG 226
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 68/307 (22%), Positives = 127/307 (41%), Gaps = 57/307 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 86
YE+ +G+G + +V + + E IKI+K K + + E+++L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLK----HAMPR 142
IV L L+FE L+ N +Y+LL+ +
Sbjct: 116 YYIVHLKRHF--MFRNHLCLVFEM------------LSYN-----LYDLLRNTNFRGVSL 156
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQ--GIMHRDVKPHNVMIDHEQ-QKLRLIDWG 199
+ + + AL + + I+H D+KP N+++ + + ++++D+G
Sbjct: 157 NLT----------RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
Query: 200 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
+ + + SR+++ PE+L+ + YD ++DMWSLGC+ M EP F G +
Sbjct: 207 SSCQLG--QRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGAN 262
Query: 260 NQDQLVKIARVLG---------TDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQ 310
DQ+ KI VLG + + +K + L+ KR + P +KL
Sbjct: 263 EVDQMNKIVEVLGIPPAHILDQAPKARKFFEK-LPDGTWNLKKTKDGKREYKPPGTRKLH 321
Query: 311 FCRSSRT 317
T
Sbjct: 322 NILGVET 328
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 69/273 (25%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLC------- 84
Y +VRK+G G +S V+ ++ NN +KI++ K + + EIK+LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 85 ---GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD------FKVLYPTLTANEIRYYIYEL 135
G +I+KLLD F H F+VL L L
Sbjct: 81 DSMGANHILKLLD------------HFNHKGPNGVHVVMVFEVLGENL---------LAL 119
Query: 136 LK----HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQ 190
+K +P + + IS L LDY H + GI+H D+KP NV+++
Sbjct: 120 IKKYEHRGIPLIYV----------KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169
Query: 191 Q-----KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 245
++++ D G A +Y + Y + +R ++ PE+L+ + D+WS C+
Sbjct: 170 SPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIF 226
Query: 246 GMIFRKEPFFYGHD------NQDQLVKIARVLG 272
+I F + + D + +I +LG
Sbjct: 227 ELITGD-FLFEPDEGHSYTKDDDHIAQIIELLG 258
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 58/251 (23%), Positives = 109/251 (43%), Gaps = 43/251 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIK------ILKPVKKKKIKREIKILQNLCG 85
++ + +K+GRG++SEV+ + + +K ++ + +EI +L+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
PN++K + + +++ E ++ D + ++KH +
Sbjct: 92 -PNVIKYYASFIEDN--ELNIVLELADAGD----------------LSRMIKHFKKQ--- 129
Query: 146 IMPGEGLMENQDISVWD-----LQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+ E VW AL++ HS+ +MHRD+KP NV I ++L D GL
Sbjct: 130 ---KRLIPERT---VWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGL 182
Query: 201 AEFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
F+ + V + Y+ PE + + Y++ D+WSLGC+ M + PF+
Sbjct: 183 GRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241
Query: 260 NQDQLV-KIAR 269
N L KI +
Sbjct: 242 NLYSLCKKIEQ 252
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 56/256 (21%), Positives = 97/256 (37%), Gaps = 58/256 (22%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------KKKIKREIKI 79
+++Y + + +G G EV +K IKI+ K ++ EI+I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELL 136
L+ L P I+K+ + + ++ E + D V L + Y Y++L
Sbjct: 69 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 KHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLR 194
A+ Y H GI+HRD+KP NV++ E ++
Sbjct: 125 ---------------------------LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIK 157
Query: 195 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGC----MFAGMI 248
+ D+G ++ + + PE+LV + Y+ ++D WSLG +G
Sbjct: 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY- 216
Query: 249 FRKEPFFYGHDNQDQL 264
P F H Q L
Sbjct: 217 ----PPFSEHRTQVSL 228
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 52/253 (20%), Positives = 98/253 (38%), Gaps = 61/253 (24%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 90
V R + G ++ V+E +V + + +K L + K + I +E+ ++ L G PNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 91 KLLD--IVRDQHSKTPSLIF----EHVNSTDFKVLYPT-----LTANEIRYYIYELLKHA 139
+ + + S T F E + L L+ + + Y+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC--- 146
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHRDVKPHNVMIDHEQQKLRLID 197
+A+ + H Q I+HRD+K N+++ ++ ++L D
Sbjct: 147 ------------------------RAVQHMHRQKPPIIHRDLKVENLLLSNQGT-IKLCD 181
Query: 198 WGLAEFYHPGKEYNVRVASR-------------YFKGPELLVDL---QDYDYSLDMWSLG 241
+G A +Y+ R ++ PE ++DL D+W+LG
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALG 240
Query: 242 CMFAGMIFRKEPF 254
C+ + FR+ PF
Sbjct: 241 CILYLLCFRQHPF 253
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 37/256 (14%), Positives = 77/256 (30%), Gaps = 58/256 (22%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCG 85
++ + K+G G++ VF+ + + IK K V ++ RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 86 GPNIVKLLDIVRDQHSKTPSLIF-EHVNS-------TDFKVLYPTLTANEIRYYIYELLK 137
++V+ + LI E+ N ++ + E++ + ++ +
Sbjct: 70 HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
L Y HS ++H D+KP N+ I +
Sbjct: 127 ---------------------------GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159
Query: 198 WGLAEFYHPGKEY---------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 242
G + + K V F E+L + + D+++L
Sbjct: 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALAL 219
Query: 243 MFAGMIFRKEPFFYGH 258
+ G
Sbjct: 220 TVVCAAGAEPLPRNGD 235
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 51/218 (23%)
Query: 29 GDQEDYEVVRKV-GRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGP 87
+DY+V +V G G +V + N EK +K+L+ K +RE+++ P
Sbjct: 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCP 71
Query: 88 NIVKLLDIVRDQHSKTPS--LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
+IV+++D+ + ++ ++ E ++ + L+ + + + E + A +++
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAF-TE--REA--SEIM 123
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH--EQQKLRLIDWGLAEF 203
+ I +A+ Y HS I HRDVKP N++ L+L D+G A
Sbjct: 124 ----------KSI----GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-- 167
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
E + YD S DMWSLG
Sbjct: 168 ------------------KETT--GEKYDKSCDMWSLG 185
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 47/247 (19%), Positives = 107/247 (43%), Gaps = 40/247 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 86
E Y ++K+G G + + + + + +IK + ++++ +RE+ +L N+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PNIV+ + + + + ++ ++ D +++ +
Sbjct: 83 PNIVQYRESFEE--NGSLYIVMDYCEGGD----------------LFKRINAQ------- 117
Query: 147 MPGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
L + I W +Q AL + H + I+HRD+K N+ + + ++L D+G+A
Sbjct: 118 --KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARV 174
Query: 204 YHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ E + + Y+ PE+ + + Y+ D+W+LGC+ + K F ++
Sbjct: 175 LNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKN 232
Query: 263 QLVKIAR 269
++KI
Sbjct: 233 LVLKIIS 239
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 37/258 (14%), Positives = 89/258 (34%), Gaps = 42/258 (16%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN-----EKCIIKILKPVKKKKIKREIKILQNLC 84
+ V +G G +++V+E N +K ++K+ KP + ++++ L
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 85 GG--PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
+K Q+ L+ E + N + +++ +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAI-----NLYKNTPEKVMPQGLVI 175
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH----------EQQK 192
+ + L ++ H I+H D+KP N ++ +
Sbjct: 176 SFAM----------RM----LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 193 LRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249
L LID G + + + G + + + F+ E+L + + ++Y +D + + M+F
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLF 280
Query: 250 RKEPFFYGHDNQDQLVKI 267
+ + +
Sbjct: 281 GTYMKVKNEGGECKPEGL 298
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 53/253 (20%), Positives = 94/253 (37%), Gaps = 53/253 (20%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 87
++ + + +G G +SEVF + +K + + ++ EI +L+ +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-HE 66
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNST-----DFKVLYPTLTANEIRYYIYELLKHAMPR 142
NIV L DI L+ + V + D + T + I ++L
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLS----- 117
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH--EQQKLRLIDWGL 200
A+ Y H GI+HRD+KP N++ E K+ + D+GL
Sbjct: 118 ----------------------AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL 155
Query: 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFY 256
++ G + + + PE+L + Y ++D WS+G + G P FY
Sbjct: 156 SKMEQNGI-MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGY-----PPFY 208
Query: 257 GHDNQDQLVKIAR 269
KI
Sbjct: 209 EETESKLFEKIKE 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 60/242 (24%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL------KPVKKKKIKREIKILQNLCG 85
Y R +G+G +++ FE + E KI+ KP +++K+ EI I ++L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNS---TDFKVLYPTLTANEIRYYIYELLKHAMPR 142
++V D + ++ E + LT E RYY+ +++
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV------ 151
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
Y H ++HRD+K N+ ++ + + +++ D+GLA
Sbjct: 152 ---------------------LGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLAT 189
Query: 203 FYHPGKE----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
E Y +A PE+L + + + +D+WS+GC+ ++ K
Sbjct: 190 KVEYDGERKKVLCGTPNY---IA------PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKP 239
Query: 253 PF 254
PF
Sbjct: 240 PF 241
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 55/241 (22%), Positives = 95/241 (39%), Gaps = 54/241 (22%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----------PVKKKKIKREIKILQ 81
Y + +G G + V+ ++ N++ ++K +K K K+ EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIF----EHVNST---DFKVLYPTLTANEIRYYIYE 134
+ NI+K+LDI + +H + F +P L Y +
Sbjct: 85 RVEH-ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 135 LLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
L+ A+ Y + I+HRD+K N++I E ++
Sbjct: 139 LV---------------------------SAVGYLRLKDIIHRDIKDENIVIA-EDFTIK 170
Query: 195 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEP 253
LID+G A + GK + + + PE+L+ Y L+MWSLG ++F + P
Sbjct: 171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENP 229
Query: 254 F 254
F
Sbjct: 230 F 230
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-26
Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 60/242 (24%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL------KPVKKKKIKREIKILQNLCG 85
Y R +G+G +++ FE + E KI+ KP +++K+ EI I ++L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNS---TDFKVLYPTLTANEIRYYIYELLKHAMPR 142
++V D + ++ E + LT E RYY+ +++
Sbjct: 75 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV------ 125
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
Y H ++HRD+K N+ ++ + + +++ D+GLA
Sbjct: 126 ---------------------LGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLAT 163
Query: 203 FYHPGKE----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
E Y +A PE+L + + + +D+WS+GC+ ++ K
Sbjct: 164 KVEYDGERKKVLCGTPNY---IA------PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 253 PF 254
PF
Sbjct: 214 PF 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 49/288 (17%), Positives = 106/288 (36%), Gaps = 57/288 (19%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL----KPVKKKKIKREIKILQNLCGG 86
D+E ++ +GRG + VFE N ++ IK + + + ++K+ RE+K L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV-- 144
P IV+ + + + + + D +P + + + ++ +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 145 --------------IIM---PGEGLM----------ENQDISVWD-----LQALDYCHSQ 172
I M E L + + +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 221
G+MHRD+KP N+ + +++ D+GL +E +
Sbjct: 184 GLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 222 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267
PE + +Y + +D++SLG + +++ F + + +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV 286
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 49/235 (20%), Positives = 83/235 (35%), Gaps = 42/235 (17%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 89
+ +VGRG + EV + +C +K ++ + E+ L P I
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRI 112
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNS---TDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
V L VR+ ++ E + L + YY+ + L
Sbjct: 113 VPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL---------- 160
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
+ L+Y H++ I+H DVK NV++ + + L D+G A P
Sbjct: 161 -----------------EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203
Query: 207 GKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+ Y G PE +V + D +D+WS CM M+ P+
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 49/223 (21%), Positives = 97/223 (43%), Gaps = 46/223 (20%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 86
E+Y++ ++G+G +S V + V ++ I L +K++RE +I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNST-----DFKVLYPTLTANEIRYYIYELLKHAMP 141
PNIV+L D + ++ LIF+ V T + V + + + I ++L
Sbjct: 70 PNIVRLHDSISEEGHH--YLIFDLV--TGGELFEDIVAREYYSEADASHCIQQIL----- 120
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWG 199
+A+ +CH G++HR++KP N+++ + ++L D+G
Sbjct: 121 ----------------------EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158
Query: 200 LAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
LA + + + + PE+L Y +D+W+ G
Sbjct: 159 LAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACG 200
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 59/258 (22%), Positives = 108/258 (41%), Gaps = 63/258 (24%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK--------KIKREIKILQNL 83
ED+E+ R +G+GK+ V+ + +K+L K + +++RE++I +L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-FKVLYPT--LTANEIRYYIYELLKHAM 140
PNI++L D + LI E+ ++ L YI EL
Sbjct: 67 RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA---- 119
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
AL YCHS+ ++HRD+KP N+++ + L++ D+G
Sbjct: 120 -----------------------NALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGW 155
Query: 201 AEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
+ + +Y + PE++ + +D +D+WSLG + + K
Sbjct: 156 SVHAPSSRRTDLCGTLDY---LP------PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKP 205
Query: 253 PFFYGHDNQDQLVKIARV 270
P F + Q+ +I+RV
Sbjct: 206 P-FEANTYQETYKRISRV 222
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 58/320 (18%), Positives = 126/320 (39%), Gaps = 81/320 (25%)
Query: 34 YEVVRKVGRGKYSEVFEGINV-TNNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 85
YE+V +G G + +V E I+ +KI+K V + + + EI++L++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNST--DFKVLYPTLTANEIRYYIYELLK----HA 139
V++L+ FEH F++L + Y+ +K
Sbjct: 76 TFRCVQMLEW------------FEHHGHICIVFELLGLST---------YDFIKENGFLP 114
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-------- 191
I + ++ +++++ HS + H D+KP N++
Sbjct: 115 FRLDHI----------RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 192 ----------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
++++D+G A + + V++R+++ PE+++ L + D+WS+G
Sbjct: 165 KRDERTLINPDIKVVDFGSATYDDE-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIG 221
Query: 242 C----MFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
C + G F HD+++ L + R+LG L K+ ++ + +
Sbjct: 222 CILIEYYLG-----FTVFPTHDSKEHLAMMERILGP------LPKHMIQKTRKRKYFHHD 270
Query: 298 KRVWPIPNNKKLQFCRSSRT 317
+ W ++ R+ +
Sbjct: 271 RLDWDEHSSAGRYVSRACKP 290
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 58/279 (20%), Positives = 114/279 (40%), Gaps = 79/279 (28%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNL----CGGP 87
+ V+RK+G G + V ++ N + +K+++ +KK + K E IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 88 NIVKLLDIVRDQHSKTPSLIFEH------VNSTDFKVLYPTLTANEIRYYIYELLK---- 137
NIVK F + + F+ L P+L YE++
Sbjct: 97 NIVKYHGK------------FMYYDHMCLI----FEPLGPSL---------YEIITRNNY 131
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQK----- 192
+ + I + + L+AL+Y + H D+KP N+++D +
Sbjct: 132 NGFHIEDI----------KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181
Query: 193 -------------------LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 233
++LID+G A F ++ + +R ++ PE++++L +D
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSI-INTRQYRAPEVILNLG-WDV 238
Query: 234 SLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLG 272
S DMWS GC+ A + + F H++ + L + ++
Sbjct: 239 SSDMWSFGCVLAEL-YTGSLLFRTHEHMEHLAMMESIIQ 276
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 56/271 (20%), Positives = 110/271 (40%), Gaps = 67/271 (24%)
Query: 34 YEVVRKVGRGKYSEVFEGI-NVTNNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 85
YE+V +G G + +V E + + + +KI++ V K + + EI +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNST--DFKVLYPTLTANEIRYYIYELLK----HA 139
V + D F F++L +E LK
Sbjct: 81 KFLCVLMSDW------------FNFHGHMCIAFELLGKNT---------FEFLKENNFQP 119
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQK------- 192
P + + ++ AL + H + H D+KP N++ + + +
Sbjct: 120 YPLPHV----------RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 193 -----------LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
+R+ D+G A F H + VA+R+++ PE++++L + D+WS+G
Sbjct: 170 SCEEKSVKNTSIRVADFGSATFDHE-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIG 226
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLG 272
C+ +R F H+N++ LV + ++LG
Sbjct: 227 CILFEY-YRGFTLFQTHENREHLVMMEKILG 256
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-24
Identities = 51/243 (20%), Positives = 103/243 (42%), Gaps = 61/243 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL------KPVKKKKIKREIKILQNLCG 85
ED++V +G+G ++ V+ ++ + IK++ K ++++ E+KI L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-FKVLYP---TLTANEIRYYIYELLKHAMP 141
P+I++L + D S L+ E ++ + + L + NE R+++++++
Sbjct: 71 -PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----- 122
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+ Y HS GI+HRD+ N+++ +++ D+GLA
Sbjct: 123 ----------------------TGMLYLHSHGILHRDLTLSNLLLTRNMN-IKIADFGLA 159
Query: 202 EFYHPGKE----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251
E Y ++ PE+ + D+WSLGCMF ++ +
Sbjct: 160 TQLKMPHEKHYTLCGTPNY---IS------PEIATR-SAHGLESDVWSLGCMFYTLLIGR 209
Query: 252 EPF 254
PF
Sbjct: 210 PPF 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 36/263 (13%), Positives = 84/263 (31%), Gaps = 34/263 (12%)
Query: 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------KKIKREIKILQN 82
+G+ E + E + + ++ K++K E+ L+
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEI--RYYIYELLKHAM 140
L G N + +R P + + + + R+++Y ++ +
Sbjct: 130 LRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 141 PRKV-----IIMPGEGLMENQDISVWD--LQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193
+ L+ + + + ++ L H G++H ++P ++++D ++ +
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-QRGGV 245
Query: 194 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSLDMWSLGCM 243
L + V SR F+ PEL +S D W+LG +
Sbjct: 246 FLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 244 FAGMIFRKEPFFYGHDNQDQLVK 266
+ P D +
Sbjct: 303 IYWIWCADLPI--TKDAALGGSE 323
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 55/225 (24%)
Query: 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 87
+Y +++ +G+G +++V ++ + IKI L P +K+ RE++I++ L P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74
Query: 88 NIVKLLDIVRDQHSKTPS---LIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
NIVKL +++ +T LI E+ + E+ +
Sbjct: 75 NIVKLFEVI-----ETEKTLYLIMEYASGG-------------------EVFDY------ 104
Query: 145 IIMPGEGLMEN-------QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
++ + E Q +S A+ YCH + I+HRD+K N+++D +++ D
Sbjct: 105 -LVAHGRMKEKEARSKFRQIVS-----AVQYCHQKRIVHRDLKAENLLLD-ADMNIKIAD 157
Query: 198 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
+G + + G + + + + PEL + YD +D+WSLG
Sbjct: 158 FGFSNEFTVGGKLDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLG 201
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 51/226 (22%), Positives = 97/226 (42%), Gaps = 50/226 (22%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-------PVKKKKIKREIKILQNLCGG 86
Y + +G G Y +V E ++ + +KILK P + +K+EI++L+ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
N+++L+D++ ++ + ++ E+ + E+L ++
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCG-----------------MQEMLDSVPEKR--- 105
Query: 147 MPGEGLMEN-------QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
Q I L+Y HSQGI+H+D+KP N+++ L++ G
Sbjct: 106 -----FPVCQAHGYFCQLID-----GLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALG 154
Query: 200 LAEFYHPGKEYNV---RVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
+AE HP + S F+ PE+ L + + +D+WS G
Sbjct: 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAG 200
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-23
Identities = 52/259 (20%), Positives = 106/259 (40%), Gaps = 65/259 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK--------KIKREIKILQNL 83
+D+++ R +G+GK+ V+ N +K+L K + +++REI+I +L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVEHQLRREIEIQSHL 71
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-FKVL--YPTLTANEIRYYIYELLKHAM 140
PNI+++ + D K L+ E + +K L + ++ EL
Sbjct: 72 RH-PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA---- 124
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
AL YCH + ++HRD+KP N+++ ++ + L++ D+G
Sbjct: 125 -----------------------DALHYCHERKVIHRDIKPENLLMGYKGE-LKIADFGW 160
Query: 201 AEFYHPGK---------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251
+ + P +Y + PE++ + +D +D+W G + +
Sbjct: 161 S-VHAPSLRRRTMCGTLDY---LP------PEMIEG-KTHDEKVDLWCAGVLCYEFLVGM 209
Query: 252 EPFFYGHDNQDQLVKIARV 270
P F + + +I V
Sbjct: 210 PP-FDSPSHTETHRRIVNV 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-23
Identities = 47/242 (19%), Positives = 92/242 (38%), Gaps = 44/242 (18%)
Query: 39 KVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLL 93
++GRG + V++G++ + L+ K K K E ++L+ L PNIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91
Query: 94 DIVRDQHSKTPSLIF--EHVNS---TDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
D ++ E + S + + + +R + ++L
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL------------ 139
Query: 149 GEGLMENQDISVWDLQALDYCHSQG--IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
+ L + H++ I+HRD+K N+ I +++ D GLA
Sbjct: 140 ---------------KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
Query: 207 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266
V + + F PE+ + YD S+D+++ G M + P + N Q+ +
Sbjct: 185 SFAKAV-IGTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYR 240
Query: 267 IA 268
Sbjct: 241 RV 242
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 51/227 (22%), Positives = 88/227 (38%), Gaps = 55/227 (24%)
Query: 40 VGRGKYSEVFEGINVTNNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIV 96
+G+G Y V+ G +++N + IK + + + EI + ++L NIV+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88
Query: 97 RDQHSKTPSLIFEHVN----STDFKVLYPTLTANE--IRYYIYELLKHAMPRKVIIMPGE 150
+ + E V S + + L NE I +Y ++L
Sbjct: 89 SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------------- 132
Query: 151 GLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY 210
+ L Y H I+HRD+K NV+I+ L++ D+G + +
Sbjct: 133 -------------EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS-----KRLA 174
Query: 211 NVRVASRYFKG------PE-LLVDLQDYDYSLDMWSLGC----MFAG 246
+ + F G PE + + Y + D+WSLGC M G
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-22
Identities = 52/245 (21%), Positives = 97/245 (39%), Gaps = 52/245 (21%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI--LKPVKKKKIKREIKILQNLCGGPN 88
+E+V VG G Y +V++G +V + IK+ + ++++IK+EI +L+ N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 89 IVKLLDIVRDQHSKTPS----LIFEH---------VNSTDFKVLYPTLTANEIRYYIYEL 135
I ++ L+ E + +T TL I Y E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L+ L + H ++HRD+K NV++ + ++L
Sbjct: 139 LR---------------------------GLSHLHQHKVIHRDIKGQNVLLTENAE-VKL 170
Query: 196 IDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFR 250
+D+G+ A+ N + + Y+ PE++ ++ YD+ D+WSLG M
Sbjct: 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 251 KEPFF 255
P
Sbjct: 231 APPLC 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 52/255 (20%), Positives = 93/255 (36%), Gaps = 75/255 (29%)
Query: 22 ESLTVQW-GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKRE 76
+S + W +++DYE+ +G G + V EK IK + ++ +E
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63
Query: 77 IKILQNLCGGPNIVK----------------------LLDIVRDQHSKTPSLIFEHVNST 114
I+ + C PNIV +LDI++ +K
Sbjct: 64 IQAMS-QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------- 114
Query: 115 DFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174
L + I + E+L+ L+Y H G
Sbjct: 115 -----SGVLDESTIATILREVLE---------------------------GLEYLHKNGQ 142
Query: 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDL 228
+HRDVK N+++ E +++ D+G++ F G + + F G PE++ +
Sbjct: 143 IHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201
Query: 229 QDYDYSLDMWSLGCM 243
+ YD+ D+WS G
Sbjct: 202 RGYDFKADIWSFGIT 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 46/220 (20%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNI 89
+ Y+ V+ +G G + + E +K + + ++REI ++L PNI
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78
Query: 90 VKLLDIVRDQHSKTPSLIF---EHVNST---DFKVLYPTLTANEIRYYIYELLKHAMPRK 143
V+ +++ TP+ + E+ + + + +E R++ +L
Sbjct: 79 VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL-------- 125
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID-HEQQKLRLIDWGLAE 202
+S + YCHS I HRD+K N ++D +L++ D+G ++
Sbjct: 126 --------------LS-----GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
+ V + + PE+L+ Q+YD D+WS G
Sbjct: 167 SSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCG 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 55/256 (21%), Positives = 112/256 (43%), Gaps = 65/256 (25%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKK------------------- 71
Y + ++G+G Y V N +N +K+L K +++
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 72 -------KIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-FKVLYPT- 122
++ +EI IL+ PN+VKL++++ D + ++FE VN +V
Sbjct: 75 QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 123 LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182
L+ ++ R+Y QD+ ++ ++Y H Q I+HRD+KP
Sbjct: 134 LSEDQARFYF-----------------------QDL----IKGIEYLHYQKIIHRDIKPS 166
Query: 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDL-QDYD-YSLDMWS 239
N+++ E +++ D+G++ + + V + F PE L + + + +LD+W+
Sbjct: 167 NLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWA 225
Query: 240 LGC-MFAGMIFRKEPF 254
+G ++ +F + PF
Sbjct: 226 MGVTLYC-FVFGQCPF 240
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 54/256 (21%), Positives = 103/256 (40%), Gaps = 57/256 (22%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 87
ED+++V+ +G G Y EV +N E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 88 NIVKLLDIVRDQHSKTPSLIF---EHVNST---DFKVLYPTLTANEIRYYIYELLKHAMP 141
N+VK + ++ + E+ + D + + + + ++L
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 114
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
++ + Y H GI HRD+KP N+++D E+ L++ D+GLA
Sbjct: 115 ----------------MA-----GVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 202 EFYHPGKEYNV---RVASRYFKGPELLVDLQDYD-YSLDMWSLG----CMFAGMIFRKEP 253
+ + + + PELL +++ +D+WS G M AG + P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGEL----P 207
Query: 254 FFYGHDNQDQLVKIAR 269
+ D+ +
Sbjct: 208 WDQPSDSCQEYSDWKE 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 47/220 (21%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 87
Y + +G G + +V + +K +K + K +++REI L+ L P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69
Query: 88 NIVKLLDIVRDQHSKTPSLIF---EHVNST--DFKVLYPTLTANEIRYYIYELLKHAMPR 142
+I+KL D++ TP+ I E+ D+ V +T +E R +
Sbjct: 70 HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ--------- 115
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
Q I A++YCH I+HRD+KP N+++D + +++ D+GL+
Sbjct: 116 -------------QIIC-----AIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSN 156
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
G S + PE++ + Y +D+WS G
Sbjct: 157 IMTDGNFLKTSCGSPNYAAPEVING-KLYAGPEVDVWSCG 195
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-21
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 48/221 (21%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGP 87
Y + +G G + +V G + K +KIL K KIKREI+ L+ P
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71
Query: 88 NIVKLLDIVRDQHSKTPSLIF---EHVNST---DFKVLYPTLTANEIRYYIYELLKHAMP 141
+I+KL ++ TP+ F E+V+ D+ + + E R ++
Sbjct: 72 HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------ 120
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+S A+DYCH ++HRD+KP NV++D ++ D+GL+
Sbjct: 121 ----------------LS-----AVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLS 158
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
G+ S + PE++ + Y +D+WS G
Sbjct: 159 NMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSCG 198
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 27/244 (11%), Positives = 71/244 (29%), Gaps = 29/244 (11%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------KKIKREIKILQNLCGGP 87
+G+ E + E + + ++ K++K E+ L+ L G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY---------ELLKH 138
N + +R P + + + + + +
Sbjct: 140 NQKQAKVHLRFIF---PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
+ +++ ++ L H G++H ++P ++++D ++ + L +
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD-QRGGVFLTGF 255
Query: 199 GLAEFYHPGKEYNVRVASRY----FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFR 250
G + + +L Q ++ D W+LG +
Sbjct: 256 EHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 251 KEPF 254
P
Sbjct: 314 DLPN 317
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 54/256 (21%), Positives = 103/256 (40%), Gaps = 57/256 (22%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 87
ED+++V+ +G G Y EV +N E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 88 NIVKLLDIVRDQHSKTPSLIF---EHVNST---DFKVLYPTLTANEIRYYIYELLKHAMP 141
N+VK + ++ + E+ + D + + + + ++L
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------ 114
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
++ + Y H GI HRD+KP N+++D E+ L++ D+GLA
Sbjct: 115 ----------------MA-----GVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLA 152
Query: 202 EFYHPGKEYNV---RVASRYFKGPELLVDLQDYD-YSLDMWSLG----CMFAGMIFRKEP 253
+ + + + PELL +++ +D+WS G M AG + P
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGEL----P 207
Query: 254 FFYGHDNQDQLVKIAR 269
+ D+ +
Sbjct: 208 WDQPSDSCQEYSDWKE 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 48/221 (21%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGP 87
Y + +G G + +V G + K +KIL K KI+REI+ L+ P
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76
Query: 88 NIVKLLDIVRDQHSKTPSLIF---EHVNST---DFKVLYPTLTANEIRYYIYELLKHAMP 141
+I+KL ++ TPS IF E+V+ D+ L E R ++L
Sbjct: 77 HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----- 126
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+DYCH ++HRD+KP NV++D ++ D+GL+
Sbjct: 127 ----------------------SGVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLS 163
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLG 241
G+ S + PE++ + Y +D+WS G
Sbjct: 164 NMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDIWSSG 203
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 50/221 (22%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNI 89
+E ++V+ K+G G Y V++ I+ + IK + ++I +EI I+Q C P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86
Query: 90 VKLLDIVRDQHSKTPSL--IFEHVNS---TD-FKVLYPTLTANEIRYYIYELLKHAMPRK 143
VK + K L + E+ + +D ++ TLT +EI + LK
Sbjct: 87 VKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK------ 136
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-AE 202
L+Y H +HRD+K N++++ + +L D+G+ +
Sbjct: 137 ---------------------GLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQ 174
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
+ N + + ++ PE++ + Y+ D+WSLG
Sbjct: 175 LTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGIT 214
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGG 86
+E + + K+G+G + EVF+GI+ + IKI+ + + I++EI +L C
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79
Query: 87 PNIVKLLDIVRDQHSKTPSL--IFEHVN--STDFKVLYPTLTANEIRYYIYELLKHAMPR 142
P + K + K L I E++ S + L +I + E+LK
Sbjct: 80 PYVTKYYG----SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILK----- 130
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-A 201
LDY HS+ +HRD+K NV++ E +++L D+G+
Sbjct: 131 ----------------------GLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAG 167
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
+ + N V + ++ PE++ YD D+WSLG + + P
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHS 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-19
Identities = 54/238 (22%), Positives = 98/238 (41%), Gaps = 49/238 (20%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK------IKREIKILQNLC 84
++ + +R++G G + V+ +V N+E IK + K+ I +E++ LQ
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-L 111
Query: 85 GGPNIVKLLDIVRDQHSKTPSL--IFEHVN---STDFKVLYPTLTANEIRYYIYELLKHA 139
PN ++ + + + + E+ S +V L EI + L+
Sbjct: 112 RHPNTIQYRG----CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ-- 165
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
L Y HS ++HRDVK N+++ E ++L D+G
Sbjct: 166 -------------------------GLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFG 199
Query: 200 LAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFF 255
A P + V + Y+ PE+++ + + YD +D+WSLG + RK P F
Sbjct: 200 SASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 49/273 (17%), Positives = 97/273 (35%), Gaps = 69/273 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--------------------PVKKK 71
DY ++R + +GK++++ +N+ +K + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 72 KIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV-----------NSTDFKVLY 120
K E++I+ ++ + I+ + +I+E++ K
Sbjct: 89 DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 121 PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDV 179
+ I+ I +L + Y H++ I HRDV
Sbjct: 146 CFIPIQVIKCIIKSVLN---------------------------SFSYIHNEKNICHRDV 178
Query: 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD-YSLDMW 238
KP N+++D + +++L D+G +E Y K+ + F PE + Y+ +D+W
Sbjct: 179 KPSNILMD-KNGRVKLSDFGESE-YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 239 SLGCMFAGMIFRKEPFFYGHDNQDQLV-KIARV 270
SLG M + P F + +L I
Sbjct: 237 SLGICLYVMFYNVVP-FSLKISLVELFNNIRTK 268
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 47/242 (19%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGP 87
E +E+V ++G G + +V++ N K+++ + + EI+IL C P
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76
Query: 88 NIVKLLDIVRDQHSKTPSL--IFEHVNS---TD-FKVLYPTLTANEIRYYIYELLKHAMP 141
IVKLL + L + E L LT +I+ ++L+
Sbjct: 77 YIVKLLG----AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE---- 128
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL- 200
AL++ HS+ I+HRD+K NV++ + +RL D+G+
Sbjct: 129 -----------------------ALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVS 164
Query: 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFY 256
A+ ++ + + + Y+ PE+++ YDY D+WSLG M + P
Sbjct: 165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224
Query: 257 GH 258
+
Sbjct: 225 LN 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 44/237 (18%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 87
++ Y K+G+G V+ ++V ++ I+ + + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 88 NIVKLLDIVRDQHSKTPSL--IFEHVNS---TDFKVLYPTLTANEIRYYIYELLKHAMPR 142
NIV LD + L + E++ TD V + +I E L+
Sbjct: 78 NIVNYLD----SYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQ----- 127
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL-A 201
AL++ HS ++HRD+K N+++ + ++L D+G A
Sbjct: 128 ----------------------ALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCA 164
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
+ + + V + Y+ PE +V + Y +D+WSLG M MI + P+ +
Sbjct: 165 QITPEQSKRSTMVGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 47/239 (19%), Positives = 98/239 (41%), Gaps = 48/239 (20%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 87
+ + K+G G V + + +K++ K +++ + E+ I+++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102
Query: 88 NIVKLLD--IVRDQHSKTPSL--IFEHVNS---TDFKVLYPTLTANEIRYYIYELLKHAM 140
N+V++ +V ++ L + E + TD V L +I +L+
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQ--- 152
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
AL Y H+QG++HRD+K ++++ + + ++L D+G
Sbjct: 153 ------------------------ALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGF 187
Query: 201 -AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
A+ + V + Y+ PE++ Y +D+WSLG M M+ + P+F
Sbjct: 188 CAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 43/229 (18%), Positives = 80/229 (34%), Gaps = 42/229 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVT-NNEKCIIKILKPVK----KKKIKREIKILQNLCGGPN 88
YEV + G ++ ++ N ++K L + E + L + P+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 89 IVKLLDIVRDQHSKTPSLIF---EHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
IV++ + V + + E+V K +P
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----------------RSKGQKLP---- 180
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
E + + L AL Y HS G+++ D+KP N+M+ EQ K LID G
Sbjct: 181 --VAEAI----AYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLK--LIDLGAV---S 229
Query: 206 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+ + F+ PE++ + D++++G A +
Sbjct: 230 RINSFGYLYGTPGFQAPEIVRTGPT-VAT-DIYTVGRTLAALTLDLPTR 276
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 46/244 (18%)
Query: 30 DQEDYEVVRKVGRG--KYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKILQN 82
+ YE++ +G+G V E ++ + ++ E+ + +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
L PNIV + + V+ + + +L+
Sbjct: 82 LFNHPNIVPYRAT--------------FIADNELWVVTSFMAYGSAK----DLICTHFM- 122
Query: 143 KVIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+G+ E I L+ALDY H G +HR VK +++I K+ L
Sbjct: 123 -------DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRS 174
Query: 201 AE--FYHPGKEYNVRVASRYFKG------PELLV-DLQDYDYSLDMWSLGCMFAGMIFRK 251
H ++ V +Y PE+L +LQ YD D++S+G +
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
Query: 252 EPFF 255
PF
Sbjct: 235 VPFK 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 57/283 (20%), Positives = 104/283 (36%), Gaps = 67/283 (23%)
Query: 20 DYESLTVQWGDQE-------DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK 72
Y + +QW E + R +G+G + EV + K L+ KK+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKR 221
Query: 73 IKR---------EIKILQNLCGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD--- 115
IK+ E +IL+ +V L +T L+ +N D
Sbjct: 222 IKKRKGEAMALNEKQILE-KVNSRFVVSL-------AYAYETKDALCLVLTLMNGGDLKF 273
Query: 116 --FKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173
+ + +Y E+ L+ H +
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEIC---------------------------CGLEDLHRER 306
Query: 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 233
I++RD+KP N+++D +R+ D GLA G+ RV + + PE++ + + Y +
Sbjct: 307 IVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTF 364
Query: 234 SLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDEL 276
S D W+LGC+ MI + P F + + ++ R++
Sbjct: 365 SPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVERLVKEVPE 406
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 30/190 (15%), Positives = 63/190 (33%), Gaps = 36/190 (18%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNIVK 91
+ + +K+G G + ++ EK ++K + + E+K Q + I K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIY--ELL----------KHA 139
++ + + P Y E L
Sbjct: 99 WIERKQLDYLGIPLFYG-----------SGLTEFKGRSYRFMVMERLGIDLQKISGQNGT 147
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDW 198
+ ++ G + L L+Y H +H D+K N+++ ++ ++ L D+
Sbjct: 148 FKKSTVLQLGIRM----------LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADY 197
Query: 199 GLAEFYHPGK 208
GL+ Y P
Sbjct: 198 GLSYRYCPNG 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 60/259 (23%), Positives = 101/259 (38%), Gaps = 59/259 (22%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR---------EIKILQ- 81
D+ V R +GRG + EV+ + +K L KK+IK E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245
Query: 82 -NLCGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLY--PTLTANEIRYYI 132
+ P IV + TP I + +N D L + ++R+Y
Sbjct: 246 VSTGDCPFIVCM-------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298
Query: 133 YELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQK 192
E++ L++ H++ +++RD+KP N+++D
Sbjct: 299 AEII---------------------------LGLEHMHNRFVVYRDLKPANILLDEHGH- 330
Query: 193 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
+R+ D GLA K+ + V + + PE+L YD S D +SLGCM ++
Sbjct: 331 VRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 253 PFFYGHDNQDQLVKIARVL 271
P F H +D+ L
Sbjct: 390 P-FRQHKTKDKHEIDRMTL 407
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 163 LQALDYCHSQGIMHRDVKPHNVMI---DHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRY 218
+ ++Y H+QG++HRD+KP N++ + +R+ D+G A+ +
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 219 FKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNQDQLVKIARVL 271
F PE+L + Q YD + D+WSLG M G F + +AR+
Sbjct: 186 FVAPEVL-ERQGYDAACDIWSLGVLLYTMLTGY-----TPFANGPDDTPEEILARIG 236
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 1/70 (1%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 91
+ YEV +G G YS I+ N + +KI+ K+ EI+IL PNI+
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 92 LLDIVRDQHS 101
L D+ D
Sbjct: 81 LKDVYDDGKY 90
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 66/336 (19%), Positives = 117/336 (34%), Gaps = 103/336 (30%)
Query: 9 DVNVHRPRDYWDYESLTVQWGD--QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK 66
D P DY V+ GD Y V+RK+G G +S V+ ++ + +K++K
Sbjct: 12 DDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71
Query: 67 PVKK--KKIKREIKILQNLC-------GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-- 115
+ + EI++L+++ +V+LLD F+
Sbjct: 72 SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD------------FKISGVNGTH 119
Query: 116 ----FKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171
F+VL L I Y +P + + I LQ LDY H+
Sbjct: 120 ICMVFEVLGHHLLK-WIIKSNY----QGLPLPCV----------KKIIQQVLQGLDYLHT 164
Query: 172 Q-GIMHRDVKPHNVMI-------------------------------------------- 186
+ I+H D+KP N+++
Sbjct: 165 KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNP 224
Query: 187 ----DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 242
+ E+ K+++ D G A K + + +R ++ E+L+ Y+ D+WS C
Sbjct: 225 LEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTAC 281
Query: 243 MFAGMIFRKEPFFYGHDNQ------DQLVKIARVLG 272
M + + F H + D + I +LG
Sbjct: 282 MAFE-LATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 51/238 (21%), Positives = 85/238 (35%), Gaps = 53/238 (22%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-KKKIKREIKILQNLCGGPN 88
D ++ EV VGRG + V + + IK ++ +K E++ L + PN
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNH-PN 62
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
IVKL L+ E+ LY L E Y +
Sbjct: 63 IVKLYGACL----NPVCLVMEYAEGGS---LYNVLHGAEPLPYY------TAAHAMSWC- 108
Query: 149 GEGLMENQDISVWDLQALDYCHS---QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
S Q + Y HS + ++HRD+KP N+++ L++ D+G A
Sbjct: 109 -------LQCS----QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA---- 153
Query: 206 PGKEYNVRVASRYFKG---------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
+ PE+ +Y D++S G + +I R++PF
Sbjct: 154 -------CDIQTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 44/250 (17%), Positives = 87/250 (34%), Gaps = 42/250 (16%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL----KPVKKKKIKREIKILQNLCG 85
+ D E + ++G G +V++ +K + + K+I ++ ++
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVN--STDFKVLYP-TLTANEIRYYIYELLKHAMPR 142
P IV+ + E + + K + + ++K
Sbjct: 83 CPYIVQCFGTFITNTDV--FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK----- 135
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
AL Y + G++HRDVKP N+++D Q ++L D+G++
Sbjct: 136 ----------------------ALYYLKEKHGVIHRDVKPSNILLDERGQ-IKLCDFGIS 172
Query: 202 EFYHPGKEYNVRVASRYFKGPE----LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
K + + PE DYD D+WSLG + + P+
Sbjct: 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232
Query: 258 HDNQDQLVKI 267
+ + L K+
Sbjct: 233 KTDFEVLTKV 242
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 34/174 (19%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 87
Y++V K+G G S V+ + N K IK + K+ +RE+ L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
NIV ++D+ + L+ E++ PTL YI + I
Sbjct: 72 NIVSMIDVDEEDD--CYYLVMEYIEG-------PTL-----SEYIES--HGPLSVDTAI- 114
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+ + L + + H I+HRD+KP N++ID + L++ D+G+A
Sbjct: 115 ---------NFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 37/174 (21%), Positives = 77/174 (44%), Gaps = 29/174 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 92
Y + RK+G G + +++ G ++ E+ IK+ K ++ E KI + + GG I +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
+ ++ E +L P+L ++ K +++ + +
Sbjct: 71 RWCGAEGDYNV--MVME--------LLGPSL------EDLFNFCSRKFSLKTVLLLADQM 114
Query: 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ--KLRLIDWGLAEFY 204
+ ++Y HS+ +HRDVKP N ++ ++ + +ID+GLA+ Y
Sbjct: 115 ----------ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-15
Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 31/176 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKL 92
+ V +K+G G + E+ G N+ NE IK+ + ++ E + + L G I ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
++ E +L P+L +++L K ++M L
Sbjct: 71 YYFGPCGKYNA--MVLE--------LLGPSL------EDLFDLCDRTFSLKTVLMIAIQL 114
Query: 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI----DHEQQKLRLIDWGLAEFY 204
+ ++Y HS+ +++RDVKP N +I + QQ + +ID+ LA+ Y
Sbjct: 115 ----------ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 36/176 (20%), Positives = 74/176 (42%), Gaps = 31/176 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 92
Y+V R++G G + +FEG N+ NN++ IK +++ E + + L G I +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
++ L+ + +L P+L + +L K + M + +
Sbjct: 72 YYFGQEGLHNV--LVID--------LLGPSL------EDLLDLCGRKFSVKTVAMAAKQM 115
Query: 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI----DHEQQKLRLIDWGLAEFY 204
L + H + +++RD+KP N +I + ++D+G+ +FY
Sbjct: 116 ----------LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 39/174 (22%), Positives = 80/174 (45%), Gaps = 29/174 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 92
+ + RK+G G + E++ G N+ NE+ IK+ K ++ E KI + L GG I +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
+ L+ + +L P+L ++ + K ++M
Sbjct: 69 RWFGVEGDYNV--LVMD--------LLGPSL------EDLFNFCSRKLSLKTVLM----- 107
Query: 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ--KLRLIDWGLAEFY 204
++ + +++ HS+ +HRD+KP N ++ ++ ++ +ID+GLA+ Y
Sbjct: 108 -----LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 41/245 (16%), Positives = 83/245 (33%), Gaps = 85/245 (34%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 87
ED + + ++GRG Y V + ++ + + +K + ++K++ ++ ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 88 NIVK---------------------LLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTAN 126
IV+ + +S +I E +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126
Query: 127 EIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG-IMHRDVKPHNVM 185
+ +K AL++ I+HRD+KP N++
Sbjct: 127 -LGKITLATVK---------------------------ALNHLKENLKIIHRDIKPSNIL 158
Query: 186 IDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL---VDLQDYDYSLD 236
+D ++L D+G++ + +A G PE + Q YD D
Sbjct: 159 LDRSGN-IKLCDFGIS------GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 211
Query: 237 MWSLG 241
+WSLG
Sbjct: 212 VWSLG 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 35/189 (18%), Positives = 74/189 (39%), Gaps = 31/189 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGI-----NVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 88
++V +G+G + ++ +V ++ C++K+ +P + E+K Q
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 89 IVKLLDIVRDQHSKTPSLIF---EHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAM 140
I K + + ++ P N ++ + L IYE
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ------KIYEANAKRF 149
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDWG 199
RK ++ + L L+Y H +H D+K N++++++ ++ L+D+G
Sbjct: 150 SRKTVLQLSLRI----------LDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 200 LAEFYHPGK 208
LA Y P
Sbjct: 200 LAYRYCPEG 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 60/286 (20%), Positives = 104/286 (36%), Gaps = 70/286 (24%)
Query: 20 DYESLTVQWGDQE-------DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK 72
Y +QW E + R +GRG + EVF + K L KK+
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKR 222
Query: 73 IKR---------EIKILQNLCGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD--- 115
+K+ E KIL IV L +T + L+ +N D
Sbjct: 223 LKKRKGYQGAMVEKKILA-KVHSRFIVSL-------AYAFETKTDLCLVMTIMNGGDIRY 274
Query: 116 ----FKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171
P +Y +++ L++ H
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIV---------------------------SGLEHLHQ 307
Query: 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 230
+ I++RD+KP NV++D + +R+ D GLA E + + F PELL+ ++
Sbjct: 308 RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EE 365
Query: 231 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDEL 276
YD+S+D ++LG MI + P F + + ++ + + +
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGP-FRARGEKVENKELKQRVLEQAV 410
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 2e-14
Identities = 46/276 (16%), Positives = 83/276 (30%), Gaps = 42/276 (15%)
Query: 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-----------KPVKKKKIKR 75
E + K+G G + EVF+ I ++ IKI+ ++I
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 76 EIKILQNLCG--------GPNIVKLLDIVRDQHSKTPSLIFEHV---NSTDFKVLYPTLT 124
EI I + L + L + Q S P L+ ++ P
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 125 ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHN 183
++ + + E + + + L + I +L + HRD+ N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243
V++ + Y + S L V + DY S +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 244 FAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAY 279
F + E F G D I R++ + N +
Sbjct: 239 FCDV-SMDEDLFTGD--GDYQFDIYRLMKKENNNRW 271
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-14
Identities = 56/252 (22%), Positives = 103/252 (40%), Gaps = 60/252 (23%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKI---KREIKILQNLCG 85
ED++ + +G G +S V + + + IKIL+ +K+ K+ RE ++ L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88
Query: 86 GPNIVKLLDIVRDQHS-KTPS---LIFEHVNSTD-FKVLYP--TLTANEIRYYIYELLKH 138
P VKL + + + + + K + + R+Y E++
Sbjct: 89 HPFFVKLY------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV-- 140
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
AL+Y H +GI+HRD+KP N++++ E +++ D+
Sbjct: 141 -------------------------SALEYLHGKGIIHRDLKPENILLN-EDMHIQITDF 174
Query: 199 GLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252
G A+ + R S F G PELL + + S D+W+LGC+ ++
Sbjct: 175 GTAK-VLSPESKQARANS--FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLP 230
Query: 253 PFFYGHDNQDQL 264
PF N+ +
Sbjct: 231 PFR--AGNEYLI 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 43/231 (18%), Positives = 79/231 (34%), Gaps = 46/231 (19%)
Query: 24 LTVQWG-DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREI 77
+ G D + + K+ E+++G ++K+LK K + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 78 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV-NSTDFKVLYPTLTANEIRYYIYELL 136
L+ PN++ +L + + P+LI + + + VL + +
Sbjct: 59 PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAV 114
Query: 137 KHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHRDVKPHNVMIDHEQQKLR 194
K A+ D++ + + + H+ I + +VMID E R
Sbjct: 115 KFAL----------------DMA----RGMAFLHTLEPLIPRHALNSRSVMID-EDMTAR 153
Query: 195 LIDWGLA-EFYHPGKEYNVR-VASRYFKGPELLVDLQDYDYSL--DMWSLG 241
+ + F PG+ Y VA PE L + DMWS
Sbjct: 154 ISMADVKFSFQSPGRMYAPAWVA------PEALQKKPEDTNRRSADMWSFA 198
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 34/176 (19%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 87
YE+ +G G SEV ++ ++ +K+L+ P + +RE + L P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 88 NIVKLLDI--VRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
IV + D P ++ E+V+ TL R ++ + M K
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGV-------TL-----RDIVHT--EGPMTPKRA 118
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
I ++ QAL++ H GI+HRDVKP N+MI ++++D+G+A
Sbjct: 119 I----------EVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 49/226 (21%), Positives = 84/226 (37%), Gaps = 57/226 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI----LKPVKKKKIKREIKILQNLCGGP 87
+D+E + ++G G VF+ + + K+ +KP + +I RE+++L C P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKV 144
IV S+ EH++ + + + ++K
Sbjct: 92 YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK------- 142
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQG-IMHRDVKPHNVMIDHEQQ-KL-------RL 195
L Y + IMHRDVKP N++++ + KL +L
Sbjct: 143 --------------------GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
ID +A N V +R + PE L Y D+WS+G
Sbjct: 183 ID-SMA---------NSFVGTRSYMSPERL-QGTHYSVQSDIWSMG 217
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 65/251 (25%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----------KKKKIKREIKI 79
+ E +++G+G + V +G V + IK L K ++ +RE+ I
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA 139
+ NL PNIVKL ++ + P ++ E V D LY L L+
Sbjct: 77 MSNLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLM 128
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHRDVKPHNVMIDHEQQK----L 193
+ DI+ ++Y +Q I+HRD++ N+ + +
Sbjct: 129 L----------------DIA----LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168
Query: 194 RLIDWGLAEFYHPGKEYNVRVASRYFKG---------PELLVDLQD-YDYSLDMWSLGCM 243
++ D+GL+ + + G PE + ++ Y D +S +
Sbjct: 169 KVADFGLS-----------QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 244 FAGMIFRKEPF 254
++ + PF
Sbjct: 218 LYTILTGEGPF 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 41/181 (22%), Positives = 72/181 (39%), Gaps = 48/181 (26%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKI---LQNLC 84
Y + R VGRG +V+E + +K++ PV + +++RE + LQ
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLK--HAMP- 141
P++V + D + + +N D +L+ +
Sbjct: 94 --PHVVPIHD--FGEIDGQLYVDMRLINGVDLA----------------AMLRRQGPLAP 133
Query: 142 -RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
R V I+ + I ALD H+ G HRDVKP N+++ + L+D+G+
Sbjct: 134 PRAVAIV--------RQI----GSALDAAHAAGATHRDVKPENILVSADDF-AYLVDFGI 180
Query: 201 A 201
A
Sbjct: 181 A 181
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 26/106 (24%), Positives = 46/106 (43%), Gaps = 16/106 (15%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 221
ALDY +Q I+HRD+KP N+++D E + + D+ +A G
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIA------AMLPRETQITTMAGTKP 179
Query: 222 ---PELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
PE+ Y +++D WSLG ++ + P ++ +
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTS 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 59/265 (22%), Positives = 98/265 (36%), Gaps = 74/265 (27%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR--------EIKILQNL 83
ED+E+++ +GRG + EV ++ +KIL K + +KR E +L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130
Query: 84 CGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLY---PTLTANEIRYYIYE 134
I L H + + L+ ++ D +L L R+Y+ E
Sbjct: 131 GDSKWITTL-------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 135 LLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
++ A+D H +HRD+KP N+++D +R
Sbjct: 184 MV---------------------------IAIDSVHQLHYVHRDIKPDNILMDM-NGHIR 215
Query: 195 LIDWGLAEFYHPGKE--YNVRVASRYFKG------PELLVDLQD----YDYSLDMWSLGC 242
L D+G + + V S G PE+L ++ Y D WSLG
Sbjct: 216 LADFGSC------LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 243 MFAGMIFRKEPFFYGHDNQDQLVKI 267
M++ + P FY + KI
Sbjct: 270 CMYEMLYGETP-FYAESLVETYGKI 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 45/250 (18%), Positives = 93/250 (37%), Gaps = 46/250 (18%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGG 86
D +G+G + + + + E ++K L ++ +E+K+++ L
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH- 66
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PN++K + ++ K + I E++ L + + + +Y + + A
Sbjct: 67 PNVLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAK------ 115
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF--- 203
DI+ + Y HS I+HRD+ HN ++ E + + + D+GLA
Sbjct: 116 ----------DIA----SGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVD 160
Query: 204 ------YHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251
+ R G PE++ + YD +D++S G + +I R
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRV 219
Query: 252 EPFFYGHDNQ 261
Sbjct: 220 NADPDYLPRT 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 56/264 (21%), Positives = 97/264 (36%), Gaps = 77/264 (29%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR--------EIKILQNL 83
+D+E+++ +GRG +SEV + +KI+ K +KR E +L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117
Query: 84 CGGPNIVKLLDIVRDQHS-KTPS---LIFEHVNSTD-FKVLY---PTLTANEIRYYIYEL 135
I +L + + + L+ E+ D +L + A R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
+ A+D H G +HRD+KP N+++D +RL
Sbjct: 172 V---------------------------MAIDSVHRLGYVHRDIKPDNILLDR-CGHIRL 203
Query: 196 IDWGLAEFYHPGKEYNV--RVASRYFKG------PELL------VDLQDYDYSLDMWSLG 241
D+G + V S G PE+L Y D W+LG
Sbjct: 204 ADFGSC------LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 242 -CMFAGMIFRKEPFFYGHDNQDQL 264
+ M + + PF+ D+ +
Sbjct: 258 VFAYE-MFYGQTPFY--ADSTAET 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 57/256 (22%), Positives = 95/256 (37%), Gaps = 66/256 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKR---EIKILQNLCG 85
EDYEVV+ +GRG + EV + + + +K+L +K+ E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127
Query: 86 GPNIVKLLDIVRDQHS-KTPS---LIFEHVNSTD-FKVLYPT-LTANEIRYYIYELLKHA 139
P +V+L ++ + ++ E++ D ++ + R+Y E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV--- 178
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
ALD HS G +HRDVKP N+++D L+L D+G
Sbjct: 179 ------------------------LALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFG 213
Query: 200 LAEFYHPGKEYNV--RVASRYFKG------PELLVD---LQDYDYSLDMWSLGCMFAGMI 248
+ N V G PE+L Y D WS+G M+
Sbjct: 214 TC------MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 249 FRKEPFFYGHDNQDQL 264
PF+ D+
Sbjct: 268 VGDTPFY--ADSLVGT 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 29/185 (15%), Positives = 64/185 (34%), Gaps = 21/185 (11%)
Query: 34 YEVVRKVGRGKYSEVFEGINVT--------NNEKCIIKILKPVKKKKIKREIKILQNLCG 85
+++ R ++E + +K +K+ K ++ E Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVI 145
+ K + P+ + V+ ++ L ++ + KH + + +
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDWGLAEFY 204
+ L L AL++ H +H +V N+ +D E Q ++ L +G A Y
Sbjct: 162 LQVACRL----------LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
Query: 205 HPGKE 209
P +
Sbjct: 212 CPSGK 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 54/251 (21%), Positives = 99/251 (39%), Gaps = 63/251 (25%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKK----IKREIKILQNLCG 85
+ ++ ++ +G G + V + + +KIL V K K E +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 86 GPNIVKLLDIVRDQHSKTPS---LIFEHVNSTD-FKVLY--PTLTANEIRYYIYELLKHA 139
P +VKL + K S ++ E+V + F L + R+Y +++
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV--- 151
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+Y HS +++RD+KP N++ID + +++ D+G
Sbjct: 152 ------------------------LTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFG 186
Query: 200 LAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253
A K R + G PE+++ + Y+ ++D W+LG + M P
Sbjct: 187 FA------KRVKGRTWT--LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 254 FFYGHDNQDQL 264
FF D Q+
Sbjct: 238 FF--ADQPIQI 246
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 62/264 (23%), Positives = 108/264 (40%), Gaps = 76/264 (28%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKK----IKREIKILQNLCG 85
+D++++R +GRG Y++V + +K++K V + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 86 GPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLY--PTLTANEIRYYIYELLK 137
P +V L HS +T S + E+VN D + L R+Y E+
Sbjct: 69 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS- 120
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
AL+Y H +GI++RD+K NV++D E ++L D
Sbjct: 121 --------------------------LALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTD 153
Query: 198 WGLA-EFYHPGK---------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247
+G+ E PG Y +A PE+L +DY +S+D W+LG + M
Sbjct: 154 YGMCKEGLRPGDTTSTFCGTPNY---IA------PEILRG-EDYGFSVDWWALGVLMFEM 203
Query: 248 IFRKEPFFYGH-------DNQDQL 264
+ + PF + +D L
Sbjct: 204 MAGRSPFDIVGSSDNPDQNTEDYL 227
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 77/260 (29%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKI---------KREIKILQN 82
+++E +R +G+G + +V + +K+LK K I E +IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 83 LCGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLYPT--LTANEIRYYIYE 134
P + +L +TP + E VN D + + R+Y E
Sbjct: 80 ARNHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 135 LLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
++ AL + H +GI++RD+K NV++DHE +
Sbjct: 133 II---------------------------SALMFLHDKGIIYRDLKLDNVLLDHEGH-CK 164
Query: 195 LIDWGLA-EFYHPGK---------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244
L D+G+ E G +Y +A PE+L + Y ++D W++G +
Sbjct: 165 LADFGMCKEGICNGVTTATFCGTPDY---IA------PEILQE-MLYGPAVDWWAMGVLL 214
Query: 245 AGMIFRKEPFFYGHDNQDQL 264
M+ PF +N+D L
Sbjct: 215 YEMLCGHAPFE--AENEDDL 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 29/271 (10%), Positives = 72/271 (26%), Gaps = 68/271 (25%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP------VKKKKIKREIKILQNLCGGP 87
Y ++ G + ++ ++ + + + + P ++ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA-MPRKVII 146
+ ++LD+V + ++ E + + E+ + P I
Sbjct: 92 GVARVLDVVHTRA--GGLVVAEWIRGGSLQ----------------EVADTSPSPVGAIR 133
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
+ L A D H G+ P V + + G
Sbjct: 134 A-MQSL----------AAAADAAHRAGVALSIDHPSRVRVSID---------G------- 166
Query: 207 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266
+V +A + D+ +G ++ + P +
Sbjct: 167 ----DVVLAYPATMPDA--------NPQDDIRGIGASLYALLVNRWPL--PEAGVRSGLA 212
Query: 267 IARVLGTDELNAYLDKYHLELDPQLEALVGR 297
A + ++ Q+ A+ R
Sbjct: 213 PAERDTAGQPIE-PADIDRDIPFQISAVAAR 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 41/239 (17%), Positives = 91/239 (38%), Gaps = 53/239 (22%)
Query: 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQ-NLC 84
VQ + +G+G++ EV+ G E+ +KI +++ RE +I Q +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVML 93
Query: 85 GGPNIVKLLDIVRDQHSKTP--SLIFE-HVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
NI+ + + L+ + H + + L+ L + ++K A+
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVE--GMIKLAL- 146
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQ--------GIMHRDVKPHNVMIDHEQQKL 193
+ L + H + I HRD+K N+++ +
Sbjct: 147 ---------------STA----SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTC 186
Query: 194 RLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL---VDLQDYDYSL--DMWSLG 241
+ D GLA + + + +A + G PE+L ++++ ++ D++++G
Sbjct: 187 CIADLGLAVRHDSATDT-IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 56/259 (21%), Positives = 98/259 (37%), Gaps = 75/259 (28%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR--------EIKILQNL 83
D+ ++ +G+G + +V + +K+L+ KK +K+ E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95
Query: 84 CGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLY--PTLTANEIRYYIYEL 135
P +V L H +T + +++N + F L R+Y E+
Sbjct: 96 VKHPFLVGL-------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
AL Y HS I++RD+KP N+++D + + L
Sbjct: 149 A---------------------------SALGYLHSLNIVYRDLKPENILLDSQGH-IVL 180
Query: 196 IDWGLA-EFYHPGK---------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 245
D+GL E EY +A PE+L Q YD ++D W LG +
Sbjct: 181 TDFGLCKENIEHNSTTSTFCGTPEY---LA------PEVLHK-QPYDRTVDWWCLGAVLY 230
Query: 246 GMIFRKEPFFYGHDNQDQL 264
M++ PF+ N ++
Sbjct: 231 EMLYGLPPFY--SRNTAEM 247
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 48/247 (19%), Positives = 93/247 (37%), Gaps = 56/247 (22%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLC 84
E E+ +G+G++ +V+ G + + I+++ + K KRE+ +
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 85 GGPNIVKLLDIVRDQHSKTPSL--IFEHV-NSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
N+V + P L I T LY + +I + + + A
Sbjct: 88 H-ENVVLFMGAC----MSPPHLAIITSLCKGRT----LYSVVRDAKIVLDVNKTRQIA-- 136
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
Q+I + + Y H++GI+H+D+K NV D+ K+ + D+GL
Sbjct: 137 --------------QEIV----KGMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLF 176
Query: 202 EFYHPGKEYNVRVASRYFKG------PELL--------VDLQDYDYSLDMWSLGCMFAGM 247
+ R G PE++ D + D+++LG ++ +
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 248 IFRKEPF 254
R+ PF
Sbjct: 237 HAREWPF 243
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 45/225 (20%), Positives = 95/225 (42%), Gaps = 46/225 (20%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLC 84
D + K+G G + V + +KIL + RE+ I++ L
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
PNIV + V S++ E+++ LY L + R + R++
Sbjct: 93 H-PNIVLFMGAVTQP--PNLSIVTEYLSRGS---LYRLLHKSGAREQL------DERRRL 140
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQG--IMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+ D++ + ++Y H++ I+HR++K N+++D ++ +++ D+GL+
Sbjct: 141 SMA--------YDVA----KGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSR 187
Query: 203 FYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLG 241
+ + ++S+ G PE+L D + + D++S G
Sbjct: 188 L-----KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFG 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 69/248 (27%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKK----IKREIKILQNLCG 85
+D++++R +GRG Y++V + ++++K V + ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 86 GPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLY--PTLTANEIRYYIYELLK 137
P +V L HS +T S + E+VN D + L R+Y E+
Sbjct: 112 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS- 163
Query: 138 HAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLID 197
AL+Y H +GI++RD+K NV++D E ++L D
Sbjct: 164 --------------------------LALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTD 196
Query: 198 WGLA-EFYHPGK---------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247
+G+ E PG Y +A PE+L +DY +S+D W+LG + M
Sbjct: 197 YGMCKEGLRPGDTTSTFCGTPNY---IA------PEILRG-EDYGFSVDWWALGVLMFEM 246
Query: 248 IFRKEPFF 255
+ + PF
Sbjct: 247 MAGRSPFD 254
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 56/267 (20%), Positives = 94/267 (35%), Gaps = 84/267 (31%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKI---------KREIKILQN 82
D+ + +G+G + +V +E +KILK K + E ++L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 83 LCGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLYPT--LTANEIRYYIYE 134
P + +L HS +T + E+VN D + +Y E
Sbjct: 77 PGKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 135 LLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
+ L + S+GI++RD+K NVM+D E ++
Sbjct: 130 IA---------------------------IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IK 161
Query: 195 LIDWGLA-EFYHPGK---------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC-- 242
+ D+G+ E G +Y +A PE++ Q Y S+D W+ G
Sbjct: 162 IADFGMCKENIWDGVTTKTFCGTPDY---IA------PEIIAY-QPYGKSVDWWAFGVLL 211
Query: 243 --MFAGMIFRKEPFFYGHDNQDQLVKI 267
M AG + F G D + I
Sbjct: 212 YEMLAG-----QAPFEGEDEDELFQSI 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 21/109 (19%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 221
AL+Y HS+ +++RD+K N+M+D + +++ D+GL KE + + F G
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLC------KEGISDGATMKT--FCG 167
Query: 222 ------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
PE+L D DY ++D W LG + M+ + P FY + ++L
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYN-QDHERL 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 57/261 (21%), Positives = 96/261 (36%), Gaps = 72/261 (27%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKR--------EIKILQNL 83
D+ + +G+G + +V +E +KILK K I+ E ++L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398
Query: 84 CGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLYPT--LTANEIRYYIYEL 135
P + +L HS +T + E+VN D + +Y E+
Sbjct: 399 GKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L + S+GI++RD+K NVM+D E +++
Sbjct: 452 A---------------------------IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKI 483
Query: 196 IDWGLAEFYHPGKE---YNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAG 246
D+G+ KE V + F G PE++ Q Y S+D W+ G +
Sbjct: 484 ADFGMC------KENIWDGVTTKT--FCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYE 534
Query: 247 MIFRKEPFFYGHDNQDQLVKI 267
M+ + P F G D + I
Sbjct: 535 MLAGQAP-FEGEDEDELFQSI 554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 46/250 (18%), Positives = 102/250 (40%), Gaps = 50/250 (20%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLC 84
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHV-NSTDFKVLYPTLTANEIRYYIYELLKHAMPRK 143
NI+ + +++ + S+ LY L A+E ++ + +L+ A
Sbjct: 79 H-VNILLFMGYSTAPQ---LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIAR--- 127
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
+ + +DY H++ I+HRD+K +N+ + E +++ D+GLA
Sbjct: 128 -------------QTA----RGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATE 169
Query: 204 YHPGKEYNVRVASRYFKG------PELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFF 255
+ G PE++ YS D+++ G + ++ + P+
Sbjct: 170 KSRWSGSHQFEQL---SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
Query: 256 YGHDNQDQLV 265
+N+DQ++
Sbjct: 227 -NINNRDQII 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 1e-10
Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 30/117 (25%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGK---------EYNVRV 214
AL + H +GI++RD+KP N+M++H+ ++L D+GL E H G EY +
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEY---M 188
Query: 215 ASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNQDQLVKI 267
A PE+L+ ++ ++D WSLG M G P F G + + + KI
Sbjct: 189 A------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTIDKI 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 30/110 (27%), Positives = 59/110 (53%), Gaps = 23/110 (20%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGK---------EYNVRV 214
L + HS+GI++RD+K N+++D + +++ D+G+ E +Y +
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDY---I 185
Query: 215 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
A PE+L+ Q Y++S+D WS G + M+ + P F+G ++++L
Sbjct: 186 A------PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHG-QDEEEL 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 22/113 (19%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGK---------EYNVRV 214
ALD+ HS GI++RD+KP N+++D E ++L D+GL+ E K EY +
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEY---M 193
Query: 215 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267
A PE++ + + S D WS G + M+ P F G D ++ + I
Sbjct: 194 A------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 18/106 (16%)
Query: 165 ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 221
AL+Y HS+ I++RD+KP N+++D +++ D+G A K + G
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYT--LCGTPD 168
Query: 222 ---PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
PE++ + Y+ S+D WS G + M+ PF+ N +
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKT 211
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 53/242 (21%)
Query: 23 SLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQ- 81
L VQ + ++V+++G+G+Y EV+ G EK +K+ ++ RE +I Q
Sbjct: 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFRETEIYQT 85
Query: 82 NLCGGPNIVKLLDIVRDQHSKTP--SLIFE-HVNSTDFKVLYPTLTANEIRYYIYELLKH 138
L NI+ + LI + H N + LY L + + +LK
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS----LYDYLKSTTLDAK--SMLKL 139
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ--------GIMHRDVKPHNVMIDHEQ 190
A L + H++ I HRD+K N+++ +
Sbjct: 140 AY----------------SSV----SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KN 178
Query: 191 QKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL---VDLQDYDYSL--DMWS 239
+ D GLA + V + G PE+L ++ + + DM+S
Sbjct: 179 GTCCIADLGLAVKFISDTN-EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 240 LG 241
G
Sbjct: 238 FG 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 81/278 (29%)
Query: 32 EDYEVVRKVGRGKYSEVF---EGINVTNNEKCIIKILKP---VKKKK----IKREIKILQ 81
E++E+++ +G G Y +VF + + +K+LK V+K K + E ++L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 82 NLCGGPNIVKLLDIVRDQHS--KTPS---LIFEHVNSTD-FKVLY--PTLTANEIRYYIY 133
++ P +V L H +T + LI +++N + F L T +E++ Y+
Sbjct: 114 HIRQSPFLVTL-------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166
Query: 134 ELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193
E++ AL++ H GI++RD+K N+++D +
Sbjct: 167 EIV---------------------------LALEHLHKLGIIYRDIKLENILLDSNGH-V 198
Query: 194 RLIDWGLAEFYHPGKE----YNVRVASRYFKG------PELLVDL-QDYDYSLDMWSLGC 242
L D+GL+ KE R F G P+++ +D ++D WSLG
Sbjct: 199 VLTDFGLS------KEFVADETERAYD--FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 243 ----MFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDEL 276
+ G F ++ +I+R + E
Sbjct: 251 LMYELLTGA-----SPFTVDGEKNSQAEISRRILKSEP 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 50/240 (20%), Positives = 86/240 (35%), Gaps = 53/240 (22%)
Query: 25 TVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQ-NL 83
++Q D ++ VG+G+Y EV+ G E +KI +K RE ++ +
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRETELYNTVM 58
Query: 84 CGGPNIVKLL--DIVRDQHSKTPSLIFE-HVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
NI+ + D+ S LI H + LY L + L+ +
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGS----LYDYLQLTTLDTV--SCLRIVL 112
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQ--------GIMHRDVKPHNVMIDHEQQK 192
I+ L + H + I HRD+K N+++ + +
Sbjct: 113 ----------------SIA----SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQ 151
Query: 193 LRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-----VDLQDYDYSLDMWSLG 241
+ D GLA + + V + G PE+L VD D +D+W+ G
Sbjct: 152 CCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 33/105 (31%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 165 ALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGP 222
ALDY HS+ +++RD+K N+M+D + +++ D+GL E G + + P
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 223 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267
E+L D DY ++D W LG + M+ + P FY D++ I
Sbjct: 319 EVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHEKLFELI 361
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 45/248 (18%), Positives = 92/248 (37%), Gaps = 61/248 (24%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-------KKKIKREIKILQN 82
D + + +G G + +V+ ++ +K + + +++E K+
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
L PNI+ L + + L+ E L L+ I I L+ A+
Sbjct: 63 LK-HPNIIALRGVCLKE--PNLCLVMEFARGGP---LNRVLSGKRIPPDI--LVNWAV-- 112
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQG---IMHRDVKPHNVMIDHEQQK------- 192
I+ + ++Y H + I+HRD+K N++I + +
Sbjct: 113 --------------QIA----RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154
Query: 193 LRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAG 246
L++ D+GLA +H + + G PE++ + D+WS G +
Sbjct: 155 LKITDFGLAREWHRTTKMS-------AAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWE 206
Query: 247 MIFRKEPF 254
++ + PF
Sbjct: 207 LLTGEVPF 214
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 49/222 (22%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 87
+D E + ++GRG Y V + +V + + K I + ++K++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD----------- 55
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR--KVI 145
LDI + + F Y L + EL+ ++ + K +
Sbjct: 56 -----LDISMRTV--------DCPFTVTF---YGALFREGDVWICMELMDTSLDKFYKQV 99
Query: 146 IMPGEGLMENQ--DISVWDLQALDYCHSQG-IMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
I G+ + E+ I+V ++AL++ HS+ ++HRDVKP NV+I+ Q +++ D+G++
Sbjct: 100 IDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISG 158
Query: 203 FYHPGKEYNVRVASRYFKGPE---LLVDLQDYDYSLDMWSLG 241
+ ++ + + PE ++ + Y D+WSLG
Sbjct: 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 50/246 (20%), Positives = 87/246 (35%), Gaps = 57/246 (23%)
Query: 19 WDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKK--KIKRE 76
E+L Q +++ RG++ V++ NE +KI K+ + + E
Sbjct: 14 LGTENLYFQS---MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 77 IKILQNLCGGPNIVKLL--DIVRDQHSKTPSLIFE-HVNSTDFKVLYPTLTANEIRYYIY 133
+ L + NI++ + + LI H + L L AN + +
Sbjct: 69 VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGS----LSDFLKANVVSWN-- 121
Query: 134 ELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ----------GIMHRDVKPHN 183
EL A ++ + L Y H I HRD+K N
Sbjct: 122 ELCHIAE----------------TMA----RGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161
Query: 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVAS----RYFKGPELLVD----LQDYDYSL 235
V++ + + D+GLA + GK RY PE+L +D +
Sbjct: 162 VLLKNNLT-ACIADFGLALKFEAGKSAGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRI 219
Query: 236 DMWSLG 241
DM+++G
Sbjct: 220 DMYAMG 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 60/267 (22%), Positives = 99/267 (37%), Gaps = 53/267 (19%)
Query: 15 PRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----VKK 70
P+D W + ED + ++GRG + EVF G +N +K + K
Sbjct: 105 PKDKWVL--------NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK 156
Query: 71 KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI-FEHVNSTDFKVLYPTLTANEIR 129
K +E +IL+ PNIV+L+ + + P I E V DF L R
Sbjct: 157 AKFLQEARILKQYS-HPNIVRLIGVCTQKQ---PIYIVMELVQGGDFLTF---LRTEGAR 209
Query: 130 YYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE 189
+ LL+ D + ++Y S+ +HRD+ N ++ E
Sbjct: 210 LRVKTLLQMV----------------GDAA----AGMEYLESKCCIHRDLAARNCLVT-E 248
Query: 190 QQKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELLVDLQDYDYSL--DMWSLG-C 242
+ L++ D+G++ G Y R PE L + YS D+WS G
Sbjct: 249 KNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEALNYGR---YSSESDVWSFGIL 304
Query: 243 MFAGMIFRKEPFFYGHDNQDQLVKIAR 269
++ P + NQ + +
Sbjct: 305 LWETFSLGASP-YPNLSNQQTREFVEK 330
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 40/255 (15%), Positives = 84/255 (32%), Gaps = 69/255 (27%)
Query: 20 DYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKI 79
++ ++ +++ +GRG+Y V++G + +K+ ++ E I
Sbjct: 4 AASEPSLDL---DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEKNI 58
Query: 80 -----LQNLCGGPNIVKLL--DIVRDQHSKTP-SLIFE-HVNSTDFKVLYPTLTANEIRY 130
+++ NI + + D + L+ E + N + L L+ + +
Sbjct: 59 YRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGS----LXKYLSLHTSDW 110
Query: 131 YIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ---------GIMHRDVKP 181
L H++ R L Y H++ I HRD+
Sbjct: 111 VSSCRLAHSVTR----------------------GLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PELL------V 226
NV++ + D+GL+ + PE+L
Sbjct: 149 RNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207
Query: 227 DLQDYDYSLDMWSLG 241
D + +DM++LG
Sbjct: 208 DXESALKQVDMYALG 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 45/253 (17%), Positives = 97/253 (38%), Gaps = 49/253 (19%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 276
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHA-------M 140
N+V+LL + + P I I E + +
Sbjct: 277 NLVQLLGVCTREP---PFYI------------------------ITEFMTYGNLLDYLRE 309
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+ + L IS A++Y + +HR++ N ++ E +++ D+GL
Sbjct: 310 CNRQEVSAVVLLYMATQIS----SAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGL 364
Query: 201 AEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 256
+ G Y +++ + PE L + D+W+ G ++ + P +
Sbjct: 365 SRLMT-GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP-YP 421
Query: 257 GHDNQDQLVKIAR 269
G D + +
Sbjct: 422 GIDLSQVYELLEK 434
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 2e-05
Identities = 42/296 (14%), Positives = 87/296 (29%), Gaps = 60/296 (20%)
Query: 5 RVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKI 64
+V+A NV R + Y ++ ++ + +G GK ++V + K K+
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA---LDVCLSYKVQCKM 180
Query: 65 LKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKV 118
+ + +++LQ L I D S
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLL--YQIDPNWTSRSDHSSNIK-------------- 224
Query: 119 LYPTLTANEIRYYIYELLKHAM-PRKVIIMPGEGLMENQDISVWDLQALDY----CHSQG 173
L + I+ + LLK ++++ +V + +A + C
Sbjct: 225 ----LRIHSIQAELRRLLKSKPYENCLLVL---------L-NVQNAKAWNAFNLSCKIL- 269
Query: 174 IMHRDVKPHNVMIDHEQQKLRLID--WGLAEFYHPGKEYNVRVAS-RYFKGPELLVDLQD 230
+ R + + + + L L K ++ R P ++
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 231 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAR----VLGTDELNAYLDK 282
S+ + + + + H N D+L I VL E D+
Sbjct: 328 RRLSI----IAESIRDGLATWD--NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 4e-05
Identities = 63/381 (16%), Positives = 119/381 (31%), Gaps = 108/381 (28%)
Query: 13 HRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK 72
H + D+E+ Q+ ++ V + + F+ +V + K I+
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILSVFED----AFVDNFDCKDVQDMPKSILS--------- 47
Query: 73 IKREIKILQNLCGGPNIV----KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTL----- 123
K EI ++ + V +L + + + E V ++K L +
Sbjct: 48 -KEEID---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR 103
Query: 124 -TANEIRYYIYE----------LLKHAMPRKVIIMP-GEGLME---NQDISV-------- 160
+ R YI + K+ + R + + L+E +++ +
Sbjct: 104 QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163
Query: 161 WDLQALDYCHSQGI------------MHRDVKPHNVMIDHEQQKL-RLIDWGLAEFYHPG 207
+ ALD C S + + P V+ QKL ID
Sbjct: 164 TWV-ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE--MLQKLLYQIDPNWTSRSDHS 220
Query: 208 KEYNVRVAS------RYFKGPE----LLV--DLQDYDYSLDMWSLGC------MFAGMIF 249
+R+ S R K LLV ++Q+ + + ++L C F +
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCKILLTTRFKQVTD 279
Query: 250 RKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELD------------PQLEALVG- 296
H L + L DE+ + L KY L+ P+ +++
Sbjct: 280 FLSAATTTH---ISLDHHSMTLTPDEVKSLLLKY-LDCRPQDLPREVLTTNPRRLSIIAE 335
Query: 297 --RKRV-----WPIPNNKKLQ 310
R + W N KL
Sbjct: 336 SIRDGLATWDNWKHVNCDKLT 356
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 2e-04
Identities = 44/317 (13%), Positives = 103/317 (32%), Gaps = 64/317 (20%)
Query: 33 DYEVVRKVGRGKYSEVF-----EGINVTNNEKCIIKILKPVKKKKIKREIK----ILQNL 83
+V + + + + + ++K L + + + RE+ ++
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD-CRPQDLPREVLTTNPRRLSI 332
Query: 84 CG-----GPNIVK-LLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLT-----ANEIRYYI 132
G + D+ + + +++ ++ L+ A+ I +
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-IPTIL 391
Query: 133 YELLKHAMPRKVII-----MPGEGLMENQD----ISVWDLQALDYCHSQGIMHRDVKP-- 181
L+ + + ++ + L+E Q IS+ + L+ + + +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY-LELK-----VKLENEYAL 445
Query: 182 HNVMIDHEQQKLRLIDWGLAE------FY-HPGKEY---NVRVASRYFKGPELLVDLQDY 231
H ++DH L FY H G + N+ R + +D +
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG--HHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 232 DYSLDMWSLGCMFAGMI------FRK-EPFFYGHDNQ-DQLVK-IARVLGTDELNAYLDK 282
+ + S +G I + +P+ +D + ++LV I L E N K
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
Query: 283 Y----HLELDPQLEALV 295
Y + L + EA+
Sbjct: 564 YTDLLRIALMAEDEAIF 580
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 48/241 (19%)
Query: 13 HRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGI-NVTNNEKCI---IKILK-- 66
P D + + + +R +G G + +V + TN+ +K LK
Sbjct: 20 QGPGDPTVFH--------KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD 71
Query: 67 --PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLT 124
P + K+EI IL+ L +I+K D + + L+ E+V
Sbjct: 72 AGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCEDAGAASLQLVMEYVPLGSL-------- 122
Query: 125 ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184
R Y L +H++ ++ L Q I + + Y H+Q +HRD+ NV
Sbjct: 123 ----RDY---LPRHSIGLAQLL-----LFAQQ-IC----EGMAYLHAQHYIHRDLAARNV 165
Query: 185 MIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSL 240
++D + +++ D+GLA + Y VR PE L + + + Y+ D+WS
Sbjct: 166 LLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSF 223
Query: 241 G 241
G
Sbjct: 224 G 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 39/192 (20%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKP----VKKKKIKREIKILQ 81
++ + +R +G G + +V E+ +K LKP +K+EI+IL+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS---TDFKVLYPTLTANEIRYYIYELLKH 138
NL NIVK I + LI E + S ++ L N+ + + + LK+
Sbjct: 79 NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY------LPKNKNKINLKQQLKY 131
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
A I + +DY S+ +HRD+ NV+++ + ++++ D+
Sbjct: 132 A----------------VQIC----KGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDF 170
Query: 199 GLAEFYHPGKEY 210
GL + KEY
Sbjct: 171 GLTKAIETDKEY 182
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 33/205 (16%), Positives = 72/205 (35%), Gaps = 38/205 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGI-------NVTNNEKCIIKILKP----VKKKKIKREIKIL 80
+ + + +G G + +V +K+LK + E++++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
+ + NI+ LL +I E+ + + + E L+
Sbjct: 95 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLR----------------EYLRARR 136
Query: 141 PRKVIIMPGEGLMENQDISVWDL--------QALDYCHSQGIMHRDVKPHNVMIDHEQQK 192
P + + + ++ DL + ++Y SQ +HRD+ NV++ E
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNV 195
Query: 193 LRLIDWGLAEFYHPGKEYNVRVASR 217
+++ D+GLA + Y R
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGR 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 37/207 (17%), Positives = 83/207 (40%), Gaps = 40/207 (19%)
Query: 11 NVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILK 66
++ +D + ++ + + ++G+G + V +K L+
Sbjct: 10 QLYACQDPTIF--------EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ 61
Query: 67 ---PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTL 123
P +++ +REI+IL+ L IVK + ++ L+ E++ S L L
Sbjct: 62 HSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC---LRDFL 117
Query: 124 TANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183
+ R LL ++ I + ++Y S+ +HRD+ N
Sbjct: 118 QRHRARLDASRLLLYS----------------SQIC----KGMEYLGSRRCVHRDLAARN 157
Query: 184 VMIDHEQQKLRLIDWGLAEFYHPGKEY 210
++++ + +++ D+GLA+ K+Y
Sbjct: 158 ILVE-SEAHVKIADFGLAKLLPLDKDY 183
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 41/263 (15%), Positives = 94/263 (35%), Gaps = 55/263 (20%)
Query: 32 EDYEVVRKVGRGKYSEVFEG-----INVTNNEKCIIKILKP----VKKKKIKREIKILQN 82
+ ++ + +GRG + +V E +K+LK + + + E+KIL +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 83 LCGGPNIVKLL-----------------------DIVRDQHSKTPSLIFEHVNSTDFKVL 119
+ N+V LL +R + ++ + K
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 120 Y---------------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQ 164
+ ++ + + L + + + + + + Q
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 165 ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRY-FK 220
+++ S+ +HRD+ N+++ E+ +++ D+GLA + +Y + +R K
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 221 --GPELLVDLQDYDYSLDMWSLG 241
PE + D + Y D+WS G
Sbjct: 261 WMAPETIFD-RVYTIQSDVWSFG 282
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 31/189 (16%), Positives = 69/189 (36%), Gaps = 38/189 (20%)
Query: 32 EDYEVVRKVGRGKYSEVFEGI-------NVTNNEKCIIKILKP----VKKKKIKREIKIL 80
+ + + +G G + +V +K+LK + E++++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
+ + NI+ LL +I E+ + + + E L+
Sbjct: 141 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLR----------------EYLRARR 182
Query: 141 PRKVIIMPGEGLMENQDISVWDL--------QALDYCHSQGIMHRDVKPHNVMIDHEQQK 192
P + + + ++ DL + ++Y SQ +HRD+ NV++ E
Sbjct: 183 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNV 241
Query: 193 LRLIDWGLA 201
+++ D+GLA
Sbjct: 242 MKIADFGLA 250
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 3e-04
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 12/85 (14%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI---IKILKP----VKKKKIKREIKILQN 82
+ED + R +G G + EV+EG+ + + I +K K K+K E I++N
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLI 107
L P+IVKL+ I+ + P+ I
Sbjct: 70 LD-HPHIVKLIGII----EEEPTWI 89
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 47/247 (19%), Positives = 98/247 (39%), Gaps = 39/247 (15%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
+E + K+G+G + EV+ G + IK LKP + + +E ++++ L
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 322
Query: 88 NIVKLLDIVRDQHSKTPSLI-FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
+V+L +V S+ P I E+++ ++ + ++
Sbjct: 323 KLVQLYAVV----SEEPIYIVTEYMSKGSL------------LDFLKGETGKYLRLPQLV 366
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
D++ + Y +HRD++ N+++ E ++ D+GLA
Sbjct: 367 ----------DMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE- 414
Query: 207 GKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNQD 262
EY R +++ K PE + + D+WS G + + P + G N++
Sbjct: 415 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNRE 472
Query: 263 QLVKIAR 269
L ++ R
Sbjct: 473 VLDQVER 479
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 37/262 (14%), Positives = 88/262 (33%), Gaps = 56/262 (21%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGI-------NVTNNEKCIIKILKPV---KKKKIKREIKI 79
ED +G+G ++++F+G+ + + ++K+L + +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 80 LQNLCGGPNIVKLLDIVRDQHSKTPSLI-FEHVNSTDFKVLYPTLTANEIRYYIYELLKH 138
+ L ++V + +++ E V Y L N+ I L+
Sbjct: 66 MSKLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TY--LKKNKNCINILWKLEV 118
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLI-- 196
A + ++ A+ + ++H +V N+++ E+ +
Sbjct: 119 A----------------KQLA----AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158
Query: 197 -----DWGLAEFYHPGKEYNVRV---ASRYFKGPELLVDLQDYDYSLDMWSLG-CMFAGM 247
D G++ P R+ PE + + ++ + + D WS G ++
Sbjct: 159 FIKLSDPGISITVLPKDILQERIPWVP------PECIENPKNLNLATDKWSFGTTLWEIC 212
Query: 248 IFRKEPFFYGHDNQDQLVKIAR 269
+P D+Q +L
Sbjct: 213 SGGDKP-LSALDSQRKLQFYED 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 43/230 (18%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGI--NVTNNEKCI---IKILKP----VKKKKIKREIKILQN 82
+ ++ + +GRG + +V E + C +K+LK + + + E+KIL +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
+ N+V LL + +I E + L+
Sbjct: 87 IGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLS----------------TYLRSKRNE 129
Query: 143 KVIIMPGEGLMENQDISVWDL--------QALDYCHSQGIMHRDVKPHNVMIDHEQQKLR 194
V + +++ L + +++ S+ +HRD+ N+++ E+ ++
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVK 188
Query: 195 LIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 241
+ D+GLA + +Y + +R K PE + D + Y D+WS G
Sbjct: 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 49/285 (17%), Positives = 116/285 (40%), Gaps = 52/285 (18%)
Query: 7 YADVNVHRPRDYWDYESLTVQWGDQEDYEV-------VRKVGRGKYSEVFEG----INVT 55
+ D ++ + + ++ + D++ + ++++G+G + V +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68
Query: 56 NNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVN 112
E +K L+ ++ ++ REI+IL++L NIVK + + LI E++
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 113 STDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172
L L ++ R +LL++ I + ++Y ++
Sbjct: 128 YGS---LRDYLQKHKERIDHIKLLQYT----------------SQIC----KGMEYLGTK 164
Query: 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 228
+HRD+ N++++ + ++++ D+GL + Y V+ PE L +
Sbjct: 165 RYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 229 QDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNQDQLVKIARVLG 272
+ + + D+WS G ++ E F Y ++ + R++G
Sbjct: 224 K-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 260
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 46/247 (18%), Positives = 98/247 (39%), Gaps = 39/247 (15%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
+E + K+G+G + EV+ G + IK LKP + + +E ++++ L
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 239
Query: 88 NIVKLLDIVRDQHSKTPSLI-FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
+V+L +V S+ P I E+++ ++ + ++
Sbjct: 240 KLVQLYAVV----SEEPIYIVTEYMSKGSL------------LDFLKGETGKYLRLPQLV 283
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206
D++ + Y +HRD++ N+++ E ++ D+GLA
Sbjct: 284 ----------DMAAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE- 331
Query: 207 GKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNQD 262
EY R +++ + PE + + D+WS G + + P + G N++
Sbjct: 332 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNRE 389
Query: 263 QLVKIAR 269
L ++ R
Sbjct: 390 VLDQVER 396
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 332 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.68 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.6 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.01 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.99 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.88 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.77 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.06 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 83.59 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.1 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-55 Score=386.13 Aligned_cols=232 Identities=25% Similarity=0.439 Sum_probs=190.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||+||+|++..+++.||+|++++. ..+.+.+|+.+++++ +||||++++++|.+ ...
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~ 106 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEK 106 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCE
Confidence 457899999999999999999999999999999999642 346789999999999 99999999999954 467
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++|+|..++ +.+++..++.++.|++. ||+|||++||+|||||
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~---------------------------al~ylH~~~IiHRDlK 159 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS---------------------------ALEYLHGKGIIHRDLK 159 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCS
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCccCCCC
Confidence 99999999999998875 46888888888888877 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|+|||++.++ .+||+|||+|+.+.... ...+.+||+.|||||++.+ ..|+.++|||||||++|+|+||..||. +
T Consensus 160 PeNILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~ 236 (311)
T 4aw0_A 160 PENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-A 236 (311)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC-C
T ss_pred HHHeEEcCCC-CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-C
Confidence 9999999766 79999999999875332 3456789999999999987 789999999999999999999999993 5
Q ss_pred CCCHHHHHHHHHHhC------CchHHHHHHhcCCCCChhHHHHh
Q 040656 258 HDNQDQLVKIARVLG------TDELNAYLDKYHLELDPQLEALV 295 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i 295 (332)
.+..+.+.++..... ++...+++.++ +..+|..|..+
T Consensus 237 ~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l-L~~dp~~R~t~ 279 (311)
T 4aw0_A 237 GNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL-LVLDATKRLGC 279 (311)
T ss_dssp SSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH-SCSSGGGSTTS
T ss_pred CCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH-ccCCHhHCcCh
Confidence 555556666655321 22334444444 44444444443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=389.16 Aligned_cols=206 Identities=20% Similarity=0.382 Sum_probs=176.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.+.|+++++||+|+||+||+|++..+|+.||||+++. ...+.+.+|+.+|+++ +|||||+++++|.+. ..+|+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence 4679999999999999999999999999999999963 2345689999999999 999999999999654 579999
Q ss_pred EeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
|||+++|+|..++ ..+++..+..++.|++. ||+|||++||+||||||+|||
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~---------------------------aL~ylH~~~IiHRDlKp~NIL 202 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQ---------------------------ALSVLHAQGVIHRDIKSDSIL 202 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGGGEE
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccccCCHHHEE
Confidence 9999999988875 45778877777777766 999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~ 264 (332)
++.++ .+||+|||+|+.+... ......+||+.|||||++.+ ..|+.++|||||||++|||++|..||. +.+..+.+
T Consensus 203 l~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~ 279 (346)
T 4fih_A 203 LTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAM 279 (346)
T ss_dssp ECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHH
T ss_pred ECCCC-CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHH
Confidence 99776 7999999999887543 34566799999999999877 789999999999999999999999994 44445555
Q ss_pred HHHHH
Q 040656 265 VKIAR 269 (332)
Q Consensus 265 ~~~~~ 269 (332)
..+..
T Consensus 280 ~~i~~ 284 (346)
T 4fih_A 280 KMIRD 284 (346)
T ss_dssp HHHHH
T ss_pred HHHHc
Confidence 55543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=392.67 Aligned_cols=207 Identities=21% Similarity=0.440 Sum_probs=169.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.-++|++++.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +|||||+++++|.+ ...+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~--~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE--NGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEE
Confidence 447999999999999999999999999999999999643 245789999999999 99999999999954 4679
Q ss_pred eeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 105 SLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
|+||||+++|+|..++. .+++..+..++.|++. ||+|||++||+||||
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~---------------------------aL~ylH~~~IiHRDl 151 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL---------------------------ALKHVHDRKILHRDI 151 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCEETTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeeccC
Confidence 99999999999987752 2456666666666665 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||+|||++.++ .+||+|||+|+...... .....+||+.|||||++.+ ..|+.++|||||||++|||+||..|| .+.
T Consensus 152 Kp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~ 228 (350)
T 4b9d_A 152 KSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF-EAG 228 (350)
T ss_dssp CGGGEEECTTC-CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCS
T ss_pred CHHHEEECCCC-CEEEcccccceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCc
Confidence 99999999766 79999999998764322 2345689999999999987 78999999999999999999999999 355
Q ss_pred CCHHHHHHHHH
Q 040656 259 DNQDQLVKIAR 269 (332)
Q Consensus 259 ~~~~~~~~~~~ 269 (332)
+..+.+.++..
T Consensus 229 ~~~~~~~~i~~ 239 (350)
T 4b9d_A 229 SMKNLVLKIIS 239 (350)
T ss_dssp SHHHHHHHHHH
T ss_pred CHHHHHHHHHc
Confidence 55555565554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-54 Score=374.40 Aligned_cols=236 Identities=23% Similarity=0.449 Sum_probs=173.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++++.||+|+||+||+|.+..+++.||+|++++. ....+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKS--KDEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEE
Confidence 36899999999999999999999999999999998632 235689999999999 99999999999954 4678
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||||++ |++...+ ..+++..+..++.|++. ||+|||++||+||||||
T Consensus 89 ~ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~---------------------------al~ylH~~~IiHRDiKP 140 (275)
T 3hyh_A 89 IMVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIIS---------------------------AVEYCHRHKIVHRDLKP 140 (275)
T ss_dssp EEEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCCCCCT
T ss_pred EEEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccccCCh
Confidence 99999995 4554443 45788888877777776 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+|||++.++ .+||+|||+|+.........+.+||+.|||||++.+...++.++|||||||++|+|+||..||. +.+..
T Consensus 141 ~NILl~~~~-~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~ 218 (275)
T 3hyh_A 141 ENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIP 218 (275)
T ss_dssp TTEEECTTC-CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHH
T ss_pred HHeEECCCC-CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHH
Confidence 999999666 7999999999877655556678999999999999874445789999999999999999999993 33333
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.....+..... ......++++++++ ..||+.||++||+
T Consensus 219 ~~~~~i~~~~~---------~~p~~~s~~~~~li------------------------~~~L~~dP~~R~s 256 (275)
T 3hyh_A 219 VLFKNISNGVY---------TLPKFLSPGAAGLI------------------------KRMLIVNPLNRIS 256 (275)
T ss_dssp HHHHHHHHTCC---------CCCTTSCHHHHHHH------------------------HHHSCSSGGGSCC
T ss_pred HHHHHHHcCCC---------CCCCCCCHHHHHHH------------------------HHHccCChhHCcC
Confidence 34444433211 11123455555554 4589999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=374.61 Aligned_cols=240 Identities=21% Similarity=0.390 Sum_probs=186.5
Q ss_pred CCCCc-eEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc--CC
Q 040656 30 DQEDY-EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HS 101 (332)
Q Consensus 30 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~ 101 (332)
...+| ++.++||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++++ +|||||+++++|.+. ..
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCC
Confidence 34455 7888999999999999999999999999998632 235689999999999 999999999998653 23
Q ss_pred CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC--Cee
Q 040656 102 KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMH 176 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH 176 (332)
..+++||||+++|+|..++ ..+++..+..++.|++. ||+|||+++ |+|
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------aL~ylH~~~~~IiH 154 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK---------------------------GLQFLHTRTPPIIH 154 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHTSSSCCCC
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCCEEe
Confidence 4689999999999998876 34666666666666655 999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||||+|||++..++.+||+|||+|+... .....+.+||+.|||||++.+ .|+.++|||||||++|||+||..||..
T Consensus 155 RDlKp~NILl~~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 155 RDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccChhheeEECCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999998544579999999997543 344556789999999999865 699999999999999999999999943
Q ss_pred CCCCHHHH-HHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQL-VKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+...+ ..+.....+.. .....+|++++++ ..||+.||++||+
T Consensus 232 -~~~~~~~~~~i~~~~~~~~-------~~~~~~~~~~~li------------------------~~~L~~dP~~R~s 276 (290)
T 3fpq_A 232 -CQNAAQIYRRVTSGVKPAS-------FDKVAIPEVKEII------------------------EGCIRQNKDERYS 276 (290)
T ss_dssp -CSSHHHHHHHHTTTCCCGG-------GGGCCCHHHHHHH------------------------HHHSCSSGGGSCC
T ss_pred -CCcHHHHHHHHHcCCCCCC-------CCccCCHHHHHHH------------------------HHHccCChhHCcC
Confidence 3333332 22222111111 1123445555555 5599999999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=389.98 Aligned_cols=206 Identities=20% Similarity=0.382 Sum_probs=176.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.+.|+++++||+|+||.||+|++..+|+.||||+++. ...+.+.+|+.+|+++ +|||||+++++|.+. ..+|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEEC--CEEEEE
Confidence 4679999999999999999999999999999999963 2346789999999999 999999999999654 579999
Q ss_pred EeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
||||++|+|..++ ..+++..+..++.|++. ||+|||++||+||||||+|||
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~---------------------------aL~ylH~~~IiHRDiKp~NIL 279 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQ---------------------------ALSVLHAQGVIHRDIKSDSIL 279 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSTTTEE
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeecccCCHHHEE
Confidence 9999999988875 45777777777777666 999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~ 264 (332)
++.++ .+||+|||+|+.+... ......+||+.|||||++.+ ..|+.++|||||||++|||++|..||. +.+..+.+
T Consensus 280 l~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~ 356 (423)
T 4fie_A 280 LTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAM 356 (423)
T ss_dssp ECTTC-CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHH
T ss_pred EcCCC-CEEEecCccceECCCCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHH
Confidence 99776 7999999999877543 34566799999999999877 789999999999999999999999994 44445555
Q ss_pred HHHHH
Q 040656 265 VKIAR 269 (332)
Q Consensus 265 ~~~~~ 269 (332)
..+..
T Consensus 357 ~~i~~ 361 (423)
T 4fie_A 357 KMIRD 361 (423)
T ss_dssp HHHHH
T ss_pred HHHHc
Confidence 54443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=380.32 Aligned_cols=207 Identities=28% Similarity=0.479 Sum_probs=169.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEc---cCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
+.++|++++.||+|+||+||+|++. .+++.||+|++++. ....+.+|+.+++++ +||||++++++|.+ .
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~ 98 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQT--E 98 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEE--T
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--C
Confidence 4578999999999999999999874 46789999998642 234688999999999 99999999999965 4
Q ss_pred CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||||+++|+|..++ ..+++..++.++.|++. ||+|||++||+|||
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~---------------------------aL~ylH~~~IiHRD 151 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL---------------------------ALDHLHSLGIIYRD 151 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSS
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCcCCC
Confidence 6799999999999998875 45788888877777776 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|||+|||++.++ .+||+|||+|+.... .....+.+||+.|||||++.+ ..|+.++|||||||++|||+||..|| .+
T Consensus 152 lKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF-~~ 228 (304)
T 3ubd_A 152 LKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF-QG 228 (304)
T ss_dssp CCGGGEEECTTS-CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSS-CC
T ss_pred CCHHHeEEcCCC-CEEecccccceeccCCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCC-CC
Confidence 999999999776 799999999986543 334456789999999999987 78999999999999999999999999 45
Q ss_pred CCCHHHHHHHHH
Q 040656 258 HDNQDQLVKIAR 269 (332)
Q Consensus 258 ~~~~~~~~~~~~ 269 (332)
.+..+.+..+.+
T Consensus 229 ~~~~~~~~~i~~ 240 (304)
T 3ubd_A 229 KDRKETMTMILK 240 (304)
T ss_dssp SSHHHHHHHHHH
T ss_pred cCHHHHHHHHHc
Confidence 555556666554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=383.37 Aligned_cols=238 Identities=22% Similarity=0.319 Sum_probs=190.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
.+.|++.++||+|+||.||+|++..+|+.||||+++... ...+|+.+++++ +|||||+++++|.+ ...+++||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~--~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVRE--GPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEE--TTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEEec
Confidence 356999999999999999999999999999999997432 235799999999 99999999999954 4578999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
+++++|..++ +.+++..+..++.|++. ||+|||++||+||||||+|||++
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~---------------------------aL~ylH~~~IiHRDlKp~NILl~ 184 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALE---------------------------GLEYLHTRRILHGDVKADNVLLS 184 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHTTTEECSCCCGGGEEEC
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCceecccCHHHEEEe
Confidence 9999998876 45788887777777766 99999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCCc------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 188 HEQQKLRLIDWGLAEFYHPGKE------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
.++.++||+|||+|+.+..... ....+||+.|||||++.+ ..|+.++|||||||++|||+||..||. +....
T Consensus 185 ~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~ 262 (336)
T 4g3f_A 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT-QYFRG 262 (336)
T ss_dssp TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSST-TTCCS
T ss_pred CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHH
Confidence 7765799999999987654321 223579999999999987 789999999999999999999999994 44444
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+... .... ......+++.+++++.+ ||+.||++||+
T Consensus 263 ~~~~~i~~~--~~~~----~~~~~~~s~~~~~li~~------------------------~L~~dP~~R~s 303 (336)
T 4g3f_A 263 PLCLKIASE--PPPI----REIPPSCAPLTAQAIQE------------------------GLRKEPVHRAS 303 (336)
T ss_dssp CCHHHHHHS--CCGG----GGSCTTSCHHHHHHHHH------------------------HTCSSGGGSCC
T ss_pred HHHHHHHcC--CCCc----hhcCccCCHHHHHHHHH------------------------HccCCHhHCcC
Confidence 445555442 1111 12334566666666644 88888888885
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-53 Score=374.30 Aligned_cols=257 Identities=18% Similarity=0.246 Sum_probs=187.6
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
+..++++|.+.+.||+|+||+||+|.+. .++..||||+++... .+.+.+|+++|+++ +||||++++++|.+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE 86 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee
Confidence 3456789999999999999999999864 357889999997533 46789999999999 99999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
...+++||||+++|+|..++......... .. .........+.+...++.|+++||+|||+++|+|||
T Consensus 87 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~------~~-----~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 153 (299)
T 4asz_A 87 --GDPLIMVFEYMKHGDLNKFLRAHGPDAVL------MA-----EGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRD 153 (299)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHHTSHHHHH------C---------CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCccccc------cc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCc
Confidence 45789999999999998876321110000 00 000000112223345666777799999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+|||++.++ .+||+|||+|+....... .....||..|||||++.+ ..|+.++|||||||++|||+| |..||
T Consensus 154 lKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf 231 (299)
T 4asz_A 154 LATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW 231 (299)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cCHhhEEECCCC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999666 799999999986543322 223468999999999987 689999999999999999999 89998
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+.+..+......+ .+..+++++.+++ ..||+.||++||+
T Consensus 232 -~~~~~~~~~~~i~~~~~~~--------~p~~~~~~~~~li------------------------~~cl~~dP~~RPs 276 (299)
T 4asz_A 232 -YQLSNNEVIECITQGRVLQ--------RPRTCPQEVYELM------------------------LGCWQREPHMRKN 276 (299)
T ss_dssp -TTSCHHHHHHHHHHTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred -CCCCHHHHHHHHHcCCCCC--------CCccchHHHHHHH------------------------HHHcCCChhHCcC
Confidence 4555555555555432111 1134455555555 5599999999996
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=380.79 Aligned_cols=274 Identities=27% Similarity=0.476 Sum_probs=204.0
Q ss_pred ccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 24 LTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 24 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
....+.-.++|++++.||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+.+|+++ +||||+++++++..
T Consensus 46 ~~~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 46 FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRP 124 (398)
T ss_dssp --CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCC
T ss_pred cCCCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeec
Confidence 334444557899999999999999999999999999999999642 235678999999999 99999999999864
Q ss_pred c----CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 99 Q----HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 99 ~----~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
. +...+|+||||++++ +..++ +.+++..++.++.|++. ||.|||+
T Consensus 125 ~~~~~~~~~~~ivmE~~~g~-L~~~i~~~~~l~~~~~~~~~~qil~---------------------------al~ylH~ 176 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLR---------------------------GLKYMHS 176 (398)
T ss_dssp SSCTTTCCCEEEEEECCSEE-HHHHHTSSSCCCHHHHHHHHHHHHH---------------------------HHHHHHH
T ss_pred ccccccCCEEEEEEeCCCCC-HHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHH
Confidence 3 345789999999755 44433 45788888888888776 9999999
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccceeecCC-----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
+||+||||||+|||++.++ .+||+|||+|+.+... ....+.+||+.|||||++.+...++.++||||+||++||
T Consensus 177 ~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~e 255 (398)
T 4b99_A 177 AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE 255 (398)
T ss_dssp TTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCcCCCcCccccccCCCC-CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHH
Confidence 9999999999999999766 7999999999865322 234567999999999998886678999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcc--cccccccccccCceEEE
Q 040656 247 MIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNK--KLQFCRSSRTSTNICIT 324 (332)
Q Consensus 247 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~~~~~cl~ 324 (332)
|++|..|| .+.+..+++..|....+.+....+.. ......+..+....++...... .........+|+..||.
T Consensus 256 ll~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~ 330 (398)
T 4b99_A 256 MLARRQLF-PGKNYVHQLQLIMMVLGTPSPAVIQA----VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLR 330 (398)
T ss_dssp HHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGGTC---------CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSC
T ss_pred HHHCCCCC-CCCCHHHHHHHHHHhcCCCChHHhhh----hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCc
Confidence 99999998 67778888999988887654321100 0111122222222111110000 00112233467788999
Q ss_pred eCCCCCCC
Q 040656 325 FSPSGFPF 332 (332)
Q Consensus 325 ~dP~~RP~ 332 (332)
+||++||+
T Consensus 331 ~dP~~R~t 338 (398)
T 4b99_A 331 FEPSARIS 338 (398)
T ss_dssp SSTTTSCC
T ss_pred CChhHCcC
Confidence 99999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=376.43 Aligned_cols=272 Identities=24% Similarity=0.382 Sum_probs=210.4
Q ss_pred CCceEEEeecccCCceEEEEEEc---cCCceEEEEEecc-cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||+|+||+||+|++. .+++.||+|.+.+ ....++.+|+++++.+.+||||++++++|.+ ..++++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEEE
Confidence 67999999999999999999874 4578999998864 3456788999999999789999999999955 4679999
Q ss_pred EeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 108 FEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
|||++++++..++..+++..++.++.|++. ||+|||++||+||||||+|||++
T Consensus 99 mE~~~g~~L~~~~~~l~~~~~~~~~~qll~---------------------------al~ylH~~gIiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 99 MPYLEHESFLDILNSLSFQEVREYMLNLFK---------------------------ALKRIHQFGIVHRDVKPSNFLYN 151 (361)
T ss_dssp EECCCCCCHHHHHTTCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCSGGGEEEE
T ss_pred EeCCCcccHHHHHcCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEeCcCCHHHeEEe
Confidence 999999999999888999998888888877 99999999999999999999998
Q ss_pred CCCCeEEEEecccceeecCCC-----------------------------cccccccccceeccccccCCCCCCCcccHH
Q 040656 188 HEQQKLRLIDWGLAEFYHPGK-----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMW 238 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiw 238 (332)
.+.+.+||+|||+|+...... ..+..+||+.|+|||++.+...++.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 775689999999998654221 123457999999999998866799999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCC-------CCChhHHHHhccCCC-----------
Q 040656 239 SLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHL-------ELDPQLEALVGRKRV----------- 300 (332)
Q Consensus 239 SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~i~~~~~----------- 300 (332)
|+||++|||+||..||+.+.++.+++..+....+++........... ......+...++...
T Consensus 232 SlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~ 311 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD 311 (361)
T ss_dssp HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------
T ss_pred hhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccc
Confidence 99999999999999999888889999999998887654443322211 011112222211100
Q ss_pred ---CCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 301 ---WPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 301 ---~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.......+........+|+.+||++||++||+
T Consensus 312 ~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t 346 (361)
T 4f9c_A 312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT 346 (361)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSCTTTSCC
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 00000111222333457899999999999996
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=371.57 Aligned_cols=257 Identities=16% Similarity=0.250 Sum_probs=184.1
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
..+.++|.+.++||+|+||.||+|... .+++.||||+++... .+.|.+|+++|+++ +|||||+++++|.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~- 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE- 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE-
Confidence 345788999999999999999999864 367899999997433 46799999999999 99999999999954
Q ss_pred CCCCceeEEeeecCCCceeeccccchhh-HHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYPTLTANE-IRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
...+++||||+++|+|..++....... ........ ......+.+...++.|+++||+|||+++|+|||
T Consensus 115 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~----------~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 183 (329)
T 4aoj_A 115 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV----------APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRD 183 (329)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHTSSCC---------------------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccc----------cCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccc
Confidence 457899999999999988753311110 00000000 001123334456777788899999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+|||++.++ .+||+|||+|+....... .....||..|||||++.+ ..++.++|||||||++|||+| |..||
T Consensus 184 LKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 184 LATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp CCGGGEEEETTT-EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccHhhEEECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCC
Confidence 999999999665 899999999987643322 234578999999999987 789999999999999999999 89999
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
. +....+.+..+......+ .+..+++++.+++ ..||+.||++||+
T Consensus 262 ~-~~~~~~~~~~i~~g~~~~--------~p~~~~~~~~~li------------------------~~cl~~dP~~RPs 306 (329)
T 4aoj_A 262 Y-QLSNTEAIDCITQGRELE--------RPRACPPEVYAIM------------------------RGCWQREPQQRHS 306 (329)
T ss_dssp C-SSCHHHHHHHHHHTCCCC--------CCTTCCHHHHHHH------------------------HHHCCSSTTTSCC
T ss_pred C-CCCHHHHHHHHHcCCCCC--------CcccccHHHHHHH------------------------HHHcCcChhHCcC
Confidence 4 445555555554432211 1134555666555 4599999999996
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=369.66 Aligned_cols=259 Identities=18% Similarity=0.269 Sum_probs=188.7
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeee
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVR 97 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 97 (332)
...+.+++++.++||+|+||+||+|... .+++.||||+++.. ..+.|.+|+.+++++ +||||++++|+|.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEE
Confidence 3446678999999999999999999853 46789999999642 346799999999999 9999999999995
Q ss_pred ccCCCCceeEEeeecCCCceeeccccch-hhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 98 DQHSKTPSLIFEHVNSTDFKVLYPTLTA-NEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
+ ...+++||||+++|+|..++..... .... .............+.+...++.||++||+|||+++|||
T Consensus 100 ~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~---------~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiH 168 (308)
T 4gt4_A 100 K--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVG---------STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVH 168 (308)
T ss_dssp S--SSSCEEEEECCSSCBHHHHHHTTCSSCCCC--------------CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred E--CCEEEEEEEcCCCCcHHHHHHhhCcccccc---------ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 4 4578999999999998877522100 0000 00000001111223334567778888999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
|||||+|||++.++ .+||+|||+|+...... ......||..|||||++.+ ..++.++|||||||++|||+| |..
T Consensus 169 RDLK~~NILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~ 246 (308)
T 4gt4_A 169 KDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQ 246 (308)
T ss_dssp SCCSGGGEEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCccccceEECCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCC
Confidence 99999999999666 79999999998654322 2334578999999999987 689999999999999999998 888
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
|| .+....+....+......+ .+.++++.+.+++ ..||+.||++||+
T Consensus 247 Pf-~~~~~~~~~~~i~~~~~~~--------~p~~~~~~~~~li------------------------~~C~~~dP~~RPs 293 (308)
T 4gt4_A 247 PY-CGYSNQDVVEMIRNRQVLP--------CPDDCPAWVYALM------------------------IECWNEFPSRRPR 293 (308)
T ss_dssp TT-TTCCHHHHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CC-CCCCHHHHHHHHHcCCCCC--------CcccchHHHHHHH------------------------HHHcCCChhHCcC
Confidence 98 4555555554444322111 1124455555554 5599999999996
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=367.26 Aligned_cols=239 Identities=18% Similarity=0.352 Sum_probs=179.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+.+++++.++||+|+||+||+|+.. ..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNL 106 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeE
Confidence 5789999999999999999999753 46999998632 235789999999999 99999999998843 358
Q ss_pred eeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++||||+++|+|..++. .++...+.. ++.|+++||+|||+++|+|||||
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~---------------------------i~~qia~gL~yLH~~~IiHRDlK 159 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLID---------------------------IARQTAQGMDYLHAKNIIHRDMK 159 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHTTCBCSCCC
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCccCCccC
Confidence 99999999999887652 344444444 55555669999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+|||++.++ .+||+|||+|+...... .....+||+.|||||++.+. ..|+.++|||||||++|||+||..||.
T Consensus 160 p~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~ 238 (307)
T 3omv_A 160 SNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS 238 (307)
T ss_dssp SSSEEEETTE-EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEECCCC-cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence 9999999665 89999999998654322 23456899999999998642 358999999999999999999999994
Q ss_pred CCCCCHHHHHHHHH-HhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIAR-VLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.++...+..+.. ....+.. .....++++.+.+++ ..||+.||++||+
T Consensus 239 -~~~~~~~~~~~~~~~~~~p~~----~~~~~~~~~~l~~li------------------------~~cl~~dP~~RPs 287 (307)
T 3omv_A 239 -HINNRDQIIFMVGRGYASPDL----SKLYKNCPKAMKRLV------------------------ADCVKKVKEERPL 287 (307)
T ss_dssp -TCCCHHHHHHHHHTTCCCCCS----TTSCTTSCHHHHHHH------------------------HHHTCSSSTTSCC
T ss_pred -CCChHHHHHHHHhcCCCCCCc----ccccccchHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 4444444433332 2222211 122234455555555 5599999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=368.74 Aligned_cols=304 Identities=69% Similarity=1.177 Sum_probs=266.0
Q ss_pred CccccccccccCCCCCccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHH
Q 040656 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQ 81 (332)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~ 81 (332)
++++++.+.+...|++||++.+..+.+.+.++|++++.||+|+||.||+|.+..+++.||+|+++....+.+.+|+.+++
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~ 85 (330)
T 3nsz_A 6 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE 85 (330)
T ss_dssp CCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHH
T ss_pred CceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHH
Confidence 57888999999999999999999999999999999999999999999999999999999999998888889999999999
Q ss_pred hccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHh
Q 040656 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVW 161 (332)
Q Consensus 82 ~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (332)
++.+|+||+++++++.+......+++||++.++++..+...++...+..++.+++.
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~------------------------ 141 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK------------------------ 141 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHH------------------------
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHH------------------------
Confidence 99669999999999987667788999999999999988888888877777777666
Q ss_pred HHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHH
Q 040656 162 DLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241 (332)
Q Consensus 162 i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG 241 (332)
||+|||++||+||||||+|||++.++..++|+|||+++............+|..|+|||++.+...++.++||||||
T Consensus 142 ---~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 218 (330)
T 3nsz_A 142 ---ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218 (330)
T ss_dssp ---HHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred ---HHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHH
Confidence 99999999999999999999999777689999999998877666666678999999999987756789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcc--cccccccccc
Q 040656 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNK--KLQFCRSSRT 317 (332)
Q Consensus 242 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~--~~~~~~~~~~ 317 (332)
|++|+|++|..||..+.+..+.+..+....+.+...+.+.+.....++.....+.+. ..|...... .........+
T Consensus 219 ~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (330)
T 3nsz_A 219 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 298 (330)
T ss_dssp HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHH
T ss_pred HHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHH
Confidence 999999999999988888888999999999988888888888888888888887654 333322111 1223444568
Q ss_pred cCceEEEeCCCCCCC
Q 040656 318 STNICITFSPSGFPF 332 (332)
Q Consensus 318 ~~~~cl~~dP~~RP~ 332 (332)
++..||+.||++||+
T Consensus 299 li~~~L~~dP~~Rpt 313 (330)
T 3nsz_A 299 FLDKLLRYDHQSRLT 313 (330)
T ss_dssp HHHTTSCSSGGGSCC
T ss_pred HHHHHhcCCcccCCC
Confidence 899999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=363.25 Aligned_cols=191 Identities=25% Similarity=0.469 Sum_probs=149.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC------
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS------ 101 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~------ 101 (332)
++|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+|+++ +||||++++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999999999999999998642 235688999999999 99999999999865432
Q ss_pred ----CCceeEEeeecCCCceeeccc---cch---hhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 102 ----KTPSLIFEHVNSTDFKVLYPT---LTA---NEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 102 ----~~~~lv~e~~~~~~l~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
..++++|||+++++|..++.. +.+ ..+.. ++.|+++||+|||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~---------------------------i~~qi~~al~ylH~ 136 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH---------------------------IFLQIAEAVEFLHS 136 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHH---------------------------HHHHHHHHHHHHHH
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHH---------------------------HHHHHHHHHHHHHH
Confidence 236899999999998887532 111 12333 44455569999999
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc-------------ccccccccceeccccccCCCCCCCcccHH
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDMW 238 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~sDiw 238 (332)
+||+||||||+|||++.++ .+||+|||+|+....... .+..+||+.|||||++.+ ..|+.++|||
T Consensus 137 ~~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~Diw 214 (299)
T 4g31_A 137 KGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIF 214 (299)
T ss_dssp TTCCCCCCCGGGEEECTTC-CEEECCCCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHH
T ss_pred CcCccccCcHHHeEECCCC-cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHH
Confidence 9999999999999999776 799999999987653321 234579999999999987 7899999999
Q ss_pred HHHHHHHHHHhCCCCCC
Q 040656 239 SLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 239 SlG~il~elltg~~pf~ 255 (332)
||||++|||++ ||.
T Consensus 215 SlGvilyell~---Pf~ 228 (299)
T 4g31_A 215 SLGLILFELLY---PFS 228 (299)
T ss_dssp HHHHHHHHHHS---CCS
T ss_pred HHHHHHHHHcc---CCC
Confidence 99999999996 773
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=367.54 Aligned_cols=260 Identities=17% Similarity=0.243 Sum_probs=186.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC-----ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
++++|++++.||+|+||.||+|.+..++ +.||||.++.. ..+.+.+|+.+|.++.+|||||+++++|..+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 5789999999999999999999875543 67999998643 2356899999999996779999999998543
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+..+++|||||++|+|..++.......... .....-.......+.+...++.|||+||+|||+++|||||||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~--------~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPY--------KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC---------------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccc--------cccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 346899999999999888763211100000 000000000111223344677778889999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~ 256 (332)
|+|||++.++ .+||+|||+|+....... .....||..|||||++.+ ..|+.++|||||||++|||+| |..||..
T Consensus 213 ~~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 213 ARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp GGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999666 799999999987654332 234578999999999987 689999999999999999998 8999843
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..........+......+ .+...++++.+++ ..||+.||++||+
T Consensus 291 ~~~~~~~~~~i~~g~~~~--------~p~~~~~~~~~li------------------------~~c~~~dP~~RPt 334 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMR--------APDYTTPEMYQTM------------------------LDCWHGEPSQRPT 334 (353)
T ss_dssp CCCSHHHHHHHHHTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCHHHHHHHHHHcCCCCC--------CCccCCHHHHHHH------------------------HHHcCcChhHCcC
Confidence 333333333333322111 1123455555555 4599999999996
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=373.84 Aligned_cols=194 Identities=25% Similarity=0.441 Sum_probs=167.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHH---HHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKRE---IKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++++.||+|+||.||+|++..+|+.||+|++++.. .....+| +.+++.+ +||||++++++|.+
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~-- 263 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT-- 263 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEE--
Confidence 4588999999999999999999999999999999996422 2334444 4555556 89999999999954
Q ss_pred CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 101 SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...+|+||||++||+|..++ +.+++..++.|+.|++. ||+|||++||+||
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~---------------------------aL~yLH~~gIiHR 316 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL---------------------------GLEHMHNRFVVYR 316 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HHHHHHTTTEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccc
Confidence 46799999999999998876 46889999988888887 9999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||||+|||++.++ ++||+|||+|+.+... ...+.+||+.|||||++.+...|+.++|||||||++|||++|..||.
T Consensus 317 DLKPeNILld~~G-~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 317 DLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp CCSGGGEEECTTS-CEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCchHHeEEeCCC-CEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999776 7999999999877533 34567999999999999765679999999999999999999999995
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=371.79 Aligned_cols=207 Identities=23% Similarity=0.457 Sum_probs=180.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
++|++++.||+|+||.||+|.+..+|+.||+|+++... .+.+.+|+.+|+.+ +||||++++++|.+ ...++++|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 68999999999999999999999999999999986432 45688999999999 99999999999954 46799999
Q ss_pred eeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||+++|+|..++ ..+++..++.++.|++. ||.|||++||+||||||+||
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~---------------------------al~ylH~~~iiHRDlKp~Ni 286 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---------------------------GLCHMHENNYVHLDLKPENI 286 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGGGE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeeccCChhhc
Confidence 999999987654 35778888888887776 99999999999999999999
Q ss_pred eecCC-CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHE-QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++.+ .+.+||+|||+|+.+.........+||+.|||||++.+ ..|+.++|||||||++|+|++|..|| .+.+..+.
T Consensus 287 ll~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~ 364 (573)
T 3uto_A 287 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDET 364 (573)
T ss_dssp EESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHH
T ss_pred cccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHH
Confidence 99854 34799999999998877777777899999999999987 78999999999999999999999999 45555666
Q ss_pred HHHHHHH
Q 040656 264 LVKIARV 270 (332)
Q Consensus 264 ~~~~~~~ 270 (332)
+..+...
T Consensus 365 ~~~i~~~ 371 (573)
T 3uto_A 365 LRNVKSC 371 (573)
T ss_dssp HHHHHTT
T ss_pred HHHHHhC
Confidence 6666554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=346.95 Aligned_cols=193 Identities=21% Similarity=0.291 Sum_probs=152.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHH--HHhccCCCCeeeeeeeeeccCC--CCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKI--LQNLCGGPNIVKLLDIVRDQHS--KTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~--l~~l~~h~niv~~~~~~~~~~~--~~~~lv 107 (332)
++|.+.++||+|+||+||+|++ +|+.||||+++......+..|.++ +.++ +||||+++++++.+.+. ..+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 5689999999999999999976 689999999987666555555544 4567 89999999999976533 257999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc--------CCeec
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ--------GIMHR 177 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~ivHr 177 (332)
|||+++|+|..++. .++..... .++.|++.||+|||++ +|+||
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~---------------------------~i~~~ia~gl~ylH~~~~~~~~~~~IiHR 132 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMI---------------------------KLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHH---------------------------HHHHHHHHHHHHHHCCBCSTTCBCCEECS
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHH---------------------------HHHHHHHHHHHHHHHhhhhccCCCCEeec
Confidence 99999999887763 23333333 4555666799999987 99999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCC-----CCCCcccHHHHHHHHHHH
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~sDiwSlG~il~el 247 (332)
||||+|||++.++ .+||+|||+|+....... ....+||+.|||||++.+.. .++.++|||||||++|||
T Consensus 133 DlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 133 DLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred cCCcccEEECCCC-CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence 9999999999766 799999999987754332 22357999999999987531 356799999999999999
Q ss_pred HhCCCCCC
Q 040656 248 IFRKEPFF 255 (332)
Q Consensus 248 ltg~~pf~ 255 (332)
+||..||.
T Consensus 212 ~tg~~~~~ 219 (303)
T 3hmm_A 212 ARRCSIGG 219 (303)
T ss_dssp HHTBCBTT
T ss_pred HHCCCCCC
Confidence 99987763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=344.91 Aligned_cols=269 Identities=24% Similarity=0.426 Sum_probs=205.5
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC--
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH-- 100 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 100 (332)
+...++|++++.||+|+||.||+|.+..+++.||+|++... ..+++.+|+.+++.+ +||||+++++++....
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcc
Confidence 34468999999999999999999999999999999999642 245688999999999 9999999999996532
Q ss_pred --CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 101 --SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 101 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
....++||||++++.+..+...+++..+..++.|++. ||.|||++||+|||
T Consensus 137 ~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~---------------------------aL~~lH~~~iiHrD 189 (464)
T 3ttj_A 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC---------------------------GIKHLHSAGIIHRD 189 (464)
T ss_dssp TTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCCC
T ss_pred ccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccCC
Confidence 2356999999998766666666777777777777665 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
|||+|||++.++ .+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.
T Consensus 190 lkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~ 266 (464)
T 3ttj_A 190 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGR 266 (464)
T ss_dssp CCGGGEEECTTS-CEEECCCCCC-----CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCS
T ss_pred CChHhEEEeCCC-CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCC
Confidence 999999999766 799999999987765555667789999999999988 68999999999999999999999998 677
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCc--------------ccccccccccccCceEEE
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN--------------KKLQFCRSSRTSTNICIT 324 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--------------~~~~~~~~~~~~~~~cl~ 324 (332)
+..+++..+...++.+.... +. ...+..+..+.....+..... ..........+|+..||+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~ 341 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEF-MK----KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHH-HT----TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHHHHHHHHhcCCCCHHH-HH----HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC
Confidence 78888999999888765432 22 223444444433211111000 000012334688999999
Q ss_pred eCCCCCCC
Q 040656 325 FSPSGFPF 332 (332)
Q Consensus 325 ~dP~~RP~ 332 (332)
+||++||+
T Consensus 342 ~dP~~R~t 349 (464)
T 3ttj_A 342 IDPAKRIS 349 (464)
T ss_dssp SSTTTSCC
T ss_pred CChhhCCC
Confidence 99999996
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.90 Aligned_cols=242 Identities=23% Similarity=0.472 Sum_probs=190.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEE
Confidence 47899999999999999999999999999999998643 235688999999999 89999999999954 45789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||++++++..++ +.+++..+..++.+++. ||.|||++||+||||||+
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------al~~lH~~~ivHrDlkp~ 143 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS---------------------------AVQYCHQKRIVHRDLKAE 143 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCCGG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCEeccCCCHH
Confidence 999999999887765 45677766666666665 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|||++.++ .+||+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|..|| .+.+..+
T Consensus 144 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~ 221 (328)
T 3fe3_A 144 NLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKE 221 (328)
T ss_dssp GEEECTTS-CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS-CCSSHHH
T ss_pred HEEEcCCC-CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC-CCCCHHH
Confidence 99999766 799999999987765666667789999999999988444568999999999999999999999 3444444
Q ss_pred HHHHHHHHhC------CchHHHHHHhcCCCCChhHHHHhccC--CCCCCCC
Q 040656 263 QLVKIARVLG------TDELNAYLDKYHLELDPQLEALVGRK--RVWPIPN 305 (332)
Q Consensus 263 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~ 305 (332)
....+..... ++...+++.++ +..+|..|..+.++ |||....
T Consensus 222 ~~~~i~~~~~~~p~~~s~~~~~li~~~-L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 222 LRERVLRGKYRIPFYMSTDCENLLKRF-LVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHH-CCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHH-CCCChhHCcCHHHHhcCHhhcCC
Confidence 4444443311 23444555554 45555544444444 6665443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=331.55 Aligned_cols=218 Identities=30% Similarity=0.605 Sum_probs=170.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++.. .....+.+|+.+++++.+||||+++++++...+...++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 4789999999999999999999999999999999853 23356789999999995699999999999766666789
Q ss_pred eEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 106 LIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 106 lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+||||+++ ++..++ ..++......++.+++ .||.|||+.||+||||||+|
T Consensus 88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~---------------------------~~L~~LH~~~ivHrDlkp~N 139 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLI---------------------------KVIKYLHSGGLLHRDMKPSN 139 (388)
T ss_dssp EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCCCGGG
T ss_pred EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCEEeCCCCHHH
Confidence 99999985 444333 2355555555555555 49999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCC----------------------CcccccccccceeccccccCCCCCCCcccHHHHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPG----------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG 241 (332)
||++.++ .+||+|||+++..... ...+..+||+.|+|||++.+...++.++||||||
T Consensus 140 Ill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 218 (388)
T 3oz6_A 140 ILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218 (388)
T ss_dssp EEECTTC-CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred eEEcCCC-CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHH
Confidence 9999776 7999999999865321 1123457999999999998766799999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHH
Q 040656 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNA 278 (332)
Q Consensus 242 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 278 (332)
|++|||++|..|| .+.+..+.+..+....+.+....
T Consensus 219 ~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~p~~~~ 254 (388)
T 3oz6_A 219 CILGEILCGKPIF-PGSSTMNQLERIIGVIDFPSNED 254 (388)
T ss_dssp HHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHH
Confidence 9999999999998 57777888888888877665443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=324.69 Aligned_cols=207 Identities=27% Similarity=0.497 Sum_probs=175.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~ 87 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN--R 87 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--S
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe--C
Confidence 467999999999999999999999999999999997432 36789999999999 89999999999954 4
Q ss_pred CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||||+++++|..++ ..+++..+..++.+++. ||.|||++||+|||
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~---------------------------aL~~LH~~givHrD 140 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---------------------------GVNYLHTKKIAHFD 140 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccCC
Confidence 6789999999999988765 34667776666666665 99999999999999
Q ss_pred CCCCCeeecCCCC---eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 179 VKPHNVMIDHEQQ---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||+|||++.++. .++|+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999986553 699999999988776555666789999999999876 678999999999999999999999994
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
+.+..+.+..+..
T Consensus 220 -~~~~~~~~~~i~~ 232 (361)
T 2yab_A 220 -GDTKQETLANITA 232 (361)
T ss_dssp -CSSHHHHHHHHHT
T ss_pred -CCCHHHHHHHHHh
Confidence 4444445554443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=317.09 Aligned_cols=260 Identities=30% Similarity=0.533 Sum_probs=197.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEe--CCEEEE
Confidence 6899999999999999999999999999999998632 235688999999999 99999999999954 457899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||++++.+..+. ..+++..+..++.+++. ||+|||++||+||||||+|
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~---------------------------~l~~lH~~~ivH~dikp~N 131 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK---------------------------GLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGGG
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeecCCCCHHH
Confidence 99999876554443 34666666666665555 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+++.++ .+||+|||+++..... .......+|..|+|||++.+...++.++|||||||++|+|++|..||+.+.+..+
T Consensus 132 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~ 210 (292)
T 3o0g_A 132 LLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp EEECTTS-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred EEEcCCC-CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 9999766 7999999999876533 2334557899999999998755689999999999999999999999888877778
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCC------CCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWP------IPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+.+..+.+....+... ... ....++. ..............+++..||+.||++||+
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 276 (292)
T 3o0g_A 211 QLKRIFRLLGTPTEEQWPSM---------TKL-PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTG---------GGS-TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHhCCCChhhhhhh---------ccc-ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC
Confidence 88888877665432211110 000 0000000 000011112233357888899999999996
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.85 Aligned_cols=264 Identities=31% Similarity=0.565 Sum_probs=192.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
-.++|++++.||+|+||.||+|.+ .+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 94 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ERCL 94 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SSCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CCEE
Confidence 358899999999999999999998 468999999986322 35688999999999 99999999999954 4678
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||||++++....+. ..+++..+..++.+++. ||.|||++||+||||||
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~---------------------------~l~~LH~~~ivH~Dikp 147 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR---------------------------GVAHCHQHRILHRDLKP 147 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCG
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccCCCch
Confidence 9999999874433332 22566666666666555 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
+|||++.++ .+||+|||+++..... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+...
T Consensus 148 ~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~ 225 (311)
T 3niz_A 148 QNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTD 225 (311)
T ss_dssp GGEEECTTC-CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSST
T ss_pred HhEEECCCC-CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCCh
Confidence 999999776 7999999999876533 23345578999999999877567899999999999999999999999 46666
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC-CCCCCCC--cccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK-RVWPIPN--NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+....+.+....+.... .+.....+. ..+.... ......+....+++..||+.||++||+
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 294 (311)
T 3niz_A 226 DDQLPKIFSILGTPNPREWPQVQ------ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294 (311)
T ss_dssp TTHHHHHHHHHCCCCTTTSGGGT------TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHCCCChHHhhhhh------ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC
Confidence 67777777777654432221110 000000001 0000000 001112333457888899999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=326.29 Aligned_cols=208 Identities=24% Similarity=0.419 Sum_probs=169.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|++..+++.||+|++++. ....+.+|..++..+.+||||+++++++.+ ...
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence 457899999999999999999999999999999999743 235678899999998789999999999954 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||++++++..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~givHrDlk 151 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS---------------------------ALMFLHDKGIIYRDLK 151 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCcccCCC
Confidence 89999999999987765 45777777777777666 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||++.++ .+||+|||+++.... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+
T Consensus 152 p~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~ 228 (353)
T 3txo_A 152 LDNVLLDHEG-HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPF-EAEN 228 (353)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCSCC---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSS-CCSS
T ss_pred HHHEEECCCC-CEEEccccceeecccCCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCC-CCCC
Confidence 9999999776 799999999975432 233456689999999999876 67899999999999999999999999 3455
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+....+..
T Consensus 229 ~~~~~~~i~~ 238 (353)
T 3txo_A 229 EDDLFEAILN 238 (353)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHc
Confidence 5555555554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=319.90 Aligned_cols=205 Identities=24% Similarity=0.453 Sum_probs=171.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++++. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--~~~ 79 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEe--CCE
Confidence 357899999999999999999999999999999999642 345688999999999 99999999999954 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||++++++..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~~ivHrDlk 132 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------------------------ALEYLHSRDVVYRDIK 132 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeecCcCC
Confidence 89999999999987665 34667766666666665 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||++.++ .+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+
T Consensus 133 p~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~ 209 (337)
T 1o6l_A 133 LENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQD 209 (337)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSS
T ss_pred HHHEEECCCC-CEEEeeccchhhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCC-CCC
Confidence 9999999776 79999999998643 2334456789999999999877 678999999999999999999999994 333
Q ss_pred CHHHHHHH
Q 040656 260 NQDQLVKI 267 (332)
Q Consensus 260 ~~~~~~~~ 267 (332)
.......+
T Consensus 210 ~~~~~~~i 217 (337)
T 1o6l_A 210 HERLFELI 217 (337)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 33343333
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=330.54 Aligned_cols=195 Identities=26% Similarity=0.498 Sum_probs=169.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|++..+++.||+|++++.. ...+.+|..++.++.+||||++++++|.+ ...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence 4578999999999999999999999999999999997432 24578999999988789999999999954 467
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++++|..++ ..+++..++.++.+++. ||+|||++||+|||||
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------aL~~LH~~givHrDLK 180 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL---------------------------ALNYLHERGIIYRDLK 180 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCEEeccCC
Confidence 89999999999987765 35777777777777766 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceee-cCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+|||++.++ .+||+|||+++.. .........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 181 p~NILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 181 LDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred HHHEEECCCC-CEEEeecceeeecccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 9999999776 7999999999863 33444566789999999999987 679999999999999999999999994
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=315.65 Aligned_cols=205 Identities=25% Similarity=0.471 Sum_probs=170.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEE--CCEEEE
Confidence 45789999999999999999999999999999999863 2356788999999999 99999999999965 356899
Q ss_pred EEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 107 IFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 107 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||||+.++++..++. .+++..+..++.+++. ||.|||++||+||||||+||
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~---------------------------~l~~lH~~~i~H~Dlkp~Ni 147 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---------------------------ALEFLHSNQVIHRDIKSDNI 147 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGGGE
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCceeCCCCHHHE
Confidence 999999999887753 3566656555555554 99999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++.++ .++|+|||++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+....
T Consensus 148 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~ 224 (297)
T 3fxz_A 148 LLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRA 224 (297)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHH
T ss_pred EECCCC-CEEEeeCCCceecCCcccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHH
Confidence 999766 79999999998765433 2345689999999999987 678999999999999999999999994 3333333
Q ss_pred HHHH
Q 040656 264 LVKI 267 (332)
Q Consensus 264 ~~~~ 267 (332)
...+
T Consensus 225 ~~~~ 228 (297)
T 3fxz_A 225 LYLI 228 (297)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 3333
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=317.81 Aligned_cols=207 Identities=25% Similarity=0.458 Sum_probs=173.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
.++|++.+.||+|+||.||+|.+..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....+++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEec--CCEEEEEE
Confidence 47899999999999999999999999999999998743 335688999999999 99999999999955 35789999
Q ss_pred eeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||++++++...+. .+++..+..++.+++. ||.|||++||+||||||+||
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~---------------------------al~~lH~~givH~Dlkp~NI 133 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCE---------------------------ALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGGGE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCCcCCCCHHHE
Confidence 9999998877652 3566666655555554 99999999999999999999
Q ss_pred eecCC-CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHE-QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++.+ ++.++|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.
T Consensus 134 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~ 211 (321)
T 1tki_A 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQI 211 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHH
T ss_pred EEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHH
Confidence 99862 44799999999998776666666789999999999877 568999999999999999999999994 4444455
Q ss_pred HHHHHH
Q 040656 264 LVKIAR 269 (332)
Q Consensus 264 ~~~~~~ 269 (332)
...+..
T Consensus 212 ~~~i~~ 217 (321)
T 1tki_A 212 IENIMN 217 (321)
T ss_dssp HHHHHH
T ss_pred HHHHHc
Confidence 555544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.68 Aligned_cols=200 Identities=22% Similarity=0.395 Sum_probs=169.2
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++........
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceE
Confidence 3468899999999999999999999999999999998742 346678999999999 89999999999977666688
Q ss_pred eeEEeeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 105 SLIFEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
++||||++++++..++.. ++...+..++.+++ .||+|||++||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~---------------------------~~L~~LH~~~ivH~D 137 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV---------------------------GGMNHLRENGIVHRN 137 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSC
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCEecCC
Confidence 999999999998877633 55555555555554 599999999999999
Q ss_pred CCCCCeee----cCCCCeEEEEecccceeecCCCcccccccccceeccccccC-------CCCCCCcccHHHHHHHHHHH
Q 040656 179 VKPHNVMI----DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 179 lkp~Nilv----~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~sDiwSlG~il~el 247 (332)
|||+|||+ +.++ .+||+|||+++............+|..|+|||++.. ...++.++|||||||++|+|
T Consensus 138 lkp~NIll~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 138 IKPGNIMRVIGEDGQS-VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp CSGGGEEEEECTTSCE-EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred CCHHHEEEeccCCCCc-eEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 99999998 5333 799999999998776666666789999999998752 25789999999999999999
Q ss_pred HhCCCCCCCC
Q 040656 248 IFRKEPFFYG 257 (332)
Q Consensus 248 ltg~~pf~~~ 257 (332)
++|..||...
T Consensus 217 ~~g~~pf~~~ 226 (319)
T 4euu_A 217 ATGSLPFRPF 226 (319)
T ss_dssp HHSSCSEECT
T ss_pred HhCCCCCCCC
Confidence 9999999543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=322.20 Aligned_cols=196 Identities=21% Similarity=0.489 Sum_probs=170.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+.++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||++++++|.+ ...
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~ 89 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQD--EED 89 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCE
Confidence 458899999999999999999999999999999998642 235688999999999 99999999999954 457
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+.+++|..++. .+++..+..++.+++. ||.|||++||+|||||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------aL~~LH~~givHrDlk 142 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM---------------------------ALDYLQNQRIIHRDMK 142 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCS
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCceeccCc
Confidence 899999999999877653 4677777777776665 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+|||++.++ .++|+|||+++...........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..
T Consensus 143 p~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 143 PDNILLDEHG-HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHeEECCCC-CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 9999999766 7999999999987766666778999999999998642 4589999999999999999999999953
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=318.98 Aligned_cols=208 Identities=23% Similarity=0.434 Sum_probs=172.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++++. ....+..|..++..+.+||||+++++++.+ ...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence 468999999999999999999999999999999999743 335678899999987689999999999954 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++++|..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~~ivHrDlk 145 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL---------------------------GLQFLHSKGIVYRDLK 145 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEeCCCC
Confidence 89999999999987765 34666666666666655 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||++.++ .+||+|||+++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+
T Consensus 146 p~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~ 222 (345)
T 1xjd_A 146 LDNILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQD 222 (345)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSS
T ss_pred hhhEEECCCC-CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCC
Confidence 9999999776 799999999976432 233456689999999999977 678999999999999999999999994 444
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+....+..
T Consensus 223 ~~~~~~~i~~ 232 (345)
T 1xjd_A 223 EEELFHSIRM 232 (345)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 4444444443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=328.83 Aligned_cols=265 Identities=27% Similarity=0.447 Sum_probs=194.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeecc----CCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----HSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----~~~~~~lv 107 (332)
.+|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+++++++ +|+||++++++|... +...++++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEee
Confidence 4799999999999999999999999999999998643 33445799999999 999999999988542 22346789
Q ss_pred EeeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 108 FEHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 108 ~e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
|||++++.+..+. ..++...+..++. |++.||.|||++||+||||||
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~---------------------------qi~~aL~~LH~~~ivHrDlkp 184 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---------------------------QLFRSLAYIHSFGICHRDIKP 184 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHH---------------------------HHHHHHHHHHTTTEECSCCSG
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCccccCCCh
Confidence 9999874332221 2344444444444 445599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+|||++.+++.+||+|||+++............+|..|+|||++.+...++.++|||||||++|||++|..|| .+.+..
T Consensus 185 ~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~ 263 (420)
T 1j1b_A 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGV 263 (420)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHH
T ss_pred hhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHH
Confidence 9999997766899999999998765555566789999999999877557999999999999999999999998 566667
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.+..+.+.++.+....+... ....... .+.++ .+|.... .........+++.+||.+||++||+
T Consensus 264 ~~l~~i~~~lg~p~~~~~~~~-~~~~~~~---~~p~~~~~~~~~~~--~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 264 DQLVEIIKVLGTPTREQIREM-NPNYTEF---KFPQIKAHPWTKVF--RPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp HHHHHHHHHHCSCCHHHHHHH-CSCCCCC---CCCCCCCCCHHHHS--CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHhCCCCHHHHHhh-Chhhhhh---ccCccCCCCHHHhc--CCCCCHHHHHHHHHhccCChhHCCC
Confidence 788888888877654433221 1111000 00000 1111000 0011223346778899999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.62 Aligned_cols=278 Identities=25% Similarity=0.474 Sum_probs=199.5
Q ss_pred ccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeee
Q 040656 18 YWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKL 92 (332)
Q Consensus 18 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~ 92 (332)
|.........+.-.++|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++
T Consensus 11 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l 89 (367)
T 1cm8_A 11 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGL 89 (367)
T ss_dssp BCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCC
T ss_pred ceEEEecCceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCc
Confidence 333333334455578999999999999999999999999999999998532 235688999999999 89999999
Q ss_pred eeeeeccCC----CCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHH
Q 040656 93 LDIVRDQHS----KTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL 166 (332)
Q Consensus 93 ~~~~~~~~~----~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 166 (332)
++++..... ...+++||++ ++++..++ ..+++..+..++.+++. ||
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~---------------------------~L 141 (367)
T 1cm8_A 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLK---------------------------GL 141 (367)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HH
T ss_pred eeeEecCCccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HH
Confidence 999865422 3569999999 66666554 34566666555555554 99
Q ss_pred HHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 167 DYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 167 ~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
.|||++||+||||||+||+++.++ .+||+|||+++... .......+|..|+|||++.+...++.++|||||||++|+
T Consensus 142 ~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 218 (367)
T 1cm8_A 142 RYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218 (367)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred HHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecccccc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHH
Confidence 999999999999999999999766 79999999998754 234456889999999998875679999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC--cccccccccccccCceEEE
Q 040656 247 MIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN--NKKLQFCRSSRTSTNICIT 324 (332)
Q Consensus 247 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~ 324 (332)
|++|..|| .+.+..+.+..+....+.+... ++..+ .+...+..+.......... ...........+++..||.
T Consensus 219 ll~g~~pf-~~~~~~~~l~~i~~~~g~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~ 293 (367)
T 1cm8_A 219 MITGKTLF-KGSDHLDQLKEIMKVTGTPPAE-FVQRL---QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 293 (367)
T ss_dssp HHHSSCSS-CCSSHHHHHHHHHHHHCCCCHH-HHHTC---SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSC
T ss_pred HHhCCCCC-CCCCHHHHHHHHHHhcCCCCHH-HHHHh---hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHcc
Confidence 99999998 5667778888888887765432 22222 1222333332221111000 0011122334577888999
Q ss_pred eCCCCCCC
Q 040656 325 FSPSGFPF 332 (332)
Q Consensus 325 ~dP~~RP~ 332 (332)
.||++||+
T Consensus 294 ~dP~~R~t 301 (367)
T 1cm8_A 294 LDAEQRVT 301 (367)
T ss_dssp SSTTTSCC
T ss_pred CChhHCCC
Confidence 99999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=310.63 Aligned_cols=197 Identities=27% Similarity=0.569 Sum_probs=163.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------------------------hHHHHHHHHHH
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------------------------KKKIKREIKIL 80 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l 80 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999999999999999986432 24578999999
Q ss_pred HhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhh
Q 040656 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDI 158 (332)
Q Consensus 81 ~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (332)
+++ +||||+++++++.+......+++|||++++++..+. ..+++..+..++.+++.
T Consensus 91 ~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~--------------------- 148 (298)
T 2zv2_A 91 KKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIK--------------------- 148 (298)
T ss_dssp HTC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHH---------------------
T ss_pred HhC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHH---------------------
Confidence 999 999999999999776567889999999999888764 34666666666665555
Q ss_pred HHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCC--CCCcc
Q 040656 159 SVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD--YDYSL 235 (332)
Q Consensus 159 ~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~s 235 (332)
||+|||++||+||||||+|||++.++ .+||+|||+++....... .....||..|+|||++.+... ++.++
T Consensus 149 ------~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 221 (298)
T 2zv2_A 149 ------GIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKAL 221 (298)
T ss_dssp ------HHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHH
T ss_pred ------HHHHHHHCCeeccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchh
Confidence 99999999999999999999999666 799999999987654332 345578999999999876332 37789
Q ss_pred cHHHHHHHHHHHHhCCCCCC
Q 040656 236 DMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 236 DiwSlG~il~elltg~~pf~ 255 (332)
|||||||++|+|++|..||.
T Consensus 222 Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 222 DVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp HHHHHHHHHHHHHHSSCSSC
T ss_pred hhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999994
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=319.08 Aligned_cols=208 Identities=23% Similarity=0.384 Sum_probs=173.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++++. ....+..|..++..+.+||||+++++++.+ ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 458899999999999999999999889999999999743 335678899999988789999999999954 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++++|..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~givHrDlk 148 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI---------------------------GLFFLQSKGIIYRDLK 148 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCEEeccCC
Confidence 89999999999988765 35677777666666665 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||++.++ .+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+
T Consensus 149 p~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~ 225 (353)
T 2i0e_A 149 LDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GED 225 (353)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSS
T ss_pred HHHEEEcCCC-cEEEEeCCcccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCC
Confidence 9999999776 79999999998643 2334456689999999999877 678999999999999999999999994 444
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+....+..
T Consensus 226 ~~~~~~~i~~ 235 (353)
T 2i0e_A 226 EDELFQSIME 235 (353)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 4445555443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=323.53 Aligned_cols=266 Identities=26% Similarity=0.469 Sum_probs=195.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeecc----------
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---------- 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---------- 99 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.+ +||||++++++|...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC----------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCccccccccc
Confidence 357899999999999999999999999999999998633 33445899999999 999999999998542
Q ss_pred --------------------------CCCCceeEEeeecCCCceeec-------cccchhhHHHHHHHHHhhcCCcceee
Q 040656 100 --------------------------HSKTPSLIFEHVNSTDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVII 146 (332)
Q Consensus 100 --------------------------~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (332)
....+++||||++++ +...+ ..++...+..++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~---------- 151 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT-LHKVLKSFIRSGRSIPMNLISIYIYQLF---------- 151 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHH----------
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCcc-HHHHHHHHHhcCCCCCHHHHHHHHHHHH----------
Confidence 223478999999863 32222 2355555555555554
Q ss_pred cCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceecccccc
Q 040656 147 MPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 226 (332)
Q Consensus 147 ~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 226 (332)
.||.|||++||+||||||+|||++.+++.+||+|||+++............+|..|+|||++.
T Consensus 152 -----------------~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 214 (383)
T 3eb0_A 152 -----------------RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML 214 (383)
T ss_dssp -----------------HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT
T ss_pred -----------------HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc
Confidence 599999999999999999999998555589999999999876666666778899999999988
Q ss_pred CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCC
Q 040656 227 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIP 304 (332)
Q Consensus 227 ~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~ 304 (332)
+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+.+....+.... ...... ..... ..|...
T Consensus 215 ~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~g~p~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~ 289 (383)
T 3eb0_A 215 GATEYTPSIDLWSIGCVFGELILGKPLF-SGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEV---RFPTLKAKDWRKI 289 (383)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHC-TTC--C---CCCCCCCCCHHHH
T ss_pred CCCCCCcchhhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhC-cccccc---cCCccCcccHHhh
Confidence 7566899999999999999999999998 5677788888888888876654443321 111000 00000 000000
Q ss_pred CcccccccccccccCceEEEeCCCCCCC
Q 040656 305 NNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 305 ~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..........+++..||++||++||+
T Consensus 290 --~~~~~~~~~~~li~~~L~~dP~~R~t 315 (383)
T 3eb0_A 290 --LPEGTPSLAIDLLEQILRYEPDLRIN 315 (383)
T ss_dssp --SCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCCC
Confidence 00011222347788899999999996
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=318.82 Aligned_cols=195 Identities=27% Similarity=0.495 Sum_probs=167.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++++.. ...+.+|..++.++.+||||++++++|.+ ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 4578999999999999999999999999999999997431 34578899999988789999999999954 467
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++++|..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~---------------------------aL~~LH~~~ivHrDlk 137 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL---------------------------ALNYLHERGIIYRDLK 137 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCceecCCC
Confidence 89999999999987765 34677777766666665 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+|||++.++ .+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 138 p~NIll~~~g-~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 138 LDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp GGGEEECTTS-CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEECCCC-CEEEEeccccccccCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 9999999766 79999999998643 2334456689999999999987 678999999999999999999999995
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=312.99 Aligned_cols=214 Identities=31% Similarity=0.613 Sum_probs=172.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--------hHHHHHHHHHHHhcc--CCCCeeeeeeeeecc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~ 99 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++. +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999999999999999986322 346778888888773 499999999998654
Q ss_pred CCC---CceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 100 HSK---TPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 100 ~~~---~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
... ..++++|++.+ ++..++. .+++..+..++.+++. ||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~---------------------------al~~lH~ 138 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLR---------------------------GLDFLHA 138 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHH---------------------------HHHHHHH
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHH---------------------------HHHHHHH
Confidence 322 47899999985 5554432 1556655555555554 9999999
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCC
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~ 251 (332)
+||+||||||+|||++.++ .++|+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 139 ~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 139 NCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp TTCCCSCCCTTTEEECTTS-CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSS
T ss_pred CCcccCCCCHHHEEEcCCC-CEEEeeCccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCC
Confidence 9999999999999999666 799999999987665555666789999999999977 67899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHhCCc
Q 040656 252 EPFFYGHDNQDQLVKIARVLGTD 274 (332)
Q Consensus 252 ~pf~~~~~~~~~~~~~~~~~~~~ 274 (332)
.|| .+.+..+.+..+....+.+
T Consensus 217 ~pf-~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 217 PLF-CGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp CSC-CCSSHHHHHHHHHHHHCCC
T ss_pred CCC-CCCCHHHHHHHHHHHhCCC
Confidence 998 4566667777777766544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=314.78 Aligned_cols=207 Identities=25% Similarity=0.480 Sum_probs=172.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence 46799999999999999999999999999999998642 246789999999999 99999999999954 4
Q ss_pred CCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
...++||||+++++|..++. .+++..+..++.+++. ||.|||++||+|||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~---------------------------al~~lH~~~ivH~D 139 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---------------------------GVYYLHSLQIAHFD 139 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEcCC
Confidence 57899999999999887653 3566666665555554 99999999999999
Q ss_pred CCCCCeeecCCCC---eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 179 VKPHNVMIDHEQQ---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||+||+++.++. .++|+|||+++............||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 140 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 140 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 9999999985542 699999999988765555566789999999999876 678999999999999999999999994
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
+....+.+..+..
T Consensus 219 -~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 219 -GDTKQETLANVSA 231 (326)
T ss_dssp -CSSHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHh
Confidence 4444444444443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=317.29 Aligned_cols=194 Identities=27% Similarity=0.500 Sum_probs=162.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~ 99 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS--DG 99 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 46799999999999999999999999999999998632 346789999999999 99999999999955 45
Q ss_pred CceeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 103 TPSLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
.+++||||+++++|...+. .+++..+..++.+++ .||.|||++||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~---------------------------~al~~lH~~~iv 152 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---------------------------EALRYCHDNNII 152 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEE
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCce
Confidence 7899999999998865431 245555555555554 599999999999
Q ss_pred ecCCCCCCeeecCCC--CeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 176 HRDVKPHNVMIDHEQ--QKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~--~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
||||||+|||++.++ ..+||+|||++........ .....||..|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 153 HrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~ 231 (351)
T 3c0i_A 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCL 231 (351)
T ss_dssp CSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCC
Confidence 999999999997543 2499999999987754332 345679999999999877 678999999999999999999999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 232 pf~ 234 (351)
T 3c0i_A 232 PFY 234 (351)
T ss_dssp SSC
T ss_pred CCC
Confidence 994
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=320.23 Aligned_cols=206 Identities=25% Similarity=0.502 Sum_probs=170.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence 36799999999999999999999999999999999642 235688999999999 99999999999954 45789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||+.++++...+ ..+++..+..++.+++. ||.|||++||+||||||+
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------al~~lH~~~ivH~Dlkp~ 157 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---------------------------SIAYCHSNGIVHRNLKPE 157 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCSGG
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEeccCchH
Confidence 999999999886654 23566666666666555 999999999999999999
Q ss_pred CeeecCCC--CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQ--QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.++ ..+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.
T Consensus 158 NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~-~~~~ 235 (362)
T 2bdw_A 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQ 235 (362)
T ss_dssp GEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSH
T ss_pred HEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCH
Confidence 99997543 3699999999987765555566789999999999877 678999999999999999999999994 3333
Q ss_pred HHHHHHHH
Q 040656 261 QDQLVKIA 268 (332)
Q Consensus 261 ~~~~~~~~ 268 (332)
.+....+.
T Consensus 236 ~~~~~~i~ 243 (362)
T 2bdw_A 236 HRLYAQIK 243 (362)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 44444443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=316.04 Aligned_cols=206 Identities=22% Similarity=0.408 Sum_probs=172.9
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++++.||+|+||.||+|.+..+++.||+|++++. ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CC
Confidence 3468999999999999999999999999999999998642 335688999999999 99999999999954 45
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++||||++++++..++ ..+++..+..++.+++. ||+|||++||+||||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~~ivHrDl 167 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---------------------------TFEYLHSLDLIYRDL 167 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccccC
Confidence 789999999999987765 34667766666666665 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
||+|||++.++ .++|+|||+++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+
T Consensus 168 kp~NIll~~~g-~~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~ 242 (350)
T 1rdq_E 168 KPENLLIDQQG-YIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQ 242 (350)
T ss_dssp SGGGEEECTTS-CEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSS
T ss_pred ccceEEECCCC-CEEEcccccceeccC--CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC-CCC
Confidence 99999999766 799999999987643 2345689999999999877 678999999999999999999999994 444
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+....+..
T Consensus 243 ~~~~~~~i~~ 252 (350)
T 1rdq_E 243 PIQIYEKIVS 252 (350)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHc
Confidence 4444444443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.96 Aligned_cols=205 Identities=22% Similarity=0.457 Sum_probs=171.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++++. ....+.+|..+++.+ +||||+++++++.+ ...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~ 80 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQ 80 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEe--CCE
Confidence 357899999999999999999999999999999999642 345678899999999 99999999999954 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||++++++..++ ..+++..+..++.+++. ||.|||++||+|||||
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~~ivHrDlk 133 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL---------------------------ALEYLHSKDIIYRDLK 133 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHH---------------------------HHHHHHTTTEECCCCC
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCccccCCC
Confidence 89999999999988775 34666666666666655 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+|||++.++ .+||+|||+++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.
T Consensus 134 p~NIll~~~g-~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~ 208 (318)
T 1fot_A 134 PENILLDKNG-HIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNT 208 (318)
T ss_dssp GGGEEECTTS-CEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSH
T ss_pred hheEEEcCCC-CEEEeecCcceecCC--ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCH
Confidence 9999999666 799999999987542 3345689999999999877 678999999999999999999999994 4444
Q ss_pred HHHHHHHHH
Q 040656 261 QDQLVKIAR 269 (332)
Q Consensus 261 ~~~~~~~~~ 269 (332)
.+....+..
T Consensus 209 ~~~~~~i~~ 217 (318)
T 1fot_A 209 MKTYEKILN 217 (318)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 444444443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=309.41 Aligned_cols=209 Identities=34% Similarity=0.697 Sum_probs=165.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++++.||+|+||.||+|.+ .+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEcc--CCeEEE
Confidence 6899999999999999999998 778999999986322 35688999999999 99999999999954 457899
Q ss_pred EEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||++++ ++..++ ..++...+..++.++ +.||+|||++||+||||||+
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~i~H~dlkp~ 129 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL---------------------------LNGIAYCHDRRVLHRDLKPQ 129 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTCCCSCCCGG
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCCCHH
Confidence 9999986 443332 234555555444444 55999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||+++.++ .+||+|||+++..... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..
T Consensus 130 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~ 207 (288)
T 1ob3_A 130 NLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEA 207 (288)
T ss_dssp GEEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHH
T ss_pred HEEEcCCC-CEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHH
Confidence 99999666 7999999998765422 23344578999999999877566899999999999999999999998 455566
Q ss_pred HHHHHHHHHhCCc
Q 040656 262 DQLVKIARVLGTD 274 (332)
Q Consensus 262 ~~~~~~~~~~~~~ 274 (332)
+.+..+.+..+.+
T Consensus 208 ~~~~~~~~~~~~~ 220 (288)
T 1ob3_A 208 DQLMRIFRILGTP 220 (288)
T ss_dssp HHHHHHHHHHCCC
T ss_pred HHHHHHHHHHCCC
Confidence 6777777766543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.73 Aligned_cols=207 Identities=25% Similarity=0.460 Sum_probs=169.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISE--EGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC--SSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE--CCEEE
Confidence 467999999999999999999999999999999986432 35688999999999 99999999999954 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||+.++++...+ ..+++..+..++.+++. ||.|||++||+||||||+
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~---------------------------aL~~lH~~givHrDlKp~ 139 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---------------------------AVLHCHQMGVVHRNLKPE 139 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCSST
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCccccCCCHH
Confidence 999999999886654 44667766666666655 999999999999999999
Q ss_pred CeeecC--CCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 183 NVMIDH--EQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~--~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|||++. +++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+
T Consensus 140 NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~ 217 (444)
T 3soa_A 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DED 217 (444)
T ss_dssp TEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSS
T ss_pred HEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-Ccc
Confidence 999984 23479999999997765433 2345689999999999877 678999999999999999999999993 444
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+....+..
T Consensus 218 ~~~~~~~i~~ 227 (444)
T 3soa_A 218 QHRLYQQIKA 227 (444)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 4444444443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=310.06 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=183.3
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
...-.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~-- 82 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE-- 82 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--
Confidence 344568899999999999999999999999999999998531 235688999999999 99999999999843
Q ss_pred CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 101 SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++++|||++++++..++ ..++...+..++.+++. ||+|||++||+||
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------~l~~lH~~~i~H~ 135 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD---------------------------GIKHAHDMRIVHR 135 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCC
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccC
Confidence 46789999999999988765 23566666555555554 9999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||||+||+++.++ .++|+|||++....... ......||..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 136 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 136 DIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp CCCGGGEEECTTS-CEEECCCSSSTTC-------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEECCCC-CEEEEeCCCccccccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999666 79999999997654322 2234578999999999987 678999999999999999999999994
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFP 331 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP 331 (332)
+....+........... ..........++.+..++. .||+.||++||
T Consensus 214 -~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~------------------------~~l~~dp~~R~ 260 (294)
T 4eqm_A 214 -GETAVSIAIKHIQDSVP----NVTTDVRKDIPQSLSNVIL------------------------RATEKDKANRY 260 (294)
T ss_dssp -SSCHHHHHHHHHSSCCC----CHHHHSCTTSCHHHHHHHH------------------------HHSCSSGGGSC
T ss_pred -CCChHHHHHHHhhccCC----CcchhcccCCCHHHHHHHH------------------------HHhcCCHhHcc
Confidence 33332322222211111 1122333456666666664 48888999888
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.86 Aligned_cols=270 Identities=27% Similarity=0.492 Sum_probs=198.4
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC-
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS- 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 101 (332)
+.-.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+++.+|+.+++++ +|+||+++++++.....
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCC
Confidence 34468999999999999999999999999999999999642 235788999999999 89999999999865432
Q ss_pred --CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 102 --KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 102 --~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...++|||++.+ ++..++ ..+++..+..++.+++. ||.|||+.||+|
T Consensus 101 ~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~---------------------------aL~~LH~~givH 152 (432)
T 3n9x_A 101 KFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL---------------------------GENFIHESGIIH 152 (432)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEEC
T ss_pred cCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCCC
Confidence 568999999875 555443 23667777666666665 999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCC-----------------------cccccccccceeccccccCCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-----------------------EYNVRVASRYFKGPELLVDLQDYDY 233 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~ 233 (332)
|||||+|||++.++ .+||+|||+++...... ..+..+||..|+|||++.....++.
T Consensus 153 rDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 231 (432)
T 3n9x_A 153 RDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231 (432)
T ss_dssp CCCCGGGEEECTTC-CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCT
T ss_pred CCCCHHHeEECCCC-CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCc
Confidence 99999999999766 79999999998764332 1355688999999999766577999
Q ss_pred cccHHHHHHHHHHHHhC----------CCCCCCCCC-----------------CHHHHHHHHHHhCCchHHHHHHhcCCC
Q 040656 234 SLDMWSLGCMFAGMIFR----------KEPFFYGHD-----------------NQDQLVKIARVLGTDELNAYLDKYHLE 286 (332)
Q Consensus 234 ~sDiwSlG~il~elltg----------~~pf~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (332)
++|||||||++|||++| ..|++++.+ ..+++..+...++.+....+.. .
T Consensus 232 ~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~----~ 307 (432)
T 3n9x_A 232 SIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN----I 307 (432)
T ss_dssp HHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHT----C
T ss_pred ccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHh----c
Confidence 99999999999999975 444444443 2567777888888766543321 1
Q ss_pred CChhHHHHhccCCCCCCCCc---ccccccccccccCceEEEeCCCCCCC
Q 040656 287 LDPQLEALVGRKRVWPIPNN---KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 287 ~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+.....+.... ...... ..........+++..||++||++||+
T Consensus 308 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 355 (432)
T 3n9x_A 308 NKPEVIKYIKLFP-HRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT 355 (432)
T ss_dssp CCHHHHHHHHTSC-CCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCHHHHHHHHhCC-CCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC
Confidence 2344444443321 111100 01122333457888999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.06 Aligned_cols=270 Identities=29% Similarity=0.475 Sum_probs=183.3
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc---
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--- 99 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 99 (332)
+.-.++|++++.||+|+||.||+|.+..+++.||+|++... ..+++.+|+.+++++ +|+||+++++++...
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcc
Confidence 44468899999999999999999999999999999998642 235788999999999 999999999998543
Q ss_pred CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....+++|||++.+ ++..++ ..+++..+..++.+++. ||.|||+.||+|
T Consensus 128 ~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~---------------------------aL~~LH~~~iiH 179 (458)
T 3rp9_A 128 KFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLV---------------------------GVKYVHSAGILH 179 (458)
T ss_dssp TCCCEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBC
T ss_pred cCceEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCcCC
Confidence 23568999999865 444433 23667777766666665 999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCC----------------------------cccccccccceeccccccCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK----------------------------EYNVRVASRYFKGPELLVDL 228 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~ 228 (332)
|||||+|||++.++ .+||+|||+++...... ..+..+||+.|+|||++...
T Consensus 180 rDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 258 (458)
T 3rp9_A 180 RDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258 (458)
T ss_dssp CCCCGGGEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC
T ss_pred CCCChhhEEECCCC-CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC
Confidence 99999999999776 79999999998654221 22445789999999987665
Q ss_pred CCCCCcccHHHHHHHHHHHHh-----------CCCCCCCCCC--------------------CHHHHHHHHHHhCCchHH
Q 040656 229 QDYDYSLDMWSLGCMFAGMIF-----------RKEPFFYGHD--------------------NQDQLVKIARVLGTDELN 277 (332)
Q Consensus 229 ~~~~~~sDiwSlG~il~ellt-----------g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~~~ 277 (332)
..++.++|||||||++|||++ |..+| ++.+ ..+++..+...++.+...
T Consensus 259 ~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f-~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~ 337 (458)
T 3rp9_A 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF-PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEE 337 (458)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSC-C--------------------CHHHHHHHHHHHHHHCCCCHH
T ss_pred CCCCcHhHHHHHHHHHHHHHHhccccccccccccccC-CCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHH
Confidence 779999999999999999999 44444 4433 245666777777766543
Q ss_pred HHHHhcCCCCChhHHHHhccCCCC--CCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 278 AYLDKYHLELDPQLEALVGRKRVW--PIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 278 ~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+- .. .....+..+...... ...............+|+..||.+||++||+
T Consensus 338 ~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 390 (458)
T 3rp9_A 338 DIE-AL---EKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390 (458)
T ss_dssp HHH-TS---SCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHh-hc---CCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC
Confidence 322 11 122333333222100 0000111112333457888999999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=319.67 Aligned_cols=207 Identities=24% Similarity=0.477 Sum_probs=172.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEe--CCEEEEE
Confidence 36899999999999999999999999999999998753 335688999999999 99999999999954 4678999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||+.+++|...+. .+++..+..++.+++. ||+|||++||+||||||+|
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~---------------------------aL~~LH~~givHrDlkp~N 179 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---------------------------GLKHMHEHSIVHLDIKPEN 179 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGGG
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeeecccchHH
Confidence 99999999877652 3566666666665555 9999999999999999999
Q ss_pred eeecCC-CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHE-QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.+ .+.+||+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+
T Consensus 180 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~ 257 (387)
T 1kob_A 180 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLE 257 (387)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHH
T ss_pred eEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHH
Confidence 999743 34799999999998766555566689999999999877 678999999999999999999999994 444444
Q ss_pred HHHHHHH
Q 040656 263 QLVKIAR 269 (332)
Q Consensus 263 ~~~~~~~ 269 (332)
.+..+..
T Consensus 258 ~~~~i~~ 264 (387)
T 1kob_A 258 TLQNVKR 264 (387)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 4444443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.53 Aligned_cols=195 Identities=24% Similarity=0.473 Sum_probs=163.9
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~ 82 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITT--PT 82 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SS
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CC
Confidence 3457899999999999999999999999999999998642 235788999999999 99999999999954 45
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..++||||+.+ ++...+ ..+++..+..++.+++. ||.|||++||+||||
T Consensus 83 ~~~lv~E~~~g-~l~~~l~~~~~l~~~~~~~i~~qi~~---------------------------aL~~LH~~givH~Dl 134 (336)
T 3h4j_B 83 DIVMVIEYAGG-ELFDYIVEKKRMTEDEGRRFFQQIIC---------------------------AIEYCHRHKIVHRDL 134 (336)
T ss_dssp EEEEEECCCCE-EHHHHHHHHCSCCHHHHHHHHHHHHH---------------------------HHHHHHHHTCCCCCC
T ss_pred EEEEEEECCCC-cHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEecCC
Confidence 68999999954 443332 34666666666666655 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+|||++.++ .+||+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.
T Consensus 135 kp~NIll~~~~-~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 135 KPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp STTTEEECTTC-CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred chhhEEEcCCC-CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 99999999666 7999999999877655556667899999999999874444789999999999999999999994
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=318.39 Aligned_cols=197 Identities=23% Similarity=0.419 Sum_probs=156.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILT--PTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEee--CCEEEEE
Confidence 468899999999999999999999999999999999743 346789999999999 99999999999954 4578999
Q ss_pred EeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|||+.++++..++ ..++...+..++.+++. ||+|||++||+||||||+||
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~---------------------------~L~~LH~~~ivH~Dlkp~Ni 147 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLS---------------------------GVSYCHSMQICHRDLKLENT 147 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCSCCCCGGGE
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccCCCCHHHE
Confidence 9999999887764 34667766666666655 99999999999999999999
Q ss_pred eecCCCC-eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 185 MIDHEQQ-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 185 lv~~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|++.++. ++||+|||+++............||..|+|||++.+....+.++|||||||++|+|++|..||..
T Consensus 148 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp EECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred EEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 9985542 59999999997654444455668999999999998743334559999999999999999999953
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=317.40 Aligned_cols=206 Identities=27% Similarity=0.449 Sum_probs=152.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....+++||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFET--PTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEec--CCeEEEEEE
Confidence 47799999999999999999999989999999999753 345688999999999 99999999999954 457899999
Q ss_pred eecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 110 HVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 110 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
|++++++...+. .++...+..++.+++ .||.|||++||+||||||+|||+
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~---------------------------~~L~~LH~~~ivH~Dikp~NIll 181 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQIL---------------------------EAVAYLHENGIVHRDLKPENLLY 181 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCCCCCGGGEEE
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeEecCCCcccEEE
Confidence 999998876542 355555555555554 49999999999999999999999
Q ss_pred cC--CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 040656 187 DH--EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264 (332)
Q Consensus 187 ~~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~ 264 (332)
+. +++.+||+|||+++............||..|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 182 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 260 (349)
T 2w4o_A 182 ATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260 (349)
T ss_dssp SSSSTTCCEEECCCC----------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH
T ss_pred ecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH
Confidence 74 244799999999987654444456689999999999877 678999999999999999999999995444333333
Q ss_pred HHH
Q 040656 265 VKI 267 (332)
Q Consensus 265 ~~~ 267 (332)
..+
T Consensus 261 ~~i 263 (349)
T 2w4o_A 261 RRI 263 (349)
T ss_dssp HHH
T ss_pred HHH
Confidence 333
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.07 Aligned_cols=198 Identities=27% Similarity=0.456 Sum_probs=165.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEEE
Confidence 478999999999999999999999999999999986332 35688999999999 99999999999954 467899
Q ss_pred EEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+|||++++++..++. .+++..+..++.+++. ||.|||++||+||||||+|
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~---------------------------aL~~LH~~givH~Dlkp~N 135 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------------------------GVVYLHGIGITHRDIKPEN 135 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCSGGG
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCccccccchHH
Confidence 999999998887763 4666666666666655 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
||++.++ .++|+|||+++...... ......||..|+|||++.+...++.++|||||||++|+|++|..||.....
T Consensus 136 Ill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 136 LLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EEECTTC-CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred EEEeCCC-CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 9999666 79999999998654222 233567899999999998744457899999999999999999999954443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=322.48 Aligned_cols=267 Identities=24% Similarity=0.425 Sum_probs=188.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---- 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 100 (332)
..++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccccc
Confidence 357899999999999999999999999999999998642 235678999999999 9999999999986543
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....++||||+.++....+...++...+..++.+++. ||.|||++||+|||||
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~---------------------------al~~lH~~~ivH~Dlk 154 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC---------------------------GIKHLHSAGIIHRDLK 154 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCC
T ss_pred ccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHH---------------------------HHHHHHHCCeecccCC
Confidence 2367999999987544444445666665555555554 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+|||++.++ .+||+|||+++............+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+.
T Consensus 155 p~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~ 231 (371)
T 2xrw_A 155 PSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDH 231 (371)
T ss_dssp GGGEEECTTS-CEEECCCCC----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSH
T ss_pred HHHEEEcCCC-CEEEEEeecccccccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCH
Confidence 9999999766 799999999987654444556688999999999987 67899999999999999999999998 45666
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCC--------------CcccccccccccccCceEEEeC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIP--------------NNKKLQFCRSSRTSTNICITFS 326 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--------------~~~~~~~~~~~~~~~~~cl~~d 326 (332)
.+.+..+....+.+... +.. ...+..+..+.....+... ............+++..||+.|
T Consensus 232 ~~~~~~i~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 306 (371)
T 2xrw_A 232 IDQWNKVIEQLGTPCPE-FMK----KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306 (371)
T ss_dssp HHHHHHHHC-CCCCCHH-HHT----TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHhCCCCHH-HHH----HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCC
Confidence 66777777666654332 121 2233333333222111110 0000111233458899999999
Q ss_pred CCCCCC
Q 040656 327 PSGFPF 332 (332)
Q Consensus 327 P~~RP~ 332 (332)
|++||+
T Consensus 307 P~~R~t 312 (371)
T 2xrw_A 307 ASKRIS 312 (371)
T ss_dssp GGGSCC
T ss_pred hhhCCC
Confidence 999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.39 Aligned_cols=210 Identities=32% Similarity=0.630 Sum_probs=156.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence 47899999999999999999999999999999998643 235788999999999 99999999999954 457899
Q ss_pred EEeeecCCCceeecc---------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 107 IFEHVNSTDFKVLYP---------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 107 v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
||||+++ ++..++. .++...+..++ .|++.||.|||++||+||
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~---------------------------~qi~~aL~~lH~~~ivH~ 132 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ---------------------------WQLLQGLAFCHENKILHR 132 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHH---------------------------HHHHHHHHHHHHTTEECC
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHH---------------------------HHHHHHHHHHHHCCeeeC
Confidence 9999985 4443321 23444444444 455569999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||||+|||++.++ .+||+|||+++..... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .
T Consensus 133 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~ 210 (317)
T 2pmi_A 133 DLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-P 210 (317)
T ss_dssp CCCGGGEEECTTC-CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-C
T ss_pred CCChHHeEEcCCC-CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-C
Confidence 9999999999766 7999999999876532 23345578999999999877567899999999999999999999999 4
Q ss_pred CCCCHHHHHHHHHHhCC
Q 040656 257 GHDNQDQLVKIARVLGT 273 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~ 273 (332)
+.+..+.+..+....+.
T Consensus 211 ~~~~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 211 GTNDEEQLKLIFDIMGT 227 (317)
T ss_dssp CSSHHHHHHHHHHHHCS
T ss_pred CCChHHHHHHHHHHhCC
Confidence 55666677777776654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=319.88 Aligned_cols=209 Identities=23% Similarity=0.443 Sum_probs=165.2
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHH-HhccCCCCeeeeeeeeeccC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l-~~l~~h~niv~~~~~~~~~~ 100 (332)
....++|++++.||+|+||.||+|++..+++.||+|++++.. ...+..|..++ +.+ +||||++++++|.+
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~-- 110 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT-- 110 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEEC--
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEe--
Confidence 345689999999999999999999999999999999996432 23456676664 445 89999999999954
Q ss_pred CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 101 SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...+++||||++++++..++ ..+++..++.++.+++. ||+|||++||+||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~givHr 163 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS---------------------------ALGYLHSLNIVYR 163 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCceec
Confidence 46789999999999987765 34666666666666665 9999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||||+|||++.++ ++||+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.
T Consensus 164 Dlkp~NIll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~- 240 (373)
T 2r5t_A 164 DLKPENILLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY- 240 (373)
T ss_dssp CCCGGGEEECTTS-CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCHHHEEECCCC-CEEEeeCccccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC-
Confidence 9999999999776 79999999997533 2334556789999999999877 679999999999999999999999994
Q ss_pred CCCCHHHHHHHHH
Q 040656 257 GHDNQDQLVKIAR 269 (332)
Q Consensus 257 ~~~~~~~~~~~~~ 269 (332)
+.+..+....+..
T Consensus 241 ~~~~~~~~~~i~~ 253 (373)
T 2r5t_A 241 SRNTAEMYDNILN 253 (373)
T ss_dssp CSBHHHHHHHHHH
T ss_pred CCCHHHHHHHHHh
Confidence 4444445555443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=320.53 Aligned_cols=217 Identities=33% Similarity=0.584 Sum_probs=174.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCC----CCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS----KTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~----~~~~l 106 (332)
..+|++.+.||+|+||.||+|.+..+++ +|+|.+.. ......+|+.+++.+ +||||++++++|..... ..+++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~-~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-DKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEEC-CTTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEec-CcchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence 3579999999999999999999876666 77777643 223345799999999 99999999999865332 23789
Q ss_pred EEeeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 107 IFEHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 107 v~e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
||||++++.+..+. ..++...+..++.+++ .||+|||++||+|||||
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~---------------------------~aL~~LH~~~ivHrDlk 168 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---------------------------RSLAYIHSIGICHRDIK 168 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSCCS
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCccCCCCC
Confidence 99999876544332 3455555555555555 49999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+|||++..++.+||+|||+++............+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+.
T Consensus 169 p~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~ 247 (394)
T 4e7w_A 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESG 247 (394)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSH
T ss_pred HHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCH
Confidence 99999985455899999999998766666667789999999999877567999999999999999999999998 56677
Q ss_pred HHHHHHHHHHhCCchHHH
Q 040656 261 QDQLVKIARVLGTDELNA 278 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~ 278 (332)
.+.+..+.+.++.+....
T Consensus 248 ~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 248 IDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp HHHHHHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHhCCCCHHH
Confidence 788888888888765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=316.58 Aligned_cols=228 Identities=24% Similarity=0.449 Sum_probs=170.7
Q ss_pred cccCCCCCccccccccccCCC-CCCceE--EEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhc
Q 040656 10 VNVHRPRDYWDYESLTVQWGD-QEDYEV--VRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNL 83 (332)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~-~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l 83 (332)
++.+.|+..++.......... .+.|.+ .+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 143 (373)
T 2x4f_A 64 VDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143 (373)
T ss_dssp -CCCCCCCSSCCCCCCCEESCGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCCCCccccceeccccccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC
Confidence 344445544544333332222 233444 67899999999999999999999999999753 346789999999999
Q ss_pred cCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhH
Q 040656 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDIS 159 (332)
Q Consensus 84 ~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (332)
+||||+++++++.+ ....++||||+++++|...+ ..+++.....++.++
T Consensus 144 -~hpnIv~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi------------------------ 196 (373)
T 2x4f_A 144 -DHANLIQLYDAFES--KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI------------------------ 196 (373)
T ss_dssp -CCTTBCCEEEEEEC--SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHH------------------------
T ss_pred -CCCCCCeEEEEEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHH------------------------
Confidence 99999999999954 45789999999998876654 234555554444444
Q ss_pred HhHHHHHHHHHHcCCeecCCCCCCeeecC-CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHH
Q 040656 160 VWDLQALDYCHSQGIMHRDVKPHNVMIDH-EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMW 238 (332)
Q Consensus 160 ~~i~~~l~~LH~~~ivHrdlkp~Nilv~~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiw 238 (332)
+.||.|||+.||+||||||+|||+.. +++.+||+|||+++............||..|+|||++.+ ..++.++|||
T Consensus 197 ---~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diw 272 (373)
T 2x4f_A 197 ---CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMW 272 (373)
T ss_dssp ---HHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHH
T ss_pred ---HHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC-CCCCcHHhHH
Confidence 45999999999999999999999842 344899999999998776655566689999999999876 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 040656 239 SLGCMFAGMIFRKEPFFYGHDNQDQLVKIAR 269 (332)
Q Consensus 239 SlG~il~elltg~~pf~~~~~~~~~~~~~~~ 269 (332)
||||++|+|++|..||. +.+..+.+..+..
T Consensus 273 slG~il~elltg~~pf~-~~~~~~~~~~i~~ 302 (373)
T 2x4f_A 273 SVGVIAYMLLSGLSPFL-GDNDAETLNNILA 302 (373)
T ss_dssp HHHHHHHHHHHSSCTTC-CSSHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh
Confidence 99999999999999994 4444455555544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.05 Aligned_cols=268 Identities=25% Similarity=0.482 Sum_probs=187.5
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc---
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--- 99 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 99 (332)
|.-.++|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcc
Confidence 33458999999999999999999999999999999998632 235688999999999 899999999998543
Q ss_pred -CCCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 -HSKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 -~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
.....++++|++ +++|..++ ..++...+..++.+++. ||.|||+.||+|
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~---------------------------aL~~LH~~givH 155 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILR---------------------------GLKYIHSADIIH 155 (367)
T ss_dssp GGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCC
T ss_pred ccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeee
Confidence 235679999998 56666654 34666666666666655 999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||||+|||++.++ .+||+|||+++... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .
T Consensus 156 ~Dlkp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~ 231 (367)
T 2fst_X 156 RDLKPSNLAVNEDC-ELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-P 231 (367)
T ss_dssp CCCCGGGEEECTTC-CEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-C
T ss_pred CCCCHhhEEECCCC-CEEEeecccccccc--ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-C
Confidence 99999999999766 79999999997653 23345688999999999877567899999999999999999999998 5
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCc--ccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN--KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.+..+.+..+.+..+.+... .+... .+...+..++.+........ ..........+++.+||..||++||+
T Consensus 232 ~~~~~~~l~~i~~~~g~p~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t 305 (367)
T 2fst_X 232 GTDHIDQLKLILRLVGTPGAE-LLKKI---SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305 (367)
T ss_dssp CSSHHHHHHHHHHHHCSCCHH-HHTTC---CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCHHHHHHHHHHHhCCCCHH-HHHHh---hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC
Confidence 677778888888888876532 22222 22333444433311111100 00112233357888899999999996
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.04 Aligned_cols=195 Identities=21% Similarity=0.359 Sum_probs=162.1
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
...++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYK--DKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEec--CCeeE
Confidence 3568999999999999999999999999999999988542 346788999999999 89999999999964 35789
Q ss_pred eEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+||||++++++..++. .++...... ++.|+++||+|||++||+||||||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~al~~lH~~~ivH~dlkp 136 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVS---------------------------FAKDIASGMAYLHSMNIIHRDLNS 136 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHH---------------------------HHHHHHHHHHHHHHTTEECSCCST
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCccCCCCCc
Confidence 9999999999877653 244444444 444555699999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc---------------cccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY---------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
+||+++.++ .++|+|||+++........ ....||..|+|||++.+ ..++.++||||||+++|+
T Consensus 137 ~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~e 214 (310)
T 3s95_A 137 HNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCE 214 (310)
T ss_dssp TSEEECTTS-CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHH
T ss_pred CeEEECCCC-CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHH
Confidence 999999666 7999999999876432221 14578999999999977 778999999999999999
Q ss_pred HHhCCCCCC
Q 040656 247 MIFRKEPFF 255 (332)
Q Consensus 247 lltg~~pf~ 255 (332)
|++|..||.
T Consensus 215 l~~g~~~~~ 223 (310)
T 3s95_A 215 IIGRVNADP 223 (310)
T ss_dssp HHHTCCSST
T ss_pred HhcCCCCCc
Confidence 999999984
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=324.28 Aligned_cols=207 Identities=25% Similarity=0.443 Sum_probs=173.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~--~~~ 90 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST--PSD 90 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCE
Confidence 347899999999999999999999999999999999643 235688999999999 99999999999954 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++||||++++++..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~---------------------------aL~~LH~~givHrDLk 143 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---------------------------GVDYCHRHMVVHRDLK 143 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHH---------------------------HHHHHHTTTEECSCCS
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCCccccc
Confidence 89999999999887765 34666666666666655 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+|||++.++ .+||+|||++............+||+.|+|||++.+....+.++|||||||++|+|++|..||. +.+.
T Consensus 144 p~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~ 221 (476)
T 2y94_A 144 PENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHV 221 (476)
T ss_dssp GGGEEECTTC-CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSS
T ss_pred HHHEEEecCC-CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCH
Confidence 9999999666 7999999999887655555667899999999999874445789999999999999999999994 4444
Q ss_pred HHHHHHHH
Q 040656 261 QDQLVKIA 268 (332)
Q Consensus 261 ~~~~~~~~ 268 (332)
......+.
T Consensus 222 ~~~~~~i~ 229 (476)
T 2y94_A 222 PTLFKKIC 229 (476)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 44444444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=321.52 Aligned_cols=209 Identities=27% Similarity=0.439 Sum_probs=174.1
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++++.||+|+||.||+|.+..+++.||+|++++. ....+.+|+.++..+ +||||++++++|.+ ..
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~ 142 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DR 142 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CC
Confidence 3568999999999999999999999999999999998642 234588999999999 99999999999954 46
Q ss_pred CceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 103 TPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.+++||||+++++|..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~---------------------------aL~~LH~~givHrDLK 195 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL---------------------------ALDAIHSMGFIHRDVK 195 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCS
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEeccCC
Confidence 789999999999988765 34666666666666665 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCC---CCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~---~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+|||++.++ .+||+|||+++....... ....+||+.|+|||++.+... ++.++|||||||++|||++|..||.
T Consensus 196 p~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 196 PDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HHHeeECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 9999999776 799999999987654432 345689999999999876321 7899999999999999999999994
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
+.+..+...++..
T Consensus 275 -~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 275 -ADSLVGTYSKIMN 287 (410)
T ss_dssp -CSSHHHHHHHHHT
T ss_pred -CCChhhHHHHHHh
Confidence 4555556666654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=309.21 Aligned_cols=207 Identities=27% Similarity=0.476 Sum_probs=160.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEc---cCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC-
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc-
Confidence 4688999999999999999999875 68899999998743 234578899999999 99999999999954
Q ss_pred CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...+++||||++++++..++ ..+++..+..++.+++ .||.|||++||+|
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~al~~lH~~~ivH 144 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS---------------------------MALGHLHQKGIIY 144 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCEEc
Confidence 46789999999998887665 2355555555555555 4999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||||+|||++.++ .+||+|||+++..... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 145 ~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 145 RDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp CCCCTTTEEECTTS-CEEECCCSCC----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHeEECCCC-cEEEEeCCcccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC
Confidence 99999999999666 7999999998754322 23345678999999999877 678999999999999999999999994
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
+.+..+....+..
T Consensus 223 -~~~~~~~~~~i~~ 235 (327)
T 3a62_A 223 -GENRKKTIDKILK 235 (327)
T ss_dssp -CSSHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHh
Confidence 4444444444444
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.65 Aligned_cols=210 Identities=33% Similarity=0.620 Sum_probs=167.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeec--CCeEEE
Confidence 68999999999999999999999999999999985432 35578899999999 89999999999954 457899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||++++++..+. ..++...+..++.+++. ||.|||++||+||||||+|
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~---------------------------~l~~lH~~~ivH~dlkp~N 132 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ---------------------------AVNFCHKHNCIHRDVKPEN 132 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGGG
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCcCCCCChhh
Confidence 99999998877654 33566655555555554 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+++.++ .++|+|||++....... ......+|..|+|||++.+...++.++||||||+++|+|++|..|| .+....+
T Consensus 133 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~ 210 (311)
T 4agu_A 133 ILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVD 210 (311)
T ss_dssp EEECTTS-CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHH
T ss_pred EEEcCCC-CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHH
Confidence 9999666 79999999998765332 2345578999999999977667899999999999999999999998 4555566
Q ss_pred HHHHHHHHhCC
Q 040656 263 QLVKIARVLGT 273 (332)
Q Consensus 263 ~~~~~~~~~~~ 273 (332)
....+....+.
T Consensus 211 ~~~~~~~~~~~ 221 (311)
T 4agu_A 211 QLYLIRKTLGD 221 (311)
T ss_dssp HHHHHHHHHCS
T ss_pred HHHHHHHHhcc
Confidence 66666665543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=307.19 Aligned_cols=206 Identities=26% Similarity=0.484 Sum_probs=170.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ .||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN--R 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 46799999999999999999999999999999998642 246789999999999 89999999999954 4
Q ss_pred CCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
...+++|||++++++..++. .++...+..++.+++ .||.|||++||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~---------------------------~aL~~lH~~~ivH~d 140 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL---------------------------DGVNYLHTKKIAHFD 140 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeecCC
Confidence 57899999999998877653 355555555555554 499999999999999
Q ss_pred CCCCCeeecCCCC---eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 179 VKPHNVMIDHEQQ---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||+||+++.++. .++|+|||++.............+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 141 ikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 9999999986653 699999999988765555566689999999999876 678999999999999999999999994
Q ss_pred CCCCCHHHHHHHH
Q 040656 256 YGHDNQDQLVKIA 268 (332)
Q Consensus 256 ~~~~~~~~~~~~~ 268 (332)
+....+....+.
T Consensus 220 -~~~~~~~~~~i~ 231 (321)
T 2a2a_A 220 -GDTKQETLANIT 231 (321)
T ss_dssp -CSSHHHHHHHHH
T ss_pred -CCCHHHHHHHHH
Confidence 334444444433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.79 Aligned_cols=267 Identities=27% Similarity=0.472 Sum_probs=195.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC---CCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---SKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---~~~ 103 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccce
Confidence 47899999999999999999999999999999998642 235688999999999 9999999999986432 246
Q ss_pred ceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 104 PSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
.++++|++.+ ++..++ ..++...+..++.+++ .||+|||++||+||||||
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~---------------------------~aL~~LH~~~ivH~Dikp 156 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQIL---------------------------RGLKYIHSANVLHRDLKP 156 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCCCG
T ss_pred EEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeecCCCCh
Confidence 7999999986 444332 3355555555555555 499999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
+|||++.++ .++|+|||++........ .....||..|+|||++.+...++.++|||||||++|+|++|..|| .+
T Consensus 157 ~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~ 234 (364)
T 3qyz_A 157 SNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PG 234 (364)
T ss_dssp GGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CC
T ss_pred HhEEECCCC-CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CC
Confidence 999999666 799999999987643322 234578999999999877567899999999999999999999998 56
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC-CCCCCCCc-ccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK-RVWPIPNN-KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~-~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+.+..+....+.+....+.. ......+...... ........ ..........+++..||+.||++||+
T Consensus 235 ~~~~~~~~~i~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 307 (364)
T 3qyz_A 235 KHYLDQLNHILGILGSPSQEDLNC----IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307 (364)
T ss_dssp SSGGGHHHHHHHHHCSCCHHHHHT----CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred CChHHHHHHHHHHhCCCCHHHHHH----hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC
Confidence 677778888888777655433221 1111111111111 00000000 00111223346778899999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.88 Aligned_cols=288 Identities=25% Similarity=0.462 Sum_probs=204.4
Q ss_pred ccccCCCCCccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhc
Q 040656 9 DVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNL 83 (332)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l 83 (332)
+|+.-.++-|+........|.-.++|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+
T Consensus 19 ~m~~~~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l 98 (371)
T 4exu_A 19 SMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 98 (371)
T ss_dssp --CCSSCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC
T ss_pred ceeeeccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc
Confidence 445555666655555555566678999999999999999999999999999999998642 235688999999999
Q ss_pred cCCCCeeeeeeeeeccCCC----CceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhH
Q 040656 84 CGGPNIVKLLDIVRDQHSK----TPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDIS 159 (332)
Q Consensus 84 ~~h~niv~~~~~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (332)
+||||+++++++...... ..+++||++.+.....+...++...+..++.+++.
T Consensus 99 -~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~---------------------- 155 (371)
T 4exu_A 99 -QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLK---------------------- 155 (371)
T ss_dssp -CCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHH----------------------
T ss_pred -CCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHH----------------------
Confidence 899999999999654322 24999999985433333345667666666666655
Q ss_pred HhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHH
Q 040656 160 VWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWS 239 (332)
Q Consensus 160 ~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwS 239 (332)
||+|||++||+||||||+|||++.++ .++|+|||+++... .......+|..|+|||++.+...++.++||||
T Consensus 156 -----aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (371)
T 4exu_A 156 -----GLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWS 227 (371)
T ss_dssp -----HHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred -----HHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcccccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence 99999999999999999999999666 79999999997653 23345678999999999877567899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCC--Ccccccccccccc
Q 040656 240 LGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIP--NNKKLQFCRSSRT 317 (332)
Q Consensus 240 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~~~~~ 317 (332)
|||++|+|++|..|| .+.+..+.+..+....+.+... +.... ........+......... ............+
T Consensus 228 lG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (371)
T 4exu_A 228 VGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTE-FVQKL---NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAAD 302 (371)
T ss_dssp HHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHH-HHTTC---SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHH
T ss_pred HHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHH-HHHHh---hhhhhhhhhhccCCCcchhHHHhccccChHHHH
Confidence 999999999999999 4566667777777776654321 22221 111222222221111100 0001112333457
Q ss_pred cCceEEEeCCCCCCC
Q 040656 318 STNICITFSPSGFPF 332 (332)
Q Consensus 318 ~~~~cl~~dP~~RP~ 332 (332)
++..||+.||++||+
T Consensus 303 li~~~L~~dP~~Rpt 317 (371)
T 4exu_A 303 LLEKMLELDVDKRLT 317 (371)
T ss_dssp HHHHHSCSCTTTSCC
T ss_pred HHHHHCCCChhhcCC
Confidence 788899999999996
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.23 Aligned_cols=211 Identities=32% Similarity=0.648 Sum_probs=164.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccch----HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++++.||+|+||.||+|.+..+++.||+|+++.... ..+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee--CCEEEEE
Confidence 689999999999999999999999999999999864332 2355799999999 89999999999954 4578999
Q ss_pred EeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||+++ ++...+ ..++...+..++.+++ .||.|||++||+||||||+|
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~---------------------------~aL~~LH~~~ivH~Dikp~N 130 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---------------------------RGLAYCHRQKVLHRDLKPQN 130 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEEESSCCGGG
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCccCCCcCHHH
Confidence 999986 333332 2245555555555554 59999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|+++.++ .++|+|||++...... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+
T Consensus 131 Il~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~ 208 (324)
T 3mtl_A 131 LLINERG-ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEE 208 (324)
T ss_dssp EEECTTC-CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHH
T ss_pred EEECCCC-CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHH
Confidence 9999776 7999999999765422 22344578999999999877567899999999999999999999998 5666677
Q ss_pred HHHHHHHHhCCch
Q 040656 263 QLVKIARVLGTDE 275 (332)
Q Consensus 263 ~~~~~~~~~~~~~ 275 (332)
.+..+.+..+.+.
T Consensus 209 ~~~~i~~~~~~~~ 221 (324)
T 3mtl_A 209 QLHFIFRILGTPT 221 (324)
T ss_dssp HHHHHHHHHCCCC
T ss_pred HHHHHHHHhCCCC
Confidence 7888887776543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.59 Aligned_cols=241 Identities=25% Similarity=0.477 Sum_probs=189.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----------------chHHHHHHHHHHHhccCCCCeeeee
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNIVKLL 93 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~h~niv~~~ 93 (332)
-.++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLF 112 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence 357899999999999999999999999999999998642 235688999999999 999999999
Q ss_pred eeeeccCCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 94 DIVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
+++.+ ....++||||++++++...+ ..+++..+..++.+++. ||.|||
T Consensus 113 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~---------------------------~l~~lH 163 (504)
T 3q5i_A 113 DVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS---------------------------GICYLH 163 (504)
T ss_dssp EEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHH
T ss_pred EEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHH
Confidence 99954 46789999999999886654 34666666666666655 999999
Q ss_pred HcCCeecCCCCCCeeecCCCC--eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 171 SQGIMHRDVKPHNVMIDHEQQ--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 171 ~~~ivHrdlkp~Nilv~~~~~--~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
++||+||||||+|||++.++. .++|+|||+++............||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 164 ~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll 241 (504)
T 3q5i_A 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILL 241 (504)
T ss_dssp HTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHH
T ss_pred HCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHH
Confidence 999999999999999986653 599999999998776666667789999999999864 6899999999999999999
Q ss_pred hCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCC
Q 040656 249 FRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPS 328 (332)
Q Consensus 249 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~ 328 (332)
+|..|| .+.+..+.+..+...........+ ...++.+++++ ..||+.||+
T Consensus 242 ~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~-----~~~s~~~~~li------------------------~~~L~~dp~ 291 (504)
T 3q5i_A 242 CGYPPF-GGQNDQDIIKKVEKGKYYFDFNDW-----KNISDEAKELI------------------------KLMLTYDYN 291 (504)
T ss_dssp HSSCSS-CCSSHHHHHHHHHHCCCCCCHHHH-----TTSCHHHHHHH------------------------HHHTCSSTT
T ss_pred hCCCCC-CCCCHHHHHHHHHcCCCCCCcccc-----CCCCHHHHHHH------------------------HHHcCCChh
Confidence 999999 344555555555543222111110 23455555555 448889999
Q ss_pred CCCC
Q 040656 329 GFPF 332 (332)
Q Consensus 329 ~RP~ 332 (332)
+||+
T Consensus 292 ~R~t 295 (504)
T 3q5i_A 292 KRCT 295 (504)
T ss_dssp TSCC
T ss_pred HCCC
Confidence 9986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=314.62 Aligned_cols=258 Identities=17% Similarity=0.262 Sum_probs=183.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-------cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-------TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.. ....+.+|+.+++++.+||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4688999999999999999999864 34567999999743 235688999999999789999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
...+++||||+++++|..++......... +..... ........+.+.+.++.|++.||+|||++||+|||
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 228 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGME-YSYDIN-------RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCcccc-cccccc-------ccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 45789999999999987765321100000 000000 00000112223345667777899999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+|||++.++ .+||+|||+++....... .....+|..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 229 lkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~ 306 (370)
T 2psq_A 229 LAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 306 (370)
T ss_dssp CCGGGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cchhhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999666 799999999987653322 233456788999999877 679999999999999999999 89898
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
. +....+....+...... ......++.+..+ +..||+.||++||+
T Consensus 307 ~-~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~l------------------------i~~~l~~dP~~Rpt 351 (370)
T 2psq_A 307 P-GIPVEELFKLLKEGHRM--------DKPANCTNELYMM------------------------MRDCWHAVPSQRPT 351 (370)
T ss_dssp T-TCCGGGHHHHHHTTCCC--------CCCTTSCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred C-CCCHHHHHHHHhcCCCC--------CCCCCCCHHHHHH------------------------HHHHcCCChhhCcC
Confidence 3 44433333333221111 0112334444444 45599999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=298.19 Aligned_cols=239 Identities=26% Similarity=0.455 Sum_probs=188.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|++.+.||+|+||.||+|.+..++..+|+|++.. .....+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence 4679999999999999999999999999999999864 3456789999999999 99999999999954 4578999
Q ss_pred EeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|||++++++...+ ..++...+..++.+++. ||.|||++||+||||||+||
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~---------------------------~l~~lH~~~i~H~dlkp~Ni 137 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLS---------------------------AVAYCHKLNVAHRDLKPENF 137 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGGGE
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCccCCCCCHHHE
Confidence 9999998886654 33556655555555554 99999999999999999999
Q ss_pred ee---cCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 185 MI---DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 185 lv---~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
++ +.++ .++|+|||++.............+|..|+|||++.+ .++.++||||||+++|+|++|..||. .....
T Consensus 138 l~~~~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~ 213 (277)
T 3f3z_A 138 LFLTDSPDS-PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS-APTDS 213 (277)
T ss_dssp EESSSSTTC-CEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHH
T ss_pred EEecCCCCC-cEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC-CCCHH
Confidence 99 5444 799999999988776666667789999999999865 48999999999999999999999994 44444
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+........... ....++.++.++ ..||+.||++||+
T Consensus 214 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li------------------------~~~l~~dp~~R~s 255 (277)
T 3f3z_A 214 EVMLKIREGTFTFPEKD-----WLNVSPQAESLI------------------------RRLLTKSPKQRIT 255 (277)
T ss_dssp HHHHHHHHCCCCCCHHH-----HTTSCHHHHHHH------------------------HHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCCCchh-----hhcCCHHHHHHH------------------------HHHccCChhhCcC
Confidence 44444444222211111 123455555555 4599999999996
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=305.77 Aligned_cols=237 Identities=20% Similarity=0.330 Sum_probs=173.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|+.+++++ +||||+++++++.+ ....
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 109 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--PPNL 109 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--TTCC
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCce
Confidence 467899999999999999999975 68899999986432 34688999999999 89999999999954 4568
Q ss_pred eeEEeeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC--Cee
Q 040656 105 SLIFEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMH 176 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--ivH 176 (332)
++||||++++++..++.. ++...+.. ++.|++.||+|||++| |+|
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------------------------i~~qi~~aL~~LH~~~~~ivH 162 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLS---------------------------MAYDVAKGMNYLHNRNPPIVH 162 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHH---------------------------HHHHHHHHHHHHHTSSSCCCC
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHcCCCCEEC
Confidence 999999999998877633 44444444 4445556999999999 999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||||+||+++.++ .+||+|||+++...... ......||..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 163 ~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~ 240 (309)
T 3p86_A 163 RNLKSPNLLVDKKY-TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG 240 (309)
T ss_dssp TTCCGGGEEECTTC-CEEECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred CCCChhhEEEeCCC-cEEECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999666 79999999997544322 2344578999999999877 678999999999999999999999993
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+..+....+....... ......++.+..++ ..||+.||++||+
T Consensus 241 -~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li------------------------~~~l~~dP~~Rps 285 (309)
T 3p86_A 241 -NLNPAQVVAAVGFKCKRL-------EIPRNLNPQVAAII------------------------EGCWTNEPWKRPS 285 (309)
T ss_dssp -TSCHHHHHHHHHHSCCCC-------CCCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred -CCCHHHHHHHHHhcCCCC-------CCCccCCHHHHHHH------------------------HHHccCChhhCcC
Confidence 333333333322211111 11223455555555 5599999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=330.37 Aligned_cols=196 Identities=24% Similarity=0.414 Sum_probs=170.3
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|++++. ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEee--CC
Confidence 5678899999999999999999999999999999998642 235678999999999 99999999999954 45
Q ss_pred CceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 103 TPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
.+++||||+++++|..++. .+++..+..++.+++. ||+|||++||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~---------------------------aL~yLH~~gIvHr 310 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC---------------------------GLEDLHRERIVYR 310 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCEecc
Confidence 7899999999999877652 2666666666666665 9999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||||+|||++.++ .+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 311 DLKPeNILld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 311 DLKPENILLDDHG-HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred CCchheEEEeCCC-CeEEEecccceecccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999666 799999999988765555566789999999999977 6789999999999999999999999954
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=299.08 Aligned_cols=207 Identities=26% Similarity=0.497 Sum_probs=169.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++.+ ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 80 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFH 80 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEc--CCEE
Confidence 3578999999999999999999999999999999986432 35678999999999 99999999999954 4568
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+++||++.++++...+ ..++...+..++.+++ .||.|||++||+||||||
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~---------------------------~~l~~lH~~~i~H~dikp 133 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---------------------------ESIAYCHSNGIVHRNLKP 133 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSCCCG
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCcCcCCCCH
Confidence 9999999998875543 2355665555555555 499999999999999999
Q ss_pred CCeeecCCC--CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 182 HNVMIDHEQ--QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 182 ~Nilv~~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
+||+++.++ ..++|+|||.+.............+|..|+|||++.+ ..++.++||||||+++|+|++|..||. +.+
T Consensus 134 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~ 211 (284)
T 3kk8_A 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DED 211 (284)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSS
T ss_pred HHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCC-CCc
Confidence 999997543 2499999999987765555566789999999999877 678999999999999999999999993 334
Q ss_pred CHHHHHHHH
Q 040656 260 NQDQLVKIA 268 (332)
Q Consensus 260 ~~~~~~~~~ 268 (332)
.......+.
T Consensus 212 ~~~~~~~~~ 220 (284)
T 3kk8_A 212 QHRLYAQIK 220 (284)
T ss_dssp HHHHHHHHH
T ss_pred hhHHHHHHH
Confidence 344444433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=312.30 Aligned_cols=194 Identities=21% Similarity=0.353 Sum_probs=162.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++.+|+||+++++++.+ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEE
Confidence 57899999999999999999999999999999998643 345689999999999889999999999855 457899999
Q ss_pred eecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
++ +++|..++. .++...+..++.+++ .||+|||++||+||||||+|||
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~---------------------------~~l~~LH~~~iiHrDlkp~Nil 137 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLI---------------------------SRMEYVHSKNLIYRDVKPENFL 137 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCCCGGGEE
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeeccCCCHHHee
Confidence 99 787776642 355555555555554 5999999999999999999999
Q ss_pred ecCCCCe-----EEEEecccceeecCCCc--------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 186 IDHEQQK-----LRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 186 v~~~~~~-----vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
++.++ . ++|+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 138 l~~~~-~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~ 215 (330)
T 2izr_A 138 IGRPG-NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSL 215 (330)
T ss_dssp ECCGG-GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eccCC-CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCC
Confidence 98655 4 99999999987643322 245679999999999887 678999999999999999999999
Q ss_pred CCCC
Q 040656 253 PFFY 256 (332)
Q Consensus 253 pf~~ 256 (332)
||..
T Consensus 216 Pf~~ 219 (330)
T 2izr_A 216 PWQG 219 (330)
T ss_dssp TTTT
T ss_pred Cccc
Confidence 9953
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=310.50 Aligned_cols=210 Identities=26% Similarity=0.505 Sum_probs=170.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhcc----CCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++++.||+|+||.||+|.+..+++.||+|+++.. .......|+.+++.+. .||||+++++++... ...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~~~ 111 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--DHM 111 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--TEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--Cee
Confidence 47899999999999999999999999999999999742 3456788999999994 399999999999653 578
Q ss_pred eeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 105 SLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
++|||++ ++++..++. .++...+..++.+++ .||+|||++||+||||
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~---------------------------~aL~~LH~~~ivHrDl 163 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEIL---------------------------KALNYLRKMSLTHTDL 163 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSCC
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeeeCCC
Confidence 9999999 777666542 255555555555554 5999999999999999
Q ss_pred CCCCeeecC------------------------CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcc
Q 040656 180 KPHNVMIDH------------------------EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 235 (332)
Q Consensus 180 kp~Nilv~~------------------------~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~s 235 (332)
||+|||++. ..+.+||+|||+++.... ......||..|+|||++.+ ..++.++
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~ 240 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSS 240 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTH
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCcc
Confidence 999999974 244799999999986432 3345678999999999987 6799999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCc
Q 040656 236 DMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTD 274 (332)
Q Consensus 236 DiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 274 (332)
|||||||++|+|++|..||. ..+..+.+..+....+..
T Consensus 241 DiwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~~~ 278 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFR-THEHMEHLAMMESIIQPI 278 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHHTCCC
T ss_pred chHHHHHHHHHHHHCCCCCC-CCcHHHHHHHHHHhcCCC
Confidence 99999999999999999994 555566666666655543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=308.89 Aligned_cols=194 Identities=28% Similarity=0.525 Sum_probs=148.0
Q ss_pred CCceEE---EeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVV---RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
++|++. +.||+|+||.||+|.+..+++.||+|+++......+.+|+.+++.+.+||||+++++++.+ ....++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEE
Confidence 346664 7899999999999999999999999999877778899999999999669999999999954 46789999
Q ss_pred eeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 109 EHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 109 e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
||++++++...+ ..+++..+..++.+++. ||+|||++||+||||||+|||
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~---------------------------~l~~LH~~~ivH~Dlkp~NIl 138 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVS---------------------------AVSHMHDVGVVHRDLKPENLL 138 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGGGEE
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCeecCCCHHHEE
Confidence 999999887765 34666666666666655 999999999999999999999
Q ss_pred ecCCCC--eEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 IDHEQQ--KLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~~~~~--~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++.++. .++|+|||+++...... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 139 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 210 (325)
T 3kn6_A 139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQ 210 (325)
T ss_dssp EEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 975442 79999999998664332 2345578999999999877 678999999999999999999999994
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=316.17 Aligned_cols=196 Identities=28% Similarity=0.476 Sum_probs=157.9
Q ss_pred CCCceEE-EeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeec--cCCCCceeE
Q 040656 31 QEDYEVV-RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~~~lv 107 (332)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. ...+.+|+.++.++.+||||++++++|.. .+...+++|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 4678887 789999999999999999999999999863 45678999998777699999999998854 234568999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+.+++|..++. .+++..+..++.+++. ||.|||++||+||||||+
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~---------------------------aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE---------------------------AIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGG
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCccccCcCcc
Confidence 99999998877653 2566666666666655 999999999999999999
Q ss_pred CeeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 183 NVMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 183 Nilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||++.+ ++.+||+|||+++...........+||..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 9999862 34799999999987665555566788999999999876 6799999999999999999999999953
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=319.03 Aligned_cols=222 Identities=24% Similarity=0.404 Sum_probs=181.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++++.. ...+.+|..++..+ +||||++++++|.+ ...
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~~ 148 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD--DNN 148 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCE
Confidence 4588999999999999999999999999999999996422 23488999999999 99999999999954 467
Q ss_pred ceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
+++||||+++++|..++ ..+++..++.++.+++. ||.|||++||+||||
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~---------------------------aL~~LH~~giiHrDL 201 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI---------------------------AIDSVHQLHYVHRDI 201 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeEeccc
Confidence 89999999999988876 34677777777777666 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceecccccc----CCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~----~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
||+|||++.++ .+||+|||+++....... ....+||+.|+|||++. +...++.++|||||||++|||++|..|
T Consensus 202 Kp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P 280 (437)
T 4aw2_A 202 KPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280 (437)
T ss_dssp SGGGEEECTTS-CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHeeEcCCC-CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence 99999999766 799999999987654433 23458999999999986 235689999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHh-----------CCchHHHHHHhc
Q 040656 254 FFYGHDNQDQLVKIARVL-----------GTDELNAYLDKY 283 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ 283 (332)
|. +.+..+...++.... .++...+++.++
T Consensus 281 f~-~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~l 320 (437)
T 4aw2_A 281 FY-AESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRL 320 (437)
T ss_dssp TC-CSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTT
T ss_pred CC-CCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHH
Confidence 94 555556666665421 134556667665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=313.37 Aligned_cols=248 Identities=14% Similarity=0.211 Sum_probs=177.9
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccC-----CceEEEEEecccchHHHHHH---------------HHHHHhccCCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTN-----NEKCIIKILKPVKKKKIKRE---------------IKILQNLCGGP 87 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~E---------------~~~l~~l~~h~ 87 (332)
....++|++.+.||+|+||.||+|.+..+ ++.||+|++.... ..+.+| +..+..+ .|+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ 108 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKL-KYL 108 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCC
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCC
Confidence 34567999999999999999999988654 5889999986432 233334 4444555 699
Q ss_pred CeeeeeeeeeccC--CCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHh
Q 040656 88 NIVKLLDIVRDQH--SKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVW 161 (332)
Q Consensus 88 niv~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (332)
||+++++++.... ....+++|||+ +++|..++ ..++...+..++.+++
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~------------------------- 162 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRIL------------------------- 162 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHH-------------------------
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHH-------------------------
Confidence 9999999986542 24579999999 88877765 3355655555555554
Q ss_pred HHHHHHHHHHcCCeecCCCCCCeeec--CCCCeEEEEecccceeecCCCc--------ccccccccceeccccccCCCCC
Q 040656 162 DLQALDYCHSQGIMHRDVKPHNVMID--HEQQKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDY 231 (332)
Q Consensus 162 i~~~l~~LH~~~ivHrdlkp~Nilv~--~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~ 231 (332)
.||+|||++||+||||||+|||++ .++ .+||+|||+++.+..... .....||..|+|||++.+ ..+
T Consensus 163 --~~l~~lH~~~iiHrDlkp~Nill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 238 (364)
T 3op5_A 163 --DILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAP 238 (364)
T ss_dssp --HHHHHHHHTTEECCCCCGGGEEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCC
T ss_pred --HHHHHHHHCCeEEecCCHHHEEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCC
Confidence 599999999999999999999998 555 799999999987643221 133459999999999877 678
Q ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcC--CCCChhHHHHhccCCCCCCCCcccc
Q 040656 232 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYH--LELDPQLEALVGRKRVWPIPNNKKL 309 (332)
Q Consensus 232 ~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~~~~~~~~~~~~ 309 (332)
+.++|||||||++|+|+||..||................. ...+.++++... ...++.+..++
T Consensus 239 ~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li-------------- 303 (364)
T 3op5_A 239 SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRY-RENIASLMDKCFPAANAPGEIAKYM-------------- 303 (364)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH-HHCHHHHHHHHSCTTCCCHHHHHHH--------------
T ss_pred CchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHh-hhhHHHHHHHhcccccCHHHHHHHH--------------
Confidence 9999999999999999999999954333333322222211 122233333221 23444555554
Q ss_pred cccccccccCceEEEeCCCCCCC
Q 040656 310 QFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 310 ~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..||+.||++||+
T Consensus 304 ----------~~cl~~~p~~RP~ 316 (364)
T 3op5_A 304 ----------ETVKLLDYTEKPL 316 (364)
T ss_dssp ----------HHHHTCCTTCCCC
T ss_pred ----------HHHhcCCCCCCCC
Confidence 5599999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=314.71 Aligned_cols=202 Identities=21% Similarity=0.249 Sum_probs=165.8
Q ss_pred CCCCceEEEeeccc--CCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRG--KYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.++|++++.||+| +||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DN 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEE--CC
Confidence 56899999999999 99999999999999999999996432 35678899999999 99999999999965 45
Q ss_pred CceeEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 103 TPSLIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
.+++||||++++++..++ ..+++..+..++.+++. ||+|||++||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~---------------------------~l~~LH~~~ivHr 152 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK---------------------------ALDYIHHMGYVHR 152 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECC
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeecC
Confidence 789999999999987765 33566666655555554 9999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCC--------cccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHH
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~ell 248 (332)
||||+|||++.++ .++|+|||.+....... ......||..|+|||++.+. ..++.++|||||||++|+|+
T Consensus 153 Dlkp~NIll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 231 (389)
T 3gni_B 153 SVKASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231 (389)
T ss_dssp CCSGGGEEECTTC-CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence 9999999999666 79999999886542211 12234788899999998764 46899999999999999999
Q ss_pred hCCCCCCCCCCCHHH
Q 040656 249 FRKEPFFYGHDNQDQ 263 (332)
Q Consensus 249 tg~~pf~~~~~~~~~ 263 (332)
+|..||. +.+..+.
T Consensus 232 ~g~~pf~-~~~~~~~ 245 (389)
T 3gni_B 232 NGHVPFK-DMPATQM 245 (389)
T ss_dssp HSSCTTT-TCCSTTH
T ss_pred HCCCCCC-CCCHHHH
Confidence 9999994 3333333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=301.91 Aligned_cols=195 Identities=23% Similarity=0.473 Sum_probs=157.7
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.-.++|.+.+.||+|+||.||+|.+..+++.+|+|++... ....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED--YHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--CCeE
Confidence 3457899999999999999999999999999999998643 346789999999999 99999999999954 4578
Q ss_pred eeEEeeecCCCceeec-------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 105 SLIFEHVNSTDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
++||||++++++...+ ..++...+..++.+++ .||+|||++||+||
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~---------------------------~~L~~LH~~~ivH~ 148 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM---------------------------NALAYFHSQHVVHK 148 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCEEEC
Confidence 9999999998877654 2355555555555554 59999999999999
Q ss_pred CCCCCCeeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 178 DVKPHNVMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 178 dlkp~Nilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||||+||+++.+ .+.++|+|||++.............+|..|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 149 dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCC
Confidence 999999999532 34799999999987665555566789999999999854 68899999999999999999999993
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.21 Aligned_cols=197 Identities=26% Similarity=0.382 Sum_probs=168.2
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
-...++|++.+.||+|+||.||+|.+..+++.||+|++++. ....+.+|+.+++++ +||||++++++|.+ .
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~ 257 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFET--K 257 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEee--C
Confidence 34568999999999999999999999999999999999642 235688999999999 99999999999954 4
Q ss_pred CCceeEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 102 KTPSLIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
..+++||||+++++|..++. .+++..+..++.+++. ||.|||++||
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~---------------------------aL~~LH~~gI 310 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS---------------------------GLEHLHQRNI 310 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHH---------------------------HHHHHHHcCC
Confidence 57899999999999876642 3566666666666655 9999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
+||||||+|||++.++ .+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 311 vHrDLKP~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~P 388 (543)
T 3c4z_A 311 IYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP 388 (543)
T ss_dssp ECCCCCGGGEEECTTS-CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCChHHEEEeCCC-CEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCC
Confidence 9999999999999766 799999999987754433 334589999999999987 6799999999999999999999999
Q ss_pred CCC
Q 040656 254 FFY 256 (332)
Q Consensus 254 f~~ 256 (332)
|..
T Consensus 389 F~~ 391 (543)
T 3c4z_A 389 FRA 391 (543)
T ss_dssp SCC
T ss_pred CCC
Confidence 954
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.32 Aligned_cols=208 Identities=23% Similarity=0.384 Sum_probs=174.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++++. ....+..|..++..+.+|+||++++++|. +...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence 357899999999999999999999999999999998742 23567889999999878999999999994 4467
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++++|..++ ..+++..+..++.+++. ||+|||++||+|||||
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~gIiHrDLK 469 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI---------------------------GLFFLQSKGIIYRDLK 469 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTSEECCCCC
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeEeccCC
Confidence 89999999999988775 35777777777776665 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeec-CCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||++.++ .+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+
T Consensus 470 p~NILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~-~~~ 546 (674)
T 3pfq_A 470 LDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GED 546 (674)
T ss_dssp STTEEECSSS-CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSS
T ss_pred hhhEEEcCCC-cEEEeecceeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCC-CCC
Confidence 9999999776 79999999998643 2334456789999999999977 689999999999999999999999993 445
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+....+..
T Consensus 547 ~~~~~~~i~~ 556 (674)
T 3pfq_A 547 EDELFQSIME 556 (674)
T ss_dssp HHHHHHHHHS
T ss_pred HHHHHHHHHh
Confidence 5555555543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.35 Aligned_cols=206 Identities=25% Similarity=0.555 Sum_probs=169.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++.. .....+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999999853 2346789999999999 99999999999954 46789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+|+||+.++++...+ ..+++..+..++.+++. ||.|||++||+||||||+
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~---------------------------al~~lH~~~ivH~Dlkp~ 150 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---------------------------GITYMHKHNIVHRDLKPE 150 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCSGG
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeEeccCchH
Confidence 999999999886654 34666666666666655 999999999999999999
Q ss_pred CeeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.. ++.+||+|||+++............||+.|+|||++.+ .++.++|||||||++|+|++|..||. +...
T Consensus 151 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~ 227 (486)
T 3mwu_A 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNE 227 (486)
T ss_dssp GEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC-CSSH
T ss_pred HEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC-CCCH
Confidence 9999632 33699999999987665555566789999999999876 58999999999999999999999993 4445
Q ss_pred HHHHHHHHH
Q 040656 261 QDQLVKIAR 269 (332)
Q Consensus 261 ~~~~~~~~~ 269 (332)
.+.+..+..
T Consensus 228 ~~~~~~i~~ 236 (486)
T 3mwu_A 228 YDILKRVET 236 (486)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 555555544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=308.67 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=178.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC--
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK-- 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~-- 102 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence 578999999999999999999999999999999996431 24688999999999 999999999998654322
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..++||||+++++|..++ ..++...+..++.+++ .||+|||++||+||||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~ivH~dl 142 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC---------------------------QALNFSHQNGIIHRDV 142 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCCCC
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCCCcCCC
Confidence 358999999998887765 2355555555555555 4999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+||+++.++ .+||+|||++....... ......||..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 143 kp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 143 KPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp CGGGEEEETTS-CEEECCCSCC------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHEEEcCCC-CEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999766 79999999997654322 1233468999999999987 678999999999999999999999993
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+...........+. .......++.+..++ ..||+.||++||+
T Consensus 221 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li------------------------~~~l~~dP~~R~~ 267 (311)
T 3ork_A 221 -GDSPVSVAYQHVREDPIPP-----SARHEGLSADLDAVV------------------------LKALAKNPENRYQ 267 (311)
T ss_dssp -CSSHHHHHHHHHHCCCCCH-----HHHSTTCCHHHHHHH------------------------HHHTCSSGGGSCS
T ss_pred -CCChHHHHHHHhcCCCCCc-----ccccCCCCHHHHHHH------------------------HHHHhcCHhhChh
Confidence 3333333333332111111 111234555566655 4489999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=309.88 Aligned_cols=211 Identities=34% Similarity=0.651 Sum_probs=165.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--CC
Confidence 578999999999999999999998899999999986321 23578999999999 99999999999954 46
Q ss_pred CceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++||||++++ +...+ ..++...+..++.++ ++||.|||++||+|||
T Consensus 86 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~ivH~D 137 (346)
T 1ua2_A 86 NISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMT---------------------------LQGLEYLHQHWILHRD 137 (346)
T ss_dssp CCEEEEECCSEE-HHHHHTTCCSSCCSSHHHHHHHHH---------------------------HHHHHHHHHTTCCCCC
T ss_pred ceEEEEEcCCCC-HHHHHHhcCcCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCEECCC
Confidence 789999999873 33332 124555555555554 4599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|||+||+++.++ .+||+|||+++..... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+
T Consensus 138 lkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~ 215 (346)
T 1ua2_A 138 LKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PG 215 (346)
T ss_dssp CCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CC
T ss_pred CCHHHEEEcCCC-CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CC
Confidence 999999999666 7999999999765432 23345678999999999877566899999999999999999999887 56
Q ss_pred CCCHHHHHHHHHHhCCc
Q 040656 258 HDNQDQLVKIARVLGTD 274 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~ 274 (332)
.+..+.+..+....+.+
T Consensus 216 ~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 216 DSDLDQLTRIFETLGTP 232 (346)
T ss_dssp SSHHHHHHHHHHHHCCC
T ss_pred CCHHHHHHHHHHHcCCC
Confidence 66667777777766543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=317.67 Aligned_cols=209 Identities=26% Similarity=0.428 Sum_probs=174.1
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++++.||+|+||.||+|.+..+++.||+|++++. ....+.+|..++..+ +|+||++++++|.+ ..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~ 134 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQD--EN 134 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SS
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee--CC
Confidence 4568999999999999999999999999999999999642 223478999999999 99999999999954 46
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.+++||||+++++|..++. .+++..++.++.+++. ||+|||++||+|||
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~---------------------------aL~~LH~~giiHrD 187 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM---------------------------AIDSVHRLGYVHRD 187 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeecc
Confidence 7899999999999888752 4667777766666665 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccC------CCCCCCcccHHHHHHHHHHHHhC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~sDiwSlG~il~elltg 250 (332)
|||+|||++.++ ++||+|||+++....... ....+||+.|+|||++.. ...++.++|||||||++|||++|
T Consensus 188 LKp~NILld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 188 IKPDNILLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp CSGGGEEECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred cCHHHeeecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence 999999999766 799999999987654433 234589999999999862 24689999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHH
Q 040656 251 KEPFFYGHDNQDQLVKIAR 269 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~ 269 (332)
..||. +.+..+...++..
T Consensus 267 ~~Pf~-~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 267 QTPFY-ADSTAETYGKIVH 284 (412)
T ss_dssp SCTTC-CSSHHHHHHHHHT
T ss_pred CCCCC-CCCHHHHHHHHHh
Confidence 99994 4455555555543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.27 Aligned_cols=239 Identities=25% Similarity=0.453 Sum_probs=184.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++++.||+|+||.||+|.+..++..||+|+++.. ....+.+|+.+++.+ +||||++++++|.+ ....++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEEE
Confidence 5799999999999999999999999999999998642 346789999999999 99999999999954 467899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||+.++++...+ ..+++..+..++.+++. ||.|||++||+||||||+|
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~---------------------------~l~~lH~~~ivH~Dlkp~N 166 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---------------------------GVTYLHKHNIVHRDLKPEN 166 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCSGGG
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCceeccCChhh
Confidence 99999999876543 34566666555555554 9999999999999999999
Q ss_pred eeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 184 VMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 184 ilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||++.. ...+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||. +....
T Consensus 167 il~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~ 243 (494)
T 3lij_A 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFG-GQTDQ 243 (494)
T ss_dssp EEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHH
T ss_pred EEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCCHH
Confidence 999753 23599999999988776666667789999999999864 68999999999999999999999993 44444
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.+..+........... ....++.+++++ ..||+.||++||+
T Consensus 244 ~~~~~i~~~~~~~~~~~-----~~~~s~~~~~li------------------------~~~L~~dp~~R~s 285 (494)
T 3lij_A 244 EILRKVEKGKYTFDSPE-----WKNVSEGAKDLI------------------------KQMLQFDSQRRIS 285 (494)
T ss_dssp HHHHHHHHTCCCCCSGG-----GTTSCHHHHHHH------------------------HHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCCCchh-----cccCCHHHHHHH------------------------HHHCCCChhhCcc
Confidence 55555444322111000 023344444444 5599999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=309.27 Aligned_cols=238 Identities=18% Similarity=0.315 Sum_probs=180.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc---eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++.+.||+|+||.||+|.+..+++ .||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--GR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--GG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 56899999999999999999999876555 4999999743 235688999999999 89999999999954 45
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++||||+++++|..++. .++...+..++.++ +.||.|||++||+|||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi---------------------------~~~L~~LH~~~ivH~D 176 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV---------------------------GAGMRYLSDLGYVHRD 176 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECSC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeeCCC
Confidence 7899999999999887752 34555555545544 4599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
|||+|||++.++ .++|+|||+++....... .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 177 lkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p 254 (325)
T 3kul_A 177 LAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERP 254 (325)
T ss_dssp CSGGGEEECTTC-CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCcceEEECCCC-CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999666 799999999987653322 122345678999999876 578999999999999999999 9999
Q ss_pred CCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
|. +....+....+......+ .....++.+..++ ..||+.||++||+
T Consensus 255 ~~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li------------------------~~~l~~dp~~Rps 300 (325)
T 3kul_A 255 YW-NMTNRDVISSVEEGYRLP--------APMGCPHALHQLM------------------------LDCWHKDRAQRPR 300 (325)
T ss_dssp TT-TSCHHHHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred cc-cCCHHHHHHHHHcCCCCC--------CCCCcCHHHHHHH------------------------HHHccCChhhCcC
Confidence 83 444444444333321111 1123444555554 5599999999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=323.23 Aligned_cols=199 Identities=22% Similarity=0.406 Sum_probs=167.8
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+++++++ +||||+++++++.+......
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCee
Confidence 3467899999999999999999999999999999999742 346678999999999 89999999999977666678
Q ss_pred eeEEeeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 105 SLIFEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
++||||++++++..++.. ++...+..++.+++ .||+|||++||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~---------------------------~aL~~LH~~~ivH~D 137 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV---------------------------GGMNHLRENGIVHRN 137 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCC
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCEEECC
Confidence 999999999998887643 55555555555555 499999999999999
Q ss_pred CCCCCeee----cCCCCeEEEEecccceeecCCCcccccccccceeccccccCC-------CCCCCcccHHHHHHHHHHH
Q 040656 179 VKPHNVMI----DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 179 lkp~Nilv----~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~sDiwSlG~il~el 247 (332)
|||+|||+ +.+ ..+||+|||+++............||..|+|||++.+. ..++.++|||||||++|+|
T Consensus 138 lkp~NIll~~~~~~~-~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 138 IKPGNIMRVIGEDGQ-SVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp CCGGGEEEEECTTSC-EEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHEEEeecCCCc-eeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 99999998 533 37999999999887655555667899999999987541 3467899999999999999
Q ss_pred HhCCCCCCC
Q 040656 248 IFRKEPFFY 256 (332)
Q Consensus 248 ltg~~pf~~ 256 (332)
++|..||..
T Consensus 217 ~tg~~Pf~~ 225 (396)
T 4eut_A 217 ATGSLPFRP 225 (396)
T ss_dssp HHSSCSEEC
T ss_pred HHCCCCCCC
Confidence 999999954
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=313.92 Aligned_cols=195 Identities=29% Similarity=0.486 Sum_probs=163.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+|++++.++.+||||+++++++.+ ....++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence 477999999999999999999999999999999996433 3456899999998789999999999954 4678999999
Q ss_pred ecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 111 VNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 111 ~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
+.++++...+ ..+++..+..++.+++. ||.|||++||+||||||+|||+.
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~---------------------------al~~lH~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITK---------------------------TVEYLHAQGVVHRDLKPSNILYV 150 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCCGGGEEES
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcEeccCCHHHEEEe
Confidence 9999877654 34666666666666655 99999999999999999999985
Q ss_pred CCCC---eEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 188 HEQQ---KLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 188 ~~~~---~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
.+++ .+||+|||+++...... .....++|..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 4432 49999999998765432 3445688999999999876 5688999999999999999999999954
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=304.01 Aligned_cols=191 Identities=21% Similarity=0.407 Sum_probs=162.0
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.|...+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++... ...+++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVG--EELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEEe
Confidence 488999999999999999999889999999998632 346788999999999 999999999999653 56899999
Q ss_pred eecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeec
Q 040656 110 HVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187 (332)
Q Consensus 110 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~ 187 (332)
|++++++..++. .++...+..++.++ +.||.|||++||+||||||+||+++
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi---------------------------~~~L~~LH~~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAV---------------------------LQALAYLHAQGVIHRDIKSDSILLT 175 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCCCHHHEEEC
Confidence 999999887653 35555555555544 4599999999999999999999999
Q ss_pred CCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 188 HEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 188 ~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.++ .++|+|||++....... ......||..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 176 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~ 242 (321)
T 2c30_A 176 LDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYF 242 (321)
T ss_dssp TTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCC-cEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 666 79999999998765332 2345679999999999876 678999999999999999999999994
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.34 Aligned_cols=267 Identities=25% Similarity=0.415 Sum_probs=188.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--------------hHHHHHHHHHHHhccCCCCeeeeeeee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLLDIV 96 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~~~~~~ 96 (332)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... .+.+.+|+.+++++ +||||+++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 98 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIF 98 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeE
Confidence 478999999999999999999874 58999999985321 26789999999999 899999999998
Q ss_pred ec---cCCCCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 97 RD---QHSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 97 ~~---~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
.. ......++|||++.++.+..+.. .++...+..++.+++. ||.|||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~---------------------------~l~~lH 151 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILL---------------------------GLHVLH 151 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHH---------------------------HHHHHH
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHH---------------------------HHHHHH
Confidence 54 23346799999998644433322 3555555555555554 999999
Q ss_pred HcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 171 SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 171 ~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
++||+||||||+||+++.++ .++|+|||++.............+|..|+|||++.+...++.++|||||||++|+|++|
T Consensus 152 ~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 230 (362)
T 3pg1_A 152 EAGVVHRDLHPGNILLADNN-DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230 (362)
T ss_dssp HTTCCCCCCCGGGEEECTTC-CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred HCcCEecCCChHHEEEcCCC-CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhC
Confidence 99999999999999999666 79999999998665555555668899999999987756789999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCC-CCCCCC--cccccccccccccCceEEEeCC
Q 040656 251 KEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKR-VWPIPN--NKKLQFCRSSRTSTNICITFSP 327 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~--~~~~~~~~~~~~~~~~cl~~dP 327 (332)
..|| .+....+.+..+....+.+...+... ...+..+..+.... ...... ...........+++..||+.||
T Consensus 231 ~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 231 KALF-RGSTFYNQLNKIVEVVGTPKIEDVVM----FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp SCSC-CCSSHHHHHHHHHHHHCCCCHHHHHH----TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred CCCC-CCCCHHHHHHHHHHHcCCCChHHhhh----ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 9999 45666777888888777765544332 12333444432221 110000 0011112233477888999999
Q ss_pred CCCCC
Q 040656 328 SGFPF 332 (332)
Q Consensus 328 ~~RP~ 332 (332)
++||+
T Consensus 306 ~~Rpt 310 (362)
T 3pg1_A 306 QRRIS 310 (362)
T ss_dssp GGSCC
T ss_pred hhCCC
Confidence 99996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=309.80 Aligned_cols=213 Identities=31% Similarity=0.647 Sum_probs=164.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 108 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH--NHRL 108 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEE--TTEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEec--CCEE
Confidence 4578999999999999999999999999999999986432 24577999999999 99999999999954 4578
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||||+++ ++..++ ..++...+..++.+++ .||.|||++||+||||||
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~---------------------------~~l~~LH~~~ivH~Dlkp 160 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---------------------------NGVNFCHSRRCLHRDLKP 160 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCSCCCG
T ss_pred EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCEECCCCCH
Confidence 999999986 444443 2355555555555554 599999999999999999
Q ss_pred CCeeecC----CCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 182 HNVMIDH----EQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 182 ~Nilv~~----~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+|||++. +...++|+|||+++..... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~ 239 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-P 239 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-C
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-C
Confidence 9999953 2336999999999765422 23344578999999999987566899999999999999999999998 4
Q ss_pred CCCCHHHHHHHHHHhCCc
Q 040656 257 GHDNQDQLVKIARVLGTD 274 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~ 274 (332)
+....+.+..+....+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp CSSHHHHHHHHHHHHCCC
T ss_pred CCCHHHHHHHHHHHhCCC
Confidence 556666777777665543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=304.59 Aligned_cols=208 Identities=23% Similarity=0.445 Sum_probs=166.9
Q ss_pred CCCceEE-EeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVV-RKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+.+||||+++++++.+ ....
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 4678888 8999999999999999999999999998742 346789999999999778999999999954 4578
Q ss_pred eeEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 105 SLIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
++||||+.++++..++ ..+++..+..++.+++. ||+|||++||+||||
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~---------------------------~L~~LH~~givH~Di 157 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---------------------------GVYYLHQNNIVHLDL 157 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeecCcC
Confidence 9999999999887775 33566666655555555 999999999999999
Q ss_pred CCCCeeecC--CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 180 KPHNVMIDH--EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 180 kp~Nilv~~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
||+||+++. ..+.++|+|||+++............+|..|+|||++.+ ..++.++||||||+++|+|++|..||. +
T Consensus 158 kp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~ 235 (327)
T 3lm5_A 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-G 235 (327)
T ss_dssp CGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-C
T ss_pred ChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCC-C
Confidence 999999986 134799999999988765555556689999999999876 678999999999999999999999993 4
Q ss_pred CCCHHHHHHHHH
Q 040656 258 HDNQDQLVKIAR 269 (332)
Q Consensus 258 ~~~~~~~~~~~~ 269 (332)
.+..+....+..
T Consensus 236 ~~~~~~~~~i~~ 247 (327)
T 3lm5_A 236 EDNQETYLNISQ 247 (327)
T ss_dssp SSHHHHHHHHHH
T ss_pred CCchHHHHHHHh
Confidence 444444444444
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=303.09 Aligned_cols=244 Identities=16% Similarity=0.293 Sum_probs=187.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++.+|+|++.+++++.+ ....+++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEE
Confidence 357899999999999999999999999999999998643 345689999999999889999999999843 45789999
Q ss_pred eeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|++ +++|..++. .++...+..++.+++ .||+|||++||+||||||+||
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~---------------------------~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQML---------------------------ARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHH---------------------------HHHHHHHTTTEECCCCCGGGE
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCEecCCCCHHHE
Confidence 999 888777653 355555555555554 599999999999999999999
Q ss_pred eecCCC----CeEEEEecccceeecCCCc--------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 185 MIDHEQ----QKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 185 lv~~~~----~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
+++.++ ..++|+|||+++....... .....||..|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCC
Confidence 997544 1399999999987654322 234578999999999877 678999999999999999999999
Q ss_pred CCCCCC--CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCC
Q 040656 253 PFFYGH--DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGF 330 (332)
Q Consensus 253 pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R 330 (332)
||.... ........+......... .......++.+..++ ..||+.||++|
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li------------------------~~~l~~dp~~R 268 (298)
T 1csn_A 217 PWQGLKAATNKQKYERIGEKKQSTPL----RELCAGFPEEFYKYM------------------------HYARNLAFDAT 268 (298)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCH----HHHTTTSCHHHHHHH------------------------HHHHHCCTTCC
T ss_pred CcchhhccccHHHHHHHHhhccCccH----HHHHhhCcHHHHHHH------------------------HHHhcCCcccC
Confidence 995432 222333333332211111 122235566666666 44999999999
Q ss_pred CC
Q 040656 331 PF 332 (332)
Q Consensus 331 P~ 332 (332)
|+
T Consensus 269 P~ 270 (298)
T 1csn_A 269 PD 270 (298)
T ss_dssp CC
T ss_pred CC
Confidence 96
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.07 Aligned_cols=196 Identities=24% Similarity=0.469 Sum_probs=155.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------hHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence 478999999999999999999999999999999986432 12478999999999 99999999999853
Q ss_pred CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...++||||++++++...+ ..+++..+..++.+++. ||+|||++||+|
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~---------------------------~l~~LH~~~ivH 262 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL---------------------------AVQYLHENGIIH 262 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCC
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCccc
Confidence 2478999999999987765 34666666666666555 999999999999
Q ss_pred cCCCCCCeeecCCC--CeEEEEecccceeecCCCcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 177 RDVKPHNVMIDHEQ--QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|||||+|||++.++ ..+||+|||+++............||..|+|||++.+ ...++.++|||||||++|+|++|..
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999997443 2599999999987665545556789999999999853 2467889999999999999999999
Q ss_pred CCCCC
Q 040656 253 PFFYG 257 (332)
Q Consensus 253 pf~~~ 257 (332)
||...
T Consensus 343 pf~~~ 347 (419)
T 3i6u_A 343 PFSEH 347 (419)
T ss_dssp SSCCC
T ss_pred CCCCC
Confidence 99543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=305.18 Aligned_cols=214 Identities=32% Similarity=0.602 Sum_probs=169.8
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+...++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++.+ ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 97 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKK--KK 97 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeec--CC
Confidence 345689999999999999999999999999999999985322 34577899999999 89999999999954 45
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..++||||++++++..+. ..++...+..++.+++ .||.|||++||+||||
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~---------------------------~~l~~LH~~~ivH~dl 150 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII---------------------------NGIGFCHSHNIIHRDI 150 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCCCC
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCEEccCc
Confidence 789999999998877653 3455555555555555 4999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||+||+++.++ .++|+|||++...... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.
T Consensus 151 kp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~ 228 (331)
T 4aaa_A 151 KPENILVSQSG-VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGD 228 (331)
T ss_dssp CGGGEEECTTS-CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCS
T ss_pred ChheEEEcCCC-cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCC
Confidence 99999999666 7999999999765432 23345578999999999987557899999999999999999999998 455
Q ss_pred CCHHHHHHHHHHhCC
Q 040656 259 DNQDQLVKIARVLGT 273 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~ 273 (332)
...+.+..+....+.
T Consensus 229 ~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGN 243 (331)
T ss_dssp SHHHHHHHHHHHHCS
T ss_pred CcHHHHHHHHHHhCC
Confidence 556666666665554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=307.05 Aligned_cols=241 Identities=22% Similarity=0.404 Sum_probs=187.2
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
++|++.+.||+|+||.||+|.+..+|+.||||+++... ...+.+|+.+++++.+||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 57999999999999999999998899999999986432 34678999999999789999999999854
Q ss_pred CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 101 SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
....++||||++++++..++ ..++...+..++.+++ .||.|||+.||+||
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~---------------------------~~L~~LH~~gi~H~ 224 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL---------------------------EAVSFLHANNIVHR 224 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeecC
Confidence 45789999999999887765 2355555555555555 49999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC-----CCCCCcccHHHHHHHHHHHHhCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~sDiwSlG~il~elltg~~ 252 (332)
||||+||+++.++ .++|+|||++.............||..|+|||++.+. ..++.++|||||||++|+|++|..
T Consensus 225 Dlkp~NIl~~~~~-~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 225 DLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp CCSGGGEEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEECCCC-CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 9999999999666 7999999999887766666667899999999998531 357899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
||. ..........+...........+ ...++.+.++ +..||+.||++||+
T Consensus 304 pf~-~~~~~~~~~~i~~~~~~~~~~~~-----~~~~~~~~~l------------------------i~~~L~~dP~~Rps 353 (365)
T 2y7j_A 304 PFW-HRRQILMLRMIMEGQYQFSSPEW-----DDRSSTVKDL------------------------ISRLLQVDPEARLT 353 (365)
T ss_dssp SSC-CSSHHHHHHHHHHTCCCCCHHHH-----SSSCHHHHHH------------------------HHHHSCSSTTTSCC
T ss_pred CCC-CCCHHHHHHHHHhCCCCCCCccc-----ccCCHHHHHH------------------------HHHHcCCChhHCcC
Confidence 994 33333344443332211111100 2334444444 45599999999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=321.90 Aligned_cols=205 Identities=24% Similarity=0.451 Sum_probs=160.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||++++++|.+ ...
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~--~~~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDR 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEE--TTE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEee--CCE
Confidence 357899999999999999999999999999999998642 224577899999999 89999999999954 356
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdl 179 (332)
+++||||++++++...+ ..++...+..++.+++. ||+|||+ +||+||||
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------aL~~LH~~~giiHrDl 275 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS---------------------------ALDYLHSEKNVVYRDL 275 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHHTCCCCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHhhcCCEEECCC
Confidence 89999999999887665 34566666665665555 9999998 99999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||+|||++.++ .+||+|||+++.... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.
T Consensus 276 kp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~ 352 (446)
T 4ejn_A 276 KLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQ 352 (446)
T ss_dssp CGGGEEECSSS-CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CS
T ss_pred CHHHEEECCCC-CEEEccCCCceeccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCC-CC
Confidence 99999999766 799999999975332 233455689999999999977 679999999999999999999999994 33
Q ss_pred CCHHHHHHH
Q 040656 259 DNQDQLVKI 267 (332)
Q Consensus 259 ~~~~~~~~~ 267 (332)
+.......+
T Consensus 353 ~~~~~~~~i 361 (446)
T 4ejn_A 353 DHEKLFELI 361 (446)
T ss_dssp SHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 333333333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=304.29 Aligned_cols=196 Identities=20% Similarity=0.381 Sum_probs=159.4
Q ss_pred CCCCceEEEeecccCCceEEEEE----EccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++++.||+|+||.||+|. +..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++...+..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 56899999999999999999998 56788999999987543 35688999999999 899999999998766556
Q ss_pred CceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++||||+++++|..++.. ++...+..++.+ ++.||.|||++||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q---------------------------i~~~l~~lH~~~ivH~D 139 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ---------------------------ICKGMEYLGTKRYIHRD 139 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHH---------------------------HHHHHHHHHHTTCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHH---------------------------HHHHHHHHhcCCcccCC
Confidence 78999999999998877532 455544444444 45599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
|||+||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|+||..||
T Consensus 140 ikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 140 LATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp CSGGGEEEEETT-EEEECCCCSCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred CCHhhEEEcCCC-eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhccccc
Confidence 999999999666 899999999987643322 223356777999999877 67899999999999999999999998
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 218 ~ 218 (295)
T 3ugc_A 218 K 218 (295)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=311.39 Aligned_cols=268 Identities=16% Similarity=0.230 Sum_probs=185.4
Q ss_pred CCCCceEEEeecccCCceEEEEE-----EccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGI-----NVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|. ...+++.||+|+++.. ....+.+|++++.++.+||||+++++++.+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 47899999999999999999998 4566789999999743 23568999999999988999999999986533
Q ss_pred CCCceeEEeeecCCCceeeccccch-----hhHHHHHHHHHh------hcC-----------------------------
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTA-----NEIRYYIYELLK------HAM----------------------------- 140 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~------~~~----------------------------- 140 (332)
...+++|||+++++|..++..... ......+.+... ...
T Consensus 100 -~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 100 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp -SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred -CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 458999999999998877533211 000000000000 000
Q ss_pred --CcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---cccccc
Q 040656 141 --PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVA 215 (332)
Q Consensus 141 --~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~ 215 (332)
.............+.+.++.|++.||+|||++||+||||||+|||++.++ .++|+|||+++....... .....+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCC
Confidence 00000000022333456778889999999999999999999999999666 799999999986543322 234467
Q ss_pred ccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHH
Q 040656 216 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEAL 294 (332)
Q Consensus 216 t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (332)
|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+............ ......++.+.++
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~l 328 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKIDEEFCRRLKEGTRM-------RAPDYTTPEMYQT 328 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TCCCSHHHHHHHHHTCCC-------CCCTTCCHHHHHH
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCC-ccchhHHHHHHHHcCCCC-------CCCCCCCHHHHHH
Confidence 888999999876 678999999999999999998 999984 333333333322221111 1112344455555
Q ss_pred hccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 295 VGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 295 i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+ ..||+.||++||+
T Consensus 329 i------------------------~~~l~~dP~~Rps 342 (359)
T 3vhe_A 329 M------------------------LDCWHGEPSQRPT 342 (359)
T ss_dssp H------------------------HHHTCSSGGGSCC
T ss_pred H------------------------HHHccCChhhCCC
Confidence 4 5599999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=314.84 Aligned_cols=211 Identities=26% Similarity=0.528 Sum_probs=170.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhcc-----CCCCeeeeeeeeeccCCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~~~~~~~~~~~~~ 103 (332)
..+|++++.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+. .|+||+++++.+.. ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CCe
Confidence 467999999999999999999999999999999997543 356778999988873 46799999999954 357
Q ss_pred ceeEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 104 PSLIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.+++||++.++ +..++ ..++...+..++.+ ++.||+|||++||+|||
T Consensus 174 ~~lv~e~~~~~-L~~~l~~~~~~~~~~~~~~~i~~q---------------------------i~~aL~~LH~~~ivHrD 225 (429)
T 3kvw_A 174 ICMTFELLSMN-LYELIKKNKFQGFSLPLVRKFAHS---------------------------ILQCLDALHKNRIIHCD 225 (429)
T ss_dssp EEEEECCCCCB-HHHHHHHTTTCCCCHHHHHHHHHH---------------------------HHHHHHHHHHHTEECSC
T ss_pred EEEEEeccCCC-HHHHHHhccCCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCeecCC
Confidence 89999999754 33332 12455545444444 45599999999999999
Q ss_pred CCCCCeeecCCCC-eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQ-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 179 lkp~Nilv~~~~~-~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|||+|||++.++. .+||+|||+++... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+
T Consensus 226 lKp~NILl~~~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~ 301 (429)
T 3kvw_A 226 LKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PG 301 (429)
T ss_dssp CSGGGEEESSTTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CC
T ss_pred CCHHHeEEccCCCcceEEeecccceecC--CcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CC
Confidence 9999999997652 29999999997643 33345688999999999987 67999999999999999999999998 56
Q ss_pred CCCHHHHHHHHHHhCCch
Q 040656 258 HDNQDQLVKIARVLGTDE 275 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~ 275 (332)
.+..+.+..+....+.+.
T Consensus 302 ~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 302 EDEGDQLACMIELLGMPS 319 (429)
T ss_dssp SSHHHHHHHHHHHHCCCC
T ss_pred CCHHHHHHHHHHHcCCCC
Confidence 677778888888777554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=306.02 Aligned_cols=193 Identities=23% Similarity=0.419 Sum_probs=156.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC------
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS------ 101 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~------ 101 (332)
++|++++.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence 6799999999999999999999999999999998632 346789999999999 99999999998854322
Q ss_pred -------------------------------------------------CCceeEEeeecCCCceeecccc------chh
Q 040656 102 -------------------------------------------------KTPSLIFEHVNSTDFKVLYPTL------TAN 126 (332)
Q Consensus 102 -------------------------------------------------~~~~lv~e~~~~~~l~~~~~~~------~~~ 126 (332)
...+++|||++++++..++... ...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 1378999999999988775321 111
Q ss_pred hHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecC
Q 040656 127 EIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP 206 (332)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~ 206 (332)
.+. .++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 165 ~~~---------------------------~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~ 216 (332)
T 3qd2_B 165 VCL---------------------------HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQ 216 (332)
T ss_dssp HHH---------------------------HHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSC
T ss_pred HHH---------------------------HHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCccccccc
Confidence 122 3555666799999999999999999999999666 799999999987654
Q ss_pred CC-------------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 207 GK-------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 207 ~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
.. ......||..|+|||++.+ ..++.++|||||||++|+|++|..|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp C--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred chhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 32 2234578999999999987 67899999999999999999987665
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=315.65 Aligned_cols=200 Identities=24% Similarity=0.417 Sum_probs=160.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcE
Confidence 5689999999999999999999998899999999987432 24678999999999 99999999999954 45789
Q ss_pred eEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 106 LIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
+||||++++++..++. .++...+.. ++.|++.||+|||++||+||||||
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~---------------------------~~~qi~~~l~~LH~~~ivHrDlkp 241 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQ---------------------------MVGDAAAGMEYLESKCCIHRDLAA 241 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHH---------------------------HHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCcCCcccCH
Confidence 9999999998877652 244444433 455556699999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG 257 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~ 257 (332)
+|||++.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+
T Consensus 242 ~Nil~~~~~-~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~-~~ 318 (377)
T 3cbl_A 242 RNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPY-PN 318 (377)
T ss_dssp GGEEECTTC-CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSS-TT
T ss_pred HHEEEcCCC-cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CC
Confidence 999999666 7999999999865422111 11234667999999876 568999999999999999998 88888 34
Q ss_pred CCCHH
Q 040656 258 HDNQD 262 (332)
Q Consensus 258 ~~~~~ 262 (332)
....+
T Consensus 319 ~~~~~ 323 (377)
T 3cbl_A 319 LSNQQ 323 (377)
T ss_dssp SCHHH
T ss_pred CCHHH
Confidence 43333
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=308.71 Aligned_cols=214 Identities=33% Similarity=0.549 Sum_probs=172.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC----
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH---- 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 100 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence 458899999999999999999999999999999998532 235678999999999 8999999999986543
Q ss_pred --CCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 101 --SKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 101 --~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
....++||||+.++.+..+. ..++...+..++.+++. ||+|||++||+
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~---------------------------~l~~LH~~~iv 146 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---------------------------GLYYIHRNKIL 146 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEE
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCee
Confidence 34689999999874443332 34566666655555554 99999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCC-----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
||||||+|||++.++ .++|+|||+++..... .......+|..|+|||++.+...++.++|||||||++|+|++|
T Consensus 147 H~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 147 HRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp CCCCSGGGEEECTTS-CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCCHHHEEEcCCC-CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 999999999999766 7999999999876422 2234457899999999987756789999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHhCC
Q 040656 251 KEPFFYGHDNQDQLVKIARVLGT 273 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~~~~~ 273 (332)
..|| .+....+....+....+.
T Consensus 226 ~~pf-~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 226 SPIM-QGNTEQHQLALISQLCGS 247 (351)
T ss_dssp SCSC-CCSSHHHHHHHHHHHHCC
T ss_pred CCCC-CCCChHHHHHHHHHHhCC
Confidence 9998 455666677777766554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=306.15 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=182.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED--EQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc--CC
Confidence 37799999999999999999999999999999998632 235788999999999 89999999999954 45
Q ss_pred CceeEEeeecCCCceeeccccchhh---------------HHHHHHHHHhhcCCcceeecCCC--CcccchhhHHhHHHH
Q 040656 103 TPSLIFEHVNSTDFKVLYPTLTANE---------------IRYYIYELLKHAMPRKVIIMPGE--GLMENQDISVWDLQA 165 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~ 165 (332)
..++||||+++++|...+....... .......... ............ .....+.++.|+++|
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN-GSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHH-SCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccc-cccccccccccccccHHHHHHHHHHHHHH
Confidence 7899999999999877653110000 0000000000 000000000000 011123466778889
Q ss_pred HHHHHHcCCeecCCCCCCeeecCCCC-eEEEEecccceeecCCC-----cccccccccceeccccccCC-CCCCCcccHH
Q 040656 166 LDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDMW 238 (332)
Q Consensus 166 l~~LH~~~ivHrdlkp~Nilv~~~~~-~vkL~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiw 238 (332)
|+|||++||+||||||+||+++.++. .++|+|||++....... ......+|..|+|||++.+. ..++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 99999999999999999999985442 69999999998754221 13455789999999998643 5688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCccccccccccccc
Q 040656 239 SLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTS 318 (332)
Q Consensus 239 SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 318 (332)
||||++|+|++|..||. +....+....+.......... .....++.++++
T Consensus 261 slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l------------------------ 310 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFP-GVNDADTISQVLNKKLCFENP-----NYNVLSPLARDL------------------------ 310 (345)
T ss_dssp HHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCTTSG-----GGGGSCHHHHHH------------------------
T ss_pred HHHHHHHHHHHCCCCCC-CCChHHHHHHHHhcccccCCc-----ccccCCHHHHHH------------------------
Confidence 99999999999999993 444444444443321111000 001234444444
Q ss_pred CceEEEeCCCCCCC
Q 040656 319 TNICITFSPSGFPF 332 (332)
Q Consensus 319 ~~~cl~~dP~~RP~ 332 (332)
+..||+.||++||+
T Consensus 311 i~~~l~~~p~~Rps 324 (345)
T 3hko_A 311 LSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHSCSCTTTSCC
T ss_pred HHHHcCCChhHCCC
Confidence 45599999999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.79 Aligned_cols=216 Identities=28% Similarity=0.458 Sum_probs=162.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC-----CC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS-----KT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-----~~ 103 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+++..+..+ +||||++++++|..... ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence 47899999999999999999999999999999998542 234677888888888 99999999999865322 23
Q ss_pred ceeEEeeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH--HcCCe
Q 040656 104 PSLIFEHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH--SQGIM 175 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~iv 175 (332)
.+++|||++++....+. ..++...+.. ++.|++.||.||| ++||+
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~---------------------------~~~qi~~al~~lH~~~~~iv 153 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV---------------------------FLFQLIRSIGCLHLPSVNVC 153 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHH---------------------------HHHHHHHHHHHHTSTTTCCB
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHH---------------------------HHHHHHHHHHHHhCCCCCee
Confidence 78999999976433221 1233433433 4445556999999 99999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||||||+|||++..++.+||+|||+++............+|..|+|||++.+...++.++|||||||++|+|++|..||
T Consensus 154 H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf- 232 (360)
T 3e3p_A 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF- 232 (360)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-
T ss_pred cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-
Confidence 9999999999996455899999999987766655666788999999999877566899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhCCch
Q 040656 256 YGHDNQDQLVKIARVLGTDE 275 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~ 275 (332)
.+.+....+..+.+..+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 233 RGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCSSHHHHHHHHHHHHCCCC
T ss_pred CCCChHHHHHHHHHHcCCCC
Confidence 45666677777777766544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=295.35 Aligned_cols=240 Identities=25% Similarity=0.454 Sum_probs=182.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFEN--KT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecC--CC
Confidence 5799999999999999999999889999999998642 256789999999999 89999999999954 45
Q ss_pred CceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..+++||+++++++..++. .++...+..++.+++ .||.|||++|++||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~---------------------------~~l~~lH~~~i~H~dl 134 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL---------------------------DGVHYLHSKRIAHFDL 134 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSCC
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCccCCCC
Confidence 6899999999998877652 355555555555554 5999999999999999
Q ss_pred CCCCeeecCCCC---eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 180 KPHNVMIDHEQQ---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 180 kp~Nilv~~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||+||+++.++. .++|+|||.+.............+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 135 ~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~- 212 (283)
T 3bhy_A 135 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL- 212 (283)
T ss_dssp SGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred ChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC-
Confidence 999999985542 699999999987765555556678999999999876 678999999999999999999999994
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+....+........ . ......++.+++++ ..||+.||++||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~li------------------------~~~l~~dp~~Rps 259 (283)
T 3bhy_A 213 GETKQETLTNISAVNYDFD-E----EYFSNTSELAKDFI------------------------RRLLVKDPKRRMT 259 (283)
T ss_dssp CSSHHHHHHHHHTTCCCCC-H----HHHTTCCHHHHHHH------------------------HTTSCSSGGGSCC
T ss_pred CcchHHHHHHhHhcccCCc-c----hhcccCCHHHHHHH------------------------HHHccCCHhHCcC
Confidence 3333333333332111111 0 01123444455544 5599999999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=323.52 Aligned_cols=206 Identities=26% Similarity=0.536 Sum_probs=172.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecc------cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence 4789999999999999999999999999999999853 2356789999999999 99999999999954 4678
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++|+|++.++++...+ ..+++..+..++.+++. ||.|||++||+||||||
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~---------------------------~l~~lH~~~ivH~Dlkp 154 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---------------------------GITYMHKNKIVHRDLKP 154 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCCG
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeeCCCCH
Confidence 9999999999886654 34666666666666655 99999999999999999
Q ss_pred CCeeecC--CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 182 HNVMIDH--EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 182 ~Nilv~~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
+|||++. .++.+||+|||+++............||+.|+|||++.+ .++.++|||||||++|+|++|..|| .+.+
T Consensus 155 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~ 231 (484)
T 3nyv_A 155 ENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF-NGAN 231 (484)
T ss_dssp GGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS-CCSS
T ss_pred HHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC-CCCC
Confidence 9999952 334799999999987766666666789999999999876 6899999999999999999999999 4555
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+.+..+..
T Consensus 232 ~~~~~~~i~~ 241 (484)
T 3nyv_A 232 EYDILKKVEK 241 (484)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHc
Confidence 5555555544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=310.53 Aligned_cols=194 Identities=28% Similarity=0.527 Sum_probs=164.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----------chHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence 47899999999999999999999999999999998743 224578899999999 99999999999954
Q ss_pred CCCCceeEEeeecCC-Cceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 100 HSKTPSLIFEHVNST-DFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~-~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
....+++||++.++ ++..++ ..+++..+..++.+++. ||.|||++||+
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~---------------------------~L~~LH~~~iv 152 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS---------------------------AVGYLRLKDII 152 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEE
T ss_pred -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeE
Confidence 45789999999766 666554 24566666555555554 99999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||||||+|||++.++ .+||+|||++.............||..|+|||++.+...++.++|||||||++|+|++|..||.
T Consensus 153 H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 153 HRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp CSCCSGGGEEECTTS-CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred EeccCHHHEEEcCCC-cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 999999999999666 7999999999887766666667899999999999874444889999999999999999999994
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.00 Aligned_cols=241 Identities=18% Similarity=0.275 Sum_probs=178.6
Q ss_pred CCCCCCceEEEeecccCCceEEEEE-----EccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGI-----NVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
....++|++.+.||+|+||.||+|. ...+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec
Confidence 3456889999999999999999998 4457789999998632 234688999999999 99999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccc----------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHH
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPT----------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDY 168 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 168 (332)
....++||||+++++|..++.. ++...+. .++.|++.||+|
T Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~---------------------------~i~~qi~~aL~~ 196 (367)
T 3l9p_A 146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL---------------------------HVARDIACGCQY 196 (367)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHH---------------------------HHHHHHHHHHHH
T ss_pred --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHH---------------------------HHHHHHHHHHHH
Confidence 4567999999999888776522 3333333 355556669999
Q ss_pred HHHcCCeecCCCCCCeeecCCC--CeEEEEecccceeecCC---CcccccccccceeccccccCCCCCCCcccHHHHHHH
Q 040656 169 CHSQGIMHRDVKPHNVMIDHEQ--QKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243 (332)
Q Consensus 169 LH~~~ivHrdlkp~Nilv~~~~--~~vkL~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~i 243 (332)
||++||+||||||+|||++.++ ..+||+|||+++..... .......+|..|+|||++.+ ..++.++|||||||+
T Consensus 197 LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~i 275 (367)
T 3l9p_A 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVL 275 (367)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHH
T ss_pred HHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHH
Confidence 9999999999999999998433 25999999999754211 22334567889999999876 678999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceE
Q 040656 244 FAGMIF-RKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNIC 322 (332)
Q Consensus 244 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~c 322 (332)
+|||++ |..|| .+....+....+....... .....++.+..+ +..|
T Consensus 276 l~ellt~g~~pf-~~~~~~~~~~~i~~~~~~~--------~~~~~~~~l~~l------------------------i~~~ 322 (367)
T 3l9p_A 276 LWEIFSLGYMPY-PSKSNQEVLEFVTSGGRMD--------PPKNCPGPVYRI------------------------MTQC 322 (367)
T ss_dssp HHHHHTTSCCSS-TTCCHHHHHHHHHTTCCCC--------CCTTCCHHHHHH------------------------HHHH
T ss_pred HHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCC--------CCccCCHHHHHH------------------------HHHH
Confidence 999998 88888 3444444433333211110 112334444444 4559
Q ss_pred EEeCCCCCCC
Q 040656 323 ITFSPSGFPF 332 (332)
Q Consensus 323 l~~dP~~RP~ 332 (332)
|+.||++||+
T Consensus 323 l~~dP~~Rps 332 (367)
T 3l9p_A 323 WQHQPEDRPN 332 (367)
T ss_dssp TCSSGGGSCC
T ss_pred cCCCHhHCcC
Confidence 9999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=301.33 Aligned_cols=191 Identities=23% Similarity=0.322 Sum_probs=152.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++.++||+|+||+||+|.+..+++.||+|++... .......|+..+.++.+|+||++++++|.+ ...+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 6799999999999999999999989999999998532 223456677777776699999999999954 467899
Q ss_pred EEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||++.+ ++...+ ..++...+..++.++ +.||+|||+++|+||||||+
T Consensus 135 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi---------------------------~~aL~~LH~~~ivH~Dikp~ 186 (311)
T 3p1a_A 135 QTELCGP-SLQQHCEAWGASLPEAQVWGYLRDT---------------------------LLALAHLHSQGLVHLDVKPA 186 (311)
T ss_dssp EEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECCCCSGG
T ss_pred EEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCEecCCCCHH
Confidence 9999955 443332 235555555555554 45999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||++.++ .+||+|||++.............||..|+|||++.+ .++.++|||||||++|||++|..|+.
T Consensus 187 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 187 NIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp GEEECGGG-CEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred HEEECCCC-CEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99998666 799999999987765555556679999999999876 68999999999999999999977763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.98 Aligned_cols=237 Identities=18% Similarity=0.344 Sum_probs=181.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||.||+|.+. +++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 83 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 83 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEEE
Confidence 5688999999999999999999875 6778999999743 457799999999999 89999999999954 4568999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||++++++..++. .++...+..++.++ +.||+|||++||+||||||+|
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i---------------------------~~~l~~lH~~~i~H~dikp~N 136 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV---------------------------CEGMAYLEEACVIHRDLAARN 136 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTCCCSCCCGGG
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHH---------------------------HHHHHHHHhCCeecCCcchhe
Confidence 99999998877652 24555554444444 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDN 260 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~ 260 (332)
|+++.++ .++|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++ |..||. ....
T Consensus 137 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~-~~~~ 213 (269)
T 4hcu_A 137 CLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSN 213 (269)
T ss_dssp EEECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCH
T ss_pred EEEcCCC-CEEeccccccccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCC-CCCH
Confidence 9998666 79999999997654222 1233456778999999876 678999999999999999999 898983 4443
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+....... .....++.+..+ +..||+.||++||+
T Consensus 214 ~~~~~~~~~~~~~~--------~~~~~~~~~~~l------------------------i~~~l~~~p~~Rps 253 (269)
T 4hcu_A 214 SEVVEDISTGFRLY--------KPRLASTHVYQI------------------------MNHCWRERPEDRPA 253 (269)
T ss_dssp HHHHHHHHTTCCCC--------CCTTSCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred HHHHHHHhcCccCC--------CCCcCCHHHHHH------------------------HHHHccCCcccCcC
Confidence 34433333211110 011233444444 45699999999996
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.36 Aligned_cols=196 Identities=21% Similarity=0.293 Sum_probs=158.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccC--CCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQH--SKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--~~~~~ 105 (332)
+.++|++.+.||+|+||.||+|.+ .++.||+|+++.... .....|+.++.++ +||||+++++++.+.. ...++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEE
Confidence 458899999999999999999976 489999999975443 3455688889999 9999999999997643 23479
Q ss_pred eEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc----------C
Q 040656 106 LIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ----------G 173 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----------~ 173 (332)
+||||+++++|..++. .++...+..++.+ ++.||+|||+. |
T Consensus 99 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~q---------------------------i~~al~~LH~~~~~l~~~~~~~ 151 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKANVVSWNELCHIAET---------------------------MARGLAYLHEDIPGLKDGHKPA 151 (322)
T ss_dssp EEEECCTTCBHHHHHHHCCBCHHHHHHHHHH---------------------------HHHHHHHHTCCEEEETTEEECE
T ss_pred EEEecCCCCCHHHHHHhcCCCHHHHHHHHHH---------------------------HHHHHHHHHhhccccccccCCC
Confidence 9999999999887752 3555555444444 45599999999 9
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCC----CCCCCcccHHHHHHHHHH
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~e 246 (332)
|+||||||+|||++.++ .+||+|||+++....... .....||..|+|||++.+. ..++.++|||||||++|+
T Consensus 152 ivH~Dlkp~Nill~~~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~e 230 (322)
T 3soc_A 152 ISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230 (322)
T ss_dssp EECSCCSGGGEEECTTC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCChHhEEECCCC-eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHH
Confidence 99999999999999666 799999999987654332 2335789999999998763 234568899999999999
Q ss_pred HHhCCCCCCC
Q 040656 247 MIFRKEPFFY 256 (332)
Q Consensus 247 lltg~~pf~~ 256 (332)
|+||..||..
T Consensus 231 l~tg~~pf~~ 240 (322)
T 3soc_A 231 LASRCTAADG 240 (322)
T ss_dssp HHTTBTTSSS
T ss_pred HHhCCCCCCC
Confidence 9999999953
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.28 Aligned_cols=266 Identities=26% Similarity=0.461 Sum_probs=192.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC---
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS--- 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--- 101 (332)
-.++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccc
Confidence 357899999999999999999999999999999998642 235678999999999 89999999999865432
Q ss_pred -CCceeEEeeecCCCceeec-cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 102 -KTPSLIFEHVNSTDFKVLY-PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 102 -~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
...+++||++.+ ++.... ..++...+..++.+++. ||.|||++||+||||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~---------------------------al~~LH~~~ivH~dl 152 (353)
T 3coi_A 101 FYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK---------------------------GLKYIHSAGVVHRDL 152 (353)
T ss_dssp CCCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSSC
T ss_pred ceeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCcccCCC
Confidence 245999999985 444433 45666666666666555 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
||+||+++.++ .++|+|||+++... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+
T Consensus 153 kp~NIl~~~~~-~~kl~Dfg~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~ 228 (353)
T 3coi_A 153 KPGNLAVNEDC-ELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKD 228 (353)
T ss_dssp CGGGEEECTTC-CEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSC
T ss_pred CHHHEeECCCC-cEEEeecccccCCC--CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCC
Confidence 99999999666 79999999997643 22345578999999999877567899999999999999999999999 4555
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCC--CCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKR--VWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+.+..+.+..+.+.. ++.... ........++... +................+++..||+.||++||+
T Consensus 229 ~~~~~~~i~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt 299 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGT-EFVQKL---NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299 (353)
T ss_dssp HHHHHHHHHHHHCBCCH-HHHTTC---SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHhCCCCH-HHHHHH---hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC
Confidence 66677777776665432 222221 1122222222221 111111111122333457888899999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=295.43 Aligned_cols=204 Identities=26% Similarity=0.476 Sum_probs=163.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 83 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATR 83 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEec--CCE
Confidence 357899999999999999999999999999999998532 245688999999999 89999999999954 456
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.+++|||++++++...+ ..++......++.+++ .||.|||++||+|||||
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~l~~LH~~~i~H~dlk 136 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA---------------------------NALSYCHSKRVIHRDIK 136 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHH---------------------------HHHHHHHTTTCEECCCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCEecccCC
Confidence 89999999998876654 3355555555555555 49999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|+||+++.++ .++|+|||++..... .......+|..|+|||.+.+ ..++.++||||||+++|+|++|..||. ....
T Consensus 137 p~Nili~~~~-~~~l~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~ 212 (279)
T 3fdn_A 137 PENLLLGSAG-ELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTY 212 (279)
T ss_dssp GGGEEECTTS-CEEECSCCEESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSH
T ss_pred hHhEEEcCCC-CEEEEeccccccCCc-ccccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcH
Confidence 9999999666 799999998865432 23345578999999999877 678999999999999999999999993 3333
Q ss_pred HHHHHHH
Q 040656 261 QDQLVKI 267 (332)
Q Consensus 261 ~~~~~~~ 267 (332)
.+....+
T Consensus 213 ~~~~~~~ 219 (279)
T 3fdn_A 213 QETYKRI 219 (279)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 3333333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=304.12 Aligned_cols=197 Identities=24% Similarity=0.354 Sum_probs=159.9
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHh--ccCCCCeeeeeeeeecc--CCCCc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQN--LCGGPNIVKLLDIVRDQ--HSKTP 104 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~~--~~~~~ 104 (332)
...++|++.+.||+|+||.||+|.+ +++.||+|++.......+..|.+++.. + +||||+++++++.+. .....
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETTEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCCCcee
Confidence 3468899999999999999999976 789999999987777778888888887 5 899999999987543 23458
Q ss_pred eeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH--------HcCC
Q 040656 105 SLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH--------SQGI 174 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~i 174 (332)
+++|||++++++..++. .++......++. |++.||+||| +.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~---------------------------~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVL---------------------------SIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHH---------------------------HHHHHHHHHHSCBCSTTCBCEE
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHH---------------------------HHHHHHHHHHHhhhhccCCCCe
Confidence 89999999999887753 344554444444 4555999999 9999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCcc-----cccccccceeccccccCCC-----CCCCcccHHHHHHHH
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMF 244 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~sDiwSlG~il 244 (332)
+||||||+|||++.++ .+||+|||+++........ ....||..|+|||++.+.. .++.++|||||||++
T Consensus 135 vH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il 213 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213 (301)
T ss_dssp ECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCC-CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence 9999999999999666 7999999999876543322 2347899999999987632 234689999999999
Q ss_pred HHHHhC----------CCCCCC
Q 040656 245 AGMIFR----------KEPFFY 256 (332)
Q Consensus 245 ~elltg----------~~pf~~ 256 (332)
|||++| ..||..
T Consensus 214 ~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 214 WEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTT
T ss_pred HHHHhhhcCccccccccccccc
Confidence 999999 788854
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=293.61 Aligned_cols=193 Identities=16% Similarity=0.338 Sum_probs=159.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.+ .++..||+|+++.. ....+.+|+.+++++ +||||+++++++. +....+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~--~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCS--KEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEEC--SSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEc--cCCceEEE
Confidence 468899999999999999999976 46778999999753 456789999999999 8999999999994 44678999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||+++++++..++. .++...+..++.++ +.||+|||++||+||||||+|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi---------------------------~~~l~~lH~~~i~H~dikp~N 134 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV---------------------------CEGMAFLESHQFIHRDLAARN 134 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEEESSCSGGG
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCcCcce
Confidence 99999998877652 25555555555544 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||++......... ....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 135 il~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~ 207 (268)
T 3sxs_A 135 CLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD 207 (268)
T ss_dssp EEECTTC-CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEECCCC-CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence 9999666 7999999999876543321 22345667999999876 568999999999999999999 999983
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=308.83 Aligned_cols=239 Identities=18% Similarity=0.298 Sum_probs=181.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC-------CceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN-------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
..++|.+.+.||+|+||.||+|.+..+ +..||+|+++... ...+.+|+++++++.+||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 468999999999999999999987533 3579999987432 35688999999999889999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccc-------------------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhH
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPT-------------------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDIS 159 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (332)
....++||||+.+++|..++.. ++...+.. ++
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~---------------------------i~ 197 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS---------------------------CA 197 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHH---------------------------HH
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHH---------------------------HH
Confidence 4578999999999998776522 44444444 44
Q ss_pred HhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCccc
Q 040656 160 VWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLD 236 (332)
Q Consensus 160 ~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sD 236 (332)
.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...... ......+|..|+|||++.+ ..++.++|
T Consensus 198 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~D 275 (382)
T 3tt0_A 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSD 275 (382)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHH
T ss_pred HHHHHHHHHHHhCCEecCCCCcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhH
Confidence 4555599999999999999999999999666 79999999998664332 2233456788999999887 67899999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccc
Q 040656 237 MWSLGCMFAGMIF-RKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSS 315 (332)
Q Consensus 237 iwSlG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 315 (332)
||||||++|+|++ |..|| .+....+....+...... ......++.+..++
T Consensus 276 iwslG~il~ellt~g~~p~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li-------------------- 326 (382)
T 3tt0_A 276 VWSFGVLLWEIFTLGGSPY-PGVPVEELFKLLKEGHRM--------DKPSNCTNELYMMM-------------------- 326 (382)
T ss_dssp HHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTTCCC--------CCCSSCCHHHHHHH--------------------
T ss_pred HHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCC--------CCCccCCHHHHHHH--------------------
Confidence 9999999999999 99898 333333333332221111 01123444444444
Q ss_pred cccCceEEEeCCCCCCC
Q 040656 316 RTSTNICITFSPSGFPF 332 (332)
Q Consensus 316 ~~~~~~cl~~dP~~RP~ 332 (332)
..||+.||++||+
T Consensus 327 ----~~~l~~dP~~Rps 339 (382)
T 3tt0_A 327 ----RDCWHAVPSQRPT 339 (382)
T ss_dssp ----HHHTCSSGGGSCC
T ss_pred ----HHHcCCChhhCcC
Confidence 5599999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=311.67 Aligned_cols=234 Identities=24% Similarity=0.453 Sum_probs=174.8
Q ss_pred ccCCCCCcc--ccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccC-
Q 040656 11 NVHRPRDYW--DYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCG- 85 (332)
Q Consensus 11 ~~~~~~~~~--~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~- 85 (332)
....+..|- ++....+.....++|++.+.||+|+||.||+|++..+++.||+|+++... ...+.+|+.+++.+.+
T Consensus 14 ~~e~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (397)
T 1wak_A 14 EQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93 (397)
T ss_dssp --------CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHS
T ss_pred cccccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhc
Confidence 344455552 33334444444689999999999999999999999999999999997532 4678899999999842
Q ss_pred ------CCCeeeeeeeeecc--CCCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcc
Q 040656 86 ------GPNIVKLLDIVRDQ--HSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLM 153 (332)
Q Consensus 86 ------h~niv~~~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (332)
|+||+++++++... +....++|||++.++.+..+.. .++...+..++.+++
T Consensus 94 ~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~----------------- 156 (397)
T 1wak_A 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL----------------- 156 (397)
T ss_dssp CTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHH-----------------
T ss_pred CCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHH-----------------
Confidence 78899999998632 4457899999997666555432 355555555555555
Q ss_pred cchhhHHhHHHHHHHHHHc-CCeecCCCCCCeeecCCC------------------------------------------
Q 040656 154 ENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQ------------------------------------------ 190 (332)
Q Consensus 154 ~~~~~~~~i~~~l~~LH~~-~ivHrdlkp~Nilv~~~~------------------------------------------ 190 (332)
.||.|||++ ||+||||||+|||++.++
T Consensus 157 ----------~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (397)
T 1wak_A 157 ----------QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226 (397)
T ss_dssp ----------HHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTS
T ss_pred ----------HHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccc
Confidence 499999998 999999999999998654
Q ss_pred ------CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC-----
Q 040656 191 ------QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD----- 259 (332)
Q Consensus 191 ------~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~----- 259 (332)
..++|+|||++..... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 227 ~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 303 (397)
T 1wak_A 227 PKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR 303 (397)
T ss_dssp GGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH
T ss_pred cccccccceEeccccccccccc--cCccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc
Confidence 2699999999987642 3445578999999999987 6799999999999999999999999953322
Q ss_pred CHHHHHHHHHHhCCc
Q 040656 260 NQDQLVKIARVLGTD 274 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~ 274 (332)
..+.+..+....+..
T Consensus 304 ~~~~~~~~~~~~~~~ 318 (397)
T 1wak_A 304 DEDHIALIIELLGKV 318 (397)
T ss_dssp HHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHhcCCC
Confidence 234555566655543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=304.68 Aligned_cols=252 Identities=14% Similarity=0.180 Sum_probs=179.8
Q ss_pred ccCCCCCCceEEEeecccCCceEEEEEEcc---CCceEEEEEecccc--------------hHHHHHHHHHHHhccCCCC
Q 040656 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVT---NNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPN 88 (332)
Q Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~n 88 (332)
+.....++|++.+.||+|+||.||+|.+.. ++..+|+|++.... ...+.+|+..+..+ .|+|
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~n 109 (345)
T 2v62_A 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLG 109 (345)
T ss_dssp EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCC
T ss_pred eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccC
Confidence 344456899999999999999999999876 78899999986432 12356778888888 9999
Q ss_pred eeeeeeeeecc--CCCCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHH
Q 040656 89 IVKLLDIVRDQ--HSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDL 163 (332)
Q Consensus 89 iv~~~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (332)
|+++++++... .....+++||++ +++|..++. .++...+..++.+++
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~--------------------------- 161 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRML--------------------------- 161 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHH---------------------------
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------
Confidence 99999998652 245789999999 888877653 356666655555555
Q ss_pred HHHHHHHHcCCeecCCCCCCeeecCCC-CeEEEEecccceeecCCC--------cccccccccceeccccccCCCCCCCc
Q 040656 164 QALDYCHSQGIMHRDVKPHNVMIDHEQ-QKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYS 234 (332)
Q Consensus 164 ~~l~~LH~~~ivHrdlkp~Nilv~~~~-~~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~ 234 (332)
.||+|||++||+||||||+|||++.++ +.++|+|||+++.+.... ......+|..|+|||++.+ ..++.+
T Consensus 162 ~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 240 (345)
T 2v62_A 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRR 240 (345)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHH
T ss_pred HHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCch
Confidence 499999999999999999999998554 269999999998764221 1134578999999999887 678999
Q ss_pred ccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCC--CCChhHHHHhccCCCCCCCCccccccc
Q 040656 235 LDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHL--ELDPQLEALVGRKRVWPIPNNKKLQFC 312 (332)
Q Consensus 235 sDiwSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~ 312 (332)
+|||||||++|+|++|..||.................... ....+..... ..++.+..++
T Consensus 241 ~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li----------------- 302 (345)
T 2v62_A 241 SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE-LPQSVLKWAPSGSSCCEIAQFL----------------- 302 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHT-TTHHHHHHSCTTSCCHHHHHHH-----------------
T ss_pred hhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccc-ccHHHHhhccccccHHHHHHHH-----------------
Confidence 9999999999999999999954334433333332221111 1111111111 4455555555
Q ss_pred ccccccCceEEEeCCCCCCC
Q 040656 313 RSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 313 ~~~~~~~~~cl~~dP~~RP~ 332 (332)
..||+.||++||+
T Consensus 303 -------~~~l~~dp~~Rps 315 (345)
T 2v62_A 303 -------VCAHSLAYDEKPN 315 (345)
T ss_dssp -------HHHHTCCTTCCCC
T ss_pred -------HHHhhcCcccCCC
Confidence 4599999999996
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=295.27 Aligned_cols=196 Identities=23% Similarity=0.420 Sum_probs=161.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc--CCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 102 (332)
+...|.+.+.||+|+||.||+|.+..++..||+|++... ....+.+|+.+++++ +||||+++++++.+. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence 345689999999999999999999999999999998632 235688999999999 999999999998653 335
Q ss_pred CceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC--Ceec
Q 040656 103 TPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHR 177 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--ivHr 177 (332)
.+++||||++++++..++. .++...+..++.++ +.||.|||+++ |+||
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~~~i~H~ 155 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI---------------------------LKGLQFLHTRTPPIIHR 155 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHH---------------------------HHHHHHHHTSSSCCCCS
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHH---------------------------HHHHHHHHcCCCCEEEC
Confidence 6899999999999877753 35555555555554 45999999999 9999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||||+||+++.+++.++|+|||++.... ........+|..|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 156 dikp~Nil~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 156 DLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCHHHEEEECCCCCEEEeeCCCccccc-ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998444589999999997543 233345578999999998865 589999999999999999999999953
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.99 Aligned_cols=216 Identities=24% Similarity=0.520 Sum_probs=156.8
Q ss_pred CCceE-EEeecccCCceEEEEEEc--cCCceEEEEEecccc-hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEV-VRKVGRGKYSEVFEGINV--TNNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.|++ .++||+|+||.||+|.+. .+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+......++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence 55776 458999999999999965 568899999997543 45788999999999 89999999999977666789999
Q ss_pred EeeecCCCceeecc-----------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 108 FEHVNSTDFKVLYP-----------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
|||+.++.+..+.. .++...+.. ++.|++.||.|||++||+|
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~---------------------------i~~qi~~al~~LH~~~ivH 151 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS---------------------------LLYQILDGIHYLHANWVLH 151 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCEeC
Confidence 99998643332210 144444444 4445556999999999999
Q ss_pred cCCCCCCeeec---CCCCeEEEEecccceeecCC----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh
Q 040656 177 RDVKPHNVMID---HEQQKLRLIDWGLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 177 rdlkp~Nilv~---~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt 249 (332)
|||||+|||+. .+.+.+||+|||+++..... .......||..|+|||++.+...++.++|||||||++|+|++
T Consensus 152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 231 (405)
T 3rgf_A 152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231 (405)
T ss_dssp CCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh
Confidence 99999999993 23347999999999876432 223446789999999999875668999999999999999999
Q ss_pred CCCCCCCCCC--------CHHHHHHHHHHhCCch
Q 040656 250 RKEPFFYGHD--------NQDQLVKIARVLGTDE 275 (332)
Q Consensus 250 g~~pf~~~~~--------~~~~~~~~~~~~~~~~ 275 (332)
|..||..... ..+.+..+...++.+.
T Consensus 232 g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~ 265 (405)
T 3rgf_A 232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 265 (405)
T ss_dssp SSCTTCCCC------CCCCHHHHHHHHHHHCCCC
T ss_pred CCCCCCCccccccccccchHHHHHHHHHhhCCCC
Confidence 9999943222 2467777777776543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=300.34 Aligned_cols=259 Identities=15% Similarity=0.229 Sum_probs=181.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|.+.+.||+|+||.||+|.+. .+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec--
Confidence 4688999999999999999999873 45588999998643 235688999999999 99999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhh---H---HHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANE---I---RYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
....+++|||+++++|..++....... . ......... ..........+.+.++.|+++||.|||++||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 171 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD------HPDERALTMGDLISFAWQISQGMQYLAEMKL 171 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccc------cccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 457899999999998877653211000 0 000000000 0000001122234566677779999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-C
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-R 250 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g 250 (332)
+||||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++ |
T Consensus 172 vH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 172 VHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp ECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTS
T ss_pred cccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999665 799999999987654332 123356778999999876 678999999999999999999 9
Q ss_pred CCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCC
Q 040656 251 KEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGF 330 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R 330 (332)
..||. +.........+...... ......++.+..++ ..||+.||++|
T Consensus 250 ~~p~~-~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li------------------------~~~l~~dp~~R 296 (314)
T 2ivs_A 250 GNPYP-GIPPERLFNLLKTGHRM--------ERPDNCSEEMYRLM------------------------LQCWKQEPDKR 296 (314)
T ss_dssp CCSST-TCCGGGHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSGGGS
T ss_pred CCCCC-CCCHHHHHHHhhcCCcC--------CCCccCCHHHHHHH------------------------HHHccCChhhC
Confidence 99983 33333333332221110 11123444455544 55999999999
Q ss_pred CC
Q 040656 331 PF 332 (332)
Q Consensus 331 P~ 332 (332)
|+
T Consensus 297 ps 298 (314)
T 2ivs_A 297 PV 298 (314)
T ss_dssp CC
T ss_pred cC
Confidence 96
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.18 Aligned_cols=197 Identities=27% Similarity=0.451 Sum_probs=163.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....+++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc--CCEEEEE
Confidence 6799999999999999999999889999999998632 236788999999999 99999999999854 4578999
Q ss_pred EeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
+|+++++++...+. .++...+..++.+++ .||.|||++|++||||||+||
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~---------------------------~~l~~lH~~~i~H~dl~p~Ni 136 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------------------------AGVVYLHGIGITHRDIKPENL 136 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSCCSGGGE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeeccCCChHHE
Confidence 99999988877753 355555555555555 499999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
+++.++ .++|+|||.+....... ......+|..|+|||++.+...++.++||||||+++|+|++|..||.....
T Consensus 137 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 137 LLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp EECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred EEccCC-CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 999666 79999999997654222 234457899999999987744457899999999999999999999954443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=299.96 Aligned_cols=199 Identities=24% Similarity=0.449 Sum_probs=166.8
Q ss_pred cccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 25 TVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 25 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
.+.....++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +|+||+++++++.+
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED 112 (335)
T ss_dssp EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred ecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec
Confidence 33445678999999999999999999999999999999998643 245688999999999 99999999999954
Q ss_pred cCCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
....+++|||+.++++..+. ..++...+..++.+++ .||.|||++||+
T Consensus 113 --~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~---------------------------~aL~~LH~~~iv 163 (335)
T 2owb_A 113 --NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV---------------------------LGCQYLHRNRVI 163 (335)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEE
T ss_pred --CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCCE
Confidence 45789999999998887764 2355555555555555 499999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||||||+||+++.++ .++|+|||++...... .......+|..|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 164 H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf 241 (335)
T 2owb_A 164 HRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241 (335)
T ss_dssp CSCCCGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCchhEEEcCCC-CEEEeeccCceecccCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCC
Confidence 999999999999666 7999999999876532 23345578999999999877 67899999999999999999999999
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 242 ~ 242 (335)
T 2owb_A 242 E 242 (335)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.87 Aligned_cols=198 Identities=25% Similarity=0.474 Sum_probs=161.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------hHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence 367999999999999999999999999999999986421 23478999999999 999999999998543
Q ss_pred CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
..+++|||++++++...+ ..++......++.+++ .||.|||++||+|
T Consensus 88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~ivH 137 (322)
T 2ycf_A 88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---------------------------LAVQYLHENGIIH 137 (322)
T ss_dssp ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEEC
T ss_pred ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeec
Confidence 379999999998876654 2355555555555555 4999999999999
Q ss_pred cCCCCCCeeecCCCC--eEEEEecccceeecCCCcccccccccceecccccc--CCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 177 RDVKPHNVMIDHEQQ--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~--~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|||||+||+++.++. .++|+|||++.............+|..|+|||++. +...++.++|||||||++|+|++|..
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999985542 49999999998775444444567899999999974 23568899999999999999999999
Q ss_pred CCCCCCC
Q 040656 253 PFFYGHD 259 (332)
Q Consensus 253 pf~~~~~ 259 (332)
||.....
T Consensus 218 pf~~~~~ 224 (322)
T 2ycf_A 218 PFSEHRT 224 (322)
T ss_dssp SSCSTTC
T ss_pred CCcccch
Confidence 9954433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.51 Aligned_cols=216 Identities=19% Similarity=0.265 Sum_probs=161.4
Q ss_pred CCCCceEEEeecccCCceEEEEEE-----ccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGIN-----VTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+|+.+++++.+||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 468899999999999999999984 456789999999743 246788999999999889999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHH-HHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIR-YYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
....+++||+++++++..++......... ........ .........+.+.++.|++.||.|||++||+||||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 171 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME-------DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccc-------cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 45789999999998887765321110000 00000000 00000122223456666677999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 172 kp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 172 AARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp SGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999665 899999999987654332 123356778999999876 678999999999999999999 999984
Q ss_pred C
Q 040656 256 Y 256 (332)
Q Consensus 256 ~ 256 (332)
.
T Consensus 250 ~ 250 (313)
T 1t46_A 250 G 250 (313)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=298.02 Aligned_cols=198 Identities=14% Similarity=0.221 Sum_probs=160.1
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCC-------ceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNN-------EKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
...++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC 83 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe
Confidence 35789999999999999999999987777 46999998643 346789999999999 89999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
....+++|||+.+++|..++.. ++......+ +.|++.||.|||++||
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i---------------------------~~qi~~~L~~LH~~~i 134 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV---------------------------AKQLAAAMHFLEENTL 134 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHH---------------------------HHHHHHHHHHHHHTTC
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHH---------------------------HHHHHHHHHHHhhCCe
Confidence 4568999999999998777532 444444444 4455559999999999
Q ss_pred eecCCCCCCeeecCCCC-------eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHH
Q 040656 175 MHRDVKPHNVMIDHEQQ-------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~-------~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~el 247 (332)
+||||||+|||++.++. .++|+|||++.... ......+|..|+|||++.+...++.++||||||+++|+|
T Consensus 135 vH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 211 (289)
T 4fvq_A 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211 (289)
T ss_dssp CCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHH
T ss_pred ECCCcCcceEEEecCCcccccccceeeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHH
Confidence 99999999999986652 19999999986432 223446788899999997756789999999999999999
Q ss_pred HhCCCCCCCCCC
Q 040656 248 IFRKEPFFYGHD 259 (332)
Q Consensus 248 ltg~~pf~~~~~ 259 (332)
++|..|++...+
T Consensus 212 ~~g~~~~~~~~~ 223 (289)
T 4fvq_A 212 CSGGDKPLSALD 223 (289)
T ss_dssp HTTTCCTTTTSC
T ss_pred HcCCCCCccccc
Confidence 997666654443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=305.67 Aligned_cols=191 Identities=30% Similarity=0.474 Sum_probs=156.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+. ...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~ 129 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTA 129 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CeE
Confidence 36699999999999999999999999999999998632 124688999999999 999999999999653 578
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||||+.++....+. ..++...+..++. |+++||.|||++||+||||||
T Consensus 130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~---------------------------qi~~aL~~LH~~~ivH~Dlkp 182 (348)
T 1u5q_A 130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH---------------------------GALQGLAYLHSHNMIHRDVKA 182 (348)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHH---------------------------HHHHHHHHHHHTTCBCCCCSG
T ss_pred EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeeeCCCCH
Confidence 9999999864332221 2345554444444 445599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++.++ .+||+|||++..... .....||..|+|||++.+ ...++.++|||||||++|+|++|..||.
T Consensus 183 ~NIll~~~~-~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 183 GNILLSEPG-LVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp GGEEEETTT-EEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHEEECCCC-CEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999666 899999999976542 234578999999999853 3568999999999999999999999994
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=297.34 Aligned_cols=212 Identities=29% Similarity=0.554 Sum_probs=162.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeecc--------
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ-------- 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-------- 99 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence 578999999999999999999999999999999986433 35688999999999 999999999987432
Q ss_pred ----CCCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 100 ----HSKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 100 ----~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
+....+++|||+.+ ++..++ ..++...+..++.++ +.||+|||++|
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~ 140 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQL---------------------------LRGLKYIHSAN 140 (320)
T ss_dssp --CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHH---------------------------HHHHHHHHHTT
T ss_pred ccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHH---------------------------HHHHHHHHhCC
Confidence 23567899999985 555544 235555555555554 45999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCC----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt 249 (332)
|+||||||+||+++.++..++|+|||+++..... .......+|..|+|||.+.+...++.++||||||+++|+|++
T Consensus 141 i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~ 220 (320)
T 2i6l_A 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220 (320)
T ss_dssp CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH
T ss_pred EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh
Confidence 9999999999999866668999999999865422 122344678889999998765678999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhC
Q 040656 250 RKEPFFYGHDNQDQLVKIARVLG 272 (332)
Q Consensus 250 g~~pf~~~~~~~~~~~~~~~~~~ 272 (332)
|..||. +.+..+....+.....
T Consensus 221 g~~pf~-~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 221 GKTLFA-GAHELEQMQLILESIP 242 (320)
T ss_dssp SSCSSC-CSSHHHHHHHHHHHSC
T ss_pred CCCCCC-CCCHHHHHHHHHHhcC
Confidence 999994 4555556666665544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.23 Aligned_cols=196 Identities=27% Similarity=0.488 Sum_probs=165.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------------hHHHHHHHHHHHhccCCCCeeeeeeeee
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVR 97 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~~~~~~~ 97 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++.+||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3588999999999999999999999999999999986321 3457899999999966999999999995
Q ss_pred ccCCCCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 98 DQHSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
+ ....+++||+++++++..++. .++...+..++.++ +.||.|||++|+
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~i 145 (298)
T 1phk_A 95 T--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL---------------------------LEVICALHKLNI 145 (298)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHH---------------------------HHHHHHHHHTTE
T ss_pred c--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCc
Confidence 4 467899999999988877652 35555555555555 459999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceecccccc-----CCCCCCCcccHHHHHHHHHHHHh
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDMWSLGCMFAGMIF 249 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~sDiwSlG~il~ellt 249 (332)
+||||||+||+++.++ .++|+|||++.............+|..|+|||++. ....++.++||||||+++|+|++
T Consensus 146 ~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 224 (298)
T 1phk_A 146 VHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224 (298)
T ss_dssp ECSCCSGGGEEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCCC-cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence 9999999999999666 79999999998876655556678899999999875 23567899999999999999999
Q ss_pred CCCCCC
Q 040656 250 RKEPFF 255 (332)
Q Consensus 250 g~~pf~ 255 (332)
|..||.
T Consensus 225 g~~p~~ 230 (298)
T 1phk_A 225 GSPPFW 230 (298)
T ss_dssp SSCSSC
T ss_pred CCCCCc
Confidence 999994
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=305.23 Aligned_cols=265 Identities=18% Similarity=0.294 Sum_probs=182.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--
Confidence 5689999999999999999999986 345899999987432 35688999999999 99999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....+++|||+++++|..++...............+.................+.+.++.|+++||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 46789999999999988776432211110000000000000000000112233345577788889999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~ 256 (332)
|+||+++.++ .++|+|||+++...... ......+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 202 p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~- 278 (343)
T 1luf_A 202 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY- 278 (343)
T ss_dssp GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-
T ss_pred cceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC-
Confidence 9999999666 79999999987653221 2233467888999999876 578999999999999999999 999984
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+....+...... ......++.+..+ +..||+.||++||+
T Consensus 279 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~l------------------------i~~~l~~~p~~Rps 322 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNIL--------ACPENCPLELYNL------------------------MRLCWSKLPADRPS 322 (343)
T ss_dssp TSCHHHHHHHHHTTCCC--------CCCTTCCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred CCChHHHHHHHhCCCcC--------CCCCCCCHHHHHH------------------------HHHHcccCcccCCC
Confidence 33333333332221100 1112334444444 45599999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=292.33 Aligned_cols=240 Identities=20% Similarity=0.350 Sum_probs=179.8
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----------hHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence 45689999999999999999999999999999999985321 15788999999999 89999999999854
Q ss_pred cCCCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC-
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG- 173 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~- 173 (332)
. .+++|||++++++...+ ..++......++.++ +.||+|||++|
T Consensus 95 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l---------------------------~~~l~~lH~~~~ 143 (287)
T 4f0f_A 95 P----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDI---------------------------ALGIEYMQNQNP 143 (287)
T ss_dssp T----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHH---------------------------HHHHHHHHTSSS
T ss_pred C----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHH---------------------------HHHHHHHHhCCC
Confidence 3 37999999988875543 234555554444444 45999999999
Q ss_pred -CeecCCCCCCeeecCCCC----eEEEEecccceeecCCCcccccccccceeccccccC-CCCCCCcccHHHHHHHHHHH
Q 040656 174 -IMHRDVKPHNVMIDHEQQ----KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 174 -ivHrdlkp~Nilv~~~~~----~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~sDiwSlG~il~el 247 (332)
|+||||||+||+++.++. .++|+|||+++... .......+|..|+|||++.+ ...++.++||||||+++|+|
T Consensus 144 ~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l 221 (287)
T 4f0f_A 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTI 221 (287)
T ss_dssp CCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHH
T ss_pred CeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHH
Confidence 999999999999985552 39999999997543 23445678999999999843 24578899999999999999
Q ss_pred HhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCC
Q 040656 248 IFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSP 327 (332)
Q Consensus 248 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP 327 (332)
++|..||.................... .......++.+..++ ..||+.||
T Consensus 222 ~~g~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li------------------------~~~l~~dp 271 (287)
T 4f0f_A 222 LTGEGPFDEYSYGKIKFINMIREEGLR------PTIPEDCPPRLRNVI------------------------ELCWSGDP 271 (287)
T ss_dssp HHSSCTTTTCCCCHHHHHHHHHHSCCC------CCCCTTSCHHHHHHH------------------------HHHTCSSG
T ss_pred HcCCCCCccccccHHHHHHHHhccCCC------CCCCcccCHHHHHHH------------------------HHHhcCCh
Confidence 999999954433332222222111110 011123444555554 55999999
Q ss_pred CCCCC
Q 040656 328 SGFPF 332 (332)
Q Consensus 328 ~~RP~ 332 (332)
++||+
T Consensus 272 ~~Rps 276 (287)
T 4f0f_A 272 KKRPH 276 (287)
T ss_dssp GGSCC
T ss_pred hhCcC
Confidence 99996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=303.56 Aligned_cols=219 Identities=21% Similarity=0.285 Sum_probs=161.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.. ....+.+|+.++.++..||||+++++++.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 4689999999999999999999863 35678999998642 346789999999999889999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccc----hhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLT----ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....+++|||+++++|..++.... ............. ...........+.+.++.|++.||.|||++||+|
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE-----EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC--------------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccc-----cccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 457899999999999887763211 1100000000000 0000001122233456777788999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
|||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|+| |..
T Consensus 196 ~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 196 RDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999666 899999999976643322 223456778999999876 678999999999999999998 999
Q ss_pred CCCCC
Q 040656 253 PFFYG 257 (332)
Q Consensus 253 pf~~~ 257 (332)
||...
T Consensus 274 p~~~~ 278 (344)
T 1rjb_A 274 PYPGI 278 (344)
T ss_dssp SSTTC
T ss_pred CcccC
Confidence 98433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=319.67 Aligned_cols=238 Identities=18% Similarity=0.332 Sum_probs=183.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.+..++..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence 467899999999999999999999888999999999743 457899999999999 99999999999954 4578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+.+++|..++.. ++...+. .++.|++.||+|||++||+||||||+
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~---------------------------~i~~qi~~~L~~LH~~~ivHrDlkp~ 347 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLL---------------------------YMATQISSAMEYLEKKNFIHRNLAAR 347 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHH---------------------------HHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHH---------------------------HHHHHHHHHHHHHHhCCcccCCCChh
Confidence 999999988776532 3333333 34555566999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
|||++.++ .+||+|||+++....... .....++..|+|||++.. ..++.++|||||||++|||++ |..|| .+.+
T Consensus 348 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~ 424 (495)
T 1opk_A 348 NCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGID 424 (495)
T ss_dssp GEEECGGG-CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCC
T ss_pred hEEECCCC-cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCC
Confidence 99998666 799999999987643321 122345678999999876 578999999999999999999 88888 4444
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+....+...... ......++.+..++ ..||+.||++||+
T Consensus 425 ~~~~~~~~~~~~~~--------~~~~~~~~~l~~li------------------------~~cl~~dP~~RPs 465 (495)
T 1opk_A 425 LSQVYELLEKDYRM--------ERPEGCPEKVYELM------------------------RACWQWNPSDRPS 465 (495)
T ss_dssp GGGHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHHHcCCCC--------CCCCCCCHHHHHHH------------------------HHHcCcChhHCcC
Confidence 44444333321111 01123344444444 5599999999996
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=293.29 Aligned_cols=195 Identities=24% Similarity=0.462 Sum_probs=164.4
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|.+.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +|+||+++++++.+ ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--ND 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeecc--CC
Confidence 3568899999999999999999999999999999998643 245688999999999 99999999999954 45
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..+++||+++++++..+. ..++......++.+++ .||+|||++|++||||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~---------------------------~~l~~lH~~~i~H~dl 141 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV---------------------------LGCQYLHRNRVIHRDL 141 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCccccCC
Confidence 789999999998877764 2355555555555555 4999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+||+++.++ .++|+|||++...... .......+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 142 ~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 142 KLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp CGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ChHhEEEcCCC-CEEEEeccCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999666 7999999999876532 23344578999999999876 678999999999999999999999994
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=295.42 Aligned_cols=237 Identities=23% Similarity=0.405 Sum_probs=170.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC---CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++.+.||+|+||.||+|.+..+ +..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---C
Confidence 468999999999999999999988554 456999998642 235688999999999 99999999999843 4
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++||||++++++..++. .++...+..++. |++.||.|||++||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~---------------------------qi~~~l~~lH~~~i~H~d 141 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY---------------------------QLSTALAYLESKRFVHRD 141 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCSC
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeeccc
Confidence 6799999999988877653 244444444444 445599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||+||+++.++ .++|+|||+++....... .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 142 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 142 IAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp CSGGGEEEEETT-EEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccHHHEEECCCC-CEEECccccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 999999999666 899999999987643322 223356678999999876 678999999999999999997 888984
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+....+...... ......++.+..++ ..||+.||++||+
T Consensus 220 -~~~~~~~~~~i~~~~~~--------~~~~~~~~~l~~li------------------------~~~l~~~p~~Rps 263 (281)
T 1mp8_A 220 -GVKNNDVIGRIENGERL--------PMPPNCPPTLYSLM------------------------TKCWAYDPSRRPR 263 (281)
T ss_dssp -TCCGGGHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred -cCCHHHHHHHHHcCCCC--------CCCCCCCHHHHHHH------------------------HHHccCChhhCcC
Confidence 44444444443321111 11123445555544 5599999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=294.20 Aligned_cols=194 Identities=27% Similarity=0.474 Sum_probs=164.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..+.|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 96 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLW 96 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEE
Confidence 457899999999999999999999999999999998632 346789999999999 999999999999653 5689
Q ss_pred eEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 106 LIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
++|||++++++..++. .++...+..++.+++ .||.+||++||+||||||+|
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~i~H~dl~p~N 149 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREIL---------------------------KGLDYLHSEKKIHRDIKAAN 149 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCCSGGG
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCCccCCCChhe
Confidence 9999999988877653 355555555555554 59999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+++.++ .++|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 150 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 150 VLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp EEECTTS-CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEECCCC-CEEEeecccceecCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 9999666 79999999998765433 2344578999999999877 678999999999999999999999984
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=295.90 Aligned_cols=204 Identities=24% Similarity=0.449 Sum_probs=164.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhccc--CCEEEEE
Confidence 46799999999999999999999999999999999743 335688999999999 99999999999954 4578999
Q ss_pred EeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 108 FEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 108 ~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||+++++++...+ ..+++..+..++.+++ .||.|||++||+||||||+||
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~i~H~dikp~NI 137 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVL---------------------------SAVKYLHENGIVHRDLKPENL 137 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCCSCCGGGC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCccccCCCHHHE
Confidence 9999998876654 3355555555555555 499999999999999999999
Q ss_pred ee---cCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 185 MI---DHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 185 lv---~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
++ +.+ +.++|+|||++.... ........+|..|+|||++.+ ..++.++||||||+++|+|++|..||. .....
T Consensus 138 l~~~~~~~-~~~kl~Dfg~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~ 213 (304)
T 2jam_A 138 LYLTPEEN-SKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY-EETES 213 (304)
T ss_dssp EESSSSTT-CCEEBCSCSTTCCCC-CBTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTT-TSCHH
T ss_pred EEecCCCC-CCEEEccCCcceecC-CCccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHH
Confidence 99 434 479999999987543 223344578999999999876 678999999999999999999999994 33333
Q ss_pred HHHHHHH
Q 040656 262 DQLVKIA 268 (332)
Q Consensus 262 ~~~~~~~ 268 (332)
.....+.
T Consensus 214 ~~~~~i~ 220 (304)
T 2jam_A 214 KLFEKIK 220 (304)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 3444443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=313.71 Aligned_cols=235 Identities=17% Similarity=0.330 Sum_probs=180.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.++|++.+.||+|+||.||+|.. .++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.... ..+++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTT-SCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCC-CceEEEE
Confidence 568999999999999999999976 4789999999754 456789999999999 9999999999986432 3689999
Q ss_pred eeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||+++++|..++.. ++...+. .++.|++.||+|||++||+||||||+|
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~---------------------------~~~~qi~~~l~~LH~~~ivHrDlkp~N 319 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLL---------------------------KFSLDVCEAMEYLEGNNFVHRDLAARN 319 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHH---------------------------HHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHH---------------------------HHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence 99999988776532 2333333 345556669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~~~ 262 (332)
||++.++ .+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +....+
T Consensus 320 ill~~~~-~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~ 394 (450)
T 1k9a_A 320 VLVSEDN-VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKD 394 (450)
T ss_dssp EEECTTS-CEEECCCTTCEECC--------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST-TSCTTT
T ss_pred EEECCCC-CEEEeeCCCccccccc--ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHH
Confidence 9999666 7999999999864322 223356788999999977 679999999999999999998 999983 444444
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+......+ .....++.+.+++ ..||+.||++||+
T Consensus 395 ~~~~i~~~~~~~--------~p~~~~~~l~~li------------------------~~cl~~dp~~Rpt 432 (450)
T 1k9a_A 395 VVPRVEKGYKMD--------APDGCPPAVYDVM------------------------KNCWHLDAATRPT 432 (450)
T ss_dssp HHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHcCCCCC--------CCCcCCHHHHHHH------------------------HHHcCCChhHCcC
Confidence 444443322111 1123455555555 4599999999996
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=301.99 Aligned_cols=193 Identities=17% Similarity=0.363 Sum_probs=155.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCce----EEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
..++|++.+.||+|+||.||+|.+..+++. ||+|.+... ....+.+|+.+++++ +||||+++++++.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---
Confidence 468899999999999999999998888876 677766422 234678899999999 99999999999853
Q ss_pred CCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++|+||+.++++..++. .++...+..++.++ +.||+|||++||+||
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~ivH~ 139 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI---------------------------AKGMYYLEEHGMVHR 139 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHH---------------------------HHHHHHHHHTTCCCS
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHH---------------------------HHHHHHHHhCCCCCC
Confidence 45899999999998877652 35555555555554 459999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||||+|||++.++ .++|+|||+++....... .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 140 Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 140 NLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp CCSSTTEEESSSS-CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccchheEEECCCC-eEEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 9999999998666 799999999987643322 234467778999999876 578999999999999999999 9999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 218 ~~ 219 (325)
T 3kex_A 218 YA 219 (325)
T ss_dssp TT
T ss_pred cc
Confidence 94
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=291.92 Aligned_cols=194 Identities=23% Similarity=0.457 Sum_probs=163.1
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 87 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHD--RK 87 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEc--CC
Confidence 3457899999999999999999999889999999998632 235688999999999 99999999999954 45
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
..+++||+++++++...+ ..++......++.+++ .||.|||++||+||||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~i~H~dl 140 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA---------------------------DALHYCHERKVIHRDI 140 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHH---------------------------HHHHHHHTTTEECCCC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCceecCC
Confidence 789999999998876654 2355555555555554 5999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+||+++.++ .++|+|||++..... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 141 ~p~Nil~~~~~-~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 141 KPENLLMGYKG-ELKIADFGWSVHAPS-LRRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp SGGGEEECTTC-CEEECCCTTCEECSS-SCBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred CHHHEEEcCCC-CEEEecccccccCcc-cccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 99999999666 799999999876543 23345678999999999877 678999999999999999999999994
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=296.57 Aligned_cols=205 Identities=20% Similarity=0.370 Sum_probs=146.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHH-HHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIK-REIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~-~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ..... ++...++.+ +||||+++++++.+ ....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~--~~~~ 81 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFR--EGDV 81 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSSE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeec--cCCE
Confidence 4688999999999999999999999999999999986432 12233 344445666 99999999999954 4578
Q ss_pred eeEEeeecCCCceeec-------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCee
Q 040656 105 SLIFEHVNSTDFKVLY-------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMH 176 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivH 176 (332)
+++|||+++ ++..++ ..+++..+..++.++ +.||.|||++ ||+|
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi---------------------------~~~l~~lH~~~~i~H 133 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSI---------------------------VKALEHLHSKLSVIH 133 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHH---------------------------HHHHHHHHHHSCCCC
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHH---------------------------HHHHHHHhhcCCeec
Confidence 999999986 433322 234555555444444 5599999998 9999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceecccccc---CCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|||||+||+++.++ .++|+|||++.............+|..|+|||++. ....++.++||||||+++|+|++|..|
T Consensus 134 ~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 134 RDVKPSNVLINALG-QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CCCSGGGCEECTTC-CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred CCCCHHHEEECCCC-CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999666 79999999998776555555567999999999972 335688999999999999999999999
Q ss_pred CCCCCCCHHHHHH
Q 040656 254 FFYGHDNQDQLVK 266 (332)
Q Consensus 254 f~~~~~~~~~~~~ 266 (332)
|.........+..
T Consensus 213 ~~~~~~~~~~~~~ 225 (290)
T 3fme_A 213 YDSWGTPFQQLKQ 225 (290)
T ss_dssp SCCCSCHHHHHHH
T ss_pred ccccCchHHHHHH
Confidence 9543444333333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=296.40 Aligned_cols=239 Identities=25% Similarity=0.408 Sum_probs=182.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 57899999999999999999999999999999998632 235688999999999 999999999998766667889
Q ss_pred eEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC-----
Q 040656 106 LIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG----- 173 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----- 173 (332)
++|||+++++|..++.. ++...+..+ +.|++.||+|||+.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i---------------------------~~~i~~~l~~lH~~~~~~~~ 136 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRV---------------------------MTQLTLALKECHRRSDGGHT 136 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHH---------------------------HHHHHHHHHHHHHHC-----
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHH---------------------------HHHHHHHHHHHhcccCCCCe
Confidence 99999999888776532 444444444 445555999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCCc-ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|+||||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 137 ivH~dl~p~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~ 214 (279)
T 2w5a_A 137 VLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMP 214 (279)
T ss_dssp -CCCCCSGGGEEECSSS-CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred eEEeccchhhEEEcCCC-CEEEecCchheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999666 799999999876543322 234578899999999877 578999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
||. ..+..+....+...... ......++.+..++ ..||+.||++||+
T Consensus 215 p~~-~~~~~~~~~~i~~~~~~--------~~~~~~~~~l~~li------------------------~~~l~~~p~~Rps 261 (279)
T 2w5a_A 215 PFT-AFSQKELAGKIREGKFR--------RIPYRYSDELNEII------------------------TRMLNLKDYHRPS 261 (279)
T ss_dssp SSC-CSSHHHHHHHHHHTCCC--------CCCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCc-ccCHHHHHHHHhhcccc--------cCCcccCHHHHHHH------------------------HHHcCCCcccCCC
Confidence 984 33333333333321110 11123444454444 5599999999996
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.52 Aligned_cols=270 Identities=25% Similarity=0.467 Sum_probs=191.4
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeecc---CC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ---HS 101 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---~~ 101 (332)
.-.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++... ..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence 34688999999999999999999999999999999986432 34678999999999 999999999987543 23
Q ss_pred CCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 102 KTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
...++++|++.+ ++...+ ..++...+..++.++ +.||.|||++||+||||
T Consensus 87 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi---------------------------~~~L~~LH~~~ivH~Dl 138 (353)
T 2b9h_A 87 NEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT---------------------------LRAVKVLHGSNVIHRDL 138 (353)
T ss_dssp CCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECSCC
T ss_pred ceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCC
Confidence 568999999985 444432 235555555555554 45999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc-----------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
||+||+++.++ .++|+|||++........ .....||..|+|||++.+...++.++|||||||++|+|+
T Consensus 139 kp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 217 (353)
T 2b9h_A 139 KPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217 (353)
T ss_dssp CGGGEEECTTC-CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHeEEcCCC-cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHH
Confidence 99999999666 799999999987642211 223468999999998876567899999999999999999
Q ss_pred hCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCc--ccccccccccccCceEEEeC
Q 040656 249 FRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN--KKLQFCRSSRTSTNICITFS 326 (332)
Q Consensus 249 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~cl~~d 326 (332)
+|..|| .+.+..+.+..+....+.+....... ....+..+..+.....+..... ..........+++..||+.|
T Consensus 218 ~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 218 LRRPIF-PGRDYRHQLLLIFGIIGTPHSDNDLR---CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp HSSCSC-CCSSHHHHHHHHHHHHCCCCSTTTTT---TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred hCCCCC-CCCCcHHHHHHHHHHhCCCchhcccc---ccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 999998 45555566666666655433211110 1122233333322211111000 00112233346778899999
Q ss_pred CCCCCC
Q 040656 327 PSGFPF 332 (332)
Q Consensus 327 P~~RP~ 332 (332)
|++||+
T Consensus 294 P~~Rpt 299 (353)
T 2b9h_A 294 PAKRIT 299 (353)
T ss_dssp GGGSCC
T ss_pred cccCCC
Confidence 999996
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.92 Aligned_cols=195 Identities=26% Similarity=0.457 Sum_probs=154.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 85 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIST--PTD 85 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCe
Confidence 457899999999999999999999889999999998642 235788999999999 89999999999854 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++++|+++++++..++ ..++......++.++ +.||.+||++|++|||||
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~i~H~dl~ 138 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI---------------------------LSAVDYCHRHMVVHRDLK 138 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHH---------------------------HHHHHHHHHHCSSCCCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCCccCCCC
Confidence 89999999998887765 235555555555554 459999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++.............+|..|+|||.+.+....+.++||||||+++|+|++|..||.
T Consensus 139 p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 139 PENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp GGGEEECTTS-CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred hhhEEECCCC-CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 9999999666 7999999999876554444556789999999998774344689999999999999999999994
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=315.12 Aligned_cols=236 Identities=18% Similarity=0.325 Sum_probs=182.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.+ .++..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~---~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEeC---CccEEE
Confidence 568899999999999999999987 45788999999743 457899999999999 99999999999852 468999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+.+++|..++.. ++...+. .++.|++.||+|||+++|+||||||+
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~---------------------------~~~~qi~~~l~~LH~~~ivHrDlkp~ 313 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLI---------------------------DFSAQIAEGMAFIEQRNYIHRDLRAA 313 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHH---------------------------HHHHHHHHHHHHHHHTTCCCSSCSGG
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHH---------------------------HHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 999999998877632 3333333 35556666999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
|||++.++ .+||+|||+++....... .....+|..|+|||++.. ..++.++|||||||++|||+| |..|| .+.+
T Consensus 314 Nill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~ 390 (454)
T 1qcf_A 314 NILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMS 390 (454)
T ss_dssp GEEECTTC-CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCC
T ss_pred HEEECCCC-cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCC
Confidence 99999666 799999999976542211 122345678999999876 578999999999999999999 99998 4555
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+....+......+. ....++.+..++ ..||+.||++||+
T Consensus 391 ~~~~~~~i~~~~~~~~--------~~~~~~~l~~li------------------------~~cl~~dp~~RPt 431 (454)
T 1qcf_A 391 NPEVIRALERGYRMPR--------PENCPEELYNIM------------------------MRCWKNRPEERPT 431 (454)
T ss_dssp HHHHHHHHHHTCCCCC--------CTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHHHcCCCCCC--------CCCCCHHHHHHH------------------------HHHccCChhHCcC
Confidence 5555555444322111 123444555544 5599999999996
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=295.57 Aligned_cols=237 Identities=17% Similarity=0.297 Sum_probs=178.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++++.||+|+||.||+|.+ .++..||+|+++.. ....+.+|+.+++++ +|+||+++++++. +....+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~--~~~~~~lv 97 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCT--KQRPIFII 97 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEEC--SSSSEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEe--cCCCeEEE
Confidence 568999999999999999999976 47788999999743 457789999999999 8999999999994 44678999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||+.++++..++. .++...+..++.++ +.||.|||++||+||||||+|
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi---------------------------~~~l~~lH~~~i~H~dikp~N 150 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDV---------------------------CEAMEYLESKQFLHRDLAARN 150 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTCCCSSCSGGG
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCccCCCCccce
Confidence 99999998877652 35555555555554 459999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDN 260 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~ 260 (332)
|+++.++ .++|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++ |..||. ....
T Consensus 151 ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~-~~~~ 227 (283)
T 3gen_A 151 CLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE-RFTN 227 (283)
T ss_dssp EEECTTS-CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTT-TSCH
T ss_pred EEEcCCC-CEEEccccccccccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccCh
Confidence 9999666 79999999997654221 1223356778999999876 578999999999999999998 999983 3333
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+....... .....++.+..+ +..||+.||++||+
T Consensus 228 ~~~~~~~~~~~~~~--------~~~~~~~~l~~l------------------------i~~~l~~~p~~Rps 267 (283)
T 3gen_A 228 SETAEHIAQGLRLY--------RPHLASEKVYTI------------------------MYSCWHEKADERPT 267 (283)
T ss_dssp HHHHHHHHTTCCCC--------CCTTCCHHHHHH------------------------HHHTTCSSGGGSCC
T ss_pred hHHHHHHhcccCCC--------CCCcCCHHHHHH------------------------HHHHccCChhHCcC
Confidence 33433333221110 011233444444 45599999999996
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.99 Aligned_cols=214 Identities=31% Similarity=0.637 Sum_probs=169.5
Q ss_pred CCCceEEEeecccCCceEEEEEEc-cCCceEEEEEecccc-----hHHHHHHHHHHHhcc--CCCCeeeeeeeeec---c
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINV-TNNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD---Q 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~~~~~~~~---~ 99 (332)
.++|++.+.||+|+||.||+|.+. .+++.||+|+++... ...+.+|+.+++.+. .||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999985 678999999986422 235778888887764 79999999999852 2
Q ss_pred CCCCceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
.....++++|++.+ ++..++. .++...+..++.++ +.||.|||++||
T Consensus 90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~gi 141 (326)
T 1blx_A 90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL---------------------------LRGLDFLHSHRV 141 (326)
T ss_dssp SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHH---------------------------HHHHHHHHHTTC
T ss_pred CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCc
Confidence 34568999999985 5555432 24555555444444 559999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
+||||||+||+++.++ .++|+|||++.............+|..|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 142 ~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf 219 (326)
T 1blx_A 142 VHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF 219 (326)
T ss_dssp CCCCCCGGGEEECTTC-CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred eeccCCHHHeEEcCCC-CEEEecCcccccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999666 799999999987654444455678999999999877 67899999999999999999999998
Q ss_pred CCCCCCHHHHHHHHHHhCCch
Q 040656 255 FYGHDNQDQLVKIARVLGTDE 275 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~ 275 (332)
.+....+.+..+....+.+.
T Consensus 220 -~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 220 -RGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp -CCSSHHHHHHHHHHHHCCCC
T ss_pred -CCCCHHHHHHHHHHHcCCCC
Confidence 45555666777776665443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.11 Aligned_cols=258 Identities=16% Similarity=0.243 Sum_probs=180.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-------cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-------TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.. ....+.+|+.+++++.+||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 5689999999999999999999875 45678999999743 235688999999999889999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
....++||||+++++|..++......... ................+.+.++.|+++||.|||++||+|||
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 182 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGME--------YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCC--------SCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred --CCceEEEEECCCCCcHHHHHHHhcccccc--------ccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 45789999999999887765321100000 00000000000011222345666777799999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+||+++.++ .+||+|||+++....... .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 183 lkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 183 LAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp CSGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 999999999666 799999999987654332 223356778999999876 568999999999999999999 99998
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
. +....+....+...... ......++.+..++ ..||+.||++||+
T Consensus 261 ~-~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li------------------------~~~l~~dp~~Rps 305 (334)
T 2pvf_A 261 P-GIPVEELFKLLKEGHRM--------DKPANCTNELYMMM------------------------RDCWHAVPSQRPT 305 (334)
T ss_dssp T-TCCHHHHHHHHHHTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred C-cCCHHHHHHHHhcCCCC--------CCCccCCHHHHHHH------------------------HHHccCChhhCcC
Confidence 3 33333333333221111 01123344444444 5599999999996
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=300.72 Aligned_cols=209 Identities=19% Similarity=0.352 Sum_probs=150.0
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCc---eEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
...++|++.+.||+|+||.||+|.+..++. .||+|+++.. ....+.+|+.+++++ +||||+++++++.+..
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence 356889999999999999999998876665 8999998642 346789999999999 9999999999986543
Q ss_pred CC----CceeEEeeecCCCceeecc---------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHH
Q 040656 101 SK----TPSLIFEHVNSTDFKVLYP---------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALD 167 (332)
Q Consensus 101 ~~----~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 167 (332)
.. ..++++||+.++++..++. .++...+..++. |+++||.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~---------------------------qi~~al~ 151 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV---------------------------DIACGME 151 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHH---------------------------HHHHHHH
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHH---------------------------HHHHHHH
Confidence 22 2389999999998877652 244444444444 4555999
Q ss_pred HHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHH
Q 040656 168 YCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244 (332)
Q Consensus 168 ~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il 244 (332)
|||++||+||||||+|||++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++
T Consensus 152 ~LH~~~ivH~Dikp~NIli~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il 229 (323)
T 3qup_A 152 YLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTM 229 (323)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHH
T ss_pred HHHcCCcccCCCCcceEEEcCCC-CEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHH
Confidence 99999999999999999999666 799999999976643322 123356778999999877 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCCCHHHHHHHH
Q 040656 245 AGMIF-RKEPFFYGHDNQDQLVKIA 268 (332)
Q Consensus 245 ~ellt-g~~pf~~~~~~~~~~~~~~ 268 (332)
|+|++ |..|| .+....+....+.
T Consensus 230 ~ell~~g~~p~-~~~~~~~~~~~~~ 253 (323)
T 3qup_A 230 WEIMTRGQTPY-AGIENAEIYNYLI 253 (323)
T ss_dssp HHHHTTSCCTT-TTCCGGGHHHHHH
T ss_pred HHHHhCCCCCc-cccChHHHHHHHh
Confidence 99999 88888 3444444444433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=301.80 Aligned_cols=194 Identities=19% Similarity=0.365 Sum_probs=153.0
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceE----EEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC----IIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
...++|++.+.||+|+||.||+|.+..+++.+ |+|.++. ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-
Confidence 45688999999999999999999987777654 7777642 2346789999999999 999999999999653
Q ss_pred CCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
..+++++++.++++..++. .++...+..++. |++.||+|||++||+|
T Consensus 90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~---------------------------qi~~~l~~LH~~~ivH 140 (327)
T 3poz_A 90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV---------------------------QIAKGMNYLEDRRLVH 140 (327)
T ss_dssp --SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCC
T ss_pred --CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHH---------------------------HHHHHHHHHhhCCeeC
Confidence 4789999999998877642 244554444444 4455999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
|||||+|||++.++ .+||+|||+++........ ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 141 ~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~ 218 (327)
T 3poz_A 141 RDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp SCCCGGGEEEEETT-EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCChheEEECCCC-CEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCC
Confidence 99999999999666 7999999999876533322 23355778999999877 678999999999999999999 999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 219 p~~ 221 (327)
T 3poz_A 219 PYD 221 (327)
T ss_dssp TTT
T ss_pred Ccc
Confidence 983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=295.74 Aligned_cols=238 Identities=19% Similarity=0.344 Sum_probs=183.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence 568899999999999999999999999999999999753 346788999999999 89999999999954 4578999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
||++.++++..++.. ++...+..++.+ ++.||.|||++||+||||||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~---------------------------i~~~l~~lH~~~i~H~dikp~ 140 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ---------------------------ISSAMEYLEKKNFIHRDLAAR 140 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHH---------------------------HHHHHHHHHHHTCCCSCCSGG
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHH---------------------------HHHHHHHHHHCCccCCCCCcc
Confidence 999999888776532 444444444444 455999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..|| ...+
T Consensus 141 Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~-~~~~ 217 (288)
T 3kfa_A 141 NCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGID 217 (288)
T ss_dssp GEEECGGG-CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCC
T ss_pred eEEEcCCC-CEEEccCccceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCC
Confidence 99998666 799999999976543322 223356778999999876 578999999999999999999 88888 3444
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.......+...... ......++.+..+ +..||+.||++||+
T Consensus 218 ~~~~~~~~~~~~~~--------~~~~~~~~~l~~l------------------------i~~~l~~dp~~Rps 258 (288)
T 3kfa_A 218 LSQVYELLEKDYRM--------ERPEGCPEKVYEL------------------------MRACWQWNPSDRPS 258 (288)
T ss_dssp GGGHHHHHHTTCCC--------CCCTTCCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred HHHHHHHHhccCCC--------CCCCCCCHHHHHH------------------------HHHHhCCChhhCcC
Confidence 33333333221111 0112334444444 45599999999996
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.22 Aligned_cols=193 Identities=24% Similarity=0.505 Sum_probs=143.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFED--SNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEEC--SSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEcc--CCeE
Confidence 47899999999999999999999899999999998642 236788999999999 99999999999954 4578
Q ss_pred eeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++++|+++++++..++. .++...+..++.+++ .||.|||++|++|||||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~i~H~dl~ 139 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII---------------------------TGMLYLHSHGILHRDLT 139 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSSCC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCeecCCCC
Confidence 99999999988777642 355555555555554 49999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 140 p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 213 (278)
T 3cok_A 140 LSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD 213 (278)
T ss_dssp GGGEEECTTC-CEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEEcCCC-CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999666 79999999998765322 2334578999999999876 678999999999999999999999994
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=296.93 Aligned_cols=244 Identities=17% Similarity=0.310 Sum_probs=181.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ .|++++..+..+.. .....+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccC-CCCceEEEE
Confidence 357899999999999999999999999999999998643 346789999999999 77776666655533 345679999
Q ss_pred eeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|++ ++++..++. .++...+..++.++ +.||+|||++||+||||||+||
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi---------------------------~~~l~~lH~~~ivH~dlkp~NI 136 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQM---------------------------ISRIEYIHSKNFIHRDVKPDNF 136 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECSCCCGGGE
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCeeeCCCCHHHe
Confidence 999 777766543 35555555555555 4599999999999999999999
Q ss_pred eec--CCCCeEEEEecccceeecCCCc--------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 185 MID--HEQQKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 185 lv~--~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
+++ .+++.++|+|||++........ .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf 215 (296)
T 3uzp_A 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPW 215 (296)
T ss_dssp EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 994 2334799999999987654322 234578999999999887 67899999999999999999999999
Q ss_pred CCCC--CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGH--DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.... ........+......... .......++.+..++ ..||+.||++||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li------------------------~~~l~~dp~~Rps 267 (296)
T 3uzp_A 216 QGLKAATKRQKYERISEKKMSTPI----EVLCKGYPSEFATYL------------------------NFCRSLRFDDKPD 267 (296)
T ss_dssp SSCCCSSSSSHHHHHHHHHHHSCH----HHHTTTSCHHHHHHH------------------------HHHHTSCTTCCCC
T ss_pred CCcCchhhhhhhhhhcccccCCch----HHHHhhCCHHHHHHH------------------------HHHHhcCcCcCCC
Confidence 5322 222333333332111111 112234566666666 4499999999996
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.54 Aligned_cols=193 Identities=27% Similarity=0.467 Sum_probs=150.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccC-CCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++.+.||+|+||.||+|.+. +++.||+|++... ....+.+|+.++.++.+ |+||+++++++... ..+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEE
Confidence 456999999999999999999875 4899999998632 23568999999999954 69999999998543 468
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||| +.+++|..++ ..++...+..++. |++.||.|||++||+||||||
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~---------------------------qi~~aL~~lH~~~ivHrDlkp 183 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWK---------------------------NMLEAVHTIHQHGIVHSDLKP 183 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHH---------------------------HHHHHHHHHHTTTCCCCCCCG
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCeeecCCCH
Confidence 99999 5566665554 2344444444444 455599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCC----------CCCCCcccHHHHHHHHHHHH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~sDiwSlG~il~ell 248 (332)
+|||++ ++ .+||+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|+|+
T Consensus 184 ~NIll~-~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 184 ANFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp GGEEES-SS-CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred HHEEEE-CC-eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 999996 44 699999999987643322 2345799999999998641 35889999999999999999
Q ss_pred hCCCCCCC
Q 040656 249 FRKEPFFY 256 (332)
Q Consensus 249 tg~~pf~~ 256 (332)
+|..||..
T Consensus 262 ~G~~Pf~~ 269 (390)
T 2zmd_A 262 YGKTPFQQ 269 (390)
T ss_dssp HSSCTTTT
T ss_pred HCCCcchh
Confidence 99999953
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=296.13 Aligned_cols=198 Identities=25% Similarity=0.438 Sum_probs=157.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--cchHHHHHHHHHHHhccCCCCeeeeeeeeeccC----CCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQH----SKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~ 103 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. .....+.+|+.+++++.+||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 46889999999999999999999999999999999864 345678999999999978999999999986543 457
Q ss_pred ceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 104 PSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.+++|||++++++..++. .++...+..++. |++.||.|||++||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~---------------------------qi~~~l~~lH~~~ivH~d 154 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR---------------------------EILRGLSHLHQHKVIHRD 154 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCCC
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCccccC
Confidence 899999999988877653 244444444444 445599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|||+||+++.++ .++|+|||++....... ......+|..|+|||++.. ...++.++|||||||++|+|++|..|
T Consensus 155 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 155 IKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp CSGGGEEECTTC-CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred CcHHHEEEcCCC-CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 999999999666 79999999987654322 2344578999999999863 25688999999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 234 ~~ 235 (326)
T 2x7f_A 234 LC 235 (326)
T ss_dssp TT
T ss_pred CC
Confidence 94
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.22 Aligned_cols=192 Identities=19% Similarity=0.411 Sum_probs=150.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+.++|++.+.||+|+||.||+|.+ +++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 79 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK--EP 79 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--C-
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--CC
Confidence 467899999999999999999986 5899999998632 235688999999999 99999999999954 45
Q ss_pred CceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC---Ceec
Q 040656 103 TPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG---IMHR 177 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---ivHr 177 (332)
..+++|||++++++..++ ..++...+..++.++ ++||.|||++| |+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l---------------------------~~~l~~lH~~~~~~i~H~ 132 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI---------------------------ARGMNYLHDEAIVPIIHR 132 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHH---------------------------HHHHHHHHHSSSSCCCCS
T ss_pred ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCCCceeec
Confidence 789999999999887765 345555555555554 45999999999 8999
Q ss_pred CCCCCCeeecCC-------CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 178 DVKPHNVMIDHE-------QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 178 dlkp~Nilv~~~-------~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
||||+||+++.+ ++.++|+|||++....... .....+|..|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 133 dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp CCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHC
T ss_pred CCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhC
Confidence 999999999852 4479999999997655332 234578999999999876 6789999999999999999999
Q ss_pred CCCCC
Q 040656 251 KEPFF 255 (332)
Q Consensus 251 ~~pf~ 255 (332)
..||.
T Consensus 211 ~~p~~ 215 (271)
T 3dtc_A 211 EVPFR 215 (271)
T ss_dssp CCTTT
T ss_pred CCCCC
Confidence 99994
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=295.71 Aligned_cols=198 Identities=24% Similarity=0.436 Sum_probs=157.4
Q ss_pred CCCCceEE-EeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVV-RKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++|++. +.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.++.++.+||||+++++++.+ ....+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~ 87 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFY 87 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEE
Confidence 45789996 7899999999999999899999999999643 356789999999996589999999999965 45789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||++++++..++ ..+++..+..++.+++ .||+|||++||+||||||+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~---------------------------~~l~~lH~~~ivH~dlkp~ 140 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVA---------------------------SALDFLHNKGIAHRDLKPE 140 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCCCCCGG
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCceeCCCCHH
Confidence 999999998887765 2355555555555554 5999999999999999999
Q ss_pred CeeecCCCC--eEEEEecccceeecCCC--------cccccccccceeccccccCC----CCCCCcccHHHHHHHHHHHH
Q 040656 183 NVMIDHEQQ--KLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 183 Nilv~~~~~--~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~sDiwSlG~il~ell 248 (332)
||+++.++. .+||+|||++....... ......||..|+|||++.+. ..++.++|||||||++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999986552 39999999987653221 12234689999999998641 34789999999999999999
Q ss_pred hCCCCCCC
Q 040656 249 FRKEPFFY 256 (332)
Q Consensus 249 tg~~pf~~ 256 (332)
+|..||..
T Consensus 221 ~g~~pf~~ 228 (316)
T 2ac3_A 221 SGYPPFVG 228 (316)
T ss_dssp HSSCSCCC
T ss_pred HCCCCCcc
Confidence 99999953
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=302.30 Aligned_cols=199 Identities=20% Similarity=0.364 Sum_probs=166.0
Q ss_pred cCCCCCCceEEEeecccCCceEEEEE----EccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
...+.++|++.+.||+|+||.||+|. +..+++.||+|++.... .+.+.+|+.+++++ +|+||+++++++..+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGP 96 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecC
Confidence 34467899999999999999999998 46788999999997543 35689999999999 999999999998776
Q ss_pred CCCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
+....++||||++++++..++. .++...+..++.++ +.||+|||++||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi---------------------------~~al~~lH~~~iv 149 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI---------------------------CKGMEYLGSRRCV 149 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCcc
Confidence 6777899999999999887653 25555555555554 4599999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~ 251 (332)
||||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 150 H~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~ 227 (327)
T 3lxl_A 150 HRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYC 227 (327)
T ss_dssp CSCCSGGGEEEEETT-EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCChhhEEECCCC-CEEEcccccceecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCC
Confidence 999999999999666 799999999987654332 223457788999999876 56899999999999999999999
Q ss_pred CCCC
Q 040656 252 EPFF 255 (332)
Q Consensus 252 ~pf~ 255 (332)
.||.
T Consensus 228 ~p~~ 231 (327)
T 3lxl_A 228 DKSC 231 (327)
T ss_dssp CGGG
T ss_pred CCCc
Confidence 9984
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=308.05 Aligned_cols=194 Identities=21% Similarity=0.368 Sum_probs=147.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEc---cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--SK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CC
Confidence 4578999999999999999999875 46778999998643 235689999999999 99999999999954 46
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++||||+++++|..++. .++...+.. ++.|++.||+|||++||+|||
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~aL~~LH~~~ivH~D 172 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG---------------------------MLRGIASGMKYLSDMGYVHRD 172 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCSC
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCeeCCC
Confidence 7899999999999887753 244444444 445555699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
|||+|||++.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++||||||+++|||++ |..|
T Consensus 173 lkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 173 LAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp CCGGGEEECTTC-CEEECCC----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred CCcceEEEcCCC-CEEECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 999999999666 7999999999876433211 12234667999999876 678999999999999999998 9999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 251 ~~ 252 (373)
T 2qol_A 251 YW 252 (373)
T ss_dssp TT
T ss_pred CC
Confidence 84
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.27 Aligned_cols=197 Identities=23% Similarity=0.434 Sum_probs=160.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEc---cCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV---TNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
..++|++.+.||+|+||.||+|.+. .+++.||+|+++.. ....+.+|+.++.++.+|+||+++++++.+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence 4479999999999999999999874 58899999998642 235678899999999789999999999854
Q ss_pred CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....++||||+++++|..++ ..++...+..++.+++ .||.|||++||+|
T Consensus 131 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~---------------------------~aL~~LH~~~ivH 182 (355)
T 1vzo_A 131 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV---------------------------LALEHLHKLGIIY 182 (355)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCC
T ss_pred -CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCccc
Confidence 35689999999999887765 2355555555555555 4999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|||||+|||++.++ .+||+|||+++...... ......||..|+|||++.+. ..++.++|||||||++|+|++|..|
T Consensus 183 ~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~p 261 (355)
T 1vzo_A 183 RDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261 (355)
T ss_dssp CCCCGGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCHHHEEECCCC-cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999666 79999999998654222 22345789999999998753 3478999999999999999999999
Q ss_pred CCC
Q 040656 254 FFY 256 (332)
Q Consensus 254 f~~ 256 (332)
|..
T Consensus 262 f~~ 264 (355)
T 1vzo_A 262 FTV 264 (355)
T ss_dssp TSC
T ss_pred Ccc
Confidence 953
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.04 Aligned_cols=214 Identities=26% Similarity=0.441 Sum_probs=165.4
Q ss_pred ccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeee
Q 040656 20 DYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIV 96 (332)
Q Consensus 20 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~ 96 (332)
++..........++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 85 (302)
T 2j7t_A 7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAY 85 (302)
T ss_dssp ---CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hhcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeee
Confidence 3455555666789999999999999999999999999999999998643 346788999999999 999999999999
Q ss_pred eccCCCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 97 RDQHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
.+ ....++++|+++++++..++ ..++...+..++.+++ .||.|||++
T Consensus 86 ~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~---------------------------~~l~~lH~~ 136 (302)
T 2j7t_A 86 YH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---------------------------EALNFLHSK 136 (302)
T ss_dssp EC--C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHH---------------------------HHHHHHHHT
T ss_pred ee--CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHH---------------------------HHHHHHhcC
Confidence 54 35789999999998887654 2355555555555554 599999999
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeecC-CCcccccccccceecccccc----CCCCCCCcccHHHHHHHHHHH
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~----~~~~~~~~sDiwSlG~il~el 247 (332)
|++||||||+||+++.++ .++|+|||++..... ........+|..|+|||++. ....++.++||||||+++|+|
T Consensus 137 ~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 215 (302)
T 2j7t_A 137 RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215 (302)
T ss_dssp TCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEECCCC-CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999666 799999998753221 11223457889999999984 335788999999999999999
Q ss_pred HhCCCCCCCCCCCHHHHH
Q 040656 248 IFRKEPFFYGHDNQDQLV 265 (332)
Q Consensus 248 ltg~~pf~~~~~~~~~~~ 265 (332)
++|..||. ..+......
T Consensus 216 ~~g~~p~~-~~~~~~~~~ 232 (302)
T 2j7t_A 216 AQIEPPHH-ELNPMRVLL 232 (302)
T ss_dssp HHSSCTTT-TSCHHHHHH
T ss_pred hcCCCCCc-cCCHHHHHH
Confidence 99999984 333333333
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.19 Aligned_cols=211 Identities=27% Similarity=0.469 Sum_probs=168.8
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhccCCCC-----eeeeeeeeeccCCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGPN-----IVKLLDIVRDQHSKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~n-----iv~~~~~~~~~~~~~ 103 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+..|+.+++.+.+|+| |+++++++.. ...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--CCc
Confidence 478999999999999999999999999999999997433 3567789999998855664 8899998854 357
Q ss_pred ceeEEeeecCCCceeec-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH--HcCCee
Q 040656 104 PSLIFEHVNSTDFKVLY-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH--SQGIMH 176 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~ivH 176 (332)
.++|||++.+ ++..++ ..++...+..++. |++.||.||| +.||+|
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~---------------------------qi~~al~~lH~~~~~ivH 182 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQ---------------------------QMCTALLFLATPELSIIH 182 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHH---------------------------HHHHHHHHHTSTTTCEEC
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHH---------------------------HHHHHHHHhccCCCCEEc
Confidence 8999999976 544443 1244554444444 4455999999 579999
Q ss_pred cCCCCCCeeecC-CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 177 RDVKPHNVMIDH-EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 177 rdlkp~Nilv~~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||||+|||++. ..+.+||+|||+++... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 183 rDlkp~NIll~~~~~~~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf- 258 (382)
T 2vx3_A 183 CDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF- 258 (382)
T ss_dssp CCCSGGGEEESSTTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-
T ss_pred CCCCcccEEEecCCCCcEEEEeccCceecc--cccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-
Confidence 999999999963 33479999999998764 23345688999999999987 67999999999999999999999998
Q ss_pred CCCCCHHHHHHHHHHhCCch
Q 040656 256 YGHDNQDQLVKIARVLGTDE 275 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~ 275 (332)
.+.+..+.+..+....+.+.
T Consensus 259 ~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 259 SGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp CCSSHHHHHHHHHHHHCSCC
T ss_pred CCCCHHHHHHHHHHHhCCCC
Confidence 46666777888887776543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=292.96 Aligned_cols=192 Identities=25% Similarity=0.360 Sum_probs=152.7
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.+.++|++.+.||+|+||.||+|.+ .++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ..++|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~lv 77 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN----PVCLV 77 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT----TTEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC----CcEEE
Confidence 4568899999999999999999976 5789999999643 346789999999999 99999999999853 47999
Q ss_pred EeeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH---cCCeecC
Q 040656 108 FEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS---QGIMHRD 178 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~ivHrd 178 (332)
|||++++++..++.. ++..... .++.|+++||+|||+ +||+|||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~---------------------------~~~~qi~~~l~~LH~~~~~~ivH~d 130 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAM---------------------------SWCLQCSQGVAYLHSMQPKALIHRD 130 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHH---------------------------HHHHHHHHHHHHHHTCSSSCCCCCC
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHH---------------------------HHHHHHHHHHHHHHhCCCCCeecCC
Confidence 999999988776532 2233333 344556669999999 8999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|||+||+++.++..+||+|||++..... ......||..|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 131 LKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp CSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred CChhHEEEeCCCCEEEEccccccccccc--ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 9999999987775689999999976532 2234468999999999877 67899999999999999999999999543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.97 Aligned_cols=194 Identities=21% Similarity=0.348 Sum_probs=163.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeec-----------
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD----------- 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----------- 98 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++++ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-SGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC-------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccccc
Confidence 347899999999999999999999889999999999643 35678999999999 99999999998754
Q ss_pred ---cCCCCceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 99 ---QHSKTPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 99 ---~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
.....++++|||+++++|..++. .++...+..++ .|++.||.|||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~---------------------------~qi~~~l~~lH 139 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF---------------------------EQITKGVDYIH 139 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH---------------------------HHHHHHHHHHH
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH---------------------------HHHHHHHHHHH
Confidence 12345789999999998877652 24444444444 45555999999
Q ss_pred HcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC
Q 040656 171 SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 171 ~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg 250 (332)
++||+||||||+||+++.++ .++|+|||++.............+|..|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 140 ~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~ 217 (284)
T 2a19_B 140 SKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHV 217 (284)
T ss_dssp HTTEECSCCSGGGEEEEETT-EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSC
T ss_pred hCCeeeccCCHHHEEEcCCC-CEEECcchhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhc
Confidence 99999999999999999666 899999999988765555556678999999999877 6789999999999999999999
Q ss_pred CCCC
Q 040656 251 KEPF 254 (332)
Q Consensus 251 ~~pf 254 (332)
..|+
T Consensus 218 ~~~~ 221 (284)
T 2a19_B 218 CDTA 221 (284)
T ss_dssp CSSH
T ss_pred CCcc
Confidence 9887
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=292.68 Aligned_cols=194 Identities=23% Similarity=0.427 Sum_probs=152.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~ 108 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEI--DGQ 108 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEee--CCe
Confidence 3578999999999999999999998999999999986431 25688999999999 99999999999955 457
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++++|+++++++..++. .++...+..++.+++ .||.|||++||+|||||
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~---------------------------~~l~~lH~~~i~H~dlk 161 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG---------------------------SALDAAHAAGATHRDVK 161 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCSCCC
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCcCCcCCCC
Confidence 899999999988877652 355555555555554 59999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 162 p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 162 PENILVSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp GGGEEECTTS-CEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred hHHEEEcCCC-CEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 9999999666 79999999987654332 2234578999999999877 678999999999999999999999994
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.08 Aligned_cols=195 Identities=23% Similarity=0.425 Sum_probs=142.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++... ...+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCcE
Confidence 468899999999999999999998889999999998642 235678999999999 999999999999553 5689
Q ss_pred eEEeeecCCCceeeccc-----------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 106 LIFEHVNSTDFKVLYPT-----------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
++|||++++++..++.. ++...+.. ++.|++.||.|||++|+
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~---------------------------i~~qi~~~l~~lH~~~i 142 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT---------------------------ILREVLEGLEYLHKNGQ 142 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHH---------------------------HHHHHHHHHHHHHHTTC
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCC
Confidence 99999999988776532 34444444 44455569999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCC------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
+||||||+||+++.++ .++|+|||++....... ......+|..|+|||++.+...++.++||||||+++|+|+
T Consensus 143 ~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 143 IHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp CCCCCSGGGEEECTTC-CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhEEEcCCC-CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 9999999999999666 79999999986553221 1234578999999999865456899999999999999999
Q ss_pred hCCCCCC
Q 040656 249 FRKEPFF 255 (332)
Q Consensus 249 tg~~pf~ 255 (332)
+|..||.
T Consensus 222 ~g~~pf~ 228 (303)
T 2vwi_A 222 TGAAPYH 228 (303)
T ss_dssp HSSCTTT
T ss_pred hCCCCCc
Confidence 9999994
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=292.63 Aligned_cols=240 Identities=17% Similarity=0.335 Sum_probs=170.2
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
...++|++.+.||+|+||.||+|.+ ...||+|+++.. ....+.+|+.+++++ +|+||+++++++. ...
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~---~~~ 93 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST---APQ 93 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSS
T ss_pred cCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeecc---CCc
Confidence 3578899999999999999999975 345999998632 235688999999999 9999999999753 246
Q ss_pred ceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++|||+.++++...+. .++...+..++. |++.||.|||++||+||||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~---------------------------qi~~~L~~lH~~~i~H~Dl 146 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR---------------------------QTARGMDYLHAKSIIHRDL 146 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCSCC
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCcccccC
Confidence 899999999988766552 244444444444 4455999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC---CcccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+||+++.++ .++|+|||++...... .......+|..|+|||++.. ...++.++||||||+++|+|++|..||
T Consensus 147 kp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 147 KSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp CGGGEEEETTT-EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccceEEECCCC-CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 99999999666 8999999998765422 22234578999999999862 256788999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHH-hCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARV-LGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.. ....+.+...... ...+.. .......++.++.++ ..||+.||++||+
T Consensus 226 ~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li------------------------~~~l~~~p~~Rps 275 (289)
T 3og7_A 226 SN-INNRDQIIEMVGRGSLSPDL----SKVRSNCPKRMKRLM------------------------AECLKKKRDERPS 275 (289)
T ss_dssp SS-CCCHHHHHHHHHHTSCCCCT----TSSCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred cc-cchHHHHHHHhcccccCcch----hhccccCCHHHHHHH------------------------HHHccCChhhCCC
Confidence 53 3333433333322 111111 112234445555555 5599999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=298.67 Aligned_cols=213 Identities=22% Similarity=0.299 Sum_probs=160.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc-----eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+..+++ .||+|+++.. ....+.+|+.+++++.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 46889999999999999999999876654 7999998743 345688999999999789999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....++||||+++++|..++..... ... .................+.++.|++.||+|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~-~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 191 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSR---------VLE-TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHH---------HHS-CC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhcc---------ccc-ccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence 4578999999999888776522100 000 000000000001222234566677779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~ 256 (332)
|+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|+| |..||..
T Consensus 192 p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 192 ARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp GGGCEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cceEEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999666 899999999986543322 123356778999999876 678999999999999999998 8889843
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.85 Aligned_cols=258 Identities=17% Similarity=0.235 Sum_probs=181.5
Q ss_pred CCCCceEEEeecccCCceEEEEEE-----ccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGIN-----VTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+ ..+++.||+|+++.. ....+.+|+.++.++.+||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 468999999999999999999984 356789999998743 2346889999999997899999999998643
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHH--HHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIR--YYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
....+++|||+++++|..++......... ...... ........+.+.++.|+++||.|||++||+|||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL----------YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-----------------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhh----------hccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 34589999999999887765321110000 000000 000001112234555666699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+||+++.++ .++|+|||+++....... .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 174 ikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 174 LAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp CSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CccceEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999998666 799999999986543322 223467788999999876 678999999999999999998 99998
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
............+...... ......++.+..++ ..||+.||++||+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li------------------------~~~l~~dp~~Rps 297 (316)
T 2xir_A 252 PGVKIDEEFCRRLKEGTRM--------RAPDYTTPEMYQTM------------------------LDCWHGEPSQRPT 297 (316)
T ss_dssp TTCCCSHHHHHHHHHTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred cccchhHHHHHHhccCccC--------CCCCCCCHHHHHHH------------------------HHHcCCChhhCcC
Confidence 5433333333332221111 01123445555554 5599999999996
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=294.38 Aligned_cols=199 Identities=25% Similarity=0.529 Sum_probs=151.8
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.....++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++++.+
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 103 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE-- 103 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--
Confidence 334567899999999999999999999899999999998631 235688999999999 99999999999965
Q ss_pred CCCceeEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
....+++||++.++++..++.. ++...+..++. +++.||.|||++|
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~---------------------------qi~~~l~~LH~~~ 156 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV---------------------------QLCSALEHMHSRR 156 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHH---------------------------HHHHHHHHHHHTT
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHH---------------------------HHHHHHHHHhhCC
Confidence 3578999999999988776532 44444444444 4555999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
++||||||+||+++.++ .++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 157 i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~ 234 (310)
T 2wqm_A 157 VMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQS 234 (310)
T ss_dssp CCCCCCCGGGEEECTTS-CEEECCC------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeCCCCcHHHEEEcCCC-CEEEEeccceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999666 79999999987654332 2234578899999999877 678999999999999999999999
Q ss_pred CCCCC
Q 040656 253 PFFYG 257 (332)
Q Consensus 253 pf~~~ 257 (332)
||...
T Consensus 235 p~~~~ 239 (310)
T 2wqm_A 235 PFYGD 239 (310)
T ss_dssp TTC--
T ss_pred CCccc
Confidence 99543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=311.27 Aligned_cols=236 Identities=19% Similarity=0.339 Sum_probs=176.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.+. .+..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv 256 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 256 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEE
Confidence 5688999999999999999999874 4567999999743 456799999999999 99999999999854 468999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+++++|..++.. ++...+. .++.|++.||+|||++||+||||||+
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~---------------------------~i~~qi~~~l~~LH~~~ivHrDlkp~ 309 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLV---------------------------DMAAQIASGMAYVERMNYVHRDLRAA 309 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHH---------------------------HHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHH---------------------------HHHHHHHHHHHHHHhCCeeCCCCChh
Confidence 999999998877632 3333333 35555666999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
|||++.++ .+||+|||+++....... .....++..|+|||++.+ ..++.++||||||+++|||++ |..|| .+..
T Consensus 310 Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~ 386 (452)
T 1fmk_A 310 NILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMV 386 (452)
T ss_dssp GEEECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCC
T ss_pred hEEECCCC-CEEECCCccceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCC
Confidence 99998666 799999999986643221 223356778999999876 578999999999999999999 89888 4444
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+....+......+ .....++.+..++ ..||+.||++||+
T Consensus 387 ~~~~~~~i~~~~~~~--------~~~~~~~~l~~li------------------------~~cl~~dP~~Rpt 427 (452)
T 1fmk_A 387 NREVLDQVERGYRMP--------CPPECPESLHDLM------------------------CQCWRKEPEERPT 427 (452)
T ss_dssp HHHHHHHHHTTCCCC--------CCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHHHcCCCCC--------CCCCCCHHHHHHH------------------------HHHccCChhhCcC
Confidence 444444443322111 1123444444444 5599999999996
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=306.23 Aligned_cols=196 Identities=22% Similarity=0.395 Sum_probs=162.3
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.....++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 104 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DG 104 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE--TT
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE--CC
Confidence 344568999999999999999999999999999999998643 235688999999999 99999999999965 35
Q ss_pred CceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHrd 178 (332)
..++||||+++++|..++. .++...+..++.++ +.||.|||++ ||+|||
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i---------------------------~~~l~~lh~~~~i~H~d 157 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV---------------------------IKGLTYLREKHKIMHRD 157 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHH---------------------------HHHHHHHHHHHCCCCSC
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHhCCEEcCC
Confidence 6899999999999877652 35555555555554 4599999996 999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||+||+++.++ .++|+|||++..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 158 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 158 VKPSNILVNSRG-EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp CSGGGEEECTTC-CEEECCCCCCHHHHH-HC----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred ccHHHEEECCCC-CEEEEECCCCccccc-ccccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999766 799999999865431 22344578999999999877 678999999999999999999999994
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=294.38 Aligned_cols=195 Identities=25% Similarity=0.427 Sum_probs=160.5
Q ss_pred CCCCceEEEeecccCCceEEEEE----EccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
..++|++++.||+|+||.||+|. +..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG 97 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence 35679999999999999999998 5678999999998743 346789999999999 99999999999977666
Q ss_pred CCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...+++|||++++++..++ ..++......++.++ +.||+|||++||+||
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i---------------------------~~~l~~lH~~~i~H~ 150 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI---------------------------CKGMDYLGSRQYVHR 150 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECS
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHH---------------------------HHHHHHhhcCCcccC
Confidence 7789999999999987775 234555555445544 459999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 151 dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p 228 (302)
T 4e5w_A 151 DLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDS 228 (302)
T ss_dssp CCSGGGEEEEETT-EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCchheEEEcCCC-CEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCC
Confidence 9999999999666 899999999987754432 233467788999999877 5688999999999999999999988
Q ss_pred C
Q 040656 254 F 254 (332)
Q Consensus 254 f 254 (332)
+
T Consensus 229 ~ 229 (302)
T 4e5w_A 229 D 229 (302)
T ss_dssp G
T ss_pred C
Confidence 6
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=300.84 Aligned_cols=194 Identities=27% Similarity=0.473 Sum_probs=150.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCC-CCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~ 103 (332)
..++|++.+.||+|+||.||+|.+ .+++.||+|+++.. ....+.+|+.++.++.+| +||+++++++.+ ...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCE
Confidence 467899999999999999999987 57899999998632 235688999999999433 999999999954 457
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.+++||+ .++++..++ ..++......++.+++ .||.|||++||+|||||
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~---------------------------~al~~lH~~~iiHrDik 135 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNML---------------------------EAVHTIHQHGIVHSDLK 135 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTCCCCCCC
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCeecCCCC
Confidence 8999994 555665554 3355555555555554 49999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccC----------CCCCCCcccHHHHHHHHHHH
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~sDiwSlG~il~el 247 (332)
|+|||++ ++ .+||+|||+++....... .....||..|+|||++.+ ...++.++|||||||++|+|
T Consensus 136 p~NIll~-~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el 213 (343)
T 3dbq_A 136 PANFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213 (343)
T ss_dssp GGGEEEE-TT-EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred cceEEEE-CC-cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence 9999997 44 799999999987643322 234579999999999853 14678899999999999999
Q ss_pred HhCCCCCCC
Q 040656 248 IFRKEPFFY 256 (332)
Q Consensus 248 ltg~~pf~~ 256 (332)
++|..||..
T Consensus 214 l~g~~pf~~ 222 (343)
T 3dbq_A 214 TYGKTPFQQ 222 (343)
T ss_dssp HHSSCTTTT
T ss_pred HhCCCcchh
Confidence 999999953
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=297.87 Aligned_cols=194 Identities=19% Similarity=0.384 Sum_probs=152.0
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceE----EEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKC----IIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
...++|++++.||+|+||.||+|.+..+++.+ |+|.+.. .....+.+|+.+++++ +||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC-
Confidence 34688999999999999999999988888765 5665532 2456789999999999 999999999999653
Q ss_pred CCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
..+++++++.++++..++. .++...+..++.++ +.||.|||++||+|
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi---------------------------~~aL~~LH~~~ivH 140 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---------------------------AKGMNYLEDRRLVH 140 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTCCC
T ss_pred --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHH---------------------------HHHHHHHhhCCCcC
Confidence 4789999999988877642 35555555555554 45999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
|||||+|||++.++ .++|+|||+++....... .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 141 ~Dikp~NIl~~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~ 218 (327)
T 3lzb_A 141 RDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSK 218 (327)
T ss_dssp SCCCGGGEEEEETT-EEEECCTTC----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCHHHEEEcCCC-CEEEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999666 799999999987643322 223356778999999877 678999999999999999999 999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 219 p~~ 221 (327)
T 3lzb_A 219 PYD 221 (327)
T ss_dssp TTT
T ss_pred CCC
Confidence 983
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.98 Aligned_cols=224 Identities=15% Similarity=0.230 Sum_probs=161.4
Q ss_pred ccccccCCCCCcccccccc---ccCC-CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHH
Q 040656 7 YADVNVHRPRDYWDYESLT---VQWG-DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKRE 76 (332)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~---~~~~-~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E 76 (332)
++.+....+..+|+..... .++. ..++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|
T Consensus 44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E 123 (377)
T 3byv_A 44 QSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 123 (377)
T ss_dssp HHHHHHHHHHHTCC-CCEEEEEESSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHH
T ss_pred cchhhhhhHHHhcCCCCcEEEEeecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHH
Confidence 3344444445566666544 3343 347899999999999999999999889999999998632 23678899
Q ss_pred HHHHHhcc--CCCCeeeee-------eeeeccCC----------C-----CceeEEeeecCCCceeecc---ccchhhHH
Q 040656 77 IKILQNLC--GGPNIVKLL-------DIVRDQHS----------K-----TPSLIFEHVNSTDFKVLYP---TLTANEIR 129 (332)
Q Consensus 77 ~~~l~~l~--~h~niv~~~-------~~~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 129 (332)
+.+++.+. +||||++++ +++.+... . ..+++|||+. ++|..++. .+++...
T Consensus 124 ~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~- 201 (377)
T 3byv_A 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHK- 201 (377)
T ss_dssp HHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTH-
T ss_pred HHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccc-
Confidence 95555443 799999998 44433211 1 3689999994 57666543 2222110
Q ss_pred HHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc
Q 040656 130 YYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE 209 (332)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~ 209 (332)
.+.. ...+.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 202 ~l~~-------------------~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~ 259 (377)
T 3byv_A 202 SLVH-------------------HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDG--AR 259 (377)
T ss_dssp HHHH-------------------HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETT--CE
T ss_pred cccH-------------------HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEechhheecC--Cc
Confidence 0000 11124666777799999999999999999999999766 79999999998633 33
Q ss_pred ccccccccceeccccccCC----------CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 210 YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 210 ~~~~~~t~~y~aPE~~~~~----------~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
.....| ..|+|||++.+. ..++.++|||||||++|+|++|..||.
T Consensus 260 ~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~ 314 (377)
T 3byv_A 260 VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314 (377)
T ss_dssp EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCc
Confidence 445567 889999999773 168999999999999999999999993
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.39 Aligned_cols=243 Identities=17% Similarity=0.310 Sum_probs=176.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ .|++++..+..+.. .....+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecC-CCCceEEEE
Confidence 347899999999999999999999999999999987533 335689999999999 67666666655532 345679999
Q ss_pred eeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|++ ++++..++. .++...+..++.++ +.||.|||++||+||||||+||
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi---------------------------~~~l~~LH~~~ivH~Dlkp~NI 136 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQM---------------------------ISRIEYIHSKNFIHRDVKPDNF 136 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECSCCSGGGE
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeecCCCCHHHe
Confidence 999 777766642 35555555555554 4599999999999999999999
Q ss_pred ee---cCCCCeEEEEecccceeecCCCc--------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 185 MI---DHEQQKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 185 lv---~~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|+ +.++ .++|+|||+++....... .....+|..|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 137 l~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p 214 (296)
T 4hgt_A 137 LMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLP 214 (296)
T ss_dssp EECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeeccCCCC-eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCC
Confidence 99 5444 799999999987654322 234578999999999887 6789999999999999999999999
Q ss_pred CCCCCC--CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCC
Q 040656 254 FFYGHD--NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFP 331 (332)
Q Consensus 254 f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP 331 (332)
|..... .......+........ ........++.+..++ ..||+.||++||
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li------------------------~~~l~~~p~~Rp 266 (296)
T 4hgt_A 215 WQGLKAATKRQKYERISEKKMSTP----IEVLCKGYPSEFATYL------------------------NFCRSLRFDDKP 266 (296)
T ss_dssp TSSCCCSSSSSHHHHHHHHHHHSC----HHHHTTTSCHHHHHHH------------------------HHHHTSCTTCCC
T ss_pred Ccccchhhhhhhhhhhhcccccch----hhhhhccCCHHHHHHH------------------------HHHHhcCCCCCC
Confidence 953222 1223333332211111 1112234456666665 449999999999
Q ss_pred C
Q 040656 332 F 332 (332)
Q Consensus 332 ~ 332 (332)
+
T Consensus 267 t 267 (296)
T 4hgt_A 267 D 267 (296)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=307.82 Aligned_cols=195 Identities=18% Similarity=0.299 Sum_probs=161.6
Q ss_pred CCCCceEEEeecccCCceEEEE-----EEccCCceEEEEEecccchHHHHHHHHHHHhccC--CCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEG-----INVTNNEKCIIKILKPVKKKKIKREIKILQNLCG--GPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~--h~niv~~~~~~~~~~~~ 102 (332)
..++|.+.+.||+|+||.||+| .+..+++.||+|+++......+..|+.++.++.. |+||+++++++.. ..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~--~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF--QN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC--SS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec--CC
Confidence 3578999999999999999999 4677899999999988888889999999999832 8999999999854 35
Q ss_pred CceeEEeeecCCCceeecc--------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 103 TPSLIFEHVNSTDFKVLYP--------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
..++||||+++++|..++. .+++..+..++.++ +.||+|||++||
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi---------------------------~~~L~~lH~~~i 193 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM---------------------------LYMIEQVHDCEI 193 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHH---------------------------HHHHHHHHTTTE
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHH---------------------------HHHHHHHhhCCe
Confidence 6899999999999887753 24555555555554 459999999999
Q ss_pred eecCCCCCCeeecC-----------CCCeEEEEecccceeec---CCCcccccccccceeccccccCCCCCCCcccHHHH
Q 040656 175 MHRDVKPHNVMIDH-----------EQQKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240 (332)
Q Consensus 175 vHrdlkp~Nilv~~-----------~~~~vkL~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSl 240 (332)
+||||||+|||++. ++ .+||+|||+++... .........||..|+|||++.+ ..++.++|||||
T Consensus 194 vHrDiKp~NIll~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl 271 (365)
T 3e7e_A 194 IHGDIKPDNFILGNGFLEQDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGV 271 (365)
T ss_dssp ECCCCSGGGEEECGGGTCC------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHH
T ss_pred ecCCCCHHHEEecccccCccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHH
Confidence 99999999999986 44 79999999997653 2233455679999999999987 669999999999
Q ss_pred HHHHHHHHhCCCCCC
Q 040656 241 GCMFAGMIFRKEPFF 255 (332)
Q Consensus 241 G~il~elltg~~pf~ 255 (332)
||++|||+||..||.
T Consensus 272 G~il~elltg~~pf~ 286 (365)
T 3e7e_A 272 AATVYCMLFGTYMKV 286 (365)
T ss_dssp HHHHHHHHHSSCCCE
T ss_pred HHHHHHHHhCCCccc
Confidence 999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=288.65 Aligned_cols=236 Identities=19% Similarity=0.345 Sum_probs=179.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.+ .++..||+|+++.. ....+.+|+++++++ +||||+++++++.+ ...+++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v 85 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII 85 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEE
Confidence 468899999999999999999986 46778999998743 457789999999999 99999999999853 357999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
||++++++|..++. .++...+..+ +.|++.||+|||++||+||||||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i---------------------------~~qi~~~l~~lH~~~i~H~dikp~ 138 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDM---------------------------AAQIAEGMAFIEERNYIHRDLRAA 138 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHH---------------------------HHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHH---------------------------HHHHHHHHHHHHHCCeeccCCCHh
Confidence 99999999888764 2444444444 445555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +..
T Consensus 139 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~ 215 (279)
T 1qpc_A 139 NILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYP-GMT 215 (279)
T ss_dssp GEEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSST-TCC
T ss_pred hEEEcCCC-CEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCc-ccC
Confidence 99999665 799999999987653322 123356678999999876 568899999999999999999 888883 444
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+....+...... ......++.+..+ +..||+.||++||+
T Consensus 216 ~~~~~~~~~~~~~~--------~~~~~~~~~l~~l------------------------i~~~l~~~p~~Rps 256 (279)
T 1qpc_A 216 NPEVIQNLERGYRM--------VRPDNCPEELYQL------------------------MRLCWKERPEDRPT 256 (279)
T ss_dssp HHHHHHHHHTTCCC--------CCCTTCCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred HHHHHHHHhcccCC--------CCcccccHHHHHH------------------------HHHHhccChhhCCC
Confidence 33333333221111 0112334444444 45599999999996
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=295.12 Aligned_cols=240 Identities=18% Similarity=0.302 Sum_probs=171.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc---CCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT---NNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
+.++|.+.+.||+|+||.||+|.... ++..||+|+++.. ....+.+|+.+++++ +||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence 56889999999999999999998765 4568999998632 235688999999999 89999999999866433
Q ss_pred C---CceeEEeeecCCCceeec---------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHH
Q 040656 102 K---TPSLIFEHVNSTDFKVLY---------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYC 169 (332)
Q Consensus 102 ~---~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 169 (332)
. ..++++|+++++++..++ ..++...+..++. |+++||.||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~---------------------------qi~~aL~~L 163 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV---------------------------DIALGMEYL 163 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHH---------------------------HHHHHHHHH
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHH---------------------------HHHHHHHHH
Confidence 2 459999999999887764 2244454444444 445599999
Q ss_pred HHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 170 HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 170 H~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
|++||+||||||+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 164 H~~~ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e 241 (313)
T 3brb_A 164 SNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWE 241 (313)
T ss_dssp HTTTCCCCCCSGGGEEECTTS-CEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHH
T ss_pred HhCCcccCCCCcceEEEcCCC-cEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHH
Confidence 999999999999999999666 799999999976643321 223456778999999877 678999999999999999
Q ss_pred HHh-CCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEe
Q 040656 247 MIF-RKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITF 325 (332)
Q Consensus 247 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 325 (332)
|++ |..|| .+.........+...... ......++.+..+ +..||+.
T Consensus 242 l~~~g~~p~-~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~l------------------------i~~~l~~ 288 (313)
T 3brb_A 242 IATRGMTPY-PGVQNHEMYDYLLHGHRL--------KQPEDCLDELYEI------------------------MYSCWRT 288 (313)
T ss_dssp HHTTSCCSS-TTCCGGGHHHHHHTTCCC--------CCBTTCCHHHHHH------------------------HHHTTCS
T ss_pred HHhcCCCCC-ccCCHHHHHHHHHcCCCC--------CCCccccHHHHHH------------------------HHHHcCC
Confidence 999 78787 344444444333321111 1112334444444 4559999
Q ss_pred CCCCCCC
Q 040656 326 SPSGFPF 332 (332)
Q Consensus 326 dP~~RP~ 332 (332)
||++||+
T Consensus 289 dp~~Rps 295 (313)
T 3brb_A 289 DPLDRPT 295 (313)
T ss_dssp SGGGSCC
T ss_pred ChhhCcC
Confidence 9999996
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=290.39 Aligned_cols=204 Identities=25% Similarity=0.565 Sum_probs=166.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeC--CCeEE
Confidence 47899999999999999999999889999999998632 346789999999999 99999999999954 45789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+++|++.++++...+ ..++...+..++.++ +.||.+||++|++||||||+
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi---------------------------~~~l~~LH~~~i~H~dl~p~ 150 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQV---------------------------FSGITYMHKHNIVHRDLKPE 150 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHH---------------------------HHHHHHHHHTTCCCSCCCGG
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCeeccCCChh
Confidence 999999998876553 345555555555554 45999999999999999999
Q ss_pred CeeecCCC--CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQ--QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~--~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
||+++.++ ..++|+|||++.............+|..|+|||.+.+ .++.++||||||+++|+|++|..||. +.+.
T Consensus 151 NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~ 227 (287)
T 2wei_A 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNE 227 (287)
T ss_dssp GEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSH
T ss_pred hEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC-CCCH
Confidence 99997543 2699999999987655555555678899999999876 48999999999999999999999994 3333
Q ss_pred HHHHHHH
Q 040656 261 QDQLVKI 267 (332)
Q Consensus 261 ~~~~~~~ 267 (332)
.+....+
T Consensus 228 ~~~~~~~ 234 (287)
T 2wei_A 228 YDILKRV 234 (287)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 3333333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=303.72 Aligned_cols=199 Identities=19% Similarity=0.326 Sum_probs=156.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHh--ccCCCCeeeeeeeeec---cCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQN--LCGGPNIVKLLDIVRD---QHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~---~~~~~~ 104 (332)
+.++|++.+.||+|+||.||+|.. +++.||+|+++......+..|.+++.. + .|+||+++++.+.. .....+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceE
Confidence 468999999999999999999965 789999999987666677777666553 6 89999999975532 233457
Q ss_pred eeEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc---------C
Q 040656 105 SLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ---------G 173 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---------~ 173 (332)
++||||+++++|..++. ..+...... ++.|+++||.|||+. |
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~---------------------------i~~qi~~~L~~LH~~~~~~~~~~~~ 140 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCR---------------------------LAHSVTRGLAYLHTELPRGDHYKPA 140 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHH---------------------------HHHHHHHHHHHHHCCBCCGGGCBCC
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHH---------------------------HHHHHHHHHHHHHhhhccccccccc
Confidence 89999999999877652 233333333 455556699999999 9
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCC---------cccccccccceeccccccCC------CCCCCcccHH
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDMW 238 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~sDiw 238 (332)
|+||||||+|||++.++ .+||+|||+++...... ......||..|+|||++.+. ..++.++|||
T Consensus 141 ivH~Dikp~Nill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw 219 (336)
T 3g2f_A 141 ISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219 (336)
T ss_dssp EECSSCSGGGEEECTTS-CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred eeecccccceEEEcCCC-cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence 99999999999999666 79999999998764321 12244789999999998762 2356789999
Q ss_pred HHHHHHHHHHhCCCCCCCCCC
Q 040656 239 SLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 239 SlG~il~elltg~~pf~~~~~ 259 (332)
||||++|||++|..||+.+..
T Consensus 220 slG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 220 ALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp HHHHHHHHHHTTBGGGSTTSC
T ss_pred HHHHHHHHHHhcCCcCCCccc
Confidence 999999999999888866544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=288.14 Aligned_cols=203 Identities=18% Similarity=0.351 Sum_probs=162.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||.||+|.+. +++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 81 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 81 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEE
Confidence 5689999999999999999999874 6788999999743 456789999999999 99999999999954 4578999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||+++++++..++. .++...+..++. |+++||.+||++|++||||||+|
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~---------------------------~i~~~l~~lH~~~i~H~dl~p~N 134 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCL---------------------------DVCEGMAYLEEACVIHRDLAARN 134 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCSSCCGGG
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHH---------------------------HHHHHHHHHHhCCcccCCCchhe
Confidence 99999998877652 244444444444 45559999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDN 260 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~ 260 (332)
|+++.++ .++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+.
T Consensus 135 ili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~ 211 (267)
T 3t9t_A 135 CLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSN 211 (267)
T ss_dssp EEECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCH
T ss_pred EEECCCC-CEEEcccccccccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCC-CCCH
Confidence 9998666 79999999987653221 1223356778999999876 578999999999999999999 898883 3333
Q ss_pred HHHHHH
Q 040656 261 QDQLVK 266 (332)
Q Consensus 261 ~~~~~~ 266 (332)
.+....
T Consensus 212 ~~~~~~ 217 (267)
T 3t9t_A 212 SEVVED 217 (267)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 333333
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.69 Aligned_cols=194 Identities=26% Similarity=0.456 Sum_probs=158.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....+++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFK--NTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEEEEe
Confidence 458899999999999999999999889999999998743 346789999999999 99999999999854 35689999
Q ss_pred eeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|+++++++..++. .++...+..++.+++ .||.|||+.|++|+||||+||
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~---------------------------~~l~~lH~~~i~H~dl~p~Ni 156 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---------------------------KGLEYLHFMRKIHRDIKAGNI 156 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCCSGGGE
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCCcCCCcCHHHE
Confidence 9999988877642 355555555555554 599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+++.++ .++|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 157 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 157 LLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp EECTTC-CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred EECCCC-CEEEeecccchhhhhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 999666 79999999998765332 2344578999999999877 678999999999999999999999994
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=295.34 Aligned_cols=207 Identities=18% Similarity=0.348 Sum_probs=157.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+. .+++.||+|++... ....+.+|+.+++++ +|+||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc--
Confidence 4688999999999999999999875 45788999998643 234688999999999 99999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....+++||++++++|..++....... .. . .........+.+.++.|++.||.|||++||+|||||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~-~-----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik 165 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAM--------AN-N-----PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA 165 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHH--------HH-C-----TTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhh--------cc-C-----CCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCc
Confidence 457899999999998877653211000 00 0 000001112233456667779999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+||+++.++ .++|+|||+++....... .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 166 p~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 166 ARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp GGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred cceEEEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 9999999666 799999999875532221 123356788999999876 678999999999999999999 788883
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=290.06 Aligned_cols=192 Identities=17% Similarity=0.230 Sum_probs=158.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+..+..+.+||||+++++++.+ ....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 47899999999999999999999989999999998742 345688899999998789999999999954 35789
Q ss_pred eEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 106 LIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
++|||+++++|..++. .++...+..++.++ +.||.|||++||+|||
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi---------------------------~~al~~lH~~~ivH~D 140 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV---------------------------GRGLRYIHSMSLVHMD 140 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECSC
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCEeecC
Confidence 9999999999887752 24555555555544 5599999999999999
Q ss_pred CCCCCeeecCCC------------------CeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHH
Q 040656 179 VKPHNVMIDHEQ------------------QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 240 (332)
Q Consensus 179 lkp~Nilv~~~~------------------~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSl 240 (332)
|||+||+++.++ ..++|+|||.+...... ....+|..|+|||++.+...++.++|||||
T Consensus 141 ikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 217 (289)
T 1x8b_A 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFAL 217 (289)
T ss_dssp CSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHH
T ss_pred CCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHH
Confidence 999999997432 26899999999876532 234689999999999875567789999999
Q ss_pred HHHHHHHHhCCCCC
Q 040656 241 GCMFAGMIFRKEPF 254 (332)
Q Consensus 241 G~il~elltg~~pf 254 (332)
|+++|+|++|..|+
T Consensus 218 G~il~~l~~~~~~~ 231 (289)
T 1x8b_A 218 ALTVVCAAGAEPLP 231 (289)
T ss_dssp HHHHHHHTTCCCCC
T ss_pred HHHHHHHhcCCCCC
Confidence 99999999998766
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=288.15 Aligned_cols=237 Identities=24% Similarity=0.374 Sum_probs=176.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC---CceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++.+.||+|+||.||+|.+... +..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---C
Confidence 568899999999999999999986543 346999998743 346788999999999 99999999999853 3
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||+++++++..++. .++...+..++ .|++.||.|||++||+|||
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------------------------~~i~~~l~~lH~~~i~H~d 138 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---------------------------LQICKAMAYLESINCVHRD 138 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHH---------------------------HHHHHHHHHHHHTTCCCCC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHH---------------------------HHHHHHHHHHHHCCcccCC
Confidence 4689999999998877652 24444444444 4555599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 139 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 139 IAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp CSGGGEEEEETT-EEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CccceEEECCCC-cEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 999999999666 899999999876543322 233456778999999876 678999999999999999998 999994
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.....+....+......+ .....++.+..++ ..||+.||++||+
T Consensus 217 -~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li------------------------~~~l~~~p~~Rps 260 (281)
T 3cc6_A 217 -WLENKDVIGVLEKGDRLP--------KPDLCPPVLYTLM------------------------TRCWDYDPSDRPR 260 (281)
T ss_dssp -TSCGGGHHHHHHHTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred -cCChHHHHHHHhcCCCCC--------CCCCCCHHHHHHH------------------------HHHccCCchhCcC
Confidence 333333333333211110 1122344444444 5599999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=291.22 Aligned_cols=196 Identities=26% Similarity=0.431 Sum_probs=156.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +|+||+++++++.+.+...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 36899999999999999999999999999999999642 235689999999999 8999999999987666678
Q ss_pred ceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++|||+.++....+. ..++......++ .|++.||.|||++||+||||
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~---------------------------~qi~~al~~LH~~~i~H~dl 135 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF---------------------------CQLIDGLEYLHSQGIVHKDI 135 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHH---------------------------HHHHHHHHHHHHTTEECSCC
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHH---------------------------HHHHHHHHHHHHCCeeecCC
Confidence 99999999877322221 224444444444 45555999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC---CcccccccccceeccccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+||+++.++ .++|+|||++...... .......+|..|+|||++.+.. .++.++||||||+++|+|++|..||.
T Consensus 136 kp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 136 KPGNLLLTTGG-TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp SGGGEEECTTC-CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccEEEcCCC-cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999666 7999999999876432 2223457899999999987632 24779999999999999999999994
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.97 Aligned_cols=194 Identities=18% Similarity=0.332 Sum_probs=151.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC----ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
+.++|++.+.||+|+||.||+|.+..++ ..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--C
Confidence 5689999999999999999999876553 35999998743 234688999999999 99999999999944 4
Q ss_pred CCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++|||+++++++..++. .++...+..++. |++.||.|||++||+||
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~---------------------------qi~~aL~~LH~~~ivH~ 171 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---------------------------GIAAGMKYLANMNYVHR 171 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCS
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCeeCC
Confidence 67899999999988877652 244444444444 45559999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++ |..
T Consensus 172 Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 172 DLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp CCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCChheEEECCCC-cEEECCCCcchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999666 799999999987643221 122345778999999876 678999999999999999999 999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 250 pf~ 252 (333)
T 1mqb_A 250 PYW 252 (333)
T ss_dssp TTT
T ss_pred Ccc
Confidence 983
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=288.43 Aligned_cols=235 Identities=19% Similarity=0.322 Sum_probs=178.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
+.++|++.+.||+|+||.||+|.+ .++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+......
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence 568899999999999999999987 5899999998743 235688999999999 99999999999977656788
Q ss_pred eeEEeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC--Ceec
Q 040656 105 SLIFEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHR 177 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--ivHr 177 (332)
+++|||+++++|..++.. ++...+..++.+++ .||.|||+++ ++||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~---------------------------~~l~~lH~~~~~i~H~ 137 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA---------------------------RGMAFLHTLEPLIPRH 137 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHH---------------------------HHHHHHTTSSSCCTTC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHH---------------------------HHHHHHhcCCCceecC
Confidence 999999999998877632 45555555555554 5999999999 9999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCC---CcccHHHHHHHHHHHHhCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD---YSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~sDiwSlG~il~elltg~~pf 254 (332)
||||+||+++.++ .++|+|||++.... .....+|..|+|||++.+ ..++ .++||||||+++|+|++|..||
T Consensus 138 dikp~Nil~~~~~-~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~~~~~Di~slG~il~el~~g~~p~ 211 (271)
T 3kmu_A 138 ALNSRSVMIDEDM-TARISMADVKFSFQ----SPGRMYAPAWVAPEALQK-KPEDTNRRSADMWSFAVLLWELVTREVPF 211 (271)
T ss_dssp CCSGGGEEECTTS-CEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHS-CGGGSCHHHHHHHHHHHHHHHHHHCSCTT
T ss_pred CCccceEEEcCCc-ceeEEeccceeeec----ccCccCCccccChhhhcc-CCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999999666 68999888765322 233478899999999876 3333 3799999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
. +....+....+......+ ......++.+..++ ..||+.||++||+
T Consensus 212 ~-~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li------------------------~~~l~~~p~~Rps 257 (271)
T 3kmu_A 212 A-DLSNMEIGMKVALEGLRP-------TIPPGISPHVSKLM------------------------KICMNEDPAKRPK 257 (271)
T ss_dssp T-TSCHHHHHHHHHHSCCCC-------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred c-ccChHHHHHHHHhcCCCC-------CCCCCCCHHHHHHH------------------------HHHcCCChhhCcC
Confidence 4 333333333332211111 11123444455544 5599999999996
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.30 Aligned_cols=214 Identities=17% Similarity=0.249 Sum_probs=158.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceE--EEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKC--IIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--avK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+.++|++.+.||+|+||.||+|.+..++..+ |+|.++.. ....+.+|+.+++++.+||||+++++++.+ ...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCc
Confidence 4578999999999999999999998888765 99988632 335688999999999889999999999954 357
Q ss_pred ceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 104 PSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
.+++||++++++|..++.......... ...+.. .........+.+.++.|+++||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDP-AFAIAN-------STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCH-HHHHHT-------TBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccc-cccccc-------cccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 899999999999887753211000000 000000 000011222234556666779999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||+++............++..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 173 Il~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 173 ILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp EEECGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEEcCCC-eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9998666 799999999874432223334456788999999876 568999999999999999998 999983
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=295.35 Aligned_cols=203 Identities=22% Similarity=0.418 Sum_probs=165.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch--------------------HHHHHHHHHHHhccCCCCee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNIV 90 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~~l~~l~~h~niv 90 (332)
.++|++.+.||+|+||.||+|.+ +++.||+|++..... ..+.+|+.+++++ +||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence 47899999999999999999987 899999999863211 7889999999999 899999
Q ss_pred eeeeeeeccCCCCceeEEeeecCCCceee------c-----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhH
Q 040656 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVL------Y-----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDIS 159 (332)
Q Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (332)
++++++.+ ....++||||+++++|..+ + ..++...+..++.++
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi------------------------ 160 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV------------------------ 160 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHH------------------------
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHH------------------------
Confidence 99999955 4578999999999998887 3 234555555555555
Q ss_pred HhHHHHHHHHHH-cCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCC-cccH
Q 040656 160 VWDLQALDYCHS-QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDM 237 (332)
Q Consensus 160 ~~i~~~l~~LH~-~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~sDi 237 (332)
+.||.|||+ +||+||||||+||+++.++ .++|+|||.+...... ......+|..|+|||++.+...++. ++||
T Consensus 161 ---~~~l~~lH~~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 235 (348)
T 2pml_X 161 ---LNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235 (348)
T ss_dssp ---HHHHHHHHHTSCEECCCCCGGGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred ---HHHHHHHhccCCEeecCCChHhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhH
Confidence 459999999 9999999999999999666 7999999999876533 3445678999999999987435555 9999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 040656 238 WSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 267 (332)
Q Consensus 238 wSlG~il~elltg~~pf~~~~~~~~~~~~~ 267 (332)
||||+++|+|++|..||.......+....+
T Consensus 236 ~slG~il~~l~~g~~pf~~~~~~~~~~~~i 265 (348)
T 2pml_X 236 WSLGICLYVMFYNVVPFSLKISLVELFNNI 265 (348)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 999999999999999995433334444433
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=290.61 Aligned_cols=237 Identities=18% Similarity=0.331 Sum_probs=177.5
Q ss_pred CCCCceEEE-eecccCCceEEEEEE--ccCCceEEEEEecccc-----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVR-KVGRGKYSEVFEGIN--VTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
+.++|++.+ .||+|+||.||+|.+ ..+++.||+|+++... .+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA--- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECC---
Confidence 568899999 999999999999954 5667899999987432 45788999999999 99999999999832
Q ss_pred CCceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
...+++||+++++++..++. .++...+..++.++ +.||+|||++||+|||
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi---------------------------~~~l~~LH~~~i~H~d 142 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV---------------------------SMGMKYLEESNFVHRD 142 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECSC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCeEcCC
Confidence 46799999999988877652 25555555444444 5599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
|||+||+++.++ .++|+|||++......... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|
T Consensus 143 ikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p 220 (291)
T 1xbb_A 143 LAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKP 220 (291)
T ss_dssp CSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCcceEEEeCCC-cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCC
Confidence 999999999666 8999999999876543322 22345678999999876 568899999999999999999 9999
Q ss_pred CCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
|. +.+..+....+...... ......++.+..++ ..||+.||++||+
T Consensus 221 ~~-~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li------------------------~~~l~~dp~~Rps 266 (291)
T 1xbb_A 221 YR-GMKGSEVTAMLEKGERM--------GCPAGCPREMYDLM------------------------NLCWTYDVENRPG 266 (291)
T ss_dssp ST-TCCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSTTTSCC
T ss_pred CC-CCCHHHHHHHHHcCCCC--------CCCCCCCHHHHHHH------------------------HHHcCCChhhCcC
Confidence 84 33333332222221100 11123444555554 5599999999996
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=288.91 Aligned_cols=237 Identities=18% Similarity=0.352 Sum_probs=180.0
Q ss_pred CCCCceEEE-eecccCCceEEEEEEc--cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVR-KVGRGKYSEVFEGINV--TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|.+.+ .||+|+||.||+|.+. .++..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---C
Confidence 467888887 9999999999999753 46788999999753 245688999999999 99999999999833 3
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||+++++++..++. .++...+..++.++ ++||.+||++||+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~i~H~d 135 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV---------------------------SMGMKYLEEKNFVHRD 135 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHH---------------------------HHHHHHHHHTTEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHH---------------------------HHHHHHHHHCCEeeCC
Confidence 5899999999998877652 35555555555554 4599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
|||+||+++.++ .++|+|||++......... ....+|..|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 136 lkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p 213 (287)
T 1u59_A 136 LAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKP 213 (287)
T ss_dssp CSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CchheEEEcCCC-CEEECcccceeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999666 8999999999876533321 22345788999999876 568999999999999999998 9999
Q ss_pred CCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
|. .....+....+...... ......++.+..++ ..||+.||++||+
T Consensus 214 ~~-~~~~~~~~~~i~~~~~~--------~~~~~~~~~l~~li------------------------~~~l~~~p~~Rps 259 (287)
T 1u59_A 214 YK-KMKGPEVMAFIEQGKRM--------ECPPECPPELYALM------------------------SDCWIYKWEDRPD 259 (287)
T ss_dssp TT-TCCTHHHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHTTCSSGGGSCC
T ss_pred cc-cCCHHHHHHHHhcCCcC--------CCCCCcCHHHHHHH------------------------HHHcCCChhhCcC
Confidence 84 44444443333321110 11124455555555 5599999999996
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=296.86 Aligned_cols=193 Identities=19% Similarity=0.343 Sum_probs=159.9
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|++.+.||+|+||.||+|.+ .+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 113 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMILI 113 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEEE
T ss_pred HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEEE
Confidence 47899999999999999999985 57899999998643 346789999999999 99999999999954 4678999
Q ss_pred EeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 108 FEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
|||++++++..++.. ++...... ++.|++.||.|||++||+|||||
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~---------------------------i~~~i~~~l~~lH~~~ivH~dlk 166 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLE---------------------------ICIGAARGLHYLHTRAIIHRDVK 166 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHH---------------------------HHHHHHHHHHHHHHTTEECSCCC
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHH---------------------------HHHHHHHHHHHhcCCCeecCCCC
Confidence 999999998877632 33444444 44455569999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+||+++.++ .+||+|||+++...... ......||..|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 167 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 167 SINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp STTEEECTTC-CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred HHHEEECCCC-CEEEeecccccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 9999999666 79999999998654222 2234468999999999876 5789999999999999999999999953
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=293.13 Aligned_cols=209 Identities=23% Similarity=0.500 Sum_probs=164.2
Q ss_pred CCCCceEEEeecccCCceEEEEEE-ccCCceEEEEEecccc--hHHHHHHHHHHHhccCCC------CeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGIN-VTNNEKCIIKILKPVK--KKKIKREIKILQNLCGGP------NIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~------niv~~~~~~~~~~ 100 (332)
..++|++.+.||+|+||.||+|.+ ..+++.||+|+++... ...+.+|+.+++.+ .|+ +++++++++.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~-- 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEH-- 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEE--
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeeccccc--
Confidence 357899999999999999999988 5678999999997532 46688999999988 544 59999999854
Q ss_pred CCCceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
....+++||++ ++++..++. .++...+..++. |++.||+|||++||+
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~---------------------------qi~~~l~~lH~~~iv 140 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY---------------------------QICKSVNFLHSNKLT 140 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHH---------------------------HHHHHHHHHHHTTEE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHH---------------------------HHHHHHHHHHHCCCc
Confidence 45789999999 555544431 234444444444 455599999999999
Q ss_pred ecCCCCCCeeecCC------------------CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccH
Q 040656 176 HRDVKPHNVMIDHE------------------QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 237 (332)
Q Consensus 176 Hrdlkp~Nilv~~~------------------~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDi 237 (332)
||||||+|||++.+ ++.++|+|||+++... .......+|..|+|||++.+ ..++.++||
T Consensus 141 H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di 217 (339)
T 1z57_A 141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILA-LGWSQPCDV 217 (339)
T ss_dssp CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTT-SCCCTHHHH
T ss_pred CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhC-CCCCcchhh
Confidence 99999999999863 3369999999998643 23345678999999999877 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 040656 238 WSLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273 (332)
Q Consensus 238 wSlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 273 (332)
|||||++|+|++|..|| ...+..+....+....+.
T Consensus 218 ~slG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~ 252 (339)
T 1z57_A 218 WSIGCILIEYYLGFTVF-PTHDSKEHLAMMERILGP 252 (339)
T ss_dssp HHHHHHHHHHHHSSCSC-CCSCHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCC
Confidence 99999999999999999 455555566666655543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=295.72 Aligned_cols=210 Identities=26% Similarity=0.519 Sum_probs=164.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC-ceEEEEEeccc--chHHHHHHHHHHHhccCCCC------eeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN-EKCIIKILKPV--KKKKIKREIKILQNLCGGPN------IVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~n------iv~~~~~~~~~~ 100 (332)
-.++|++.+.||+|+||.||+|.+..++ +.||+|+++.. ....+.+|+.+++++ .|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~-- 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNF-- 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEE--
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeee--
Confidence 3589999999999999999999987776 78999999753 345688899999998 5544 8888888854
Q ss_pred CCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 SKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....+++||++.++.+..+.. .++...+..++.++ +.||.|||++||+|
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi---------------------------~~~L~~lH~~~ivH 146 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQL---------------------------CHALRFLHENQLTH 146 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHH---------------------------HHHHHHHHTTTEEC
T ss_pred CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCCccc
Confidence 357899999996665544431 34555555555544 45999999999999
Q ss_pred cCCCCCCeeecC------------------CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHH
Q 040656 177 RDVKPHNVMIDH------------------EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMW 238 (332)
Q Consensus 177 rdlkp~Nilv~~------------------~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiw 238 (332)
|||||+|||++. ..+.++|+|||+++... .......+|..|+|||++.+ ..++.++|||
T Consensus 147 ~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~ 223 (355)
T 2eu9_A 147 TDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILE-LGWAQPCDVW 223 (355)
T ss_dssp CCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTT-CCCCTHHHHH
T ss_pred CCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeec-CCCCCccchH
Confidence 999999999932 23479999999998643 23345678999999999977 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC
Q 040656 239 SLGCMFAGMIFRKEPFFYGHDNQDQLVKIARVLGT 273 (332)
Q Consensus 239 SlG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 273 (332)
||||++|+|++|..||. ..+..+.+..+....+.
T Consensus 224 slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~ 257 (355)
T 2eu9_A 224 SIGCILFEYYRGFTLFQ-THENREHLVMMEKILGP 257 (355)
T ss_dssp HHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCC
Confidence 99999999999999994 45555566666665554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.02 Aligned_cols=238 Identities=19% Similarity=0.299 Sum_probs=178.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCc---eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
-.|.+.+.||+|+||.||+|.+..+++ .||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+.+ ...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPE-GLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS-SCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCC-CCc
Confidence 357788999999999999998765554 7999998643 235688999999999 9999999999996543 345
Q ss_pred eeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++++|++.++++..++. .++...+..++. |++.||+|||++||+|||||
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~---------------------------qi~~~l~~LH~~~i~H~dik 151 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL---------------------------QVARGMEYLAEQKFVHRDLA 151 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCcccCCCC
Confidence 89999999998877653 244444444444 44559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCC-----CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|+||+++.++ .++|+|||+++..... .......+|..|+|||.+.+ ..++.++||||||+++|+|++|..|++
T Consensus 152 p~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 152 ARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp GGGEEECTTC-CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred cceEEEcCCC-cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 9999999666 7999999999754322 12233467888999999877 678999999999999999999777776
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
...+..+....+......+. ....++.+..+ +..||+.||++||+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~l------------------------i~~~l~~~p~~Rps 274 (298)
T 3pls_A 230 RHIDPFDLTHFLAQGRRLPQ--------PEYCPDSLYQV------------------------MQQCWEADPAVRPT 274 (298)
T ss_dssp TTSCGGGHHHHHHTTCCCCC--------CTTCCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred ccCCHHHHHHHhhcCCCCCC--------CccchHHHHHH------------------------HHHHccCChhhCcC
Confidence 66655554444433221111 12233444444 45599999999996
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.31 Aligned_cols=240 Identities=19% Similarity=0.282 Sum_probs=176.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC---ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
...+|++.+.||+|+||.||+|.+..++ ..||+|.++.. ....+.+|+.+++++ +||||+++++++... ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CC
Confidence 3466999999999999999999864433 35899998642 235688999999999 899999999986543 35
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++|||++++++..++. .++...+..++.+ ++.||.|||++||+|||
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q---------------------------l~~~l~~lH~~~i~H~d 153 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ---------------------------VAKGMKYLASKKFVHRD 153 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHH---------------------------HHHHHHHHHHTTCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHH---------------------------HHHHHHHHHhCCccCCC
Confidence 7899999999999877653 2444444444444 45599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCC-----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|||+||+++.++ .++|+|||+++...... ......+|..|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 154 ikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 154 LAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp CSGGGEEECTTC-CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CchheEEECCCC-CEEECcccccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999666 79999999997654322 1233456778999999876 6789999999999999999996666
Q ss_pred CCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
++.+....+....+........ ....++.+..+ +..||+.||++||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~l------------------------i~~~l~~~p~~Rps 278 (298)
T 3f66_A 232 PYPDVNTFDITVYLLQGRRLLQ--------PEYCPDPLYEV------------------------MLKCWHPKAEMRPS 278 (298)
T ss_dssp SSTTSCTTTHHHHHHTTCCCCC--------CTTCCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred CCccCCHHHHHHHHhcCCCCCC--------CccCCHHHHHH------------------------HHHHcCCChhhCcC
Confidence 5555555554444433211100 11233344444 45699999999996
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=308.74 Aligned_cols=243 Identities=19% Similarity=0.327 Sum_probs=179.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+..|+++++.+.+++++..+..++. .....+++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~--~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV--EGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE--ETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe--eCCEEEEEEE
Confidence 47899999999999999999999999999999998643 34568999999999955566666655553 3456799999
Q ss_pred eecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
|+ +++|..++. .++...+..++.+++ .||.|||++||+||||||+|||
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~---------------------------~aL~yLH~~gIvHrDIKP~NIL 135 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMI---------------------------NRVEFVHSKSFLHRDIKPDNFL 135 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCCCGGGEE
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCEeecccCcceEE
Confidence 99 777766652 355555555555554 5999999999999999999999
Q ss_pred ec--CCCCeEEEEecccceeecCCCc--------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 186 ID--HEQQKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 186 v~--~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
++ .+++.+||+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~ 214 (483)
T 3sv0_A 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (483)
T ss_dssp ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 93 2334799999999987654332 125578999999999887 678999999999999999999999995
Q ss_pred CCCCC--HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDN--QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..... ...+..+......... ..+....++++..++ ..||+.||++||+
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~----~~l~~~~p~~l~~li------------------------~~cl~~dP~~RPs 265 (483)
T 3sv0_A 215 GLKAGTKKQKYEKISEKKVATSI----EALCRGYPTEFASYF------------------------HYCRSLRFDDKPD 265 (483)
T ss_dssp SCCCSSHHHHHHHHHHHHHHSCH----HHHHTTSCHHHHHHH------------------------HHHHTCCTTCCCC
T ss_pred cccchhHHHHHHHHhhccccccH----HHHhcCCcHHHHHHH------------------------HHHhcCChhhCcC
Confidence 32221 2233333322111111 122234455555555 4599999999995
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=294.39 Aligned_cols=196 Identities=18% Similarity=0.312 Sum_probs=152.4
Q ss_pred CCCCCceEEEeecccCCceEEEEE-----EccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGI-----NVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
...++|++.+.||+|+||.||+|. ...+++.||+|++... ....+.+|+.+++++ +||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~- 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ- 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC-
Confidence 356899999999999999999998 4567889999998632 235688999999999 99999999999954
Q ss_pred CCCCceeEEeeecCCCceeeccc----------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHH
Q 040656 100 HSKTPSLIFEHVNSTDFKVLYPT----------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYC 169 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 169 (332)
....+++|||+++++|..++.. ++...+. .++.|++.||.||
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~---------------------------~i~~qi~~al~~L 156 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL---------------------------HVARDIACGCQYL 156 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHH---------------------------HHHHHHHHHHHHH
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHH---------------------------HHHHHHHHHHHHH
Confidence 4568999999999888776522 2333333 3455566699999
Q ss_pred HHcCCeecCCCCCCeeecCC--CCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHH
Q 040656 170 HSQGIMHRDVKPHNVMIDHE--QQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244 (332)
Q Consensus 170 H~~~ivHrdlkp~Nilv~~~--~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il 244 (332)
|++||+||||||+||+++.+ +..++|+|||++....... ......+|..|+|||++.+ ..++.++||||||+++
T Consensus 157 H~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLL 235 (327)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHH
T ss_pred hhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHH
Confidence 99999999999999999843 2369999999987543222 1233467888999999876 6789999999999999
Q ss_pred HHHHh-CCCCCC
Q 040656 245 AGMIF-RKEPFF 255 (332)
Q Consensus 245 ~ellt-g~~pf~ 255 (332)
|+|++ |..||.
T Consensus 236 ~ellt~g~~p~~ 247 (327)
T 2yfx_A 236 WEIFSLGYMPYP 247 (327)
T ss_dssp HHHHTTSCCSST
T ss_pred HHHHcCCCCCCC
Confidence 99998 888883
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=287.72 Aligned_cols=191 Identities=18% Similarity=0.373 Sum_probs=149.9
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.++|++.+.||+|+||.||+|.+ +++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+. ....++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEE
Confidence 468899999999999999999976 5889999999754 446789999999999 999999999987543 34689999
Q ss_pred eeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|+++++++..++.. ++...+. .++.|++.||+|||++|++||||||+|
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLL---------------------------KFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHH---------------------------HHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHH---------------------------HHHHHHHHHHHHHHhCCccccCCCcce
Confidence 99999888776532 3333333 345555669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+++.++ .++|+|||++...... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 148 il~~~~~-~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 148 VLVSEDN-VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp EEECTTS-CEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred EEEeCCC-cEEEeecccccccccc--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 9999666 7999999998765422 223456788999999876 678999999999999999998 999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=295.08 Aligned_cols=191 Identities=24% Similarity=0.349 Sum_probs=151.7
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhc-cCCCCeeeeeeeeeccCC--CCce
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQHS--KTPS 105 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~~~~~~~~~~~--~~~~ 105 (332)
.-.++|++.+.||+|+||.||+|.+ +++.||+|++..........|.+++..+ .+||||+++++++.+... ...+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 3457899999999999999999976 4899999999876667777777776654 289999999999865432 5689
Q ss_pred eEEeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc--------CCe
Q 040656 106 LIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ--------GIM 175 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--------~iv 175 (332)
++|||+++++|..++. .++...+..++. |++.||.|||++ ||+
T Consensus 112 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~---------------------------~i~~~l~~lH~~~~~~~~~~~iv 164 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKSTTLDAKSMLKLAY---------------------------SSVSGLCHLHTEIFSTQGKPAIA 164 (337)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHH---------------------------HHHHHHHHHHSCBCSTTCBCCEE
T ss_pred EEEeccCCCcHHHHhhccCCCHHHHHHHHH---------------------------HHHHHHHHHHHhhhhhccCCCEE
Confidence 9999999999877753 345554444444 445599999998 999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcc-----cccccccceeccccccCCCCCCCc------ccHHHHHHHH
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDMWSLGCMF 244 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~------sDiwSlG~il 244 (332)
||||||+|||++.++ .+||+|||++......... ....||..|+|||++.+ ...+.. +|||||||++
T Consensus 165 H~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il 242 (337)
T 3mdy_A 165 HRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLIL 242 (337)
T ss_dssp CSCCCGGGEEECTTS-CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHH
T ss_pred ecccchHHEEECCCC-CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHH
Confidence 999999999999666 7999999999766433221 24578999999999876 344444 9999999999
Q ss_pred HHHHhC
Q 040656 245 AGMIFR 250 (332)
Q Consensus 245 ~elltg 250 (332)
|||+||
T Consensus 243 ~el~tg 248 (337)
T 3mdy_A 243 WEVARR 248 (337)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999999
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=300.01 Aligned_cols=203 Identities=17% Similarity=0.245 Sum_probs=158.7
Q ss_pred CCCCCceEEEeecccCCceEEEEEEcc--------CCceEEEEEecccchHHHHHHHHHHHhccCCCCeee---------
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVT--------NNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK--------- 91 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~--------- 91 (332)
...++|++.+.||+|+||.||+|.+.. .++.||+|+++.. ..+.+|+.+++++ .||||++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTP 115 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCT
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCC
Confidence 346899999999999999999999877 4889999998643 5788999999999 8999988
Q ss_pred ------eeeeeeccCCCCceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHH
Q 040656 92 ------LLDIVRDQHSKTPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISV 160 (332)
Q Consensus 92 ------~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (332)
+++++.. .....++||||+ +++|..++. .++...+..++.++
T Consensus 116 ~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi------------------------- 168 (352)
T 2jii_A 116 LLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL------------------------- 168 (352)
T ss_dssp TCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHH-------------------------
T ss_pred ccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHH-------------------------
Confidence 4445433 245789999999 888877653 34555555555544
Q ss_pred hHHHHHHHHHHcCCeecCCCCCCeeecCCC-CeEEEEecccceeecCCC--------cccccccccceeccccccCCCCC
Q 040656 161 WDLQALDYCHSQGIMHRDVKPHNVMIDHEQ-QKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDY 231 (332)
Q Consensus 161 ~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~-~~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~ 231 (332)
+.||.|||++||+||||||+||+++.++ ..++|+|||+++...... ......+|..|+|||++.+ ..+
T Consensus 169 --~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 245 (352)
T 2jii_A 169 --LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGP 245 (352)
T ss_dssp --HHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCC
T ss_pred --HHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCC
Confidence 5599999999999999999999999554 179999999997654221 1233478999999999877 678
Q ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 040656 232 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264 (332)
Q Consensus 232 ~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~ 264 (332)
+.++|||||||++|+|++|..||.........+
T Consensus 246 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 278 (352)
T 2jii_A 246 SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278 (352)
T ss_dssp CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence 999999999999999999999996444343333
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=291.17 Aligned_cols=193 Identities=27% Similarity=0.461 Sum_probs=152.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeecc---------
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--------- 99 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--------- 99 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999999899999999998643 235688999999999 999999999987543
Q ss_pred --CCCCceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 100 --HSKTPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 100 --~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
.....+++|||++++++..++.. ++...+.. ++.|++.||+|||++|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~~l~~LH~~~ 136 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR---------------------------LFRQILEALSYIHSQG 136 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHH---------------------------HHHHHHHHHHHHHHTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHH---------------------------HHHHHHHHHHHHHhCC
Confidence 23567899999999988776532 23333333 4455566999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCC---------------CcccccccccceeccccccCCCCCCCcccHH
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMW 238 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiw 238 (332)
|+||||||+||+++.++ .++|+|||++...... .......+|..|+|||++.+...++.++|||
T Consensus 137 i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 215 (303)
T 1zy4_A 137 IIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215 (303)
T ss_dssp CCCSCCCGGGEEECTTS-CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHH
T ss_pred eecccCCHHhEEEcCCC-CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHH
Confidence 99999999999999666 7999999998765321 1223456888999999987655789999999
Q ss_pred HHHHHHHHHHhCCCCCC
Q 040656 239 SLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 239 SlG~il~elltg~~pf~ 255 (332)
|||+++|+|++ ||.
T Consensus 216 slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 216 SLGIIFFEMIY---PFS 229 (303)
T ss_dssp HHHHHHHHHHS---CCS
T ss_pred HHHHHHHHHHh---ccC
Confidence 99999999998 663
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=294.63 Aligned_cols=197 Identities=23% Similarity=0.384 Sum_probs=157.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeecc--CCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~~ 104 (332)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++ +||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCcee
Confidence 468899999999999999999999999999999998543 345688999999999 999999999998642 33468
Q ss_pred eeEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 105 SLIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
++++||+.+++|..++.. ++...+..++. |++.||.|||++||+||
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~---------------------------qi~~~L~~LH~~~ivH~ 158 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL---------------------------GICRGLEAIHAKGYAHR 158 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHH---------------------------HHHHHHHHHHHTTEECC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCcccC
Confidence 899999999988766532 44554444444 45559999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc----------ccccccccceeccccccCCC--CCCCcccHHHHHHHHH
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFA 245 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~sDiwSlG~il~ 245 (332)
||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+.. .++.++||||||+++|
T Consensus 159 dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 159 DLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237 (317)
T ss_dssp CCCGGGEEECTTS-CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHH
Confidence 9999999998666 799999999876432111 12235688999999986522 2689999999999999
Q ss_pred HHHhCCCCCC
Q 040656 246 GMIFRKEPFF 255 (332)
Q Consensus 246 elltg~~pf~ 255 (332)
+|++|..||.
T Consensus 238 el~~g~~p~~ 247 (317)
T 2buj_A 238 AMMFGEGPYD 247 (317)
T ss_dssp HHHHSSCTTH
T ss_pred HHHhCCCChh
Confidence 9999999993
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=314.45 Aligned_cols=237 Identities=18% Similarity=0.339 Sum_probs=177.9
Q ss_pred CCCCceEEE-eecccCCceEEEEEEc--cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVR-KVGRGKYSEVFEGINV--TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..+++.+.+ .||+|+||.||+|.+. .++..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence 456677777 8999999999999765 35567999999742 356799999999999 99999999999954 3
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.+++||||+.+++|..++. .++...+..++. |++.||+|||++||+|||
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~---------------------------qi~~~L~~LH~~~iiHrD 461 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---------------------------QVSMGMKYLEEKNFVHRN 461 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCSC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCEEcCc
Confidence 5899999999999887652 245555544444 445599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
|||+|||++.++ .+||+|||+++........ ....+|..|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 462 lkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~P 539 (613)
T 2ozo_A 462 LAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKP 539 (613)
T ss_dssp CSGGGEEEEETT-EEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCHHHEEEcCCC-cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999666 8999999999765432221 12234578999999876 679999999999999999998 9999
Q ss_pred CCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
| .+.+..+....+....... .....++.+..++ ..||+.||++||+
T Consensus 540 f-~~~~~~~~~~~i~~~~~~~--------~p~~~~~~l~~li------------------------~~cl~~dP~~RPs 585 (613)
T 2ozo_A 540 Y-KKMKGPEVMAFIEQGKRME--------CPPECPPELYALM------------------------SDCWIYKWEDRPD 585 (613)
T ss_dssp T-TTCCSHHHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHTTCSSTTTSCC
T ss_pred C-CCCCHHHHHHHHHcCCCCC--------CCCcCCHHHHHHH------------------------HHHcCCChhHCcC
Confidence 8 4555555554444322111 1123455555555 5599999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=313.19 Aligned_cols=236 Identities=19% Similarity=0.340 Sum_probs=180.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
..++|++.+.||+|+||.||+|.+. .+..||||+++.. ..+.+.+|+.+++++ +|+||+++++++.+ ...++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEe
Confidence 5688999999999999999999874 4567999999743 356799999999999 99999999999854 468999
Q ss_pred EeeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+.+++|..++.. ++...+. .++.|++.||+|||+++|+||||||+
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~---------------------------~i~~qi~~~L~~LH~~~ivHrDlkp~ 392 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLV---------------------------DMAAQIASGMAYVERMNYVHRDLRAA 392 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHH---------------------------HHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHH---------------------------HHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 999999988777632 3333333 35555666999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD 259 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~ 259 (332)
|||++.++ .+||+|||+++...... ......++..|+|||++.. ..++.++|||||||++|||++ |..|| .+..
T Consensus 393 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~ 469 (535)
T 2h8h_A 393 NILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMV 469 (535)
T ss_dssp GEEECGGG-CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCC
T ss_pred hEEEcCCC-cEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCC
Confidence 99998666 79999999997654221 1122345678999999876 578999999999999999999 88888 4444
Q ss_pred CHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 260 NQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
..+....+......+ .....++.+.++ +..||+.||++||+
T Consensus 470 ~~~~~~~i~~~~~~~--------~~~~~~~~l~~l------------------------i~~cl~~dP~~RPt 510 (535)
T 2h8h_A 470 NREVLDQVERGYRMP--------CPPECPESLHDL------------------------MCQCWRKEPEERPT 510 (535)
T ss_dssp HHHHHHHHHTTCCCC--------CCTTCCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred HHHHHHHHHcCCCCC--------CCCCCCHHHHHH------------------------HHHHcCCChhHCcC
Confidence 444444443321111 112334444444 45599999999996
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=298.95 Aligned_cols=193 Identities=20% Similarity=0.320 Sum_probs=159.0
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
..++|++.+.||+|+||.||+|.. .+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 103 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--PTERL 103 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--SSCCE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--CCceE
Confidence 468899999999999999999974 578999999987432 23689999999999 89999999999954 45689
Q ss_pred eEEeeecCCCceeeccc-------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc---CCe
Q 040656 106 LIFEHVNSTDFKVLYPT-------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ---GIM 175 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~iv 175 (332)
++|||+.++++..++.. ++...... ++.|++.||+|||++ ||+
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~---------------------------i~~~i~~~l~~lH~~~~~~iv 156 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQR---------------------------IALGSARGLAYLHDHCDPKII 156 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHSSSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCCCCeE
Confidence 99999999998776532 34444444 444555699999999 999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
||||||+|||++.++ .++|+|||++........ .....||..|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 157 H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p 234 (326)
T 3uim_A 157 HRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRA 234 (326)
T ss_dssp CCCCSGGGEEECTTC-CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCS
T ss_pred eCCCchhhEEECCCC-CEEeccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCc
Confidence 999999999999666 799999999987653322 234468999999999876 5689999999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 235 f~ 236 (326)
T 3uim_A 235 FD 236 (326)
T ss_dssp BC
T ss_pred cc
Confidence 93
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=291.80 Aligned_cols=196 Identities=23% Similarity=0.414 Sum_probs=143.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeec------cCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRD------QHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~~~ 101 (332)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.++.++.+||||+++++++.. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 568999999999999999999999999999999985432 35688999999999569999999998842 233
Q ss_pred CCceeEEeeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC--
Q 040656 102 KTPSLIFEHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG-- 173 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-- 173 (332)
...++++|++.+ ++..++ ..++...+..++. |++.||.|||++|
T Consensus 107 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~---------------------------qi~~~l~~LH~~~~~ 158 (337)
T 3ll6_A 107 AEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFY---------------------------QTCRAVQHMHRQKPP 158 (337)
T ss_dssp EEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHH---------------------------HHHHHHHHHHTSSSC
T ss_pred ceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHH---------------------------HHHHHHHHHHhCCCC
Confidence 457899999975 443332 1245555544444 4455999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCCcc-------------cccccccceecccccc--CCCCCCCcccHH
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDMW 238 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~sDiw 238 (332)
|+||||||+|||++.++ .++|+|||+++........ ....+|..|+|||++. ....++.++|||
T Consensus 159 ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~ 237 (337)
T 3ll6_A 159 IIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237 (337)
T ss_dssp CBCCCCCGGGCEECTTS-CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHH
T ss_pred EEEccCCcccEEECCCC-CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHH
Confidence 99999999999999666 7999999999866432221 1346889999999983 225678899999
Q ss_pred HHHHHHHHHHhCCCCCC
Q 040656 239 SLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 239 SlG~il~elltg~~pf~ 255 (332)
|||+++|+|++|..||.
T Consensus 238 slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 238 ALGCILYLLCFRQHPFE 254 (337)
T ss_dssp HHHHHHHHHHHSSCCC-
T ss_pred HHHHHHHHHHhCCCCCc
Confidence 99999999999999994
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=298.45 Aligned_cols=204 Identities=20% Similarity=0.351 Sum_probs=149.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCC---ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..|++.+.||+|+||.||+|....++ ..||+|.++.. ....+.+|+.+++++ +||||+++++++... ....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCCe
Confidence 45889999999999999999875443 46899998632 346788999999999 999999999987543 3467
Q ss_pred eeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++||||+++++|..++.. ++...+.. ++.|+++||+|||++||+|||||
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~aL~~LH~~~ivHrDlk 219 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIG---------------------------FGLQVAKGMKFLASKKFVHRDLA 219 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCSCCC
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHH---------------------------HHHHHHHHHHHHHHCCEecCccc
Confidence 899999999998777532 33343433 44455569999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhC-CCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPF 254 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg-~~pf 254 (332)
|+|||++.++ .+||+|||+++....... .....+|..|+|||++.+ ..++.++|||||||++|+|+|| ..||
T Consensus 220 p~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~ 297 (373)
T 3c1x_A 220 ARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPY 297 (373)
T ss_dssp GGGEEECTTC-CEEECCC---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred hheEEECCCC-CEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCC
Confidence 9999999666 799999999976542221 223456778999999876 6789999999999999999994 5555
Q ss_pred CCCCCCHHHHHHH
Q 040656 255 FYGHDNQDQLVKI 267 (332)
Q Consensus 255 ~~~~~~~~~~~~~ 267 (332)
...+..+....+
T Consensus 298 -~~~~~~~~~~~~ 309 (373)
T 3c1x_A 298 -PDVNTFDITVYL 309 (373)
T ss_dssp -TTSCSSCHHHHH
T ss_pred -CCCCHHHHHHHH
Confidence 454444443333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.75 Aligned_cols=196 Identities=21% Similarity=0.338 Sum_probs=159.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhc-cCCCCeeeeeeeeeccCC--CCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQHS--KTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~~~~~~~~~~~--~~~~lv 107 (332)
.++|++.+.||+|+||.||+|.+ +++.||+|+++......+.+|.+++..+ .+||||+++++++..... ...+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 47899999999999999999986 6899999999877778889999999883 289999999999865432 268999
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH--------HcCCeec
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH--------SQGIMHR 177 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--------~~~ivHr 177 (332)
|||+++++|..++. .++...... ++.|++.||.||| +.+|+||
T Consensus 119 ~e~~~~g~L~~~l~~~~~~~~~~~~---------------------------i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRYTVTVEGMIK---------------------------LALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHH---------------------------HHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred EeecCCCcHHHHHhccCccHHHHHH---------------------------HHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 99999998877653 344444444 4445556999999 8999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCC-----CCCcccHHHHHHHHHHH
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~sDiwSlG~il~el 247 (332)
||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+... ++.++||||||+++|+|
T Consensus 172 Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 172 DLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp CCSGGGEEECTTS-CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCC-CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence 9999999999666 799999999987754432 234578999999999876322 23689999999999999
Q ss_pred HhC----------CCCCCC
Q 040656 248 IFR----------KEPFFY 256 (332)
Q Consensus 248 ltg----------~~pf~~ 256 (332)
+|| ..||..
T Consensus 251 ~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 251 ARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp HTTBCBTTBCCCCCCTTTT
T ss_pred HhccCcCCcccccccCccc
Confidence 999 778753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=291.49 Aligned_cols=194 Identities=23% Similarity=0.402 Sum_probs=158.5
Q ss_pred CCceEEEeecccCCceEEEEE----EccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..|++++.||+|+||.||++. +..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+.....
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCce
Confidence 335999999999999998764 34578999999997532 35689999999999 8999999999998766677
Q ss_pred ceeEEeeecCCCceeeccc--cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 104 PSLIFEHVNSTDFKVLYPT--LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++++|||++++++..++.. ++...+..++.+++ .||++||+.||+||||||
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~---------------------------~~l~~LH~~~ivH~Dikp 162 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC---------------------------EGMAYLHAQHYIHRDLAA 162 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSCCSG
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCccCCCCch
Confidence 8999999999998887633 55555555555554 599999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 163 ~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 163 RNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp GGEEECTTC-CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred heEEEcCCC-CEEECCccccccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 999999666 799999999987754432 223457788999999876 568899999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=303.89 Aligned_cols=202 Identities=17% Similarity=0.166 Sum_probs=144.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhcc-CCCCeeeee-------eee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLC-GGPNIVKLL-------DIV 96 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~-~h~niv~~~-------~~~ 96 (332)
...|.+.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+. +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999999999999999997532 345778877777774 499988755 333
Q ss_pred eccCC---------------CCceeEEeeecCCCceeeccc---cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhh
Q 040656 97 RDQHS---------------KTPSLIFEHVNSTDFKVLYPT---LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDI 158 (332)
Q Consensus 97 ~~~~~---------------~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (332)
..+.. ..+++||||++ ++|..++.. ......+.. .. -+..+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~--~~------------------vk~~i 199 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEG--IL------------------ALHIL 199 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHH--HH------------------HHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhh--hh------------------hHHHH
Confidence 22211 23799999999 676665422 111111100 00 00234
Q ss_pred HHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC-CCCCCcccH
Q 040656 159 SVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDM 237 (332)
Q Consensus 159 ~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~sDi 237 (332)
+.|++.||+|||++||+||||||+|||++.++ .+||+|||+++... .......+|..|+|||++.+. ..++.++||
T Consensus 200 ~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Di 276 (371)
T 3q60_A 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNA 276 (371)
T ss_dssp HHHHHHHHHHHHHTTEEETTCSGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred HHHHHHHHHHHHHCCCccCcCCHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccH
Confidence 46667799999999999999999999999766 79999999998653 222245667899999998642 368999999
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 040656 238 WSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 238 wSlG~il~elltg~~pf~~ 256 (332)
|||||++|+|++|..||..
T Consensus 277 wSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 277 WQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp HHHHHHHHHHHHSSCSTTB
T ss_pred HHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999953
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=285.95 Aligned_cols=195 Identities=24% Similarity=0.410 Sum_probs=155.5
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
++|.....||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....++++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSE--NGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEe--CCcEEEEE
Confidence 3455556899999999999999999999999998643 246788999999999 99999999999954 35789999
Q ss_pred eeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 109 EHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 109 e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|+++++++..++.. +++..+.. ++.|++.||.|||++||+||||||+
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------------------------~~~qi~~~l~~lH~~~i~H~dl~p~ 151 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGF---------------------------YTKQILEGLKYLHDNQIVHRDIKGD 151 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHH---------------------------HHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHH---------------------------HHHHHHHHHHHHHhCCEEccCCChh
Confidence 99999887776532 22333333 3445556999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||+++..++.++|+|||++....... ......+|..|+|||++.+. ..++.++||||||+++|+|++|..||..
T Consensus 152 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp GEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred hEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 99998745589999999998765322 23445789999999998653 2378999999999999999999999953
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=290.75 Aligned_cols=196 Identities=20% Similarity=0.375 Sum_probs=158.9
Q ss_pred CCCCceEEEeecccCCceEEEEE----EccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGI----NVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++++.||+|+||.||+|. +..+++.||+|++.... ...+.+|+.+++++ +||||+++++++......
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCC
Confidence 35779999999999999999998 45689999999987432 35688999999999 999999999998766556
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++|||++++++|..++. .++...+..++ .|++.||.+||++||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~---------------------------~qi~~aL~~LH~~~ivH~d 170 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT---------------------------SQICKGMEYLGTKRYIHRD 170 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHH---------------------------HHHHHHHHHHHHTTEECSC
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHH---------------------------HHHHHHHHHHHhCCEeccC
Confidence 7899999999998877652 24444444444 4555599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
|||+||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|+||..||
T Consensus 171 ikp~NIli~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~ 248 (326)
T 2w1i_A 171 LATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKS 248 (326)
T ss_dssp CCGGGEEEEETT-EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred CCcceEEEcCCC-cEEEecCcchhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 999999999666 899999999987654332 122356777999999876 56889999999999999999999998
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 249 ~ 249 (326)
T 2w1i_A 249 K 249 (326)
T ss_dssp G
T ss_pred C
Confidence 3
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=295.42 Aligned_cols=213 Identities=27% Similarity=0.502 Sum_probs=164.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccC----------CCCeeeeeeeee
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCG----------GPNIVKLLDIVR 97 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~----------h~niv~~~~~~~ 97 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++.+ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357899999999999999999999999999999999743 34568899999998832 899999999986
Q ss_pred cc--CCCCceeEEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHH
Q 040656 98 DQ--HSKTPSLIFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCH 170 (332)
Q Consensus 98 ~~--~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 170 (332)
.. +....++++|++ ++++..++. .++...+..+ +.|++.||+|||
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i---------------------------~~qi~~aL~~lH 148 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI---------------------------SKQLLLGLDYMH 148 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHH---------------------------HHHHHHHHHHHH
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHH---------------------------HHHHHHHHHHHH
Confidence 53 233688999999 666655442 2444444444 445555999999
Q ss_pred Hc-CCeecCCCCCCeeecCC-----CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHH
Q 040656 171 SQ-GIMHRDVKPHNVMIDHE-----QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244 (332)
Q Consensus 171 ~~-~ivHrdlkp~Nilv~~~-----~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il 244 (332)
++ ||+||||||+|||++.+ ...++|+|||++..... ......+|..|+|||++.+ ..++.++|||||||++
T Consensus 149 ~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il 225 (373)
T 1q8y_A 149 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLI 225 (373)
T ss_dssp HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHH
T ss_pred hcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHH
Confidence 98 99999999999999532 22799999999987542 3344578999999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCCC-----CCHHHHHHHHHHhCC
Q 040656 245 AGMIFRKEPFFYGH-----DNQDQLVKIARVLGT 273 (332)
Q Consensus 245 ~elltg~~pf~~~~-----~~~~~~~~~~~~~~~ 273 (332)
|+|++|..||.... ...+.+..+....+.
T Consensus 226 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (373)
T 1q8y_A 226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259 (373)
T ss_dssp HHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred HHHHhCCCCCCCCcccccCChHHHHHHHHHhcCC
Confidence 99999999995322 133455556555554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.59 Aligned_cols=200 Identities=26% Similarity=0.453 Sum_probs=160.2
Q ss_pred ccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---------hHHHHHHHHHHHhccC-CCCeeeeeee
Q 040656 26 VQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------KKKIKREIKILQNLCG-GPNIVKLLDI 95 (332)
Q Consensus 26 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~-h~niv~~~~~ 95 (332)
......++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++.+ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33345688999999999999999999999999999999986432 2457789999999953 6999999999
Q ss_pred eeccCCCCceeEEeeecC-CCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 96 VRDQHSKTPSLIFEHVNS-TDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 96 ~~~~~~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
+.+ ....++++|++.+ +++..++ ..++...+..++.+ ++.||+|||+
T Consensus 117 ~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~q---------------------------i~~~L~~LH~ 167 (320)
T 3a99_A 117 FER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ---------------------------VLEAVRHCHN 167 (320)
T ss_dssp EEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHH---------------------------HHHHHHHHHH
T ss_pred Eec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHH---------------------------HHHHHHHHHH
Confidence 954 4568999999975 6665543 23455555444444 4559999999
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCC
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 251 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~ 251 (332)
+||+||||||+|||++.+++.+||+|||++..... .......+|..|+|||++.+....+.++||||||+++|+|++|.
T Consensus 168 ~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred CCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 99999999999999985555899999999987653 33445678999999999876444578899999999999999999
Q ss_pred CCCC
Q 040656 252 EPFF 255 (332)
Q Consensus 252 ~pf~ 255 (332)
.||.
T Consensus 247 ~pf~ 250 (320)
T 3a99_A 247 IPFE 250 (320)
T ss_dssp CSCC
T ss_pred CCCC
Confidence 9993
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=287.87 Aligned_cols=240 Identities=20% Similarity=0.305 Sum_probs=158.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch----HH-HHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KK-IKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~-~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .+ +.++..+++.+ +||||+++++++.+ ....+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~--~~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT--NTDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC--SSEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEec--CCcEE
Confidence 5789999999999999999999988999999999964321 22 33344456666 99999999999954 35789
Q ss_pred eEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCeecCCC
Q 040656 106 LIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVK 180 (332)
Q Consensus 106 lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~ivHrdlk 180 (332)
++||++ ++.+..+. ..++...+..++ .++++||.|||++ ||+|||||
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~---------------------------~~i~~~l~~lH~~~~i~H~dlk 152 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMT---------------------------VAIVKALYYLKEKHGVIHRDVK 152 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHH---------------------------HHHHHHHHHHHHHHCCCCCCCC
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHH---------------------------HHHHHHHHHHHhhCCEEeCCCC
Confidence 999999 33333322 234444444444 4555599999995 99999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|+||+++.++ .++|+|||++.............+|..|+|||++.. ...++.++||||||+++|+|++|..||..
T Consensus 153 p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 153 PSNILLDERG-QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp GGGEEECTTS-CEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHEEECCCC-CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 9999999666 799999999977654444455678999999999852 25688999999999999999999999954
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.....+.+..+........ ......++.+..++ ..||+.||++||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li------------------------~~~l~~dp~~Rps 277 (318)
T 2dyl_A 232 CKTDFEVLTKVLQEEPPLL------PGHMGFSGDFQSFV------------------------KDCLTKDHRKRPK 277 (318)
T ss_dssp CCSHHHHHHHHHHSCCCCC------CSSSCCCHHHHHHH------------------------HHHTCSCTTTSCC
T ss_pred CCccHHHHHHHhccCCCCC------CccCCCCHHHHHHH------------------------HHHccCChhHCcC
Confidence 4444444444333111100 00012344444444 5599999999996
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=285.58 Aligned_cols=197 Identities=21% Similarity=0.307 Sum_probs=158.5
Q ss_pred cccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeee
Q 040656 25 TVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVR 97 (332)
Q Consensus 25 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 97 (332)
+..+.....|...+.||+|+||.||+|.. +++.||+|++... ....+.+|+.+++++ +||||+++++++.
T Consensus 24 ~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 100 (307)
T 2nru_A 24 TNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSS 100 (307)
T ss_dssp TTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred HcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEe
Confidence 33444556677789999999999999975 7889999998632 246788999999999 9999999999995
Q ss_pred ccCCCCceeEEeeecCCCceeeccc------cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH
Q 040656 98 DQHSKTPSLIFEHVNSTDFKVLYPT------LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS 171 (332)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 171 (332)
+ ....+++||+++++++..++.. ++...... ++.|++.||.|||+
T Consensus 101 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~---------------------------i~~~i~~~l~~lH~ 151 (307)
T 2nru_A 101 D--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK---------------------------IAQGAANGINFLHE 151 (307)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHH---------------------------HHHHHHHHHHHHHH
T ss_pred c--CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHH---------------------------HHHHHHHHHHHHhc
Confidence 4 4578999999999988766531 33333333 45555669999999
Q ss_pred cCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 172 QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 172 ~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
+||+||||||+||+++.++ .++|+|||++........ .....||..|+|||.+.+ .++.++||||||+++|+|+
T Consensus 152 ~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~ 228 (307)
T 2nru_A 152 NHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEII 228 (307)
T ss_dssp TTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCC-cEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHH
Confidence 9999999999999999666 799999999987643222 233478999999998865 4789999999999999999
Q ss_pred hCCCCCCC
Q 040656 249 FRKEPFFY 256 (332)
Q Consensus 249 tg~~pf~~ 256 (332)
+|..||..
T Consensus 229 ~g~~p~~~ 236 (307)
T 2nru_A 229 TGLPAVDE 236 (307)
T ss_dssp HCCCSBCT
T ss_pred HCCCCccc
Confidence 99999953
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=314.49 Aligned_cols=235 Identities=17% Similarity=0.308 Sum_probs=173.8
Q ss_pred CCceEE-EeecccCCceEEEEEE--ccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 32 EDYEVV-RKVGRGKYSEVFEGIN--VTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 32 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+.+.+. +.||+|+||.||+|.+ ..+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~ 443 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ES 443 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CC
Confidence 344443 4799999999999954 456689999999743 246799999999999 89999999999853 34
Q ss_pred ceeEEeeecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++||||+.+++|..++. .++...+..++.+ ++.||+|||++||+|||||
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~q---------------------------i~~~L~yLH~~~iiHrDLk 496 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ---------------------------VSMGMKYLEESNFVHRDLA 496 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHH---------------------------HHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHH---------------------------HHHHHHHHHHCCEeCCCCC
Confidence 789999999998877652 3455555444444 4559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+|||++.++ .+||+|||+++....... .....+|..|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 497 p~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf- 573 (635)
T 4fl3_A 497 ARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY- 573 (635)
T ss_dssp GGGEEEEETT-EEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-
T ss_pred hHhEEEeCCC-CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-
Confidence 9999999666 899999999976543321 223356778999999976 678999999999999999998 99998
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+....+...... ......++.+.+++ ..||+.||++||+
T Consensus 574 ~~~~~~~~~~~i~~~~~~--------~~p~~~~~~l~~li------------------------~~cl~~dP~~RPs 618 (635)
T 4fl3_A 574 RGMKGSEVTAMLEKGERM--------GCPAGCPREMYDLM------------------------NLCWTYDVENRPG 618 (635)
T ss_dssp TTCCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSTTTSCC
T ss_pred CCCCHHHHHHHHHcCCCC--------CCCCCCCHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 344444444443332111 11123444555544 5599999999996
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=291.79 Aligned_cols=195 Identities=28% Similarity=0.504 Sum_probs=139.9
Q ss_pred CCCCceEEE-eecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeecc--CCCCcee
Q 040656 30 DQEDYEVVR-KVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HSKTPSL 106 (332)
Q Consensus 30 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~~~l 106 (332)
-.++|.+.+ .||+|+||.||+|.+..+++.||+|++... ....+|+..+.+...|+||+++++++... ....+++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 457899965 599999999999999999999999998643 33345555544444999999999998652 2345799
Q ss_pred EEeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 107 IFEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 107 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
||||+.+++|..++. .+++..+..++.+++. ||.|||++||+||||||
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~---------------------------~l~~LH~~~ivH~dlkp 156 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT---------------------------AIQFLHSHNIAHRDVKP 156 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCSG
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeecCCCCH
Confidence 999999998877652 3566666555555554 99999999999999999
Q ss_pred CCeeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+||+++.+ .+.++|+|||++..... .......+|..|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred HHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999753 33599999999986542 33345678999999999866 678899999999999999999999994
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=291.82 Aligned_cols=194 Identities=21% Similarity=0.411 Sum_probs=134.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHH-HHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..++|++++.||+|+||.||+|.+..+++.||+|+++... ...+..|+. +++.+ +||||+++++++.+ ....
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~--~~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFR--EGDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEEC--SSEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEe--CCce
Confidence 5689999999999999999999998999999999996432 234556666 45555 99999999999954 3578
Q ss_pred eeEEeeecCCCceeec--------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc-CCe
Q 040656 105 SLIFEHVNSTDFKVLY--------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ-GIM 175 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~iv 175 (332)
+++||++.++ +..++ ..++...+.. ++.+++.||.|||+. ||+
T Consensus 97 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~---------------------------i~~~i~~~l~~lH~~~~iv 148 (327)
T 3aln_A 97 WICMELMSTS-FDKFYKYVYSVLDDVIPEEILGK---------------------------ITLATVKALNHLKENLKII 148 (327)
T ss_dssp EEEECCCSEE-HHHHHHHHHHTTCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHHHSCC
T ss_pred EEEEeecCCC-hHHHHHHHHhhhcccCcHHHHHH---------------------------HHHHHHHHHHHHhccCCEe
Confidence 9999999863 32221 2233443333 445555699999999 999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceecccccc---CCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
||||||+||+++.++ .+||+|||+++............+|..|+|||++. ....++.++||||||+++|+|++|..
T Consensus 149 H~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 149 HRDIKPSNILLDRSG-NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp CSCCCGGGEEEETTT-EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred ECCCCHHHEEEcCCC-CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999999666 89999999998765444444557899999999983 22568999999999999999999999
Q ss_pred CCC
Q 040656 253 PFF 255 (332)
Q Consensus 253 pf~ 255 (332)
||.
T Consensus 228 pf~ 230 (327)
T 3aln_A 228 PYP 230 (327)
T ss_dssp CSS
T ss_pred CCC
Confidence 994
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=283.22 Aligned_cols=195 Identities=19% Similarity=0.345 Sum_probs=148.8
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEcc-CCc--eEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVT-NNE--KCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
....++|++.+.||+|+||.||+|.+.. +++ .||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcc
Confidence 3456899999999999999999998643 333 6899998632 235788999999999 99999999999865
Q ss_pred cCCCCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
. ..++++|++.++++...+. .++...+..++.+ ++.||.+||++|+
T Consensus 93 ~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~---------------------------i~~~l~~lH~~~i 142 (291)
T 1u46_A 93 P---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ---------------------------VAEGMGYLESKRF 142 (291)
T ss_dssp S---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHH---------------------------HHHHHHHHHHTTE
T ss_pred C---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHH---------------------------HHHHHHHHHhCCc
Confidence 3 3789999999988877652 2455555444444 4559999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF- 249 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt- 249 (332)
+||||||+||+++.++ .++|+|||++........ .....+|..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 143 ~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~ 220 (291)
T 1u46_A 143 IHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTY 220 (291)
T ss_dssp ECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCchheEEEcCCC-CEEEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999666 899999999987654332 123356778999999876 568899999999999999999
Q ss_pred CCCCCC
Q 040656 250 RKEPFF 255 (332)
Q Consensus 250 g~~pf~ 255 (332)
|..||.
T Consensus 221 g~~p~~ 226 (291)
T 1u46_A 221 GQEPWI 226 (291)
T ss_dssp SCCTTT
T ss_pred CCCCcc
Confidence 999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=300.71 Aligned_cols=195 Identities=22% Similarity=0.332 Sum_probs=148.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
...+|.+.+.||+|+||+|+. ....+++.||||++.......+.+|+.+++.+.+||||+++++++.+ ....+++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEE
Confidence 346799999999999999764 33568999999999766556678999999998789999999999854 457899999
Q ss_pred eecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
++.+ ++..++.. ...... +.++.|++.||.|||++||+||||||+|||
T Consensus 99 ~~~g-~L~~~l~~~~~~~~~~~~---------------------------~~i~~qi~~aL~~LH~~~ivHrDlKp~NIl 150 (432)
T 3p23_A 99 LCAA-TLQEYVEQKDFAHLGLEP---------------------------ITLLQQTTSGLAHLHSLNIVHRDLKPHNIL 150 (432)
T ss_dssp CCSE-EHHHHHHSSSCCCCSSCH---------------------------HHHHHHHHHHHHHHHHTTCCCCCCSTTSEE
T ss_pred CCCC-CHHHHHHhcCCCccchhH---------------------------HHHHHHHHHHHHHHHHCcCEeCCCCHHHEE
Confidence 9975 44333211 122222 345556667999999999999999999999
Q ss_pred ecCCC----CeEEEEecccceeecCCC----cccccccccceeccccccC--CCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 186 IDHEQ----QKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 186 v~~~~----~~vkL~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
++.++ .+++|+|||+++...... ......||..|+|||++.+ ...++.++|||||||++|+|++ |..||
T Consensus 151 l~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf 230 (432)
T 3p23_A 151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230 (432)
T ss_dssp ECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred EecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 95322 258899999998765332 2344579999999999874 2457889999999999999999 88888
Q ss_pred C
Q 040656 255 F 255 (332)
Q Consensus 255 ~ 255 (332)
.
T Consensus 231 ~ 231 (432)
T 3p23_A 231 G 231 (432)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=287.73 Aligned_cols=196 Identities=26% Similarity=0.481 Sum_probs=153.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---------hHHHHHHHHHHHhcc---CCCCeeeeeeeee
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------KKKIKREIKILQNLC---GGPNIVKLLDIVR 97 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~---~h~niv~~~~~~~ 97 (332)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.++.++. +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3578999999999999999999998999999999986432 234567999998885 6999999999985
Q ss_pred ccCCCCceeEEee-ecCCCceeecc---ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 98 DQHSKTPSLIFEH-VNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 98 ~~~~~~~~lv~e~-~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
+ ....++++|+ +.++++..++. .++...+..++.++ +.||.|||++|
T Consensus 109 ~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi---------------------------~~~l~~lH~~~ 159 (312)
T 2iwi_A 109 T--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV---------------------------VAAIQHCHSRG 159 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHH---------------------------HHHHHHHHHHT
T ss_pred c--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHH---------------------------HHHHHHHHHCC
Confidence 4 3568999999 67777766542 35555555555554 45999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
|+||||||+||+++.+++.++|+|||++..... .......+|..|+|||++.+....+.++||||||+++|+|++|..|
T Consensus 160 i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 238 (312)
T 2iwi_A 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238 (312)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCSSCEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred eeecCCChhhEEEeCCCCeEEEEEcchhhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCC
Confidence 999999999999985455899999999987653 3345567899999999987644445689999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 239 f~ 240 (312)
T 2iwi_A 239 FE 240 (312)
T ss_dssp CC
T ss_pred CC
Confidence 94
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.11 Aligned_cols=237 Identities=22% Similarity=0.402 Sum_probs=177.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC---CceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
..++|++.+.||+|+||.||+|.+..+ +..||+|.++... ...+.+|+.+++++ +||||+++++++.+ .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---C
Confidence 467899999999999999999987543 4579999986422 35688999999999 99999999999843 4
Q ss_pred CceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..++||||+++++|..++. .++...... ++.|++.||.|||++||+|||
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~---------------------------i~~qi~~aL~~LH~~givHrD 516 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLIL---------------------------YAYQLSTALAYLESKRFVHRD 516 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCSC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCccccc
Confidence 5899999999999877653 234444444 444555699999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcc--cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||+|||++.++ .+||+|||+++........ ....+|..|+|||++.+ ..++.++||||||+++|||++ |..||
T Consensus 517 ikp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf- 593 (656)
T 2j0j_A 517 IAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF- 593 (656)
T ss_dssp CSGGGEEEEETT-EEEECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-
T ss_pred cchHhEEEeCCC-CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-
Confidence 999999999666 8999999999866433221 23356678999999876 678999999999999999997 88888
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+....+......+ .....++.+..++ ..||+.||++||+
T Consensus 594 ~~~~~~~~~~~i~~~~~~~--------~~~~~~~~l~~li------------------------~~~l~~dP~~RPs 638 (656)
T 2j0j_A 594 QGVKNNDVIGRIENGERLP--------MPPNCPPTLYSLM------------------------TKCWAYDPSRRPR 638 (656)
T ss_dssp TTCCHHHHHHHHHHTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCCCHHHHHHHHHcCCCCC--------CCccccHHHHHHH------------------------HHHcCCChhHCcC
Confidence 3444444444444321111 1133445555554 5599999999996
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=282.81 Aligned_cols=195 Identities=27% Similarity=0.459 Sum_probs=149.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccC-CCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~~~ 103 (332)
..++|++.+.||+|+||.||+|.+ .+++.||+|++... ....+.+|+.++.++.+ |+||+++++++.+ ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 102 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 102 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSE
T ss_pred ccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCE
Confidence 357899999999999999999987 46889999998632 23568899999999954 6999999999854 356
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.+++|| +.++++..++ ..++......++. |+++||.|||++||+|||||
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~---------------------------qi~~aL~~LH~~~ivH~dlk 154 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWK---------------------------NMLEAVHTIHQHGIVHSDLK 154 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCCCCC
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHH---------------------------HHHHHHHHHHHCCceecCCC
Confidence 899999 5556665543 2344444444444 44559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCC----------CCCCCcccHHHHHHHHHHH
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~sDiwSlG~il~el 247 (332)
|+||+++ ++ .++|+|||++........ .....+|..|+|||++.+. ..++.++||||||+++|+|
T Consensus 155 p~NIl~~-~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 232 (313)
T 3cek_A 155 PANFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232 (313)
T ss_dssp GGGEEEE-TT-EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred cccEEEE-CC-eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence 9999997 44 799999999986643322 2345789999999998652 3578899999999999999
Q ss_pred HhCCCCCCCC
Q 040656 248 IFRKEPFFYG 257 (332)
Q Consensus 248 ltg~~pf~~~ 257 (332)
++|..||...
T Consensus 233 ~~g~~pf~~~ 242 (313)
T 3cek_A 233 TYGKTPFQQI 242 (313)
T ss_dssp HHSSCTTTTC
T ss_pred HhCCCchhhH
Confidence 9999999543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=312.12 Aligned_cols=197 Identities=26% Similarity=0.448 Sum_probs=163.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec----cCCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD----QHSK 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~ 102 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence 37899999999999999999999899999999998642 245688999999999 99999999998754 2256
Q ss_pred CceeEEeeecCCCceeecc------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 103 TPSLIFEHVNSTDFKVLYP------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
..++||||+++++|..++. .+++..+..++.+++ .||+|||+.||+|
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl---------------------------~aL~yLHs~gIVH 144 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS---------------------------SALRYLHENRIIH 144 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH---------------------------HHHHHHHHTTBCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH---------------------------HHHHHHHHCCCcc
Confidence 7899999999999877653 255555555555554 5999999999999
Q ss_pred cCCCCCCeeecCCCC--eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 177 RDVKPHNVMIDHEQQ--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 177 rdlkp~Nilv~~~~~--~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
|||||+||+++.++. .++|+|||++.............+|..|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 999999999986543 489999999987765555566789999999999876 67899999999999999999999999
Q ss_pred CC
Q 040656 255 FY 256 (332)
Q Consensus 255 ~~ 256 (332)
..
T Consensus 224 ~~ 225 (676)
T 3qa8_A 224 LP 225 (676)
T ss_dssp CS
T ss_pred Cc
Confidence 54
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=293.39 Aligned_cols=204 Identities=21% Similarity=0.277 Sum_probs=152.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
.+.|.+.+.||+|+||+||.+. ..+++.||||++.......+.+|+.+++++.+||||+++++++.+ ....+++||+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEec
Confidence 4567888999999999998754 568999999999776667789999999987689999999999844 4678999999
Q ss_pred ecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeeecCC-
Q 040656 111 VNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE- 189 (332)
Q Consensus 111 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~- 189 (332)
+++ +|..++......... .. .......+.++.|++.||+|||++||+||||||+|||++.+
T Consensus 91 ~~g-sL~~~l~~~~~~~~~------~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~ 152 (434)
T 2rio_A 91 CNL-NLQDLVESKNVSDEN------LK-----------LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSS 152 (434)
T ss_dssp CSE-EHHHHHHTC-----------------------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCH
T ss_pred CCC-CHHHHHhccCCCchh------hh-----------hccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCc
Confidence 964 665554321110000 00 00111224577788889999999999999999999999743
Q ss_pred -----------CCeEEEEecccceeecCCCc-----ccccccccceeccccccC------CCCCCCcccHHHHHHHHHHH
Q 040656 190 -----------QQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 190 -----------~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~sDiwSlG~il~el 247 (332)
...++|+|||+++....... .....||..|+|||++.+ ...++.++|||||||++|+|
T Consensus 153 ~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~el 232 (434)
T 2rio_A 153 RFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232 (434)
T ss_dssp HHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHH
T ss_pred ccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHH
Confidence 23799999999987654322 234578999999999865 24689999999999999999
Q ss_pred Hh-CCCCCC
Q 040656 248 IF-RKEPFF 255 (332)
Q Consensus 248 lt-g~~pf~ 255 (332)
++ |..||.
T Consensus 233 lt~g~~Pf~ 241 (434)
T 2rio_A 233 LSKGKHPFG 241 (434)
T ss_dssp HTTSCCTTC
T ss_pred HhCCCCCCC
Confidence 99 899984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=283.04 Aligned_cols=191 Identities=21% Similarity=0.372 Sum_probs=151.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
..++|++.+.||+|+||.||+|.+. ..+|+|+++.. ..+.+.+|+.+++++ +|+||+++++++.+. ...
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 104 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSP--PHL 104 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES---SSEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECS--SCE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc---CeEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--Cce
Confidence 5688999999999999999999863 35999998632 235678899999999 999999999999643 568
Q ss_pred eeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 105 SLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
++++|+++++++..++. .++...+..++.++ +.||+|||++||+|||||
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi---------------------------~~al~~lH~~~i~H~dlk 157 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI---------------------------VKGMGYLHAKGILHKDLK 157 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHH---------------------------HHHHHHHHHTTCCCCCCC
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHH---------------------------HHHHHHHHhCCccccCCC
Confidence 99999999988877763 24555555555555 459999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCC------CcccccccccceeccccccC--------CCCCCCcccHHHHHHHHHH
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPG------KEYNVRVASRYFKGPELLVD--------LQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~--------~~~~~~~sDiwSlG~il~e 246 (332)
|+||+++ ++ .++|+|||+++..... .......||..|+|||++.+ ...++.++||||||+++|+
T Consensus 158 p~NIl~~-~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 235 (319)
T 2y4i_B 158 SKNVFYD-NG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235 (319)
T ss_dssp STTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHH
T ss_pred hhhEEEe-CC-CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHH
Confidence 9999998 44 6999999998654311 22234468899999999864 2357889999999999999
Q ss_pred HHhCCCCCC
Q 040656 247 MIFRKEPFF 255 (332)
Q Consensus 247 lltg~~pf~ 255 (332)
|++|..||.
T Consensus 236 l~~g~~p~~ 244 (319)
T 2y4i_B 236 LHAREWPFK 244 (319)
T ss_dssp HHHSSCSSS
T ss_pred HHhCCCCCC
Confidence 999999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=303.24 Aligned_cols=190 Identities=23% Similarity=0.366 Sum_probs=156.2
Q ss_pred CCCceEEEeecccCCceEEEEEEcc-CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC---
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVT-NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK--- 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~--- 102 (332)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... ....+.+|+.++.++ +||||+++++++......
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCc
Confidence 3789999999999999999999876 7899999998643 234678999999999 899999999999654321
Q ss_pred CceeEEeeecCCCceeec-cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 103 TPSLIFEHVNSTDFKVLY-PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
..++||||++++++.... ..++...+..++.+++. ||.|||++||+||||||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~---------------------------aL~~lH~~giiHrDlkp 210 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILP---------------------------ALSYLHSIGLVYNDLKP 210 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSG
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCeecccCh
Confidence 169999999999988765 34566666555555554 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
+|||++. + .+||+|||+++..... ....||..|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 211 ~NIll~~-~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 211 ENIMLTE-E-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp GGEEECS-S-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred HHeEEeC-C-cEEEEecccchhcccC---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCc
Confidence 9999985 4 6999999999876433 45579999999999876 34889999999999999999988873
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=272.05 Aligned_cols=174 Identities=29% Similarity=0.494 Sum_probs=144.0
Q ss_pred CCCceEE-EeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeec--cCCCCceeE
Q 040656 31 QEDYEVV-RKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~~~lv 107 (332)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. .....+|+.++.++.+||||+++++++.. ......+++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 4678888 789999999999999999999999999863 45678999999776699999999999854 234568999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||++++++..++. .++...+..++.+++ .||.|||++||+||||||+
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~---------------------------~~l~~lH~~~i~H~dlkp~ 146 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIG---------------------------EAIQYLHSINIAHRDVKPE 146 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHH---------------------------HHHHHHHHTTEECCCCSGG
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHH---------------------------HHHHHHHhCCcccCCCCHH
Confidence 99999988877652 355665555555555 4999999999999999999
Q ss_pred CeeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+++.+ ++.++|+|||++..... ..++.++|||||||++|+|++|..||.
T Consensus 147 Nil~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 147 NLLYTSKRPNAILKLTDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HEEEecCCCCCcEEEecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999863 34799999999875421 346789999999999999999999994
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=283.46 Aligned_cols=198 Identities=14% Similarity=0.187 Sum_probs=138.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCC-CCeeeeeee---------
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGG-PNIVKLLDI--------- 95 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h-~niv~~~~~--------- 95 (332)
..|.+.+.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+.+++.+ .| +|...+...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence 4589999999999999999999999999999998722 246788999999998 54 332221111
Q ss_pred ------------eeccC---CCCceeEEeeecCCCceeeccccc---hhhHHHHHHHHHhhcCCcceeecCCCCcccchh
Q 040656 96 ------------VRDQH---SKTPSLIFEHVNSTDFKVLYPTLT---ANEIRYYIYELLKHAMPRKVIIMPGEGLMENQD 157 (332)
Q Consensus 96 ------------~~~~~---~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (332)
+.... ....+++|+.+ ++++..++..+. ... ..+. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~-~~l~-------------------~~~~~~ 215 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTH-KSLV-------------------HHARLQ 215 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTS-HHHH-------------------HHHHHH
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccC-CCCC-------------------HHHHHH
Confidence 11111 22344455543 344443331110 000 0000 111234
Q ss_pred hHHhHHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceecccccc---------CC
Q 040656 158 ISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DL 228 (332)
Q Consensus 158 ~~~~i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~ 228 (332)
++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.... ......| ..|+|||++. ..
T Consensus 216 i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~ 291 (413)
T 3dzo_A 216 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHP 291 (413)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCC
T ss_pred HHHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccC
Confidence 566778899999999999999999999999776 699999999876532 2344567 8899999983 32
Q ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 229 QDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 229 ~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
..++.++|||||||++|+|++|..||.
T Consensus 292 ~~~~~~~DvwSlGvil~elltg~~Pf~ 318 (413)
T 3dzo_A 292 TLMTFAFDTWTLGLAIYWIWCADLPNT 318 (413)
T ss_dssp EEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 557889999999999999999999994
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=268.31 Aligned_cols=167 Identities=13% Similarity=0.158 Sum_probs=138.5
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.++.++ +||||+++++++.+ ....
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 106 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHT--RAGG 106 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEE--CCcE
Confidence 378999999999999999999999999999999997432 26789999999999 99999999999955 3568
Q ss_pred eeEEeeecCCCceeeccc-cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 105 SLIFEHVNSTDFKVLYPT-LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
++||||+++++|..++.. ....++.. ++.|++.||.|||++||+||||||+|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~~~~~~~~~---------------------------i~~ql~~aL~~lH~~givH~Dikp~N 159 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTSPSPVGAIR---------------------------AMQSLAAAADAAHRAGVALSIDHPSR 159 (286)
T ss_dssp EEEEECCCEEEHHHHHTTCCCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred EEEEEecCCCCHHHHHhcCCChHHHHH---------------------------HHHHHHHHHHHHHHCCCccCCCCccc
Confidence 999999999988777532 22222333 45556669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||++.++ .++|++++ |++ .++.++|||||||++|+|+||..||.
T Consensus 160 Ill~~~g-~~kl~~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~ 203 (286)
T 3uqc_A 160 VRVSIDG-DVVLAYPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLP 203 (286)
T ss_dssp EEEETTS-CEEECSCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred EEEcCCC-CEEEEecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 9999666 68887432 322 36889999999999999999999994
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=270.23 Aligned_cols=190 Identities=19% Similarity=0.264 Sum_probs=150.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------hHHHHHHHHHHHhcc--------CCCCee
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNIV 90 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~niv 90 (332)
..++|++.+.||+|+||.||+|++ +++.||+|+++... .+.+.+|+.+++.+. .|+||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999987 78999999997432 267899999999984 366666
Q ss_pred eeeee-----------------eecc-----------CCCCceeEEeeecCCCce-eec-cccchhhHHHHHHHHHhhcC
Q 040656 91 KLLDI-----------------VRDQ-----------HSKTPSLIFEHVNSTDFK-VLY-PTLTANEIRYYIYELLKHAM 140 (332)
Q Consensus 91 ~~~~~-----------------~~~~-----------~~~~~~lv~e~~~~~~l~-~~~-~~~~~~~~~~~~~~~~~~~~ 140 (332)
++.+. |.+. ....+++||||+.++++. .+. ..+++..+..++.|++.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~--- 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTA--- 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHH---
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHH---
Confidence 55554 4321 246799999999988544 333 34566666666666665
Q ss_pred CcceeecCCCCcccchhhHHhHHHHHHHHH-HcCCeecCCCCCCeeecCCC-------------------CeEEEEeccc
Q 040656 141 PRKVIIMPGEGLMENQDISVWDLQALDYCH-SQGIMHRDVKPHNVMIDHEQ-------------------QKLRLIDWGL 200 (332)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~ivHrdlkp~Nilv~~~~-------------------~~vkL~Dfg~ 200 (332)
||+||| ++||+||||||+|||++.++ ..+||+|||+
T Consensus 173 ------------------------aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~ 228 (336)
T 2vuw_A 173 ------------------------SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228 (336)
T ss_dssp ------------------------HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTT
T ss_pred ------------------------HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccc
Confidence 999999 99999999999999998654 2799999999
Q ss_pred ceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHH-HHHHHhCCCCC
Q 040656 201 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM-FAGMIFRKEPF 254 (332)
Q Consensus 201 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~i-l~elltg~~pf 254 (332)
|+..... ...||..|+|||++.+ .. +.++|||||+++ .+++++|..||
T Consensus 229 a~~~~~~----~~~gt~~y~aPE~~~g-~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 229 SRLERDG----IVVFCDVSMDEDLFTG-DG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp CBEEETT----EEECCCCTTCSGGGCC-CS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred cEecCCC----cEEEeecccChhhhcC-CC-ccceehhhhhCCCCcccccccCCC
Confidence 9876532 3479999999999987 33 889999998777 77788899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=262.66 Aligned_cols=183 Identities=19% Similarity=0.118 Sum_probs=123.5
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc-------------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
...+.|++|.+..++....|+.+++|++.+. ....+.+|+++|+++..|+||+++++++.+ +..+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 3456778888888887888999999999632 124689999999999889999999999954 5679
Q ss_pred eeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 105 SLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
|+||||++|++|.+++.....-+...++ .||++||+|+|++|||||||||+||
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~~I~---------------------------~QIl~AL~ylH~~GIIHRDIKPeNI 370 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDREKIL---------------------------GSLLRSLAALEKQGFWHDDVRPWNV 370 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHHHHH---------------------------HHHHHHHHHHHHTTCEESCCCGGGE
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHHHHH---------------------------HHHHHHHHHHHHCCceeccCchHhE
Confidence 9999999999988876432222222334 4555599999999999999999999
Q ss_pred eecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 185 MIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 185 lv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|++.++ ++||+|||+|+..... ....+.+||+.|+|||++.+ .+..++|+||+|++++++.++..
T Consensus 371 LL~~dg-~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 371 MVDARQ-HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp EECTTS-CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred EECCCC-CEEEeecccCeeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence 999766 7999999999876533 23456689999999999876 46788999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-27 Score=225.10 Aligned_cols=196 Identities=17% Similarity=0.226 Sum_probs=139.1
Q ss_pred cccccccccCCCC----CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----------chHHHHHHHHHHHhc
Q 040656 19 WDYESLTVQWGDQ----EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----------KKKKIKREIKILQNL 83 (332)
Q Consensus 19 ~~~~~~~~~~~~~----~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l 83 (332)
|+.....+.|... ..+...+.||+|+||.||+| ...++.+++|..... ..+++.+|+++++++
T Consensus 319 ~~~dev~v~w~~~~~~~~~~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 396 (540)
T 3en9_A 319 YRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV 396 (540)
T ss_dssp CCSTTSCCCCC------------------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG
T ss_pred cccccccccccccccccccCCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc
Confidence 4555555555522 22244578999999999999 457788999986421 124578999999999
Q ss_pred cCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHH
Q 040656 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDL 163 (332)
Q Consensus 84 ~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 163 (332)
+||||+++..++.+. ...+++|||+++++|..++.. .. .++.|++
T Consensus 397 -~h~nIv~~~~~~~~~--~~~~lVmE~~~ggsL~~~l~~-----~~---------------------------~i~~qi~ 441 (540)
T 3en9_A 397 -KDFGIPAPYIFDVDL--DNKRIMMSYINGKLAKDVIED-----NL---------------------------DIAYKIG 441 (540)
T ss_dssp -GGGTCCCCCEEEEET--TTTEEEEECCCSEEHHHHSTT-----CT---------------------------HHHHHHH
T ss_pred -CCCCcCceEEEEEeC--CccEEEEECCCCCCHHHHHHH-----HH---------------------------HHHHHHH
Confidence 999999554444333 456999999999988776544 22 3555666
Q ss_pred HHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCc--------ccccccccceeccccccCC-CCCCCc
Q 040656 164 QALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDL-QDYDYS 234 (332)
Q Consensus 164 ~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~ 234 (332)
+||.|||++||+||||||+|||++. .+||+|||+++....... .....||+.|||||++... ..|+..
T Consensus 442 ~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~ 518 (540)
T 3en9_A 442 EIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV 518 (540)
T ss_dssp HHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH
Confidence 6999999999999999999999985 699999999998754322 1356899999999998641 246778
Q ss_pred ccHHHHHHHHHHHHhCCCCC
Q 040656 235 LDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 235 sDiwSlG~il~elltg~~pf 254 (332)
+|+||..+-..+-+.++.+|
T Consensus 519 ~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 519 YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTHHHHHHHHHHHHTCSCC
T ss_pred HhHHHHHHHHHHHHHhcccc
Confidence 89999998888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-24 Score=187.93 Aligned_cols=143 Identities=18% Similarity=0.252 Sum_probs=111.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---------------------chHHHHHHHHHHHhccCCCCe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNI 89 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------------------~~~~~~~E~~~l~~l~~h~ni 89 (332)
...|.+.+.||+|+||.||+|.+ .+++.||+|+++.. ....+.+|+.+++++ + |
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~- 163 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G- 163 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence 34566779999999999999998 88999999998632 234588999999999 4 5
Q ss_pred eeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHH
Q 040656 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYC 169 (332)
Q Consensus 90 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 169 (332)
+++.+++.. ...++||||+++++|..+ ....... ++.|++.||.+|
T Consensus 164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~l----~~~~~~~---------------------------i~~qi~~~l~~l 209 (282)
T 1zar_A 164 LAVPKVYAW---EGNAVLMELIDAKELYRV----RVENPDE---------------------------VLDMILEEVAKF 209 (282)
T ss_dssp SSSCCEEEE---ETTEEEEECCCCEEGGGC----CCSCHHH---------------------------HHHHHHHHHHHH
T ss_pred CCcCeEEec---cceEEEEEecCCCcHHHc----chhhHHH---------------------------HHHHHHHHHHHH
Confidence 666666533 356999999999888773 1122233 444555699999
Q ss_pred HHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceecccccc
Q 040656 170 HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 226 (332)
Q Consensus 170 H~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 226 (332)
|++||+||||||+|||++ ++ .++|+|||+++.. ..++|||.+.
T Consensus 210 H~~giiHrDlkp~NILl~-~~-~vkl~DFG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 210 YHRGIVHGDLSQYNVLVS-EE-GIWIIDFPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp HHTTEECSCCSTTSEEEE-TT-EEEECCCTTCEET------------TSTTHHHHHH
T ss_pred HHCCCEeCCCCHHHEEEE-CC-cEEEEECCCCeEC------------CCCCHHHHHH
Confidence 999999999999999999 55 8999999999743 2357888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=163.94 Aligned_cols=135 Identities=17% Similarity=0.156 Sum_probs=99.1
Q ss_pred CceEEEeecccCCceEEEEEEccCCce--EEEEEecccc---------------------------hHHHHHHHHHHHhc
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEK--CIIKILKPVK---------------------------KKKIKREIKILQNL 83 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~~---------------------------~~~~~~E~~~l~~l 83 (332)
-|++.+.||+|+||.||+|.+..+|+. ||+|+++... ...+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778999 9999975321 12578899999999
Q ss_pred cCCCCe--eeeeeeeeccCCCCceeEEeeecC-CC----ceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccch
Q 040656 84 CGGPNI--VKLLDIVRDQHSKTPSLIFEHVNS-TD----FKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQ 156 (332)
Q Consensus 84 ~~h~ni--v~~~~~~~~~~~~~~~lv~e~~~~-~~----l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (332)
.|+++ ..++.. ...++||||+.+ +. +.......++... .
T Consensus 128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~---------------------------~ 173 (258)
T 1zth_A 128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDV---------------------------E 173 (258)
T ss_dssp -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCH---------------------------H
T ss_pred -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHH---------------------------H
Confidence 66654 333332 246899999953 32 2221111112223 3
Q ss_pred hhHHhHHHHHHHHH-HcCCeecCCCCCCeeecCCCCeEEEEecccceee
Q 040656 157 DISVWDLQALDYCH-SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204 (332)
Q Consensus 157 ~~~~~i~~~l~~LH-~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~ 204 (332)
.++.|++.+|.+|| +.||+||||||+|||++. .++|+|||+|...
T Consensus 174 ~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 174 GIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 45556666999999 999999999999999985 5999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-17 Score=148.33 Aligned_cols=137 Identities=14% Similarity=0.252 Sum_probs=94.9
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-----------------hHH--------HHHHHHHHHhccCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----------------KKK--------IKREIKILQNLCGG 86 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~--------~~~E~~~l~~l~~h 86 (332)
.-|++...||+|+||.||+|.+ .+|+.||+|+++... ... ..+|...|.++ .+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence 4499999999999999999987 578999999975210 001 23566777777 33
Q ss_pred CCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHH
Q 040656 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL 166 (332)
Q Consensus 87 ~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 166 (332)
.++. +...+.. ...++||||++|..+..+.. ......+..++ +.+|
T Consensus 173 ~gv~-vp~p~~~---~~~~LVME~i~G~~L~~l~~---~~~~~~l~~ql---------------------------l~~l 218 (397)
T 4gyi_A 173 EGFP-VPEPIAQ---SRHTIVMSLVDALPMRQVSS---VPDPASLYADL---------------------------IALI 218 (397)
T ss_dssp TTCS-CCCEEEE---ETTEEEEECCSCEEGGGCCC---CSCHHHHHHHH---------------------------HHHH
T ss_pred cCCC-CCeeeec---cCceEEEEecCCccHhhhcc---cHHHHHHHHHH---------------------------HHHH
Confidence 3332 2211111 12489999999877655432 22233334444 4599
Q ss_pred HHHHHcCCeecCCCCCCeeecCCCC---------eEEEEecccceee
Q 040656 167 DYCHSQGIMHRDVKPHNVMIDHEQQ---------KLRLIDWGLAEFY 204 (332)
Q Consensus 167 ~~LH~~~ivHrdlkp~Nilv~~~~~---------~vkL~Dfg~a~~~ 204 (332)
.+||+.|||||||||.|||++.++. .+.|+||+.+...
T Consensus 219 ~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 219 LRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp HHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999999999999999985542 3899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5e-12 Score=109.51 Aligned_cols=84 Identities=18% Similarity=0.243 Sum_probs=68.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecc---cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.|++...++.|+.+.||++.. .++.+++|+... .....+.+|+.+++.+..+.++.++++++.+ ....+++|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence 4689999999999999999863 468899999864 3345789999999999667778888888753 35679999
Q ss_pred eeecCCCceee
Q 040656 109 EHVNSTDFKVL 119 (332)
Q Consensus 109 e~~~~~~l~~~ 119 (332)
|+++|..+...
T Consensus 90 e~i~G~~l~~~ 100 (263)
T 3tm0_A 90 SEADGVLCSEE 100 (263)
T ss_dssp ECCSSEEHHHH
T ss_pred EecCCeehhhc
Confidence 99999887654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=5.7e-11 Score=102.36 Aligned_cols=83 Identities=16% Similarity=0.126 Sum_probs=60.2
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCC-CeeeeeeeeeccCCCCceeEEee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQHSKTPSLIFEH 110 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~~~lv~e~ 110 (332)
..|.+....+.|..+.||++.. .+|..+++|+........+..|+.+++.+..+. .+.+++++..+ ....+++||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEe
Confidence 3466655545666799999853 567789999986554467889999999995552 24557777643 3467999999
Q ss_pred ecCCCce
Q 040656 111 VNSTDFK 117 (332)
Q Consensus 111 ~~~~~l~ 117 (332)
++|..+.
T Consensus 97 i~G~~l~ 103 (264)
T 1nd4_A 97 VPGQDLL 103 (264)
T ss_dssp CSSEETT
T ss_pred cCCcccC
Confidence 9998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=5.5e-10 Score=101.21 Aligned_cols=166 Identities=17% Similarity=0.249 Sum_probs=95.0
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEec--cc----chHHHHHHHHHHHhccC-CCCeeeeeeeeeccCC-CCce
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PV----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQHS-KTPS 105 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~----~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~-~~~~ 105 (332)
..-++.|+.|.++.||++.. .+..+++|+.. .. ....+.+|..+++.+.. +..+.+++.++.+... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 44578899999999999864 45678888875 32 23578899999999943 3457788887754321 3578
Q ss_pred eEEeeecCCCcee-eccccchhhHHHHHHHHHh----hcCC--cceeecCCCCcccchhhHHhH----------------
Q 040656 106 LIFEHVNSTDFKV-LYPTLTANEIRYYIYELLK----HAMP--RKVIIMPGEGLMENQDISVWD---------------- 162 (332)
Q Consensus 106 lv~e~~~~~~l~~-~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~~~~~~~i---------------- 162 (332)
+|||+++|..+.. ....++......+..++.. .+.. ...-. ...+.... .+..++
T Consensus 118 ~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGL-GDYGKPGN-YFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTC-TTSSCCSC-HHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccc-cccCCCCC-chHHHHHHHHHHHHhcCCcCCh
Confidence 9999999987743 3334444443333333322 1100 00000 00000000 000000
Q ss_pred --HHHHHHHH---------HcCCeecCCCCCCeeecCCCC-eEEEEeccccee
Q 040656 163 --LQALDYCH---------SQGIMHRDVKPHNVMIDHEQQ-KLRLIDWGLAEF 203 (332)
Q Consensus 163 --~~~l~~LH---------~~~ivHrdlkp~Nilv~~~~~-~vkL~Dfg~a~~ 203 (332)
...+..|. ...++|+|+++.|||++.++. .+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 01111221 146899999999999986653 358999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.4e-09 Score=96.21 Aligned_cols=209 Identities=15% Similarity=0.209 Sum_probs=110.7
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCC--eeeeeeeeeccCC-CCceeEEeeecC
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN--IVKLLDIVRDQHS-KTPSLIFEHVNS 113 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n--iv~~~~~~~~~~~-~~~~lv~e~~~~ 113 (332)
+.++.|..+.||++. ..+++|+-... ....+.+|..+++.+..+.. +..++....+... ...++||++++|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999862 56889986543 34678899999998844332 3344444322211 235789999999
Q ss_pred CCcee-eccccchhhHHHHHHHHHhhcCCcceeecCCCC---cccchh----hHHh----------------HHHHHHH-
Q 040656 114 TDFKV-LYPTLTANEIRYYIYELLKHAMPRKVIIMPGEG---LMENQD----ISVW----------------DLQALDY- 168 (332)
Q Consensus 114 ~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~----------------i~~~l~~- 168 (332)
..+.. ....++......+..++...-..-......+.. ....+. ...+ +...++.
T Consensus 101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 88764 233344433333333332210000000000000 000000 0000 0111111
Q ss_pred HHH-------cCCeecCCCCCCeeecCC-CCeEEEEecccceeecCCCccccc------cccc-------ce--ec-ccc
Q 040656 169 CHS-------QGIMHRDVKPHNVMIDHE-QQKLRLIDWGLAEFYHPGKEYNVR------VASR-------YF--KG-PEL 224 (332)
Q Consensus 169 LH~-------~~ivHrdlkp~Nilv~~~-~~~vkL~Dfg~a~~~~~~~~~~~~------~~t~-------~y--~a-PE~ 224 (332)
+.. ..++|+|++|.||+++.+ +..+.++||+.+..-.+....... .+.. .| .. |+.
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~ 260 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV 260 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence 211 358999999999999864 446789999998754321100000 0000 01 11 222
Q ss_pred ccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 225 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 225 ~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
.. ......+.|+++.++|.+.+|..+|
T Consensus 261 ~~---r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 261 LE---KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HH---HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HH---HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 1123468999999999999998777
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.9e-06 Score=76.10 Aligned_cols=76 Identities=20% Similarity=0.276 Sum_probs=53.1
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCC--CeeeeeeeeeccCCCCceeEEeeecC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGP--NIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
++.++.|....||+. +..+++|+-... ....+.+|..+++.+..+- .+.+.+.+.. ......+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEeccCC
Confidence 456788888899987 577888885432 3467889999999995432 2444555543 223457899999999
Q ss_pred CCcee
Q 040656 114 TDFKV 118 (332)
Q Consensus 114 ~~l~~ 118 (332)
..+..
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 87765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=2.3e-06 Score=73.84 Aligned_cols=80 Identities=11% Similarity=0.086 Sum_probs=59.6
Q ss_pred EeecccCCc-eEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecCCCc
Q 040656 38 RKVGRGKYS-EVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDF 116 (332)
Q Consensus 38 ~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l 116 (332)
+.+..|..| .||+......+..+++|+-.......+.+|..+|+.+..+-.+.+++.++.+. ...++|||+++|..+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEH
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCccc
Confidence 344556554 69988766677889999977666678899999999986555566777777543 467999999999776
Q ss_pred eee
Q 040656 117 KVL 119 (332)
Q Consensus 117 ~~~ 119 (332)
...
T Consensus 108 ~~~ 110 (272)
T 4gkh_A 108 FQV 110 (272)
T ss_dssp HHH
T ss_pred ccc
Confidence 554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.1e-05 Score=72.66 Aligned_cols=84 Identities=12% Similarity=0.094 Sum_probs=57.8
Q ss_pred eEEEee-cccCCceEEEEEEc--c----CCceEEEEEecccc------hHHHHHHHHHHHhccCC--CCeeeeeeeeecc
Q 040656 35 EVVRKV-GRGKYSEVFEGINV--T----NNEKCIIKILKPVK------KKKIKREIKILQNLCGG--PNIVKLLDIVRDQ 99 (332)
Q Consensus 35 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~ 99 (332)
...+.| +.|..+.+|+.... . ++..+++|+..... ...+.+|+.+++.+..+ -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 78888899987542 0 15678899865432 25688999999988554 3466677766432
Q ss_pred C-CCCceeEEeeecCCCcee
Q 040656 100 H-SKTPSLIFEHVNSTDFKV 118 (332)
Q Consensus 100 ~-~~~~~lv~e~~~~~~l~~ 118 (332)
. ....++|||+++|..+..
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 1 134689999999987765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=6.8e-05 Score=66.64 Aligned_cols=79 Identities=13% Similarity=0.162 Sum_probs=44.3
Q ss_pred EEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCC-CCeeeeeeee----eccCCCCceeEEee
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIV----RDQHSKTPSLIFEH 110 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~----~~~~~~~~~lv~e~ 110 (332)
-++.|+.|..+.||++.. .+..+++|+... ....+..|..+++.+..+ -.+.+++... ........++++++
T Consensus 36 ~~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHT--DSGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEEECC----CEEEEEEE--TTEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred EeeeccccccCcEEEEEe--CCCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 345666677889999864 334589999865 334555677777766322 1233333311 00123456899999
Q ss_pred ecCCCce
Q 040656 111 VNSTDFK 117 (332)
Q Consensus 111 ~~~~~l~ 117 (332)
++|..+.
T Consensus 113 i~G~~~~ 119 (346)
T 2q83_A 113 IEGRPFE 119 (346)
T ss_dssp CCCBCCC
T ss_pred ecCccCC
Confidence 9987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=3e-05 Score=70.86 Aligned_cols=75 Identities=16% Similarity=0.238 Sum_probs=49.6
Q ss_pred eEEEeecccCCceEEEEEEccCCceEEEEEeccc----------chHHHHHHHHHHHhccCC-CC-eeeeeeeeeccCCC
Q 040656 35 EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----------KKKKIKREIKILQNLCGG-PN-IVKLLDIVRDQHSK 102 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~~h-~n-iv~~~~~~~~~~~~ 102 (332)
.-.+.||.|..+.||++....+++.+++|..... ...++..|.++++.+..+ +. +.+++.+. . .
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~ 108 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--E 108 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--T
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--C
Confidence 3467899999999999976556788999986421 124568899999887443 33 33455432 2 2
Q ss_pred CceeEEeeecC
Q 040656 103 TPSLIFEHVNS 113 (332)
Q Consensus 103 ~~~lv~e~~~~ 113 (332)
..++|||++++
T Consensus 109 ~~~lvmE~l~g 119 (397)
T 2olc_A 109 MAVTVMEDLSH 119 (397)
T ss_dssp TTEEEECCCTT
T ss_pred ccEEEEEeCCC
Confidence 45899999976
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00041 Score=61.16 Aligned_cols=162 Identities=15% Similarity=0.138 Sum_probs=82.7
Q ss_pred eEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCC-Ceeeeeeeeec----cCCCCceeEE
Q 040656 35 EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QHSKTPSLIF 108 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~----~~~~~~~lv~ 108 (332)
.-++.|+.|....+|++.. . +..+++|+.... ....+..|+.+++.+..+. .+.+++....+ ......++++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~-~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-T-KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEE-S-SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEe-C-CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 4456778888889998864 2 347889998652 4456778999988885432 12333321100 1123457899
Q ss_pred eeecCCCceeeccccchhhHHHHHHHHHhhcCC-cceeec--CCCC---ccc----------c--hhhHHhHHHHHHHHH
Q 040656 109 EHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP-RKVIIM--PGEG---LME----------N--QDISVWDLQALDYCH 170 (332)
Q Consensus 109 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~---~~~----------~--~~~~~~i~~~l~~LH 170 (332)
++++|..+... +......+...+...+.. ...... ...+ +.. . -.+...+...+..+.
T Consensus 103 ~~l~G~~~~~~----~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 103 SFLEGMWLRKP----EAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp ECCCCBCCSSC----CHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EeCCCcCCCCC----CHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 99998765331 122222222222111110 000000 0000 000 0 000011233455554
Q ss_pred H-------cCCeecCCCCCCeeecCCCCeEEEEeccccee
Q 040656 171 S-------QGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 171 ~-------~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
. .+++|+|+.+.|||++.++ .+.++||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 2 4689999999999998443 457999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0014 Score=57.61 Aligned_cols=79 Identities=16% Similarity=0.172 Sum_probs=60.1
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCC--CCeeeeeeeeeccCCCCceeEEeee
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQHSKTPSLIFEHV 111 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~~~lv~e~~ 111 (332)
-.-.+.|+.|....+|+... ++..+++|+........+..|...|+.+..+ ..+.+++.+... ....++|||++
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l 113 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEAL 113 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECC
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEec
Confidence 34567889999999999853 5678899987665667789999999988543 456677776643 34689999999
Q ss_pred cCCCc
Q 040656 112 NSTDF 116 (332)
Q Consensus 112 ~~~~l 116 (332)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0011 Score=57.79 Aligned_cols=71 Identities=10% Similarity=0.033 Sum_probs=46.2
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeee-cC
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHV-NS 113 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~-~~ 113 (332)
++.|+.|....+|++ ..+++|+...... ....+|..+++.+..+.-..++++.+ . ..-+++++++ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~--~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--P--ATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--T--TTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--C--CCCEEEEeecCCC
Confidence 678888999999988 6688898754221 23467888888874443224555543 2 2347899999 66
Q ss_pred CCce
Q 040656 114 TDFK 117 (332)
Q Consensus 114 ~~l~ 117 (332)
..+.
T Consensus 93 ~~l~ 96 (301)
T 3dxq_A 93 QTMS 96 (301)
T ss_dssp EECC
T ss_pred ccCC
Confidence 5443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0012 Score=60.55 Aligned_cols=78 Identities=13% Similarity=0.129 Sum_probs=44.3
Q ss_pred HcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCccccccc--ccceeccccccCCC--CCCCcccHHHHHHHHHH
Q 040656 171 SQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 171 ~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~--~~~~~sDiwSlG~il~e 246 (332)
...++|+|++|.|||++.++ +.++||+.+..-.+.-....... ...|++|+...... ......++.+....+++
T Consensus 231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45799999999999998543 89999998875331111111111 12356665542100 11122344466666666
Q ss_pred HHhC
Q 040656 247 MIFR 250 (332)
Q Consensus 247 lltg 250 (332)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0014 Score=57.92 Aligned_cols=77 Identities=14% Similarity=0.263 Sum_probs=48.8
Q ss_pred EeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCC-Ceeeeeeeeecc----CCCCceeEEee
Q 040656 38 RKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQ----HSKTPSLIFEH 110 (332)
Q Consensus 38 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~----~~~~~~lv~e~ 110 (332)
+.++ |....||++.. .+|+.+++|+.... ....+..|..+++.+..+. .+.+++.. .+. .....++++++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence 4566 77789998743 45668999998632 4567788999988884332 23444432 111 12345779999
Q ss_pred ecCCCce
Q 040656 111 VNSTDFK 117 (332)
Q Consensus 111 ~~~~~l~ 117 (332)
++|..+.
T Consensus 109 i~G~~~~ 115 (328)
T 1zyl_A 109 VGGRQFE 115 (328)
T ss_dssp CCCEECC
T ss_pred cCCCCCC
Confidence 9886543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0033 Score=56.89 Aligned_cols=79 Identities=13% Similarity=0.139 Sum_probs=49.3
Q ss_pred CCceEEEeecccCCceEEEEEEcc-------CCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVT-------NNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
+..++ +.|..|-...+|++.... .++.+++|+.... ......+|..+++.+..+.-..++++.+. +
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~-- 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E-- 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--
Confidence 44554 456668788999987532 3478999986432 34567799999998855544456777663 2
Q ss_pred CceeEEeeecCCCce
Q 040656 103 TPSLIFEHVNSTDFK 117 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~ 117 (332)
.+|+|+++|..+.
T Consensus 126 --g~v~e~i~G~~l~ 138 (379)
T 3feg_A 126 --GRLEQYIPSRPLK 138 (379)
T ss_dssp --EEEEECCSEEECC
T ss_pred --ccEEEEecCccCC
Confidence 3899999985543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.005 Score=56.69 Aligned_cols=75 Identities=15% Similarity=0.114 Sum_probs=51.9
Q ss_pred EEEeecccCCceEEEEEEcc-------CCceEEEEEecccch-HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 36 VVRKVGRGKYSEVFEGINVT-------NNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
-++.|+.|....||++.... .++.+++|+...... ..+..|..+++.+..+.-..++++.+. + .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C----CEE
Confidence 35677778889999987532 257899999853222 566789999999855543456777652 2 389
Q ss_pred EeeecCCCc
Q 040656 108 FEHVNSTDF 116 (332)
Q Consensus 108 ~e~~~~~~l 116 (332)
+++++|..+
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999987444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0099 Score=51.37 Aligned_cols=77 Identities=13% Similarity=0.079 Sum_probs=54.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCC--CeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGP--NIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~--niv~~~~~~~~~~~~~~~l 106 (332)
....-++.+|.|..+.||+... .+|+.+++|+-... ....+..|...|+.+.... .+.+++++. ..++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceE
Confidence 3456678899999999999874 67899999986532 2346789999999884432 234444432 2478
Q ss_pred EEeeecCCC
Q 040656 107 IFEHVNSTD 115 (332)
Q Consensus 107 v~e~~~~~~ 115 (332)
+||++.+..
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0018 Score=57.35 Aligned_cols=162 Identities=12% Similarity=0.027 Sum_probs=77.4
Q ss_pred EEeecccCCc-eEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCC-CeeeeeeeeeccCCCCceeEEeeecCC
Q 040656 37 VRKVGRGKYS-EVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQHSKTPSLIFEHVNST 114 (332)
Q Consensus 37 ~~~lg~G~~g-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~~~lv~e~~~~~ 114 (332)
.+.|+.|... .+|+... .++..+++|.........+..|+.+++.+..+. .+.+++.+. ... .+++||.+.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCC--CEEEEeeCCCc
Confidence 3455555443 3666642 236678788754432255677888888874442 244455542 222 27899998775
Q ss_pred Cceeeccccch---hhHHHHHHHHHhhcCCcceeecCCCCc---c------cchhh-----------HHhHHHHHHHH--
Q 040656 115 DFKVLYPTLTA---NEIRYYIYELLKHAMPRKVIIMPGEGL---M------ENQDI-----------SVWDLQALDYC-- 169 (332)
Q Consensus 115 ~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~-----------~~~i~~~l~~L-- 169 (332)
.+...+...+. .........+...+....- ..+.... . ..+.. ...+...+..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTP-ELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCC-CCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCc-cCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 55433322111 2222333333322221100 0000000 0 00000 00011122222
Q ss_pred ----HHcCCeecCCCCCCeeecCC---CCeEEEEecccceee
Q 040656 170 ----HSQGIMHRDVKPHNVMIDHE---QQKLRLIDWGLAEFY 204 (332)
Q Consensus 170 ----H~~~ivHrdlkp~Nilv~~~---~~~vkL~Dfg~a~~~ 204 (332)
+...++|+|+.+.|||++.+ ...+.++||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 13469999999999999854 136899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0092 Score=55.38 Aligned_cols=75 Identities=16% Similarity=0.171 Sum_probs=49.4
Q ss_pred EEEeecccCCceEEEEEEccCCceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEeeecC
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNS 113 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 113 (332)
-++.|+.|-...+|++.....+..+++|+...... .....|..+++.|..+.-..++++.+ .+ ..|++|++|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeCC
Confidence 45677778889999987643357899998753221 12368999999995544445677776 22 359999988
Q ss_pred CCc
Q 040656 114 TDF 116 (332)
Q Consensus 114 ~~l 116 (332)
..+
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.014 Score=52.39 Aligned_cols=75 Identities=13% Similarity=0.121 Sum_probs=46.0
Q ss_pred EEEeecccCCceEEEEEEcc--------CCceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 36 VVRKVGRGKYSEVFEGINVT--------NNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~--------~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
-.+.|+.|....+|++.... .+..+++|+...... .....|..+++.+..+.-+.++++.+ . -+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~ 110 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GG 110 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----Cc
Confidence 35667778888999986532 136888998753222 23468899998885443344566544 1 37
Q ss_pred eEEeeecCCCc
Q 040656 106 LIFEHVNSTDF 116 (332)
Q Consensus 106 lv~e~~~~~~l 116 (332)
+++++++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.60 E-value=0.13 Score=45.49 Aligned_cols=75 Identities=8% Similarity=0.116 Sum_probs=44.3
Q ss_pred EEeec--ccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCC--CCeeeeeeeeec----cCCCCceeEE
Q 040656 37 VRKVG--RGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRD----QHSKTPSLIF 108 (332)
Q Consensus 37 ~~~lg--~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~----~~~~~~~lv~ 108 (332)
++.+. .|....||++.. .++ .+++|+..... ...|..+++.|..+ +++.+.+....+ ......+++|
T Consensus 26 ~~~l~~G~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp EEEETTTSCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred eEEeeccCccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence 34453 333678998863 344 89999876543 25677777776332 224444432111 1234568999
Q ss_pred eeecCCCc
Q 040656 109 EHVNSTDF 116 (332)
Q Consensus 109 e~~~~~~l 116 (332)
++++|..+
T Consensus 101 ~~i~G~~~ 108 (339)
T 3i1a_A 101 PFIHAPNG 108 (339)
T ss_dssp ECCCCCBT
T ss_pred eccCCCcC
Confidence 99998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.11 E-value=0.53 Score=42.99 Aligned_cols=75 Identities=13% Similarity=0.138 Sum_probs=49.6
Q ss_pred EEEeecccCCceEEEEEEccC-------CceEEEEEecccc--hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 36 VVRKVGRGKYSEVFEGINVTN-------NEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~-------~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
-++.+..|-...+|++..... ++.+++|+..... .....+|..+++.+..+.-..++++.+ . -+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCE
Confidence 345566677889998875321 5789999875322 223468999998885544445566544 2 378
Q ss_pred EEeeecCCCc
Q 040656 107 IFEHVNSTDF 116 (332)
Q Consensus 107 v~e~~~~~~l 116 (332)
|+++++|..+
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.06 E-value=0.59 Score=42.28 Aligned_cols=30 Identities=33% Similarity=0.609 Sum_probs=24.6
Q ss_pred CeecCCCCCCeeecC-----CCCeEEEEeccccee
Q 040656 174 IMHRDVKPHNVMIDH-----EQQKLRLIDWGLAEF 203 (332)
Q Consensus 174 ivHrdlkp~Nilv~~-----~~~~vkL~Dfg~a~~ 203 (332)
++|+|+.+.|||+.. ++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999942 344799999999865
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=83.59 E-value=17 Score=31.75 Aligned_cols=25 Identities=16% Similarity=0.203 Sum_probs=20.7
Q ss_pred CCCCCeeecCCCCeEEEEeccccee
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEF 203 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~ 203 (332)
-++.|||++.+++.+.++|-+.+..
T Consensus 213 GN~~NIL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 213 GNLDNIMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp CCGGGEEEESBTTCEEECSCCCCCC
T ss_pred CChhheEEeCCCCeEEEEcCCcccc
Confidence 5789999987776789999988854
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.10 E-value=0.08 Score=49.09 Aligned_cols=57 Identities=12% Similarity=0.158 Sum_probs=16.8
Q ss_pred EEEeecccCCceEEEEEEccCCceEEE------EEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeee
Q 040656 36 VVRKVGRGKYSEVFEGINVTNNEKCII------KILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIV 96 (332)
Q Consensus 36 ~~~~lg~G~~g~V~~~~~~~~~~~vav------K~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 96 (332)
+.+.|| ||+||++.......+||+ |..+. .....+.+|..+++.+ +|+|+++.+++-
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceE
Confidence 345565 999999987655568888 65542 1223567788888888 899999998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 332 | ||||
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-82 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-29 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-28 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-27 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-27 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-22 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-21 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-21 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-16 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 251 bits (642), Expect = 1e-82
Identities = 207/304 (68%), Positives = 242/304 (79%), Gaps = 27/304 (8%)
Query: 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI 61
SRARVY DVN HRPR+YWDYES V+WG+Q+DY++VRK+GRGKYSEVFE IN+TNNEK +
Sbjct: 5 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV 64
Query: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP 121
+KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVN+TDFK LY
Sbjct: 65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 122 TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181
TLT +IR+Y+YE+ L+ALDYCHS GIMHRDVKP
Sbjct: 125 TLTDYDIRFYMYEI---------------------------LKALDYCHSMGIMHRDVKP 157
Query: 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241
HNVMIDHE +KLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLG
Sbjct: 158 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 217
Query: 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVW 301
CM A MIFRKEPFF+GHDN DQLV+IA+VLGT++L Y+DKY++ELDP+ ++GR
Sbjct: 218 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 277
Query: 302 PIPN 305
Sbjct: 278 RWER 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-41
Identities = 80/312 (25%), Positives = 137/312 (43%), Gaps = 50/312 (16%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 89
+ Y + +G G + V++ + E IK + K+ RE++I++ L NI
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75
Query: 90 VKLLDIVRDQHSKTPS----LIFEHVNSTDFKVL------YPTLTANEIRYYIYELLKHA 139
V+L K L+ ++V T ++V TL ++ Y+Y+L +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR-- 133
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
+L Y HS GI HRD+KP N+++D + L+L D+G
Sbjct: 134 -------------------------SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 200 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
A+ G+ + SRY++ PEL+ DY S+D+WS GC+ A ++ + P F G
Sbjct: 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDS 227
Query: 260 NQDQLVKIARVLGT---DELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSR 316
DQLV+I +VLGT +++ Y PQ++A K P + + C
Sbjct: 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR-- 285
Query: 317 TSTNICITFSPS 328
+ ++P+
Sbjct: 286 -----LLEYTPT 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (350), Expect = 6e-39
Identities = 53/274 (19%), Positives = 111/274 (40%), Gaps = 45/274 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK---PVKKKKIKREIKILQNLCGGPN 88
+ Y+++ ++G G + V + + K + P+ K +K EI I+ L P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKV 144
++ L D D++ LI E ++ + ++ E+ Y+ +
Sbjct: 88 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA--------- 136
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDWGLAEF 203
+ L + H I+H D+KP N+M + ++ +++ID+GLA
Sbjct: 137 ------------------CEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+P + V A+ F PE++ D + + DMW++G + ++ P F G D+ +
Sbjct: 179 LNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLET 236
Query: 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
L + R + + + P+ + +
Sbjct: 237 LQNVKRCDWE-----FDEDAFSSVSPEAKDFIKN 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 9e-39
Identities = 48/250 (19%), Positives = 92/250 (36%), Gaps = 41/250 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 87
+D+E + ++G G VF+ + + K++ P + +I RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPRKV 144
IV S+ EH++ + + + +
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--------- 113
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQ-GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
++ L Y + IMHRDVKP N++++ + ++L D+G++
Sbjct: 114 ------------------IKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQ 154
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
N V +R + PE L Y D+WS+G M + P + +
Sbjct: 155 LIDSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212
Query: 264 LVKIARVLGT 273
L+ +V G
Sbjct: 213 LMFGCQVEGD 222
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-38
Identities = 56/261 (21%), Positives = 114/261 (43%), Gaps = 44/261 (16%)
Query: 21 YESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK---REI 77
YE +T ++ +E++ ++G G + +V++ N + K++ +++++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 78 KILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIY 133
IL + PNIVKLLD +++ ++ E + LT ++I+
Sbjct: 61 DILASCD-HPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117
Query: 134 ELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKL 193
+ L AL+Y H I+HRD+K N++ + +
Sbjct: 118 QTLD---------------------------ALNYLHDNKIIHRDLKAGNILFTLDGD-I 149
Query: 194 RLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMI 248
+L D+G++ + + + + + Y+ PE+++ + YDY D+WSLG M
Sbjct: 150 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209
Query: 249 FRKEPFFYGHDNQDQLVKIAR 269
+ P + + L+KIA+
Sbjct: 210 EIEPP-HHELNPMRVLLKIAK 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-38
Identities = 57/248 (22%), Positives = 104/248 (41%), Gaps = 43/248 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCG 85
ED+E+ R +G+GK+ V+ + +K+L + + +++RE++I +L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPR 142
PNI++L D LI E+ YI EL
Sbjct: 66 -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA------ 116
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
AL YCHS+ ++HRD+KP N+++ + L++ D+G +
Sbjct: 117 ---------------------NALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWS- 153
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ P + + PE++ + +D +D+WSLG + + K P F + Q+
Sbjct: 154 VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQE 211
Query: 263 QLVKIARV 270
+I+RV
Sbjct: 212 TYKRISRV 219
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (337), Expect = 8e-38
Identities = 56/259 (21%), Positives = 101/259 (38%), Gaps = 51/259 (19%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------------KKKIKREIK 78
E+YE +GRG S V I+ ++ +KI+ ++ +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTD-FKVLY--PTLTANEIRYYIYEL 135
IL+ + G PNI++L D L+F+ + + F L TL+ E R + L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 136 LKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL 195
L + + H I+HRD+KP N+++D + ++L
Sbjct: 120 L---------------------------EVICALHKLNIVHRDLKPENILLDDDMN-IKL 151
Query: 196 IDWGLAEFYHPGKEYNVRVASRYFKGPELL-----VDLQDYDYSLDMWSLGCMFAGMIFR 250
D+G + PG++ + + PE++ + Y +DMWS G + ++
Sbjct: 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
Query: 251 KEPFFYGHDNQDQLVKIAR 269
P F+ L I
Sbjct: 212 SPP-FWHRKQMLMLRMIMS 229
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-37
Identities = 52/271 (19%), Positives = 98/271 (36%), Gaps = 40/271 (14%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 89
E Y + +GRG++ V + ++ + + K +K + +K+EI IL NI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149
+ L + I+E + + I
Sbjct: 64 LHLHESFESMEEL---------------------------VMIFEFISGLDIFERINTSA 96
Query: 150 EGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDWGLAEFYHP 206
L E + +AL + HS I H D++P N++ + +++I++G A P
Sbjct: 97 FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 207 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVK 266
G + + + + PE+ + DMWSLG + ++ P F NQ +
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINP-FLAETNQQIIEN 214
Query: 267 IARVLGTDELNAYLDKYHLELDPQLEALVGR 297
I T + ++ E+ + V R
Sbjct: 215 IMNAEYT-----FDEEAFKEISIEAMDFVDR 240
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (339), Expect = 2e-37
Identities = 48/274 (17%), Positives = 101/274 (36%), Gaps = 45/274 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPN 88
+ Y++ ++G G + V K + K+ +++EI+ + L P
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL----YPTLTANEIRYYIYELLKHAMPRKV 144
+V L D D + +I+E ++ + + ++ +E Y+ ++
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC-------- 134
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ-KLRLIDWGLAEF 203
+ L + H +H D+KP N+M ++ +L+LID+GL
Sbjct: 135 -------------------KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
P + V + F PE+ + Y DMWS+G + ++ P F G ++ +
Sbjct: 176 LDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSP-FGGENDDET 233
Query: 264 LVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
L + D + + + +
Sbjct: 234 LRNVKSCDWN-----MDDSAFSGISEDGKDFIRK 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 34/248 (13%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 89
Y + +G G Y V + N + IK + P + ++ REIKIL NI
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-ENI 68
Query: 90 VKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG 149
+ + DI+R + Y+ L A K++
Sbjct: 69 IGINDIIRAPTIE-----------------------QMKDVYLVTHLMGADLYKLLKTQH 105
Query: 150 EGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE 209
L+ L Y HS ++HRD+KP N++++ L++ D+GLA P +
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHD 164
Query: 210 YNV----RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265
+ VA+R+++ PE++++ + Y S+D+WS+GC+ A M+ + P F G DQL
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLN 223
Query: 266 KIARVLGT 273
I +LG+
Sbjct: 224 HILGILGS 231
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-36
Identities = 58/276 (21%), Positives = 112/276 (40%), Gaps = 42/276 (15%)
Query: 32 EDYEVVRKV-GRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 90
+DY+V +V G G +V + N EK +K+L+ K +RE+++ P+IV
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 91 KLLDIVRDQHS--KTPSLIFEHVNSTDF-----KVLYPTLTANEIRYYIYELLKHAMPRK 143
+++D+ + ++ K ++ E ++ + T E + +
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG------- 121
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQK--LRLIDWGLA 201
+A+ Y HS I HRDVKP N++ ++ L+L D+G A
Sbjct: 122 --------------------EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
+ + Y+ PE+L + YD S DMWSLG + ++ P FY +
Sbjct: 162 KETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGL 219
Query: 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
+ + + + + E+ +++ L+
Sbjct: 220 AISPGMKTRIRMGQYE-FPNPEWSEVSEEVKMLIRN 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-36
Identities = 59/277 (21%), Positives = 109/277 (39%), Gaps = 43/277 (15%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 86
EDYEV+ +G G Y + ++ + + K L +K+ + E+ +L+ L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
PNIV+ D + D+ + T ++ E+ D + ++ + +
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGD----------------LASVITKGTKERQYL 106
Query: 147 MPGEGLMENQDISVWDLQALDYCHSQG-----IMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
L + AL CH + ++HRD+KP NV +D +Q ++L D+GLA
Sbjct: 107 DEEFVLRVMTQL----TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLA 161
Query: 202 EFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
+ + V + Y+ PE + Y+ D+WSLGC+ + P F
Sbjct: 162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQ 219
Query: 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
++ KI + +L ++ R
Sbjct: 220 KELAGKI--------REGKFRRIPYRYSDELNEIITR 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-35
Identities = 66/265 (24%), Positives = 119/265 (44%), Gaps = 35/265 (13%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINV-TNNEKCIIKILKPVKKKK-----IKREIKILQNLCG 85
+ YE V ++G G Y +VF+ ++ +K ++ ++ RE+ +L++L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 86 G--PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRK 143
PN+V+L D+ + + + ++E + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKL----------------------TLVFEHVDQDLTTY 104
Query: 144 VIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
+ +P G+ D+ L+ LD+ HS ++HRD+KP N+++ Q +L D+GLA
Sbjct: 105 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLA 163
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
Y V + +++ PE+L+ Y +D+WS+GC+FA M RK P F G +
Sbjct: 164 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDV 221
Query: 262 DQLVKIARVLGTDELNAYLDKYHLE 286
DQL KI V+G + L
Sbjct: 222 DQLGKILDVIGLPGEEDWPRDVALP 246
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-35
Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 42/248 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 87
ED+++V+ +G G Y EV +N E +KI+ + + IK+EI I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHV-NSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKV 144
N+VK R L E+ F + P + + + + ++L
Sbjct: 64 NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--------- 112
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+ + Y H GI HRD+KP N+++D L++ D+GLA +
Sbjct: 113 ------------------MAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVF 153
Query: 205 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
N + + PELL + + +D+WS G + M+ + + +
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDS 212
Query: 262 DQLVKIAR 269
Q +
Sbjct: 213 CQEYSDWK 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-35
Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 86
YE + K+G+G + EVF+ + +K +K + +K+ REIKILQ L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
N+V L++I R + S P Y +++ +H + +
Sbjct: 69 ENVVNLIEICRTKAS-------------------PYNRCKGSIYLVFDFCEHDLAGLLSN 109
Query: 147 MPGEGLM-ENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
+ + + E + + L L Y H I+HRD+K NV+I + L+L D+GLA +
Sbjct: 110 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFS 168
Query: 206 PGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
K Y RV + +++ PELL+ +DY +D+W GC+ A M R P G+
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTE 227
Query: 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWP 302
Q QL I+++ G+ + + + EL +LE + G+KR
Sbjct: 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-35
Identities = 52/245 (21%), Positives = 99/245 (40%), Gaps = 39/245 (15%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP---VKKKKIKREIKILQNLCGGP 87
++ Y K+G+G V+ ++V ++ I+ + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVI 145
NIV LD ++ E++ + + +I E L
Sbjct: 78 NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------- 126
Query: 146 IMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFY 204
QAL++ HS ++HRD+K N+++ + ++L D+G +
Sbjct: 127 ------------------QALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQIT 167
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+ + V + Y+ PE++ + Y +D+WSLG M MI + P + + L
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPP-YLNENPLRAL 225
Query: 265 VKIAR 269
IA
Sbjct: 226 YLIAT 230
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-35
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 86
+ YE + K+G G Y VF+ N +E +K ++ + REI +L+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVII 146
NIV+L D++ ++E + +
Sbjct: 61 KNIVRLHDVLHSDKK---------------------------LTLVFEFCDQDLKKYFDS 93
Query: 147 MPGEGLMEN-QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFY 204
G+ E + L+ L +CHS+ ++HRD+KP N++I+ + +L ++GLA F
Sbjct: 94 CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFG 152
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
P + Y+ V + +++ P++L + Y S+DMWS GC+FA + P F G+D DQL
Sbjct: 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 265 VKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN 306
+I R+LGT + L + +
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-35
Identities = 71/317 (22%), Positives = 134/317 (42%), Gaps = 42/317 (13%)
Query: 14 RPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PV 68
RP ++ E W E Y+ + VG G Y V + + +K L +
Sbjct: 1 RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 69 KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEI 128
K+ RE+++L+++ N++ LLD+ S
Sbjct: 60 HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE----------------------EFN 96
Query: 129 RYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH 188
Y+ L A ++ Q + L+ L Y HS I+HRD+KP N+ ++
Sbjct: 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156
Query: 189 EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248
+ + +++D+GLA H E VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++
Sbjct: 157 DCEL-KILDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 249 FRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKK 308
+ F G D+ DQL I R++GT EL ++ + R + + K
Sbjct: 214 TGRTL-FPGTDHIDQLKLILRLVGT---------PGAELLKKISSESARNYIQSLTQMPK 263
Query: 309 LQFCRSSRTSTNICITF 325
+ F + + +
Sbjct: 264 MNFANVFIGANPLAVDL 280
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 9e-35
Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 46/249 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK------KKIKREIKILQNLCG 85
+ + +R++G G + V+ +V N+E IK + K + I +E++ LQ L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNST---DFKVLYPTLTANEIRYYIYELLKHAMPR 142
PN ++ +H T L+ E+ + +V L EI + L
Sbjct: 75 -PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL------ 125
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
Q L Y HS ++HRDVK N+++ ++L D+G A
Sbjct: 126 ---------------------QGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSAS 163
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260
P + V + Y+ PE+++ + + YD +D+WSLG + RK P F +
Sbjct: 164 IMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNA 219
Query: 261 QDQLVKIAR 269
L IA+
Sbjct: 220 MSALYHIAQ 228
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 9e-35
Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 38/262 (14%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 86
E+++ V K+G G Y V++ N E +K ++ + + REI +L+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDF--KVLYPTLTANEIRYYIYELLKHAMPRKV 144
PNIVKLLD++ ++ F H + F + I+ Y+++
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ---------- 110
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
LQ L +CHS ++HRD+KP N++I+ E ++L D+GLA +
Sbjct: 111 -----------------LLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAF 152
Query: 205 H-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
P + Y V + +++ PE+L+ + Y ++D+WSLGC+FA M+ R+ F G DQ
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQ 211
Query: 264 LVKIARVLGTDELNAYLDKYHL 285
L +I R LGT + + +
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSM 233
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-34
Identities = 67/268 (25%), Positives = 126/268 (47%), Gaps = 42/268 (15%)
Query: 16 RDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKK 70
++ E W + Y ++ VG G Y V ++ K IK L +
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 71 KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS----LIFEHVNSTDFKVL-YPTLTA 125
K+ RE+++L+++ N++ LLD+ + L+ + + K++ + L
Sbjct: 62 KRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 126 NEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185
+ I++ +Y++LK L Y H+ GI+HRD+KP N+
Sbjct: 121 DRIQFLVYQMLK---------------------------GLRYIHAAGIIHRDLKPGNLA 153
Query: 186 IDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 245
++ + + +++D+GLA E V +R+++ PE++++ Y ++D+WS+GC+ A
Sbjct: 154 VNEDCEL-KILDFGLA--RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 246 GMIFRKEPFFYGHDNQDQLVKIARVLGT 273
MI K F G D+ DQL +I +V GT
Sbjct: 211 EMITGKTL-FKGSDHLDQLKEIMKVTGT 237
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-33
Identities = 78/263 (29%), Positives = 126/263 (47%), Gaps = 44/263 (16%)
Query: 35 EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--------KKIKREIKILQNLCGG 86
E + +G G+++ V++ + N+ IK +K + + REIK+LQ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRK 143
PNI+ LLD H SL+F+ + + ++ LT + I+ Y+ L
Sbjct: 60 PNIIGLLDA--FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL------- 110
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-E 202
Q L+Y H I+HRD+KP+N+++D E L+L D+GLA
Sbjct: 111 --------------------QGLEYLHQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKS 149
Query: 203 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
F P + Y +V +R+++ PELL + Y +DMW++GC+ A ++ R PF G + D
Sbjct: 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLD 208
Query: 263 QLVKIARVLGTDELNAYLDKYHL 285
QL +I LGT + D L
Sbjct: 209 QLTRIFETLGTPTEEQWPDMCSL 231
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (305), Expect = 4e-33
Identities = 73/263 (27%), Positives = 128/263 (48%), Gaps = 42/263 (15%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 86
E Y + K+G G Y V++ N E +K ++ K REI IL+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELK-H 59
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPRK 143
NIVKL D++ + L+FEH++ K+L L + + ++ +L
Sbjct: 60 SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL-------- 109
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
L + YCH + ++HRD+KP N++I+ E + L++ D+GLA
Sbjct: 110 -------------------LNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARA 149
Query: 204 YH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ P ++Y + + +++ P++L+ + Y ++D+WS+GC+FA M+ P F G D
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEAD 208
Query: 263 QLVKIARVLGTDELNAYLDKYHL 285
QL++I R+LGT + + L
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTEL 231
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-33
Identities = 50/254 (19%), Positives = 96/254 (37%), Gaps = 21/254 (8%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE-----KCIIKILK----PVKKKKIKREIKIL 80
+E+ E + +G G + +V ++ + +K+LK +++ + E+K++
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
L NIV LL S LIFE+ D L L + ++ E+
Sbjct: 95 TQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGD---LLNYLRSKREKFSEDEIEYENQ 149
Query: 141 PRKVIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
R L + + +++ + +HRD+ NV++ H + +++ D+
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDF 208
Query: 199 GLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
GLA Y VR + PE L + Y D+WS G + + +
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 256 YGHDNQDQLVKIAR 269
G K+ +
Sbjct: 268 PGIPVDANFYKLIQ 281
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-32
Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 40/236 (16%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------KKKIKREIKILQ 81
+ Y+V +G G + V+ GI V++N IK ++ + ++ E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 82 NLCGG-PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL--YPTLTANEIRYYIYELLKH 138
+ G +++LLD S L F + L R + +++L+
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE- 121
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
A+ +CH+ G++HRD+K N++ID + +L+LID+
Sbjct: 122 --------------------------AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 199 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254
G Y +R + PE + + + S +WSLG + M+ PF
Sbjct: 156 GSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-32
Identities = 57/276 (20%), Positives = 108/276 (39%), Gaps = 46/276 (16%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP----VKKKKIKREIKILQNLCGG 86
++ Y+ +G G +SEV + + IK + K+ ++ EI +L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66
Query: 87 PNIVKLLDIVRDQHSKTPSLIFEHVNSTD-FKVLY--PTLTANEIRYYIYELLKHAMPRK 143
PNIV L DI LI + V+ + F + T + I+++
Sbjct: 67 PNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV-------- 116
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDH--EQQKLRLIDWGLA 201
L A+ Y H GI+HRD+KP N++ E K+ + D+GL+
Sbjct: 117 -------------------LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
+ PG + + + PE+L + Y ++D WS+G + ++ P FY ++
Sbjct: 158 KMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDA 215
Query: 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
+I + + Y ++ + +
Sbjct: 216 KLFEQILKAEYE-----FDSPYWDDISDSAKDFIRH 246
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-32
Identities = 54/250 (21%), Positives = 101/250 (40%), Gaps = 45/250 (18%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP------VKKKKIKREIKILQNLCG 85
ED++ + +G G +S V + + + IKIL+ K + RE ++ L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 66
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTD---FKVLYPTLTANEIRYYIYELLKHAMPR 142
P VKL +D + + + + + R+Y E+
Sbjct: 67 HPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI------- 117
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+ AL+Y H +GI+HRD+KP N++++ + +++ D+G A+
Sbjct: 118 --------------------VSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAK 156
Query: 203 FYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
P + N V + + PELL + + S D+W+LGC+ ++ P F +
Sbjct: 157 VLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPP-FRAGN 214
Query: 260 NQDQLVKIAR 269
KI +
Sbjct: 215 EYLIFQKIIK 224
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 9e-31
Identities = 53/279 (18%), Positives = 107/279 (38%), Gaps = 48/279 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------KKKIKREIKILQN 82
+ Y+ ++G G+++ V + + + K +K + ++ I+RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
+ PN++ L ++ ++ I EL+
Sbjct: 70 IQ-HPNVITLHEVYENKTD---------------------------VILILELVAGGELF 101
Query: 143 KVIIMPGEGLMEN-QDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHE---QQKLRLIDW 198
+ E + L + Y HS I H D+KP N+M+ + ++++ID+
Sbjct: 102 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 199 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
GLA G E+ + F PE++ + + DMWS+G + ++ P F G
Sbjct: 162 GLAHKIDFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASP-FLGD 219
Query: 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
Q+ L ++ V + D+Y + + R
Sbjct: 220 TKQETLANVSAVNYE-----FEDEYFSNTSALAKDFIRR 253
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 9e-31
Identities = 48/248 (19%), Positives = 96/248 (38%), Gaps = 43/248 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN 88
+ ++GRG + V++G++ + L+ K +++ K E ++L+ L PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 89 IVKLLDIVRD--QHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPRK 143
IV+ D + K L+ E + S K + + +R + ++LK
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK------ 123
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
L + H++ I+HRD+K N+ I +++ D GLA
Sbjct: 124 ---------------------GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
V + + F PE+ + YD S+D+++ G M + P+ +
Sbjct: 163 TLKRASFAKAV-IGTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219
Query: 262 DQLVKIAR 269
++
Sbjct: 220 QIYRRVTS 227
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 44/280 (15%), Positives = 104/280 (37%), Gaps = 49/280 (17%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKKKIKREIKILQNLC 84
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 85 GGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
NI+ + + + + +
Sbjct: 63 H-VNILLFMGYSTAPQ----------------------------LAIVTQWCEGSSLYHH 93
Query: 145 IIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+ + + DI+ Q +DY H++ I+HRD+K +N+ + + +++ D+GLA
Sbjct: 94 LHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLAT 152
Query: 203 FYHPGKEYNVR---VASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYG 257
+ S + PE++ Y + D+++ G + ++ + P +
Sbjct: 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSN 211
Query: 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
+N+DQ++ + +G L+ L K ++ L+
Sbjct: 212 INNRDQIIFM---VGRGYLSPDLSKVRSNCPKAMKRLMAE 248
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (285), Expect = 2e-30
Identities = 56/281 (19%), Positives = 99/281 (35%), Gaps = 49/281 (17%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLC 84
+ YE+ +G G SEV ++ + +K+L+ P + +RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 85 GGPNIVKLLDIVRDQHSKTPS--LIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHA 139
P IV + D + P ++ E+V+ + + +T I +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA---- 120
Query: 140 MPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQ---KLRLI 196
QAL++ H GI+HRDVKP N+MI I
Sbjct: 121 -----------------------CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 157
Query: 197 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
+A+ + + + + + PE D D++SLGC+ ++ + P F
Sbjct: 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPP-FT 215
Query: 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
G + R H L L+A+V +
Sbjct: 216 GDSPVSVAYQHVREDPI-----PPSARHEGLSADLDAVVLK 251
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 4e-30
Identities = 49/246 (19%), Positives = 99/246 (40%), Gaps = 42/246 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCG 85
ED+ + + +G+G + +VF N+ IK LK + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL---YPTLTANEIRYYIYELLKHAMPR 142
P + + + + + + E++N D + +Y E++
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII------ 113
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA- 201
L + HS+GI++RD+K N+++D + ++ D+G+
Sbjct: 114 ---------------------LGLQFLHSKGIVYRDLKLDNILLDKDGHI-KIADFGMCK 151
Query: 202 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261
E + N + + PE+L+ Q Y++S+D WS G + M+ + P F+G D +
Sbjct: 152 ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEE 209
Query: 262 DQLVKI 267
+ I
Sbjct: 210 ELFHSI 215
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (288), Expect = 5e-30
Identities = 53/251 (21%), Positives = 97/251 (38%), Gaps = 37/251 (14%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCG 85
D+ V R +GRG + EV+ + +K L + + E +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 86 G--PNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRK 143
G P IV + S I + +N D L + + +
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGD--------------------LHYHLSQH 101
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
+ + + + + L++ H++ +++RD+KP N+++D E +R+ D GLA
Sbjct: 102 GVFSE----ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACD 156
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ K + + + PE+L YD S D +SLGCM ++ P F H +D+
Sbjct: 157 FSKKKPHASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDK 214
Query: 264 LVKIARVLGTD 274
L
Sbjct: 215 HEIDRMTLTMA 225
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 9e-30
Identities = 59/266 (22%), Positives = 115/266 (43%), Gaps = 40/266 (15%)
Query: 17 DYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-----PVKKK 71
++ E + + Y+ ++ +G G V + + IK L K
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 72 KIKREIKILQNLCGGPNIVKLLDIVRDQHS----KTPSLIFEHVNSTDFKVLYPTLTANE 127
+ RE+ +++ + NI+ LL++ Q + + L+ E +++ +V+ L
Sbjct: 62 RAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 128 IRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMID 187
+ Y +Y++ L + + HS GI+HRD+KP N+++
Sbjct: 121 MSYLLYQM---------------------------LCGIKHLHSAGIIHRDLKPSNIVVK 153
Query: 188 HEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247
+ +++D+GLA V +RY++ PE+++ Y ++D+WS+GC+ M
Sbjct: 154 SDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEM 211
Query: 248 IFRKEPFFYGHDNQDQLVKIARVLGT 273
+ K F G D DQ K+ LGT
Sbjct: 212 VRHK-ILFPGRDYIDQWNKVIEQLGT 236
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 2e-29
Identities = 45/250 (18%), Positives = 91/250 (36%), Gaps = 15/250 (6%)
Query: 31 QEDYEVVRKVGRGKYSEVFEG-----INVTNNEKCIIKILKPVK----KKKIKREIKILQ 81
+ + E VR +G G + VF+ + +K+LK + +RE ++
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
PNIVKLL + K L+FE++ D +++ + + + L
Sbjct: 72 EFDN-PNIVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 142 RKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA 201
P E I+ + Y + +HRD+ N ++ +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLS 187
Query: 202 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
+ Y A P + Y D+W+ G + + +YG
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 260 NQDQLVKIAR 269
+++ + +
Sbjct: 248 HEEVIYYVRD 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-29
Identities = 34/241 (14%), Positives = 95/241 (39%), Gaps = 31/241 (12%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK-PVKKKKIKREIKILQNLCGGPN 88
+ ++ ++++ +G+G++ +V G K +K +K + E ++ L N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SN 61
Query: 89 IVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMP 148
+V+LL ++ ++ ++ E++ + Y+ + + ++
Sbjct: 62 LVQLLGVIVEEKGG-LYIVTEYMAKGS------------LVDYLRSRGRSVLGGDCLL-- 106
Query: 149 GEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK 208
S+ +A++Y +HRD+ NV++ + ++ D+GL + +
Sbjct: 107 --------KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ 157
Query: 209 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIA 268
+ + PE L + + + D+WS G + + + +D + ++
Sbjct: 158 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214
Query: 269 R 269
+
Sbjct: 215 K 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-28
Identities = 38/246 (15%), Positives = 81/246 (32%), Gaps = 18/246 (7%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNL 83
D D + +G G + +V + + + I + + E+++L L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 84 CGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRK 143
PNI+ LL +H L E+ + +R A
Sbjct: 68 GHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDF--------LRKSRVLETDPAFAIA 117
Query: 144 VIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEF 203
+ + + +DY + +HRD+ N+++ E ++ D+GL+
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRG 176
Query: 204 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ + + E L Y + D+WS G + ++ + G +
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 264 LVKIAR 269
K+ +
Sbjct: 236 YEKLPQ 241
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-28
Identities = 46/251 (18%), Positives = 88/251 (35%), Gaps = 20/251 (7%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEG-----INVTNNEKCIIKILKPVK----KKKIKREIKIL 80
+ + +G G + +V E I +K+LKP ++ + E+K+L
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
L NIV LL +I E+ D L L + + M
Sbjct: 81 SYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGD---LLNFLRRKRDSFICSKTSPAIM 135
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+ + L + S + + + S+ +HRD+ N+++ H + ++ D+GL
Sbjct: 136 EDDELALD---LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGL 191
Query: 201 AEFYHPGKEYNVRVASRYFKG--PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
A Y V+ +R + Y + D+WS G + + G
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 259 DNQDQLVKIAR 269
+ K+ +
Sbjct: 252 PVDSKFYKMIK 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (272), Expect = 3e-28
Identities = 40/257 (15%), Positives = 88/257 (34%), Gaps = 45/257 (17%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKIL-KPVKKKKIKREIKILQNLCGGPNIVKL 92
Y+V R++G G + +FEG N+ NN++ IK + +++ E + + L G I +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
++ + L ++ + G
Sbjct: 67 YYFGQEGL----------------------------HNVLVIDLLGPSLEDLLDLCGRKF 98
Query: 153 MENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQK----LRLIDWGLAEFYHP 206
+ L + H + +++RD+KP N +I K + ++D+G+ +FY
Sbjct: 99 SVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158
Query: 207 G--------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258
+E + + + ++ D+ +LG +F + + G
Sbjct: 159 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGL 216
Query: 259 DNQDQLVKIARVLGTDE 275
K R+ +
Sbjct: 217 KAATNKQKYERIGEKKQ 233
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-28
Identities = 38/246 (15%), Positives = 87/246 (35%), Gaps = 37/246 (15%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
+E ++V ++G G++ EV+ G + K +K LK + E +++ L
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-Q 68
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
+V+L +V + Y I E +++ +
Sbjct: 69 RLVRLYAVVTQEP----------------------------IYIITEYMENGSLVDFLKT 100
Query: 148 PGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
P + + Q + + + +HRD++ N+++ + ++ D+GLA
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV-SDTLSCKIADFGLARLI 159
Query: 205 HPGKEYNVRVASRYFKG-PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ A K ++ + D+WS G + ++ + G N +
Sbjct: 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 264 LVKIAR 269
+ + R
Sbjct: 220 IQNLER 225
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-27
Identities = 38/254 (14%), Positives = 82/254 (32%), Gaps = 44/254 (17%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCI---IKILKPVK------KKKIKREIKIL 80
++D ++ K+G G + V G + K + +K LKP RE+ +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
+L N+++L +V + EL
Sbjct: 66 HSLDH-RNLIRLYGVVLTPP----------------------------MKMVTELAPLGS 96
Query: 141 PRKVIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
+ + +V + + Y S+ +HRD+ N+++ +++ D+
Sbjct: 97 LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDF 155
Query: 199 GLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
GL ++ V + + + + ++ D W G M + +
Sbjct: 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215
Query: 256 YGHDNQDQLVKIAR 269
G + L KI +
Sbjct: 216 IGLNGSQILHKIDK 229
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 40/244 (16%), Positives = 91/244 (37%), Gaps = 33/244 (13%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
D + V+++G G++ V G N +K IK ++ + ++ E +++ L P
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-P 60
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
+V+L + +Q L+FE + L + + +
Sbjct: 61 KLVQLYGVCLEQAP--ICLVFEFMEHGC--------------------LSDYLRTQRGLF 98
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG 207
E L+ + + + + Y ++HRD+ N ++ Q +++ D+G+ F
Sbjct: 99 AAETLL---GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDD 154
Query: 208 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLV 265
+ + + PE+ Y D+WS G + + + + N + +
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 266 KIAR 269
I+
Sbjct: 214 DIST 217
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-27
Identities = 39/247 (15%), Positives = 86/247 (34%), Gaps = 39/247 (15%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
+E + K+G+G + EV+ G + IK LKP + + +E ++++ L
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 72
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
+V+L +V ++ Y + E + +
Sbjct: 73 KLVQLYAVVSEEP----------------------------IYIVTEYMSKGSLLDFLKG 104
Query: 148 PGEGLMENQDISVWDLQA---LDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+ + Q + Y +HRD++ N+++ ++ D+GLA
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLI 163
Query: 205 HPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ + PE + + D+WS G + + + + G N++
Sbjct: 164 EDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
Query: 263 QLVKIAR 269
L ++ R
Sbjct: 223 VLDQVER 229
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 5e-27
Identities = 39/248 (15%), Positives = 92/248 (37%), Gaps = 37/248 (14%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 87
D +D ++++G G++ V G IK++K + + + E K++ NL
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-E 59
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
+V+L + Q + I E + + +
Sbjct: 60 KLVQLYGVCTKQRP---------------------------IFIITEYMANGCLLNYLRE 92
Query: 148 PGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYH 205
Q ++ +A++Y S+ +HRD+ N +++ + +++ D+GL+ +
Sbjct: 93 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVL 151
Query: 206 PGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ + + PE+L+ + D+W+ G + + + + N +
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210
Query: 264 LVKIARVL 271
IA+ L
Sbjct: 211 AEHIAQGL 218
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (261), Expect = 2e-26
Identities = 45/245 (18%), Positives = 92/245 (37%), Gaps = 40/245 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK------PVKKKKIKREIKILQNLCG 85
+D++++R +G G + V + N +K+LK + + E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 86 GPNIVKLLDIVRDQHSKTPSLIF-EHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
P I+++ +D + + E ++Y E+
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA------ 116
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
L+Y HS+ I++RD+KP N+++D +++ D+G A++
Sbjct: 117 ---------------------LEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYV 154
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+ + PE++ + Y+ S+D WS G + M+ P FY +
Sbjct: 155 P--DVTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTY 210
Query: 265 VKIAR 269
KI
Sbjct: 211 EKILN 215
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 4e-26
Identities = 45/245 (18%), Positives = 93/245 (37%), Gaps = 40/245 (16%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIK------REIKILQNLCG 85
+ ++ ++ +G G + V + + +KIL K K+K E +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 86 GPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL-YPTLTANEIRYYIYELLKHAMPRKV 144
P +VKL +D + + + + + R+Y +++
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV-------- 151
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+Y HS +++RD+KP N++ID + +++ D+G A+
Sbjct: 152 -------------------LTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRV 191
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+ PE+++ + Y+ ++D W+LG + M P F+
Sbjct: 192 KG--RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPP-FFADQPIQIY 247
Query: 265 VKIAR 269
KI
Sbjct: 248 EKIVS 252
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 5e-26
Identities = 51/280 (18%), Positives = 112/280 (40%), Gaps = 48/280 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTN---NEKCIIKILKPVK-------KKKIKREIKILQ 81
E++E+++ +G G Y +VF ++ + +K+LK + + E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVL-YPTLTANEIRYYIYELLKHAM 140
++ P +V L + + L + + + T +E++ Y+ E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+ AL++ H GI++RD+K N+++D + L D+GL
Sbjct: 139 ----------------------VLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGL 175
Query: 201 AEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
++ + + Y+ Y + +D ++D WSLG + ++ P F
Sbjct: 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-FTV 234
Query: 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR 297
++ +I+R + E Y E+ + L+ R
Sbjct: 235 DGEKNSQAEISRRILKSEP-----PYPQEMSALAKDLIQR 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 6e-26
Identities = 43/245 (17%), Positives = 84/245 (34%), Gaps = 37/245 (15%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCG 85
D++ ++ +G+G + +V +KIL+ E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63
Query: 86 GPNIVKLLDIVRD-QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKV 144
P + L + T R+Y E+
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI--------- 114
Query: 145 IIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+ AL+Y HS+ +++RD+K N+M+D + +++ D+GL +
Sbjct: 115 ------------------VSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEG 155
Query: 205 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264
+++ DY ++D W LG + M+ + P FY D++
Sbjct: 156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLF 214
Query: 265 VKIAR 269
I
Sbjct: 215 ELILM 219
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 1e-25
Identities = 36/246 (14%), Positives = 85/246 (34%), Gaps = 35/246 (14%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKKIKREIKILQNLCGGP 87
++ D + K+G G+Y EV+EG+ + +K LK ++ ++ +E +++ + P
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 73
Query: 88 NIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIM 147
N+V+LL + + Y I E + + +
Sbjct: 74 NLVQLLGVCTREPP---------------------------FYIITEFMTYGNLLDYLRE 106
Query: 148 PGEGLMENQDISVWDLQ---ALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFY 204
+ + Q A++Y + +HRD+ N ++ +++ D+GL+
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLM 165
Query: 205 HPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ + + D+W+ G + + + G D
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225
Query: 264 LVKIAR 269
+ +
Sbjct: 226 YELLEK 231
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (254), Expect = 1e-25
Identities = 41/247 (16%), Positives = 90/247 (36%), Gaps = 39/247 (15%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 92
Y + RK+G G + +++ G ++ E+ IK+ K ++ E KI + + GG I +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGL 152
+ ++ E + + ++ K +++ + +
Sbjct: 69 RWCGAEGDY--NVMVMELLGPSL--------------EDLFNFCSRKFSLKTVLLLADQM 112
Query: 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRL--IDWGLAEFYHPGKEY 210
+ ++Y HS+ +HRDVKP N ++ ++ + ID+GLA+ Y + +
Sbjct: 113 ----------ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 211 NVR--------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262
+ + + + D+ SLG + + G
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAAT 220
Query: 263 QLVKIAR 269
+ K R
Sbjct: 221 KRQKYER 227
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (251), Expect = 3e-25
Identities = 38/256 (14%), Positives = 84/256 (32%), Gaps = 47/256 (18%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-------KKIKREIKILQN 82
D ++ + +G G++ EV G ++ I +K +K + E I+
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKH 138
PN++ L +V +I E + + T ++ + +
Sbjct: 84 FDH-PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA- 139
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
+ Y +HRD+ N++++ ++ D+
Sbjct: 140 --------------------------GMKYLADMNYVHRDLAARNILVNSNLV-CKVSDF 172
Query: 199 GLAEFYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEP 253
GL+ F ++ K P + + + D+WS G + ++ E
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
Query: 254 FFYGHDNQDQLVKIAR 269
++ NQD + I +
Sbjct: 233 PYWDMTNQDVINAIEQ 248
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 1e-24
Identities = 45/252 (17%), Positives = 92/252 (36%), Gaps = 44/252 (17%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK-------KKIKREIKILQN 82
+E E+ R +G G++ +V +GI ++ + +K K +K +E ++
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKH 138
P+IVKL+ ++ + +I E + + +L + Y Y+L
Sbjct: 65 F-DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST- 119
Query: 139 AMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
AL Y S+ +HRD+ NV++ ++L D+
Sbjct: 120 --------------------------ALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDF 152
Query: 199 GLAEFYHPGKEYNV-RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257
GL+ + Y + ++ + + + D+W G ++ F G
Sbjct: 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212
Query: 258 HDNQDQLVKIAR 269
N D + +I
Sbjct: 213 VKNNDVIGRIEN 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-24
Identities = 38/250 (15%), Positives = 94/250 (37%), Gaps = 40/250 (16%)
Query: 31 QEDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKPVKKKK----IKREIKILQN 82
+ +++ ++ +G G + V++G+ + E IK L+ K I E ++ +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
+ P++ +LL I + LI + + L +
Sbjct: 68 VDN-PHVCRLLGICLTSTVQ---LITQ--------------------LMPFGCLLDYVRE 103
Query: 143 KVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+ + L+ + V + ++Y + ++HRD+ NV++ Q +++ D+GLA+
Sbjct: 104 HKDNIGSQYLL---NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAK 159
Query: 203 FYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259
++ + E ++ + Y + D+WS G ++ + G
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218
Query: 260 NQDQLVKIAR 269
+ + +
Sbjct: 219 ASEISSILEK 228
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 4e-24
Identities = 37/253 (14%), Positives = 89/253 (35%), Gaps = 44/253 (17%)
Query: 30 DQEDYEVV-RKVGRGKYSEVFEGINVTNNEKCI--IKILKPVKKKK----IKREIKILQN 82
+++ + ++G G + V +G+ ++ IK+LK +K + RE +I+
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 83 LCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPR 142
L P IV+L+ + + + + E+
Sbjct: 66 L-DNPYIVRLIGVCQAEA----------------------------LMLVMEMAGGGPLH 96
Query: 143 KVIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
K ++ E + + ++ + Y + +HRD+ NV++ + ++ D+GL
Sbjct: 97 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGL 155
Query: 201 AEFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
++ Y + PE + + + D+WS G + + +
Sbjct: 156 SKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK 214
Query: 257 GHDNQDQLVKIAR 269
+ + I +
Sbjct: 215 KMKGPEVMAFIEQ 227
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 4e-24
Identities = 44/246 (17%), Positives = 86/246 (34%), Gaps = 43/246 (17%)
Query: 38 RKVGRGKYSEVFEGINVTNNEKCI---IKILKPVKK----KKIKREIKILQNLCGGPNIV 90
+GRG + V+ G + N+ K I +K L + + E I+++ PN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 91
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGE 150
LL I + +KH R I
Sbjct: 92 SLLGICLRSEGS--------------------------PLVVLPYMKHGDLRNFIRNETH 125
Query: 151 GLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK 208
+ + + + S+ +HRD+ N M+D + +++ D+GLA + +
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKE 184
Query: 209 EYNVRVASRY-----FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+V + + E L Q + D+WS G + ++ R P + + D
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243
Query: 264 LVKIAR 269
V + +
Sbjct: 244 TVYLLQ 249
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 2e-23
Identities = 55/251 (21%), Positives = 99/251 (39%), Gaps = 23/251 (9%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNIVK 91
Y +VRK+G G +S V+ ++ NN +KI++ V + + EIK+LQ + + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV-NDADNTK 73
Query: 92 LLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEG 151
+ + K + V+ + + I + +P +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV------ 127
Query: 152 LMENQDISVWDLQALDYC-HSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY 210
+ IS L LDY GI+H D+KP NV+++ LI +A+ +
Sbjct: 128 ----KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 211 NVRVAS---RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-----FYGHDNQD 262
S R ++ PE+L+ + D+WS C+ +I F + D
Sbjct: 184 EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 263 QLVKIARVLGT 273
+ +I +LG
Sbjct: 243 HIAQIIELLGE 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.3 bits (226), Expect = 7e-22
Identities = 37/246 (15%), Positives = 80/246 (32%), Gaps = 47/246 (19%)
Query: 38 RKVGRGKYSEVFEGINVTN--NEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 90
+++G G + V +G + +KILK P K ++ E ++Q L P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYP---TLTANEIRYYIYELLKHAMPRKVIIM 147
+++ I + L+ E + I ++++
Sbjct: 72 RMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS----------- 117
Query: 148 PGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPG 207
+ Y +HRD+ NV++ + ++ D+GL++
Sbjct: 118 ----------------MGMKYLEESNFVHRDLAARNVLLVTQHY-AKISDFGLSKALRAD 160
Query: 208 KEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263
+ Y + PE + + D+WS G + + + G +
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219
Query: 264 LVKIAR 269
+ +
Sbjct: 220 TAMLEK 225
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-21
Identities = 42/259 (16%), Positives = 92/259 (35%), Gaps = 40/259 (15%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE-------KCIIKILKPVKKKK----IKREIK 78
++ + + +G G + +V + ++ K +K+LK +K + E++
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 79 ILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKH 138
+++ + NI+ LL +I E+ + + + E L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGN----------------LREYLQA 112
Query: 139 AMPRKVIIMPGEGLMENQDISVWD--------LQALDYCHSQGIMHRDVKPHNVMIDHEQ 190
P + + +S D + ++Y S+ +HRD+ NV++ +
Sbjct: 113 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172
Query: 191 QKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMI 248
++ D+GLA H Y R L D Y + D+WS G + +
Sbjct: 173 VM-KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 249 FRKEPFFYGHDNQDQLVKI 267
+ G ++ +
Sbjct: 232 TLGGSPYPGVPVEELFKLL 250
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 1e-21
Identities = 39/252 (15%), Positives = 84/252 (33%), Gaps = 44/252 (17%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEK----CIIKILKPV----KKKKIKREIKILQ 81
+ +G G++ EV++G+ T++ K IK LK ++ E I+
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMP 141
NI++L ++ I E +++
Sbjct: 65 QFSH-HNIIRLEGVISKYKP---------------------------MMIITEYMENGAL 96
Query: 142 RKVIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWG 199
K + Q + + Y + +HRD+ N++++ ++ D+G
Sbjct: 97 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFG 155
Query: 200 LAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
L+ E + + PE + + S D+WS G + ++ E +
Sbjct: 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPY 214
Query: 256 YGHDNQDQLVKI 267
+ N + + I
Sbjct: 215 WELSNHEVMKAI 226
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 2e-21
Identities = 39/253 (15%), Positives = 95/253 (37%), Gaps = 25/253 (9%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGI-----NVTNNEKCIIKILKP----VKKKKIKREIKIL 80
++ ++ + +GRG + +V E +K+LK + + + E+KIL
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
++ N+V LL +I E + +R E + + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTY--------LRSKRNEFVPYKV 121
Query: 141 PRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGL 200
+ + L S + +++ S+ +HRD+ N+++ + +++ D+GL
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGL 180
Query: 201 AEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256
A + +Y + R+ ++ + + Y D+WS G + + +
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 257 GHDNQDQLVKIAR 269
G ++ + +
Sbjct: 239 GVKIDEEFCRRLK 251
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-21
Identities = 40/254 (15%), Positives = 90/254 (35%), Gaps = 35/254 (13%)
Query: 30 DQEDYEVVRKVGRGKYSEVFEGIN-----VTNNEKCIIKILKPVK----KKKIKREIKIL 80
+E + R++G+G + V+EG+ + IK + + + E ++
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 81 QNLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAM 140
+ ++V+LL +V + +I E + D + L+
Sbjct: 78 KEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGD----------------LKSYLRSLR 118
Query: 141 PRKVIIMPGEGLMENQ--DISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDW 198
P ++ ++ + Y ++ +HRD+ N M+ + +++ D+
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDF 177
Query: 199 GLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255
G+ + Y + + PE L D + D+WS G + + E +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY 236
Query: 256 YGHDNQDQLVKIAR 269
G N+ L +
Sbjct: 237 QGLSNEQVLRFVME 250
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 5e-21
Identities = 40/255 (15%), Positives = 87/255 (34%), Gaps = 45/255 (17%)
Query: 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 90
+ +G+G++ EV+ G E+ +KI +++ RE +I Q + NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 91 KLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGE 150
+ + L + + + +H +
Sbjct: 61 GFIAADNKDNGTWTQL-----------------------WLVSDYHEHGSLFDYLNRYTV 97
Query: 151 GLMENQDISVWDLQALDYCHSQ--------GIMHRDVKPHNVMIDHEQQKLRLIDWGLAE 202
+ +++ L + H + I HRD+K N+++ + D GLA
Sbjct: 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAV 156
Query: 203 FYHPGKEY-----NVRVASRYFKGPELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKE 252
+ + N RV ++ + PE+L + + D++++G +F + R
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 253 PFFYGHDNQDQLVKI 267
D Q +
Sbjct: 217 IGGIHEDYQLPYYDL 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.9 bits (178), Expect = 6e-16
Identities = 37/217 (17%), Positives = 69/217 (31%), Gaps = 35/217 (16%)
Query: 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 93
+ + +G GK S VF + +C++K K K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSF------------------KKV 42
Query: 94 DIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPG-EGL 152
RD S++ +F+ L + Y +E M +
Sbjct: 43 KEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV 102
Query: 153 MENQDISVWDLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLA-EFYHPGKEY- 210
++ L+ + + +GI+H D+ +NV++ E +ID+ + E G
Sbjct: 103 ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREI 160
Query: 211 ---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 244
+VR YF + Y D+ S
Sbjct: 161 LERDVRNIITYFS--------RTYRTEKDINSAIDRI 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 332 | |||
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.89 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.9e-58 Score=410.44 Aligned_cols=304 Identities=69% Similarity=1.178 Sum_probs=262.7
Q ss_pred CccccccccccCCCCCccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHH
Q 040656 2 SRARVYADVNVHRPRDYWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQ 81 (332)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~ 81 (332)
|++.||++++.+.|+.||++....+++.+.++|+++++||+|+||+||+|++..+++.||+|++++...+.+.+|+.+|+
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~ 84 (328)
T d3bqca1 5 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE 84 (328)
T ss_dssp CCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHH
T ss_pred CcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999999999999999999999999999999999999888889999999999
Q ss_pred hccCCCCeeeeeeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHh
Q 040656 82 NLCGGPNIVKLLDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVW 161 (332)
Q Consensus 82 ~l~~h~niv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (332)
++.+||||++++++|.......+++||||+.++++..+.+.+++..++.++.|++.
T Consensus 85 ~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~------------------------ 140 (328)
T d3bqca1 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK------------------------ 140 (328)
T ss_dssp HHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHH------------------------
T ss_pred hccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHH------------------------
Confidence 99679999999999987777789999999999999998889999998888888877
Q ss_pred HHHHHHHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHH
Q 040656 162 DLQALDYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 241 (332)
Q Consensus 162 i~~~l~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG 241 (332)
||.|||++||+||||||+|||++.++..++|+|||+|+............+|..|+|||.+.+...++.++||||+|
T Consensus 141 ---aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 217 (328)
T d3bqca1 141 ---ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 217 (328)
T ss_dssp ---HHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred ---HHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhh
Confidence 99999999999999999999999777689999999999887666677778999999999988766789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCC--cccccccccccc
Q 040656 242 CMFAGMIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPN--NKKLQFCRSSRT 317 (332)
Q Consensus 242 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~--~~~~~~~~~~~~ 317 (332)
|++|+|++|..||....+..+....+...++.+...++.........+.....+... ..|.... ...........+
T Consensus 218 ~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 297 (328)
T d3bqca1 218 CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297 (328)
T ss_dssp HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHH
T ss_pred hhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHH
Confidence 999999999999987778788888888888887777777777666666655544333 1221111 111222334457
Q ss_pred cCceEEEeCCCCCCC
Q 040656 318 STNICITFSPSGFPF 332 (332)
Q Consensus 318 ~~~~cl~~dP~~RP~ 332 (332)
|+..||.+||++||+
T Consensus 298 li~~mL~~dP~~R~t 312 (328)
T d3bqca1 298 FLDKLLRYDHQSRLT 312 (328)
T ss_dssp HHHHHSCSSGGGSCC
T ss_pred HHHHHccCChhHCcC
Confidence 899999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=363.32 Aligned_cols=235 Identities=26% Similarity=0.447 Sum_probs=190.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++++.||+|+||.||+|++..+++.||+|++.+. ....+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 81 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRV 81 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEE--CCEE
Confidence 57899999999999999999999999999999998632 345688999999999 99999999999954 4578
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||||++++++..++ ..+++..+..++.|++. ||+|||++||+||||||
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~---------------------------al~~lH~~~ivHrDiKp 134 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN---------------------------ALSYCHSKRVIHRDIKP 134 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCCCCCG
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeeeeecc
Confidence 9999999999987765 45777777777766665 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+|||++.++ .+||+|||+|+.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..
T Consensus 135 ~Nill~~~~-~~kl~DFG~a~~~~~-~~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~ 210 (263)
T d2j4za1 135 ENLLLGSAG-ELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQ 210 (263)
T ss_dssp GGEEECTTS-CEEECCCCSCSCCCC-CCCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHH
T ss_pred ccceecCCC-CEeecccceeeecCC-CcccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCC-CCCCHH
Confidence 999999766 799999999976553 33456689999999999987 67899999999999999999999999 344444
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+.+... ..+...++++++++ ..||+.||++||+
T Consensus 211 ~~~~~i~~~~~---------~~p~~~s~~~~~li------------------------~~~L~~dp~~R~t 248 (263)
T d2j4za1 211 ETYKRISRVEF---------TFPDFVTEGARDLI------------------------SRLLKHNPSQRPM 248 (263)
T ss_dssp HHHHHHHTTCC---------CCCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHcCCC---------CCCccCCHHHHHHH------------------------HHHccCCHhHCcC
Confidence 44444432110 01123445555554 5599999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-53 Score=366.78 Aligned_cols=199 Identities=27% Similarity=0.442 Sum_probs=168.1
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.++|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeecc--CceeEE
Confidence 46799999999999999999999999999999998643 235689999999999 99999999999965 457899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||+++++|..++ ..+++..+..++.|++. ||+|||++||+||||||+|
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~---------------------------al~ylH~~~IiHrDiKp~N 133 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---------------------------GVVYLHGIGITHRDIKPEN 133 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCCGGG
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHcCCccCcccHHH
Confidence 99999999988775 34777777777777666 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
||++.++ .+||+|||+|+...... .....+||+.|||||++.+...++.++|||||||++|+|+||..||....+.
T Consensus 134 ILl~~~~-~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 134 LLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp EEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred EEECCCC-CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 9999666 79999999998764332 2345689999999999987444578899999999999999999999544433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=367.08 Aligned_cols=206 Identities=25% Similarity=0.472 Sum_probs=175.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.++|+++++||+|+||+||+|.+..+|+.||+|+++.. ..+.+.+|+.+++++ +||||++++++|.+. ..+++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEEC--CEEEEE
Confidence 46899999999999999999999999999999998642 346789999999999 999999999999654 578999
Q ss_pred EeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 108 FEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 108 ~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
|||+++++|..+. ..+++..+..++.|++. ||+|||++||+||||||+|||
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~---------------------------aL~yLH~~~iiHrDiKp~NIL 148 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---------------------------ALEFLHSNQVIHRDIKSDNIL 148 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGGGEE
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCcccCCcHHHeE
Confidence 9999999988765 34677777777776666 999999999999999999999
Q ss_pred ecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 040656 186 IDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 264 (332)
Q Consensus 186 v~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~~ 264 (332)
++.++ .+||+|||+|+.+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|+||..||. +.+..+.+
T Consensus 149 l~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~ 225 (293)
T d1yhwa1 149 LGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRAL 225 (293)
T ss_dssp ECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHH
T ss_pred ECCCC-cEeeccchhheeeccccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC-CCCHHHHH
Confidence 99766 79999999998775433 3456689999999999987 678999999999999999999999993 44444555
Q ss_pred HHHHH
Q 040656 265 VKIAR 269 (332)
Q Consensus 265 ~~~~~ 269 (332)
..+..
T Consensus 226 ~~~~~ 230 (293)
T d1yhwa1 226 YLIAT 230 (293)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 44443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=363.93 Aligned_cols=207 Identities=26% Similarity=0.483 Sum_probs=172.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
..++|++++.||+|+||.||+|.+..+++.||+|++++. ....+.+|+.+++++ +||||++++++|.+ ...
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~ 82 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEK 82 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEEC--SSE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEE--CCE
Confidence 357899999999999999999999999999999998632 335689999999999 99999999999954 467
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++++|..+. +.+++..+..++.|++. ||+|||++||+|||||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~---------------------------al~ylH~~~iiHrDiK 135 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS---------------------------ALEYLHGKGIIHRDLK 135 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECSCCS
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHH---------------------------HHHhhccccEEcCcCC
Confidence 89999999999987764 45777777777777766 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|+|||++.++ .+||+|||+|+.+.... ......||+.|+|||++.+ ..++.++|||||||++|+|+||..||. +
T Consensus 136 p~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~ 212 (288)
T d1uu3a_ 136 PENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-A 212 (288)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-C
T ss_pred ccccccCCCc-eEEecccccceecccCCcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-C
Confidence 9999999666 79999999998775332 2345689999999999987 679999999999999999999999994 4
Q ss_pred CCCHHHHHHHHH
Q 040656 258 HDNQDQLVKIAR 269 (332)
Q Consensus 258 ~~~~~~~~~~~~ 269 (332)
.+..+....+..
T Consensus 213 ~~~~~~~~~i~~ 224 (288)
T d1uu3a_ 213 GNEYLIFQKIIK 224 (288)
T ss_dssp SSHHHHHHHHHT
T ss_pred cCHHHHHHHHHc
Confidence 444555555443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=365.78 Aligned_cols=211 Identities=25% Similarity=0.441 Sum_probs=174.9
Q ss_pred cCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 27 QWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 27 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.....+.|++++.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ...
T Consensus 7 ~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~ 83 (288)
T d2jfla1 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENN 83 (288)
T ss_dssp SSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEE--TTE
T ss_pred CCCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCe
Confidence 334456799999999999999999999999999999998642 346789999999999 99999999999965 457
Q ss_pred ceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
+++||||++++++..++ ..+++..+..++.|++. ||.|||++||+||||
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~---------------------------gL~ylH~~~ivHrDi 136 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD---------------------------ALNYLHDNKIIHRDL 136 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCEEEeec
Confidence 89999999999987764 34677777777777666 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccC----CCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+|||++.++ .+||+|||+|+..... .......||+.|+|||++.. ...++.++|||||||++|+|+||..||
T Consensus 137 Kp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf 215 (288)
T d2jfla1 137 KAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 215 (288)
T ss_dssp SGGGEEECTTS-CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ChhheeECCCC-CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC
Confidence 99999999776 7999999999765422 22345689999999999842 256889999999999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 040656 255 FYGHDNQDQLVKIAR 269 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~ 269 (332)
.+.+..+.+..+..
T Consensus 216 -~~~~~~~~~~~i~~ 229 (288)
T d2jfla1 216 -HELNPMRVLLKIAK 229 (288)
T ss_dssp -TTSCGGGHHHHHHH
T ss_pred -CCCCHHHHHHHHHc
Confidence 45555566655554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=364.60 Aligned_cols=239 Identities=25% Similarity=0.418 Sum_probs=179.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
.++|++++.||+|+||+||+|++..+|+.||+|+++.. ..+.+.+|+++++++ +||||+++++++.++....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 57899999999999999999999999999999998643 234588999999999 999999999999877667889
Q ss_pred eEEeeecCCCceeecc-------ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC-----
Q 040656 106 LIFEHVNSTDFKVLYP-------TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG----- 173 (332)
Q Consensus 106 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----- 173 (332)
+||||+++++|..++. .+++..+..++.|++. ||.|||+++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~---------------------------al~ylH~~~~~~~~ 134 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL---------------------------ALKECHRRSDGGHT 134 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHH---------------------------HHHHHHHHCC----
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHhcCCCCC
Confidence 9999999999887652 3666666666666555 999999976
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|+||||||+|||++.++ .+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||+||..
T Consensus 135 IiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 135 VLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMP 212 (269)
T ss_dssp -----CCGGGEEECTTS-CEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEeCcCchhhcCcCCCC-cEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCC
Confidence 99999999999999766 79999999998765433 2345689999999999877 679999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
||. +.+..+....+...... ......++++++++ ..||+.||++||+
T Consensus 213 Pf~-~~~~~~~~~~i~~~~~~--------~~~~~~s~~l~~li------------------------~~~L~~dp~~Rps 259 (269)
T d2java1 213 PFT-AFSQKELAGKIREGKFR--------RIPYRYSDELNEII------------------------TRMLNLKDYHRPS 259 (269)
T ss_dssp SCC-CSSHHHHHHHHHHTCCC--------CCCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCC-CCCHHHHHHHHHcCCCC--------CCCcccCHHHHHHH------------------------HHHcCCChhHCcC
Confidence 993 44444444444332111 11123455555555 5599999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=374.61 Aligned_cols=198 Identities=23% Similarity=0.405 Sum_probs=168.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.++|++++.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||++++++|.++ ..+++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECS--SEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEE
Confidence 57899999999999999999999999999999998632 235788999999999 999999999999654 57899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-cCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-QGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~ivHrdlkp~ 182 (332)
||||+++++|..++ ..+++..++.++.|++. ||.|||+ +||+||||||+
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~---------------------------aL~yLH~~~~IiHRDiKP~ 134 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK---------------------------GLTYLREKHKIMHRDVKPS 134 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHHHCCCCSCCSGG
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHhCCEEccccCHH
Confidence 99999999988775 35777777777766665 9999997 49999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
|||++.++ .+||+|||+|+.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.......
T Consensus 135 NILl~~~~-~vkl~DFGla~~~~~-~~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 135 NILVNSRG-EIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp GEEECTTC-CEEECCCCCCHHHHH-HTC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred HeeECCCC-CEEEeeCCCccccCC-CccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999666 799999999986542 23345689999999999988 689999999999999999999999996544433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=356.49 Aligned_cols=239 Identities=21% Similarity=0.376 Sum_probs=184.7
Q ss_pred CCc-eEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc--CCCC
Q 040656 32 EDY-EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--HSKT 103 (332)
Q Consensus 32 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~ 103 (332)
.+| ++.++||+|+||+||+|++..+++.||+|++... ..+.+.+|+++++++ +||||++++++|.+. ....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCE
Confidence 344 7888999999999999999999999999998642 235688999999999 899999999998653 2346
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC--CeecC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG--IMHRD 178 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--ivHrd 178 (332)
+++||||+++++|..++ ..+++..+..++.|++. ||+|||+++ |+|||
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~---------------------------gl~yLH~~~~~IiHrD 139 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK---------------------------GLQFLHTRTPPIIHRD 139 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHTSSSCCCCSC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHH---------------------------HHHHHHHCCCCEEeCC
Confidence 79999999999987765 34666666666666655 999999998 99999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
|||+|||++.+++.+||+|||+|+... ........||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus 140 iKp~NILl~~~~~~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 140 LKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cChhhceeeCCCCCEEEeecCcceecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 999999997555579999999997543 334456789999999999865 59999999999999999999999995333
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.......+........ .....++++++++ ..||+.||++||+
T Consensus 217 ~~~~~~~~i~~~~~~~~-------~~~~~~~~~~~li------------------------~~~l~~dp~~R~s 259 (270)
T d1t4ha_ 217 NAAQIYRRVTSGVKPAS-------FDKVAIPEVKEII------------------------EGCIRQNKDERYS 259 (270)
T ss_dssp SHHHHHHHHTTTCCCGG-------GGGCCCHHHHHHH------------------------HHHSCSSGGGSCC
T ss_pred cHHHHHHHHHcCCCCcc-------cCccCCHHHHHHH------------------------HHHccCCHhHCcC
Confidence 33333333322111111 1123455555555 5599999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-51 Score=365.54 Aligned_cols=207 Identities=26% Similarity=0.478 Sum_probs=158.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++++ +||||++++++|.+ ...+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEE
Confidence 46799999999999999999999999999999998643 235678999999999 99999999999954 467899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||+++++|..++ ..+++..+..++.|++. ||+|||++||+||||||+|
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~---------------------------al~ylH~~~iiHrDiKp~N 137 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD---------------------------AVKYLHDLGIVHRDLKPEN 137 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCCGGG
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHH---------------------------HHHhhhhceeeeEEecccc
Confidence 99999999987765 35778777777777766 9999999999999999999
Q ss_pred eeecC--CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 184 VMIDH--EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 184 ilv~~--~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||+.. +++.+||+|||+|+...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +....
T Consensus 138 il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~ 215 (307)
T d1a06a_ 138 LLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDA 215 (307)
T ss_dssp EEESSSSTTCCEEECCC------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHH
T ss_pred eeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHH
Confidence 99953 344799999999987765655667789999999999987 679999999999999999999999994 44444
Q ss_pred HHHHHHHH
Q 040656 262 DQLVKIAR 269 (332)
Q Consensus 262 ~~~~~~~~ 269 (332)
+....+..
T Consensus 216 ~~~~~i~~ 223 (307)
T d1a06a_ 216 KLFEQILK 223 (307)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHhc
Confidence 44444443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=358.59 Aligned_cols=207 Identities=25% Similarity=0.479 Sum_probs=177.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc---------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++|++++.||+|+||+||+|.+..+|+.||+|++++. ..+.+.+|+.+++++ +||||++++++|.+ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~ 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence 36799999999999999999999999999999998632 246789999999999 99999999999954 4
Q ss_pred CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||||+++++|..++ ..+++..+..++.|++. ||+|||+++|+|||
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~---------------------------al~yLH~~~ivHrD 138 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---------------------------GVYYLHSLQIAHFD 138 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCC
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHH---------------------------HHHhhhhcceeecc
Confidence 6789999999999988765 35777777777777665 99999999999999
Q ss_pred CCCCCeeecCCCC---eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 179 VKPHNVMIDHEQQ---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~---~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||+|||++.++. .+||+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 9999999986553 599999999998876666677789999999999987 678999999999999999999999994
Q ss_pred CCCCCHHHHHHHHH
Q 040656 256 YGHDNQDQLVKIAR 269 (332)
Q Consensus 256 ~~~~~~~~~~~~~~ 269 (332)
+.+..+.+..+..
T Consensus 218 -~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 218 -GDTKQETLANVSA 230 (293)
T ss_dssp -CSSHHHHHHHHHT
T ss_pred -CCCHHHHHHHHHh
Confidence 4555555555544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=362.50 Aligned_cols=207 Identities=24% Similarity=0.446 Sum_probs=176.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.-++|++++.||+|+||.||+|++..+++.||+|++++. ..+.+.+|+.+|+++ +||||++++++|.+ ...
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~ 79 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDR 79 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecc--ccc
Confidence 346899999999999999999999999999999999642 346688999999999 89999999999954 467
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
+++||||+++++|..++ ..+++..++.++.|++. ||+|||++||+|||||
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~---------------------------al~ylH~~~iiHRDlK 132 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------------------------ALEYLHSRDVVYRDIK 132 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCC
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhh---------------------------hhhhhhhcCccccccC
Confidence 99999999999987765 45788888888887776 9999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecC-CCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 259 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~ 259 (332)
|+|||++.++ .+||+|||+|+.... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||. +.+
T Consensus 133 P~NILl~~~g-~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~ 209 (337)
T d1o6la_ 133 LENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQD 209 (337)
T ss_dssp GGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSS
T ss_pred HHHeEecCCC-CEEEeecccccccccCCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcC
Confidence 9999999776 799999999987543 334456789999999999987 789999999999999999999999994 444
Q ss_pred CHHHHHHHHH
Q 040656 260 NQDQLVKIAR 269 (332)
Q Consensus 260 ~~~~~~~~~~ 269 (332)
..+....+..
T Consensus 210 ~~~~~~~i~~ 219 (337)
T d1o6la_ 210 HERLFELILM 219 (337)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhc
Confidence 4444444443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8e-51 Score=367.00 Aligned_cols=207 Identities=23% Similarity=0.457 Sum_probs=179.0
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
++|++++.||+|+||.||+|++..+|+.||+|++.... .+.+.+|+.+++++ +||||++++++|.+ ...+++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 68999999999999999999999999999999996533 35688999999999 99999999999965 46799999
Q ss_pred eeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||+++++|..++ ..+++..+..++.|++. ||.|||++||+||||||+||
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~---------------------------aL~ylH~~~iiHrDiKp~NI 155 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---------------------------GLCHMHENNYVHLDLKPENI 155 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGGGE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhcCCeeeeechhHe
Confidence 999999987654 34778888777777776 99999999999999999999
Q ss_pred eecCC-CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHE-QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++.+ ++.+||+|||+|+............||+.|||||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.
T Consensus 156 ll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~ 233 (350)
T d1koaa2 156 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDET 233 (350)
T ss_dssp EESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHH
T ss_pred eeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCC-CCCCHHHH
Confidence 99643 34799999999998876666777899999999999987 67899999999999999999999999 35555666
Q ss_pred HHHHHHH
Q 040656 264 LVKIARV 270 (332)
Q Consensus 264 ~~~~~~~ 270 (332)
+..+...
T Consensus 234 ~~~i~~~ 240 (350)
T d1koaa2 234 LRNVKSC 240 (350)
T ss_dssp HHHHHHT
T ss_pred HHHHHhC
Confidence 6666554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-50 Score=366.18 Aligned_cols=207 Identities=24% Similarity=0.470 Sum_probs=178.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
++|++++.||+|+||.||+|++..+|+.||+|+++... ...+.+|+.+++++ +||||++++++|.+ ...+++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 67999999999999999999999999999999987533 35678999999999 99999999999954 46789999
Q ss_pred eeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||+++++|...+ ..+++..+..++.|++. ||.|||++||+||||||+||
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~---------------------------aL~ylH~~~iiHRDiKp~NI 158 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---------------------------GLKHMHEHSIVHLDIKPENI 158 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGGGE
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCeeecccccccc
Confidence 999999986643 24788888777777776 99999999999999999999
Q ss_pred eecC-CCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDH-EQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~-~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++. +.+.+||+|||+|+............+|+.|+|||++.+ ..++.++|||||||++|+|+||..|| .+.+..+.
T Consensus 159 Ll~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~ 236 (352)
T d1koba_ 159 MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLET 236 (352)
T ss_dssp EESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHH
T ss_pred cccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHH
Confidence 9973 344799999999998877766777889999999999977 77999999999999999999999999 45555666
Q ss_pred HHHHHHH
Q 040656 264 LVKIARV 270 (332)
Q Consensus 264 ~~~~~~~ 270 (332)
+..+...
T Consensus 237 ~~~i~~~ 243 (352)
T d1koba_ 237 LQNVKRC 243 (352)
T ss_dssp HHHHHHC
T ss_pred HHHHHhC
Confidence 6666553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-51 Score=357.98 Aligned_cols=239 Identities=18% Similarity=0.336 Sum_probs=187.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||+||+|.+..+++.||||+++. ...+.+.+|+.+++++ +||||++++++|.+ ...++++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEE
Confidence 56899999999999999999999999999999999864 3456799999999999 99999999999954 4678999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+++|++..++. .+++..+.. ++.|+++||+|||++||+||||||+
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~---------------------------i~~qi~~gL~yLH~~~iiHrDlKp~ 144 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLY---------------------------MATQISSAMEYLEKKNFIHRDLAAR 144 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred eecccCcchHHHhhhccccchHHHHHHH---------------------------HHHHHHHHHHHHHHCCcccCccccC
Confidence 99999998877642 234444444 4445556999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.++ .+||+|||+|+....... .....+|..|+|||++.+ ..++.++|||||||++|||++|..||+.+.+.
T Consensus 145 NILl~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~ 222 (287)
T d1opja_ 145 NCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222 (287)
T ss_dssp GEEECGGG-CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEECCCC-cEEEccccceeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchH
Confidence 99999766 799999999987653332 233457888999999877 67999999999999999999988888665554
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
......+...... ......++.+.+++ ..||+.||++||+
T Consensus 223 ~~~~~~i~~~~~~--------~~~~~~~~~l~~li------------------------~~cl~~dP~~Rps 262 (287)
T d1opja_ 223 SQVYELLEKDYRM--------ERPEGCPEKVYELM------------------------RACWQWNPSDRPS 262 (287)
T ss_dssp HHHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHhcCCCC--------CCCccchHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 4433333221111 11123445555554 5599999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-51 Score=361.72 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=168.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
+.|++++.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEEC--CEEE
Confidence 46999999999999999999999999999999986422 24688999999999 999999999999653 5789
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||+.++++..+. ..+++..+..++.|++. ||.|||++||+||||||+
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~---------------------------aL~yLH~~~iiHrDiKp~ 144 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---------------------------GLAYLHSHNMIHRDVKAG 144 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCSGG
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCEeccCCCcc
Confidence 999999998876543 45677777766666665 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.++ .+||+|||+|+.... .....||+.|||||++.+. ..|+.++|||||||++|||++|..||. +...
T Consensus 145 NILl~~~~-~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~-~~~~ 219 (309)
T d1u5ra_ 145 NILLSEPG-LVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNA 219 (309)
T ss_dssp GEEEETTT-EEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCH
T ss_pred eEEECCCC-CEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC-CCCH
Confidence 99999666 899999999986532 3456899999999998642 358999999999999999999999994 4444
Q ss_pred HHHHHHHHH
Q 040656 261 QDQLVKIAR 269 (332)
Q Consensus 261 ~~~~~~~~~ 269 (332)
.+.+..+..
T Consensus 220 ~~~~~~i~~ 228 (309)
T d1u5ra_ 220 MSALYHIAQ 228 (309)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 444444443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=348.32 Aligned_cols=238 Identities=17% Similarity=0.327 Sum_probs=177.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
++++|++++.||+|+||.||+|++. +++.||||+++. ...+++.+|+++++++ +||||+++++++.+ ....++|
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~--~~~~~lv 78 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV 78 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceecc--CCceEEE
Confidence 5688999999999999999999874 677899999874 3457799999999999 99999999999954 3578999
Q ss_pred EeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||+++++|..++. .++...... ++.|+++||.|||+++|+||||||+|
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~---------------------------i~~qia~gl~~lH~~~iiHrDlKp~N 131 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLG---------------------------MCLDVCEGMAYLEEACVIHRDLAARN 131 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCTTCSGGG
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHH---------------------------HHHHHHHHHHhhhccceeecccchhh
Confidence 99999999877642 233444433 45555669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
||++.++ .+||+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|||+|+..|++......
T Consensus 132 ill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 132 CLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp EEECGGG-CEEECSCC------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred eeecCCC-CeEecccchheeccCCCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 9999766 799999999987653332 233568899999999987 679999999999999999999766765665555
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+........ ....++++.+++ ..||+.||++||+
T Consensus 210 ~~~~~i~~~~~~~~--------p~~~~~~l~~li------------------------~~cl~~~p~~Rps 248 (263)
T d1sm2a_ 210 EVVEDISTGFRLYK--------PRLASTHVYQIM------------------------NHCWKERPEDRPA 248 (263)
T ss_dssp HHHHHHHHTCCCCC--------CTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHhcCCCCC--------ccccCHHHHHHH------------------------HHHccCCHhHCcC
Confidence 55555544322111 123344555544 5599999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-50 Score=355.44 Aligned_cols=204 Identities=23% Similarity=0.464 Sum_probs=172.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++++.||+|+||+||+|++..+|+.||+|++++. ..+.+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEee--CCee
Confidence 46799999999999999999999999999999998632 346788999999999 99999999999954 4678
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++||||+.++++..+. ..+++..++.++.|++. ||+|||++||+||||||
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~---------------------------al~~lH~~~iiHrDiKp 132 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL---------------------------ALEYLHSKDIIYRDLKP 132 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHH---------------------------HHHHHHTTTEECCCCCG
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHH---------------------------hhhhhccCcEEccccCc
Confidence 9999999999877765 34556656556666555 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+|||++.++ .+||+|||+|+... ......+||+.|+|||++.+ ..++.++|||||||++|+|+||..|| .+.+..
T Consensus 133 ~NILl~~~g-~vkL~DFG~a~~~~--~~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf-~~~~~~ 207 (316)
T d1fota_ 133 ENILLDKNG-HIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTM 207 (316)
T ss_dssp GGEEECTTS-CEEECCCSSCEECS--SCBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTT-CCSSHH
T ss_pred hheeEcCCC-CEEEecCccceEec--cccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCC-CCcCHH
Confidence 999999766 79999999998764 33445789999999999877 67999999999999999999999999 345555
Q ss_pred HHHHHHHH
Q 040656 262 DQLVKIAR 269 (332)
Q Consensus 262 ~~~~~~~~ 269 (332)
+....+..
T Consensus 208 ~~~~~i~~ 215 (316)
T d1fota_ 208 KTYEKILN 215 (316)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHc
Confidence 55555554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=350.52 Aligned_cols=237 Identities=18% Similarity=0.342 Sum_probs=185.5
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||.||+|.+ ++++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ...++|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEE
Confidence 468999999999999999999986 5678899999974 3456799999999999 99999999998843 357999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+++|++..++. .++...+.. ++.||++||.|||+++|+||||||+
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~---------------------------i~~qi~~gl~~lH~~~ivHrDiKp~ 138 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLD---------------------------MAAQIAEGMAFIEERNYIHRDLRAA 138 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHH---------------------------HHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHH---------------------------HHHHHHHHHHHHHhCCcccCccchh
Confidence 99999999877542 244444443 4555566999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.++ .+||+|||+|+....... .....+|..|+|||++.+ ..++.++|||||||++|||+||..|++.....
T Consensus 139 NIll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~ 216 (272)
T d1qpca_ 139 NILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (272)
T ss_dssp GEEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred heeeeccc-ceeeccccceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH
Confidence 99999666 799999999988754332 234568889999999876 57899999999999999999987787666665
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+........ ....++.+..++ ..||+.||++||+
T Consensus 217 ~~~~~~i~~~~~~~~--------p~~~~~~l~~li------------------------~~cl~~~P~~Rpt 256 (272)
T d1qpca_ 217 PEVIQNLERGYRMVR--------PDNCPEELYQLM------------------------RLCWKERPEDRPT 256 (272)
T ss_dssp HHHHHHHHTTCCCCC--------CTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHHhcCCCCC--------cccChHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 555555443221111 123444455444 5599999999996
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=351.78 Aligned_cols=240 Identities=18% Similarity=0.350 Sum_probs=180.2
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc-----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
.+.++|++.+.||+|+||+||+|.. +..||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~ 77 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQ 77 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SS
T ss_pred cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cE
Confidence 3578899999999999999999964 34699999863 2346789999999999 99999999998743 35
Q ss_pred ceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 104 PSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
+++||||+++++|..++ ..++...+.. ++.|+++||+|||+++|+||||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~---------------------------i~~qi~~gl~yLH~~~ivHrDl 130 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLID---------------------------IARQTAQGMDYLHAKSIIHRDL 130 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHH---------------------------HHHHHHHHHHHHhcCCEecccc
Confidence 79999999999987765 2244554444 4445556999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCC--CCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
||+|||++.++ .+||+|||+|+...... ......||+.|||||++.+. ..++.++|||||||++|||+||..||
T Consensus 131 Kp~NiLl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 131 KSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp CGGGEEEETTS-SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHEEEcCCC-CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 99999999666 79999999997664322 23455789999999998642 35789999999999999999999999
Q ss_pred CCCCCCHHHHHHHH-HHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIA-RVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
. +.++...+.... +....+.. .....+.++.+++++ ..||+.||++||+
T Consensus 210 ~-~~~~~~~~~~~~~~~~~~p~~----~~~~~~~~~~l~~li------------------------~~cl~~dp~~RPt 259 (276)
T d1uwha_ 210 S-NINNRDQIIFMVGRGYLSPDL----SKVRSNCPKAMKRLM------------------------AECLKKKRDERPL 259 (276)
T ss_dssp T-TCCCHHHHHHHHHHTSCCCCG----GGSCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred C-CCChHHHHHHHHhcCCCCCcc----hhccccchHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 4 444444443333 32222222 223345566666665 4499999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-49 Score=345.11 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=195.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc------------hHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
.++|++.+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+.+++++..||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999986421 23578999999999559999999999954
Q ss_pred cCCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCe
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIM 175 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~iv 175 (332)
+...++||||+++++|..++ ..+++..++.++.|++. ||+|||++||+
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~---------------------------al~~lH~~~iv 132 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE---------------------------VICALHKLNIV 132 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHcCCc
Confidence 56799999999999988775 45788888877777776 99999999999
Q ss_pred ecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccC-----CCCCCCcccHHHHHHHHHHHHhC
Q 040656 176 HRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFR 250 (332)
Q Consensus 176 Hrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~sDiwSlG~il~elltg 250 (332)
||||||+|||++.++ .+||+|||+++............||..|+|||.+.+ ...++.++||||+||++|+|++|
T Consensus 133 HrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 133 HRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp CSCCSGGGEEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccceEEEcCCC-CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC
Confidence 999999999999666 799999999998876666667789999999999853 23578899999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCC
Q 040656 251 KEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGF 330 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R 330 (332)
..||. +.+..+....+......... ......++++++++ .+||+.||++|
T Consensus 212 ~~Pf~-~~~~~~~~~~i~~~~~~~~~-----~~~~~~s~~~~~li------------------------~~~L~~~p~~R 261 (277)
T d1phka_ 212 SPPFW-HRKQMLMLRMIMSGNYQFGS-----PEWDDYSDTVKDLV------------------------SRFLVVQPQKR 261 (277)
T ss_dssp SCSSC-CSSHHHHHHHHHHTCCCCCT-----TTGGGSCHHHHHHH------------------------HHHCCSSGGGS
T ss_pred CCCCC-CCCHHHHHHHHHhCCCCCCC-----cccccCCHHHHHHH------------------------HHHccCChhHC
Confidence 99994 44444455555443211110 11124556666655 45999999999
Q ss_pred CC
Q 040656 331 PF 332 (332)
Q Consensus 331 P~ 332 (332)
|+
T Consensus 262 ~s 263 (277)
T d1phka_ 262 YT 263 (277)
T ss_dssp CC
T ss_pred cC
Confidence 96
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-50 Score=353.35 Aligned_cols=239 Identities=18% Similarity=0.295 Sum_probs=172.9
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCc---eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.+.++|++.+.||+|+||+||+|.+..+++ .||||.+... ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~ 99 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--S 99 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--C
Confidence 356889999999999999999999876654 5888887532 235689999999999 99999999999954 4
Q ss_pred CCceeEEeeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
...++||||+++|+|..++. .++...+..++. |+++||+|||+++|+||
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~---------------------------qia~gl~yLH~~~iiHr 152 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---------------------------GIAAGMKYLADMNYVHR 152 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCS
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHH---------------------------HHHHHHHHHhhCCCccC
Confidence 57899999999999877542 345555544444 45559999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcc------cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-C
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-R 250 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g 250 (332)
||||+|||++.++ .+||+|||+++........ ....+|..|+|||++.+ ..++.++|||||||++|||+| |
T Consensus 153 DlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g 230 (299)
T d1jpaa_ 153 DLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYG 230 (299)
T ss_dssp CCCGGGEEECTTC-CEEECCC-----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccccceEEECCCC-cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCC
Confidence 9999999999666 7999999999876533221 12356888999999877 679999999999999999998 8
Q ss_pred CCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCC
Q 040656 251 KEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGF 330 (332)
Q Consensus 251 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R 330 (332)
..|| .+....+....+......+ ...+.++.+.+++ ..||+.||++|
T Consensus 231 ~~Pf-~~~~~~~~~~~i~~~~~~~--------~~~~~~~~l~~li------------------------~~cl~~~P~~R 277 (299)
T d1jpaa_ 231 ERPY-WDMTNQDVINAIEQDYRLP--------PPMDCPSALHQLM------------------------LDCWQKDRNHR 277 (299)
T ss_dssp CCTT-TTCCHHHHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSTTTS
T ss_pred CCCC-CCCCHHHHHHHHHcCCCCC--------CCccchHHHHHHH------------------------HHHcCCCHhHC
Confidence 8888 3444444544444322211 1123445555554 55999999999
Q ss_pred CC
Q 040656 331 PF 332 (332)
Q Consensus 331 P~ 332 (332)
|+
T Consensus 278 Ps 279 (299)
T d1jpaa_ 278 PK 279 (299)
T ss_dssp CC
T ss_pred cC
Confidence 96
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-49 Score=356.50 Aligned_cols=204 Identities=22% Similarity=0.409 Sum_probs=174.7
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCc
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 104 (332)
.++|++++.||+|+||.||+|++..+|+.||+|++++. ..+.+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccc--cccc
Confidence 47899999999999999999999999999999998632 235688999999999 99999999999954 4678
Q ss_pred eeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 105 SLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 105 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
++++||+.++++...+ ..+++..+..++.|++. ||.|||++||+||||||
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~---------------------------aL~yLH~~~iiHRDIKP 169 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---------------------------TFEYLHSLDLIYRDLKP 169 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSG
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCEecCcCCH
Confidence 9999999999987765 45777777777777766 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
+|||++.++ .+||+|||+|+.... ......||+.|||||++.+ ..++.++|||||||++|+|+||..||. +.+..
T Consensus 170 ~NILl~~~g-~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~ 244 (350)
T d1rdqe_ 170 ENLLIDQQG-YIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPI 244 (350)
T ss_dssp GGEEECTTS-CEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHH
T ss_pred HHcccCCCC-CEEeeeceeeeeccc--ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCC-CcCHH
Confidence 999999776 799999999987653 3445689999999999987 779999999999999999999999993 44555
Q ss_pred HHHHHHHH
Q 040656 262 DQLVKIAR 269 (332)
Q Consensus 262 ~~~~~~~~ 269 (332)
.....+..
T Consensus 245 ~~~~~i~~ 252 (350)
T d1rdqe_ 245 QIYEKIVS 252 (350)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhc
Confidence 55555554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=351.54 Aligned_cols=210 Identities=33% Similarity=0.608 Sum_probs=174.7
Q ss_pred eEEEeecccCCceEEEEEEccCCceEEEEEecccc--------hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 35 EVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
+.++.||+|+||+||+|++..+|+.||+|+++... ...+.+|+.+++++ +||||++++++|.+ ...+++
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~i 77 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISL 77 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceee
Confidence 46789999999999999999999999999986322 24588999999999 99999999999954 467899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||||+.++++..+. ..+++..+..++.|++. ||+|||++||+||||||+|
T Consensus 78 vmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~---------------------------aL~~lH~~~iiHrDiKp~N 130 (299)
T d1ua2a_ 78 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ---------------------------GLEYLHQHWILHRDLKPNN 130 (299)
T ss_dssp EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHH---------------------------HHHHHHHTTCCCCCCCGGG
T ss_pred hhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHH---------------------------HHHHhhccceecccCCcce
Confidence 99999988766654 34677777777776665 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.++ .+||+|||+++...... .....+||+.|+|||++.+...++.++|||||||++|||+||..|| .+..+.+
T Consensus 131 Ili~~~~-~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~ 208 (299)
T d1ua2a_ 131 LLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLD 208 (299)
T ss_dssp EEECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHH
T ss_pred EEecCCC-ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHH
Confidence 9999666 79999999997654332 3345689999999999877677899999999999999999999887 5677778
Q ss_pred HHHHHHHHhCCchH
Q 040656 263 QLVKIARVLGTDEL 276 (332)
Q Consensus 263 ~~~~~~~~~~~~~~ 276 (332)
.+..+.+..+++..
T Consensus 209 ~l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 209 QLTRIFETLGTPTE 222 (299)
T ss_dssp HHHHHHHHHCCCCT
T ss_pred HHHHHHHhcCCCCh
Confidence 88888887776543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.8e-49 Score=358.03 Aligned_cols=194 Identities=25% Similarity=0.431 Sum_probs=162.6
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHH---HHHHHhccCCCCeeeeeeeeeccCC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKRE---IKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++|++++.||+|+||.||+|++..+|+.||+|++.+. ....+.+| +.+++.+ +||||++++++|.+ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEE--C
Confidence 46899999999999999999999999999999998632 12334455 5555556 79999999999954 4
Q ss_pred CCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 102 KTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
..+++||||+++++|..++ ..+++..+..++.+++. ||+|||++||+|||
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~---------------------------aL~ylH~~~iiHrD 132 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL---------------------------GLEHMHNRFVVYRD 132 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCC
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHH---------------------------HHHHHHHCCcccee
Confidence 5789999999999988765 34666666666666665 99999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
|||+|||++.++ .+||+|||+|+.+... ......||+.|+|||++.+...++.++|||||||++|+|+||..||..
T Consensus 133 lKP~NILl~~~g-~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 133 LKPANILLDEHG-HVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CSGGGEEECSSS-CEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eccceeEEcCCC-cEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 999999999666 7999999999876533 345568999999999997656799999999999999999999999953
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=353.77 Aligned_cols=208 Identities=25% Similarity=0.448 Sum_probs=178.2
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccch--HHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
-++|++++.||+|+||+||+|.+..+++.||+|+++.... ..+.+|+.+|+++ +||||++++++|.+ ...+++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 4789999999999999999999999999999999975443 4578999999999 99999999999965 45799999
Q ss_pred eeecCCCceeecc----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCe
Q 040656 109 EHVNSTDFKVLYP----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNV 184 (332)
Q Consensus 109 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Ni 184 (332)
||+++++|...+. .+++..+..++.|++. ||+|||++||+||||||+||
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~---------------------------al~yLH~~~iiHrDlKp~NI 133 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCE---------------------------ALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCGGGE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHH---------------------------HHHHHHHcCCCcccccccce
Confidence 9999999877652 4778888777777776 99999999999999999999
Q ss_pred eecCC-CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 040656 185 MIDHE-QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQ 263 (332)
Q Consensus 185 lv~~~-~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~~ 263 (332)
|++.+ ...++|+|||+++............+|+.|+|||...+ ..++.++|||||||++|+|++|..|| .+.+..+.
T Consensus 134 ll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf-~~~~~~~~ 211 (321)
T d1tkia_ 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQI 211 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHH
T ss_pred eecCCCceEEEEcccchhhccccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCC-CCCCHHHH
Confidence 99754 33799999999998776666667789999999999877 67899999999999999999999999 45555566
Q ss_pred HHHHHHH
Q 040656 264 LVKIARV 270 (332)
Q Consensus 264 ~~~~~~~ 270 (332)
+..+...
T Consensus 212 ~~~i~~~ 218 (321)
T d1tkia_ 212 IENIMNA 218 (321)
T ss_dssp HHHHHHT
T ss_pred HHHHHhC
Confidence 6666553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=359.41 Aligned_cols=195 Identities=28% Similarity=0.479 Sum_probs=169.3
Q ss_pred CCCceEEE-eecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeec--cCCCCceeE
Q 040656 31 QEDYEVVR-KVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QHSKTPSLI 107 (332)
Q Consensus 31 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~~~lv 107 (332)
.++|+++. .||+|+||.||+|++..+++.||+|+++. ...+.+|+.++.++.+||||++++++|.+ .....+++|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 36899886 59999999999999999999999999863 45678999998777689999999999865 234568999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+++|+|..++. .+++..++.++.|++. ||+|||++||+||||||+
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~---------------------------al~ylH~~~iiHRDiKp~ 140 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE---------------------------AIQYLHSINIAHRDVKPE 140 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGG
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHH---------------------------HHHHHHHcCCcccccccc
Confidence 99999999887652 4778888888887776 999999999999999999
Q ss_pred CeeecCC--CCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 183 NVMIDHE--QQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 183 Nilv~~~--~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||++.+ .+.+||+|||+|+............||+.|+|||++.+ ..|+.++|||||||++|+|+||..||.
T Consensus 141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred ccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 9999752 34799999999998876666677889999999999876 679999999999999999999999994
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=349.25 Aligned_cols=231 Identities=23% Similarity=0.408 Sum_probs=181.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCce
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPS 105 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~ 105 (332)
++|++++.||+|+||+||+|++..+++.||+|++++. ....+..|..++.+..+||||+++++++.+ ...++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 6799999999999999999999999999999999632 334577788877653399999999999954 46799
Q ss_pred eEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 106 LIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 106 lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
+||||+++|+|..++ ..+++..+..++.|++. ||+|||++||+||||||+
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~---------------------------al~ylH~~~iiHrDikp~ 132 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL---------------------------GLQFLHSKGIVYRDLKLD 132 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCBCCCCCGG
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCeeeccCccc
Confidence 999999999988875 45677777766666665 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
|||++.++ .+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|+||..|| .+.+..
T Consensus 133 NiL~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF-~~~~~~ 209 (320)
T d1xjda_ 133 NILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEE 209 (320)
T ss_dssp GEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHH
T ss_pred ceeecCCC-ceeccccchhhhcccccccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCC-CCCCHH
Confidence 99999666 7999999999865533 33445689999999999987 68999999999999999999999999 345555
Q ss_pred HHHHHHHHHhC------CchHHHHHHhcCCCCChhHHHHh
Q 040656 262 DQLVKIARVLG------TDELNAYLDKYHLELDPQLEALV 295 (332)
Q Consensus 262 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i 295 (332)
+....+..... ++.+.+++.++ +..+|..|-.+
T Consensus 210 ~~~~~i~~~~~~~p~~~s~~~~dli~~~-L~~dP~~R~s~ 248 (320)
T d1xjda_ 210 ELFHSIRMDNPFYPRWLEKEAKDLLVKL-FVREPEKRLGV 248 (320)
T ss_dssp HHHHHHHHCCCCCCTTSCHHHHHHHHHH-SCSSGGGSBTT
T ss_pred HHHHHHHcCCCCCCccCCHHHHHHHHHh-cccCCCCCcCH
Confidence 55555543211 23334444444 44455544444
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=342.23 Aligned_cols=237 Identities=17% Similarity=0.300 Sum_probs=184.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecc--cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|+++++||+|+||+||+|++ ++++.||||+++. ...+.+.+|+.+++++ +||||++++++|.+ ...+++|
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECC--SSSEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEee--CCceEEE
Confidence 568899999999999999999997 5788999999974 3457899999999999 99999999999954 4678999
Q ss_pred EeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||+.+|++..+. ..+++..+. .++.|+++||+|||++||+||||||+|
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~---------------------------~i~~qi~~gl~~LH~~~iiH~dlk~~N 130 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLL---------------------------EMCKDVCEAMEYLESKQFLHRDLAARN 130 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHH---------------------------HHHHHHHHHHHHHHHTTBCCSCCSGGG
T ss_pred EEccCCCcHHHhhhccccCCcHHHHH---------------------------HHHHHHHHHHHHHhhcCccccccccee
Confidence 9999999877663 223343333 355566669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDN 260 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~ 260 (332)
||++.++ .+||+|||+++....... .....+|..|+|||.+.+ ..++.++|||||||++|||+| |..|| .+...
T Consensus 131 ill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~ 207 (258)
T d1k2pa_ 131 CLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTN 207 (258)
T ss_dssp EEECTTC-CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCH
T ss_pred EEEcCCC-cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCH
Confidence 9999666 799999999986654332 233568899999999887 678999999999999999998 78888 34444
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+......+. ....++.+.++ +..||+.||++||+
T Consensus 208 ~~~~~~i~~~~~~~~--------p~~~~~~l~~l------------------------i~~cl~~dP~~RPt 247 (258)
T d1k2pa_ 208 SETAEHIAQGLRLYR--------PHLASEKVYTI------------------------MYSCWHEKADERPT 247 (258)
T ss_dssp HHHHHHHHTTCCCCC--------CTTCCHHHHHH------------------------HHHTTCSSGGGSCC
T ss_pred HHHHHHHHhCCCCCC--------cccccHHHHHH------------------------HHHHccCCHhHCcC
Confidence 445444443221111 12233444444 56699999999996
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=346.54 Aligned_cols=238 Identities=18% Similarity=0.322 Sum_probs=183.1
Q ss_pred CCCCCceEEEe-ecccCCceEEEEEEcc--CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 29 GDQEDYEVVRK-VGRGKYSEVFEGINVT--NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 29 ~~~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
.++++|.+.+. ||+|+||+||+|.+.. ++..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--- 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA--- 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---
Confidence 35678999995 9999999999997643 4457999998642 235789999999999 99999999999854
Q ss_pred CCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
..+++||||+++|+|..++ ..++...+..++.| +++||+|||+++|+||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~q---------------------------i~~gL~ylH~~~iiHr 133 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ---------------------------VSMGMKYLEEKNFVHR 133 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHH---------------------------HHHHHHHHHHTTEECC
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHH---------------------------HHHHHHHHHhCCeecC
Confidence 3579999999999987764 23555555544444 4559999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
||||+|||++.++ .+||+|||+++....... .....+|..|+|||++.+ ..++.++|||||||++|||+| |..
T Consensus 134 DlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 134 DLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp CCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCchhheeeccCC-ceeeccchhhhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCC
Confidence 9999999999666 899999999988754432 223467889999999876 578999999999999999998 899
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
||. +....+....+......+ .....++++.+++ ..||+.||++||+
T Consensus 212 Pf~-~~~~~~~~~~i~~~~~~~--------~p~~~~~~l~~li------------------------~~cl~~~p~~RPs 258 (285)
T d1u59a_ 212 PYK-KMKGPEVMAFIEQGKRME--------CPPECPPELYALM------------------------SDCWIYKWEDRPD 258 (285)
T ss_dssp TTT-TCCTHHHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHTTCSSGGGSCC
T ss_pred CCC-CCCHHHHHHHHHcCCCCC--------CCCcCCHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 984 444445544444322111 1134455555555 5599999999996
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=352.54 Aligned_cols=262 Identities=19% Similarity=0.278 Sum_probs=186.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc-----eEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
++++|++.+.||+|+||+||+|++..+++ .||+|.+... ....+.+|+.++.++.+||||+++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 57899999999999999999999866554 6999998532 335688999999998789999999999954
Q ss_pred CCCceeEEeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...+++||||+++|+|..++.. +++..........+. ...........+...++.|+++||+|||+++|+|
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE-----EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC--------------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccc-----cccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 4678999999999999887632 111111100000000 0000011123334567778888999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~ 252 (332)
|||||+|||++.++ .+||+|||+|+....... .....||+.|||||++.+ ..++.++|||||||++|||+| |..
T Consensus 188 RDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 188 RDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp TTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCC
Confidence 99999999999666 899999999987654332 234567999999999877 679999999999999999998 898
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
||. +......+.++...-... ......++.+++++ ..||+.||++||+
T Consensus 266 Pf~-~~~~~~~~~~~~~~~~~~-------~~p~~~~~~l~~li------------------------~~cl~~dP~~RPt 313 (325)
T d1rjba_ 266 PYP-GIPVDANFYKLIQNGFKM-------DQPFYATEEIYIIM------------------------QSCWAFDSRKRPS 313 (325)
T ss_dssp SST-TCCCSHHHHHHHHTTCCC-------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCC-CCCHHHHHHHHHhcCCCC-------CCCCcCCHHHHHHH------------------------HHHcCCChhHCcC
Confidence 984 444444444444321111 01123445555554 5599999999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-48 Score=343.15 Aligned_cols=242 Identities=23% Similarity=0.365 Sum_probs=184.3
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeeccCC--C
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS--K 102 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--~ 102 (332)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++...+. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence 36799999999999999999999999999999999632 124688999999999 99999999999876543 3
Q ss_pred CceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 103 TPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
.+++||||++++++.... +.+++..+..++.|++. ||+|||++||+||||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~---------------------------al~~lH~~~iiHrDi 137 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ---------------------------ALNFSHQNGIIHRDV 137 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCccCccc
Confidence 478999999999887654 35677777776666665 999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCC----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
||+|||++.++ .++++|||.+....... ......||+.|+|||++.+ ..++.++|||||||++|+|+||..||
T Consensus 138 KP~NIll~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf- 214 (277)
T d1o6ya_ 138 KPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF- 214 (277)
T ss_dssp SGGGEEEETTS-CEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-
T ss_pred cCcccccCccc-cceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCC-
Confidence 99999999776 69999999987654322 2345579999999999877 67999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+....+......+ ........++.+++++ .+||+.||++||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~s~~l~~li------------------------~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 215 TGDSPVSVAYQHVREDPIP-----PSARHEGLSADLDAVV------------------------LKALAKNPENRYQ 262 (277)
T ss_dssp CCSSHHHHHHHHHHCCCCC-----GGGTSSSCCHHHHHHH------------------------HHHTCSSGGGSCS
T ss_pred CCcCHHHHHHHHHhcCCCC-----CchhccCCCHHHHHHH------------------------HHHccCCHhHCHh
Confidence 3444444444444321111 1122245566666666 4499999999993
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=346.29 Aligned_cols=265 Identities=28% Similarity=0.517 Sum_probs=197.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccC-CceEEEEEeccc-----chHHHHHHHHHHHhcc--CCCCeeeeeeeeecc--
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTN-NEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQ-- 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~-- 99 (332)
..++|++++.||+|+||+||+|++..+ ++.||+|+++.. ....+.+|+.+++.+. +||||++++++|...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 458999999999999999999998665 677999998642 2235778888888763 799999999998542
Q ss_pred -CCCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 100 -HSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 100 -~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
.....++++|++.++++.... ..+++..++.++.|++. ||+|||++||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~---------------------------aL~yLH~~~i 137 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR---------------------------GLDFLHSHRV 137 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHH---------------------------HHHHHHHTTC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHH---------------------------HHHHHHhCCE
Confidence 334689999999988764432 34666666666666665 9999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 254 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf 254 (332)
+||||||+|||++.++ .+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 138 vHrDiKp~NILi~~~~-~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 138 VHRDLKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCCCCGGGEEECTTC-CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EecCCCccEEEEcCCC-CeeecchhhhhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC
Confidence 9999999999999666 799999999987665556667789999999999987 78999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+.+..+....+.+...++..... ... ...... .++.. ..........+|+..||++||++||+
T Consensus 216 -~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~---~~~~~s~~~~dli~~mL~~dP~~R~s 286 (305)
T d1blxa_ 216 -RGSSDVDQLGKILDVIGLPGEEDWPRDVA--LPR---QAFHSKSAQPIEK---FVTDIDELGKDLLLKCLTFNPAKRIS 286 (305)
T ss_dssp -CCSSHHHHHHHHHHHHCCCCGGGSCTTCS--SCG---GGSCCCCCCCGGG---TCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred -CCCCHHHHHHHHHHhhCCCchhccccccc--chh---hhhccccccchhh---ccccCCHHHHHHHHHHCcCChhHCcC
Confidence 46667778888888777654433221110 000 000000 11100 01112223346788899999999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=341.89 Aligned_cols=240 Identities=16% Similarity=0.260 Sum_probs=175.8
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCC----ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.+.+.|++.+.||+|+||.||+|.+..++ ..||||+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~-- 80 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK-- 80 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--
Confidence 34678999999999999999999876554 46999998632 234688999999999 99999999999954
Q ss_pred CCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 SKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....++++||+.++++.... ..++...+.. ++.|++.||+|||+++|+|
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~---------------------------i~~~i~~gl~~lH~~~iiH 133 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVG---------------------------MLRGIAAGMKYLANMNYVH 133 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCC
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHH---------------------------HHHHHHHhhhhcccccccc
Confidence 45789999999998876643 2344444443 4555566999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 252 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~ 252 (332)
|||||+|||++.++ .+||+|||+++....... .....||..|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 134 rDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~ 211 (283)
T d1mqba_ 134 RDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGE 211 (283)
T ss_dssp SCCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccceEEECCCC-eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCC
Confidence 99999999999766 799999999987643322 223467889999999877 689999999999999999999877
Q ss_pred CCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 253 PFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 253 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
|++......+....+......+. ....++.+.++ +..||+.||++||+
T Consensus 212 ~~~~~~~~~~~~~~i~~~~~~~~--------~~~~~~~l~~l------------------------i~~cl~~~p~~RPt 259 (283)
T d1mqba_ 212 RPYWELSNHEVMKAINDGFRLPT--------PMDCPSAIYQL------------------------MMQCWQQERARRPK 259 (283)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCCC--------CTTCBHHHHHH------------------------HHHHTCSSTTTSCC
T ss_pred CccccCCHHHHHHHHhccCCCCC--------chhhHHHHHHH------------------------HHHHCcCCHhHCcC
Confidence 87665555555444433221111 12233444444 45699999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=344.74 Aligned_cols=263 Identities=29% Similarity=0.548 Sum_probs=196.4
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++++.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||++++++|.+ ...+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccccc--ccceeE
Confidence 6899999999999999999999999999999998632 245788999999999 99999999999965 457899
Q ss_pred EEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 107 IFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 107 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
||||+.++.+.... ..+++..+..++.|++. ||+|||++||+||||||+
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~---------------------------~L~yLH~~~IiHrDiKpe 131 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ---------------------------GLAFCHSHRVLHRDLKPQ 131 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCCGG
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHH---------------------------HHHHhhcCCEEccccCch
Confidence 99999877555442 34777777777777766 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCC-CcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQ 261 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~ 261 (332)
|||++.++ .+||+|||.|+..... .......||+.|+|||++.....++.++|||||||++|+|++|..|| .+.+..
T Consensus 132 NIl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~ 209 (298)
T d1gz8a_ 132 NLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEI 209 (298)
T ss_dssp GEEECTTS-CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHH
T ss_pred heeecccC-cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHH
Confidence 99999776 7999999999776533 33455689999999999877666789999999999999999999999 456666
Q ss_pred HHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCc--ccccccccccccCceEEEeCCCCCCC
Q 040656 262 DQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNN--KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+.+..+....+.+....+.... ...........+..... ..........+|+..||+.||++||+
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 276 (298)
T d1gz8a_ 210 DQLFRIFRTLGTPDEVVWPGVT------SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276 (298)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGG------GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHHhcCCCchhhccccc------cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC
Confidence 7777777766543211110000 00000000011111110 01112233356788899999999996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=350.31 Aligned_cols=264 Identities=27% Similarity=0.463 Sum_probs=201.0
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCCCeeeeeeeeecc----CCCCceeEE
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----HSKTPSLIF 108 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----~~~~~~lv~ 108 (332)
+|+.+++||+|+||+||+|++..+++.||+|+++.. .....+|+.+++++ +|+||++++++|... +..++++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECcc-chHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 699999999999999999999999999999999643 23446899999999 999999999998542 334578999
Q ss_pred eeecCCCceeec------cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 109 EHVNSTDFKVLY------PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 109 e~~~~~~l~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
||++++++..+. ..+++..++.++.|++. ||+|||++||+||||||+
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~---------------------------aL~yLH~~~IiHrDiKp~ 151 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR---------------------------SLAYIHSFGICHRDIKPQ 151 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH---------------------------HHHHHHTTTEECCCCCGG
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHH---------------------------HHHHHHhcCCcccCCCcc
Confidence 999887544432 24677777777777666 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|||++.++..+||+|||+++............||..|+|||.+.+...++.++|||||||++|||++|..|| ...+..+
T Consensus 152 NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~ 230 (350)
T d1q5ka_ 152 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVD 230 (350)
T ss_dssp GEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHH
T ss_pred eEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHH
Confidence 999997766799999999998876666677789999999999887677999999999999999999999998 4666677
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+.+..+++....+........... ..+. .+|.... .....+...+|+..||++||++||+
T Consensus 231 ~l~~i~~~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~--~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 231 QLVEIIKVLGTPTREQIREMNPNYTEFK----FPQIKAHPWTKVF--RPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCC---CCC----CCCCCCCCGGGTS--CTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHhCCChHHhhhhhccchhhcc----ccccccCchhhhc--ccCCCHHHHHHHHHHccCChhHCcC
Confidence 8888888877765443332211000000 0000 1111110 1112233346788899999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=341.06 Aligned_cols=235 Identities=18% Similarity=0.315 Sum_probs=175.5
Q ss_pred CCceEE-EeecccCCceEEEEEEc--cCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCC
Q 040656 32 EDYEVV-RKVGRGKYSEVFEGINV--TNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKT 103 (332)
Q Consensus 32 ~~y~~~-~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 103 (332)
+.+.+. ++||+|+||.||+|.+. .+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~ 81 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ES 81 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SS
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CC
Confidence 344444 36999999999999764 34578999998632 235789999999999 99999999999854 34
Q ss_pred ceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 104 PSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
.++||||+++|+|..++ ..+++..+..++. |++.||+|||+++|+|||||
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~---------------------------qi~~gl~ylH~~~iiHrDlK 134 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH---------------------------QVSMGMKYLEESNFVHRDLA 134 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHH---------------------------HHHHHHHHHHHTTEECSCCS
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHH---------------------------HHHHHHhhHHhCCcccCCCc
Confidence 78999999999987765 2355555544444 55559999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|+|||++.++ .+||+|||+++........ ....||..|+|||++.+ ..++.++|||||||++|||+| |..||
T Consensus 135 p~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf- 211 (277)
T d1xbba_ 135 ARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY- 211 (277)
T ss_dssp GGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSS-
T ss_pred chhhcccccC-cccccchhhhhhccccccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCC-
Confidence 9999999666 8999999999876543322 23468899999999877 678999999999999999998 89998
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+....+.+.... ..+...++.+.+++ ..||+.||++||+
T Consensus 212 ~~~~~~~~~~~i~~~~~~--------~~p~~~~~~~~~li------------------------~~cl~~dp~~RPs 256 (277)
T d1xbba_ 212 RGMKGSEVTAMLEKGERM--------GCPAGCPREMYDLM------------------------NLCWTYDVENRPG 256 (277)
T ss_dssp TTCCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHH------------------------HHHTCSSTTTSCC
T ss_pred CCCCHHHHHHHHHcCCCC--------CCCcccCHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 344444444433321111 11123445555544 5599999999996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=340.39 Aligned_cols=237 Identities=19% Similarity=0.314 Sum_probs=180.3
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
+.++|++.+.||+|+||.||+|++. +++.||||+++.. ..+.+.+|+.+++++ +|+||+++++++.+ ...++|
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv 89 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 89 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEE
Confidence 4688999999999999999999875 4467999999743 346799999999999 99999999999843 347999
Q ss_pred EeeecCCCceeecc-----ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 108 FEHVNSTDFKVLYP-----TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 108 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
|||+++|++...+. .++...+.. ++.|++.||+|||++||+||||||+
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~---------------------------i~~~i~~gl~~LH~~~ivH~DlKp~ 142 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVD---------------------------MAAQIASGMAYVERMNYVHRDLRAA 142 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCchhhhhhhcccccchHHHHHH---------------------------HHHHHHHHHHHHhhhheecccccce
Confidence 99999998776542 245555444 4445555999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCC
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 260 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~ 260 (332)
|||++.++ .+||+|||+++...... ......+|..|+|||++.. ..++.++|||||||++|||++|..||......
T Consensus 143 NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~ 220 (285)
T d1fmka3 143 NILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220 (285)
T ss_dssp GEEECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred EEEECCCC-cEEEcccchhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH
Confidence 99999666 79999999998764332 2234578899999999977 67899999999999999999988888766666
Q ss_pred HHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 261 QDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.+..+......+ .....++++++++ .+||+.||++||+
T Consensus 221 ~~~~~~i~~~~~~~--------~~~~~~~~l~~li------------------------~~cl~~dP~~Rps 260 (285)
T d1fmka3 221 REVLDQVERGYRMP--------CPPECPESLHDLM------------------------CQCWRKEPEERPT 260 (285)
T ss_dssp HHHHHHHHTTCCCC--------CCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHHHhcCCCC--------CCcccCHHHHHHH------------------------HHHcccCHhHCcC
Confidence 55655554432221 1234455555555 4599999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=343.65 Aligned_cols=278 Identities=25% Similarity=0.467 Sum_probs=198.9
Q ss_pred ccccccccccCCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeee
Q 040656 18 YWDYESLTVQWGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKL 92 (332)
Q Consensus 18 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~ 92 (332)
||....-.+.|...++|++++.||+|+||+||+|++..+|+.||+|+++.. ..+.+.+|+.+|+++ +||||+++
T Consensus 4 ~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l 82 (346)
T d1cm8a_ 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGL 82 (346)
T ss_dssp BCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCC
T ss_pred cEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEE
Confidence 444444445566789999999999999999999999999999999998642 234688999999999 99999999
Q ss_pred eeeeeccC----CCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHH
Q 040656 93 LDIVRDQH----SKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQAL 166 (332)
Q Consensus 93 ~~~~~~~~----~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 166 (332)
+++|...+ ...+++||||++ .++..+. ..+++..++.++.|++. ||
T Consensus 83 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~~~~qi~~---------------------------aL 134 (346)
T d1cm8a_ 83 LDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLK---------------------------GL 134 (346)
T ss_dssp SEEECSCSSTTTCCCCEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HH
T ss_pred EEEeccCccccccceEEEEEeccc-ccHHHHHHhccccHHHHHHHHHHHHH---------------------------HH
Confidence 99996543 235799999994 4444433 45777777777777766 99
Q ss_pred HHHHHcCCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHH
Q 040656 167 DYCHSQGIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 246 (332)
Q Consensus 167 ~~LH~~~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~e 246 (332)
+|||++||+||||||+|||++.++ .+|++|||+|+... ...+...+|+.|+|||++.+...++.++|||||||++|+
T Consensus 135 ~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 211 (346)
T d1cm8a_ 135 RYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211 (346)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHH
T ss_pred HHHHhCCCcccccCcchhhccccc-ccccccccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHH
Confidence 999999999999999999999776 79999999998764 334567899999999999876678999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEE
Q 040656 247 MIFRKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICIT 324 (332)
Q Consensus 247 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~ 324 (332)
|++|..|| .+.+..+.+..+....+.+... +...............+... .+|... .....+...+|+..||.
T Consensus 212 ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~mL~ 286 (346)
T d1cm8a_ 212 MITGKTLF-KGSDHLDQLKEIMKVTGTPPAE-FVQRLQSDEAKNYMKGLPELEKKDFASI---LTNASPLAVNLLEKMLV 286 (346)
T ss_dssp HHHSSCSS-CCSSHHHHHHHHHHHHCCCCHH-HHHTCSCHHHHHHHHHSCCCCCCCGGGT---CTTCCHHHHHHHHHHSC
T ss_pred HHHCcCCC-CCCChHHHHHHHHhccCCCcHH-HHhhhcchhhhhhhccCCcccccchHHh---ccCCCHHHHHHHHHHCc
Confidence 99999998 4556667777777766654332 22222111111111111111 111111 01122233467888999
Q ss_pred eCCCCCCC
Q 040656 325 FSPSGFPF 332 (332)
Q Consensus 325 ~dP~~RP~ 332 (332)
+||++||+
T Consensus 287 ~dP~~R~t 294 (346)
T d1cm8a_ 287 LDAEQRVT 294 (346)
T ss_dssp SSTTTSCC
T ss_pred CChhHCcC
Confidence 99999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=338.24 Aligned_cols=237 Identities=23% Similarity=0.403 Sum_probs=173.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC---ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
++++|++++.||+|+||.||+|++..++ ..||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~ 80 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 80 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---C
Confidence 4689999999999999999999876544 46888888632 235689999999999 99999999999843 4
Q ss_pred CceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 103 TPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
.+++||||++++++..+. ..++...+..++. |+++||.|||+++|+|||
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~---------------------------qi~~gl~ylH~~~iiHrD 133 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY---------------------------QLSTALAYLESKRFVHRD 133 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHH---------------------------HHHHHHHHHHHTTCCCSC
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHH---------------------------HHHHHhhhhcccCeeccc
Confidence 689999999999877653 2345555544444 445599999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCCc--ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFF 255 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~ 255 (332)
|||+||+++.++ .+||+|||+|+....... .....+|..|+|||++.+ ..++.++|||||||++|||+| |..||
T Consensus 134 lKp~NIll~~~~-~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~- 210 (273)
T d1mp8a_ 134 IAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF- 210 (273)
T ss_dssp CSGGGEEEEETT-EEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-
T ss_pred cchhheeecCCC-cEEEccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-
Confidence 999999999666 799999999987653322 234467889999999977 679999999999999999998 77777
Q ss_pred CCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 256 YGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+....+....+......+ .....++.+.+++ ..||+.||++||+
T Consensus 211 ~~~~~~~~~~~i~~~~~~~--------~~~~~~~~~~~li------------------------~~cl~~dp~~Rps 255 (273)
T d1mp8a_ 211 QGVKNNDVIGRIENGERLP--------MPPNCPPTLYSLM------------------------TKCWAYDPSRRPR 255 (273)
T ss_dssp TTCCGGGHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCCCHHHHHHHHHcCCCCC--------CCCCCCHHHHHHH------------------------HHHcCCCHhHCcC
Confidence 4555556655554422111 1234555555555 5599999999996
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=340.52 Aligned_cols=195 Identities=27% Similarity=0.501 Sum_probs=162.4
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---------hHHHHHHHHHHHhcc-CCCCeeeeeeeeeccC
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQH 100 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~~ 100 (332)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ..++.+|+.+++++. .||||++++++|.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 367999999999999999999999999999999986421 234678999999994 38999999999954
Q ss_pred CCCceeEEeeecC-CCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 101 SKTPSLIFEHVNS-TDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 101 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
....++|||++.+ +++..+. ..+++..+..++.|++. ||+|||++||+|
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~---------------------------al~~lH~~~iiH 133 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE---------------------------AVRHCHNCGVLH 133 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEEC
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCcc
Confidence 4578999999976 3443332 35677777766666665 999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 255 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~ 255 (332)
|||||+|||++.+++.+||+|||+|+... ....+...||..|+|||++.+...++.++|||||||++|+|+||..||.
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCcccceEEecCCCeEEECccccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 99999999998776689999999998754 3344567899999999998774556788999999999999999999994
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-48 Score=343.32 Aligned_cols=266 Identities=18% Similarity=0.278 Sum_probs=188.8
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
.+++|++++.||+|+||.||+|+.. .+++.||||+++.. ..+++.+|+++++++ +||||+++++++.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~-- 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence 4678999999999999999999864 35578999998643 245689999999999 99999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....++++|+++++++..++.................................+...++.|++.||+|||+++|+|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 46789999999999988876432221111111100000000111111223444566788899999999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|+|||++.++ .+||+|||+|+...... ......+|..|+|||.+.+ ..++.++|||||||++|||++|..|++.+
T Consensus 168 p~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999999766 79999999997654322 2234578889999999987 67999999999999999999997655456
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+....+......+ .....++++..++ ..||+.||++||+
T Consensus 246 ~~~~e~~~~v~~~~~~~--------~p~~~~~~~~~li------------------------~~cl~~~P~~RPt 288 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILA--------CPENCPLELYNLM------------------------RLCWSKLPADRPS 288 (301)
T ss_dssp SCHHHHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCHHHHHHHHHcCCCCC--------CCccchHHHHHHH------------------------HHHcCCChhHCcC
Confidence 66555555544322111 1123445555544 5599999999996
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=341.17 Aligned_cols=237 Identities=17% Similarity=0.297 Sum_probs=176.6
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCc----eEEEEEecc----cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNE----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
..++|++++.||+|+||+||+|.+..+++ .||+|.++. ...+.+.+|+.+++++ +||||++++++|.+.
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS--
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--
Confidence 45789999999999999999999877776 588888753 2346799999999999 999999999999653
Q ss_pred CCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 102 KTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
..+++++++.++++.... ..+++..+.. ++.||++||+|||+++|+||
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~---------------------------i~~qi~~gl~yLH~~~iiHr 135 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN---------------------------WCVQIAKGMNYLEDRRLVHR 135 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHH---------------------------HHHHHHHHHHHHHHTTCCCS
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHH---------------------------HHHHHHHHHHHHHHcCcccC
Confidence 468889999988765543 2344444444 44555569999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcc---cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEP 253 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~p 253 (332)
||||+|||++.++ .+||+|||+|+........ ....||..|+|||++.+ ..++.++|||||||++|||+| |..|
T Consensus 136 DlKp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p 213 (317)
T d1xkka_ 136 DLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKP 213 (317)
T ss_dssp CCCGGGEEEEETT-EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cchhhcceeCCCC-CeEeeccccceecccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCC
Confidence 9999999999666 8999999999876543322 23467899999999887 679999999999999999999 6666
Q ss_pred CCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 254 FFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 254 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
| .+....+....+......+ .....++.+.+++ ..||+.||++||+
T Consensus 214 ~-~~~~~~~~~~~i~~~~~~~--------~p~~~~~~~~~li------------------------~~cl~~dP~~RPs 259 (317)
T d1xkka_ 214 Y-DGIPASEISSILEKGERLP--------QPPICTIDVYMIM------------------------VKCWMIDADSRPK 259 (317)
T ss_dssp T-TTSCGGGHHHHHHHTCCCC--------CCTTBCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred C-CCCCHHHHHHHHHcCCCCC--------CCcccCHHHHHHH------------------------HHhCCCChhhCcC
Confidence 6 4544444444444322111 1123455555555 5599999999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-47 Score=335.54 Aligned_cols=262 Identities=29% Similarity=0.537 Sum_probs=194.1
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++++.||+|+||+||+|++ .+++.||+|+++.. ..+.+.+|+.+++++ +||||++++++|.+ ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeeccc--CCceeE
Confidence 6899999999999999999987 47899999998642 236789999999999 99999999999954 467899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+++++.++++..+. +.+++..+..++.|++. ||+|||+.||+||||||+|
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~---------------------------~L~~LH~~~IvHrDiKp~N 130 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN---------------------------GIAYCHDRRVLHRDLKPQN 130 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCCGGG
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHH---------------------------HHHHhccCcEEecCCCCce
Confidence 99999988766653 45778877777777766 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.++ .+||+|||.+....... ......+++.|+|||.+.+...++.++|||||||++|||++|..|| .+.++.+
T Consensus 131 Ill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~ 208 (286)
T d1ob3a_ 131 LLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEAD 208 (286)
T ss_dssp EEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHH
T ss_pred eeEcCCC-CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHH
Confidence 9999776 79999999997654332 2344578899999999987677899999999999999999999999 4566677
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccC--CCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRK--RVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+....+.+....+.... .. +......... .+|.... ....+...+|+..||+.||++||+
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~s 274 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVT--EL-PKYDPNFTVYEPLPWESFL---KGLDESGIDLLSKMLKLDPNQRIT 274 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGG--GS-TTCCTTCCCCCCCCGGGTC---CSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhhCCCChhhccchh--hh-hhcccccccccCcchhhhc---ccCCHHHHHHHHHHccCChhHCcC
Confidence 777777776654332211100 00 0000000000 1111101 112223357899999999999996
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=335.75 Aligned_cols=260 Identities=17% Similarity=0.226 Sum_probs=177.2
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc-----CCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
++++|++++.||+|+||.||+|.+.. +++.||+|+++.. ....+.+|..++.++.+|+||+.+++++..+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 56889999999999999999998754 3468999998642 2356788889999887899999999987543
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHH-HHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIR-YYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
...++++|||+++|++..++......... ...... .........+...++.|+++||+|||+++|+||||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~---------~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDl 160 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED---------LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 160 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC--------------------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhh---------hhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcC
Confidence 35689999999999988875321100000 000000 00001122233456667777999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||+|||++.++ .+||+|||+|+....... .....||..|+|||++.+ ..++.++|||||||++|||+||..|++.
T Consensus 161 Kp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 161 AARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CGGGEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999666 799999999986643322 234578999999999987 6799999999999999999997654435
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+....+.+.......... ......++++.+++ ..||+.||++||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li------------------------~~cl~~dP~~Rpt 283 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRM-------RAPDYTTPEMYQTM------------------------LDCWHGEPSQRPT 283 (299)
T ss_dssp TCCCSHHHHHHHHHTCCC-------CCCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCCHHHHHHHHHhcCCCC-------CCCccCCHHHHHHH------------------------HHHcCCChhHCcC
Confidence 554444444333321111 11123455555555 5599999999996
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=343.14 Aligned_cols=265 Identities=25% Similarity=0.456 Sum_probs=198.8
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc----CCC
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----HSK 102 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----~~~ 102 (332)
++|+++++||+|+||+||+|++..+|+.||||+++.. ...++.+|+.+++++ +||||++++++|..+ ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 6899999999999999999999999999999999632 234688999999999 999999999999654 346
Q ss_pred CceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
++|++|||+.++++..+...+++..++.++.|++. ||.|||++||+||||||+
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~---------------------------gl~~LH~~giiHrDlKP~ 148 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC---------------------------GIKHLHSAGIIHRDLKPS 148 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCSCCCGG
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHH---------------------------HHHHhhhcccccccCCcc
Confidence 78999999999888888888888888888888876 999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|||++.++ .++++|||+++............+|+.|+|||++.+ ..++.++||||+||++++|++|..|| .+.+...
T Consensus 149 Nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~ 225 (355)
T d2b1pa1 149 NIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYID 225 (355)
T ss_dssp GEEECTTC-CEEECCCCC---------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHH
T ss_pred cccccccc-ceeeechhhhhccccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHH
Confidence 99999776 699999999987776666677789999999999987 68999999999999999999999998 5666777
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCC--------------CCCCcccccccccccccCceEEEeCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVW--------------PIPNNKKLQFCRSSRTSTNICITFSPS 328 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------------~~~~~~~~~~~~~~~~~~~~cl~~dP~ 328 (332)
....+....+.+.... +. ......+........+ ...............+|+..||.+||+
T Consensus 226 ~~~~i~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEF-MK----KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp HHHHHHHHHCCCCHHH-HT----TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHhccCCCHHH-HH----HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 7888887777654321 11 1233333333322111 111111222333446789999999999
Q ss_pred CCCC
Q 040656 329 GFPF 332 (332)
Q Consensus 329 ~RP~ 332 (332)
+||+
T Consensus 301 ~R~t 304 (355)
T d2b1pa1 301 KRIS 304 (355)
T ss_dssp TSCC
T ss_pred HCcC
Confidence 9996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=340.67 Aligned_cols=217 Identities=33% Similarity=0.537 Sum_probs=175.9
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc---
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--- 99 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 99 (332)
+.+.++|++++.||+|+||+||+|++..+|+.||||++... ....+.+|+.+|+++ +|+||+++++++...
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASP 84 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeeccccc
Confidence 34568999999999999999999999999999999998532 335688999999999 999999999988543
Q ss_pred ---CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcC
Q 040656 100 ---HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQG 173 (332)
Q Consensus 100 ---~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 173 (332)
.....+++||++.++++.... ..+++..++.++.|++. ||.|||++|
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~---------------------------~l~~lH~~~ 137 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---------------------------GLYYIHRNK 137 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTT
T ss_pred ccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHH---------------------------HHHHhccCC
Confidence 234689999999887765543 35666666666666665 999999999
Q ss_pred CeecCCCCCCeeecCCCCeEEEEecccceeecCCC-----cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHH
Q 040656 174 IMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 248 (332)
Q Consensus 174 ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ell 248 (332)
|+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+...++.++|||||||++|||+
T Consensus 138 ivHrDlKp~NILl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~ 216 (318)
T d3blha1 138 ILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216 (318)
T ss_dssp EECCCCCGGGEEECTTS-CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred EEecCcCchheeecCCC-cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence 99999999999999776 79999999997665322 2233578999999999987667999999999999999999
Q ss_pred hCCCCCCCCCCCHHHHHHHHHHhCCc
Q 040656 249 FRKEPFFYGHDNQDQLVKIARVLGTD 274 (332)
Q Consensus 249 tg~~pf~~~~~~~~~~~~~~~~~~~~ 274 (332)
+|..|| .+.++.+.+..+.+..++.
T Consensus 217 ~g~~pf-~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 217 TRSPIM-QGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp HSSCSC-CCSSHHHHHHHHHHHHCCC
T ss_pred hCCCCC-CCCCHHHHHHHHHHhcCCC
Confidence 999998 4566677777777776654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=332.83 Aligned_cols=240 Identities=18% Similarity=0.293 Sum_probs=174.7
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccC-C--ceEEEEEeccc------chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTN-N--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
+.+.++|++++.||+|+||.||+|..... + ..||||++++. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee
Confidence 45678899999999999999999986433 2 36899998632 235789999999999 99999999999954
Q ss_pred cCCCCceeEEeeecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGI 174 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 174 (332)
...++||||++++++.... ..++...+..++. |++.||.|||+++|
T Consensus 83 ---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~---------------------------qi~~gl~ylH~~~i 132 (273)
T d1u46a_ 83 ---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV---------------------------QVAEGMGYLESKRF 132 (273)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHH---------------------------HHHHHHHHHHHTTE
T ss_pred ---cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHH---------------------------HHHHHHHHhhhCCE
Confidence 3578999999998876653 2355555544444 55559999999999
Q ss_pred eecCCCCCCeeecCCCCeEEEEecccceeecCCCcc----cccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-
Q 040656 175 MHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF- 249 (332)
Q Consensus 175 vHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt- 249 (332)
+||||||+||+++.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||+|
T Consensus 133 iHrDikp~NIll~~~~-~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~ 210 (273)
T d1u46a_ 133 IHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTY 210 (273)
T ss_dssp ECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTT
T ss_pred eeeeecHHHhcccccc-ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhC
Confidence 9999999999999766 8999999999887544322 23357788999999987 678999999999999999998
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCC
Q 040656 250 RKEPFFYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSG 329 (332)
Q Consensus 250 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~ 329 (332)
|..|| .+.+..+....+.+....+. .....++.+++++ ..||+.||++
T Consensus 211 G~~Pf-~~~~~~~~~~~i~~~~~~~~-------~~~~~~~~l~~li------------------------~~cl~~dp~~ 258 (273)
T d1u46a_ 211 GQEPW-IGLNGSQILHKIDKEGERLP-------RPEDCPQDIYNVM------------------------VQCWAHKPED 258 (273)
T ss_dssp SCCTT-TTCCHHHHHHHHHTSCCCCC-------CCTTCCHHHHHHH------------------------HHHTCSSGGG
T ss_pred CCCCC-CCcCHHHHHHHHHhCCCCCC-------CcccccHHHHHHH------------------------HHHcCCChhH
Confidence 89998 45555555555443211110 1123445555554 5599999999
Q ss_pred CCC
Q 040656 330 FPF 332 (332)
Q Consensus 330 RP~ 332 (332)
||+
T Consensus 259 RPt 261 (273)
T d1u46a_ 259 RPT 261 (273)
T ss_dssp SCC
T ss_pred CcC
Confidence 996
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=335.09 Aligned_cols=269 Identities=26% Similarity=0.450 Sum_probs=193.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccCC--CC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQHS--KT 103 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--~~ 103 (332)
-.++|++++.||+|+||+||+|++..+++.||||++++.. .+.+.+|+.+|+++ +||||+++++++..... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence 3478999999999999999999999999999999996432 34688999999999 99999999999865422 23
Q ss_pred ceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCC
Q 040656 104 PSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKP 181 (332)
Q Consensus 104 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp 181 (332)
.+++++++.+++|..++ ..+++..++.++.|++. ||+|||++||+||||||
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~---------------------------al~yLH~~~iiHRDIKp 137 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR---------------------------GLKYIHSANVLHRDLKP 137 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCCG
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHH---------------------------HHHHHHHCCCcCCCCCc
Confidence 35566677788887765 46777777777777666 99999999999999999
Q ss_pred CCeeecCCCCeEEEEecccceeecCCCc----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 182 HNVMIDHEQQKLRLIDWGLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 182 ~Nilv~~~~~~vkL~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
+|||++.++ .+||+|||+++....... .....||+.|+|||++.....++.++||||+||++|+|++|..|| .+
T Consensus 138 ~NILl~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~ 215 (345)
T d1pmea_ 138 SNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PG 215 (345)
T ss_dssp GGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CC
T ss_pred ceEEECCCC-CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CC
Confidence 999999666 799999999987643322 344578999999999877677899999999999999999999999 45
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC--cccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN--NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+...........+...... .......+............. ...........+|+..||+.||++||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 288 (345)
T d1pmea_ 216 KHYLDQLNHILGILGSPSQEDLN----CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 288 (345)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHH----TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCHHHHHHHHhhhccCCChhhhh----hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC
Confidence 55666666666666554433211 111222222221110000000 000111222346788899999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=340.87 Aligned_cols=260 Identities=17% Similarity=0.204 Sum_probs=188.0
Q ss_pred CCCCCceEEEeecccCCceEEEEEEccCCce--EEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCC
Q 040656 29 GDQEDYEVVRKVGRGKYSEVFEGINVTNNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSK 102 (332)
Q Consensus 29 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 102 (332)
.+-++|++.+.||+|+||+||+|++..++.. ||||.++.. ..+.+.+|+++++++.+||||+++++++.+ ..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CC
Confidence 3458899999999999999999999888764 677776532 345689999999998679999999999965 35
Q ss_pred CceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCC
Q 040656 103 TPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPH 182 (332)
Q Consensus 103 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~ 182 (332)
.+++||||+++|++..++.............. .. ...........+.++.|++.||.|||+++|+||||||+
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~-~~-------~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~ 156 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI-AN-------STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHH-HT-------TBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhc-cc-------cccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccc
Confidence 78999999999999887643221111000000 00 00111233345677888888999999999999999999
Q ss_pred CeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 183 NVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 183 Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
|||++.++ .+||+|||+++............+|..|+|||.+.+ ..++.++|||||||++|||++|..|++.+.+..+
T Consensus 157 NIL~~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 157 NILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp GEEECGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred eEEEcCCC-ceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999776 799999999976554444455678999999999977 6789999999999999999998766545555555
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+......+ .....++++++++ ..||+.||++||+
T Consensus 235 ~~~~i~~~~~~~--------~~~~~~~~~~~li------------------------~~cl~~dP~~RPs 272 (309)
T d1fvra_ 235 LYEKLPQGYRLE--------KPLNCDDEVYDLM------------------------RQCWREKPYERPS 272 (309)
T ss_dssp HHHHGGGTCCCC--------CCTTBCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHhcCCCC--------CCccCCHHHHHHH------------------------HHHcCCChhHCcC
Confidence 444443321111 1123455555555 5599999999996
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=327.78 Aligned_cols=235 Identities=17% Similarity=0.328 Sum_probs=175.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCCceEEEEEecccc-hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.++|++++.||+|+||.||+|.. .+..||||++++.. .+.+.+|+++++++ +||||+++++++.+.. ..+++||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv~ 80 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVT 80 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-CcEEEEE
Confidence 467899999999999999999987 57889999997543 46799999999999 9999999999885432 4579999
Q ss_pred eeecCCCceeeccc-----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 109 EHVNSTDFKVLYPT-----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 109 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
||+++|++..++.. ++...+. .++.|++.||.|||+++|+||||||+|
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~---------------------------~i~~~i~~al~ylH~~~ivH~dlkp~N 133 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLL---------------------------KFSLDVCEAMEYLEGNNFVHRDLAARN 133 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHH---------------------------HHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHH---------------------------HHHHHHHhhccccccCceeccccchHh
Confidence 99999998877521 3444443 355556669999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf~~~~~~~~ 262 (332)
||++.++ .++|+|||+++.... ......+|..|+|||++.+ ..++.++|||||||++|||+| |..|| ......+
T Consensus 134 il~~~~~-~~kl~dfg~s~~~~~--~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~-~~~~~~~ 208 (262)
T d1byga_ 134 VLVSEDN-VAKVSDFGLTKEASS--TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKD 208 (262)
T ss_dssp EEECTTS-CEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC-TTSCGGG
T ss_pred heecCCC-CEeecccccceecCC--CCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCC-CCCCHHH
Confidence 9999776 799999999986542 2334467888999999877 679999999999999999998 56665 4555555
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+......+ .....++++++++ ..||+.||++||+
T Consensus 209 ~~~~i~~~~~~~--------~~~~~~~~~~~li------------------------~~cl~~dP~~Rps 246 (262)
T d1byga_ 209 VVPRVEKGYKMD--------APDGCPPAVYEVM------------------------KNCWHLDAAMRPS 246 (262)
T ss_dssp HHHHHTTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred HHHHHHcCCCCC--------CCccCCHHHHHHH------------------------HHHcccCHhHCcC
Confidence 554443321111 1123445555555 5599999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=332.06 Aligned_cols=261 Identities=29% Similarity=0.499 Sum_probs=198.6
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCcee
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSL 106 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~l 106 (332)
++|++++.||+|+||+||+|++..+++.||||+++.. ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccc--ccceeE
Confidence 6899999999999999999999999999999998632 236789999999999 99999999999955 456899
Q ss_pred EEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 107 IFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 107 v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
+++++.++++..+. +.+++..++.++.|++. ||+|||++||+||||||+|
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~---------------------------aL~~lH~~~IvHrDiKP~N 131 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK---------------------------GLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTEECCCCSGGG
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHH---------------------------HHHHhhcCCEeeecccCcc
Confidence 99999988876654 44666666666666665 9999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCC-cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQD 262 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~~~~~ 262 (332)
||++.++ .+||+|||.++...... ......++..|+|||.+.....++.++|||||||++|||++|..||+.+.+..+
T Consensus 132 Ili~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 210 (292)
T d1unla_ 132 LLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp EEECTTC-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred cccccCC-ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH
Confidence 9999766 79999999998876443 334446778899999988756689999999999999999999999988877777
Q ss_pred HHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhcc-CCCCCCCCc----ccccccccccccCceEEEeCCCCCCC
Q 040656 263 QLVKIARVLGTDELNAYLDKYHLELDPQLEALVGR-KRVWPIPNN----KKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~~~~~~~~~----~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+..+....+.+....+.... ..... ..+...... ..........+|+..||+.||++||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s 276 (292)
T d1unla_ 211 QLKRIFRLLGTPTEEQWPSMT---------KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGG---------GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHhhcCCCChhhhhhhh---------hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC
Confidence 887777766654322111100 00000 011110000 11112223347888999999999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=332.04 Aligned_cols=261 Identities=17% Similarity=0.222 Sum_probs=189.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEc-----cCCceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINV-----TNNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+.++|++.+.||+|+||.||+|++. .+++.||||+++.. ....+.+|+.++.++.+||||+++++++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 6789999999999999999999753 45678999999743 234688999999999779999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHH-HHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRY-YIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDV 179 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdl 179 (332)
....+++|||++++++..++.......... ....... .............++.||+.||+|||+++++||||
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~-------~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDL 171 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME-------DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccccccc-------ccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 456899999999999877753221111000 0000000 00011223344567778888999999999999999
Q ss_pred CCCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 180 KPHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 180 kp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
||+||+++.++ .++++|||.++....... .....+|+.|+|||++.+ ..++.++|||||||++|||+|+..|++.
T Consensus 172 Kp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 172 AARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp SGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999666 799999999987653322 234578999999999977 6789999999999999999997667666
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.....+.+.++......+. .....++.+.+++ ..||+.||++||+
T Consensus 250 ~~~~~~~~~~~i~~~~~~~-------~~~~~~~~l~~Li------------------------~~cl~~dP~~RPs 294 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRML-------SPEHAPAEMYDIM------------------------KTCWDADPLKRPT 294 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCC-------CCTTSCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCCHHHHHHHHHhcCCCCC-------CcccccHHHHHHH------------------------HHHcCCChhHCcC
Confidence 6666566555544221111 1123445555555 5599999999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=337.66 Aligned_cols=269 Identities=25% Similarity=0.478 Sum_probs=198.0
Q ss_pred CCCCCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-----chHHHHHHHHHHHhccCCCCeeeeeeeeecc---
Q 040656 28 WGDQEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--- 99 (332)
Q Consensus 28 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 99 (332)
|...++|++++.||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+.+++++ +||||+++++++...
T Consensus 14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSST
T ss_pred ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccc
Confidence 33468999999999999999999999999999999998642 234678999999999 999999999998543
Q ss_pred CCCCceeEEeeecCCCceeec--cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeec
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY--PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHR 177 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHr 177 (332)
.....+++++++.+++|..++ +.+++..++.++.|++. ||.|||++||+||
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~---------------------------aL~~LH~~giiHr 145 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------------------------GLKYIHSADIIHR 145 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCCC
T ss_pred ccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHH---------------------------HHHHHHhCCCccc
Confidence 223456778888898888775 45788888777777776 9999999999999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
||||+|||++.++ .++++|||.+.... .......||..|+|||...+...++.++|||||||++|+|++|..|| .+
T Consensus 146 DiKp~NILi~~~~-~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~ 221 (348)
T d2gfsa1 146 DLKPSNLAVNEDC-ELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PG 221 (348)
T ss_dssp CCCGGGEEECTTC-CEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CC
T ss_pred ccCCccccccccc-cccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CC
Confidence 9999999999776 79999999987543 33455678999999999877567899999999999999999999998 56
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCC--cccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPN--NKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.......+.+..+........ ..................... ...........+|+..||..||++||+
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 294 (348)
T d2gfsa1 222 TDHIDQLKLILRLVGTPGAELLK----KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294 (348)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHT----TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCHHHHHHHHHHhcCCCChHHhh----hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC
Confidence 66777777777776654332111 112222222222221111100 001112223346788899999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=330.03 Aligned_cols=258 Identities=17% Similarity=0.258 Sum_probs=177.1
Q ss_pred CCCCceEEEeecccCCceEEEEEEccCC-------ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeec
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVTNN-------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 98 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 98 (332)
+.++|++++.||+|+||.||+|+...++ ..||||+++.. ....+.+|+..+.++.+||||++++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 6789999999999999999999875554 37999998643 235688899999998789999999999954
Q ss_pred cCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecC
Q 040656 99 QHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRD 178 (332)
Q Consensus 99 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrd 178 (332)
....++||||+.+|++..++.......... ..... ..........+...++.|+++||+|||+++|+|||
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~-~~~~~-------~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEY-SYNPS-------HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCcccc-ccccc-------cCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence 467899999999999887752111000000 00000 00000012222345566666799999999999999
Q ss_pred CCCCCeeecCCCCeEEEEecccceeecCCC---cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHh-CCCCC
Q 040656 179 VKPHNVMIDHEQQKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPF 254 (332)
Q Consensus 179 lkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~ellt-g~~pf 254 (332)
|||+|||++.++ .+||+|||+++...... ......+|..|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 161 iKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 161 LAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp CSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 999999999776 79999999998765332 2334578889999999977 689999999999999999998 56666
Q ss_pred CCCCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 255 FYGHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
.+.........+......+ .....++.+.+ ++..||+.||++||+
T Consensus 239 -~~~~~~~~~~~i~~~~~~~--------~p~~~~~~l~~------------------------li~~cl~~dP~~Rps 283 (299)
T d1fgka_ 239 -PGVPVEELFKLLKEGHRMD--------KPSNCTNELYM------------------------MMRDCWHAVPSQRPT 283 (299)
T ss_dssp -TTCCHHHHHHHHHTTCCCC--------CCSSCCHHHHH------------------------HHHHHTCSSGGGSCC
T ss_pred -CCCCHHHHHHHHHcCCCCC--------CCccchHHHHH------------------------HHHHHccCCHhHCcC
Confidence 4444443333332211110 11233444444 456699999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=326.98 Aligned_cols=244 Identities=17% Similarity=0.293 Sum_probs=174.7
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCC-eeeeeeeeeccCCCCceeEEe
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN-IVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~~~~~lv~e 109 (332)
++|++.+.||+|+||+||+|++..+++.||||++... ....+..|+++++++ +|+| |+.+..++. +....++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l-~~~~~i~~~~~~~~--~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA--EGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHS-TTSTTCCCEEEEEE--ETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHc-cCCCcccEEEEEEe--cCCEEEEEEE
Confidence 5799999999999999999999999999999998643 345688999999999 5555 445555543 3356789999
Q ss_pred eecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCeee
Q 040656 110 HVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVMI 186 (332)
Q Consensus 110 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nilv 186 (332)
++.++....+. ..++...+..++.|++ .||+|||++||+||||||+|||+
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~---------------------------~~l~~lH~~~iiHrDiKp~NIl~ 136 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMI---------------------------SRIEYIHSKNFIHRDVKPDNFLM 136 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHH---------------------------HHHHHHHHTTEECSCCCGGGEEE
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHH---------------------------HHHHHHHHCCeeeccCCHhhccc
Confidence 99766544332 3456666555555555 49999999999999999999997
Q ss_pred cC--CCCeEEEEecccceeecCCCc--------ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 040656 187 DH--EQQKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 256 (332)
Q Consensus 187 ~~--~~~~vkL~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~ 256 (332)
+. .+..++|+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||+||..||..
T Consensus 137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp CCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccc
Confidence 53 233699999999987753322 234579999999999887 6799999999999999999999999943
Q ss_pred CCCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 257 GHDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
. ........+...... .............++++.+++ ..||+.||++||+
T Consensus 216 ~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~li------------------------~~cl~~~p~~RP~ 265 (299)
T d1ckia_ 216 L-KAATKRQKYERISEK-KMSTPIEVLCKGYPSEFATYL------------------------NFCRSLRFDDKPD 265 (299)
T ss_dssp C-C-------HHHHHHH-HHHSCHHHHTTTSCHHHHHHH------------------------HHHHHSCTTCCCC
T ss_pred c-chHHHHHHHHHhhcc-cCCCChhHhccCCCHHHHHHH------------------------HHHccCChhHCcC
Confidence 2 222222222211110 000011122235566666665 4499999999995
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=325.35 Aligned_cols=252 Identities=18% Similarity=0.301 Sum_probs=185.4
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc-----CCceEEEEEecccc----hHHHHHHHHHHHhccCCCCeeeeeeeeeccC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT-----NNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQH 100 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 100 (332)
+.++|++.+.||+|+||+||+|.+.. +++.||||+++... ...+.+|+.+++++ +||||+++++++..
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~-- 94 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 94 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--
Confidence 56899999999999999999998742 35789999997432 24588999999999 99999999999954
Q ss_pred CCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCC
Q 040656 101 SKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVK 180 (332)
Q Consensus 101 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlk 180 (332)
....++||||+++|++..++...... ... ..............++.++++||.|||+++|+|||||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~--------~~~------~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk 160 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPA--------MAN------NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLA 160 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHH--------HHH------CTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCS
T ss_pred CCceeEEEeecCCCCHHHHHHhcccc--------ccc------ccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEc
Confidence 45789999999999987664221000 000 0000001222234577778889999999999999999
Q ss_pred CCCeeecCCCCeEEEEecccceeecCCCc---ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 040656 181 PHNVMIDHEQQKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 257 (332)
Q Consensus 181 p~Nilv~~~~~~vkL~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~ 257 (332)
|+|||++.++ .+||+|||+++....... .....+|+.|+|||.+.+ ..++.++|||||||++|||+||..|++.+
T Consensus 161 ~~NiLld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 161 ARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp GGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CCceeecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 9999999666 799999999976543322 233468899999999887 67899999999999999999996555466
Q ss_pred CCCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 258 HDNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
....+.+..+.+....+ .....++.+.+++ ..||+.||++||+
T Consensus 239 ~~~~~~~~~i~~~~~~~--------~p~~~~~~l~~li------------------------~~cl~~~P~~RPs 281 (308)
T d1p4oa_ 239 LSNEQVLRFVMEGGLLD--------KPDNCPDMLFELM------------------------RMCWQYNPKMRPS 281 (308)
T ss_dssp SCHHHHHHHHHTTCCCC--------CCTTCCHHHHHHH------------------------HHHTCSSGGGSCC
T ss_pred CCHHHHHHHHHhCCCCC--------CcccchHHHHHHH------------------------HHHcCCChhHCcC
Confidence 66666655554322111 1123445555555 5599999999996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-45 Score=322.42 Aligned_cols=194 Identities=19% Similarity=0.368 Sum_probs=159.0
Q ss_pred CCCceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEEe
Q 040656 31 QEDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 109 (332)
Q Consensus 31 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~e 109 (332)
.++|++++.||+|+||+||+|++..+++.||+|+++.. ....+.+|+++++.+.+|+|++.+++++.. ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence 47899999999999999999999999999999998643 345688999999999777999999998843 467899999
Q ss_pred eecCCCceeec----cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCCee
Q 040656 110 HVNSTDFKVLY----PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHNVM 185 (332)
Q Consensus 110 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~Nil 185 (332)
++. +++..+. ..++......++.+++ .||+|||++||+||||||+|||
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~---------------------------~~l~~lH~~giiHrDiKp~Nil 133 (293)
T d1csna_ 82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQML---------------------------ARVQSIHEKSLVYRDIKPDNFL 133 (293)
T ss_dssp CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHH---------------------------HHHHHHHTTTEECCCCCGGGEE
T ss_pred ecC-CCHHHHHHhhccchhhHHHHHHHHHHH---------------------------HHHHHHHHCCceeccCCcccee
Confidence 985 4544443 2355555555555554 4999999999999999999999
Q ss_pred ecC----CCCeEEEEecccceeecCCC--------cccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q 040656 186 IDH----EQQKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 186 v~~----~~~~vkL~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~p 253 (332)
++. ..+.++|+|||+|+...... ......||+.|||||++.+ ..++.++|||||||++|||+||..|
T Consensus 134 i~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~P 212 (293)
T d1csna_ 134 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLP 212 (293)
T ss_dssp ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCc
Confidence 964 23479999999998764321 2234579999999999987 6799999999999999999999999
Q ss_pred CC
Q 040656 254 FF 255 (332)
Q Consensus 254 f~ 255 (332)
|.
T Consensus 213 f~ 214 (293)
T d1csna_ 213 WQ 214 (293)
T ss_dssp TS
T ss_pred CC
Confidence 95
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=327.52 Aligned_cols=197 Identities=23% Similarity=0.425 Sum_probs=162.4
Q ss_pred CCCCceEEEeecccCCceEEEEEE---ccCCceEEEEEeccc-------chHHHHHHHHHHHhccCCCCeeeeeeeeecc
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGIN---VTNNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 99 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 99 (332)
..++|++++.||+|+||+||+|++ ..+|+.||+|+++.. ..+.+.+|+.+++++.+||||+++++++.+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~- 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-
Confidence 458899999999999999999987 346889999998632 235688999999999666999999999954
Q ss_pred CCCCceeEEeeecCCCceeec---cccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCee
Q 040656 100 HSKTPSLIFEHVNSTDFKVLY---PTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMH 176 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivH 176 (332)
...+++++||+.++++...+ ..+++.....++.|++. ||+|+|+++|+|
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~---------------------------al~~lH~~~ivH 152 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL---------------------------ALEHLHKLGIIY 152 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTTCCC
T ss_pred -CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHH---------------------------HHHHhhcCCEEe
Confidence 45789999999999987765 34566666666666655 999999999999
Q ss_pred cCCCCCCeeecCCCCeEEEEecccceeecCCC--cccccccccceeccccccCCC-CCCCcccHHHHHHHHHHHHhCCCC
Q 040656 177 RDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEP 253 (332)
Q Consensus 177 rdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~sDiwSlG~il~elltg~~p 253 (332)
|||||+|||++.++ .++|+|||+++.+.... ......|++.|+|||.+.+.. .++.++|||||||++|+|++|..|
T Consensus 153 rDiKp~Nill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P 231 (322)
T d1vzoa_ 153 RDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231 (322)
T ss_dssp CCCCGGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCccceeecCCC-CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999776 79999999998764332 234567899999999987533 478899999999999999999999
Q ss_pred CCC
Q 040656 254 FFY 256 (332)
Q Consensus 254 f~~ 256 (332)
|..
T Consensus 232 F~~ 234 (322)
T d1vzoa_ 232 FTV 234 (322)
T ss_dssp TSC
T ss_pred CCC
Confidence 943
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=324.77 Aligned_cols=235 Identities=19% Similarity=0.286 Sum_probs=172.9
Q ss_pred eEEEeecccCCceEEEEEEccCC---ceEEEEEeccc----chHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeE
Q 040656 35 EVVRKVGRGKYSEVFEGINVTNN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLI 107 (332)
Q Consensus 35 ~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv 107 (332)
.+.++||+|+||+||+|++..++ ..||||.++.. ..+++.+|+++++++ +||||+++++++.+. ...+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEE
Confidence 33688999999999999876543 36899998632 336799999999999 999999999997543 3468999
Q ss_pred EeeecCCCceeeccc----cchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHcCCeecCCCCCC
Q 040656 108 FEHVNSTDFKVLYPT----LTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQGIMHRDVKPHN 183 (332)
Q Consensus 108 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ivHrdlkp~N 183 (332)
|||++++++..+... .+..... .++.|++.||.|||+.+|+||||||+|
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~---------------------------~i~~qia~gL~~lH~~~iiHrDLK~~N 160 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLI---------------------------GFGLQVAKGMKFLASKKFVHRDLAARN 160 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHH---------------------------HHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEeecCchhhhhccccccchHHHHH---------------------------HHHHHHHHhhhhhcccCcccCCccHHh
Confidence 999999998776532 2222222 355666679999999999999999999
Q ss_pred eeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 040656 184 VMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 258 (332)
Q Consensus 184 ilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~elltg~~pf~~~~ 258 (332)
||++.++ .+||+|||+++....... .....||..|+|||.+.+ ..++.++||||||+++|||+||..||....
T Consensus 161 ILl~~~~-~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 161 CMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp EEECTTC-CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred EeECCCC-CEEEecccchhhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 9999665 799999999987653322 223467889999999877 678999999999999999999988986555
Q ss_pred CCHHHHHHHHHHhCCchHHHHHHhcCCCCChhHHHHhccCCCCCCCCcccccccccccccCceEEEeCCCCCCC
Q 040656 259 DNQDQLVKIARVLGTDELNAYLDKYHLELDPQLEALVGRKRVWPIPNNKKLQFCRSSRTSTNICITFSPSGFPF 332 (332)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP~ 332 (332)
+..+....+....... .....++.+.++ +..||+.||++||+
T Consensus 239 ~~~~~~~~i~~g~~~~--------~p~~~~~~l~~l------------------------i~~cl~~dP~~RPs 280 (311)
T d1r0pa_ 239 NTFDITVYLLQGRRLL--------QPEYCPDPLYEV------------------------MLKCWHPKAEMRPS 280 (311)
T ss_dssp ----CHHHHHTTCCCC--------CCTTCCHHHHHH------------------------HHHHTCSSGGGSCC
T ss_pred CHHHHHHHHHcCCCCC--------CcccCcHHHHHH------------------------HHHHcCCCHhHCcC
Confidence 4444444433321111 112233444444 56699999999996
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=325.13 Aligned_cols=193 Identities=21% Similarity=0.290 Sum_probs=153.5
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccchHHHHHHHHHH--HhccCCCCeeeeeeeeeccCC--CCceeE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKIL--QNLCGGPNIVKLLDIVRDQHS--KTPSLI 107 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~~h~niv~~~~~~~~~~~--~~~~lv 107 (332)
++|.+.+.||+|+||.||+|+. +|+.||||+++......+..|.+++ .++ +||||+++++++.+++. ..+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence 5789999999999999999975 7899999999876666666666555 456 89999999999976543 357899
Q ss_pred EeeecCCCceeecc--ccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH--------cCCeec
Q 040656 108 FEHVNSTDFKVLYP--TLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS--------QGIMHR 177 (332)
Q Consensus 108 ~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--------~~ivHr 177 (332)
|||+++++|..++. .++..... .++.+++.||+|+|+ +||+||
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~---------------------------~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMI---------------------------KLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHH---------------------------HHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred EecccCCCHHHHHhcCCCCHHHHH---------------------------HHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 99999999887764 23333333 455566669999996 599999
Q ss_pred CCCCCCeeecCCCCeEEEEecccceeecCCCc-----ccccccccceeccccccCCC-----CCCCcccHHHHHHHHHHH
Q 040656 178 DVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 178 dlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~sDiwSlG~il~el 247 (332)
||||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+.. .++.++|||||||++|||
T Consensus 133 DlKp~NILl~~~~-~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el 211 (303)
T d1vjya_ 133 DLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCccceEEcCCC-CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence 9999999999666 799999999987754332 23457899999999986532 246789999999999999
Q ss_pred HhCCCCCC
Q 040656 248 IFRKEPFF 255 (332)
Q Consensus 248 ltg~~pf~ 255 (332)
+||..||.
T Consensus 212 ~tg~~~~~ 219 (303)
T d1vjya_ 212 ARRCSIGG 219 (303)
T ss_dssp HHTBCBTT
T ss_pred hhCCCCCC
Confidence 99998874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.3e-40 Score=297.74 Aligned_cols=212 Identities=27% Similarity=0.490 Sum_probs=161.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc--hHHHHHHHHHHHhcc----------CCCCeeeeeeeeecc
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGPNIVKLLDIVRDQ 99 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~~~~~~~~~ 99 (332)
++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+|+.+++.+. .|+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 56999999999999999999999999999999997543 356788999988873 258899999988665
Q ss_pred CCCCceeEEeeecCCCceee------ccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHH-c
Q 040656 100 HSKTPSLIFEHVNSTDFKVL------YPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHS-Q 172 (332)
Q Consensus 100 ~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~ 172 (332)
.....+++++++........ ...+++..++.++.+++. ||+|||+ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~---------------------------al~~lh~~~ 145 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL---------------------------GLDYMHRRC 145 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHH---------------------------HHHHHHHTT
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHH---------------------------HHHHHhhhc
Confidence 55556667776654432221 134555666666666655 9999998 8
Q ss_pred CCeecCCCCCCeeecCCCC-----eEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHHHHHH
Q 040656 173 GIMHRDVKPHNVMIDHEQQ-----KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 247 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~-----~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~il~el 247 (332)
||+||||||+|||++.++. .++++|||.+.... .......+|+.|+|||++.+ ..++.++||||+||++++|
T Consensus 146 ~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el 222 (362)
T d1q8ya_ 146 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFEL 222 (362)
T ss_dssp CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHH
T ss_pred CcccccCChhHeeeeccCcccccceeeEeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHH
Confidence 9999999999999975442 48999999997653 33455689999999999987 6789999999999999999
Q ss_pred HhCCCCCCCCCC-----CHHHHHHHHHHhCC
Q 040656 248 IFRKEPFFYGHD-----NQDQLVKIARVLGT 273 (332)
Q Consensus 248 ltg~~pf~~~~~-----~~~~~~~~~~~~~~ 273 (332)
++|..||..... ..+.+......++.
T Consensus 223 ~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~ 253 (362)
T d1q8ya_ 223 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253 (362)
T ss_dssp HHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred HHCCCCCCCCccccccchhHHHHHHHHHhCC
Confidence 999999953221 23344555555554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=7.3e-25 Score=180.05 Aligned_cols=166 Identities=17% Similarity=0.218 Sum_probs=115.3
Q ss_pred ceEEEeecccCCceEEEEEEccCCceEEEEEecccc---------------------hHHHHHHHHHHHhccCCCCeeee
Q 040656 34 YEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNIVKL 92 (332)
Q Consensus 34 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~~h~niv~~ 92 (332)
+.+.++||+|+||+||+|.+ .+|+.||||+++... ......|...+.++ .|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 56899999999999999987 578999999875210 12345688899999 88999888
Q ss_pred eeeeeccCCCCceeEEeeecCCCceeeccccchhhHHHHHHHHHhhcCCcceeecCCCCcccchhhHHhHHHHHHHHHHc
Q 040656 93 LDIVRDQHSKTPSLIFEHVNSTDFKVLYPTLTANEIRYYIYELLKHAMPRKVIIMPGEGLMENQDISVWDLQALDYCHSQ 172 (332)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 172 (332)
+++. ..+++||++++..... ++......++.+++ +++.+||++
T Consensus 80 ~~~~------~~~lvme~~~~~~~~~----l~~~~~~~i~~ql~---------------------------~~l~~lH~~ 122 (191)
T d1zara2 80 YAWE------GNAVLMELIDAKELYR----VRVENPDEVLDMIL---------------------------EEVAKFYHR 122 (191)
T ss_dssp EEEE------TTEEEEECCCCEEGGG----CCCSCHHHHHHHHH---------------------------HHHHHHHHT
T ss_pred EEec------CCEEEEEeeccccccc----hhhHHHHHHHHHHH---------------------------HHHHHHhhC
Confidence 7653 2389999999865443 33444444555554 499999999
Q ss_pred CCeecCCCCCCeeecCCCCeEEEEecccceeecCCCcccccccccceeccccccCCCCCCCcccHHHHHHH
Q 040656 173 GIMHRDVKPHNVMIDHEQQKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 243 (332)
Q Consensus 173 ~ivHrdlkp~Nilv~~~~~~vkL~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~sDiwSlG~i 243 (332)
||+||||||+|||++. + .++|+|||.|................. .-.+... ..|+.++|+||+.--
T Consensus 123 giiHrDiKP~NILv~~-~-~~~liDFG~a~~~~~~~~~~~l~rd~~-~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 123 GIVHGDLSQYNVLVSE-E-GIWIIDFPQSVEVGEEGWREILERDVR-NIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp TEECSCCSTTSEEEET-T-EEEECCCTTCEETTSTTHHHHHHHHHH-HHHHHHH--HHHCCCCCHHHHHHH
T ss_pred CEEEccCChhheeeeC-C-CEEEEECCCcccCCCCCcHHHHHHHHH-HHHHHHc--CCCCCcccHHHHHHH
Confidence 9999999999999984 4 489999999976543222111000000 0001111 357899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=3.8e-06 Score=69.99 Aligned_cols=84 Identities=18% Similarity=0.234 Sum_probs=59.3
Q ss_pred CCceEEEeecccCCceEEEEEEccCCceEEEEEecccc---hHHHHHHHHHHHhccCCCCeeeeeeeeeccCCCCceeEE
Q 040656 32 EDYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIF 108 (332)
Q Consensus 32 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~~lv~ 108 (332)
+.|++.+..+-++.+.||+.. .+++.+++|...... ...+.+|...+..+..+--+.+++.+..+ ....++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEE
Confidence 567777776656667899874 466778888875432 34578899999888555445667766643 35679999
Q ss_pred eeecCCCceee
Q 040656 109 EHVNSTDFKVL 119 (332)
Q Consensus 109 e~~~~~~l~~~ 119 (332)
++.+|..+...
T Consensus 90 ~~l~G~~~~~~ 100 (263)
T d1j7la_ 90 SEADGVLCSEE 100 (263)
T ss_dssp ECCSSEEHHHH
T ss_pred Eeccccccccc
Confidence 99998776543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.86 E-value=0.00012 Score=60.23 Aligned_cols=77 Identities=17% Similarity=0.123 Sum_probs=53.4
Q ss_pred eecccC-CceEEEEEEccCCceEEEEEecccchHHHHHHHHHHHhccCCC-CeeeeeeeeeccCCCCceeEEeeecCCCc
Q 040656 39 KVGRGK-YSEVFEGINVTNNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQHSKTPSLIFEHVNSTDF 116 (332)
Q Consensus 39 ~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~~~lv~e~~~~~~l 116 (332)
.+..|. .+.||+... .++..+++|.........+..|...++.+..+. .+.+++.+.. +....+++|++++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEeeecccc
Confidence 444454 468898763 567778899887666667889999998884432 2455666653 33567899999988765
Q ss_pred ee
Q 040656 117 KV 118 (332)
Q Consensus 117 ~~ 118 (332)
..
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00012 Score=64.57 Aligned_cols=75 Identities=15% Similarity=0.203 Sum_probs=48.9
Q ss_pred EEeecccCCceEEEEEEccCCceEEEEEecc----------cchHHHHHHHHHHHhccCC--CCeeeeeeeeeccCCCCc
Q 040656 37 VRKVGRGKYSEVFEGINVTNNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQHSKTP 104 (332)
Q Consensus 37 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~~ 104 (332)
.+.||.|....||++....+++.+++|.-.+ ....+...|.+.++.+..+ ..+.+++.+. + ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence 5568999999999998767788999997532 1224567788888877544 2344555543 2 245
Q ss_pred eeEEeeecCCC
Q 040656 105 SLIFEHVNSTD 115 (332)
Q Consensus 105 ~lv~e~~~~~~ 115 (332)
.++||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 78999997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.90 E-value=0.0031 Score=55.18 Aligned_cols=80 Identities=15% Similarity=0.130 Sum_probs=54.7
Q ss_pred CCCCceEEEeecccCCceEEEEEEcc-------CCceEEEEEecc-cchHHHHHHHHHHHhccCCCCeeeeeeeeeccCC
Q 040656 30 DQEDYEVVRKVGRGKYSEVFEGINVT-------NNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHS 101 (332)
Q Consensus 30 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 101 (332)
+.+.+++ +.|+.|-.-.+|++.... ..+.|++++... .......+|..+++.+..+.-..++++++.+
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 3455665 566768888999987543 235688888652 2334567899999998666555578888732
Q ss_pred CCceeEEeeecCCCc
Q 040656 102 KTPSLIFEHVNSTDF 116 (332)
Q Consensus 102 ~~~~lv~e~~~~~~l 116 (332)
.+|+++++|..+
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 789999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.58 E-value=0.0048 Score=52.40 Aligned_cols=72 Identities=14% Similarity=0.243 Sum_probs=44.7
Q ss_pred CceEEEEEEccCCceEEEEEeccc--chHHHHHHHHHHHhccCCC-Ceeeeeee---eeccCCCCceeEEeeecCCCce
Q 040656 45 YSEVFEGINVTNNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLDI---VRDQHSKTPSLIFEHVNSTDFK 117 (332)
Q Consensus 45 ~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~~~~~---~~~~~~~~~~lv~e~~~~~~l~ 117 (332)
.-.||++.. .+|+.+++|+.++. ..+.+..|...+..|..+. .++..... -........+.++++..|..+.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 358999864 67889999998754 4577888999888884321 11111111 0012234567788888876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.89 E-value=0.02 Score=47.90 Aligned_cols=51 Identities=12% Similarity=0.200 Sum_probs=31.9
Q ss_pred CceEEEeecccCCceEEEEEEccCCceEEEEEeccc-chHHHHHHHHHHHhccC
Q 040656 33 DYEVVRKVGRGKYSEVFEGINVTNNEKCIIKILKPV-KKKKIKREIKILQNLCG 85 (332)
Q Consensus 33 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~ 85 (332)
...-.+.|..|---+.|+... ++..+++|++... ....+..|+.++..+.+
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHHH
T ss_pred CceEeecCCCCcccCeEEEEE--CCCcEEEEEcCCCCCHHHHHHHHHHHHhhhh
Confidence 344456666777778898753 3445899998653 44567778888888743
|